data_2k20_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k20 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 121.046 0.451 . . . . 0.0 111.6 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -79.02 149.93 32.06 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.238 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.09 109.71 6.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.057 0.456 . . . . 0.0 111.649 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 85.1 m -99.52 120.81 40.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.715 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.435 ' O ' ' N ' ' A' ' 103' ' ' LEU . 28.8 m-85 -134.61 153.87 51.76 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.435 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.2 OUTLIER -110.91 111.95 23.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.901 178.86 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.433 ' CG2' ' CD1' ' A' ' 103' ' ' LEU . 17.6 t -101.32 112.4 65.01 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -177.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.431 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 94.9 Cg_endo -83.5 127.5 4.43 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.591 2.194 . . . . 0.0 110.847 178.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.477 ' HA ' ' HB1' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -122.41 28.5 7.38 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -178.778 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -39.02 -32.15 0.08 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.089 0.471 . . . . 0.0 111.17 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -109.44 -34.81 6.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.255 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.413 ' HB3' ' CB ' ' A' ' 18' ' ' LEU . 39.9 t -71.97 -5.71 36.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.236 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 18' ' ' LEU . . . -43.99 -30.18 1.68 Allowed Glycine 0 C--N 1.338 0.649 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.531 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.0 t -82.72 -38.52 23.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.915 0.388 . . . . 0.0 110.314 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -82.51 -1.74 51.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.395 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.1 -48.5 3.65 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.705 -0.759 . . . . 0.0 111.794 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.458 ' O ' ' N ' ' A' ' 54' ' ' ALA . 8.1 tp -179.72 -32.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.585 0.231 . . . . 0.0 110.55 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.444 ' HA3' ' HA3' ' A' ' 53' ' ' GLY . . . 106.9 46.45 1.1 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.457 -0.877 . . . . 0.0 113.453 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.434 ' CG1' ' CB ' ' A' ' 55' ' ' ALA . 30.1 m -157.85 154.12 5.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.037 0.446 . . . . 0.0 111.831 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.07 121.72 45.74 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.2 m -106.04 148.02 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -155.48 129.15 8.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.071 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 44' ' ' ILE . . . -107.88 166.53 13.14 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.864 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -113.2 -178.61 3.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.954 0.407 . . . . 0.0 110.93 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.04 135.82 24.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.242 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.6 m -48.35 143.58 4.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.823 0.345 . . . . 0.0 110.896 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.37 -49.16 67.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.532 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -95.33 -50.02 5.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.384 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 36.8 m-20 -66.04 -23.87 66.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.35 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 58.04 21.47 7.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.807 0.337 . . . . 0.0 110.964 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -94.18 135.52 35.47 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.871 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -46.57 132.05 10.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.536 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 38.7 mt -100.79 17.98 20.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.041 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.83 177.67 46.49 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.616 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.443 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -105.78 152.49 7.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.918 0.389 . . . . 0.0 111.202 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.444 ' CE1' ' NE2' ' A' ' 66' ' ' GLN . 2.2 m-85 -135.39 138.21 43.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.708 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.45 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 31.1 t -54.94 104.46 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.345 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.8 tptt -73.74 -42.71 60.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.757 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.5 t -168.95 119.16 0.72 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.182 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.409 ' CG1' HG12 ' A' ' 46' ' ' VAL . 80.8 mt -85.3 121.97 37.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.244 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.453 ' O ' ' N ' ' A' ' 52' ' ' GLY . 1.9 mp -59.52 107.17 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.371 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -61.17 78.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.887 0.375 . . . . 0.0 110.776 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 155.97 -28.68 0.59 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.194 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.444 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -67.19 -171.59 5.11 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.853 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.477 ' HB1' ' HA ' ' A' ' 18' ' ' LEU . . . -63.09 -40.72 98.5 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.434 ' CB ' ' CG1' ' A' ' 28' ' ' VAL . . . -64.91 -44.86 88.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.813 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.09 -28.48 66.53 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.592 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.4 mtpt -79.55 -28.23 41.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.061 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.2 -29.94 67.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.603 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.17 14.04 76.53 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.944 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -130.4 1.41 4.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.915 0.357 . . . . 0.0 111.34 179.866 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.38 128.43 50.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.882 0.372 . . . . 0.0 111.241 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.409 ' HA ' HD11 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -138.14 141.88 40.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.753 179.362 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.455 ' O ' ' CB ' ' A' ' 64' ' ' ASN . 39.0 t -55.91 146.15 5.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.213 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 18.0 m-20 87.27 13.56 0.11 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.378 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -93.4 120.6 33.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.721 0.296 . . . . 0.0 110.39 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.444 ' NE2' ' CE1' ' A' ' 45' ' ' PHE . 0.8 OUTLIER -78.2 135.05 37.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.763 -179.8 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.437 ' HB2' HG12 ' A' ' 44' ' ' ILE . 80.0 mt -85.25 140.9 30.5 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.841 0.353 . . . . 0.0 110.799 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 24.0 mt -123.17 -40.27 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.219 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.18 138.43 15.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.355 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.3 p -127.74 125.58 65.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.78 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 61.21 27.0 16.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.724 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.53 25.32 56.96 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.002 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -130.4 104.38 7.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.692 0.282 . . . . 0.0 110.779 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.8 t -58.54 155.56 12.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.013 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.451 ' HB3' ' CB ' ' A' ' 83' ' ' ALA . 1.0 OUTLIER -118.32 -9.55 10.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.697 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 30.0 mt -57.01 -20.66 25.4 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.666 0.27 . . . . 0.0 111.408 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -92.75 27.41 11.01 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.788 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -160.71 162.78 32.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.288 0.566 . . . . 0.0 111.189 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.12 164.03 16.38 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.391 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.404 ' O ' ' HG2' ' A' ' 84' ' ' MET . 20.3 m-80 -56.0 -57.51 11.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.812 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -54.76 -38.61 67.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.955 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.38 -36.16 73.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.007 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.451 ' CB ' ' HB3' ' A' ' 75' ' ' LEU . . . -69.17 -51.07 41.82 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.783 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.421 ' HA ' ' CD2' ' A' ' 87' ' ' LEU . 6.6 ptp -60.39 -29.04 68.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.801 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.39 -31.9 42.91 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.1 m -70.13 -35.79 74.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.291 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.421 ' CD2' ' HA ' ' A' ' 84' ' ' MET . 4.2 pp -78.0 -34.26 50.89 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.42 ' HG3' ' CG1' ' B' ' 13' ' ' VAL . 0.0 OUTLIER -57.26 -50.45 72.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.339 178.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.435 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.33 -38.06 68.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.171 179.697 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 63.7 m -67.4 -29.1 68.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.929 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.437 ' HB2' HG21 ' A' ' 101' ' ' ILE . 2.6 ptp -88.25 -28.23 21.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.678 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -110.77 26.58 10.54 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.476 ' O ' ' HG3' ' A' ' 97' ' ' LYS . 0.4 OUTLIER -156.06 -33.04 0.09 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.412 ' HG3' HG21 ' A' ' 93' ' ' THR . 7.6 mt-10 -115.56 -36.68 4.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.822 0.344 . . . . 0.0 111.138 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.465 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -80.44 -32.09 35.44 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.884 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.404 ' O ' ' ND2' ' A' ' 96' ' ' ASN . 0.9 OUTLIER -76.73 -34.33 58.11 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 179.543 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.476 ' HG3' ' O ' ' A' ' 93' ' ' THR . 48.4 mtpt -42.12 -32.49 0.47 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.473 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.97 -25.03 12.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.875 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 121.58 -7.63 10.34 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.789 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.435 ' SD ' ' HB3' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -157.02 144.66 19.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.89 0.376 . . . . 0.0 110.914 -179.895 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.465 ' HB ' ' HA3' ' A' ' 95' ' ' GLY . 0.1 OUTLIER -108.3 143.69 18.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.412 -179.71 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -76.94 142.18 40.17 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -137.59 145.88 43.34 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.115 0.483 . . . . 0.0 112.115 -178.757 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 22.8 mt -139.1 112.77 6.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.468 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 66' ' ' GLN . 27.4 m -132.15 150.14 33.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.855 0.36 . . . . 0.0 111.578 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -114.77 129.27 56.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.686 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.888 -179.486 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.454 -0.231 0 CA-C-O 120.929 0.395 . . . . 0.0 111.203 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 66.1 m -138.3 115.91 11.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.732 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -69.94 115.23 8.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.836 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.42 ' CG1' ' HG3' ' A' ' 88' ' ' ARG . 15.3 m . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.298 -0.858 . . . . 0.0 111.121 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.696 0.284 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -88.01 146.18 25.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.604 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.404 ' N ' ' O ' ' A' ' 105' ' ' VAL . 0.0 OUTLIER -140.82 109.86 6.14 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.9 0.381 . . . . 0.0 111.333 -179.504 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.5 m -80.55 145.49 31.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.979 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.444 ' CD1' ' HG3' ' A' ' 60' ' ' ARG . 12.8 m-85 -140.28 171.41 14.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.368 0.604 . . . . 0.0 112.132 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -143.55 103.43 4.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.028 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.414 ' CG2' ' CD1' ' A' ' 103' ' ' LEU . 17.8 t -104.83 112.05 65.26 Favored Pre-proline 0 C--N 1.329 -0.302 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -177.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.456 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 93.7 Cg_endo -83.46 127.53 4.46 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.413 2.076 . . . . 0.0 110.798 178.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.51 ' HA ' ' HB3' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -120.85 27.96 8.2 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.848 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -40.93 -30.2 0.12 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.999 0.428 . . . . 0.0 110.744 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -114.87 -31.47 6.1 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.174 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 43.0 t -72.65 -7.55 50.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.139 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -45.27 -28.3 2.05 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.624 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.6 m -85.44 -34.86 21.58 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.942 0.401 . . . . 0.0 110.677 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.14 8.97 24.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.526 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.62 -56.23 5.02 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.932 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.49 ' O ' ' N ' ' A' ' 54' ' ' ALA . 9.7 tp -178.8 -27.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.518 0.199 . . . . 0.0 111.155 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.46 ' HA3' ' HA3' ' A' ' 53' ' ' GLY . . . 109.75 35.54 2.2 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.31 -0.948 . . . . 0.0 113.536 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.485 HG12 ' HA ' ' A' ' 49' ' ' ILE . 13.0 m -158.95 157.75 3.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 117.08 0.44 . . . . 0.0 111.538 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.533 ' O ' ' N ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -114.15 134.94 54.55 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.711 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.65 143.56 32.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.119 0.485 . . . . 0.0 111.896 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.404 ' O ' ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -142.12 129.71 21.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.587 179.666 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -102.7 153.3 18.32 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.991 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -125.28 175.25 7.57 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.009 0.433 . . . . 0.0 111.252 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.5 mtt85 -122.57 157.42 32.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.736 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.5 m -51.28 155.86 1.3 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.269 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.05 -39.59 86.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.111 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.58 -78.68 0.18 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.958 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -81.64 -175.77 5.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.834 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -98.32 29.91 3.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.942 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.24 115.84 14.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.098 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.41 ' CB ' ' ND2' ' A' ' 80' ' ' ASN . 1.2 p30 -59.08 119.62 7.63 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.951 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 17.4 mt -75.58 -26.42 57.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.872 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.445 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 133.21 -176.69 19.45 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.121 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.472 HG12 ' HB2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -107.32 134.53 48.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.876 0.369 . . . . 0.0 111.262 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.464 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -117.55 144.08 45.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.565 -179.79 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.49 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 21.3 t -54.54 106.36 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.124 0.488 . . . . 0.0 110.941 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 29' ' ' SER . 0.5 OUTLIER -65.99 -52.58 48.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.638 179.86 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.6 t -169.41 133.86 1.4 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.388 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.485 ' HA ' HG12 ' A' ' 28' ' ' VAL . 65.8 mt -95.06 116.55 36.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.083 0.468 . . . . 0.0 111.826 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.425 ' N ' ' O ' ' A' ' 27' ' ' GLY . 2.3 mp -58.09 115.9 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.199 178.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -68.23 69.86 0.15 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.068 0.461 . . . . 0.0 110.69 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 168.21 -29.62 0.16 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.375 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.46 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -68.02 -172.33 6.6 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.907 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.51 ' HB3' ' HA ' ' A' ' 18' ' ' LEU . . . -62.98 -40.87 99.03 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.468 ' CB ' HG11 ' A' ' 28' ' ' VAL . . . -64.69 -48.06 76.09 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.936 0.398 . . . . 0.0 111.561 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.3 t -63.35 -30.66 71.75 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.216 0.531 . . . . 0.0 110.09 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 39.5 mtpt -76.68 -28.85 56.09 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.055 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.72 -29.26 64.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.882 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 68.05 16.51 68.71 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.202 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.444 ' HG3' ' CD1' ' A' ' 14' ' ' PHE . 0.8 OUTLIER -138.47 11.57 2.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.908 0.354 . . . . 0.0 111.274 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.414 ' HB3' ' CD1' ' A' ' 49' ' ' ILE . 0.1 OUTLIER -106.68 134.92 49.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.689 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.12 144.57 38.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.85 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.49 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 46.2 t -61.89 148.69 9.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.085 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.462 ' N ' HG11 ' A' ' 63' ' ' VAL . 23.7 m-20 88.11 -10.46 0.51 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.431 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.5 115.05 5.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.769 0.318 . . . . 0.0 110.626 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.48 ' O ' ' HA ' ' A' ' 105' ' ' VAL . 18.3 tm0? -69.16 135.86 51.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.699 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.472 ' HB2' HG12 ' A' ' 44' ' ' ILE . 93.2 mt -87.75 139.85 30.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.849 0.357 . . . . 0.0 111.148 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.464 HD12 ' CB ' ' A' ' 106' ' ' ALA . 2.4 mt -122.28 -44.36 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.888 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.83 145.57 28.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.702 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.1 p -132.68 130.0 58.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.313 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.415 ' ND2' ' O ' ' A' ' 90' ' ' SER . 23.7 m-80 61.2 26.95 16.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.819 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.97 23.69 59.05 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.389 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -131.89 108.7 9.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.804 0.335 . . . . 0.0 110.864 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.0 t -59.21 154.67 15.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.711 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.487 ' HB3' ' CB ' ' A' ' 83' ' ' ALA . 0.7 OUTLIER -115.8 -15.59 11.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.582 -179.723 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -46.66 -44.13 18.25 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.942 0.401 . . . . 0.0 111.173 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -57.51 -35.47 72.86 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.574 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.4 ptpm? -101.31 168.12 9.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.286 0.565 . . . . 0.0 111.297 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.34 174.73 6.12 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.542 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.421 ' OD1' ' N ' ' A' ' 81' ' ' GLN . 8.1 p30 -67.0 -52.26 44.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.581 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.421 ' N ' ' OD1' ' A' ' 80' ' ' ASN . 5.1 pm0 -58.12 -41.26 83.24 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.931 0.396 . . . . 0.0 110.483 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -70.45 -37.85 74.38 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.487 ' CB ' ' HB3' ' A' ' 75' ' ' LEU . . . -66.77 -33.49 75.73 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.229 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.465 ' O ' ' HB2' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -72.54 -32.32 66.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.981 179.236 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -78.48 -35.38 46.62 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.38 178.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.435 ' HA ' ' HD2' ' A' ' 89' ' ' ARG . 1.5 m -67.28 -35.72 80.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.311 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.43 ' CD2' ' HA ' ' A' ' 84' ' ' MET . 4.4 pp -78.31 -33.71 49.18 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -63.24 -50.84 68.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.788 179.312 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.435 ' HD2' ' HA ' ' A' ' 86' ' ' THR . 0.0 OUTLIER -73.03 -34.62 66.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.065 179.771 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.415 ' O ' ' ND2' ' A' ' 71' ' ' ASN . 55.9 m -72.19 -31.64 66.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.77 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.427 ' HE2' ' CD2' ' A' ' 26' ' ' LEU . 3.8 ptm -88.08 -18.72 28.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.614 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.01 18.14 14.73 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.435 HG22 ' HG3' ' A' ' 94' ' ' GLU . 0.4 OUTLIER -153.28 -37.99 0.1 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.898 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.496 ' HA ' ' CG ' ' A' ' 97' ' ' LYS . 8.6 mt-10 -104.15 -42.01 5.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.003 0.43 . . . . 0.0 111.742 -178.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.413 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -68.44 -37.94 86.25 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.806 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.422 ' O ' ' C ' ' A' ' 97' ' ' LYS . 1.1 t-20 -67.13 -33.76 76.14 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.496 ' CG ' ' HA ' ' A' ' 94' ' ' GLU . 4.2 mmmt -31.42 -51.8 0.2 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.464 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.95 -27.48 16.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.757 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 122.8 1.11 9.84 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.813 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.456 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -161.77 142.55 10.76 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 121.038 0.447 . . . . 0.0 111.371 -179.743 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.413 ' HB ' ' HA3' ' A' ' 95' ' ' GLY . 0.1 OUTLIER -114.81 138.64 44.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.853 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -76.54 149.91 36.63 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.414 ' CD1' ' CG2' ' A' ' 16' ' ' VAL . 0.3 OUTLIER -140.99 111.16 6.67 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.778 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 45.6 mt -98.35 112.77 31.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 66' ' ' GLN . 18.1 m -124.28 152.42 30.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.454 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.464 ' CB ' HD12 ' A' ' 68' ' ' ILE . . . -124.95 148.11 48.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.113 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.98 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 4.2 mm . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 120.976 0.417 . . . . 0.0 111.333 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' THR . . . . . 0.41 ' CB ' ' HG2' ' A' ' 84' ' ' MET . 3.5 m -94.33 97.93 10.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.664 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -73.93 127.81 33.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.121 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 18.4 m . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.562 -0.732 . . . . 0.0 110.693 179.683 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.711 0.291 . . . . 0.0 111.069 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.55 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 2.4 p90 -112.36 148.34 34.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.645 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.466 HD13 ' CG2' ' A' ' 105' ' ' VAL . 0.1 OUTLIER -129.14 120.72 26.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.36 -178.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.0 m -83.15 145.43 29.21 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.336 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.437 ' CD1' ' HB3' ' A' ' 60' ' ' ARG . 63.8 m-85 -140.67 171.35 14.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.383 0.611 . . . . 0.0 112.219 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -140.13 106.99 5.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.214 -0.903 . . . . 0.0 108.902 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.417 ' CG2' ' CD1' ' A' ' 103' ' ' LEU . 17.3 t -105.61 117.75 57.2 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 -177.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.414 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 90.2 Cg_endo -86.69 128.18 2.84 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.764 2.309 . . . . 0.0 110.936 178.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.643 ' HA ' ' HB1' ' A' ' 54' ' ' ALA . 0.5 OUTLIER -122.77 28.63 7.19 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -178.717 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -40.91 -30.57 0.13 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.167 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -113.01 -32.53 6.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.14 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.432 ' HB3' ' CB ' ' A' ' 18' ' ' LEU . 41.7 t -70.74 -6.56 38.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.182 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.401 ' HA2' ' CD1' ' A' ' 18' ' ' LEU . . . -42.97 -30.03 0.95 Allowed Glycine 0 C--N 1.337 0.605 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.664 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.8 m -83.16 -40.37 19.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.885 0.374 . . . . 0.0 110.434 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.98 -5.79 56.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.266 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.92 -46.8 3.12 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.953 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.472 ' O ' ' N ' ' A' ' 54' ' ' ALA . 6.2 tp 178.79 -33.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.661 0.267 . . . . 0.0 110.677 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.477 ' HA2' HD13 ' A' ' 50' ' ' ILE . . . 102.96 49.86 1.12 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.442 -0.885 . . . . 0.0 113.565 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.47 HG13 ' CB ' ' A' ' 55' ' ' ALA . 34.2 m -158.41 154.81 4.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 117.053 0.426 . . . . 0.0 111.78 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.423 ' O ' ' HB3' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -112.24 111.12 21.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.343 178.606 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.3 m -106.93 141.93 20.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.09 0.471 . . . . 0.0 111.843 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.94 129.68 17.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.199 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -91.33 158.09 25.28 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.017 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -114.0 -178.76 3.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.9 0.381 . . . . 0.0 110.929 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 67.9 mtt180 -135.96 152.67 51.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.541 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.1 m -54.36 144.38 20.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.041 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.75 -33.39 75.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.981 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.14 -68.47 0.7 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.891 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -94.3 -173.41 3.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.85 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 65.2 m-70 -101.53 31.1 3.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.036 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.74 128.34 34.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.953 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.401 ' CB ' ' ND2' ' A' ' 80' ' ' ASN . 3.7 p-10 -57.18 149.0 20.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.137 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.7 mt -113.14 -1.0 14.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.323 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.452 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 113.7 169.83 17.07 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.313 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.422 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -102.82 131.23 51.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.709 0.29 . . . . 0.0 110.951 179.757 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.445 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -119.54 144.95 46.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.866 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.482 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 39.0 t -60.78 104.57 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.641 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.423 ' HB3' ' O ' ' A' ' 29' ' ' SER . 2.2 tptt -73.71 -42.26 61.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.569 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.48 119.64 1.05 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.113 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.479 ' CD1' ' HB3' ' A' ' 61' ' ' LEU . 68.0 mt -85.18 117.8 30.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.015 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.477 HD13 ' HA2' ' A' ' 27' ' ' GLY . 1.6 mp -55.72 106.6 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.462 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -64.64 74.2 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.014 0.435 . . . . 0.0 110.73 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 162.6 -26.4 0.23 Allowed Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.326 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.427 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -71.19 -163.46 5.41 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.85 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.643 ' HB1' ' HA ' ' A' ' 18' ' ' LEU . . . -71.28 -41.61 69.8 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.47 ' CB ' HG13 ' A' ' 28' ' ' VAL . . . -65.34 -43.4 91.02 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.317 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.2 m -67.5 -36.13 80.48 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.889 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -68.85 -33.95 74.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.597 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -60.24 -26.78 66.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.756 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 58.54 26.76 60.16 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.368 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.437 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 8.7 mtm180 -121.39 -28.52 4.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.63 0.252 . . . . 0.0 111.109 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.479 ' HB3' ' CD1' ' A' ' 49' ' ' ILE . 4.2 mp -75.91 151.1 37.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.136 0.493 . . . . 0.0 111.677 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.405 ' HD3' ' O ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -146.56 131.53 18.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.172 179.701 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.482 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 47.3 t -57.69 141.69 14.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.121 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.466 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 28.4 m-20 89.91 17.41 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.577 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -103.28 123.44 46.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.327 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.407 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -81.52 136.41 35.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.789 0.328 . . . . 0.0 110.793 -179.583 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.411 HD12 ' CD1' ' A' ' 87' ' ' LEU . 7.9 mt -87.51 131.21 34.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.569 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 34.5 mt -110.98 -33.97 2.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.614 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -153.34 157.47 40.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.132 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.4 p -142.25 126.42 15.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.387 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 66.1 m-80 60.68 18.87 8.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.74 0.305 . . . . 0.0 110.931 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.0 27.46 23.58 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.118 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -129.04 101.27 5.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.826 0.346 . . . . 0.0 110.828 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.0 t -65.33 148.5 51.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.05 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.428 ' CD2' ' CD2' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -130.61 14.43 5.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.234 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.5 tp -60.47 -22.5 63.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.725 0.297 . . . . 0.0 111.04 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -82.06 -27.21 46.01 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.662 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.6 ptpm? -96.05 171.31 8.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.174 0.512 . . . . 0.0 111.24 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.81 165.02 25.27 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.467 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.402 ' OD1' ' N ' ' A' ' 81' ' ' GLN . 8.4 p30 -57.0 -47.95 79.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.252 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.402 ' N ' ' OD1' ' A' ' 80' ' ' ASN . 2.1 pp0? -59.77 -43.86 94.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.907 0.384 . . . . 0.0 110.938 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -70.01 -32.57 70.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.853 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.405 ' CB ' ' CD1' ' A' ' 44' ' ' ILE . . . -69.16 -47.42 65.05 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.619 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 6.8 ptp -61.96 -31.64 71.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.101 0.477 . . . . 0.0 109.863 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.11 -34.75 66.34 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.409 ' O ' ' HB2' ' A' ' 90' ' ' SER . 2.1 m -62.97 -34.21 77.03 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.141 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.428 ' CD2' ' CD2' ' A' ' 75' ' ' LEU . 0.1 OUTLIER -76.24 -35.05 59.17 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.868 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.06 -51.84 68.03 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.772 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.416 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -71.57 -43.42 66.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.612 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.409 ' HB2' ' O ' ' A' ' 86' ' ' THR . 1.6 t -65.6 -29.55 70.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.174 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.414 ' O ' HD13 ' A' ' 18' ' ' LEU . 2.2 ptp -89.58 -19.88 24.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.629 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.21 27.56 8.75 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 -179.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.416 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.3 OUTLIER -162.19 -31.23 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.956 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.417 ' HA ' ' HG3' ' A' ' 97' ' ' LYS . 7.4 mt-10 -111.62 -72.49 0.71 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.788 0.328 . . . . 0.0 111.55 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.424 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -49.2 -29.67 9.89 Favored Glycine 0 CA--C 1.517 0.204 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.633 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.68 -34.59 64.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.856 0.36 . . . . 0.0 110.257 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.417 ' HG3' ' HA ' ' A' ' 94' ' ' GLU . 8.9 mtpp -40.01 -34.6 0.3 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.47 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.87 -25.05 12.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.705 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 122.64 -8.3 9.44 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.006 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.414 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -154.48 144.2 21.6 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.924 0.392 . . . . 0.0 111.53 -179.636 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.425 ' CG2' ' CD2' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -110.52 140.54 29.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.034 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.88 150.48 36.03 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.417 ' CD1' ' CG2' ' A' ' 16' ' ' VAL . 0.5 OUTLIER -143.54 111.03 5.86 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -178.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 36.5 mt -102.0 113.33 38.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.732 178.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.466 ' CG2' HD13 ' A' ' 12' ' ' LEU . 4.4 m -116.83 174.9 3.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.058 0.456 . . . . 0.0 111.664 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.55 ' HA ' ' HA ' ' A' ' 11' ' ' PHE . . . -147.38 137.02 22.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.998 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.388 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.709 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . 0.472 HD12 HG22 ' B' ' 10' ' ' ILE . 1.6 mm . . . . . 0 N--CA 1.452 -0.342 0 CA-C-O 120.991 0.424 . . . . 0.0 111.237 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 99.0 m -119.27 99.48 6.72 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.687 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 9.3 ttmt -72.66 122.63 21.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.001 0.429 . . . . 0.0 110.946 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.123 179.981 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.785 0.326 . . . . 0.0 111.373 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -83.85 149.91 26.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.539 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.72 109.83 7.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.97 0.414 . . . . 0.0 111.273 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 39.6 m -101.15 127.85 47.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.584 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.448 ' CZ ' ' HB3' ' A' ' 60' ' ' ARG . 29.5 m-85 -140.86 172.62 12.44 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.424 0.63 . . . . 0.0 112.327 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.468 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.4 OUTLIER -126.38 112.43 15.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.021 179.131 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.9 t -104.77 111.7 65.24 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -177.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 85.8 Cg_endo -83.3 127.64 4.6 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.431 2.087 . . . . 0.0 110.738 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.549 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 0.5 OUTLIER -121.54 27.99 7.95 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -178.893 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -39.86 -31.06 0.1 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.289 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -112.23 -32.04 6.66 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.163 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.4 ' HB3' ' CB ' ' A' ' 18' ' ' LEU . 12.6 t -70.51 -6.0 33.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.181 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -43.83 -29.85 1.48 Allowed Glycine 0 C--N 1.337 0.621 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.732 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.39 -36.09 22.68 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.971 0.415 . . . . 0.0 110.598 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.79 -6.71 59.49 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.377 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.25 -47.47 2.87 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.948 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.458 ' O ' ' N ' ' A' ' 54' ' ' ALA . 6.8 tp 178.47 -29.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.589 0.233 . . . . 0.0 110.824 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.47 ' HA3' ' HA3' ' A' ' 53' ' ' GLY . . . 104.58 42.67 1.82 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.501 -0.857 . . . . 0.0 113.3 179.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.456 HG13 ' CB ' ' A' ' 55' ' ' ALA . 33.1 m -157.15 158.5 3.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.206 0.527 . . . . 0.0 111.988 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -117.1 118.03 31.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.208 178.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.5 m -106.35 149.61 9.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.228 0.537 . . . . 0.0 112.379 -178.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.38 130.77 15.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.026 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' A' ' 44' ' ' ILE . . . -104.76 161.59 15.04 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.266 -0.969 . . . . 0.0 113.115 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 -130.67 170.93 13.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.968 0.413 . . . . 0.0 110.907 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.26 154.24 31.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.621 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -47.45 149.21 1.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.302 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.42 -47.97 68.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.359 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -73.59 -50.07 23.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.328 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -121.14 168.36 11.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.746 0.308 . . . . 0.0 111.039 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -83.41 57.78 4.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.143 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -103.04 109.49 21.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.765 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.417 ' HB3' ' ND2' ' A' ' 80' ' ' ASN . 37.4 m-20 -45.91 119.29 2.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.722 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.8 mt -88.24 -1.3 57.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.009 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.403 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 106.91 -174.62 20.12 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.172 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.492 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -111.41 138.34 40.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.907 0.384 . . . . 0.0 111.284 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.71 141.5 49.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.629 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.43 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 38.6 t -54.7 107.2 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.841 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.2 tptt -77.21 -41.47 41.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.627 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.6 m -167.5 123.91 1.13 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.06 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.432 ' CD1' ' HB3' ' A' ' 61' ' ' LEU . 69.3 mt -90.92 124.26 43.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.359 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.422 ' O ' ' N ' ' A' ' 52' ' ' GLY . 2.1 mp -63.89 110.28 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.379 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.13 70.98 0.06 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.084 0.469 . . . . 0.0 110.892 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 166.98 -27.45 0.16 Allowed Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.111 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.47 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -70.04 -166.85 5.92 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.944 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.549 ' HB2' ' HA ' ' A' ' 18' ' ' LEU . . . -68.64 -41.09 79.89 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.456 ' CB ' HG13 ' A' ' 28' ' ' VAL . . . -66.65 -41.12 88.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.57 -179.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 t -70.07 -33.3 71.74 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.139 0.495 . . . . 0.0 110.116 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.3 mtpt -73.62 -29.05 62.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.076 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.78 -29.96 67.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.565 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 68.52 15.74 68.74 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.824 -0.703 . . . . 0.0 113.005 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.448 ' HB3' ' CZ ' ' A' ' 14' ' ' PHE . 0.5 OUTLIER -129.0 -0.72 5.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.764 0.282 . . . . 0.0 111.222 179.832 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.432 ' HB3' ' CD1' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -99.23 132.98 44.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.91 0.386 . . . . 0.0 111.18 -179.67 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.27 142.47 39.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.769 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.465 ' O ' ' CB ' ' A' ' 64' ' ' ASN . 55.0 t -56.41 147.04 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.175 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 29.9 m-20 89.76 -10.47 0.37 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.371 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -63.62 107.26 1.11 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.821 0.343 . . . . 0.0 110.729 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 21.4 tm0? -71.5 114.0 9.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.608 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.415 ' CD2' ' CG1' ' A' ' 105' ' ' VAL . 7.9 mt -68.07 142.7 55.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.958 0.408 . . . . 0.0 111.561 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 36.6 mt -129.18 -34.92 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.374 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.65 166.26 28.86 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.896 0.379 . . . . 0.0 111.288 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.3 p -155.19 118.85 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.903 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 56.72 43.82 24.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.556 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 70.93 23.54 77.94 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.722 -0.752 . . . . 0.0 111.966 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -122.55 97.37 5.43 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.778 0.323 . . . . 0.0 110.862 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.82 119.37 13.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.929 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.8 mt -72.27 -15.65 61.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.175 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 21.6 mt -52.2 93.13 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.892 0.377 . . . . 0.0 111.013 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 151.51 -24.16 0.95 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.415 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.5 ptpm? -111.93 167.75 10.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.165 0.507 . . . . 0.0 111.072 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.02 165.13 25.67 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.279 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.424 ' HB3' ' HA3' ' A' ' 32' ' ' GLY . 22.2 m-80 -52.29 -57.47 9.65 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.258 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.6 pp0? -53.82 -38.75 64.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.399 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.85 -38.88 73.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.277 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.44 ' CB ' ' CD1' ' A' ' 44' ' ' ILE . . . -66.76 -47.88 70.82 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.746 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.47 ' HA ' ' CD2' ' A' ' 87' ' ' LEU . 5.0 ptp -63.13 -29.7 71.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.977 179.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.66 -32.36 47.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.385 178.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.423 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 1.4 m -69.03 -36.59 77.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.348 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.47 ' CD2' ' HA ' ' A' ' 84' ' ' MET . 4.4 pp -78.46 -33.82 48.13 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.447 ' N ' HD12 ' A' ' 87' ' ' LEU . 1.1 ttt180 -58.4 -51.69 68.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.465 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.52 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.27 -33.88 67.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.195 179.814 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.443 ' N ' ' HD3' ' A' ' 89' ' ' ARG . 5.3 t -70.45 -29.17 65.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.25 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.472 ' CB ' HD13 ' A' ' 101' ' ' ILE . 4.2 ptp -88.77 -20.27 24.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.533 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.75 39.57 3.93 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.52 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.5 OUTLIER -171.71 -22.22 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 179.696 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -127.9 -59.0 1.21 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.91 0.386 . . . . 0.0 111.091 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.428 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -67.52 -25.28 73.87 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.998 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.408 ' O ' ' ND2' ' A' ' 96' ' ' ASN . 0.6 OUTLIER -78.44 -32.93 48.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.966 0.412 . . . . 0.0 110.24 179.517 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.5 ' HD3' ' O ' ' A' ' 93' ' ' THR . 10.5 mmmt -44.22 -40.14 4.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.258 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.63 -28.29 19.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.743 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 122.74 -7.43 9.51 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.951 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.468 ' SD ' ' HB3' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -157.05 143.45 18.14 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.061 0.458 . . . . 0.0 111.29 -179.709 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.472 HD13 ' CB ' ' A' ' 91' ' ' MET . 0.1 OUTLIER -113.94 146.99 17.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.188 -179.713 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -87.86 139.94 30.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.095 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.47 HD23 HG12 ' A' ' 101' ' ' ILE . 2.5 mm? -131.73 141.87 49.64 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.131 0.491 . . . . 0.0 112.046 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 73.5 mt -127.09 112.31 28.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.415 ' CG1' ' CD2' ' A' ' 67' ' ' LEU . 29.8 m -132.5 133.08 60.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.825 -178.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -108.93 139.48 43.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.254 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.991 0.424 . . . . 0.0 111.382 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.453 -0.316 0 CA-C-O 120.893 0.378 . . . . 0.0 111.128 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 53.2 m -126.75 134.56 50.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.974 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.27 109.48 16.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.63 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.402 ' CG1' ' HG3' ' A' ' 88' ' ' ARG . 16.8 m . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.151 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 121.013 0.435 . . . . 0.0 111.596 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.421 ' CE2' HG12 ' A' ' 68' ' ' ILE . 13.6 m-85 -95.99 151.21 19.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.695 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.445 ' HB3' ' CZ ' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -137.3 110.99 8.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.885 -179.757 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.412 ' O ' ' CD1' ' A' ' 14' ' ' PHE . 97.2 m -97.6 130.63 44.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.639 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.445 ' CZ ' ' HB3' ' A' ' 12' ' ' LEU . 28.4 m-85 -140.87 172.47 12.64 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.26 0.553 . . . . 0.0 112.416 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.413 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.5 OUTLIER -126.98 111.7 14.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.051 179.086 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.407 HG11 ' CD1' ' A' ' 26' ' ' LEU . 34.3 t -104.26 116.66 60.97 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -177.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.5 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 89.7 Cg_endo -88.57 126.53 1.86 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.47 2.113 . . . . 0.0 110.846 178.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.5 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 0.3 OUTLIER -116.16 29.09 8.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.716 0.293 . . . . 0.0 111.547 -178.823 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -38.6 -31.72 0.06 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.434 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -112.2 -32.07 6.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.312 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 t -74.39 -5.49 42.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.181 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.417 ' HA2' ' CD1' ' A' ' 18' ' ' LEU . . . -43.88 -28.77 1.26 Allowed Glycine 0 C--N 1.336 0.561 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.942 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.1 p -88.26 -33.04 18.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.762 0.315 . . . . 0.0 110.897 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.47 9.02 28.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.531 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.62 -54.39 4.95 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.966 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.454 ' O ' ' N ' ' A' ' 54' ' ' ALA . 8.4 tp -175.12 -36.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.628 0.252 . . . . 0.0 110.811 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.468 ' HA3' ' HA3' ' A' ' 53' ' ' GLY . . . 114.83 44.91 0.67 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.4 -0.905 . . . . 0.0 113.295 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.439 ' CG1' ' CB ' ' A' ' 55' ' ' ALA . 33.1 m -157.24 160.56 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.189 0.518 . . . . 0.0 111.727 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.41 ' O ' ' HB3' ' A' ' 47' ' ' LYS . 0.7 OUTLIER -117.44 110.3 17.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.31 178.774 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.3 m -106.9 137.97 35.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.949 0.404 . . . . 0.0 111.717 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.46 129.63 22.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.431 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -89.23 156.92 26.47 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.539 -0.838 . . . . 0.0 113.055 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -128.29 145.22 51.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.827 0.346 . . . . 0.0 110.93 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 45.3 mtt85 -96.22 147.63 23.56 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.646 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.4 t -45.64 141.93 2.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.405 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -25.15 64.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.049 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -85.46 -72.18 0.5 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.8 0.333 . . . . 0.0 111.023 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -106.23 -162.45 0.86 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.744 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 53.5 m-70 -93.76 33.11 1.33 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.013 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.48 105.46 4.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.977 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -54.6 106.46 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.154 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 21.6 mt -67.79 -25.52 65.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.794 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.444 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 129.14 -178.63 17.2 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.06 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.23 133.05 49.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.911 0.386 . . . . 0.0 111.301 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.455 ' CE2' ' NE2' ' A' ' 66' ' ' GLN . 0.1 OUTLIER -122.47 145.48 48.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.833 -179.935 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 42.8 t -60.9 104.9 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.691 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.41 ' HB3' ' O ' ' A' ' 29' ' ' SER . 5.2 tppt? -76.68 -37.82 55.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.721 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.64 122.76 0.87 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.871 0.367 . . . . 0.0 111.422 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.44 ' CD1' ' HB3' ' A' ' 61' ' ' LEU . 63.9 mt -89.46 127.41 42.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.166 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.422 HD11 ' HA2' ' A' ' 27' ' ' GLY . 1.6 mp -66.33 109.06 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.52 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.28 76.64 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.086 0.47 . . . . 0.0 110.33 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 159.76 -26.71 0.34 Allowed Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.468 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -76.81 174.47 54.18 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.367 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.5 ' HB2' ' HA ' ' A' ' 18' ' ' LEU . . . -47.19 -46.52 23.92 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.439 ' CB ' ' CG1' ' A' ' 28' ' ' VAL . . . -61.81 -38.18 87.15 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.735 0.303 . . . . 0.0 111.763 -178.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.7 t -70.45 -43.11 70.52 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.938 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.434 ' H ' ' HG2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -66.49 -25.94 66.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.995 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.03 -52.88 61.78 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.83 0.347 . . . . 0.0 111.33 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.87 4.71 69.18 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.401 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.431 ' HD2' ' CD1' ' A' ' 14' ' ' PHE . 1.3 mtm180 -122.15 0.96 9.69 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.761 0.315 . . . . 0.0 110.662 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.44 ' HB3' ' CD1' ' A' ' 49' ' ' ILE . 0.1 OUTLIER -100.5 136.34 40.53 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.98 -179.807 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.33 143.99 29.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.844 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.463 ' O ' ' CB ' ' A' ' 64' ' ' ASN . 58.5 t -59.18 142.85 14.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.046 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 29.1 m-20 90.26 12.45 0.05 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.694 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.74 120.93 34.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.721 0.296 . . . . 0.0 110.274 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.455 ' NE2' ' CE2' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -78.05 137.18 38.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.7 -179.831 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.6 mt -93.52 140.95 29.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.024 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.421 HG12 ' CE2' ' A' ' 11' ' ' PHE . 4.5 mp -124.89 -41.44 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.393 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -139.17 151.03 46.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.018 0.437 . . . . 0.0 111.371 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.7 p -140.38 119.56 11.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.025 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 60.96 27.95 17.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.652 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.0 22.53 54.9 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.153 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -125.51 115.07 19.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.861 0.362 . . . . 0.0 110.78 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.5 p -60.22 149.96 31.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.129 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.0 mt -115.55 -29.72 6.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.064 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.0 mt -51.6 -35.21 40.67 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.236 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.35 -21.38 47.86 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.335 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -120.64 162.14 20.17 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.367 0.603 . . . . 0.0 110.977 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.48 161.73 5.56 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.154 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.417 ' OD1' ' N ' ' A' ' 81' ' ' GLN . 10.3 p30 -56.87 -43.81 81.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.158 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.417 ' N ' ' OD1' ' A' ' 80' ' ' ASN . 1.9 pp0? -64.58 -42.62 95.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.092 0.472 . . . . 0.0 110.55 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.68 -32.1 70.52 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.649 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.4 -49.04 58.98 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.685 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.41 ' HG2' ' HA ' ' A' ' 81' ' ' GLN . 6.9 ptp -59.64 -32.93 70.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.481 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -78.15 -31.28 49.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.22 0.533 . . . . 0.0 109.832 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.3 m -69.88 -36.44 75.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.521 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.418 ' CD1' ' N ' ' A' ' 88' ' ' ARG . 4.3 pp -78.77 -34.6 45.5 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.418 0.627 . . . . 0.0 109.478 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.46 ' O ' ' HG2' ' A' ' 91' ' ' MET . 0.2 OUTLIER -61.11 -47.37 86.59 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.5 179.46 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.411 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -73.18 -43.27 61.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.424 179.544 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.3 p -61.36 -29.54 69.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.381 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.46 ' HG2' ' O ' ' A' ' 88' ' ' ARG . 3.5 ptp -86.37 -34.93 20.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.84 -179.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -102.56 25.64 8.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.833 -179.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.411 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.5 OUTLIER -152.38 -36.66 0.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.796 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.423 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 4.0 mt-10 -111.37 -60.04 1.89 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.813 0.34 . . . . 0.0 111.408 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.595 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -56.17 -27.31 51.89 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.378 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.413 ' O ' ' ND2' ' A' ' 96' ' ' ASN . 0.9 OUTLIER -77.09 -33.73 56.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.712 0.291 . . . . 0.0 110.565 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 94' ' ' GLU . 60.9 mtpt -39.33 -39.53 0.66 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.674 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.77 -27.28 13.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.191 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 121.75 -3.2 10.95 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.7 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.5 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -155.63 143.38 19.7 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.981 0.419 . . . . 0.0 111.257 -179.639 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.595 ' HB ' ' HA3' ' A' ' 95' ' ' GLY . 0.1 OUTLIER -112.71 145.11 19.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.023 179.839 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -82.04 143.76 31.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.725 179.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.433 ' CD2' HG12 ' A' ' 101' ' ' ILE . 2.5 mm? -133.82 149.56 51.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.293 0.568 . . . . 0.0 112.008 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 74.7 mt -139.34 112.35 6.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.361 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 66' ' ' GLN . 35.2 m -123.66 172.93 10.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.473 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -147.85 132.52 17.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.41 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.343 0 CA-C-O 120.919 0.39 . . . . 0.0 111.007 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 1.1 mm . . . . . 0 N--CA 1.453 -0.286 0 CA-C-O 121.181 0.515 . . . . 0.0 111.514 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 43.9 m -98.08 102.97 14.87 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.527 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.75 102.75 1.59 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.641 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 34.8 m . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.175 -0.917 . . . . 0.0 111.247 -179.887 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 . . . . . 0 C--O 1.233 0.234 0 CA-C-O 120.886 0.374 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.431 ' CD2' HD12 ' A' ' 68' ' ' ILE . 4.4 m-85 -100.51 147.07 26.31 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.516 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.424 ' CD1' ' CG2' ' A' ' 105' ' ' VAL . 0.0 OUTLIER -139.51 121.43 15.57 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.958 0.408 . . . . 0.0 111.303 -179.783 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.3 m -94.74 142.7 27.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.249 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.485 ' O ' ' HA ' ' A' ' 102' ' ' GLN . 26.6 m-85 -142.03 172.64 12.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.975 0.417 . . . . 0.0 111.587 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.4 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.7 OUTLIER -132.27 107.63 8.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.55 179.219 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 32.2 t -104.3 114.36 64.32 Favored Pre-proline 0 C--N 1.33 -0.248 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -84.58 128.12 3.92 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.645 2.23 . . . . 0.0 110.958 178.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.584 ' HA ' ' HB3' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -122.26 28.78 7.29 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -178.856 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -39.37 -31.11 0.08 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.101 0.477 . . . . 0.0 111.15 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -112.94 -32.94 6.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.24 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.425 ' HB3' ' CB ' ' A' ' 18' ' ' LEU . 43.9 t -71.31 -6.62 41.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.174 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.4 ' HA2' ' CD1' ' A' ' 18' ' ' LEU . . . -44.23 -29.79 1.74 Allowed Glycine 0 C--N 1.336 0.567 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.692 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.21 -37.93 22.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.982 0.42 . . . . 0.0 110.553 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.29 -1.03 54.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.427 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.07 -48.91 3.91 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.879 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 54' ' ' ALA . 6.1 tp 179.78 -31.34 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.611 0.243 . . . . 0.0 110.553 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.472 ' HA2' HD11 ' A' ' 50' ' ' ILE . . . 105.96 48.31 1.02 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.297 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.427 HG13 ' CB ' ' A' ' 55' ' ' ALA . 20.0 m -157.08 163.97 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.164 0.506 . . . . 0.0 111.94 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.406 ' O ' ' N ' ' A' ' 47' ' ' LYS . 49.7 m -124.7 117.37 24.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.238 178.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.4 m -111.58 145.62 17.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.079 0.466 . . . . 0.0 112.163 -178.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.409 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -143.81 130.25 19.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.37 179.331 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -103.71 156.99 17.57 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.442 -0.885 . . . . 0.0 113.142 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.456 ' OD1' ' N ' ' A' ' 33' ' ' ASN . 6.7 p-10 -105.16 178.21 4.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.909 0.385 . . . . 0.0 111.163 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -136.27 126.47 26.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.76 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.432 ' CB ' HD23 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -50.43 121.45 5.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.149 -179.752 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.46 -10.89 55.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.552 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -77.91 -64.39 1.17 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.734 0.302 . . . . 0.0 111.325 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -124.12 25.87 7.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.498 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 52.46 54.2 11.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.898 0.38 . . . . 0.0 111.153 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -110.3 120.86 43.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.989 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -48.06 118.56 2.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.3 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.456 ' HB2' ' OD1' ' A' ' 33' ' ' ASN . 21.3 mt -81.31 -28.29 34.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.62 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.4 ' HA3' ' NE2' ' A' ' 66' ' ' GLN . . . 138.53 173.96 13.21 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.494 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.445 ' CD1' ' CB ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -101.68 153.5 5.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.869 0.366 . . . . 0.0 111.38 -180.0 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.458 ' CE2' ' NE2' ' A' ' 66' ' ' GLN . 0.4 OUTLIER -140.19 141.75 35.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.662 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.436 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 42.2 t -57.74 104.64 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.59 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.409 ' HB2' ' HG2' ' A' ' 31' ' ' LYS . 21.9 tptt -75.26 -41.49 57.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.749 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.97 124.52 1.08 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.857 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.501 ' CD1' ' HB3' ' A' ' 61' ' ' LEU . 77.2 mt -91.62 119.95 39.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.218 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.472 HD11 ' HA2' ' A' ' 27' ' ' GLY . 1.7 mp -56.0 108.14 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.376 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.15 72.94 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.873 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 162.45 -26.95 0.24 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.176 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.86 -170.6 8.14 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.901 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.584 ' HB3' ' HA ' ' A' ' 18' ' ' LEU . . . -64.15 -41.49 97.15 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.441 ' CB ' ' CD1' ' A' ' 61' ' ' LEU . . . -62.87 -47.58 82.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.703 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.0 t -67.85 -29.04 68.08 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.497 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 37.4 mtpt -74.87 -32.31 61.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.151 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -61.18 -27.94 68.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.808 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 66.59 20.76 70.27 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.779 -0.724 . . . . 0.0 113.132 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.426 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 12.5 mtm180 -125.19 -16.57 5.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.778 0.323 . . . . 0.0 110.979 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.501 ' HB3' ' CD1' ' A' ' 49' ' ' ILE . 0.5 OUTLIER -88.27 135.53 33.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.195 -179.668 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.16 137.87 29.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.692 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.45 HG11 ' N ' ' A' ' 64' ' ' ASN . 48.1 t -52.52 145.91 2.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.267 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.45 ' N ' HG11 ' A' ' 63' ' ' VAL . 28.2 m-80 86.98 11.09 0.15 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.613 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -91.82 115.69 28.27 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.458 ' NE2' ' CE2' ' A' ' 45' ' ' PHE . 0.9 OUTLIER -72.89 128.97 37.06 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.779 -179.632 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 42.6 mt -83.09 152.2 25.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.772 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.431 HD12 ' CD2' ' A' ' 11' ' ' PHE . 30.6 mt -143.63 -40.98 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.637 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -138.12 158.5 44.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.83 0.348 . . . . 0.0 111.457 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.8 p -151.51 120.6 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.951 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 57.12 29.65 16.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.87 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.19 23.75 50.52 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.308 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -127.75 118.61 24.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.741 0.305 . . . . 0.0 110.753 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.8 t -70.65 150.19 46.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.115 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.42 ' HB3' ' CB ' ' A' ' 83' ' ' ALA . 22.5 mt -111.16 -19.34 12.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.102 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.8 tp -54.41 -21.99 11.25 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.32 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -91.2 28.74 7.71 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.863 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -164.81 152.04 11.22 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.27 0.557 . . . . 0.0 110.921 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.96 156.45 2.05 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.329 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -54.16 -47.85 71.52 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.044 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -60.42 -40.0 89.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.016 0.436 . . . . 0.0 110.635 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.1 -34.22 72.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.678 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.445 ' CB ' ' CD1' ' A' ' 44' ' ' ILE . . . -66.5 -50.6 62.71 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.366 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.422 ' HA ' ' CD2' ' A' ' 87' ' ' LEU . 6.9 ptp -60.67 -30.5 69.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.927 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -79.51 -32.94 42.44 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.1 m -68.08 -35.67 78.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.277 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.422 ' CD2' ' HA ' ' A' ' 84' ' ' MET . 4.4 pp -78.31 -34.35 48.73 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.412 ' HG3' ' CG1' ' B' ' 13' ' ' VAL . 0.0 OUTLIER -60.21 -52.14 66.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.655 179.293 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.431 ' HD3' ' N ' ' A' ' 90' ' ' SER . 0.0 OUTLIER -72.5 -33.91 67.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.295 179.651 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.431 ' N ' ' HD3' ' A' ' 89' ' ' ARG . 24.0 t -71.6 -29.99 65.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.958 0.409 . . . . 0.0 110.424 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.416 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 1.5 ptp -89.2 -25.14 21.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.163 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.3 t -109.22 23.18 14.87 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.425 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.5 OUTLIER -153.37 -36.19 0.11 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.902 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.436 ' HA ' ' HG3' ' A' ' 97' ' ' LYS . 4.1 mt-10 -107.61 -64.3 1.22 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.828 0.347 . . . . 0.0 111.346 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.54 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -52.92 -33.63 44.06 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.656 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.4 ' O ' ' ND2' ' A' ' 96' ' ' ASN . 0.9 OUTLIER -70.49 -34.78 72.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.702 0.287 . . . . 0.0 110.382 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.436 ' HG3' ' HA ' ' A' ' 94' ' ' GLU . 20.7 mtpt -38.23 -47.29 1.16 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.475 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.31 -25.32 19.49 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.662 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 118.97 -3.05 14.58 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.819 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.4 ' SD ' ' HB3' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -159.48 143.43 14.84 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.076 0.465 . . . . 0.0 111.383 -179.744 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.54 ' HB ' ' HA3' ' A' ' 95' ' ' GLY . 0.1 OUTLIER -114.33 141.48 30.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.529 179.932 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.485 ' HA ' ' O ' ' A' ' 14' ' ' PHE . 2.2 pp0? -86.88 131.13 34.19 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.981 -0.287 . . . . 0.0 110.403 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.427 ' CD2' HG12 ' A' ' 101' ' ' ILE . 2.8 mm? -115.87 134.39 55.04 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.275 0.559 . . . . 0.0 112.114 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 96.7 mt -118.07 112.59 39.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.611 178.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 66' ' ' GLN . 28.9 m -121.53 177.21 3.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.265 -179.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -147.29 139.18 24.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.826 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.429 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.149 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 1.6 mm . . . . . 0 CA--C 1.521 -0.172 0 CA-C-O 121.135 0.493 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 2.5 m -110.5 116.4 31.32 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.661 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 27.2 ttmt -78.13 109.2 12.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.925 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.412 ' CG1' ' HG3' ' A' ' 88' ' ' ARG . 17.3 m . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.277 -0.868 . . . . 0.0 111.275 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.921 0.391 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -100.7 148.93 24.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.802 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -133.68 110.88 10.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.026 -179.838 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.3 m -96.1 132.47 41.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.577 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.42 ' CZ ' ' HB3' ' A' ' 12' ' ' LEU . 54.9 m-85 -140.73 172.43 12.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.301 0.572 . . . . 0.0 112.113 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.401 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.3 OUTLIER -129.07 112.09 13.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.152 179.174 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 34.8 t -103.19 112.2 65.58 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -178.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 84.2 Cg_endo -82.22 127.82 5.4 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.365 2.043 . . . . 0.0 110.886 178.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.687 ' HA ' ' HB1' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -122.62 28.52 7.3 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -178.724 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -39.12 -31.49 0.07 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.172 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -113.33 -32.83 6.14 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.282 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.402 ' HB3' ' CB ' ' A' ' 18' ' ' LEU . 46.7 t -70.96 -7.7 47.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.163 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -45.25 -28.46 2.09 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.744 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.8 p -85.27 -34.28 21.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.797 0.332 . . . . 0.0 110.563 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.66 7.21 31.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.526 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.03 -54.99 4.78 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.644 -0.789 . . . . 0.0 111.985 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.461 ' CD2' ' HE2' ' A' ' 91' ' ' MET . 9.8 tp -178.89 -32.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.592 0.234 . . . . 0.0 110.948 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 50' ' ' ILE . . . 114.47 31.91 2.07 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.381 -0.914 . . . . 0.0 113.413 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.486 HG11 ' CB ' ' A' ' 55' ' ' ALA . 33.7 m -150.83 161.01 3.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 117.164 0.482 . . . . 0.0 111.75 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.42 ' O ' ' N ' ' A' ' 47' ' ' LYS . 0.9 OUTLIER -122.41 118.16 27.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.556 178.942 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.3 m -110.77 141.67 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.9 0.381 . . . . 0.0 111.937 -178.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.408 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -140.66 130.54 24.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.545 179.397 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.533 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -90.94 160.75 27.6 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.397 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.454 ' ND2' ' CE1' ' A' ' 45' ' ' PHE . 89.3 m-20 -119.57 179.91 4.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.837 0.351 . . . . 0.0 110.915 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.59 155.66 40.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.624 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.14 140.49 49.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.063 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.2 mtmm -64.51 -28.25 69.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.984 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -84.96 -74.88 0.38 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.944 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -94.41 177.26 6.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.903 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -93.07 58.42 2.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.881 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -116.78 131.63 56.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.998 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -59.37 144.31 47.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.915 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 17.0 mt -105.38 -30.98 9.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.862 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.533 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 148.51 -173.99 28.31 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.098 -0.572 . . . . 0.0 111.866 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.441 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -110.23 148.11 14.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 120.988 0.423 . . . . 0.0 111.735 -179.739 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.454 ' CE1' ' ND2' ' A' ' 33' ' ' ASN . 0.4 OUTLIER -134.4 138.43 44.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.557 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.478 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 40.0 t -54.17 104.41 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.564 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 29' ' ' SER . 5.9 tptm -73.03 -43.01 62.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.841 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 m -168.18 125.02 1.07 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.107 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.525 ' CD1' ' HB3' ' A' ' 61' ' ' LEU . 62.7 mt -88.93 116.66 30.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.297 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.432 ' N ' ' O ' ' A' ' 27' ' ' GLY . 1.9 mp -55.42 105.26 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.629 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.11 76.4 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.141 0.496 . . . . 0.0 110.588 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 158.95 -27.17 0.39 Allowed Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.907 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.45 -170.62 6.07 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.691 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.687 ' HB1' ' HA ' ' A' ' 18' ' ' LEU . . . -67.94 -38.58 83.0 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.486 ' CB ' HG11 ' A' ' 28' ' ' VAL . . . -67.66 -43.86 79.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.393 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 53.6 p -66.85 -33.28 75.25 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.204 0.526 . . . . 0.0 110.109 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -70.74 -33.53 70.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.171 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -58.05 -28.0 64.13 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.786 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.87 25.0 67.26 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.783 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.409 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 22.1 mtm180 -125.31 -24.22 4.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.812 0.339 . . . . 0.0 111.017 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.525 ' HB3' ' CD1' ' A' ' 49' ' ' ILE . 0.3 OUTLIER -71.62 164.06 26.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.444 -179.729 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.476 ' HD2' ' N ' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -160.46 138.83 10.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.713 179.876 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.478 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 37.0 t -70.5 144.75 13.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.594 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 25.4 m-20 88.75 -2.53 0.43 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.642 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.95 133.14 35.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.96 0.409 . . . . 0.0 110.599 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.426 ' NE2' ' HA3' ' A' ' 43' ' ' GLY . 1.0 OUTLIER -82.63 139.02 33.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.692 -179.806 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.7 mt -88.99 131.81 35.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.839 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 19.3 mm -113.13 -32.19 2.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.473 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -157.03 170.91 21.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.884 0.373 . . . . 0.0 111.585 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.3 p -158.17 127.39 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.767 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 60.24 22.83 12.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.668 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.07 25.53 31.32 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.993 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -130.55 108.45 9.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.796 0.332 . . . . 0.0 110.831 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.2 t -71.23 138.27 49.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.087 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.57 -13.24 20.5 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.163 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.82 94.7 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.913 0.387 . . . . 0.0 111.058 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 145.3 -31.09 1.71 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.185 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -97.56 156.89 16.3 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.239 0.542 . . . . 0.0 110.903 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.12 139.45 28.58 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.33 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.9 p30 -50.63 -28.14 8.25 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.172 0.511 . . . . 0.0 109.927 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.18 -42.04 60.49 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.013 178.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -70.11 -32.99 71.27 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.868 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.435 ' CB ' ' CD1' ' A' ' 44' ' ' ILE . . . -68.92 -45.46 70.8 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.487 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.422 ' HA ' ' CD2' ' A' ' 87' ' ' LEU . 6.5 ptp -63.49 -30.05 71.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.816 178.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -78.59 -33.46 47.51 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.479 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 3.4 m -68.34 -35.65 78.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.343 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.422 ' CD2' ' HA ' ' A' ' 84' ' ' MET . 4.4 pp -78.32 -33.83 48.99 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 178.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.427 ' O ' ' HG2' ' A' ' 91' ' ' MET . 0.0 OUTLIER -60.23 -51.24 70.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.65 179.332 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.479 ' HD3' ' O ' ' A' ' 86' ' ' THR . 0.0 OUTLIER -72.26 -34.93 68.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.618 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.441 ' N ' ' HD3' ' A' ' 89' ' ' ARG . 24.7 p -72.92 -29.8 63.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.852 0.358 . . . . 0.0 110.735 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.461 ' HE2' ' CD2' ' A' ' 26' ' ' LEU . 1.7 ptm -88.85 -17.43 29.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.288 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.85 25.45 9.68 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.518 ' O ' ' HD3' ' A' ' 97' ' ' LYS . 0.4 OUTLIER -157.14 -31.97 0.08 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.421 ' HG3' HG22 ' A' ' 93' ' ' THR . 5.7 mt-10 -117.59 -35.56 3.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.856 0.36 . . . . 0.0 111.443 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.483 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -78.26 -31.25 47.62 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.614 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.433 ' O ' ' ND2' ' A' ' 96' ' ' ASN . 0.7 OUTLIER -75.29 -31.89 60.83 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.584 -0.308 . . . . 0.0 110.176 179.576 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.518 ' HD3' ' O ' ' A' ' 93' ' ' THR . 27.1 mmmt -39.54 -47.19 1.86 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.968 0.414 . . . . 0.0 111.096 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.92 -25.49 19.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.889 178.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 114.19 1.09 23.74 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.908 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.458 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -154.66 141.0 18.66 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 120.975 0.417 . . . . 0.0 111.197 -179.588 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.483 ' HB ' ' HA3' ' A' ' 95' ' ' GLY . 0.1 OUTLIER -112.85 145.31 18.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.657 179.538 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -84.99 139.64 31.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.978 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.434 HD21 HG12 ' A' ' 101' ' ' ILE . 2.7 mm? -129.99 137.66 50.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.045 0.45 . . . . 0.0 111.801 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 72.6 mt -126.5 113.1 31.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.563 178.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 31.9 m -123.62 174.69 7.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.472 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -147.73 137.43 22.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.841 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.946 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . 0.432 HG22 HD12 ' B' ' 10' ' ' ILE . 1.1 mm . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 121.413 0.625 . . . . 0.0 111.495 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 16.5 m -92.15 114.9 27.57 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.325 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -75.09 102.85 5.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.507 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 30.0 m . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.726 -0.655 . . . . 0.0 110.532 179.147 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.791 0.329 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.415 ' CD1' ' HB1' ' A' ' 106' ' ' ALA . 30.3 m-85 -77.75 140.48 39.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.462 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.16 134.42 20.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.123 0.487 . . . . 0.0 111.238 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.428 ' O ' ' CD1' ' A' ' 14' ' ' PHE . 25.4 m -92.63 150.8 20.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.295 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.44 ' O ' ' HA ' ' A' ' 102' ' ' GLN . 15.5 m-85 -140.08 170.37 15.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.105 0.479 . . . . 0.0 111.683 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -143.43 104.95 4.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.096 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.417 ' CG1' ' HA ' ' A' ' 55' ' ' ALA . 20.7 t -109.49 110.86 59.79 Favored Pre-proline 0 CA--C 1.531 0.226 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -177.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.523 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 91.2 Cg_endo -82.49 128.11 5.3 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.527 2.151 . . . . 0.0 110.736 178.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.656 ' HA ' ' HB3' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -121.82 29.5 7.09 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -178.582 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -40.92 -31.7 0.19 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.103 0.478 . . . . 0.0 111.031 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -111.32 -33.65 6.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.203 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.402 ' HB3' ' CB ' ' A' ' 18' ' ' LEU . 29.9 t -70.52 -8.55 52.12 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.111 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -44.96 -28.05 1.66 Allowed Glycine 0 C--N 1.337 0.613 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.691 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -85.69 -33.44 21.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.834 0.349 . . . . 0.0 110.737 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.37 8.33 28.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.441 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.96 -55.64 4.99 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.629 -0.795 . . . . 0.0 111.908 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.471 ' O ' ' N ' ' A' ' 54' ' ' ALA . 10.2 tp -179.0 -34.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.601 0.239 . . . . 0.0 111.12 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.79 35.02 1.31 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.537 -0.839 . . . . 0.0 113.295 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.499 HG11 ' CB ' ' A' ' 55' ' ' ALA . 34.2 m -156.3 162.2 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.282 0.563 . . . . 0.0 112.082 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -122.65 116.4 23.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.179 178.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.4 m -106.56 146.35 13.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.143 0.497 . . . . 0.0 111.938 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.34 131.08 21.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.58 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.46 ' HA3' ' HB2' ' A' ' 80' ' ' ASN . . . -97.32 145.69 17.95 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.697 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.405 ' OD1' ' CE1' ' A' ' 45' ' ' PHE . 21.9 m120 -107.84 -179.17 3.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.828 0.347 . . . . 0.0 111.028 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.4 mtt180 -134.53 156.12 49.2 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.691 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -48.92 150.97 1.34 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.194 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -66.48 -40.33 89.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.116 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -108.24 -35.46 6.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.127 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -91.67 168.94 11.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.925 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 -103.25 31.03 4.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.79 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.66 129.5 44.73 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.089 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.436 ' CB ' ' ND2' ' A' ' 80' ' ' ASN . 1.7 p30 -57.1 142.27 43.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.079 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 24.2 mt -104.06 12.6 33.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.11 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.405 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 98.47 170.67 31.8 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.586 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.457 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -102.02 135.78 37.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.851 0.358 . . . . 0.0 110.995 179.831 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.412 ' CE2' ' HG3' ' A' ' 66' ' ' GLN . 0.1 OUTLIER -121.02 141.33 50.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.792 -179.834 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.47 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 46.7 t -56.35 104.64 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.638 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.9 -40.94 60.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.758 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.0 p -166.9 124.72 1.31 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.162 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.513 ' CD1' ' HB3' ' A' ' 61' ' ' LEU . 67.6 mt -91.25 111.86 24.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.059 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.442 ' O ' ' HB2' ' A' ' 56' ' ' SER . 2.1 mp -51.8 106.41 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.801 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.34 75.52 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.023 0.44 . . . . 0.0 110.675 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 162.56 -29.99 0.28 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.082 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.61 -170.43 3.93 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.686 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.656 ' HB3' ' HA ' ' A' ' 18' ' ' LEU . . . -68.54 -38.18 80.59 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.499 ' CB ' HG11 ' A' ' 28' ' ' VAL . . . -66.84 -45.04 79.46 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.455 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.442 ' HB2' ' O ' ' A' ' 50' ' ' ILE . 0.4 OUTLIER -66.21 -34.8 78.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.27 0.557 . . . . 0.0 109.861 179.341 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.7 mtpt -68.47 -30.33 69.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.947 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.41 ' OD1' ' CD ' ' A' ' 17' ' ' PRO . 0.8 OUTLIER -64.09 -25.87 68.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.944 179.753 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.01 26.18 65.27 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.643 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.7 mtm180 -122.26 -34.79 3.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.968 0.413 . . . . 0.0 110.769 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.513 ' HB3' ' CD1' ' A' ' 49' ' ' ILE . 2.1 mp -66.74 141.86 57.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.473 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -138.45 134.22 33.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.269 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.47 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 46.3 t -59.51 145.36 11.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.014 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.444 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 22.3 m-20 87.85 -7.3 0.58 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.392 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -76.07 125.66 29.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.787 0.327 . . . . 0.0 110.766 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.412 ' HG3' ' CE2' ' A' ' 45' ' ' PHE . 1.8 tm0? -81.51 140.48 34.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.916 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.4 ' CD1' HG13 ' A' ' 44' ' ' ILE . 30.8 mt -87.17 139.57 30.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.924 0.392 . . . . 0.0 111.183 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 19.6 mm -120.65 -31.52 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.241 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -161.72 134.73 6.18 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.973 0.416 . . . . 0.0 111.573 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.5 p -121.57 129.36 75.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.366 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.43 ' ND2' ' O ' ' A' ' 90' ' ' SER . 9.3 m-80 64.95 13.96 8.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.538 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.77 -14.72 53.03 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.005 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -99.27 125.64 44.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.879 0.371 . . . . 0.0 111.07 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 21.3 p -75.04 165.1 25.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.901 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.405 ' CD2' ' CD2' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -128.9 4.38 5.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.267 -179.828 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.88 -41.43 78.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.909 0.385 . . . . 0.0 110.934 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.23 -25.84 73.49 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.691 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.406 ' HD2' ' HA ' ' A' ' 83' ' ' ALA . 1.3 ptpm? -101.7 166.78 10.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.287 0.565 . . . . 0.0 111.179 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.24 168.04 20.41 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.189 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.46 ' HB2' ' HA3' ' A' ' 32' ' ' GLY . 7.2 p30 -58.66 -50.48 73.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.055 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.421 ' N ' ' OD1' ' A' ' 80' ' ' ASN . 2.2 pp0? -58.84 -39.69 82.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.116 0.484 . . . . 0.0 110.516 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.13 -34.48 73.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.9 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.42 ' CB ' ' CD1' ' A' ' 44' ' ' ILE . . . -69.03 -47.66 64.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.785 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.419 ' HA ' ' HG ' ' A' ' 87' ' ' LEU . 5.6 ptp -61.93 -31.52 71.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.205 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.07 -33.8 65.86 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.8 m -64.66 -33.91 77.04 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.26 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.419 ' HG ' ' HA ' ' A' ' 84' ' ' MET . 0.1 OUTLIER -76.02 -36.02 59.3 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.099 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.14 -51.99 67.62 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.843 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.44 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.42 -44.86 61.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.429 179.665 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.43 ' O ' ' ND2' ' A' ' 71' ' ' ASN . 40.4 p -64.23 -30.38 71.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.489 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.431 ' HE1' ' CD2' ' A' ' 26' ' ' LEU . 2.1 ptm -89.01 -22.29 23.06 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.683 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.26 28.87 8.31 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.483 ' O ' ' HD3' ' A' ' 97' ' ' LYS . 0.3 OUTLIER -164.96 -23.15 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -179.664 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -122.06 -54.96 1.9 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.893 0.378 . . . . 0.0 111.317 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.433 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -66.59 -26.6 72.91 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.016 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.404 ' O ' ' ND2' ' A' ' 96' ' ' ASN . 0.9 OUTLIER -77.86 -36.04 50.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.834 0.349 . . . . 0.0 110.207 179.673 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.483 ' HD3' ' O ' ' A' ' 93' ' ' THR . 25.8 mmmt -45.46 -43.04 11.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.969 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.08 -24.53 22.26 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.51 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 111.61 1.9 27.46 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.856 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.523 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -165.17 140.23 5.16 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 121.172 0.51 . . . . 0.0 111.744 -179.818 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.437 ' CG2' ' CD2' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -114.38 133.54 60.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.902 179.932 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.44 ' HA ' ' O ' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -76.72 150.2 36.29 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -138.79 112.82 8.57 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 32.6 mt -98.86 112.84 31.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 34.5 m -128.25 161.92 35.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.942 0.401 . . . . 0.0 111.48 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.415 ' HB1' ' CD1' ' A' ' 11' ' ' PHE . . . -123.55 120.38 32.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.558 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.86 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . 0.408 HG22 HD11 ' B' ' 10' ' ' ILE . 1.4 mm . . . . . 0 CA--C 1.52 -0.204 0 CA-C-O 121.254 0.549 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 55.9 m -70.51 102.82 2.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.578 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.6 120.07 20.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.92 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 11.1 m . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.151 -0.928 . . . . 0.0 110.818 179.81 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.953 0.406 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -94.61 147.46 23.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.604 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -134.23 110.17 9.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.363 -179.711 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 76.5 m -96.59 130.25 43.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.282 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.424 ' CG ' ' HB3' ' A' ' 60' ' ' ARG . 32.0 m-85 -140.21 172.37 12.84 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.467 0.651 . . . . 0.0 112.249 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.441 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.2 OUTLIER -128.93 111.71 13.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.328 179.354 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.404 HG12 ' HB2' ' A' ' 54' ' ' ALA . 8.8 t -103.39 117.17 60.77 Favored Pre-proline 0 C--N 1.33 -0.274 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -178.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.462 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 80.7 Cg_endo -86.36 127.22 2.83 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.461 2.108 . . . . 0.0 111.184 178.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.538 ' HA ' ' HB1' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -119.04 28.12 8.45 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -178.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -39.23 -30.76 0.06 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.209 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -114.63 -31.27 6.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.138 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.9 t -72.15 -7.6 50.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.095 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -44.74 -28.49 1.67 Allowed Glycine 0 C--N 1.337 0.602 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.741 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.73 -35.43 20.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.8 0.333 . . . . 0.0 110.824 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.21 8.74 25.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.455 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.87 -54.39 4.95 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.92 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' A' ' 54' ' ' ALA . 8.8 tp -178.03 -36.1 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.636 0.255 . . . . 0.0 110.657 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.452 ' HA2' HD12 ' A' ' 50' ' ' ILE . . . 115.66 41.13 0.81 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.378 -0.915 . . . . 0.0 113.373 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.484 HG11 ' CB ' ' A' ' 55' ' ' ALA . 14.2 m -156.93 157.69 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 117.147 0.474 . . . . 0.0 111.917 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.42 ' O ' ' N ' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -116.38 117.2 29.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.279 178.596 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.5 m -110.33 148.24 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.148 0.499 . . . . 0.0 112.159 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -147.82 129.67 15.24 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.292 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 44' ' ' ILE . . . -90.57 163.65 29.96 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.43 -179.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.402 ' HB2' ' CZ ' ' A' ' 45' ' ' PHE . 1.7 m-80 -124.2 179.15 5.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.819 0.343 . . . . 0.0 110.637 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 11.0 ttm180 -135.15 148.75 49.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.84 128.84 36.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.917 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.23 -28.77 69.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.139 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -80.02 -62.83 1.56 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.875 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -117.05 164.64 14.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.831 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -75.05 63.05 1.21 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.939 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -119.56 117.82 29.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.061 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -51.08 142.71 11.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.174 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 23.0 mt -107.86 -2.16 20.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.341 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.416 ' HA3' ' NE2' ' A' ' 66' ' ' GLN . . . 111.0 179.93 20.16 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.326 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.454 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -109.27 139.4 32.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.978 0.418 . . . . 0.0 111.491 -179.824 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.42 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -120.47 144.84 47.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.589 179.952 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.451 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 35.7 t -62.93 104.44 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.677 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 29' ' ' SER . 10.8 tptt -69.8 -45.4 68.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.813 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -167.88 127.91 1.34 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.009 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.508 ' CD1' ' HB3' ' A' ' 61' ' ' LEU . 61.8 mt -90.17 122.44 41.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.056 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.452 HD12 ' HA2' ' A' ' 27' ' ' GLY . 1.8 mp -61.36 110.08 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.247 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -65.19 75.73 0.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.02 0.438 . . . . 0.0 110.597 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 160.67 -28.33 0.32 Allowed Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.807 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.451 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -74.65 167.53 54.77 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.798 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.538 ' HB1' ' HA ' ' A' ' 18' ' ' LEU . . . -40.76 -45.33 2.41 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.484 ' CB ' HG11 ' A' ' 28' ' ' VAL . . . -61.6 -42.36 98.76 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.178 -0.465 . . . . 0.0 112.164 -178.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.23 -24.69 59.35 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.021 0.439 . . . . 0.0 110.588 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.41 ' CG ' ' O ' ' A' ' 53' ' ' GLY . 0.2 OUTLIER -77.53 -34.39 53.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.795 -179.894 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -60.33 -33.81 72.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.727 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.78 22.09 79.28 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.811 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.424 ' HB3' ' CG ' ' A' ' 14' ' ' PHE . 17.4 mtm180 -125.19 -20.1 4.95 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.777 0.322 . . . . 0.0 111.08 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.508 ' HB3' ' CD1' ' A' ' 49' ' ' ILE . 0.4 OUTLIER -77.39 138.81 39.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.979 0.418 . . . . 0.0 111.295 -179.771 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.82 139.92 42.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.417 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.507 ' O ' ' HB2' ' A' ' 64' ' ' ASN . 41.7 t -67.74 144.03 14.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.066 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.507 ' HB2' ' O ' ' A' ' 63' ' ' VAL . 43.9 m-80 83.4 8.12 0.65 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.119 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -84.83 126.05 33.12 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.425 ' O ' ' HA ' ' A' ' 105' ' ' VAL . 1.2 tt0 -78.15 131.93 37.42 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.734 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.4 mt -87.28 141.41 28.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.749 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.6 mt -124.91 -36.87 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.494 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.436 ' HA ' ' HA ' ' A' ' 74' ' ' SER . . . -153.29 145.47 23.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.047 0.451 . . . . 0.0 111.666 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.416 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 14.9 p -133.54 130.25 56.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.588 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 63.2 18.48 11.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.692 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.48 25.27 36.54 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.663 -0.779 . . . . 0.0 111.728 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.416 ' HG3' ' O ' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -133.03 104.11 6.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.873 0.368 . . . . 0.0 110.633 -179.538 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 0.4 OUTLIER -62.95 157.23 22.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.231 -179.712 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.95 9.49 8.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.104 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.43 -25.61 67.33 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.848 0.356 . . . . 0.0 110.984 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -94.52 25.65 21.82 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.613 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.44 ' HD2' ' HA ' ' A' ' 83' ' ' ALA . 0.5 OUTLIER -151.34 160.71 43.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.25 0.548 . . . . 0.0 111.213 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.08 158.63 25.27 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.104 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.431 ' HB2' ' HA3' ' A' ' 32' ' ' GLY . 7.8 p30 -57.35 -47.73 80.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.311 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.438 ' HA ' ' HG2' ' A' ' 84' ' ' MET . 5.8 pm0 -58.51 -37.98 76.74 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.996 0.427 . . . . 0.0 110.776 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -70.67 -38.08 73.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.998 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.44 ' HA ' ' HD2' ' A' ' 78' ' ' LYS . . . -67.24 -46.16 74.59 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.823 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.438 ' HG2' ' HA ' ' A' ' 81' ' ' GLN . 5.5 ptp -64.26 -29.66 70.75 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -81.09 -30.28 34.69 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.425 178.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.472 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 7.3 m -71.58 -35.08 70.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.209 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.422 HD13 ' HE1' ' A' ' 91' ' ' MET . 4.2 pp -78.44 -34.29 47.93 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.429 ' O ' ' HG2' ' A' ' 91' ' ' MET . 0.0 OUTLIER -59.5 -52.0 67.43 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.628 179.203 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.499 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.82 -33.62 66.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.017 179.474 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.46 ' N ' ' HD3' ' A' ' 89' ' ' ARG . 49.5 m -70.5 -29.79 66.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.486 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.429 ' HG2' ' O ' ' A' ' 88' ' ' ARG . 2.9 ptp -86.41 -23.38 26.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.248 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.5 33.12 5.76 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.499 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.4 OUTLIER -162.91 -28.35 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.44 ' HG3' HG23 ' A' ' 93' ' ' THR . 5.3 mt-10 -122.62 -37.27 2.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.912 0.387 . . . . 0.0 111.196 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.428 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -82.27 -33.06 26.88 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.458 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.424 ' O ' ' ND2' ' A' ' 96' ' ' ASN . 0.7 OUTLIER -72.83 -33.25 66.04 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.313 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.479 ' HD3' ' O ' ' A' ' 93' ' ' THR . 10.5 mmmt -40.56 -46.12 2.44 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.098 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.8 -24.31 20.36 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.816 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 118.32 -4.91 15.42 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.784 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.441 ' SD ' ' HB3' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -156.03 143.99 19.7 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.935 0.398 . . . . 0.0 111.097 -179.748 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.453 HG12 HD23 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -111.76 145.28 18.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.225 -179.643 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.24 142.55 28.49 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.128 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.453 HD23 HG12 ' A' ' 101' ' ' ILE . 2.8 mm? -133.77 139.23 46.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.1 0.476 . . . . 0.0 111.749 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 7.4 mt -126.99 112.62 29.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.506 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 66' ' ' GLN . 32.6 m -125.41 176.02 6.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.513 -179.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -147.65 136.55 22.07 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.865 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-O 120.912 0.387 . . . . 0.0 111.212 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 3.3 mm . . . . . 0 N--CA 1.453 -0.302 0 CA-C-O 120.994 0.426 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 7.9 m -120.72 113.97 20.98 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.958 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.12 131.61 42.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.591 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.426 ' CG1' ' HG3' ' A' ' 88' ' ' ARG . 10.4 m . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.316 -0.85 . . . . 0.0 111.304 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.912 0.387 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -74.92 144.42 43.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.214 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.49 109.86 4.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.034 0.445 . . . . 0.0 111.644 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.437 ' O ' ' CD1' ' A' ' 14' ' ' PHE . 11.8 m -81.09 141.4 34.35 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.706 178.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.448 ' CD2' ' CD2' ' A' ' 61' ' ' LEU . 19.5 m-85 -136.38 171.84 13.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.414 0.626 . . . . 0.0 112.595 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -143.05 102.29 3.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.242 178.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.442 HG21 HD12 ' A' ' 103' ' ' LEU . 40.4 t -104.39 106.77 55.49 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -177.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 5.3 Cg_exo -77.89 127.69 8.77 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.492 2.128 . . . . 0.0 110.623 178.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.657 ' HA ' ' HB1' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -125.78 28.93 6.05 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.748 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -38.96 -33.11 0.1 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.15 0.5 . . . . 0.0 111.139 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -108.82 -34.07 6.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.071 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.7 t -69.3 -8.3 44.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.056 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -42.44 -30.52 0.86 Allowed Glycine 0 C--N 1.337 0.619 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.837 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.2 p -82.88 -39.98 20.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.859 0.361 . . . . 0.0 110.438 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -78.63 -3.31 43.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.407 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.87 -50.75 2.87 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.005 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.419 ' CD1' ' CD2' ' A' ' 18' ' ' LEU . 10.2 tp -179.13 -35.28 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.708 0.29 . . . . 0.0 110.785 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.406 ' O ' ' N ' ' A' ' 50' ' ' ILE . . . 113.83 31.03 2.4 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.535 -0.84 . . . . 0.0 113.271 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.469 HG13 ' CB ' ' A' ' 55' ' ' ALA . 27.8 m -150.07 154.0 9.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.045 0.45 . . . . 0.0 112.0 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.4 ' O ' ' N ' ' A' ' 47' ' ' LYS . 0.9 OUTLIER -111.02 115.61 29.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.315 178.627 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.1 m -108.23 142.4 20.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.046 0.45 . . . . 0.0 111.9 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.67 131.17 19.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.15 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -92.01 157.82 24.48 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.478 -0.867 . . . . 0.0 113.351 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -117.33 -176.76 3.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.723 0.297 . . . . 0.0 110.693 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.21 152.15 47.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.684 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.16 139.51 52.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.102 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.22 -29.22 70.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.999 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -83.85 -70.41 0.57 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.998 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 34.2 p30 -100.78 -174.83 2.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.978 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -93.59 45.68 1.17 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.948 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.23 114.3 26.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.082 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -56.07 133.14 51.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.002 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 47.7 mt -94.34 16.94 13.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.274 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.442 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 86.99 179.14 48.87 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.367 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.422 HG13 ' CD1' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -103.89 136.26 37.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 120.933 0.397 . . . . 0.0 111.251 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -123.98 147.77 47.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.713 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.434 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 43.0 t -58.33 105.04 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.796 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.4 ' N ' ' O ' ' A' ' 29' ' ' SER . 4.0 tptt -75.88 -40.59 54.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.689 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -168.8 115.16 0.62 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.207 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.446 HG12 HG11 ' A' ' 28' ' ' VAL . 52.9 mt -81.31 118.75 29.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.206 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.434 ' O ' ' N ' ' A' ' 52' ' ' GLY . 2.0 mp -59.07 104.9 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.565 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.47 76.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.037 0.446 . . . . 0.0 110.615 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 159.82 -27.35 0.35 Allowed Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.022 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.06 -170.03 6.46 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.473 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.657 ' HB1' ' HA ' ' A' ' 18' ' ' LEU . . . -68.67 -39.14 80.76 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.469 ' CB ' HG13 ' A' ' 28' ' ' VAL . . . -65.96 -46.34 78.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.158 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 40.1 p -63.38 -35.38 80.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.215 0.531 . . . . 0.0 109.878 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.0 mtpt -66.68 -32.14 73.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.816 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.24 -30.3 64.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.461 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.66 27.49 66.38 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.836 -0.62 . . . . 0.0 113.406 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.442 ' HG3' ' CD1' ' A' ' 14' ' ' PHE . 15.8 ptp180 -134.85 1.74 3.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 117.162 0.481 . . . . 0.0 111.592 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.448 ' CD2' ' CD2' ' A' ' 14' ' ' PHE . 3.4 mm? -108.85 152.19 25.24 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.9 0.381 . . . . 0.0 111.06 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.44 145.48 26.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.785 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.486 ' O ' ' CB ' ' A' ' 64' ' ' ASN . 60.1 t -52.96 144.32 3.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.07 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.486 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 37.9 m-20 93.37 -14.11 0.14 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.331 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -60.99 110.0 1.23 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.767 0.317 . . . . 0.0 110.726 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.411 ' HG3' ' CE2' ' A' ' 45' ' ' PHE . 11.8 tm0? -75.34 111.24 10.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.999 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.422 ' CD1' HG13 ' A' ' 44' ' ' ILE . 42.6 mt -61.02 136.97 58.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.003 0.43 . . . . 0.0 111.085 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.401 ' CD1' ' CB ' ' A' ' 106' ' ' ALA . 29.9 mt -119.84 -34.78 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.139 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.4 143.84 20.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.457 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.419 ' CG2' ' CD1' ' A' ' 101' ' ' ILE . 7.4 p -133.04 132.04 58.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.431 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 61.88 26.21 15.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.927 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.44 24.43 63.15 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.312 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -129.98 103.86 7.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.853 0.358 . . . . 0.0 110.82 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.6 t -57.23 141.07 47.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.888 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.457 ' HB3' ' CB ' ' A' ' 83' ' ' ALA . 0.7 OUTLIER -101.23 3.19 40.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.572 -179.753 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.2 tp -63.76 -15.79 59.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.574 0.226 . . . . 0.0 111.304 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -88.92 14.34 60.66 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.127 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.52 177.34 11.58 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.251 0.548 . . . . 0.0 111.333 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.62 174.05 11.76 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.748 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -60.13 -51.52 69.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.347 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.64 -38.48 84.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.873 0.368 . . . . 0.0 110.619 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.3 -40.04 74.47 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.457 ' CB ' ' HB3' ' A' ' 75' ' ' LEU . . . -69.56 -30.91 68.81 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.873 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.435 ' O ' ' HB2' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -72.58 -33.26 66.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.73 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -78.07 -30.38 49.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.114 0.483 . . . . 0.0 109.775 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.5 m -70.65 -35.96 73.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.361 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.431 ' CD1' ' N ' ' A' ' 88' ' ' ARG . 4.3 pp -78.58 -34.85 46.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.401 0.62 . . . . 0.0 109.472 178.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.435 ' HB2' ' O ' ' A' ' 84' ' ' MET . 0.2 OUTLIER -62.49 -51.46 67.36 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.272 179.368 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.465 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -71.82 -35.42 69.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.119 179.602 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.7 m -67.23 -35.61 79.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.926 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 3.5 ptp -83.92 -27.98 28.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.868 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.13 23.58 14.28 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.465 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.4 OUTLIER -155.38 -32.18 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.426 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 5.0 mt-10 -112.94 -65.49 1.18 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.916 0.389 . . . . 0.0 111.513 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.485 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -54.2 -27.57 39.56 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.575 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.406 ' O ' ' ND2' ' A' ' 96' ' ' ASN . 0.7 OUTLIER -77.49 -32.79 54.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.692 0.282 . . . . 0.0 110.59 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 93' ' ' THR . 40.6 mtpt -41.49 -40.06 1.7 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.005 0.431 . . . . 0.0 111.521 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.77 -25.24 15.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.182 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 117.33 1.55 18.3 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.788 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.478 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -158.36 142.04 15.35 Favored 'General case' 0 N--CA 1.457 -0.089 0 CA-C-O 121.07 0.462 . . . . 0.0 111.845 -179.568 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.485 ' HB ' ' HA3' ' A' ' 95' ' ' GLY . 0.1 OUTLIER -115.62 136.25 53.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.6 179.496 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.417 ' HA ' ' O ' ' A' ' 14' ' ' PHE . 2.0 pp0? -76.55 140.85 41.26 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.442 HD12 HG21 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -134.8 112.59 10.84 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -178.715 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.1 mt -98.3 112.67 30.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.428 HG23 ' CE2' ' A' ' 14' ' ' PHE . 35.7 m -124.81 143.14 39.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.978 0.418 . . . . 0.0 111.462 -178.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.401 ' CB ' ' CD1' ' A' ' 68' ' ' ILE . . . -110.83 124.78 52.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.731 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.04 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . 0.445 HG22 HD13 ' B' ' 10' ' ' ILE . 1.8 mm . . . . . 0 CA--C 1.518 -0.284 0 CA-C-O 121.204 0.526 . . . . 0.0 111.085 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' THR . . . . . 0.4 ' CB ' ' HG2' ' A' ' 84' ' ' MET . 88.9 m -71.47 99.41 2.01 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.732 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -69.51 108.02 3.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.093 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 30.1 m . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.65 -0.691 . . . . 0.0 110.651 179.65 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.721 0.296 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -81.43 151.47 27.87 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.785 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.02 122.39 5.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.022 0.439 . . . . 0.0 111.236 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.8 m -81.46 146.24 30.34 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.209 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.456 ' N ' ' O ' ' A' ' 103' ' ' LEU . 17.6 m-85 -140.63 171.55 13.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.414 0.626 . . . . 0.0 112.243 -179.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -143.65 104.88 4.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.843 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.405 ' CG2' ' CD1' ' A' ' 103' ' ' LEU . 18.7 t -105.16 114.08 63.92 Favored Pre-proline 0 C--N 1.33 -0.268 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 97.8 Cg_endo -84.79 126.98 3.52 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.454 2.103 . . . . 0.0 110.849 178.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.436 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -121.98 28.24 7.66 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -178.672 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -39.2 -32.46 0.1 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.054 0.454 . . . . 0.0 111.205 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -108.74 -34.44 6.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.122 179.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.2 t -70.68 -6.58 38.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.288 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 18' ' ' LEU . . . -42.56 -30.51 0.89 Allowed Glycine 0 C--N 1.337 0.593 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.727 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.3 p -83.01 -39.27 21.5 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.851 0.358 . . . . 0.0 110.528 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -78.61 -15.09 58.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.3 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.04 -46.37 1.39 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.645 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.465 ' O ' ' N ' ' A' ' 54' ' ' ALA . 8.2 tp 178.06 -31.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.7 0.286 . . . . 0.0 110.704 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.432 ' HA2' HD11 ' A' ' 50' ' ' ILE . . . 106.12 43.65 1.48 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.405 -0.903 . . . . 0.0 113.384 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.422 HG13 ' CG2' ' A' ' 49' ' ' ILE . 29.0 m -157.33 155.71 4.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.304 0.573 . . . . 0.0 112.073 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.74 116.91 30.85 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 19.6 m -105.93 143.34 17.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.237 0.541 . . . . 0.0 112.222 -178.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -146.54 129.01 15.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.056 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -104.85 159.66 15.72 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.47 -0.871 . . . . 0.0 112.782 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -134.71 154.03 51.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.8 0.333 . . . . 0.0 110.971 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -109.12 154.62 22.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.097 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -40.87 151.43 0.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.439 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.94 -56.1 11.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.101 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -59.52 -71.51 0.12 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.005 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -85.41 172.89 10.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.881 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -98.54 34.6 1.99 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.85 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.04 124.91 34.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.076 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -59.55 139.33 57.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.964 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 16.7 mt -100.79 -29.76 12.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.887 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 146.25 -176.8 24.99 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.296 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.422 ' N ' HD13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -105.98 140.12 25.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.675 0.274 . . . . 0.0 110.67 179.837 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -127.09 139.37 53.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.445 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.425 ' O ' HG11 ' A' ' 63' ' ' VAL . 53.2 t -58.03 106.5 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.166 179.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.7 tptp -76.08 -40.87 52.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.879 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.3 t -168.06 122.23 0.94 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.028 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.422 ' CG2' HG13 ' A' ' 28' ' ' VAL . 69.6 mt -88.59 123.02 40.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.19 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.432 HD11 ' HA2' ' A' ' 27' ' ' GLY . 1.8 mp -60.61 109.63 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.221 179.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.82 72.49 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.074 0.464 . . . . 0.0 110.963 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 163.36 -25.85 0.21 Allowed Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.383 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.427 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -71.19 -167.4 7.77 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.574 -0.822 . . . . 0.0 113.018 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 26' ' ' LEU . . . -65.41 -42.98 91.98 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.305 0.484 . . . . 0.0 112.305 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.419 ' CB ' ' CG1' ' A' ' 28' ' ' VAL . . . -64.52 -44.65 90.18 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.582 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.4 m -67.44 -29.95 69.56 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.289 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.3 mtpt -78.53 -30.84 47.22 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.293 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.86 -30.72 58.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.711 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.71 19.3 77.91 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.757 -0.735 . . . . 0.0 113.147 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.424 ' HG3' ' CD1' ' A' ' 14' ' ' PHE . 2.6 ptp180 -142.68 17.66 2.0 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.892 0.346 . . . . 0.0 110.997 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.34 130.75 56.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.638 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.42 ' HA ' HD11 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -139.51 142.56 37.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.116 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.582 ' O ' ' HB2' ' A' ' 64' ' ' ASN . 59.3 t -53.65 152.35 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.064 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.582 ' HB2' ' O ' ' A' ' 63' ' ' VAL . 9.1 m-80 78.27 13.78 1.52 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.498 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.71 114.31 26.81 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.448 ' O ' ' HA ' ' A' ' 105' ' ' VAL . 12.7 tm0? -71.31 140.41 50.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.008 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.7 mt -98.13 131.76 44.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.122 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.1 mp -116.15 -45.15 3.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.898 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -137.44 149.85 47.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.25 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.423 ' O ' ' HB2' ' A' ' 71' ' ' ASN . 7.1 p -140.91 123.22 15.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.605 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 70' ' ' VAL . 66.2 m-80 66.22 11.23 7.74 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.521 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 109.23 -18.28 30.84 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.831 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -94.05 117.29 29.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.919 0.39 . . . . 0.0 111.151 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.71 139.65 39.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.651 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.417 ' HB2' ' HB2' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -118.29 13.13 13.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.419 -179.835 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.1 tp -60.95 -20.88 62.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.654 0.264 . . . . 0.0 111.246 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -85.36 -24.87 41.72 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.91 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.431 ' HB3' ' HE2' ' A' ' 78' ' ' LYS . 5.6 ptpt -98.16 157.29 16.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.307 0.575 . . . . 0.0 111.305 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.33 166.47 1.18 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.253 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.42 ' OD1' ' N ' ' A' ' 81' ' ' GLN . 22.7 p30 -63.12 -38.97 93.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.095 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.451 ' HA ' ' HG2' ' A' ' 84' ' ' MET . 2.4 pp0? -67.18 -41.93 85.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.184 0.516 . . . . 0.0 110.469 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.94 -35.14 72.08 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.689 179.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.417 ' CB ' ' CD1' ' A' ' 44' ' ' ILE . . . -69.12 -46.51 67.48 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.581 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.507 ' HA ' ' CD2' ' A' ' 87' ' ' LEU . 4.4 ptp -62.47 -30.99 71.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.98 179.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.11 -33.91 56.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.727 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.3 m -69.81 -36.06 75.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.367 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.507 ' CD2' ' HA ' ' A' ' 84' ' ' MET . 3.7 pp -78.4 -33.91 48.47 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.442 ' HB2' ' O ' ' A' ' 84' ' ' MET . 0.6 OUTLIER -59.19 -49.98 75.79 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.342 179.108 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.85 -37.21 67.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.456 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.6 t -70.93 -29.36 65.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.399 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.427 ' HG2' ' O ' ' A' ' 88' ' ' ARG . 4.5 ptm -89.07 -22.75 22.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.64 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.0 21.92 14.39 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.488 ' O ' ' HG3' ' A' ' 97' ' ' LYS . 0.4 OUTLIER -154.23 -35.21 0.1 Allowed 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.757 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -111.86 -39.33 4.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.84 0.352 . . . . 0.0 111.362 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.462 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -70.94 -30.8 67.53 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.9 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.405 ' O ' ' ND2' ' A' ' 96' ' ' ASN . 0.9 OUTLIER -76.97 -34.09 57.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.787 0.327 . . . . 0.0 110.262 179.609 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' A' ' 93' ' ' THR . 46.2 mtpt -39.94 -45.77 1.92 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.79 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.37 -22.98 18.61 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.838 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 115.35 0.11 22.15 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.824 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.443 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -163.82 142.61 7.76 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.992 0.425 . . . . 0.0 111.193 -179.83 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.462 ' HB ' ' HA3' ' A' ' 95' ' ' GLY . 0.1 OUTLIER -112.12 142.69 23.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.326 -179.753 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.62 147.63 37.45 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.456 ' O ' ' N ' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -143.39 110.46 5.68 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -178.729 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 57.4 mt -101.36 112.54 34.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 177.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 66' ' ' GLN . 35.3 m -123.64 157.54 29.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.092 0.472 . . . . 0.0 112.091 -178.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -129.4 122.81 30.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.373 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.41 0 CA-C-O 120.953 0.406 . . . . 0.0 111.21 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 1.6 mm . . . . . 0 CA--C 1.519 -0.218 0 CA-C-O 121.165 0.507 . . . . 0.0 111.228 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 99.0 m -77.61 102.47 7.03 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.356 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 1.3 tptp -68.78 122.33 18.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.293 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 18.3 m . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.559 -0.734 . . . . 0.0 110.758 179.748 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.896 0.379 . . . . 0.0 111.094 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -92.05 148.37 22.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.572 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.422 ' HB3' ' CZ ' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -134.7 109.88 8.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.069 0.461 . . . . 0.0 111.229 -179.645 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 94.4 m -92.24 124.63 36.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.127 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.44 ' CG ' ' HB3' ' A' ' 60' ' ' ARG . 25.1 m-85 -134.83 151.36 50.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.358 0.599 . . . . 0.0 112.103 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.456 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.4 OUTLIER -111.98 110.67 21.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.097 178.948 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.438 ' CG2' ' CD1' ' A' ' 103' ' ' LEU . 11.7 t -100.33 116.52 64.33 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -177.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 84.6 Cg_endo -87.22 127.88 2.56 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.784 2.323 . . . . 0.0 111.086 178.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.609 ' HA ' ' HB1' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -127.49 28.49 5.66 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -178.987 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -39.08 -33.27 0.12 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.151 0.5 . . . . 0.0 111.179 179.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -108.04 -33.76 7.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.072 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.2 t -70.67 -6.82 39.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.141 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -41.61 -31.35 0.69 Allowed Glycine 0 C--N 1.338 0.653 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.789 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.3 p -82.52 -41.75 19.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.888 0.375 . . . . 0.0 110.386 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -77.5 -4.66 46.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.458 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.18 -50.16 3.32 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.867 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.457 ' O ' ' N ' ' A' ' 54' ' ' ALA . 9.9 tp 179.87 -33.0 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.722 0.296 . . . . 0.0 110.635 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.487 ' HA2' HD11 ' A' ' 50' ' ' ILE . . . 109.1 44.04 1.13 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.5 -0.857 . . . . 0.0 113.426 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.496 HG13 ' CB ' ' A' ' 55' ' ' ALA . 20.8 m -157.56 173.79 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.146 0.498 . . . . 0.0 112.077 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.422 ' O ' ' N ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -134.25 117.09 16.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.312 178.907 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.4 m -109.55 149.48 12.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.009 0.433 . . . . 0.0 111.937 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.421 ' O ' ' HG3' ' A' ' 31' ' ' LYS . 13.5 ptmt -143.63 133.47 23.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.595 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -95.15 150.94 19.86 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.919 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -112.16 165.69 11.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.813 0.339 . . . . 0.0 110.894 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -128.84 140.52 51.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.629 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.2 123.41 13.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.921 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.05 -32.56 74.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.955 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -75.31 -31.52 60.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.962 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -149.03 136.55 20.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.708 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -61.45 83.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.948 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.95 126.96 12.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.844 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -50.89 145.69 6.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.222 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 43.9 mt -111.34 -23.2 10.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.801 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.406 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 132.03 162.98 10.6 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.354 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.452 ' CD1' ' CB ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -98.69 136.22 30.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.059 0.457 . . . . 0.0 111.163 -179.866 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -123.69 147.16 47.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.663 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.496 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 35.0 t -60.3 104.59 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 29' ' ' SER . 24.5 tptt -72.25 -44.12 63.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.516 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 m -166.22 128.45 1.9 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.813 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.506 ' CD1' ' HB3' ' A' ' 61' ' ' LEU . 73.4 mt -94.03 121.61 44.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.145 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.487 HD11 ' HA2' ' A' ' 27' ' ' GLY . 1.6 mp -58.71 113.59 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.406 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -68.12 74.25 0.21 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.682 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 159.89 -27.22 0.34 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.112 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.425 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -69.12 -171.91 7.84 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.601 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.609 ' HB1' ' HA ' ' A' ' 18' ' ' LEU . . . -64.12 -40.54 96.41 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.187 0.439 . . . . 0.0 112.187 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.496 ' CB ' HG13 ' A' ' 28' ' ' VAL . . . -61.57 -51.13 69.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.321 -179.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.8 t -63.43 -30.09 71.27 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.104 0.478 . . . . 0.0 109.807 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.0 mtpt -74.86 -35.01 62.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.738 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -58.9 -27.12 64.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.774 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 63.3 25.25 68.23 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.57 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.44 ' HB3' ' CG ' ' A' ' 14' ' ' PHE . 19.4 mtm180 -127.44 -29.3 2.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.693 0.283 . . . . 0.0 111.224 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.506 ' HB3' ' CD1' ' A' ' 49' ' ' ILE . 2.3 mp -74.13 143.19 45.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.117 0.484 . . . . 0.0 111.291 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.83 134.83 23.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.313 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.496 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 58.1 t -53.68 143.05 6.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.587 -0.278 . . . . 0.0 110.908 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 30.5 m-20 89.7 -8.88 0.39 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.073 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -63.11 110.21 1.76 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.854 0.359 . . . . 0.0 110.725 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.402 ' NE2' ' O ' ' A' ' 67' ' ' LEU . 20.7 tm0? -74.28 112.93 10.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.915 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.445 ' HB2' HG12 ' A' ' 44' ' ' ILE . 45.7 mt -66.84 146.44 54.42 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.044 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 52.9 mt -135.77 -42.67 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.277 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.0 126.04 13.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.067 0.461 . . . . 0.0 111.621 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.4 p -118.56 127.55 75.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.152 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.422 ' ND2' ' HB3' ' A' ' 90' ' ' SER . 2.3 m-80 62.0 35.1 16.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.959 0.409 . . . . 0.0 110.293 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 68.64 24.1 75.38 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.166 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -126.34 98.11 5.32 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.73 0.3 . . . . 0.0 110.822 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.0 t -60.81 136.95 58.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.815 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.38 12.53 34.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.309 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 12.8 mt -63.89 -23.52 67.38 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.72 0.295 . . . . 0.0 111.011 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -93.05 21.16 41.41 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.736 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -150.73 167.02 28.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.176 0.512 . . . . 0.0 111.052 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.25 175.71 9.95 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.174 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -61.73 -55.83 26.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.239 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -53.9 -38.94 65.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.009 0.433 . . . . 0.0 111.222 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.62 -37.4 73.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.22 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.452 ' CB ' ' CD1' ' A' ' 44' ' ' ILE . . . -68.96 -47.6 65.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.821 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.467 ' HA ' ' CD2' ' A' ' 87' ' ' LEU . 9.1 ptp -62.88 -30.08 71.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.295 -0.412 . . . . 0.0 109.945 179.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -79.12 -35.66 41.83 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 178.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.8 m -67.68 -35.84 79.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.194 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.467 ' CD2' ' HA ' ' A' ' 84' ' ' MET . 4.4 pp -78.22 -33.88 49.64 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 178.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.446 ' O ' ' HG2' ' A' ' 91' ' ' MET . 0.0 OUTLIER -56.17 -50.05 72.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.007 178.962 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.677 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.35 -49.74 31.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.313 178.734 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.422 ' HB3' ' ND2' ' A' ' 71' ' ' ASN . 1.4 m -54.75 -29.38 53.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.602 179.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.446 ' HG2' ' O ' ' A' ' 88' ' ' ARG . 1.5 ptp -89.98 -37.85 14.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.306 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.21 37.91 2.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.988 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.677 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 72.3 m -162.56 -41.48 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.566 -0.454 . . . . 0.0 112.214 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -111.62 -48.58 3.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.058 0.456 . . . . 0.0 110.777 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.44 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -69.74 -20.45 75.86 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.146 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.428 ' O ' ' ND2' ' A' ' 96' ' ' ASN . 0.7 OUTLIER -83.09 -32.26 26.85 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.653 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -40.8 -35.88 0.55 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.383 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.25 -30.72 11.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.69 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 125.93 -6.14 7.83 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.689 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.456 ' SD ' ' HB3' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -153.97 143.64 21.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.983 0.42 . . . . 0.0 111.147 -179.924 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.44 ' HB ' ' HA3' ' A' ' 95' ' ' GLY . 0.1 OUTLIER -109.42 147.14 14.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.452 -179.707 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.47 143.47 34.92 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.438 ' CD1' ' CG2' ' A' ' 16' ' ' VAL . 0.3 OUTLIER -138.65 148.22 43.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.125 0.488 . . . . 0.0 111.902 -179.072 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.9 mt -144.63 113.33 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.047 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 30.0 m -124.3 179.32 2.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.468 -179.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -147.75 139.89 24.28 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.93 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.997 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 mm . . . . . 0 N--CA 1.453 -0.309 0 CA-C-O 121.038 0.446 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 55.2 m -123.41 104.36 9.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.568 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.67 102.84 5.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.026 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 35.2 m . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.936 179.731 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.031 0 CA-C-O 121.005 0.431 . . . . 0.0 111.291 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -104.07 145.32 30.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.413 179.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.419 ' CD1' ' CG2' ' A' ' 105' ' ' VAL . 0.0 OUTLIER -134.32 119.58 18.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.025 0.44 . . . . 0.0 111.301 -179.676 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.409 ' O ' ' CD1' ' A' ' 14' ' ' PHE . 90.0 m -86.68 143.02 27.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.975 179.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.421 ' CE1' ' HG2' ' A' ' 60' ' ' ARG . 24.9 m-85 -139.59 169.41 17.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.286 0.565 . . . . 0.0 112.158 -179.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -139.52 107.54 5.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.173 -0.921 . . . . 0.0 108.923 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.437 ' CG2' ' CD1' ' A' ' 103' ' ' LEU . 17.6 t -104.28 111.43 65.17 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -177.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 84.6 Cg_endo -81.72 127.71 5.71 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.441 2.094 . . . . 0.0 110.794 178.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.658 ' HA ' ' HB3' ' A' ' 54' ' ' ALA . 0.5 OUTLIER -125.44 29.15 6.1 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.595 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -39.56 -32.75 0.14 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.112 0.482 . . . . 0.0 111.245 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -109.18 -35.26 6.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.105 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.9 t -67.83 -9.65 46.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.099 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.403 ' HA2' ' CD1' ' A' ' 18' ' ' LEU . . . -43.01 -29.76 0.92 Allowed Glycine 0 C--N 1.339 0.713 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.808 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.3 m -82.58 -39.09 22.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.884 0.373 . . . . 0.0 110.572 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -78.28 -20.85 50.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.197 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.29 -50.31 0.78 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.833 -0.698 . . . . 0.0 111.507 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.428 ' O ' ' N ' ' A' ' 54' ' ' ALA . 10.9 tp 179.0 -32.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.56 0.219 . . . . 0.0 110.836 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.424 ' HA3' ' HA3' ' A' ' 53' ' ' GLY . . . 110.79 37.74 1.67 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.342 -0.932 . . . . 0.0 113.171 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.488 HG11 ' CB ' ' A' ' 55' ' ' ALA . 14.4 m -156.51 164.37 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.229 0.538 . . . . 0.0 111.957 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.0 m -123.73 115.18 20.97 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.17 178.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.5 m -106.75 141.12 22.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.089 0.471 . . . . 0.0 111.93 -178.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.53 131.28 19.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.101 179.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -102.25 162.36 17.0 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.442 -0.885 . . . . 0.0 113.052 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -135.94 156.58 48.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.949 0.404 . . . . 0.0 111.019 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.454 ' HD2' ' HA ' ' A' ' 39' ' ' HIS . 0.0 OUTLIER -108.87 152.28 25.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.736 179.972 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.11 137.58 17.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.983 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.19 -23.81 65.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.494 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -71.14 -51.02 27.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.079 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -135.34 160.29 38.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.838 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.454 ' HA ' ' HD2' ' A' ' 34' ' ' ARG . 74.5 m-70 -70.39 66.0 0.3 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.87 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -126.17 121.34 32.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.172 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.411 ' CB ' ' ND2' ' A' ' 80' ' ' ASN . 3.4 p-10 -53.39 145.21 14.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.383 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 32.4 mt -109.71 -29.83 8.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.47 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.414 ' HA3' ' NE2' ' A' ' 66' ' ' GLN . . . 142.12 -178.58 20.67 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.995 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.44 ' CD1' ' CB ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -108.05 140.56 26.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.965 0.412 . . . . 0.0 111.219 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -128.6 142.3 51.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.708 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.529 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 40.0 t -57.58 104.33 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.784 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 36.4 tptt -72.66 -42.91 63.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.801 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.47 129.62 1.61 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.084 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.474 ' CD1' ' HB3' ' A' ' 61' ' ' LEU . 78.0 mt -95.16 118.31 41.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.212 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.42 ' O ' ' N ' ' A' ' 52' ' ' GLY . 1.8 mp -55.03 107.09 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.619 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.52 77.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.112 0.482 . . . . 0.0 110.593 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 155.27 -26.21 0.61 Allowed Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.872 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.424 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -67.73 -172.41 6.27 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.621 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.658 ' HB3' ' HA ' ' A' ' 18' ' ' LEU . . . -64.76 -39.35 93.47 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.488 ' CB ' HG11 ' A' ' 28' ' ' VAL . . . -64.79 -48.66 73.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.269 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 60.1 p -63.03 -31.51 72.67 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.864 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 34.6 mtpt -75.23 -34.43 61.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.911 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -59.53 -27.65 66.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.741 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.47 40.0 95.62 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.662 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.421 ' HG2' ' CE1' ' A' ' 14' ' ' PHE . 4.5 mtm180 -134.88 -40.96 0.76 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.857 0.361 . . . . 0.0 110.913 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.474 ' HB3' ' CD1' ' A' ' 49' ' ' ILE . 3.7 mp -58.22 166.89 1.47 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.294 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.6 mtm105 -162.15 118.78 2.04 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.301 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.529 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 34.1 t -47.98 143.12 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.385 -179.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.427 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 22.3 m-80 85.76 -5.36 0.83 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.326 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.15 127.41 32.53 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.754 0.311 . . . . 0.0 110.388 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.414 ' NE2' ' HA3' ' A' ' 43' ' ' GLY . 0.8 OUTLIER -79.66 136.37 36.79 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.678 -179.631 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.7 mt -89.0 133.04 34.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.274 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.8 mm -116.8 -30.09 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.994 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.86 159.02 32.0 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.06 0.457 . . . . 0.0 111.203 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.0 p -145.74 125.07 5.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.416 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 61.17 18.22 8.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.922 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.75 25.36 23.02 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.114 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -124.65 101.06 6.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.736 0.303 . . . . 0.0 110.692 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.5 p -62.67 138.26 58.46 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.018 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -104.39 -16.27 15.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.239 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.5 tp -55.27 89.72 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.913 0.387 . . . . 0.0 111.13 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 156.7 -27.92 0.53 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.294 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.458 ' HD3' ' HB3' ' A' ' 82' ' ' GLU . 0.5 OUTLIER -106.63 159.54 16.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.253 0.549 . . . . 0.0 111.048 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.13 158.0 12.08 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.135 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.411 ' ND2' ' CB ' ' A' ' 41' ' ' ASP . 26.7 m-80 -51.18 -57.38 8.91 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.164 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.429 ' NE2' ' CG ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -51.65 -37.72 51.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.562 -179.47 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.458 ' HB3' ' HD3' ' A' ' 78' ' ' LYS . 1.9 mt-10 -70.92 -40.9 71.83 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.055 0.455 . . . . 0.0 110.331 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.44 ' CB ' ' CD1' ' A' ' 44' ' ' ILE . . . -66.53 -50.07 64.41 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.835 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.45 ' HA ' ' CD2' ' A' ' 87' ' ' LEU . 5.6 ptp -60.92 -29.65 69.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.062 179.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -76.98 -33.73 57.61 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.4 m -67.95 -36.88 80.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.224 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.45 ' CD2' ' HA ' ' A' ' 84' ' ' MET . 4.4 pp -78.43 -33.36 48.59 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.462 ' O ' ' HG2' ' A' ' 91' ' ' MET . 0.0 OUTLIER -58.1 -49.03 78.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.262 178.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.467 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -73.15 -44.29 60.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.065 179.293 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.7 t -62.9 -29.8 71.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.178 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.462 ' HG2' ' O ' ' A' ' 88' ' ' ARG . 3.3 ptm -89.81 -25.25 21.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.701 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.21 31.72 6.55 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.467 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.3 OUTLIER -164.25 -33.31 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 179.849 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.411 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 7.7 mt-10 -111.09 -69.04 0.89 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.803 0.335 . . . . 0.0 111.37 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.415 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -48.8 -27.44 6.36 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.604 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.402 ' O ' ' ND2' ' A' ' 96' ' ' ASN . 0.7 OUTLIER -76.41 -33.13 58.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.626 0.25 . . . . 0.0 110.434 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 94' ' ' GLU . 38.0 mtpt -39.62 -41.51 1.06 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.066 0.46 . . . . 0.0 111.373 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.63 -26.99 15.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.061 179.092 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.434 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 120.5 -3.51 12.26 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.883 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.435 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.3 OUTLIER -154.0 141.32 19.61 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.89 0.376 . . . . 0.0 111.412 -179.628 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.437 ' CG2' ' CD2' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -110.27 141.69 24.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.036 179.82 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.61 150.47 36.45 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.437 ' CD1' ' CG2' ' A' ' 16' ' ' VAL . 0.4 OUTLIER -144.24 112.01 6.18 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.99 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 76.4 mt -103.39 113.27 39.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.419 ' CG2' ' CD1' ' A' ' 12' ' ' LEU . 16.9 m -120.99 174.99 5.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.857 0.36 . . . . 0.0 111.542 -179.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -147.36 142.82 27.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.206 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.4 ' HD2' HD12 ' A' ' 12' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.783 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 1.4 mm . . . . . 0 N--CA 1.454 -0.248 0 CA-C-O 121.185 0.516 . . . . 0.0 111.226 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 28.0 m -94.84 109.61 21.58 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.644 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 7.0 tppt? -70.99 126.72 30.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.095 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 4.1 m . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.554 -0.736 . . . . 0.0 110.862 179.747 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.801 0.334 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -86.96 147.5 25.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.891 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.77 110.46 7.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.204 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 71.2 m -103.89 128.03 51.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.489 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -140.95 172.65 12.38 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 121.354 0.597 . . . . 0.0 112.341 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -127.8 111.19 13.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.853 179.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.473 HG11 ' HA ' ' A' ' 55' ' ' ALA . 66.5 t -103.99 113.66 65.16 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -177.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.512 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 83.3 Cg_endo -84.13 127.58 4.06 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.373 2.049 . . . . 0.0 110.748 177.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.556 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -122.54 30.05 6.66 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -178.628 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -36.94 -33.87 0.06 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.172 0.511 . . . . 0.0 111.291 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -111.57 -34.47 6.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.16 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.407 ' HB3' ' HB2' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -66.26 -13.83 61.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.943 179.761 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.414 ' HA2' ' CD1' ' A' ' 18' ' ' LEU . . . -45.97 -28.01 2.69 Favored Glycine 0 C--N 1.337 0.608 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.78 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.33 -36.02 27.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.847 0.356 . . . . 0.0 110.78 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -82.64 -24.43 33.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.253 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.78 -54.59 0.64 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.932 -0.652 . . . . 0.0 111.481 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.475 ' O ' ' N ' ' A' ' 54' ' ' ALA . 10.0 tp 179.41 -35.3 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.616 0.246 . . . . 0.0 110.893 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 50' ' ' ILE . . . 117.28 32.69 1.45 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.296 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.513 HG12 ' CB ' ' A' ' 55' ' ' ALA . 33.4 m -157.88 157.04 3.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.121 0.486 . . . . 0.0 111.897 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.92 116.05 26.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.431 178.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.9 m -106.76 142.64 19.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.014 0.435 . . . . 0.0 111.691 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.5 135.18 33.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.617 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.477 ' HA3' ' HB2' ' A' ' 80' ' ' ASN . . . -89.73 152.42 22.43 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.013 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.44 ' ND2' ' CE1' ' A' ' 45' ' ' PHE . 91.2 m-20 -120.77 163.74 17.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.757 0.313 . . . . 0.0 110.873 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -116.44 151.76 35.38 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.752 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.97 167.71 0.11 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.207 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.11 -56.13 11.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.105 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -116.93 -38.22 3.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.031 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -55.06 -24.35 24.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.202 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 60.68 32.8 20.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.002 0.43 . . . . 0.0 110.737 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -107.87 135.43 49.28 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.009 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -58.17 122.3 12.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.809 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 16.0 mt -82.66 -30.23 29.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.2 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.465 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 140.99 177.85 16.68 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.017 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.425 ' CD1' ' CB ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -99.79 134.13 40.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.951 0.405 . . . . 0.0 111.297 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.468 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -123.15 143.29 50.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.54 -179.896 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.501 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 42.6 t -55.78 104.52 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.856 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.3 tptp -74.05 -42.17 60.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.644 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.42 125.57 1.53 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.949 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.532 ' CD1' ' HB3' ' A' ' 61' ' ' LEU . 69.8 mt -89.94 120.77 39.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.275 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.414 ' N ' ' O ' ' A' ' 27' ' ' GLY . 2.1 mp -61.88 108.87 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.794 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -66.68 74.24 0.1 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.926 0.393 . . . . 0.0 110.399 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 164.47 -28.04 0.21 Allowed Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.119 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.15 -176.33 23.28 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.601 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.556 ' HB2' ' HA ' ' A' ' 18' ' ' LEU . . . -61.27 -41.15 96.43 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.513 ' CB ' HG12 ' A' ' 28' ' ' VAL . . . -64.76 -48.0 76.16 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.9 0.381 . . . . 0.0 111.58 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.414 ' CB ' ' O ' ' A' ' 50' ' ' ILE . 5.6 t -63.36 -29.06 70.43 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.219 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 32.4 mtpt -75.1 -28.99 60.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.933 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.31 -26.99 69.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.016 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.11 20.24 57.89 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.282 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.9 mtm180 -118.52 -28.28 5.73 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.909 0.385 . . . . 0.0 110.791 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.532 ' HB3' ' CD1' ' A' ' 49' ' ' ILE . 0.6 OUTLIER -68.94 149.81 48.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.1 0.476 . . . . 0.0 111.271 -179.735 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 76.1 mtm-85 -146.98 128.64 15.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.722 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.501 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 46.6 t -55.39 143.91 7.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.042 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.438 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 19.2 m-20 85.21 10.37 0.31 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.136 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -88.67 115.79 26.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.822 0.344 . . . . 0.0 110.402 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 10.9 tm0? -75.31 123.28 25.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.9 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.407 HD12 ' CD2' ' A' ' 87' ' ' LEU . 9.4 mt -75.28 133.86 41.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.24 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 18.3 mt -114.47 -28.02 2.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.281 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -158.4 166.47 32.16 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.104 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.403 HG21 ' CD1' ' A' ' 103' ' ' LEU . 12.0 p -154.05 126.07 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.009 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 58.69 20.17 7.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.051 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.35 28.05 18.46 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.957 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -128.5 101.48 6.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.841 0.353 . . . . 0.0 110.747 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.1 t -66.81 133.26 49.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.816 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -93.8 -11.32 31.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.297 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.1 mt -54.01 91.52 0.01 OUTLIER 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.82 0.343 . . . . 0.0 111.118 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 151.21 -29.21 0.98 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.884 -0.675 . . . . 0.0 112.259 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.461 ' HD3' ' HB3' ' A' ' 82' ' ' GLU . 5.5 ptpp? -104.29 152.2 22.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.193 0.521 . . . . 0.0 110.943 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.85 149.73 6.05 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.108 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.477 ' HB2' ' HA3' ' A' ' 32' ' ' GLY . 25.1 p30 -52.8 -30.4 33.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.222 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.459 ' HA ' ' HG2' ' A' ' 84' ' ' MET . 1.1 pp0? -73.9 -38.28 64.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.274 0.559 . . . . 0.0 110.328 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.461 ' HB3' ' HD3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -70.23 -33.82 72.13 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.739 179.13 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.425 ' CB ' ' CD1' ' A' ' 44' ' ' ILE . . . -69.2 -44.96 71.07 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.77 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.459 ' HG2' ' HA ' ' A' ' 81' ' ' GLN . 6.1 ptp -63.53 -30.83 71.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.304 -0.407 . . . . 0.0 109.992 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -78.17 -32.98 50.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.518 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.527 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 1.9 m -69.81 -35.09 74.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.541 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.451 ' HA ' ' OG ' ' A' ' 90' ' ' SER . 4.2 pp -78.01 -34.22 50.82 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.42 ' N ' ' CD1' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -61.01 -51.11 70.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.926 -1.033 . . . . 0.0 110.964 179.464 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.527 ' HD3' ' O ' ' A' ' 86' ' ' THR . 0.0 OUTLIER -72.25 -33.39 67.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.373 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.451 ' OG ' ' HA ' ' A' ' 87' ' ' LEU . 66.6 p -71.95 -29.84 64.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.991 0.424 . . . . 0.0 110.49 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 2.9 ptp -85.42 -23.07 28.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.358 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.3 m -117.42 27.01 9.34 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.47 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.4 OUTLIER -156.81 -31.64 0.09 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.905 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.417 ' HG3' HG22 ' A' ' 93' ' ' THR . 7.0 mt-10 -115.98 -45.93 2.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.887 0.375 . . . . 0.0 111.518 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.485 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -72.23 -32.6 62.6 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.844 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.41 ' O ' ' ND2' ' A' ' 96' ' ' ASN . 0.8 OUTLIER -73.32 -32.83 64.82 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.577 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' A' ' 93' ' ' THR . 47.5 mtpt -41.12 -41.44 1.76 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.263 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.2 -27.58 16.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.688 178.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.509 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 115.77 0.82 21.39 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.696 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.512 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.2 OUTLIER -153.89 140.59 19.0 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 120.986 0.422 . . . . 0.0 111.429 -179.627 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.485 ' HB ' ' HA3' ' A' ' 95' ' ' GLY . 0.1 OUTLIER -113.29 144.15 21.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.733 179.615 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.51 142.3 31.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.04 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.452 HD21 HG12 ' A' ' 101' ' ' ILE . 2.9 mm? -131.25 136.09 47.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.98 0.419 . . . . 0.0 111.848 -179.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 73.4 mt -128.56 112.89 27.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.325 178.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.0 m -127.16 173.58 12.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.133 0.492 . . . . 0.0 111.441 -178.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -147.45 128.09 14.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.263 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 120.977 0.418 . . . . 0.0 111.25 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . 0.448 HG22 HD13 ' B' ' 10' ' ' ILE . 3.2 mm . . . . . 0 CA--C 1.521 -0.147 0 CA-C-O 121.206 0.527 . . . . 0.0 111.006 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 92.1 m -73.16 99.51 2.84 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.852 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.1 110.75 14.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.922 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 15.7 m . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.343 -0.837 . . . . 0.0 111.039 179.875 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 . . . . . 0 C--O 1.233 0.189 0 CA-C-O 120.905 0.383 . . . . 0.0 111.281 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -91.75 150.31 21.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.521 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.16 113.08 8.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.908 0.385 . . . . 0.0 111.62 -179.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 98.4 m -98.86 133.57 42.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.778 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.466 ' O ' ' HA ' ' A' ' 102' ' ' GLN . 52.0 m-85 -141.55 172.69 12.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.118 0.485 . . . . 0.0 111.939 -179.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.427 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.6 OUTLIER -128.53 109.51 11.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.547 179.272 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 34.2 t -104.55 109.21 62.5 Favored Pre-proline 0 C--N 1.33 -0.246 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.418 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 83.5 Cg_endo -81.48 127.64 5.85 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.418 2.079 . . . . 0.0 110.762 178.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.682 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -121.22 29.07 7.48 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -178.849 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -37.84 -31.4 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.366 179.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -112.95 -33.77 5.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.26 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.404 ' HB3' ' CB ' ' A' ' 18' ' ' LEU . 25.9 t -69.77 -9.87 56.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.209 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -45.57 -28.51 2.46 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.795 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.53 -35.12 25.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.85 0.357 . . . . 0.0 110.698 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -82.51 -24.45 34.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.129 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.44 -51.98 0.71 Allowed Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.448 ' O ' ' N ' ' A' ' 54' ' ' ALA . 10.5 tp 179.45 -35.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.658 0.266 . . . . 0.0 110.633 179.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.409 ' O ' ' N ' ' A' ' 50' ' ' ILE . . . 116.26 34.46 1.33 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.473 -0.87 . . . . 0.0 113.232 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.505 HG12 ' CB ' ' A' ' 55' ' ' ALA . 33.1 m -157.22 157.02 3.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 117.153 0.477 . . . . 0.0 112.0 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.4 ' O ' ' N ' ' A' ' 47' ' ' LYS . 0.9 OUTLIER -117.65 123.9 47.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.342 178.81 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.4 m -106.69 153.97 7.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.171 0.51 . . . . 0.0 112.32 -178.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.4 132.27 13.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.35 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' A' ' 44' ' ' ILE . . . -107.64 153.97 16.69 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.473 -0.87 . . . . 0.0 113.153 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.407 ' OD1' ' HB2' ' A' ' 42' ' ' LEU . 18.2 p-10 -106.73 -179.16 3.86 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.177 0.513 . . . . 0.0 111.318 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -135.86 127.54 29.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.53 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.6 t -38.61 134.67 0.9 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.739 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.13 -35.13 79.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.267 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -73.74 -57.34 4.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.012 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -119.26 161.07 21.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.932 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 40.6 m-70 -77.84 61.94 2.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.867 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.23 126.76 48.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.993 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -61.49 131.46 50.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.01 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.407 ' HB2' ' OD1' ' A' ' 33' ' ' ASN . 11.6 mt -89.54 -24.62 21.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.896 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.426 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 140.31 169.92 11.86 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.346 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.464 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -101.37 140.45 20.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.8 0.333 . . . . 0.0 111.309 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.436 ' CE2' ' HG3' ' A' ' 66' ' ' GLN . 0.1 OUTLIER -126.31 143.14 51.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.611 179.858 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.473 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 44.8 t -55.35 105.42 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.412 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.4 ' N ' ' O ' ' A' ' 29' ' ' SER . 18.3 tptt -72.6 -43.61 63.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.679 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.2 m -165.01 126.53 2.07 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.999 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.446 ' HA ' HG13 ' A' ' 28' ' ' VAL . 66.9 mt -91.82 119.04 38.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.324 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.45 ' O ' ' N ' ' A' ' 52' ' ' GLY . 1.9 mp -58.83 101.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.571 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -59.96 80.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.08 0.467 . . . . 0.0 110.584 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 153.63 -30.34 0.76 Allowed Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.624 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.37 -174.98 3.02 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.585 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.682 ' HB2' ' HA ' ' A' ' 18' ' ' LEU . . . -65.13 -36.22 83.58 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -179.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.505 ' CB ' HG12 ' A' ' 28' ' ' VAL . . . -68.74 -45.87 70.35 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.748 0.309 . . . . 0.0 111.551 -179.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.56 -29.9 70.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.104 0.478 . . . . 0.0 110.053 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.1 mtpt -72.77 -32.67 65.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.971 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.409 ' OD1' ' NH2' ' A' ' 60' ' ' ARG . 1.3 t0 -57.49 -29.78 64.56 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.787 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.16 16.84 75.37 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.045 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.409 ' NH2' ' OD1' ' A' ' 58' ' ' ASP . 0.6 OUTLIER -128.82 -2.03 5.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.933 0.366 . . . . 0.0 111.202 179.837 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.03 125.04 40.3 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.007 0.432 . . . . 0.0 111.472 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.41 ' HD2' ' N ' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -128.66 140.28 51.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.556 179.707 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.666 ' O ' ' HB2' ' A' ' 64' ' ' ASN . 39.7 t -61.41 150.86 7.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.461 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.666 ' HB2' ' O ' ' A' ' 63' ' ' VAL . 22.4 m-80 83.44 3.37 0.93 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.05 0.54 . . . . 0.0 111.95 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.1 117.76 21.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.852 0.358 . . . . 0.0 110.298 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.436 ' HG3' ' CE2' ' A' ' 45' ' ' PHE . 9.9 tm0? -75.73 115.03 14.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.248 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.407 HD11 ' CD2' ' A' ' 87' ' ' LEU . 32.8 mt -63.34 152.01 39.19 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.153 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 21.1 mt -136.77 -43.65 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.169 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -143.18 150.97 40.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.966 0.412 . . . . 0.0 111.399 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.403 ' CG2' HD13 ' A' ' 101' ' ' ILE . 10.3 p -140.62 116.28 7.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.819 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 55.79 55.36 7.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.789 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 60.89 18.69 54.53 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.435 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -118.11 88.72 2.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.881 0.372 . . . . 0.0 110.82 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.3 m -62.0 118.46 7.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.026 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.1 mt -73.59 -16.52 61.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.214 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -53.33 91.5 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.927 0.394 . . . . 0.0 111.133 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 152.77 -28.62 0.83 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.256 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.3 ptpp? -106.38 154.69 20.44 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.215 0.531 . . . . 0.0 110.963 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.36 156.42 3.29 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.303 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -53.85 -42.47 68.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.316 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -66.42 -38.01 86.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.966 0.412 . . . . 0.0 110.872 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.69 -33.18 72.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.185 0.517 . . . . 0.0 110.109 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.13 -46.69 67.01 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.782 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.413 ' HA ' ' CD2' ' A' ' 87' ' ' LEU . 6.1 ptp -63.26 -31.97 73.26 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.333 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -80.42 -32.05 37.46 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.6 m -68.73 -36.44 78.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.29 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.425 ' CD1' ' N ' ' A' ' 88' ' ' ARG . 4.3 pp -78.54 -35.05 46.7 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.369 0.604 . . . . 0.0 109.388 178.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.465 ' O ' ' HG2' ' A' ' 91' ' ' MET . 0.0 OUTLIER -60.04 -48.54 81.31 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.171 179.422 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.461 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.82 -42.33 63.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.964 179.329 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.0 t -62.75 -29.42 70.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.179 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.465 ' HG2' ' O ' ' A' ' 88' ' ' ARG . 3.2 ptp -85.47 -30.86 23.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.658 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.2 30.31 6.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.701 -179.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.461 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.4 OUTLIER -158.86 -28.98 0.07 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -179.79 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.455 ' HG3' HG22 ' A' ' 93' ' ' THR . 4.9 mt-10 -122.1 -38.98 2.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.959 0.409 . . . . 0.0 111.103 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.501 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -78.63 -31.45 45.05 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.724 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.43 ' O ' ' ND2' ' A' ' 96' ' ' ASN . 0.7 OUTLIER -75.02 -33.43 61.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.786 0.326 . . . . 0.0 110.14 179.493 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.453 ' HD3' ' O ' ' A' ' 93' ' ' THR . 26.2 mmmt -43.52 -44.8 6.23 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.157 0.504 . . . . 0.0 111.108 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.58 -23.57 21.94 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.715 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 113.69 -1.3 24.67 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.789 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.427 ' SD ' ' HB3' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -163.06 143.24 9.14 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.055 0.455 . . . . 0.0 111.341 -179.639 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.501 ' HB ' ' HA3' ' A' ' 95' ' ' GLY . 0.1 OUTLIER -116.47 139.77 41.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.277 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.466 ' HA ' ' O ' ' A' ' 14' ' ' PHE . 3.0 pp0? -87.25 135.32 33.36 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.441 HD22 ' O ' ' A' ' 101' ' ' ILE . 2.2 mm? -121.33 138.31 54.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.285 0.564 . . . . 0.0 112.286 -179.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 96.2 mt -120.02 112.67 37.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.278 178.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.5 m -125.98 154.06 34.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.448 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -125.63 135.31 52.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.417 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 CA-C-O 121.099 0.476 . . . . 0.0 111.52 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 1.6 mm . . . . . 0 N--CA 1.456 -0.172 0 CA-C-O 121.223 0.535 . . . . 0.0 111.388 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 22.7 m -101.21 100.5 11.04 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.442 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.16 124.09 23.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.219 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 12.0 m . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.386 -0.816 . . . . 0.0 110.797 179.593 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.875 0.369 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -78.43 136.06 37.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.638 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.58 111.08 11.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.902 0.382 . . . . 0.0 111.29 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.412 ' O ' ' CD1' ' A' ' 14' ' ' PHE . 99.2 m -99.93 132.12 45.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.346 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.432 ' CD1' ' HG2' ' A' ' 60' ' ' ARG . 28.4 m-85 -140.69 172.52 12.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.321 0.582 . . . . 0.0 112.202 -179.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.44 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.4 OUTLIER -130.74 111.24 11.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.276 179.295 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.2 t -103.65 117.01 60.91 Favored Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -178.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 82.9 Cg_endo -86.97 128.07 2.69 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.738 2.292 . . . . 0.0 110.898 178.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.694 ' HA ' ' HB3' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -122.71 28.75 7.16 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -178.899 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -38.38 -31.96 0.06 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.319 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -111.92 -32.5 6.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.123 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.418 ' HB3' ' CB ' ' A' ' 18' ' ' LEU . 25.0 t -71.74 -5.21 32.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.308 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.401 ' HA2' ' CD1' ' A' ' 18' ' ' LEU . . . -44.43 -29.37 1.75 Allowed Glycine 0 C--N 1.337 0.605 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.726 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.1 m -85.03 -35.1 22.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.001 0.429 . . . . 0.0 110.657 179.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.92 5.14 34.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.424 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.81 -56.35 5.04 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.958 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.447 ' O ' ' N ' ' A' ' 54' ' ' ALA . 8.4 tp -175.06 -36.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.635 0.255 . . . . 0.0 110.839 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.45 ' HA2' HD11 ' A' ' 50' ' ' ILE . . . 113.83 45.54 0.7 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.554 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.476 HG12 ' CB ' ' A' ' 55' ' ' ALA . 23.4 m -157.16 156.71 4.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.185 0.517 . . . . 0.0 112.122 179.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.414 ' O ' ' HB3' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -116.07 114.63 24.8 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.091 178.582 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.43 ' CG2' ' HG2' ' A' ' 84' ' ' MET . 0.0 OUTLIER -108.88 146.4 14.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.14 0.495 . . . . 0.0 111.993 -178.683 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.43 131.03 19.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.306 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' A' ' 44' ' ' ILE . . . -96.85 155.18 20.74 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.967 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -104.2 -171.19 1.89 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.864 0.364 . . . . 0.0 110.821 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.469 ' CD ' ' O ' ' A' ' 35' ' ' SER . 0.0 OUTLIER -145.17 141.27 28.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.505 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.469 ' O ' ' CD ' ' A' ' 34' ' ' ARG . 0.2 OUTLIER -43.7 146.68 0.52 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.119 0.485 . . . . 0.0 111.905 -179.246 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.03 -19.36 65.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.36 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -103.13 -82.27 0.49 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.692 0.282 . . . . 0.0 111.393 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -98.19 166.5 11.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.116 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.431 ' HA ' ' CG ' ' A' ' 34' ' ' ARG . 88.3 m-70 -66.74 73.52 0.1 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.917 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.65 88.34 2.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.866 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -37.97 121.93 0.97 Allowed 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.918 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 19.2 mt -88.92 6.67 38.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.04 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.437 ' HA3' ' NE2' ' A' ' 66' ' ' GLN . . . 103.16 -174.31 23.02 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.384 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.471 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -114.45 144.7 21.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.842 0.353 . . . . 0.0 111.478 -179.719 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -127.44 143.16 51.24 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.714 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.496 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 41.9 t -60.04 104.37 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.486 179.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.414 ' HB3' ' O ' ' A' ' 29' ' ' SER . 2.8 tptt -73.37 -42.35 62.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.881 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.0 m -168.66 122.6 0.86 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.028 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.514 ' CD1' ' HB3' ' A' ' 61' ' ' LEU . 75.1 mt -84.82 116.55 28.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.908 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.45 HD11 ' HA2' ' A' ' 27' ' ' GLY . 1.8 mp -52.65 101.91 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.742 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -60.1 80.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.129 0.49 . . . . 0.0 110.628 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 153.58 -30.0 0.76 Allowed Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.718 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.07 -171.19 2.82 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.366 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.694 ' HB3' ' HA ' ' A' ' 18' ' ' LEU . . . -68.43 -37.12 79.97 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.476 ' CB ' HG12 ' A' ' 28' ' ' VAL . . . -66.48 -43.54 85.15 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.468 -179.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.92 -32.11 70.24 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.049 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 26.7 mtpt -72.29 -33.21 67.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.852 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -62.16 -26.79 68.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.795 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.64 37.31 92.1 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.641 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.432 ' HG2' ' CD1' ' A' ' 14' ' ' PHE . 7.3 mtm180 -131.4 -33.48 1.46 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.674 0.273 . . . . 0.0 110.949 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.514 ' HB3' ' CD1' ' A' ' 49' ' ' ILE . 2.1 mp -64.45 157.89 25.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.048 0.451 . . . . 0.0 111.185 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -149.49 124.05 9.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.521 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.496 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 41.2 t -56.9 143.05 11.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.198 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.435 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 21.5 m-20 86.26 -2.78 0.73 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.238 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -78.43 124.03 27.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.718 0.295 . . . . 0.0 110.52 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.459 ' O ' ' HA ' ' A' ' 105' ' ' VAL . 0.7 OUTLIER -74.9 134.46 41.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.665 -179.86 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.3 mt -86.17 137.8 32.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.754 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 24.5 mt -120.99 -37.27 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.458 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.92 170.8 17.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.904 0.383 . . . . 0.0 111.275 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.43 HG21 ' OG ' ' A' ' 90' ' ' SER . 7.2 p -157.78 121.87 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.934 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 61.07 25.62 15.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.628 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.47 23.02 45.07 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.143 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -127.04 119.02 25.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.779 0.323 . . . . 0.0 110.71 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 60.9 p -69.8 153.31 43.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.097 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.8 mt -113.38 -15.4 12.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.314 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.7 mt -57.45 -18.3 17.61 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.521 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -87.87 21.28 24.05 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.079 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.423 ' HB2' ' HB3' ' A' ' 82' ' ' GLU . 1.9 ptpt -160.38 168.69 24.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.262 0.553 . . . . 0.0 111.221 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.37 174.31 7.52 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.641 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.401 ' HB3' ' HA3' ' A' ' 32' ' ' GLY . 21.1 m-80 -57.14 -58.29 8.84 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.496 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.1 pm0 -58.37 -34.12 70.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.045 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.423 ' HB3' ' HB2' ' A' ' 78' ' ' LYS . 2.8 mt-10 -70.77 -39.2 73.35 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.25 0.548 . . . . 0.0 109.867 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.402 ' CB ' ' CD1' ' A' ' 44' ' ' ILE . . . -69.13 -43.52 74.21 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.573 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.43 ' HG2' ' CG2' ' A' ' 30' ' ' VAL . 1.0 OUTLIER -64.61 -29.29 70.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.067 179.176 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -78.99 -35.76 42.4 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.408 ' HA ' ' HD2' ' A' ' 89' ' ' ARG . 1.6 m -65.36 -36.51 84.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.403 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.413 ' CD2' ' HA ' ' A' ' 84' ' ' MET . 4.4 pp -78.35 -34.26 48.55 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.428 ' O ' ' HG2' ' A' ' 91' ' ' MET . 0.2 OUTLIER -60.7 -49.45 77.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.744 179.349 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.5 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.15 -45.7 59.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.98 179.683 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.43 ' OG ' HG21 ' A' ' 70' ' ' VAL . 45.9 p -60.25 -29.35 68.72 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.763 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.428 ' HG2' ' O ' ' A' ' 88' ' ' ARG . 2.5 ptp -88.07 -29.36 20.71 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.493 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.58 35.46 4.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.761 -179.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.5 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.3 OUTLIER -166.42 -24.05 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.41 ' HG3' HG23 ' A' ' 93' ' ' THR . 6.6 mt-10 -123.92 -59.44 1.51 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.989 0.424 . . . . 0.0 111.175 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.416 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -66.59 -25.35 72.78 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.1 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.404 ' HB2' ' CD1' ' A' ' 18' ' ' LEU . 0.8 OUTLIER -78.28 -35.59 47.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.963 0.411 . . . . 0.0 110.185 179.671 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.463 ' HD3' ' O ' ' A' ' 93' ' ' THR . 27.7 mmmt -45.52 -42.28 10.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.985 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.91 -27.92 23.08 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.629 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 121.94 -6.67 10.25 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.934 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.44 ' SD ' ' HB3' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -158.33 142.38 15.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.013 0.435 . . . . 0.0 111.301 -179.759 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.431 HG12 HD23 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -109.45 144.79 17.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.996 -179.841 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.401 ' OE1' HG13 ' A' ' 104' ' ' ILE . 1.5 tm0? -85.83 140.35 30.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.168 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.431 HD23 HG12 ' A' ' 101' ' ' ILE . 2.7 mm? -130.4 139.81 50.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.039 0.447 . . . . 0.0 111.867 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.401 HG13 ' OE1' ' A' ' 102' ' ' GLN . 66.5 mt -128.6 112.91 27.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.596 178.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 66' ' ' GLN . 28.6 m -122.71 176.94 4.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.84 -178.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -147.71 117.53 7.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.475 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 5.6 ttm180 . . . . . 0 C--N 1.326 -0.433 0 CA-C-O 120.928 0.394 . . . . 0.0 110.773 -179.878 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 1.5 mm . . . . . 0 CA--C 1.52 -0.174 0 CA-C-O 121.177 0.513 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 90.5 m -79.0 116.39 19.27 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.744 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt -79.11 129.0 33.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.861 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 21.3 m . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.126 -179.978 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 121.028 0.442 . . . . 0.0 111.357 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.427 ' CD2' HG13 ' A' ' 68' ' ' ILE . 3.8 m-85 -101.95 145.03 29.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.405 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.6 137.36 22.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.126 0.489 . . . . 0.0 111.428 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.429 ' O ' ' CD1' ' A' ' 14' ' ' PHE . 86.8 m -88.77 145.9 25.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.242 179.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.456 ' CD1' ' HG3' ' A' ' 60' ' ' ARG . 21.3 m-85 -140.37 116.51 10.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.03 0.443 . . . . 0.0 111.979 -179.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.99 109.15 19.19 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.447 ' CG2' HD11 ' A' ' 103' ' ' LEU . 39.6 t -106.54 103.37 45.98 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -177.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.456 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 3.7 Cg_exo -75.42 128.01 10.83 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.606 2.204 . . . . 0.0 110.661 178.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.675 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -124.03 28.36 6.83 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.713 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -39.71 -31.2 0.1 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.069 0.461 . . . . 0.0 111.092 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -113.7 -32.69 6.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.234 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.406 ' HB3' ' CB ' ' A' ' 18' ' ' LEU . 45.9 t -70.65 -8.6 53.04 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.074 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.402 ' HA2' ' CD1' ' A' ' 18' ' ' LEU . . . -46.36 -27.64 2.91 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.603 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 52.4 m -84.9 -33.17 22.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.874 0.369 . . . . 0.0 110.693 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.78 11.13 20.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.49 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.14 -55.64 5.04 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.897 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.446 ' O ' ' N ' ' A' ' 54' ' ' ALA . 9.2 tp -178.49 -31.38 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.658 0.266 . . . . 0.0 110.96 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.418 ' HA3' ' HA3' ' A' ' 53' ' ' GLY . . . 112.73 32.49 2.26 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.421 -0.895 . . . . 0.0 113.286 179.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.512 HG13 ' CB ' ' A' ' 55' ' ' ALA . 35.2 m -156.34 150.55 10.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.1 0.476 . . . . 0.0 111.915 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.443 ' O ' ' N ' ' A' ' 47' ' ' LYS . 73.0 m -107.48 123.13 47.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.032 178.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.6 m -107.47 153.67 8.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 -178.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.505 ' O ' ' HG3' ' A' ' 31' ' ' LYS . 0.1 OUTLIER -155.62 129.93 8.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.206 179.303 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -103.97 160.46 16.09 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.181 -1.009 . . . . 0.0 113.101 -179.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -116.01 175.32 5.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.004 0.43 . . . . 0.0 111.133 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 29.5 mtt85 -121.41 153.05 38.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.749 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -47.7 156.87 0.28 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.484 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.87 -51.98 41.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.394 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.21 -51.74 28.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.704 -179.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -117.97 -177.12 3.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.752 0.31 . . . . 0.0 111.078 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 -92.34 40.38 1.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.049 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.18 110.2 17.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.829 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -48.37 124.5 8.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.443 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 17.0 mt -88.88 -36.25 16.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.72 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.46 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 154.44 -178.71 31.09 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.898 -0.667 . . . . 0.0 111.897 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.468 HG12 ' HB2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -106.58 137.82 35.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.845 0.355 . . . . 0.0 111.274 -179.854 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.461 ' CE2' ' NE2' ' A' ' 66' ' ' GLN . 0.5 OUTLIER -123.68 140.13 53.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.497 179.621 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.51 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 27.5 t -55.95 107.56 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.068 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 29' ' ' SER . 21.5 tptt -71.61 -46.87 57.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.625 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 27.2 t -166.42 123.83 1.36 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.857 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.446 ' HA ' HG11 ' A' ' 28' ' ' VAL . 66.9 mt -87.32 122.54 39.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.274 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.411 HD13 ' HA2' ' A' ' 27' ' ' GLY . 2.5 mp -64.84 111.77 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.289 179.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -68.06 72.63 0.18 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.212 0.53 . . . . 0.0 110.404 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 165.12 -28.89 0.21 Allowed Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.877 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.418 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -66.84 -170.56 4.2 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.662 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.675 ' HB2' ' HA ' ' A' ' 18' ' ' LEU . . . -69.24 -37.7 78.1 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.512 ' CB ' HG13 ' A' ' 28' ' ' VAL . . . -67.96 -44.26 77.15 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.792 0.33 . . . . 0.0 111.312 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.9 t -65.53 -34.79 79.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.224 0.535 . . . . 0.0 109.759 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -69.23 -31.41 69.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.766 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.59 -30.84 61.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.654 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 68.93 16.19 70.18 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.897 -0.668 . . . . 0.0 113.277 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.456 ' HG3' ' CD1' ' A' ' 14' ' ' PHE . 7.0 ptp180 -135.23 10.91 3.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.002 0.401 . . . . 0.0 111.143 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.414 ' HB3' ' CD1' ' A' ' 49' ' ' ILE . 0.1 OUTLIER -104.07 134.01 48.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.596 179.877 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.39 145.63 50.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.802 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.51 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 45.2 t -66.07 148.91 11.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.845 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.456 ' N ' HG12 ' A' ' 63' ' ' VAL . 15.9 m-80 84.65 -4.02 0.98 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.428 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.3 128.25 35.27 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.694 0.283 . . . . 0.0 110.697 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.461 ' NE2' ' CE2' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -85.55 130.01 34.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.937 -179.729 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.468 ' HB2' HG12 ' A' ' 44' ' ' ILE . 77.5 mt -81.13 135.95 35.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.575 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.427 HG13 ' CD2' ' A' ' 11' ' ' PHE . 18.7 mm -118.93 -29.14 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.298 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.04 148.73 17.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.983 0.42 . . . . 0.0 111.378 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.1 p -137.89 129.79 39.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.488 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 60.01 26.08 15.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.763 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.8 20.67 59.23 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.193 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -128.19 111.55 13.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.823 0.344 . . . . 0.0 110.723 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.47 149.83 20.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.158 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.411 ' HB3' ' CB ' ' A' ' 83' ' ' ALA . 4.2 mt -114.09 -20.2 11.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.347 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.1 tp -54.83 -24.35 22.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.674 0.273 . . . . 0.0 111.278 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.39 -2.17 83.48 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.031 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.6 ptpp? -135.83 161.13 36.47 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.293 0.568 . . . . 0.0 111.301 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.52 176.94 0.32 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.525 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.428 ' HB3' ' HA3' ' A' ' 32' ' ' GLY . 19.5 m-80 -67.14 -57.64 6.38 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.118 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.1 pp0? -58.36 -35.21 71.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.036 0.446 . . . . 0.0 110.591 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.53 -42.45 71.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.484 179.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.411 ' CB ' ' HB3' ' A' ' 75' ' ' LEU . . . -69.59 -30.99 68.88 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.934 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.462 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 0.5 OUTLIER -72.36 -33.32 67.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.596 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -77.63 -28.07 51.29 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.2 m -72.66 -36.85 68.03 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.528 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 84' ' ' MET . 4.4 pp -78.65 -34.24 46.57 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -61.4 -52.1 66.0 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.461 179.243 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.502 ' HD3' ' N ' ' A' ' 90' ' ' SER . 0.0 OUTLIER -72.17 -33.97 68.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.19 179.594 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.502 ' N ' ' HD3' ' A' ' 89' ' ' ARG . 41.7 m -72.57 -29.68 63.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.672 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.404 ' CB ' HD13 ' A' ' 101' ' ' ILE . 3.2 ptp -87.35 -22.4 25.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.31 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.0 t -112.81 22.65 14.26 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.946 0.351 . . . . 0.0 111.946 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.442 HG23 ' HG3' ' A' ' 94' ' ' GLU . 0.5 OUTLIER -154.77 -39.46 0.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.502 ' HA ' ' HG2' ' A' ' 97' ' ' LYS . 5.7 mt-10 -110.77 -22.06 11.76 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.868 0.366 . . . . 0.0 111.206 -179.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.489 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -93.27 -30.3 9.4 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 179.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -86.67 -37.05 18.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.791 0.329 . . . . 0.0 110.29 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.502 ' HG2' ' HA ' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -45.32 -28.53 0.85 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.31 179.627 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.415 ' N ' ' HD3' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -106.8 -27.04 11.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.534 178.964 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 118.36 -1.64 16.3 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.135 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.456 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -165.14 141.44 5.59 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.0 0.429 . . . . 0.0 111.649 -179.74 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.489 ' HB ' ' HA3' ' A' ' 95' ' ' GLY . 0.1 OUTLIER -115.47 134.56 58.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.043 179.848 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -81.55 140.32 34.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.001 178.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.447 HD11 ' CG2' ' A' ' 16' ' ' VAL . 1.8 mp -134.84 111.59 10.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.736 0.303 . . . . 0.0 111.686 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 62.6 mt -90.19 112.45 24.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 14.6 m -118.37 -179.2 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.882 0.373 . . . . 0.0 111.384 -179.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -147.01 134.99 21.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.755 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.969 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 14.5 mm . . . . . 0 N--CA 1.449 -0.495 0 CA-C-O 120.839 0.352 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 1.9 m -162.05 122.37 2.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.584 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -80.46 145.1 32.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.15 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 27.2 m . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.175 -0.917 . . . . 0.0 111.093 179.808 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.848 0.356 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -96.93 148.35 23.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.859 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.27 109.9 10.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.109 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 87.9 m -96.71 133.02 41.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.496 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.414 ' CE1' ' HG2' ' A' ' 60' ' ' ARG . 47.8 m-85 -140.59 172.67 12.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.164 0.506 . . . . 0.0 112.043 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.403 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.4 OUTLIER -129.67 112.22 13.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.228 179.105 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.8 t -105.31 111.53 64.99 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -177.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 1.2 Cg_endo -81.7 127.61 5.69 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.817 2.345 . . . . 0.0 111.049 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.519 ' HA ' ' HB1' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -122.09 28.67 7.4 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -179.002 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -38.72 -31.72 0.07 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.036 0.446 . . . . 0.0 111.195 179.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -112.26 -33.52 6.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.18 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.421 ' HB3' ' CB ' ' A' ' 18' ' ' LEU . 30.4 t -70.02 -7.57 42.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.2 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.406 ' HA2' ' CD1' ' A' ' 18' ' ' LEU . . . -45.3 -28.65 2.2 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.759 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.0 t -84.83 -34.23 22.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.783 0.325 . . . . 0.0 110.63 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.01 8.88 27.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.319 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.28 -55.26 4.94 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.969 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' A' ' 54' ' ' ALA . 8.2 tp -176.02 -34.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.508 0.194 . . . . 0.0 110.657 179.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.494 ' HA2' HD13 ' A' ' 50' ' ' ILE . . . 111.68 44.28 0.91 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.328 -0.939 . . . . 0.0 113.56 179.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.429 ' CG1' ' CB ' ' A' ' 55' ' ' ALA . 19.4 m -158.27 167.55 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.155 0.503 . . . . 0.0 111.902 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.67 116.67 21.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.276 178.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -111.18 144.47 19.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.013 0.435 . . . . 0.0 111.981 -178.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.407 ' O ' ' HG3' ' A' ' 31' ' ' LYS . 2.2 ptmt -138.05 134.06 34.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.365 179.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.495 ' HA3' ' HB3' ' A' ' 80' ' ' ASN . . . -100.07 147.6 18.19 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.939 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.404 ' ND2' ' CE1' ' A' ' 45' ' ' PHE . 76.6 m-20 -127.12 130.49 49.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.888 0.375 . . . . 0.0 110.866 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.16 145.74 26.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.468 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.3 m -44.1 130.61 6.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.269 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.13 -19.85 65.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.568 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -106.08 -44.09 4.67 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.825 0.345 . . . . 0.0 111.421 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -87.3 -16.91 33.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.522 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 30.2 m-70 61.47 21.3 11.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.746 0.308 . . . . 0.0 110.888 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -99.29 134.47 42.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.011 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -50.18 126.94 15.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.315 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 45.8 mt -94.39 -19.4 20.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.919 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.443 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 128.82 169.66 12.63 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.308 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.413 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -102.05 130.95 51.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.835 0.35 . . . . 0.0 111.29 179.85 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.463 ' CE2' ' NE2' ' A' ' 66' ' ' GLN . 0.1 OUTLIER -113.56 146.79 39.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.486 179.868 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.41 ' O ' HG12 ' A' ' 63' ' ' VAL . 49.1 t -60.53 104.66 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.563 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.1 tptt -75.48 -40.05 57.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.889 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -168.77 126.41 1.03 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.981 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.434 ' CD1' ' HB3' ' A' ' 61' ' ' LEU . 63.7 mt -94.44 121.21 44.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.048 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.494 HD13 ' HA2' ' A' ' 27' ' ' GLY . 1.5 mp -58.96 109.74 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.432 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -65.83 72.91 0.06 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.071 0.462 . . . . 0.0 110.691 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 163.76 -26.51 0.21 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.262 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.87 -165.41 6.05 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.777 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.519 ' HB1' ' HA ' ' A' ' 18' ' ' LEU . . . -69.09 -42.18 76.49 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.429 ' CB ' ' CG1' ' A' ' 28' ' ' VAL . . . -63.13 -43.84 97.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.342 -179.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.4 t -68.73 -33.56 74.13 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.132 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -72.2 -31.9 66.29 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.876 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -65.18 -25.17 67.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.709 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.12 29.7 65.9 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.575 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.414 ' HG2' ' CE1' ' A' ' 14' ' ' PHE . 15.0 mtm180 -124.9 -33.02 2.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.609 0.242 . . . . 0.0 111.254 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.434 ' HB3' ' CD1' ' A' ' 49' ' ' ILE . 5.5 mp -72.01 150.15 44.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.904 0.383 . . . . 0.0 111.055 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.11 135.71 20.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.082 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.548 ' O ' ' HB3' ' A' ' 64' ' ' ASN . 82.9 t -64.99 94.89 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.817 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.548 ' HB3' ' O ' ' A' ' 63' ' ' VAL . 12.2 p30 149.55 -4.45 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.92 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -84.22 131.78 34.71 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 121.096 0.474 . . . . 0.0 111.594 -179.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.463 ' NE2' ' CE2' ' A' ' 45' ' ' PHE . 0.3 OUTLIER -89.93 117.25 28.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.11 179.343 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.2 mt -71.91 133.52 45.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.929 0.395 . . . . 0.0 111.404 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 23.6 mt -122.12 -22.86 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.488 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.69 167.26 30.96 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.935 0.398 . . . . 0.0 111.466 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.427 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 10.3 p -158.18 126.34 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.694 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.417 ' HB2' ' O ' ' A' ' 70' ' ' VAL . 2.7 m-80 66.19 15.4 10.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.082 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 96.34 7.48 58.17 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.529 -0.843 . . . . 0.0 113.125 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.427 ' CG ' ' O ' ' A' ' 70' ' ' VAL . 2.4 pt-20 -121.13 109.15 14.66 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.889 0.376 . . . . 0.0 111.002 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.4 m -59.65 145.9 43.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.024 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.409 ' HB2' ' CB ' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -121.16 4.41 10.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.247 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.0 tp -61.21 -28.53 69.21 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.741 0.305 . . . . 0.0 111.029 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -74.87 -24.95 70.65 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.558 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -97.34 166.17 11.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.259 0.552 . . . . 0.0 111.212 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.21 165.2 16.59 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.245 -0.888 . . . . 0.0 111.418 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.495 ' HB3' ' HA3' ' A' ' 32' ' ' GLY . 20.3 m-80 -54.78 -57.77 10.24 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.269 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.0 pp0? -56.83 -34.49 67.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.83 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.72 -38.64 73.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.313 0.578 . . . . 0.0 109.625 179.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.409 ' CB ' ' HB2' ' A' ' 75' ' ' LEU . . . -69.08 -40.74 78.26 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.405 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.434 ' O ' ' HB2' ' A' ' 88' ' ' ARG . 1.1 mtm -66.3 -29.62 69.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.854 179.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -79.88 -35.88 37.37 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.421 ' HA ' ' HD2' ' A' ' 89' ' ' ARG . 2.9 m -65.21 -36.33 83.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.375 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.413 ' CD2' ' HA ' ' A' ' 84' ' ' MET . 4.4 pp -79.06 -34.6 43.57 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' A' ' 84' ' ' MET . 0.1 OUTLIER -62.32 -50.68 70.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.605 179.322 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.444 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.16 -37.34 69.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.233 179.634 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.8 m -67.11 -29.51 69.27 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.077 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.426 ' HB3' ' CD1' ' A' ' 101' ' ' ILE . 4.5 ptp -89.34 -30.28 18.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.624 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.0 23.46 13.97 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.452 ' O ' ' HG3' ' A' ' 97' ' ' LYS . 0.4 OUTLIER -155.04 -31.05 0.1 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.851 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.42 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 7.8 mt-10 -113.9 -63.89 1.39 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.894 0.378 . . . . 0.0 111.524 -179.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.457 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -58.11 -31.89 66.19 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.451 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.416 ' O ' ' ND2' ' A' ' 96' ' ' ASN . 0.7 OUTLIER -72.95 -33.71 66.07 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.715 0.293 . . . . 0.0 110.612 179.92 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 93' ' ' THR . 54.4 mtpt -43.56 -39.45 3.45 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.035 0.445 . . . . 0.0 111.325 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.31 -26.23 15.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.957 178.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 117.27 2.07 18.17 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.613 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.484 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -158.17 141.91 15.49 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.011 0.434 . . . . 0.0 111.28 -179.689 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.457 ' HB ' ' HA3' ' A' ' 95' ' ' GLY . 0.1 OUTLIER -112.86 146.15 17.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.967 179.915 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.412 ' OE1' HG13 ' A' ' 104' ' ' ILE . 1.5 tm0? -86.9 138.45 31.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.034 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.435 HD22 HG12 ' A' ' 101' ' ' ILE . 2.8 mm? -128.51 138.98 52.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.0 0.428 . . . . 0.0 111.961 -179.172 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.412 HG13 ' OE1' ' A' ' 102' ' ' GLN . 55.1 mt -127.67 112.79 28.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.745 178.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 34.7 m -121.76 175.88 4.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.048 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -147.52 141.77 26.21 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.842 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.333 0 CA-C-O 120.886 0.374 . . . . 0.0 111.175 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 1.6 mm . . . . . 0 N--CA 1.454 -0.253 0 CA-C-O 120.981 0.419 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 27.3 m -138.06 97.8 3.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.795 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 8.1 ttpt -69.19 109.67 4.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.989 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 18.5 m . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.321 -0.847 . . . . 0.0 111.103 179.973 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 . . . . . 0 C--O 1.231 0.132 0 CA-C-O 120.843 0.354 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -90.98 146.28 24.0 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.801 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -138.62 109.92 6.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.992 0.425 . . . . 0.0 111.088 -179.829 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 92.7 m -88.54 121.43 30.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.086 179.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.435 ' CG ' ' HG3' ' A' ' 60' ' ' ARG . 32.8 m-85 -131.14 150.53 52.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.214 0.53 . . . . 0.0 112.33 -179.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.456 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.6 OUTLIER -112.46 111.14 21.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.285 -0.87 . . . . 0.0 108.93 178.79 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.435 ' CG2' ' CD1' ' A' ' 103' ' ' LEU . 10.3 t -100.14 115.33 65.6 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -177.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 93.8 Cg_endo -85.98 128.2 3.19 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.758 2.305 . . . . 0.0 110.842 178.297 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.64 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -127.95 28.79 5.52 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -178.664 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -38.84 -33.35 0.11 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.061 0.458 . . . . 0.0 111.28 179.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -107.71 -33.87 7.15 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.231 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.406 ' HB3' ' CB ' ' A' ' 18' ' ' LEU . 7.6 t -70.51 -6.39 35.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.25 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.407 ' HA2' ' CD1' ' A' ' 18' ' ' LEU . . . -42.12 -30.49 0.75 Allowed Glycine 0 C--N 1.337 0.613 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.775 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.02 -38.81 20.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.866 0.365 . . . . 0.0 110.672 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -82.51 1.7 36.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.449 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.88 -53.81 4.86 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.978 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.43 ' O ' ' N ' ' A' ' 54' ' ' ALA . 7.7 tp -175.62 -36.06 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.735 0.302 . . . . 0.0 110.589 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.42 ' HA2' HD11 ' A' ' 50' ' ' ILE . . . 109.03 47.5 0.88 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.524 -0.846 . . . . 0.0 113.531 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.452 HG12 ' CB ' ' A' ' 55' ' ' ALA . 22.3 m -158.18 156.67 3.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 117.058 0.429 . . . . 0.0 111.75 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.401 ' O ' ' N ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -114.13 114.17 25.69 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.383 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.407 ' CG2' ' HG2' ' A' ' 84' ' ' MET . 0.4 OUTLIER -106.94 146.97 12.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.269 0.556 . . . . 0.0 111.979 -178.659 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.18 130.9 15.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.321 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -100.08 176.97 28.57 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.941 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.483 ' OD1' ' HB2' ' A' ' 42' ' ' LEU . 50.8 p30 -125.15 -174.8 3.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.303 0.573 . . . . 0.0 111.637 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.426 ' O ' ' C ' ' A' ' 35' ' ' SER . 4.5 mtm180 -144.27 126.13 15.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.698 179.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.462 ' CA ' HD23 ' A' ' 42' ' ' LEU . 57.7 m -28.68 142.77 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.22 -178.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -37.21 83.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.354 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.78 -63.16 1.42 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.933 0.397 . . . . 0.0 110.925 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -112.78 -179.92 3.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.882 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 53.1 m-70 -87.56 53.62 2.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.968 0.413 . . . . 0.0 110.857 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -104.24 105.0 14.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.074 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -49.06 139.75 10.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.554 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.483 ' HB2' ' OD1' ' A' ' 33' ' ' ASN . 5.4 mt -103.66 -16.37 15.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.737 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 137.5 -177.94 19.46 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.036 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.414 ' CD1' ' HB2' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -115.98 136.59 52.42 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-O 120.819 0.342 . . . . 0.0 110.672 179.749 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -126.47 144.08 50.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.87 0.366 . . . . 0.0 110.827 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.45 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 40.1 t -57.06 113.79 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.825 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 29' ' ' SER . 30.1 tptt -83.03 -38.16 22.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.653 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -168.3 120.09 0.82 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.082 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.419 ' CD1' ' HB3' ' A' ' 61' ' ' LEU . 70.4 mt -85.75 120.61 36.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.971 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.44 HD12 ' N ' ' A' ' 28' ' ' VAL . 1.4 mp -57.55 103.95 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.623 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -60.24 83.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.484 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 148.97 -28.03 1.27 Allowed Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.664 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.42 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -67.09 -176.15 7.98 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.543 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.64 ' HB2' ' HA ' ' A' ' 18' ' ' LEU . . . -61.77 -39.29 91.16 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.452 ' CB ' HG12 ' A' ' 28' ' ' VAL . . . -64.65 -48.6 74.2 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.98 0.419 . . . . 0.0 111.486 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.69 -28.52 69.95 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.113 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.7 mtpt -77.46 -29.03 52.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.948 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.407 ' OD1' ' NH2' ' A' ' 60' ' ' ARG . 4.5 t0 -56.13 -31.7 63.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.412 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.77 13.51 80.5 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.887 -0.673 . . . . 0.0 113.35 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.435 ' HG3' ' CG ' ' A' ' 14' ' ' PHE . 2.9 ptp180 -135.62 7.09 3.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 117.089 0.445 . . . . 0.0 111.373 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.419 ' HB3' ' CD1' ' A' ' 49' ' ' ILE . 0.1 OUTLIER -98.99 133.49 43.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.46 179.827 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.9 142.16 38.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.911 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.45 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 52.3 t -59.3 147.35 8.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.912 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.434 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 16.3 m-20 85.36 12.99 0.21 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.3 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -85.26 109.53 18.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.854 0.359 . . . . 0.0 110.611 179.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -73.59 111.17 8.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.841 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.8 mt -66.08 141.47 58.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.66 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.487 HD12 HG21 ' A' ' 68' ' ' ILE . 34.8 mt -129.51 -39.69 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.437 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.0 124.03 11.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.991 0.424 . . . . 0.0 111.227 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.4 p -120.33 124.93 73.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.437 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 60.93 42.74 12.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.905 0.383 . . . . 0.0 110.477 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 64.8 21.51 67.47 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.225 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -126.94 118.61 24.87 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.771 0.319 . . . . 0.0 110.767 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.3 t -60.5 152.43 25.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.941 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 36.2 mt -118.39 -31.89 4.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.233 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.5 mt -53.96 -29.73 43.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.22 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.03 -11.6 63.81 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.837 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.0 ptpp? -126.01 156.26 40.16 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.252 0.548 . . . . 0.0 111.206 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.07 162.45 0.66 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.882 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -54.66 -57.62 10.74 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.079 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -59.55 -35.4 74.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.061 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.49 -40.53 73.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.153 0.502 . . . . 0.0 109.655 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.414 ' HB2' ' CD1' ' A' ' 44' ' ' ILE . . . -69.13 -38.83 79.07 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.45 179.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.407 ' HG2' ' CG2' ' A' ' 30' ' ' VAL . 0.5 OUTLIER -65.95 -30.67 71.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.865 179.239 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -79.72 -31.95 41.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.341 178.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.419 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 1.7 m -69.48 -35.39 75.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.33 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.409 ' CD1' ' N ' ' A' ' 88' ' ' ARG . 4.3 pp -78.72 -34.61 45.81 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.409 ' N ' ' CD1' ' A' ' 87' ' ' LEU . 5.0 mtp180 -61.4 -52.11 65.98 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 114.937 -1.028 . . . . 0.0 110.616 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.468 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.42 -33.48 67.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.993 179.613 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.456 ' N ' ' HD3' ' A' ' 89' ' ' ARG . 28.6 m -70.99 -29.54 65.55 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.46 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.426 ' HB3' ' CD1' ' A' ' 101' ' ' ILE . 2.3 ptp -88.94 -21.34 23.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.386 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.5 31.81 6.29 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.468 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.4 OUTLIER -160.01 -31.68 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 179.899 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.411 ' HG3' HG21 ' A' ' 93' ' ' THR . 5.1 mt-10 -115.88 -45.94 2.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.885 0.374 . . . . 0.0 111.239 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.47 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -73.34 -35.25 56.73 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.665 -0.778 . . . . 0.0 111.945 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.422 ' O ' ' ND2' ' A' ' 96' ' ' ASN . 0.8 OUTLIER -71.25 -33.82 70.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.898 0.38 . . . . 0.0 110.089 179.568 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' A' ' 93' ' ' THR . 49.3 mtpt -40.85 -32.59 0.23 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.739 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.15 -28.21 10.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.797 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 128.22 -8.88 6.66 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.731 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.456 ' SD ' ' HB3' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -154.38 144.44 21.9 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.962 0.411 . . . . 0.0 110.852 -179.847 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.47 ' HB ' ' HA3' ' A' ' 95' ' ' GLY . 0.1 OUTLIER -107.2 144.63 15.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.597 -179.483 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -77.01 137.17 38.82 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.435 ' CD1' ' CG2' ' A' ' 16' ' ' VAL . 0.3 OUTLIER -135.57 147.12 48.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.335 0.588 . . . . 0.0 112.198 -178.807 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 8.5 mt -140.45 112.63 4.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.311 178.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.1 m -122.47 176.61 4.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.056 0.455 . . . . 0.0 111.677 -178.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -147.48 132.67 18.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.561 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.343 0 CA-C-O 120.842 0.353 . . . . 0.0 111.212 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mm . . . . . 0 CA--C 1.522 -0.097 0 CA-C-O 121.197 0.522 . . . . 0.0 111.774 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 55.0 m -140.36 106.63 5.25 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.484 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 9.2 ttmt -68.89 112.8 5.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.269 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.404 ' CG1' ' HG3' ' A' ' 88' ' ' ARG . 30.8 m . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.979 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.917 0.389 . . . . 0.0 111.467 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -94.88 144.06 25.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.264 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.46 127.78 32.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.942 0.401 . . . . 0.0 111.606 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 99.2 m -97.47 133.99 41.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.741 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.464 ' O ' ' N ' ' A' ' 103' ' ' LEU . 21.6 m-85 -140.71 148.19 40.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.268 0.556 . . . . 0.0 112.404 -179.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -112.39 111.5 22.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.401 -0.818 . . . . 0.0 108.928 178.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.438 ' CG2' ' CD1' ' A' ' 103' ' ' LEU . 21.2 t -103.41 111.22 64.97 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -177.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 86.4 Cg_endo -81.03 128.18 6.39 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.427 2.085 . . . . 0.0 111.014 178.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.606 ' HA ' ' HB1' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -126.22 29.39 5.83 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -178.85 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -37.43 -32.33 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.411 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -112.32 -34.1 6.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.248 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.41 ' HB3' ' CB ' ' A' ' 18' ' ' LEU . 10.5 t -67.03 -11.92 58.43 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.147 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.406 ' HA2' ' CD1' ' A' ' 18' ' ' LEU . . . -45.86 -28.58 2.8 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.737 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.1 t -81.68 -36.77 28.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.89 0.376 . . . . 0.0 110.67 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.17 -24.54 37.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.062 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.9 -52.59 0.7 Allowed Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.508 ' HB2' ' HE3' ' A' ' 91' ' ' MET . 9.3 tp 179.15 -32.82 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.654 0.264 . . . . 0.0 110.796 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.418 ' HA2' HD12 ' A' ' 50' ' ' ILE . . . 107.13 43.11 1.42 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.969 179.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.42 ' N ' HD13 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -164.77 151.44 2.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.068 0.461 . . . . 0.0 111.343 179.738 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.41 ' O ' ' N ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -111.85 123.32 49.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.931 179.356 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -112.43 141.36 28.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.895 0.379 . . . . 0.0 111.501 -179.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.04 130.29 25.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.648 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -96.75 144.18 17.18 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.851 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.401 ' O ' ' HA ' ' A' ' 41' ' ' ASP . 1.5 m-80 -94.4 -176.3 3.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.711 0.291 . . . . 0.0 110.624 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.3 mtt180 -142.67 148.86 38.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.906 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.3 t -66.59 137.05 56.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.938 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -67.09 -29.14 68.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.154 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -70.2 -50.36 40.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.976 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -141.28 165.32 27.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.756 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -70.48 66.05 0.31 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.908 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -120.33 119.06 32.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.94 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.401 ' HA ' ' O ' ' A' ' 33' ' ' ASN . 9.2 p-10 -53.4 142.57 21.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.175 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 43.2 mt -107.27 3.94 26.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.392 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.427 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 113.92 160.33 13.59 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.524 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.402 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -98.73 130.59 47.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.733 0.301 . . . . 0.0 111.063 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.15 142.4 47.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.808 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.473 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 39.5 t -57.8 105.84 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.903 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 29' ' ' SER . 6.3 tptt -73.92 -41.42 62.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.106 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.2 m -171.89 123.35 0.52 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.913 0.387 . . . . 0.0 111.371 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.531 ' CD1' ' HB3' ' A' ' 61' ' ' LEU . 76.1 mt -85.66 110.95 20.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.068 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.456 ' O ' ' N ' ' A' ' 52' ' ' GLY . 1.9 mp -48.74 104.01 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.774 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -62.16 75.38 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.778 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 160.33 -28.79 0.34 Allowed Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.655 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.11 -161.71 3.49 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.476 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.606 ' HB1' ' HA ' ' A' ' 18' ' ' LEU . . . -76.41 -38.13 56.08 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.919 0.341 . . . . 0.0 111.919 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.64 -38.29 89.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.889 0.376 . . . . 0.0 111.022 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.6 t -78.03 -35.49 49.72 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.149 0.5 . . . . 0.0 109.736 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.5 mtpt -69.69 -31.34 69.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.813 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -64.47 -25.43 68.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.668 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.31 28.99 65.27 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.58 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.424 ' HG2' ' CE1' ' A' ' 14' ' ' PHE . 12.7 mtm180 -125.76 -32.33 2.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.729 0.3 . . . . 0.0 111.012 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.531 ' HB3' ' CD1' ' A' ' 49' ' ' ILE . 2.7 mp -68.94 147.26 51.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.093 0.473 . . . . 0.0 111.371 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 48.8 mtm-85 -142.96 123.74 14.21 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.508 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.473 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 41.3 t -52.75 142.76 5.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.339 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.429 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 20.2 m-20 85.22 18.66 0.12 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.237 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -99.21 118.39 35.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.35 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 16.7 tm0? -74.39 126.16 30.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.945 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 73.5 mt -76.06 141.77 41.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.296 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.9 mt -123.85 -39.64 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.704 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -150.95 154.98 38.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.886 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.417 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 8.0 p -142.34 125.6 14.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.633 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 64.83 12.89 8.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.65 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.21 13.22 36.86 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.205 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.417 ' CG ' ' O ' ' A' ' 70' ' ' VAL . 4.9 pt-20 -128.18 112.2 14.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 117.036 0.418 . . . . 0.0 111.018 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.4 p -65.15 170.41 4.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.947 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.68 16.59 1.81 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.216 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.8 tp -66.18 -21.31 66.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.628 0.251 . . . . 0.0 111.052 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -91.18 14.76 62.75 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.962 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -139.35 163.76 31.65 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.403 0.621 . . . . 0.0 111.235 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.15 162.38 22.57 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.486 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -55.9 -52.51 63.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.109 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.6 pp0? -59.29 -36.29 75.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.971 0.415 . . . . 0.0 110.524 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.58 -38.65 74.07 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.344 179.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.18 -34.92 75.68 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.128 179.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.49 ' HA ' ' CD2' ' A' ' 87' ' ' LEU . 1.0 OUTLIER -69.94 -29.45 66.59 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.9 179.043 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -78.01 -39.54 41.82 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.405 ' O ' ' HB2' ' A' ' 90' ' ' SER . 1.8 m -61.79 -37.47 84.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.082 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.49 ' CD2' ' HA ' ' A' ' 84' ' ' MET . 3.5 pp -78.18 -33.54 50.06 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.434 ' O ' ' HG2' ' A' ' 91' ' ' MET . 0.6 OUTLIER -59.78 -52.0 67.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.668 179.074 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.455 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.85 -35.37 67.21 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.671 -179.909 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.44 ' N ' ' HD3' ' A' ' 89' ' ' ARG . 5.1 t -72.96 -29.85 63.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.851 0.357 . . . . 0.0 110.953 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.508 ' HE3' ' HB2' ' A' ' 26' ' ' LEU . 4.1 ptm -89.33 -18.23 27.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.283 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.28 29.71 6.59 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.469 ' O ' ' HG3' ' A' ' 97' ' ' LYS . 0.4 OUTLIER -162.26 -30.24 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 179.897 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -116.82 -44.84 2.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.905 0.383 . . . . 0.0 111.197 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -69.98 -30.22 70.21 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.908 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.59 -35.13 58.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.885 0.374 . . . . 0.0 110.173 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 93' ' ' THR . 26.9 mtpt -42.57 -40.12 2.56 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.421 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.08 -25.59 16.39 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.529 179.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 117.56 -3.1 17.95 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.907 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.85 144.06 13.12 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.895 0.379 . . . . 0.0 111.156 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.417 ' CG2' ' CD2' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -111.81 145.1 18.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.423 -179.666 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.0 150.42 33.9 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' A' ' 14' ' ' PHE . 0.4 OUTLIER -146.65 113.51 6.1 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.85 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 36.1 mt -107.32 112.91 42.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.784 178.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 22.1 m -123.27 -179.44 2.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.501 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -147.76 132.4 17.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.488 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.323 0 CA-C-O 120.962 0.411 . . . . 0.0 111.412 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . 0.432 HD12 HG22 ' B' ' 10' ' ' ILE . 1.6 mm . . . . . 0 N--CA 1.453 -0.285 0 CA-C-O 121.392 0.615 . . . . 0.0 111.264 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 20.5 m -96.47 97.76 9.69 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.665 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 13.6 ttmt -69.52 139.54 53.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.003 0.43 . . . . 0.0 111.145 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 13.8 m . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.908 179.885 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 108' ' ' ARG . 65.7 p -118.28 48.68 1.37 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.803 0.335 . . . . 0.0 110.867 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 13.5 mtm180 -144.34 132.35 21.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.477 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -142.7 134.67 27.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.046 0.451 . . . . 0.0 111.6 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -79.02 149.93 32.06 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.238 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.09 109.71 6.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.057 0.456 . . . . 0.0 111.649 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 85.1 m -99.52 120.81 40.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.715 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.435 ' O ' ' N ' ' A' ' 103' ' ' LEU . 28.8 m-85 -134.61 153.87 51.76 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.435 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.2 OUTLIER -110.91 111.95 23.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.901 178.86 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.433 ' CG2' ' CD1' ' A' ' 103' ' ' LEU . 17.6 t -101.32 112.4 65.01 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -177.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.431 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 94.9 Cg_endo -83.5 127.5 4.43 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.591 2.194 . . . . 0.0 110.847 178.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.477 ' HA ' ' HB1' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -122.41 28.5 7.38 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -178.778 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -39.02 -32.15 0.08 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.089 0.471 . . . . 0.0 111.17 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -109.44 -34.81 6.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.255 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.413 ' HB3' ' CB ' ' A' ' 18' ' ' LEU . 39.9 t -71.97 -5.71 36.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.236 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 18' ' ' LEU . . . -43.99 -30.18 1.68 Allowed Glycine 0 C--N 1.338 0.649 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.531 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.0 t -82.72 -38.52 23.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.915 0.388 . . . . 0.0 110.314 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -82.51 -1.74 51.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.395 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.1 -48.5 3.65 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.705 -0.759 . . . . 0.0 111.794 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.458 ' O ' ' N ' ' A' ' 54' ' ' ALA . 8.1 tp -179.72 -32.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.585 0.231 . . . . 0.0 110.55 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.444 ' HA3' ' HA3' ' A' ' 53' ' ' GLY . . . 106.9 46.45 1.1 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.457 -0.877 . . . . 0.0 113.453 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.434 ' CG1' ' CB ' ' A' ' 55' ' ' ALA . 30.1 m -157.85 154.12 5.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.037 0.446 . . . . 0.0 111.831 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.07 121.72 45.74 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.2 m -106.04 148.02 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -155.48 129.15 8.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.071 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 44' ' ' ILE . . . -107.88 166.53 13.14 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.864 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -113.2 -178.61 3.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.954 0.407 . . . . 0.0 110.93 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.04 135.82 24.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.242 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.6 m -48.35 143.58 4.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.823 0.345 . . . . 0.0 110.896 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.37 -49.16 67.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.532 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -95.33 -50.02 5.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.384 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 36.8 m-20 -66.04 -23.87 66.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.35 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 58.04 21.47 7.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.807 0.337 . . . . 0.0 110.964 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -94.18 135.52 35.47 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.871 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -46.57 132.05 10.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.536 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 38.7 mt -100.79 17.98 20.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.041 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.83 177.67 46.49 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.616 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.443 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -105.78 152.49 7.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.918 0.389 . . . . 0.0 111.202 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.444 ' CE1' ' NE2' ' A' ' 66' ' ' GLN . 2.2 m-85 -135.39 138.21 43.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.708 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.45 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 31.1 t -54.94 104.46 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.345 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.8 tptt -73.74 -42.71 60.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.757 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.5 t -168.95 119.16 0.72 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.182 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.409 ' CG1' HG12 ' A' ' 46' ' ' VAL . 80.8 mt -85.3 121.97 37.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.244 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.453 ' O ' ' N ' ' A' ' 52' ' ' GLY . 1.9 mp -59.52 107.17 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.371 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -61.17 78.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.887 0.375 . . . . 0.0 110.776 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 155.97 -28.68 0.59 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.194 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.444 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -67.19 -171.59 5.11 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.853 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.477 ' HB1' ' HA ' ' A' ' 18' ' ' LEU . . . -63.09 -40.72 98.5 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.434 ' CB ' ' CG1' ' A' ' 28' ' ' VAL . . . -64.91 -44.86 88.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.813 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.09 -28.48 66.53 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.592 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.4 mtpt -79.55 -28.23 41.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.061 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.2 -29.94 67.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.603 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.17 14.04 76.53 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.944 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -130.4 1.41 4.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.915 0.357 . . . . 0.0 111.34 179.866 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.38 128.43 50.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.882 0.372 . . . . 0.0 111.241 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.409 ' HA ' HD11 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -138.14 141.88 40.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.753 179.362 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.455 ' O ' ' CB ' ' A' ' 64' ' ' ASN . 39.0 t -55.91 146.15 5.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.213 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 18.0 m-20 87.27 13.56 0.11 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.378 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -93.4 120.6 33.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.721 0.296 . . . . 0.0 110.39 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.444 ' NE2' ' CE1' ' A' ' 45' ' ' PHE . 0.8 OUTLIER -78.2 135.05 37.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.763 -179.8 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.437 ' HB2' HG12 ' A' ' 44' ' ' ILE . 80.0 mt -85.25 140.9 30.5 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.841 0.353 . . . . 0.0 110.799 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 24.0 mt -123.17 -40.27 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.219 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.18 138.43 15.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.355 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.3 p -127.74 125.58 65.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.78 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 61.21 27.0 16.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.724 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.53 25.32 56.96 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.002 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -130.4 104.38 7.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.692 0.282 . . . . 0.0 110.779 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.8 t -58.54 155.56 12.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.013 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.451 ' HB3' ' CB ' ' A' ' 83' ' ' ALA . 1.0 OUTLIER -118.32 -9.55 10.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.697 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 30.0 mt -57.01 -20.66 25.4 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.666 0.27 . . . . 0.0 111.408 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -92.75 27.41 11.01 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.788 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -160.71 162.78 32.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.288 0.566 . . . . 0.0 111.189 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.12 164.03 16.38 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.391 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.404 ' O ' ' HG2' ' A' ' 84' ' ' MET . 20.3 m-80 -56.0 -57.51 11.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.812 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -54.76 -38.61 67.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.955 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.38 -36.16 73.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.007 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.451 ' CB ' ' HB3' ' A' ' 75' ' ' LEU . . . -69.17 -51.07 41.82 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.783 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.421 ' HA ' ' CD2' ' A' ' 87' ' ' LEU . 6.6 ptp -60.39 -29.04 68.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.801 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.39 -31.9 42.91 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.1 m -70.13 -35.79 74.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.291 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.421 ' CD2' ' HA ' ' A' ' 84' ' ' MET . 4.2 pp -78.0 -34.26 50.89 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.42 ' HG3' ' CG1' ' B' ' 13' ' ' VAL . 0.0 OUTLIER -57.26 -50.45 72.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.339 178.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.435 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.33 -38.06 68.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.171 179.697 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 63.7 m -67.4 -29.1 68.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.929 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.437 ' HB2' HG21 ' A' ' 101' ' ' ILE . 2.6 ptp -88.25 -28.23 21.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.678 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -110.77 26.58 10.54 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.476 ' O ' ' HG3' ' A' ' 97' ' ' LYS . 0.4 OUTLIER -156.06 -33.04 0.09 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.412 ' HG3' HG21 ' A' ' 93' ' ' THR . 7.6 mt-10 -115.56 -36.68 4.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.822 0.344 . . . . 0.0 111.138 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.465 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -80.44 -32.09 35.44 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.884 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.404 ' O ' ' ND2' ' A' ' 96' ' ' ASN . 0.9 OUTLIER -76.73 -34.33 58.11 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 179.543 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.476 ' HG3' ' O ' ' A' ' 93' ' ' THR . 48.4 mtpt -42.12 -32.49 0.47 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.473 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.97 -25.03 12.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.875 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 121.58 -7.63 10.34 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.789 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.435 ' SD ' ' HB3' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -157.02 144.66 19.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.89 0.376 . . . . 0.0 110.914 -179.895 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.465 ' HB ' ' HA3' ' A' ' 95' ' ' GLY . 0.1 OUTLIER -108.3 143.69 18.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.412 -179.71 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -76.94 142.18 40.17 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -137.59 145.88 43.34 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.115 0.483 . . . . 0.0 112.115 -178.757 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 22.8 mt -139.1 112.77 6.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.468 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 66' ' ' GLN . 27.4 m -132.15 150.14 33.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.855 0.36 . . . . 0.0 111.578 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -114.77 129.27 56.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.686 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.416 ' HG2' ' N ' ' A' ' 108' ' ' ARG . 1.8 tmm_? -129.61 143.58 50.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.888 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.416 ' N ' ' HG2' ' A' ' 107' ' ' ARG . 72.3 mtm-85 -85.59 148.28 26.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.971 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 31.5 mt -73.41 108.7 5.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.114 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.829 -179.985 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.911 0.386 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -84.72 170.33 13.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.859 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -94.43 23.98 4.84 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.128 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 59.47 28.97 18.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.853 0.359 . . . . 0.0 110.968 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -139.66 30.85 2.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.83 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.31 -165.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.902 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 178.75 147.14 0.17 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.145 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -108.23 155.29 9.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.929 0.395 . . . . 0.0 111.203 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 66.1 m -138.3 115.91 11.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.732 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -69.94 115.23 8.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.836 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.42 ' CG1' ' HG3' ' A' ' 88' ' ' ARG . 15.3 m . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.298 -0.858 . . . . 0.0 111.121 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.378 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.5 p -143.03 24.16 1.84 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.627 0.251 . . . . 0.0 110.981 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.6 ttp180 -78.06 146.99 34.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.923 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -155.11 148.09 24.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.04 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -88.01 146.18 25.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.604 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.404 ' N ' ' O ' ' A' ' 105' ' ' VAL . 0.0 OUTLIER -140.82 109.86 6.14 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.9 0.381 . . . . 0.0 111.333 -179.504 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.5 m -80.55 145.49 31.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.979 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.444 ' CD1' ' HG3' ' A' ' 60' ' ' ARG . 12.8 m-85 -140.28 171.41 14.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.368 0.604 . . . . 0.0 112.132 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -143.55 103.43 4.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.028 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.414 ' CG2' ' CD1' ' A' ' 103' ' ' LEU . 17.8 t -104.83 112.05 65.26 Favored Pre-proline 0 C--N 1.329 -0.302 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -177.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.456 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 93.7 Cg_endo -83.46 127.53 4.46 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.413 2.076 . . . . 0.0 110.798 178.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.51 ' HA ' ' HB3' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -120.85 27.96 8.2 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.848 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -40.93 -30.2 0.12 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.999 0.428 . . . . 0.0 110.744 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -114.87 -31.47 6.1 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.174 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 43.0 t -72.65 -7.55 50.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.139 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -45.27 -28.3 2.05 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.624 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.6 m -85.44 -34.86 21.58 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.942 0.401 . . . . 0.0 110.677 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.14 8.97 24.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.526 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.62 -56.23 5.02 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.932 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.49 ' O ' ' N ' ' A' ' 54' ' ' ALA . 9.7 tp -178.8 -27.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.518 0.199 . . . . 0.0 111.155 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.46 ' HA3' ' HA3' ' A' ' 53' ' ' GLY . . . 109.75 35.54 2.2 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.31 -0.948 . . . . 0.0 113.536 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.485 HG12 ' HA ' ' A' ' 49' ' ' ILE . 13.0 m -158.95 157.75 3.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 117.08 0.44 . . . . 0.0 111.538 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.533 ' O ' ' N ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -114.15 134.94 54.55 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.711 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.65 143.56 32.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.119 0.485 . . . . 0.0 111.896 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.404 ' O ' ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -142.12 129.71 21.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.587 179.666 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -102.7 153.3 18.32 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.991 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -125.28 175.25 7.57 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.009 0.433 . . . . 0.0 111.252 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.5 mtt85 -122.57 157.42 32.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.736 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.5 m -51.28 155.86 1.3 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.269 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.05 -39.59 86.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.111 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.58 -78.68 0.18 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.958 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -81.64 -175.77 5.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.834 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -98.32 29.91 3.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.942 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.24 115.84 14.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.098 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.41 ' CB ' ' ND2' ' A' ' 80' ' ' ASN . 1.2 p30 -59.08 119.62 7.63 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.951 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 17.4 mt -75.58 -26.42 57.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.872 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.445 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 133.21 -176.69 19.45 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.121 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.472 HG12 ' HB2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -107.32 134.53 48.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.876 0.369 . . . . 0.0 111.262 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.464 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -117.55 144.08 45.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.565 -179.79 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.49 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 21.3 t -54.54 106.36 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.124 0.488 . . . . 0.0 110.941 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 29' ' ' SER . 0.5 OUTLIER -65.99 -52.58 48.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.638 179.86 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.6 t -169.41 133.86 1.4 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.388 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.485 ' HA ' HG12 ' A' ' 28' ' ' VAL . 65.8 mt -95.06 116.55 36.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.083 0.468 . . . . 0.0 111.826 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.425 ' N ' ' O ' ' A' ' 27' ' ' GLY . 2.3 mp -58.09 115.9 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.199 178.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -68.23 69.86 0.15 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.068 0.461 . . . . 0.0 110.69 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 168.21 -29.62 0.16 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.375 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.46 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -68.02 -172.33 6.6 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.907 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.51 ' HB3' ' HA ' ' A' ' 18' ' ' LEU . . . -62.98 -40.87 99.03 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.468 ' CB ' HG11 ' A' ' 28' ' ' VAL . . . -64.69 -48.06 76.09 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.936 0.398 . . . . 0.0 111.561 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.3 t -63.35 -30.66 71.75 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.216 0.531 . . . . 0.0 110.09 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 39.5 mtpt -76.68 -28.85 56.09 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.055 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.72 -29.26 64.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.882 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 68.05 16.51 68.71 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.202 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.444 ' HG3' ' CD1' ' A' ' 14' ' ' PHE . 0.8 OUTLIER -138.47 11.57 2.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.908 0.354 . . . . 0.0 111.274 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.414 ' HB3' ' CD1' ' A' ' 49' ' ' ILE . 0.1 OUTLIER -106.68 134.92 49.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.689 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.12 144.57 38.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.85 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.49 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 46.2 t -61.89 148.69 9.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.085 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.462 ' N ' HG11 ' A' ' 63' ' ' VAL . 23.7 m-20 88.11 -10.46 0.51 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.431 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.5 115.05 5.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.769 0.318 . . . . 0.0 110.626 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.48 ' O ' ' HA ' ' A' ' 105' ' ' VAL . 18.3 tm0? -69.16 135.86 51.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.699 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.472 ' HB2' HG12 ' A' ' 44' ' ' ILE . 93.2 mt -87.75 139.85 30.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.849 0.357 . . . . 0.0 111.148 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.464 HD12 ' CB ' ' A' ' 106' ' ' ALA . 2.4 mt -122.28 -44.36 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.888 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.83 145.57 28.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.702 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.1 p -132.68 130.0 58.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.313 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.415 ' ND2' ' O ' ' A' ' 90' ' ' SER . 23.7 m-80 61.2 26.95 16.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.819 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.97 23.69 59.05 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.389 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -131.89 108.7 9.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.804 0.335 . . . . 0.0 110.864 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.0 t -59.21 154.67 15.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.711 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.487 ' HB3' ' CB ' ' A' ' 83' ' ' ALA . 0.7 OUTLIER -115.8 -15.59 11.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.582 -179.723 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -46.66 -44.13 18.25 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.942 0.401 . . . . 0.0 111.173 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -57.51 -35.47 72.86 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.574 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.4 ptpm? -101.31 168.12 9.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.286 0.565 . . . . 0.0 111.297 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.34 174.73 6.12 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.542 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.421 ' OD1' ' N ' ' A' ' 81' ' ' GLN . 8.1 p30 -67.0 -52.26 44.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.581 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.421 ' N ' ' OD1' ' A' ' 80' ' ' ASN . 5.1 pm0 -58.12 -41.26 83.24 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.931 0.396 . . . . 0.0 110.483 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -70.45 -37.85 74.38 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.487 ' CB ' ' HB3' ' A' ' 75' ' ' LEU . . . -66.77 -33.49 75.73 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.229 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.465 ' O ' ' HB2' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -72.54 -32.32 66.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.981 179.236 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -78.48 -35.38 46.62 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.38 178.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.435 ' HA ' ' HD2' ' A' ' 89' ' ' ARG . 1.5 m -67.28 -35.72 80.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.311 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.43 ' CD2' ' HA ' ' A' ' 84' ' ' MET . 4.4 pp -78.31 -33.71 49.18 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -63.24 -50.84 68.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.788 179.312 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.435 ' HD2' ' HA ' ' A' ' 86' ' ' THR . 0.0 OUTLIER -73.03 -34.62 66.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.065 179.771 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.415 ' O ' ' ND2' ' A' ' 71' ' ' ASN . 55.9 m -72.19 -31.64 66.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.77 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.427 ' HE2' ' CD2' ' A' ' 26' ' ' LEU . 3.8 ptm -88.08 -18.72 28.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.614 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.01 18.14 14.73 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.435 HG22 ' HG3' ' A' ' 94' ' ' GLU . 0.4 OUTLIER -153.28 -37.99 0.1 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.898 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.496 ' HA ' ' CG ' ' A' ' 97' ' ' LYS . 8.6 mt-10 -104.15 -42.01 5.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.003 0.43 . . . . 0.0 111.742 -178.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.413 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -68.44 -37.94 86.25 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.806 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.422 ' O ' ' C ' ' A' ' 97' ' ' LYS . 1.1 t-20 -67.13 -33.76 76.14 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.496 ' CG ' ' HA ' ' A' ' 94' ' ' GLU . 4.2 mmmt -31.42 -51.8 0.2 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.464 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.95 -27.48 16.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.757 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 122.8 1.11 9.84 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.813 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.456 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -161.77 142.55 10.76 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 121.038 0.447 . . . . 0.0 111.371 -179.743 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.413 ' HB ' ' HA3' ' A' ' 95' ' ' GLY . 0.1 OUTLIER -114.81 138.64 44.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.853 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -76.54 149.91 36.63 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.414 ' CD1' ' CG2' ' A' ' 16' ' ' VAL . 0.3 OUTLIER -140.99 111.16 6.67 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.778 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 45.6 mt -98.35 112.77 31.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 66' ' ' GLN . 18.1 m -124.28 152.42 30.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.454 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.464 ' CB ' HD12 ' A' ' 68' ' ' ILE . . . -124.95 148.11 48.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.113 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.59 171.85 18.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.98 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 21.4 mtm180 -94.22 135.08 35.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.009 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 7.1 mt -62.61 115.22 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.02 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 46.6 t . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.896 -179.998 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.848 0.356 . . . . 0.0 110.755 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -78.75 170.07 17.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.964 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.41 39.1 1.73 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.536 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 74.34 114.8 0.06 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.695 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 63.02 80.58 0.23 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.75 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 1.1 m -81.46 -93.58 0.05 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.93 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 167.15 154.79 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 4.2 mm -136.36 109.18 8.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.976 0.417 . . . . 0.0 111.333 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' THR . . . . . 0.41 ' CB ' ' HG2' ' A' ' 84' ' ' MET . 3.5 m -94.33 97.93 10.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.664 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -73.93 127.81 33.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.121 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 18.4 m . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.562 -0.732 . . . . 0.0 110.693 179.683 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.422 -0.271 . . . . 0.0 112.422 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.3 p -124.05 20.89 9.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.679 0.276 . . . . 0.0 111.029 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 12.0 mtm180 -104.63 121.37 43.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.872 0.368 . . . . 0.0 110.708 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.27 169.1 18.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.069 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.55 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 2.4 p90 -112.36 148.34 34.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.645 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.466 HD13 ' CG2' ' A' ' 105' ' ' VAL . 0.1 OUTLIER -129.14 120.72 26.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.36 -178.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.0 m -83.15 145.43 29.21 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.336 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.437 ' CD1' ' HB3' ' A' ' 60' ' ' ARG . 63.8 m-85 -140.67 171.35 14.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.383 0.611 . . . . 0.0 112.219 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -140.13 106.99 5.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.214 -0.903 . . . . 0.0 108.902 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.417 ' CG2' ' CD1' ' A' ' 103' ' ' LEU . 17.3 t -105.61 117.75 57.2 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 -177.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.414 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 90.2 Cg_endo -86.69 128.18 2.84 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.764 2.309 . . . . 0.0 110.936 178.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.643 ' HA ' ' HB1' ' A' ' 54' ' ' ALA . 0.5 OUTLIER -122.77 28.63 7.19 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -178.717 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -40.91 -30.57 0.13 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.167 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -113.01 -32.53 6.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.14 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.432 ' HB3' ' CB ' ' A' ' 18' ' ' LEU . 41.7 t -70.74 -6.56 38.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.182 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.401 ' HA2' ' CD1' ' A' ' 18' ' ' LEU . . . -42.97 -30.03 0.95 Allowed Glycine 0 C--N 1.337 0.605 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.664 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.8 m -83.16 -40.37 19.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.885 0.374 . . . . 0.0 110.434 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.98 -5.79 56.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.266 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.92 -46.8 3.12 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.953 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.472 ' O ' ' N ' ' A' ' 54' ' ' ALA . 6.2 tp 178.79 -33.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.661 0.267 . . . . 0.0 110.677 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.477 ' HA2' HD13 ' A' ' 50' ' ' ILE . . . 102.96 49.86 1.12 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.442 -0.885 . . . . 0.0 113.565 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.47 HG13 ' CB ' ' A' ' 55' ' ' ALA . 34.2 m -158.41 154.81 4.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 117.053 0.426 . . . . 0.0 111.78 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.423 ' O ' ' HB3' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -112.24 111.12 21.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.343 178.606 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.3 m -106.93 141.93 20.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.09 0.471 . . . . 0.0 111.843 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.94 129.68 17.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.199 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -91.33 158.09 25.28 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.017 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -114.0 -178.76 3.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.9 0.381 . . . . 0.0 110.929 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 67.9 mtt180 -135.96 152.67 51.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.541 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.1 m -54.36 144.38 20.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.041 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.75 -33.39 75.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.981 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.14 -68.47 0.7 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.891 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -94.3 -173.41 3.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.85 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 65.2 m-70 -101.53 31.1 3.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.036 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.74 128.34 34.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.953 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.401 ' CB ' ' ND2' ' A' ' 80' ' ' ASN . 3.7 p-10 -57.18 149.0 20.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.137 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.7 mt -113.14 -1.0 14.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.323 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.452 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 113.7 169.83 17.07 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.313 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.422 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -102.82 131.23 51.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.709 0.29 . . . . 0.0 110.951 179.757 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.445 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -119.54 144.95 46.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.866 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.482 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 39.0 t -60.78 104.57 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.641 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.423 ' HB3' ' O ' ' A' ' 29' ' ' SER . 2.2 tptt -73.71 -42.26 61.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.569 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.48 119.64 1.05 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.113 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.479 ' CD1' ' HB3' ' A' ' 61' ' ' LEU . 68.0 mt -85.18 117.8 30.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.015 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.477 HD13 ' HA2' ' A' ' 27' ' ' GLY . 1.6 mp -55.72 106.6 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.462 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -64.64 74.2 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.014 0.435 . . . . 0.0 110.73 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 162.6 -26.4 0.23 Allowed Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.326 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.427 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -71.19 -163.46 5.41 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.85 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.643 ' HB1' ' HA ' ' A' ' 18' ' ' LEU . . . -71.28 -41.61 69.8 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.47 ' CB ' HG13 ' A' ' 28' ' ' VAL . . . -65.34 -43.4 91.02 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.317 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.2 m -67.5 -36.13 80.48 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.889 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -68.85 -33.95 74.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.597 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -60.24 -26.78 66.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.756 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 58.54 26.76 60.16 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.368 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.437 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 8.7 mtm180 -121.39 -28.52 4.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.63 0.252 . . . . 0.0 111.109 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.479 ' HB3' ' CD1' ' A' ' 49' ' ' ILE . 4.2 mp -75.91 151.1 37.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.136 0.493 . . . . 0.0 111.677 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.405 ' HD3' ' O ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -146.56 131.53 18.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.172 179.701 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.482 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 47.3 t -57.69 141.69 14.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.121 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.466 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 28.4 m-20 89.91 17.41 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.577 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -103.28 123.44 46.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.327 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.407 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -81.52 136.41 35.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.789 0.328 . . . . 0.0 110.793 -179.583 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.411 HD12 ' CD1' ' A' ' 87' ' ' LEU . 7.9 mt -87.51 131.21 34.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.569 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 34.5 mt -110.98 -33.97 2.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.614 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -153.34 157.47 40.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.132 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.4 p -142.25 126.42 15.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.387 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 66.1 m-80 60.68 18.87 8.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.74 0.305 . . . . 0.0 110.931 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.0 27.46 23.58 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.118 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -129.04 101.27 5.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.826 0.346 . . . . 0.0 110.828 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.0 t -65.33 148.5 51.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.05 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.428 ' CD2' ' CD2' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -130.61 14.43 5.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.234 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.5 tp -60.47 -22.5 63.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.725 0.297 . . . . 0.0 111.04 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -82.06 -27.21 46.01 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.662 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.6 ptpm? -96.05 171.31 8.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.174 0.512 . . . . 0.0 111.24 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.81 165.02 25.27 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.467 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.402 ' OD1' ' N ' ' A' ' 81' ' ' GLN . 8.4 p30 -57.0 -47.95 79.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.252 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.402 ' N ' ' OD1' ' A' ' 80' ' ' ASN . 2.1 pp0? -59.77 -43.86 94.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.907 0.384 . . . . 0.0 110.938 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -70.01 -32.57 70.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.853 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.405 ' CB ' ' CD1' ' A' ' 44' ' ' ILE . . . -69.16 -47.42 65.05 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.619 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 6.8 ptp -61.96 -31.64 71.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.101 0.477 . . . . 0.0 109.863 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.11 -34.75 66.34 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.409 ' O ' ' HB2' ' A' ' 90' ' ' SER . 2.1 m -62.97 -34.21 77.03 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.141 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.428 ' CD2' ' CD2' ' A' ' 75' ' ' LEU . 0.1 OUTLIER -76.24 -35.05 59.17 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.868 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.06 -51.84 68.03 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.772 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.416 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -71.57 -43.42 66.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.612 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.409 ' HB2' ' O ' ' A' ' 86' ' ' THR . 1.6 t -65.6 -29.55 70.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.174 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.414 ' O ' HD13 ' A' ' 18' ' ' LEU . 2.2 ptp -89.58 -19.88 24.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.629 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.21 27.56 8.75 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 -179.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.416 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.3 OUTLIER -162.19 -31.23 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.956 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.417 ' HA ' ' HG3' ' A' ' 97' ' ' LYS . 7.4 mt-10 -111.62 -72.49 0.71 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.788 0.328 . . . . 0.0 111.55 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.424 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -49.2 -29.67 9.89 Favored Glycine 0 CA--C 1.517 0.204 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.633 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.68 -34.59 64.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.856 0.36 . . . . 0.0 110.257 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.417 ' HG3' ' HA ' ' A' ' 94' ' ' GLU . 8.9 mtpp -40.01 -34.6 0.3 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.47 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.87 -25.05 12.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.705 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 122.64 -8.3 9.44 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.006 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.414 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -154.48 144.2 21.6 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.924 0.392 . . . . 0.0 111.53 -179.636 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.425 ' CG2' ' CD2' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -110.52 140.54 29.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.034 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.88 150.48 36.03 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.417 ' CD1' ' CG2' ' A' ' 16' ' ' VAL . 0.5 OUTLIER -143.54 111.03 5.86 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -178.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 36.5 mt -102.0 113.33 38.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.732 178.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.466 ' CG2' HD13 ' A' ' 12' ' ' LEU . 4.4 m -116.83 174.9 3.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.058 0.456 . . . . 0.0 111.664 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.55 ' HA ' ' HA ' ' A' ' 11' ' ' PHE . . . -147.38 137.02 22.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.998 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.5 -178.18 7.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.709 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -107.58 133.73 51.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.906 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 47.1 mt -64.81 105.38 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.93 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.7 t . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.868 179.99 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.828 0.347 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -112.45 163.48 14.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.967 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -98.9 31.75 2.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.746 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 60.94 81.53 0.19 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.801 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 26.8 m170 58.89 102.63 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.702 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.72 -87.96 0.39 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.134 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 170.21 151.71 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . 0.472 HD12 HG22 ' B' ' 10' ' ' ILE . 1.6 mm -112.09 144.54 19.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.991 0.424 . . . . 0.0 111.237 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 99.0 m -119.27 99.48 6.72 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.687 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 9.3 ttmt -72.66 122.63 21.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.001 0.429 . . . . 0.0 110.946 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.123 179.981 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 N-CA-C 112.544 -0.222 . . . . 0.0 112.544 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.404 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 28.8 p -135.54 69.57 1.44 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.891 0.376 . . . . 0.0 110.895 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.02 123.15 9.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.728 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -136.82 137.53 39.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.373 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -83.85 149.91 26.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.539 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.72 109.83 7.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.97 0.414 . . . . 0.0 111.273 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 39.6 m -101.15 127.85 47.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.584 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.448 ' CZ ' ' HB3' ' A' ' 60' ' ' ARG . 29.5 m-85 -140.86 172.62 12.44 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.424 0.63 . . . . 0.0 112.327 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.468 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.4 OUTLIER -126.38 112.43 15.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.021 179.131 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.9 t -104.77 111.7 65.24 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -177.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 85.8 Cg_endo -83.3 127.64 4.6 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.431 2.087 . . . . 0.0 110.738 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.549 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 0.5 OUTLIER -121.54 27.99 7.95 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -178.893 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -39.86 -31.06 0.1 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.289 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -112.23 -32.04 6.66 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.163 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.4 ' HB3' ' CB ' ' A' ' 18' ' ' LEU . 12.6 t -70.51 -6.0 33.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.181 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -43.83 -29.85 1.48 Allowed Glycine 0 C--N 1.337 0.621 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.732 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.39 -36.09 22.68 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.971 0.415 . . . . 0.0 110.598 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.79 -6.71 59.49 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.377 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.25 -47.47 2.87 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.948 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.458 ' O ' ' N ' ' A' ' 54' ' ' ALA . 6.8 tp 178.47 -29.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.589 0.233 . . . . 0.0 110.824 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.47 ' HA3' ' HA3' ' A' ' 53' ' ' GLY . . . 104.58 42.67 1.82 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.501 -0.857 . . . . 0.0 113.3 179.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.456 HG13 ' CB ' ' A' ' 55' ' ' ALA . 33.1 m -157.15 158.5 3.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.206 0.527 . . . . 0.0 111.988 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -117.1 118.03 31.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.208 178.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.5 m -106.35 149.61 9.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.228 0.537 . . . . 0.0 112.379 -178.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.38 130.77 15.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.026 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' A' ' 44' ' ' ILE . . . -104.76 161.59 15.04 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.266 -0.969 . . . . 0.0 113.115 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 -130.67 170.93 13.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.968 0.413 . . . . 0.0 110.907 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.26 154.24 31.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.621 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -47.45 149.21 1.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.302 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.42 -47.97 68.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.359 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -73.59 -50.07 23.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.328 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -121.14 168.36 11.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.746 0.308 . . . . 0.0 111.039 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -83.41 57.78 4.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.143 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -103.04 109.49 21.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.765 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.417 ' HB3' ' ND2' ' A' ' 80' ' ' ASN . 37.4 m-20 -45.91 119.29 2.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.722 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.8 mt -88.24 -1.3 57.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.009 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.403 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 106.91 -174.62 20.12 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.172 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.492 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -111.41 138.34 40.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.907 0.384 . . . . 0.0 111.284 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.71 141.5 49.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.629 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.43 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 38.6 t -54.7 107.2 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.841 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.2 tptt -77.21 -41.47 41.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.627 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.6 m -167.5 123.91 1.13 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.06 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.432 ' CD1' ' HB3' ' A' ' 61' ' ' LEU . 69.3 mt -90.92 124.26 43.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.359 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.422 ' O ' ' N ' ' A' ' 52' ' ' GLY . 2.1 mp -63.89 110.28 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.379 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.13 70.98 0.06 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.084 0.469 . . . . 0.0 110.892 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 166.98 -27.45 0.16 Allowed Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.111 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.47 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -70.04 -166.85 5.92 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.944 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.549 ' HB2' ' HA ' ' A' ' 18' ' ' LEU . . . -68.64 -41.09 79.89 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.456 ' CB ' HG13 ' A' ' 28' ' ' VAL . . . -66.65 -41.12 88.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.57 -179.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 t -70.07 -33.3 71.74 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.139 0.495 . . . . 0.0 110.116 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.3 mtpt -73.62 -29.05 62.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.076 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.78 -29.96 67.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.565 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 68.52 15.74 68.74 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.824 -0.703 . . . . 0.0 113.005 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.448 ' HB3' ' CZ ' ' A' ' 14' ' ' PHE . 0.5 OUTLIER -129.0 -0.72 5.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.764 0.282 . . . . 0.0 111.222 179.832 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.432 ' HB3' ' CD1' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -99.23 132.98 44.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.91 0.386 . . . . 0.0 111.18 -179.67 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.27 142.47 39.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.769 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.465 ' O ' ' CB ' ' A' ' 64' ' ' ASN . 55.0 t -56.41 147.04 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.175 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 29.9 m-20 89.76 -10.47 0.37 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.371 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -63.62 107.26 1.11 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.821 0.343 . . . . 0.0 110.729 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 21.4 tm0? -71.5 114.0 9.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.608 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.415 ' CD2' ' CG1' ' A' ' 105' ' ' VAL . 7.9 mt -68.07 142.7 55.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.958 0.408 . . . . 0.0 111.561 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 36.6 mt -129.18 -34.92 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.374 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.65 166.26 28.86 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.896 0.379 . . . . 0.0 111.288 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.3 p -155.19 118.85 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.903 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 56.72 43.82 24.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.556 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 70.93 23.54 77.94 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.722 -0.752 . . . . 0.0 111.966 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -122.55 97.37 5.43 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.778 0.323 . . . . 0.0 110.862 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.82 119.37 13.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.929 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.8 mt -72.27 -15.65 61.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.175 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 21.6 mt -52.2 93.13 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.892 0.377 . . . . 0.0 111.013 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 151.51 -24.16 0.95 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.415 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.5 ptpm? -111.93 167.75 10.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.165 0.507 . . . . 0.0 111.072 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.02 165.13 25.67 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.279 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.424 ' HB3' ' HA3' ' A' ' 32' ' ' GLY . 22.2 m-80 -52.29 -57.47 9.65 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.258 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.6 pp0? -53.82 -38.75 64.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.399 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.85 -38.88 73.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.277 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.44 ' CB ' ' CD1' ' A' ' 44' ' ' ILE . . . -66.76 -47.88 70.82 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.746 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.47 ' HA ' ' CD2' ' A' ' 87' ' ' LEU . 5.0 ptp -63.13 -29.7 71.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.977 179.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.66 -32.36 47.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.385 178.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.423 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 1.4 m -69.03 -36.59 77.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.348 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.47 ' CD2' ' HA ' ' A' ' 84' ' ' MET . 4.4 pp -78.46 -33.82 48.13 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.447 ' N ' HD12 ' A' ' 87' ' ' LEU . 1.1 ttt180 -58.4 -51.69 68.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.465 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.52 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.27 -33.88 67.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.195 179.814 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.443 ' N ' ' HD3' ' A' ' 89' ' ' ARG . 5.3 t -70.45 -29.17 65.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.25 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.472 ' CB ' HD13 ' A' ' 101' ' ' ILE . 4.2 ptp -88.77 -20.27 24.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.533 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.75 39.57 3.93 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.52 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.5 OUTLIER -171.71 -22.22 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 179.696 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -127.9 -59.0 1.21 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.91 0.386 . . . . 0.0 111.091 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.428 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -67.52 -25.28 73.87 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.998 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.408 ' O ' ' ND2' ' A' ' 96' ' ' ASN . 0.6 OUTLIER -78.44 -32.93 48.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.966 0.412 . . . . 0.0 110.24 179.517 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.5 ' HD3' ' O ' ' A' ' 93' ' ' THR . 10.5 mmmt -44.22 -40.14 4.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.258 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.63 -28.29 19.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.743 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 122.74 -7.43 9.51 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.951 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.468 ' SD ' ' HB3' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -157.05 143.45 18.14 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.061 0.458 . . . . 0.0 111.29 -179.709 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.472 HD13 ' CB ' ' A' ' 91' ' ' MET . 0.1 OUTLIER -113.94 146.99 17.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.188 -179.713 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -87.86 139.94 30.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.095 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.47 HD23 HG12 ' A' ' 101' ' ' ILE . 2.5 mm? -131.73 141.87 49.64 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.131 0.491 . . . . 0.0 112.046 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 73.5 mt -127.09 112.31 28.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.415 ' CG1' ' CD2' ' A' ' 67' ' ' LEU . 29.8 m -132.5 133.08 60.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.825 -178.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -108.93 139.48 43.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.254 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.52 175.77 9.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.991 0.424 . . . . 0.0 111.382 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 8' ' ' THR . 5.1 mtm180 -97.76 143.77 28.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.175 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 19.4 mt -87.15 109.85 19.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.937 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 76.6 p . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.013 -179.89 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.886 0.374 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -102.34 166.17 10.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.844 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.82 34.45 4.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.904 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 60.83 169.33 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.808 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 59.2 m170 60.95 30.21 19.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.934 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.0 -175.0 0.53 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.839 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . 0.417 ' O ' ' NE2' ' B' ' 9' ' ' GLN . 1.2 pp0? -178.67 156.61 0.89 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.044 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.53 155.15 18.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.893 0.378 . . . . 0.0 111.128 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 53.2 m -126.75 134.56 50.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.974 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.27 109.48 16.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.63 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.402 ' CG1' ' HG3' ' A' ' 88' ' ' ARG . 16.8 m . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.151 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 N-CA-C 112.523 -0.231 . . . . 0.0 112.523 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.401 ' O ' HG13 ' A' ' 109' ' ' ILE . 82.8 p -88.3 -27.22 21.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.773 0.321 . . . . 0.0 111.071 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.3 ttt180 -76.76 113.37 14.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.821 0.343 . . . . 0.0 110.611 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -130.19 156.8 43.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.013 0.435 . . . . 0.0 111.596 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.421 ' CE2' HG12 ' A' ' 68' ' ' ILE . 13.6 m-85 -95.99 151.21 19.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.695 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.445 ' HB3' ' CZ ' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -137.3 110.99 8.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.885 -179.757 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.412 ' O ' ' CD1' ' A' ' 14' ' ' PHE . 97.2 m -97.6 130.63 44.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.639 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.445 ' CZ ' ' HB3' ' A' ' 12' ' ' LEU . 28.4 m-85 -140.87 172.47 12.64 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.26 0.553 . . . . 0.0 112.416 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.413 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.5 OUTLIER -126.98 111.7 14.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.051 179.086 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.407 HG11 ' CD1' ' A' ' 26' ' ' LEU . 34.3 t -104.26 116.66 60.97 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -177.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.5 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 89.7 Cg_endo -88.57 126.53 1.86 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.47 2.113 . . . . 0.0 110.846 178.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.5 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 0.3 OUTLIER -116.16 29.09 8.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.716 0.293 . . . . 0.0 111.547 -178.823 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -38.6 -31.72 0.06 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.434 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -112.2 -32.07 6.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.312 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 t -74.39 -5.49 42.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.181 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.417 ' HA2' ' CD1' ' A' ' 18' ' ' LEU . . . -43.88 -28.77 1.26 Allowed Glycine 0 C--N 1.336 0.561 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.942 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.1 p -88.26 -33.04 18.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.762 0.315 . . . . 0.0 110.897 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.47 9.02 28.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.531 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.62 -54.39 4.95 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.966 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.454 ' O ' ' N ' ' A' ' 54' ' ' ALA . 8.4 tp -175.12 -36.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.628 0.252 . . . . 0.0 110.811 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.468 ' HA3' ' HA3' ' A' ' 53' ' ' GLY . . . 114.83 44.91 0.67 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.4 -0.905 . . . . 0.0 113.295 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.439 ' CG1' ' CB ' ' A' ' 55' ' ' ALA . 33.1 m -157.24 160.56 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.189 0.518 . . . . 0.0 111.727 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.41 ' O ' ' HB3' ' A' ' 47' ' ' LYS . 0.7 OUTLIER -117.44 110.3 17.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.31 178.774 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.3 m -106.9 137.97 35.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.949 0.404 . . . . 0.0 111.717 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.46 129.63 22.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.431 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -89.23 156.92 26.47 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.539 -0.838 . . . . 0.0 113.055 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -128.29 145.22 51.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.827 0.346 . . . . 0.0 110.93 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 45.3 mtt85 -96.22 147.63 23.56 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.646 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.4 t -45.64 141.93 2.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.405 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -25.15 64.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.049 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -85.46 -72.18 0.5 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.8 0.333 . . . . 0.0 111.023 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -106.23 -162.45 0.86 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.744 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 53.5 m-70 -93.76 33.11 1.33 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.013 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.48 105.46 4.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.977 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -54.6 106.46 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.154 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 21.6 mt -67.79 -25.52 65.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.794 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.444 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 129.14 -178.63 17.2 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.06 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.23 133.05 49.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.911 0.386 . . . . 0.0 111.301 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.455 ' CE2' ' NE2' ' A' ' 66' ' ' GLN . 0.1 OUTLIER -122.47 145.48 48.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.833 -179.935 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 42.8 t -60.9 104.9 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.691 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.41 ' HB3' ' O ' ' A' ' 29' ' ' SER . 5.2 tppt? -76.68 -37.82 55.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.721 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.64 122.76 0.87 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.871 0.367 . . . . 0.0 111.422 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.44 ' CD1' ' HB3' ' A' ' 61' ' ' LEU . 63.9 mt -89.46 127.41 42.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.166 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.422 HD11 ' HA2' ' A' ' 27' ' ' GLY . 1.6 mp -66.33 109.06 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.52 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.28 76.64 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.086 0.47 . . . . 0.0 110.33 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 159.76 -26.71 0.34 Allowed Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.468 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -76.81 174.47 54.18 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.367 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.5 ' HB2' ' HA ' ' A' ' 18' ' ' LEU . . . -47.19 -46.52 23.92 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.439 ' CB ' ' CG1' ' A' ' 28' ' ' VAL . . . -61.81 -38.18 87.15 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.735 0.303 . . . . 0.0 111.763 -178.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.7 t -70.45 -43.11 70.52 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.938 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.434 ' H ' ' HG2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -66.49 -25.94 66.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.995 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.03 -52.88 61.78 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.83 0.347 . . . . 0.0 111.33 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.87 4.71 69.18 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.401 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.431 ' HD2' ' CD1' ' A' ' 14' ' ' PHE . 1.3 mtm180 -122.15 0.96 9.69 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.761 0.315 . . . . 0.0 110.662 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.44 ' HB3' ' CD1' ' A' ' 49' ' ' ILE . 0.1 OUTLIER -100.5 136.34 40.53 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.98 -179.807 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.33 143.99 29.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.844 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.463 ' O ' ' CB ' ' A' ' 64' ' ' ASN . 58.5 t -59.18 142.85 14.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.046 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 29.1 m-20 90.26 12.45 0.05 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.694 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.74 120.93 34.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.721 0.296 . . . . 0.0 110.274 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.455 ' NE2' ' CE2' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -78.05 137.18 38.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.7 -179.831 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.6 mt -93.52 140.95 29.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.024 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.421 HG12 ' CE2' ' A' ' 11' ' ' PHE . 4.5 mp -124.89 -41.44 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.393 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -139.17 151.03 46.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.018 0.437 . . . . 0.0 111.371 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.7 p -140.38 119.56 11.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.025 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 60.96 27.95 17.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.652 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.0 22.53 54.9 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.153 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -125.51 115.07 19.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.861 0.362 . . . . 0.0 110.78 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.5 p -60.22 149.96 31.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.129 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.0 mt -115.55 -29.72 6.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.064 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.0 mt -51.6 -35.21 40.67 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.236 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.35 -21.38 47.86 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.335 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -120.64 162.14 20.17 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.367 0.603 . . . . 0.0 110.977 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.48 161.73 5.56 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.154 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.417 ' OD1' ' N ' ' A' ' 81' ' ' GLN . 10.3 p30 -56.87 -43.81 81.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.158 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.417 ' N ' ' OD1' ' A' ' 80' ' ' ASN . 1.9 pp0? -64.58 -42.62 95.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.092 0.472 . . . . 0.0 110.55 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.68 -32.1 70.52 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.649 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.4 -49.04 58.98 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.685 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.41 ' HG2' ' HA ' ' A' ' 81' ' ' GLN . 6.9 ptp -59.64 -32.93 70.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.481 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -78.15 -31.28 49.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.22 0.533 . . . . 0.0 109.832 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.3 m -69.88 -36.44 75.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.521 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.418 ' CD1' ' N ' ' A' ' 88' ' ' ARG . 4.3 pp -78.77 -34.6 45.5 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.418 0.627 . . . . 0.0 109.478 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.46 ' O ' ' HG2' ' A' ' 91' ' ' MET . 0.2 OUTLIER -61.11 -47.37 86.59 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.5 179.46 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.411 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -73.18 -43.27 61.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.424 179.544 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.3 p -61.36 -29.54 69.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.381 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.46 ' HG2' ' O ' ' A' ' 88' ' ' ARG . 3.5 ptp -86.37 -34.93 20.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.84 -179.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -102.56 25.64 8.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.833 -179.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.411 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.5 OUTLIER -152.38 -36.66 0.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.796 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.423 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 4.0 mt-10 -111.37 -60.04 1.89 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.813 0.34 . . . . 0.0 111.408 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.595 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -56.17 -27.31 51.89 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.378 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.413 ' O ' ' ND2' ' A' ' 96' ' ' ASN . 0.9 OUTLIER -77.09 -33.73 56.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.712 0.291 . . . . 0.0 110.565 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 94' ' ' GLU . 60.9 mtpt -39.33 -39.53 0.66 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.674 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.77 -27.28 13.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.191 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 121.75 -3.2 10.95 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.7 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.5 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -155.63 143.38 19.7 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.981 0.419 . . . . 0.0 111.257 -179.639 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.595 ' HB ' ' HA3' ' A' ' 95' ' ' GLY . 0.1 OUTLIER -112.71 145.11 19.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.023 179.839 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -82.04 143.76 31.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.725 179.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.433 ' CD2' HG12 ' A' ' 101' ' ' ILE . 2.5 mm? -133.82 149.56 51.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.293 0.568 . . . . 0.0 112.008 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 74.7 mt -139.34 112.35 6.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.361 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 66' ' ' GLN . 35.2 m -123.66 172.93 10.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.473 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -147.85 132.52 17.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.41 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.55 -179.99 6.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.919 0.39 . . . . 0.0 111.007 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 2.1 tpp85 -116.49 132.29 56.72 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.01 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.422 HG22 HD13 ' A' ' 109' ' ' ILE . 47.9 mt -59.68 -25.75 32.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.962 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.834 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.879 0.371 . . . . 0.0 110.986 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -97.56 170.14 9.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.763 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -124.58 -50.13 1.75 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.127 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.88 93.01 1.41 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.781 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 60.99 -175.39 0.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.792 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 33.2 t -166.67 -156.28 0.23 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.657 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -161.37 129.91 4.43 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 1.1 mm -102.38 120.19 51.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.181 0.515 . . . . 0.0 111.514 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 43.9 m -98.08 102.97 14.87 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.527 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.75 102.75 1.59 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.641 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 34.8 m . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.175 -0.917 . . . . 0.0 111.247 -179.887 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.267 -0.333 . . . . 0.0 112.267 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 69.4 p -74.76 -6.69 50.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.642 0.258 . . . . 0.0 111.597 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -76.7 109.74 10.71 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.807 0.337 . . . . 0.0 110.676 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -126.71 163.59 23.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.135 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.431 ' CD2' HD12 ' A' ' 68' ' ' ILE . 4.4 m-85 -100.51 147.07 26.31 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.516 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.424 ' CD1' ' CG2' ' A' ' 105' ' ' VAL . 0.0 OUTLIER -139.51 121.43 15.57 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.958 0.408 . . . . 0.0 111.303 -179.783 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.3 m -94.74 142.7 27.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.249 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.485 ' O ' ' HA ' ' A' ' 102' ' ' GLN . 26.6 m-85 -142.03 172.64 12.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.975 0.417 . . . . 0.0 111.587 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.4 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.7 OUTLIER -132.27 107.63 8.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.55 179.219 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 32.2 t -104.3 114.36 64.32 Favored Pre-proline 0 C--N 1.33 -0.248 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -84.58 128.12 3.92 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.645 2.23 . . . . 0.0 110.958 178.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.584 ' HA ' ' HB3' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -122.26 28.78 7.29 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -178.856 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -39.37 -31.11 0.08 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.101 0.477 . . . . 0.0 111.15 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -112.94 -32.94 6.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.24 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.425 ' HB3' ' CB ' ' A' ' 18' ' ' LEU . 43.9 t -71.31 -6.62 41.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.174 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.4 ' HA2' ' CD1' ' A' ' 18' ' ' LEU . . . -44.23 -29.79 1.74 Allowed Glycine 0 C--N 1.336 0.567 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.692 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.21 -37.93 22.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.982 0.42 . . . . 0.0 110.553 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.29 -1.03 54.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.427 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.07 -48.91 3.91 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.879 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 54' ' ' ALA . 6.1 tp 179.78 -31.34 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.611 0.243 . . . . 0.0 110.553 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.472 ' HA2' HD11 ' A' ' 50' ' ' ILE . . . 105.96 48.31 1.02 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.297 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.427 HG13 ' CB ' ' A' ' 55' ' ' ALA . 20.0 m -157.08 163.97 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.164 0.506 . . . . 0.0 111.94 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.406 ' O ' ' N ' ' A' ' 47' ' ' LYS . 49.7 m -124.7 117.37 24.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.238 178.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.4 m -111.58 145.62 17.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.079 0.466 . . . . 0.0 112.163 -178.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.409 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -143.81 130.25 19.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.37 179.331 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -103.71 156.99 17.57 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.442 -0.885 . . . . 0.0 113.142 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.456 ' OD1' ' N ' ' A' ' 33' ' ' ASN . 6.7 p-10 -105.16 178.21 4.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.909 0.385 . . . . 0.0 111.163 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -136.27 126.47 26.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.76 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.432 ' CB ' HD23 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -50.43 121.45 5.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.149 -179.752 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.46 -10.89 55.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.552 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -77.91 -64.39 1.17 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.734 0.302 . . . . 0.0 111.325 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -124.12 25.87 7.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.498 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 52.46 54.2 11.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.898 0.38 . . . . 0.0 111.153 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -110.3 120.86 43.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.989 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -48.06 118.56 2.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.3 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.456 ' HB2' ' OD1' ' A' ' 33' ' ' ASN . 21.3 mt -81.31 -28.29 34.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.62 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.4 ' HA3' ' NE2' ' A' ' 66' ' ' GLN . . . 138.53 173.96 13.21 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.494 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.445 ' CD1' ' CB ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -101.68 153.5 5.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.869 0.366 . . . . 0.0 111.38 -180.0 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.458 ' CE2' ' NE2' ' A' ' 66' ' ' GLN . 0.4 OUTLIER -140.19 141.75 35.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.662 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.436 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 42.2 t -57.74 104.64 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.59 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.409 ' HB2' ' HG2' ' A' ' 31' ' ' LYS . 21.9 tptt -75.26 -41.49 57.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.749 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.97 124.52 1.08 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.857 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.501 ' CD1' ' HB3' ' A' ' 61' ' ' LEU . 77.2 mt -91.62 119.95 39.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.218 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.472 HD11 ' HA2' ' A' ' 27' ' ' GLY . 1.7 mp -56.0 108.14 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.376 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.15 72.94 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.873 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 162.45 -26.95 0.24 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.176 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.86 -170.6 8.14 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.901 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.584 ' HB3' ' HA ' ' A' ' 18' ' ' LEU . . . -64.15 -41.49 97.15 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.441 ' CB ' ' CD1' ' A' ' 61' ' ' LEU . . . -62.87 -47.58 82.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.703 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.0 t -67.85 -29.04 68.08 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.497 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 37.4 mtpt -74.87 -32.31 61.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.151 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -61.18 -27.94 68.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.808 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 66.59 20.76 70.27 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.779 -0.724 . . . . 0.0 113.132 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.426 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 12.5 mtm180 -125.19 -16.57 5.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.778 0.323 . . . . 0.0 110.979 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.501 ' HB3' ' CD1' ' A' ' 49' ' ' ILE . 0.5 OUTLIER -88.27 135.53 33.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.195 -179.668 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.16 137.87 29.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.692 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.45 HG11 ' N ' ' A' ' 64' ' ' ASN . 48.1 t -52.52 145.91 2.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.267 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.45 ' N ' HG11 ' A' ' 63' ' ' VAL . 28.2 m-80 86.98 11.09 0.15 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.613 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -91.82 115.69 28.27 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.458 ' NE2' ' CE2' ' A' ' 45' ' ' PHE . 0.9 OUTLIER -72.89 128.97 37.06 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.779 -179.632 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 42.6 mt -83.09 152.2 25.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.772 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.431 HD12 ' CD2' ' A' ' 11' ' ' PHE . 30.6 mt -143.63 -40.98 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.637 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -138.12 158.5 44.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.83 0.348 . . . . 0.0 111.457 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.8 p -151.51 120.6 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.951 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 57.12 29.65 16.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.87 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.19 23.75 50.52 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.308 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -127.75 118.61 24.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.741 0.305 . . . . 0.0 110.753 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.8 t -70.65 150.19 46.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.115 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.42 ' HB3' ' CB ' ' A' ' 83' ' ' ALA . 22.5 mt -111.16 -19.34 12.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.102 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.8 tp -54.41 -21.99 11.25 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.32 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -91.2 28.74 7.71 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.863 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -164.81 152.04 11.22 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.27 0.557 . . . . 0.0 110.921 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.96 156.45 2.05 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.329 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -54.16 -47.85 71.52 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.044 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -60.42 -40.0 89.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.016 0.436 . . . . 0.0 110.635 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.1 -34.22 72.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.678 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.445 ' CB ' ' CD1' ' A' ' 44' ' ' ILE . . . -66.5 -50.6 62.71 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.366 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.422 ' HA ' ' CD2' ' A' ' 87' ' ' LEU . 6.9 ptp -60.67 -30.5 69.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.927 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -79.51 -32.94 42.44 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.1 m -68.08 -35.67 78.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.277 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.422 ' CD2' ' HA ' ' A' ' 84' ' ' MET . 4.4 pp -78.31 -34.35 48.73 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.412 ' HG3' ' CG1' ' B' ' 13' ' ' VAL . 0.0 OUTLIER -60.21 -52.14 66.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.655 179.293 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.431 ' HD3' ' N ' ' A' ' 90' ' ' SER . 0.0 OUTLIER -72.5 -33.91 67.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.295 179.651 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.431 ' N ' ' HD3' ' A' ' 89' ' ' ARG . 24.0 t -71.6 -29.99 65.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.958 0.409 . . . . 0.0 110.424 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.416 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 1.5 ptp -89.2 -25.14 21.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.163 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.3 t -109.22 23.18 14.87 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.425 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.5 OUTLIER -153.37 -36.19 0.11 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.902 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.436 ' HA ' ' HG3' ' A' ' 97' ' ' LYS . 4.1 mt-10 -107.61 -64.3 1.22 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.828 0.347 . . . . 0.0 111.346 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.54 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -52.92 -33.63 44.06 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.656 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.4 ' O ' ' ND2' ' A' ' 96' ' ' ASN . 0.9 OUTLIER -70.49 -34.78 72.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.702 0.287 . . . . 0.0 110.382 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.436 ' HG3' ' HA ' ' A' ' 94' ' ' GLU . 20.7 mtpt -38.23 -47.29 1.16 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.475 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.31 -25.32 19.49 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.662 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 118.97 -3.05 14.58 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.819 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.4 ' SD ' ' HB3' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -159.48 143.43 14.84 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.076 0.465 . . . . 0.0 111.383 -179.744 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.54 ' HB ' ' HA3' ' A' ' 95' ' ' GLY . 0.1 OUTLIER -114.33 141.48 30.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.529 179.932 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.485 ' HA ' ' O ' ' A' ' 14' ' ' PHE . 2.2 pp0? -86.88 131.13 34.19 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.981 -0.287 . . . . 0.0 110.403 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.427 ' CD2' HG12 ' A' ' 101' ' ' ILE . 2.8 mm? -115.87 134.39 55.04 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.275 0.559 . . . . 0.0 112.114 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 96.7 mt -118.07 112.59 39.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.611 178.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 66' ' ' GLN . 28.9 m -121.53 177.21 3.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.265 -179.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -147.29 139.18 24.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.826 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.2 177.04 11.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.149 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 15.7 mtm180 -94.46 127.88 40.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.079 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.2 mt -64.04 -41.03 91.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.798 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.938 179.928 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.837 0.351 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.25 155.77 16.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.923 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -98.3 34.25 2.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.814 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 64.08 129.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.92 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 27.2 m170 60.64 85.01 0.12 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.866 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.71 -165.55 0.83 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.902 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -168.94 127.62 1.04 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 1.6 mm -101.97 134.92 41.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.135 0.493 . . . . 0.0 111.123 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 2.5 m -110.5 116.4 31.32 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.661 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 27.2 ttmt -78.13 109.2 12.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.925 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.412 ' CG1' ' HG3' ' A' ' 88' ' ' ARG . 17.3 m . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.277 -0.868 . . . . 0.0 111.275 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 N-CA-C 112.566 -0.214 . . . . 0.0 112.566 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.2 p -111.74 48.27 0.97 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.903 0.382 . . . . 0.0 110.931 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -112.98 146.54 38.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.692 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -151.73 155.25 37.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.211 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -100.7 148.93 24.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.802 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -133.68 110.88 10.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.026 -179.838 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.3 m -96.1 132.47 41.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.577 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.42 ' CZ ' ' HB3' ' A' ' 12' ' ' LEU . 54.9 m-85 -140.73 172.43 12.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.301 0.572 . . . . 0.0 112.113 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.401 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.3 OUTLIER -129.07 112.09 13.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.152 179.174 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 34.8 t -103.19 112.2 65.58 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -178.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 84.2 Cg_endo -82.22 127.82 5.4 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.365 2.043 . . . . 0.0 110.886 178.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.687 ' HA ' ' HB1' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -122.62 28.52 7.3 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -178.724 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -39.12 -31.49 0.07 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.172 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -113.33 -32.83 6.14 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.282 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.402 ' HB3' ' CB ' ' A' ' 18' ' ' LEU . 46.7 t -70.96 -7.7 47.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.163 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -45.25 -28.46 2.09 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.744 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.8 p -85.27 -34.28 21.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.797 0.332 . . . . 0.0 110.563 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.66 7.21 31.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.526 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.03 -54.99 4.78 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.644 -0.789 . . . . 0.0 111.985 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.461 ' CD2' ' HE2' ' A' ' 91' ' ' MET . 9.8 tp -178.89 -32.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.592 0.234 . . . . 0.0 110.948 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 50' ' ' ILE . . . 114.47 31.91 2.07 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.381 -0.914 . . . . 0.0 113.413 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.486 HG11 ' CB ' ' A' ' 55' ' ' ALA . 33.7 m -150.83 161.01 3.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 117.164 0.482 . . . . 0.0 111.75 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.42 ' O ' ' N ' ' A' ' 47' ' ' LYS . 0.9 OUTLIER -122.41 118.16 27.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.556 178.942 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.3 m -110.77 141.67 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.9 0.381 . . . . 0.0 111.937 -178.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.408 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -140.66 130.54 24.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.545 179.397 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.533 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -90.94 160.75 27.6 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.397 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.454 ' ND2' ' CE1' ' A' ' 45' ' ' PHE . 89.3 m-20 -119.57 179.91 4.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.837 0.351 . . . . 0.0 110.915 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.59 155.66 40.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.624 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.14 140.49 49.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.063 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.2 mtmm -64.51 -28.25 69.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.984 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -84.96 -74.88 0.38 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.944 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -94.41 177.26 6.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.903 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -93.07 58.42 2.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.881 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -116.78 131.63 56.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.998 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -59.37 144.31 47.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.915 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 17.0 mt -105.38 -30.98 9.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.862 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.533 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 148.51 -173.99 28.31 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.098 -0.572 . . . . 0.0 111.866 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.441 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -110.23 148.11 14.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 120.988 0.423 . . . . 0.0 111.735 -179.739 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.454 ' CE1' ' ND2' ' A' ' 33' ' ' ASN . 0.4 OUTLIER -134.4 138.43 44.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.557 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.478 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 40.0 t -54.17 104.41 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.564 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 29' ' ' SER . 5.9 tptm -73.03 -43.01 62.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.841 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 m -168.18 125.02 1.07 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.107 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.525 ' CD1' ' HB3' ' A' ' 61' ' ' LEU . 62.7 mt -88.93 116.66 30.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.297 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.432 ' N ' ' O ' ' A' ' 27' ' ' GLY . 1.9 mp -55.42 105.26 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.629 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.11 76.4 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.141 0.496 . . . . 0.0 110.588 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 158.95 -27.17 0.39 Allowed Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.907 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.45 -170.62 6.07 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.691 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.687 ' HB1' ' HA ' ' A' ' 18' ' ' LEU . . . -67.94 -38.58 83.0 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.486 ' CB ' HG11 ' A' ' 28' ' ' VAL . . . -67.66 -43.86 79.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.393 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 53.6 p -66.85 -33.28 75.25 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.204 0.526 . . . . 0.0 110.109 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -70.74 -33.53 70.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.171 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -58.05 -28.0 64.13 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.786 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.87 25.0 67.26 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.783 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.409 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 22.1 mtm180 -125.31 -24.22 4.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.812 0.339 . . . . 0.0 111.017 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.525 ' HB3' ' CD1' ' A' ' 49' ' ' ILE . 0.3 OUTLIER -71.62 164.06 26.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.444 -179.729 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.476 ' HD2' ' N ' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -160.46 138.83 10.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.713 179.876 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.478 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 37.0 t -70.5 144.75 13.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.594 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 25.4 m-20 88.75 -2.53 0.43 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.642 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.95 133.14 35.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.96 0.409 . . . . 0.0 110.599 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.426 ' NE2' ' HA3' ' A' ' 43' ' ' GLY . 1.0 OUTLIER -82.63 139.02 33.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.692 -179.806 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.7 mt -88.99 131.81 35.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.839 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 19.3 mm -113.13 -32.19 2.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.473 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -157.03 170.91 21.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.884 0.373 . . . . 0.0 111.585 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.3 p -158.17 127.39 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.767 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 60.24 22.83 12.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.668 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.07 25.53 31.32 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.993 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -130.55 108.45 9.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.796 0.332 . . . . 0.0 110.831 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.2 t -71.23 138.27 49.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.087 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.57 -13.24 20.5 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.163 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.82 94.7 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.913 0.387 . . . . 0.0 111.058 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 145.3 -31.09 1.71 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.185 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -97.56 156.89 16.3 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.239 0.542 . . . . 0.0 110.903 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.12 139.45 28.58 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.33 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.9 p30 -50.63 -28.14 8.25 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.172 0.511 . . . . 0.0 109.927 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.18 -42.04 60.49 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.013 178.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -70.11 -32.99 71.27 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.868 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.435 ' CB ' ' CD1' ' A' ' 44' ' ' ILE . . . -68.92 -45.46 70.8 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.487 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.422 ' HA ' ' CD2' ' A' ' 87' ' ' LEU . 6.5 ptp -63.49 -30.05 71.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.816 178.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -78.59 -33.46 47.51 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.479 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 3.4 m -68.34 -35.65 78.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.343 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.422 ' CD2' ' HA ' ' A' ' 84' ' ' MET . 4.4 pp -78.32 -33.83 48.99 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 178.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.427 ' O ' ' HG2' ' A' ' 91' ' ' MET . 0.0 OUTLIER -60.23 -51.24 70.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.65 179.332 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.479 ' HD3' ' O ' ' A' ' 86' ' ' THR . 0.0 OUTLIER -72.26 -34.93 68.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.618 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.441 ' N ' ' HD3' ' A' ' 89' ' ' ARG . 24.7 p -72.92 -29.8 63.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.852 0.358 . . . . 0.0 110.735 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.461 ' HE2' ' CD2' ' A' ' 26' ' ' LEU . 1.7 ptm -88.85 -17.43 29.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.288 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.85 25.45 9.68 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.518 ' O ' ' HD3' ' A' ' 97' ' ' LYS . 0.4 OUTLIER -157.14 -31.97 0.08 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.421 ' HG3' HG22 ' A' ' 93' ' ' THR . 5.7 mt-10 -117.59 -35.56 3.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.856 0.36 . . . . 0.0 111.443 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.483 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -78.26 -31.25 47.62 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.614 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.433 ' O ' ' ND2' ' A' ' 96' ' ' ASN . 0.7 OUTLIER -75.29 -31.89 60.83 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.584 -0.308 . . . . 0.0 110.176 179.576 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.518 ' HD3' ' O ' ' A' ' 93' ' ' THR . 27.1 mmmt -39.54 -47.19 1.86 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.968 0.414 . . . . 0.0 111.096 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.92 -25.49 19.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.889 178.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 114.19 1.09 23.74 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.908 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.458 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -154.66 141.0 18.66 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 120.975 0.417 . . . . 0.0 111.197 -179.588 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.483 ' HB ' ' HA3' ' A' ' 95' ' ' GLY . 0.1 OUTLIER -112.85 145.31 18.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.657 179.538 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -84.99 139.64 31.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.978 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.434 HD21 HG12 ' A' ' 101' ' ' ILE . 2.7 mm? -129.99 137.66 50.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.045 0.45 . . . . 0.0 111.801 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 72.6 mt -126.5 113.1 31.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.563 178.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 31.9 m -123.62 174.69 7.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.472 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -147.73 137.43 22.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.841 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.37 -178.62 6.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.946 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.54 151.6 24.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.02 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 31.1 mt -93.61 -39.84 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.074 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.914 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.755 0.312 . . . . 0.0 110.972 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -90.76 135.53 33.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.726 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -113.36 -41.16 3.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.922 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.85 -175.98 3.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.732 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.22 98.03 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.926 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 31.8 t -59.59 -160.77 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.859 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -159.77 130.66 5.82 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . 0.432 HG22 HD12 ' B' ' 10' ' ' ILE . 1.1 mm -104.43 121.8 56.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.413 0.625 . . . . 0.0 111.495 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 16.5 m -92.15 114.9 27.57 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.325 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -75.09 102.85 5.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.507 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 30.0 m . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.726 -0.655 . . . . 0.0 110.532 179.147 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.21 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.1 p -133.77 41.33 3.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.867 0.365 . . . . 0.0 110.911 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 18.5 mtm-85 -108.85 135.28 50.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.699 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -123.95 122.74 38.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.217 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.415 ' CD1' ' HB1' ' A' ' 106' ' ' ALA . 30.3 m-85 -77.75 140.48 39.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.462 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.16 134.42 20.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.123 0.487 . . . . 0.0 111.238 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.428 ' O ' ' CD1' ' A' ' 14' ' ' PHE . 25.4 m -92.63 150.8 20.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.295 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.44 ' O ' ' HA ' ' A' ' 102' ' ' GLN . 15.5 m-85 -140.08 170.37 15.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.105 0.479 . . . . 0.0 111.683 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -143.43 104.95 4.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.096 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.417 ' CG1' ' HA ' ' A' ' 55' ' ' ALA . 20.7 t -109.49 110.86 59.79 Favored Pre-proline 0 CA--C 1.531 0.226 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -177.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.523 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 91.2 Cg_endo -82.49 128.11 5.3 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.527 2.151 . . . . 0.0 110.736 178.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.656 ' HA ' ' HB3' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -121.82 29.5 7.09 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -178.582 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -40.92 -31.7 0.19 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.103 0.478 . . . . 0.0 111.031 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -111.32 -33.65 6.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.203 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.402 ' HB3' ' CB ' ' A' ' 18' ' ' LEU . 29.9 t -70.52 -8.55 52.12 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.111 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -44.96 -28.05 1.66 Allowed Glycine 0 C--N 1.337 0.613 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.691 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -85.69 -33.44 21.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.834 0.349 . . . . 0.0 110.737 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.37 8.33 28.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.441 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.96 -55.64 4.99 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.629 -0.795 . . . . 0.0 111.908 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.471 ' O ' ' N ' ' A' ' 54' ' ' ALA . 10.2 tp -179.0 -34.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.601 0.239 . . . . 0.0 111.12 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.79 35.02 1.31 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.537 -0.839 . . . . 0.0 113.295 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.499 HG11 ' CB ' ' A' ' 55' ' ' ALA . 34.2 m -156.3 162.2 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.282 0.563 . . . . 0.0 112.082 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -122.65 116.4 23.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.179 178.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.4 m -106.56 146.35 13.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.143 0.497 . . . . 0.0 111.938 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.34 131.08 21.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.58 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.46 ' HA3' ' HB2' ' A' ' 80' ' ' ASN . . . -97.32 145.69 17.95 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.697 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.405 ' OD1' ' CE1' ' A' ' 45' ' ' PHE . 21.9 m120 -107.84 -179.17 3.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.828 0.347 . . . . 0.0 111.028 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.4 mtt180 -134.53 156.12 49.2 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.691 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -48.92 150.97 1.34 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.194 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -66.48 -40.33 89.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.116 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -108.24 -35.46 6.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.127 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -91.67 168.94 11.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.925 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 -103.25 31.03 4.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.79 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.66 129.5 44.73 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.089 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.436 ' CB ' ' ND2' ' A' ' 80' ' ' ASN . 1.7 p30 -57.1 142.27 43.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.079 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 24.2 mt -104.06 12.6 33.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.11 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.405 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 98.47 170.67 31.8 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.586 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.457 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -102.02 135.78 37.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.851 0.358 . . . . 0.0 110.995 179.831 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.412 ' CE2' ' HG3' ' A' ' 66' ' ' GLN . 0.1 OUTLIER -121.02 141.33 50.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.792 -179.834 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.47 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 46.7 t -56.35 104.64 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.638 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.9 -40.94 60.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.758 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.0 p -166.9 124.72 1.31 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.162 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.513 ' CD1' ' HB3' ' A' ' 61' ' ' LEU . 67.6 mt -91.25 111.86 24.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.059 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.442 ' O ' ' HB2' ' A' ' 56' ' ' SER . 2.1 mp -51.8 106.41 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.801 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.34 75.52 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.023 0.44 . . . . 0.0 110.675 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 162.56 -29.99 0.28 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.082 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.61 -170.43 3.93 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.686 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.656 ' HB3' ' HA ' ' A' ' 18' ' ' LEU . . . -68.54 -38.18 80.59 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.499 ' CB ' HG11 ' A' ' 28' ' ' VAL . . . -66.84 -45.04 79.46 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.455 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.442 ' HB2' ' O ' ' A' ' 50' ' ' ILE . 0.4 OUTLIER -66.21 -34.8 78.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.27 0.557 . . . . 0.0 109.861 179.341 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.7 mtpt -68.47 -30.33 69.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.947 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.41 ' OD1' ' CD ' ' A' ' 17' ' ' PRO . 0.8 OUTLIER -64.09 -25.87 68.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.944 179.753 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.01 26.18 65.27 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.643 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.7 mtm180 -122.26 -34.79 3.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.968 0.413 . . . . 0.0 110.769 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.513 ' HB3' ' CD1' ' A' ' 49' ' ' ILE . 2.1 mp -66.74 141.86 57.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.473 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -138.45 134.22 33.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.269 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.47 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 46.3 t -59.51 145.36 11.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.014 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.444 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 22.3 m-20 87.85 -7.3 0.58 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.392 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -76.07 125.66 29.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.787 0.327 . . . . 0.0 110.766 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.412 ' HG3' ' CE2' ' A' ' 45' ' ' PHE . 1.8 tm0? -81.51 140.48 34.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.916 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.4 ' CD1' HG13 ' A' ' 44' ' ' ILE . 30.8 mt -87.17 139.57 30.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.924 0.392 . . . . 0.0 111.183 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 19.6 mm -120.65 -31.52 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.241 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -161.72 134.73 6.18 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.973 0.416 . . . . 0.0 111.573 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.5 p -121.57 129.36 75.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.366 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.43 ' ND2' ' O ' ' A' ' 90' ' ' SER . 9.3 m-80 64.95 13.96 8.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.538 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.77 -14.72 53.03 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.005 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -99.27 125.64 44.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.879 0.371 . . . . 0.0 111.07 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 21.3 p -75.04 165.1 25.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.901 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.405 ' CD2' ' CD2' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -128.9 4.38 5.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.267 -179.828 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.88 -41.43 78.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.909 0.385 . . . . 0.0 110.934 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.23 -25.84 73.49 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.691 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.406 ' HD2' ' HA ' ' A' ' 83' ' ' ALA . 1.3 ptpm? -101.7 166.78 10.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.287 0.565 . . . . 0.0 111.179 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.24 168.04 20.41 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.189 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.46 ' HB2' ' HA3' ' A' ' 32' ' ' GLY . 7.2 p30 -58.66 -50.48 73.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.055 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.421 ' N ' ' OD1' ' A' ' 80' ' ' ASN . 2.2 pp0? -58.84 -39.69 82.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.116 0.484 . . . . 0.0 110.516 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.13 -34.48 73.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.9 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.42 ' CB ' ' CD1' ' A' ' 44' ' ' ILE . . . -69.03 -47.66 64.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.785 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.419 ' HA ' ' HG ' ' A' ' 87' ' ' LEU . 5.6 ptp -61.93 -31.52 71.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.205 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.07 -33.8 65.86 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.8 m -64.66 -33.91 77.04 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.26 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.419 ' HG ' ' HA ' ' A' ' 84' ' ' MET . 0.1 OUTLIER -76.02 -36.02 59.3 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.099 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.14 -51.99 67.62 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.843 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.44 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.42 -44.86 61.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.429 179.665 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.43 ' O ' ' ND2' ' A' ' 71' ' ' ASN . 40.4 p -64.23 -30.38 71.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.489 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.431 ' HE1' ' CD2' ' A' ' 26' ' ' LEU . 2.1 ptm -89.01 -22.29 23.06 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.683 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.26 28.87 8.31 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.483 ' O ' ' HD3' ' A' ' 97' ' ' LYS . 0.3 OUTLIER -164.96 -23.15 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -179.664 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -122.06 -54.96 1.9 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.893 0.378 . . . . 0.0 111.317 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.433 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -66.59 -26.6 72.91 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.016 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.404 ' O ' ' ND2' ' A' ' 96' ' ' ASN . 0.9 OUTLIER -77.86 -36.04 50.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.834 0.349 . . . . 0.0 110.207 179.673 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.483 ' HD3' ' O ' ' A' ' 93' ' ' THR . 25.8 mmmt -45.46 -43.04 11.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.969 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.08 -24.53 22.26 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.51 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 111.61 1.9 27.46 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.856 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.523 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -165.17 140.23 5.16 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 121.172 0.51 . . . . 0.0 111.744 -179.818 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.437 ' CG2' ' CD2' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -114.38 133.54 60.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.902 179.932 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.44 ' HA ' ' O ' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -76.72 150.2 36.29 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -138.79 112.82 8.57 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 32.6 mt -98.86 112.84 31.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 34.5 m -128.25 161.92 35.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.942 0.401 . . . . 0.0 111.48 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.415 ' HB1' ' CD1' ' A' ' 11' ' ' PHE . . . -123.55 120.38 32.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.558 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.411 ' HG2' ' N ' ' A' ' 108' ' ' ARG . 0.0 OUTLIER -110.6 146.34 36.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.86 -179.664 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.411 ' N ' ' HG2' ' A' ' 107' ' ' ARG . 0.4 OUTLIER -76.55 126.02 30.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.98 -179.856 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 9.6 mt -62.86 -51.7 68.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.093 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 27.2 t . . . . . 0 C--N 1.326 -0.425 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.928 179.95 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.892 0.377 . . . . 0.0 110.916 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -149.03 170.03 19.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.882 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -106.67 -70.15 0.8 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.879 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -152.53 -56.9 0.13 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.663 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -132.29 145.17 51.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.686 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 32.8 t -120.38 -164.13 1.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.965 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -167.84 127.81 1.34 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . 0.408 HG22 HD11 ' B' ' 10' ' ' ILE . 1.4 mm -99.87 100.58 10.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.254 0.549 . . . . 0.0 111.161 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 55.9 m -70.51 102.82 2.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.578 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.6 120.07 20.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.92 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 11.1 m . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.151 -0.928 . . . . 0.0 110.818 179.81 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.3 p 49.44 34.71 6.99 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.718 0.294 . . . . 0.0 111.277 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.3 mtt85 -92.42 116.59 29.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.65 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -124.12 152.39 42.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.063 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -94.61 147.46 23.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.604 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -134.23 110.17 9.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.363 -179.711 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 76.5 m -96.59 130.25 43.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.282 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.424 ' CG ' ' HB3' ' A' ' 60' ' ' ARG . 32.0 m-85 -140.21 172.37 12.84 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.467 0.651 . . . . 0.0 112.249 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.441 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.2 OUTLIER -128.93 111.71 13.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.328 179.354 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.404 HG12 ' HB2' ' A' ' 54' ' ' ALA . 8.8 t -103.39 117.17 60.77 Favored Pre-proline 0 C--N 1.33 -0.274 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -178.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.462 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 80.7 Cg_endo -86.36 127.22 2.83 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.461 2.108 . . . . 0.0 111.184 178.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.538 ' HA ' ' HB1' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -119.04 28.12 8.45 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -178.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -39.23 -30.76 0.06 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.209 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -114.63 -31.27 6.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.138 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.9 t -72.15 -7.6 50.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.095 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -44.74 -28.49 1.67 Allowed Glycine 0 C--N 1.337 0.602 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.741 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.73 -35.43 20.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.8 0.333 . . . . 0.0 110.824 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.21 8.74 25.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.455 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.87 -54.39 4.95 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.92 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' A' ' 54' ' ' ALA . 8.8 tp -178.03 -36.1 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.636 0.255 . . . . 0.0 110.657 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.452 ' HA2' HD12 ' A' ' 50' ' ' ILE . . . 115.66 41.13 0.81 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.378 -0.915 . . . . 0.0 113.373 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.484 HG11 ' CB ' ' A' ' 55' ' ' ALA . 14.2 m -156.93 157.69 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 117.147 0.474 . . . . 0.0 111.917 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.42 ' O ' ' N ' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -116.38 117.2 29.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.279 178.596 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.5 m -110.33 148.24 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.148 0.499 . . . . 0.0 112.159 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -147.82 129.67 15.24 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.292 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 44' ' ' ILE . . . -90.57 163.65 29.96 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.43 -179.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.402 ' HB2' ' CZ ' ' A' ' 45' ' ' PHE . 1.7 m-80 -124.2 179.15 5.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.819 0.343 . . . . 0.0 110.637 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 11.0 ttm180 -135.15 148.75 49.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.84 128.84 36.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.917 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.23 -28.77 69.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.139 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -80.02 -62.83 1.56 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.875 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -117.05 164.64 14.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.831 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -75.05 63.05 1.21 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.939 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -119.56 117.82 29.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.061 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -51.08 142.71 11.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.174 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 23.0 mt -107.86 -2.16 20.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.341 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.416 ' HA3' ' NE2' ' A' ' 66' ' ' GLN . . . 111.0 179.93 20.16 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.326 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.454 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -109.27 139.4 32.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.978 0.418 . . . . 0.0 111.491 -179.824 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.42 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -120.47 144.84 47.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.589 179.952 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.451 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 35.7 t -62.93 104.44 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.677 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 29' ' ' SER . 10.8 tptt -69.8 -45.4 68.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.813 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -167.88 127.91 1.34 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.009 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.508 ' CD1' ' HB3' ' A' ' 61' ' ' LEU . 61.8 mt -90.17 122.44 41.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.056 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.452 HD12 ' HA2' ' A' ' 27' ' ' GLY . 1.8 mp -61.36 110.08 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.247 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -65.19 75.73 0.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.02 0.438 . . . . 0.0 110.597 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 160.67 -28.33 0.32 Allowed Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.807 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.451 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -74.65 167.53 54.77 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.798 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.538 ' HB1' ' HA ' ' A' ' 18' ' ' LEU . . . -40.76 -45.33 2.41 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.484 ' CB ' HG11 ' A' ' 28' ' ' VAL . . . -61.6 -42.36 98.76 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.178 -0.465 . . . . 0.0 112.164 -178.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.23 -24.69 59.35 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.021 0.439 . . . . 0.0 110.588 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.41 ' CG ' ' O ' ' A' ' 53' ' ' GLY . 0.2 OUTLIER -77.53 -34.39 53.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.795 -179.894 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -60.33 -33.81 72.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.727 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.78 22.09 79.28 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.811 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.424 ' HB3' ' CG ' ' A' ' 14' ' ' PHE . 17.4 mtm180 -125.19 -20.1 4.95 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.777 0.322 . . . . 0.0 111.08 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.508 ' HB3' ' CD1' ' A' ' 49' ' ' ILE . 0.4 OUTLIER -77.39 138.81 39.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.979 0.418 . . . . 0.0 111.295 -179.771 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.82 139.92 42.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.417 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.507 ' O ' ' HB2' ' A' ' 64' ' ' ASN . 41.7 t -67.74 144.03 14.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.066 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.507 ' HB2' ' O ' ' A' ' 63' ' ' VAL . 43.9 m-80 83.4 8.12 0.65 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.119 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -84.83 126.05 33.12 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.425 ' O ' ' HA ' ' A' ' 105' ' ' VAL . 1.2 tt0 -78.15 131.93 37.42 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.734 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.4 mt -87.28 141.41 28.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.749 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.6 mt -124.91 -36.87 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.494 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.436 ' HA ' ' HA ' ' A' ' 74' ' ' SER . . . -153.29 145.47 23.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.047 0.451 . . . . 0.0 111.666 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.416 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 14.9 p -133.54 130.25 56.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.588 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 63.2 18.48 11.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.692 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.48 25.27 36.54 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.663 -0.779 . . . . 0.0 111.728 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.416 ' HG3' ' O ' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -133.03 104.11 6.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.873 0.368 . . . . 0.0 110.633 -179.538 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 0.4 OUTLIER -62.95 157.23 22.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.231 -179.712 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.95 9.49 8.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.104 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.43 -25.61 67.33 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.848 0.356 . . . . 0.0 110.984 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -94.52 25.65 21.82 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.613 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.44 ' HD2' ' HA ' ' A' ' 83' ' ' ALA . 0.5 OUTLIER -151.34 160.71 43.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.25 0.548 . . . . 0.0 111.213 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.08 158.63 25.27 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.104 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.431 ' HB2' ' HA3' ' A' ' 32' ' ' GLY . 7.8 p30 -57.35 -47.73 80.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.311 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.438 ' HA ' ' HG2' ' A' ' 84' ' ' MET . 5.8 pm0 -58.51 -37.98 76.74 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.996 0.427 . . . . 0.0 110.776 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -70.67 -38.08 73.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.998 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.44 ' HA ' ' HD2' ' A' ' 78' ' ' LYS . . . -67.24 -46.16 74.59 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.823 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.438 ' HG2' ' HA ' ' A' ' 81' ' ' GLN . 5.5 ptp -64.26 -29.66 70.75 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -81.09 -30.28 34.69 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.425 178.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.472 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 7.3 m -71.58 -35.08 70.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.209 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.422 HD13 ' HE1' ' A' ' 91' ' ' MET . 4.2 pp -78.44 -34.29 47.93 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.429 ' O ' ' HG2' ' A' ' 91' ' ' MET . 0.0 OUTLIER -59.5 -52.0 67.43 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.628 179.203 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.499 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.82 -33.62 66.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.017 179.474 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.46 ' N ' ' HD3' ' A' ' 89' ' ' ARG . 49.5 m -70.5 -29.79 66.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.486 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.429 ' HG2' ' O ' ' A' ' 88' ' ' ARG . 2.9 ptp -86.41 -23.38 26.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.248 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.5 33.12 5.76 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.499 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.4 OUTLIER -162.91 -28.35 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.44 ' HG3' HG23 ' A' ' 93' ' ' THR . 5.3 mt-10 -122.62 -37.27 2.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.912 0.387 . . . . 0.0 111.196 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.428 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -82.27 -33.06 26.88 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.458 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.424 ' O ' ' ND2' ' A' ' 96' ' ' ASN . 0.7 OUTLIER -72.83 -33.25 66.04 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.313 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.479 ' HD3' ' O ' ' A' ' 93' ' ' THR . 10.5 mmmt -40.56 -46.12 2.44 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.098 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.8 -24.31 20.36 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.816 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 118.32 -4.91 15.42 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.784 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.441 ' SD ' ' HB3' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -156.03 143.99 19.7 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.935 0.398 . . . . 0.0 111.097 -179.748 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.453 HG12 HD23 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -111.76 145.28 18.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.225 -179.643 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.24 142.55 28.49 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.128 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.453 HD23 HG12 ' A' ' 101' ' ' ILE . 2.8 mm? -133.77 139.23 46.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.1 0.476 . . . . 0.0 111.749 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 7.4 mt -126.99 112.62 29.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.506 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 66' ' ' GLN . 32.6 m -125.41 176.02 6.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.513 -179.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -147.65 136.55 22.07 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.865 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.32 -178.88 6.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.912 0.387 . . . . 0.0 111.212 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.02 146.32 24.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.934 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.415 HD13 HG23 ' A' ' 109' ' ' ILE . 34.4 mt -75.47 -62.59 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.11 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.876 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.941 0.4 . . . . 0.0 111.129 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -134.46 169.02 17.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.966 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -109.63 39.18 2.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.802 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 65.73 -72.91 0.07 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.054 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 4.6 m80 -78.86 119.53 22.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.068 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.12 -169.47 1.47 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.646 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -174.32 125.1 0.32 Allowed 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 3.3 mm -101.2 137.02 30.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.994 0.426 . . . . 0.0 110.903 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 7.9 m -120.72 113.97 20.98 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.958 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.12 131.61 42.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.591 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.426 ' CG1' ' HG3' ' A' ' 88' ' ' ARG . 10.4 m . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.316 -0.85 . . . . 0.0 111.304 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 67.5 p -149.09 87.6 1.55 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.824 0.345 . . . . 0.0 110.99 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 48.0 mtt-85 -150.55 114.6 5.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.651 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -110.89 122.27 47.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.912 0.387 . . . . 0.0 111.138 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -74.92 144.42 43.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.214 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.49 109.86 4.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.034 0.445 . . . . 0.0 111.644 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.437 ' O ' ' CD1' ' A' ' 14' ' ' PHE . 11.8 m -81.09 141.4 34.35 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.706 178.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.448 ' CD2' ' CD2' ' A' ' 61' ' ' LEU . 19.5 m-85 -136.38 171.84 13.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.414 0.626 . . . . 0.0 112.595 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -143.05 102.29 3.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.242 178.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.442 HG21 HD12 ' A' ' 103' ' ' LEU . 40.4 t -104.39 106.77 55.49 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -177.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 5.3 Cg_exo -77.89 127.69 8.77 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.492 2.128 . . . . 0.0 110.623 178.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.657 ' HA ' ' HB1' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -125.78 28.93 6.05 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.748 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -38.96 -33.11 0.1 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.15 0.5 . . . . 0.0 111.139 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -108.82 -34.07 6.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.071 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.7 t -69.3 -8.3 44.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.056 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -42.44 -30.52 0.86 Allowed Glycine 0 C--N 1.337 0.619 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.837 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.2 p -82.88 -39.98 20.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.859 0.361 . . . . 0.0 110.438 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -78.63 -3.31 43.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.407 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.87 -50.75 2.87 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.005 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.419 ' CD1' ' CD2' ' A' ' 18' ' ' LEU . 10.2 tp -179.13 -35.28 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.708 0.29 . . . . 0.0 110.785 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.406 ' O ' ' N ' ' A' ' 50' ' ' ILE . . . 113.83 31.03 2.4 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.535 -0.84 . . . . 0.0 113.271 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.469 HG13 ' CB ' ' A' ' 55' ' ' ALA . 27.8 m -150.07 154.0 9.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.045 0.45 . . . . 0.0 112.0 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.4 ' O ' ' N ' ' A' ' 47' ' ' LYS . 0.9 OUTLIER -111.02 115.61 29.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.315 178.627 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.1 m -108.23 142.4 20.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.046 0.45 . . . . 0.0 111.9 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.67 131.17 19.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.15 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -92.01 157.82 24.48 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.478 -0.867 . . . . 0.0 113.351 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -117.33 -176.76 3.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.723 0.297 . . . . 0.0 110.693 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.21 152.15 47.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.684 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.16 139.51 52.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.102 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.22 -29.22 70.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.999 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -83.85 -70.41 0.57 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.998 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 34.2 p30 -100.78 -174.83 2.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.978 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -93.59 45.68 1.17 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.948 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.23 114.3 26.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.082 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -56.07 133.14 51.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.002 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 47.7 mt -94.34 16.94 13.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.274 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.442 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 86.99 179.14 48.87 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.367 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.422 HG13 ' CD1' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -103.89 136.26 37.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 120.933 0.397 . . . . 0.0 111.251 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -123.98 147.77 47.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.713 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.434 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 43.0 t -58.33 105.04 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.796 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.4 ' N ' ' O ' ' A' ' 29' ' ' SER . 4.0 tptt -75.88 -40.59 54.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.689 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -168.8 115.16 0.62 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.207 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.446 HG12 HG11 ' A' ' 28' ' ' VAL . 52.9 mt -81.31 118.75 29.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.206 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.434 ' O ' ' N ' ' A' ' 52' ' ' GLY . 2.0 mp -59.07 104.9 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.565 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.47 76.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.037 0.446 . . . . 0.0 110.615 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 159.82 -27.35 0.35 Allowed Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.022 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.06 -170.03 6.46 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.473 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.657 ' HB1' ' HA ' ' A' ' 18' ' ' LEU . . . -68.67 -39.14 80.76 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.469 ' CB ' HG13 ' A' ' 28' ' ' VAL . . . -65.96 -46.34 78.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.158 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 40.1 p -63.38 -35.38 80.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.215 0.531 . . . . 0.0 109.878 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.0 mtpt -66.68 -32.14 73.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.816 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.24 -30.3 64.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.461 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.66 27.49 66.38 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.836 -0.62 . . . . 0.0 113.406 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.442 ' HG3' ' CD1' ' A' ' 14' ' ' PHE . 15.8 ptp180 -134.85 1.74 3.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 117.162 0.481 . . . . 0.0 111.592 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.448 ' CD2' ' CD2' ' A' ' 14' ' ' PHE . 3.4 mm? -108.85 152.19 25.24 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.9 0.381 . . . . 0.0 111.06 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.44 145.48 26.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.785 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.486 ' O ' ' CB ' ' A' ' 64' ' ' ASN . 60.1 t -52.96 144.32 3.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.07 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.486 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 37.9 m-20 93.37 -14.11 0.14 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.331 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -60.99 110.0 1.23 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.767 0.317 . . . . 0.0 110.726 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.411 ' HG3' ' CE2' ' A' ' 45' ' ' PHE . 11.8 tm0? -75.34 111.24 10.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.999 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.422 ' CD1' HG13 ' A' ' 44' ' ' ILE . 42.6 mt -61.02 136.97 58.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.003 0.43 . . . . 0.0 111.085 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.401 ' CD1' ' CB ' ' A' ' 106' ' ' ALA . 29.9 mt -119.84 -34.78 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.139 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.4 143.84 20.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.457 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.419 ' CG2' ' CD1' ' A' ' 101' ' ' ILE . 7.4 p -133.04 132.04 58.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.431 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 61.88 26.21 15.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.927 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.44 24.43 63.15 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.312 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -129.98 103.86 7.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.853 0.358 . . . . 0.0 110.82 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.6 t -57.23 141.07 47.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.888 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.457 ' HB3' ' CB ' ' A' ' 83' ' ' ALA . 0.7 OUTLIER -101.23 3.19 40.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.572 -179.753 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.2 tp -63.76 -15.79 59.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.574 0.226 . . . . 0.0 111.304 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -88.92 14.34 60.66 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.127 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.52 177.34 11.58 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.251 0.548 . . . . 0.0 111.333 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.62 174.05 11.76 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.748 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -60.13 -51.52 69.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.347 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.64 -38.48 84.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.873 0.368 . . . . 0.0 110.619 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.3 -40.04 74.47 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.457 ' CB ' ' HB3' ' A' ' 75' ' ' LEU . . . -69.56 -30.91 68.81 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.873 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.435 ' O ' ' HB2' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -72.58 -33.26 66.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.73 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -78.07 -30.38 49.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.114 0.483 . . . . 0.0 109.775 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.5 m -70.65 -35.96 73.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.361 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.431 ' CD1' ' N ' ' A' ' 88' ' ' ARG . 4.3 pp -78.58 -34.85 46.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.401 0.62 . . . . 0.0 109.472 178.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.435 ' HB2' ' O ' ' A' ' 84' ' ' MET . 0.2 OUTLIER -62.49 -51.46 67.36 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.272 179.368 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.465 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -71.82 -35.42 69.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.119 179.602 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.7 m -67.23 -35.61 79.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.926 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 3.5 ptp -83.92 -27.98 28.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.868 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.13 23.58 14.28 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.465 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.4 OUTLIER -155.38 -32.18 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.426 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 5.0 mt-10 -112.94 -65.49 1.18 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.916 0.389 . . . . 0.0 111.513 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.485 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -54.2 -27.57 39.56 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.575 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.406 ' O ' ' ND2' ' A' ' 96' ' ' ASN . 0.7 OUTLIER -77.49 -32.79 54.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.692 0.282 . . . . 0.0 110.59 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 93' ' ' THR . 40.6 mtpt -41.49 -40.06 1.7 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.005 0.431 . . . . 0.0 111.521 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.77 -25.24 15.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.182 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 117.33 1.55 18.3 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.788 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.478 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -158.36 142.04 15.35 Favored 'General case' 0 N--CA 1.457 -0.089 0 CA-C-O 121.07 0.462 . . . . 0.0 111.845 -179.568 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.485 ' HB ' ' HA3' ' A' ' 95' ' ' GLY . 0.1 OUTLIER -115.62 136.25 53.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.6 179.496 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.417 ' HA ' ' O ' ' A' ' 14' ' ' PHE . 2.0 pp0? -76.55 140.85 41.26 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.442 HD12 HG21 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -134.8 112.59 10.84 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -178.715 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.1 mt -98.3 112.67 30.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.428 HG23 ' CE2' ' A' ' 14' ' ' PHE . 35.7 m -124.81 143.14 39.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.978 0.418 . . . . 0.0 111.462 -178.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.401 ' CB ' ' CD1' ' A' ' 68' ' ' ILE . . . -110.83 124.78 52.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.731 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.56 146.58 39.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.04 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.08 124.81 26.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.718 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.431 HD11 HG23 ' A' ' 109' ' ' ILE . 44.8 mt -69.15 -32.7 55.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.226 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 25.9 t . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.824 -179.857 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.914 0.388 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -74.01 132.7 42.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.987 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -105.05 -31.84 9.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.774 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -113.0 -172.86 2.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.914 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.31 -22.8 65.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.072 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 11.7 t 64.22 -162.38 0.27 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.765 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -176.03 126.9 0.22 Allowed 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . 0.445 HG22 HD13 ' B' ' 10' ' ' ILE . 1.8 mm -95.74 100.51 11.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.204 0.526 . . . . 0.0 111.085 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' THR . . . . . 0.4 ' CB ' ' HG2' ' A' ' 84' ' ' MET . 88.9 m -71.47 99.41 2.01 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.732 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -69.51 108.02 3.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.093 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 30.1 m . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.65 -0.691 . . . . 0.0 110.651 179.65 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.383 0 N-CA-C 112.573 -0.211 . . . . 0.0 112.573 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 35.8 p -121.94 29.83 6.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.778 0.323 . . . . 0.0 110.878 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.81 125.88 30.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.951 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -133.55 133.94 42.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.937 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -81.43 151.47 27.87 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.785 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.02 122.39 5.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.022 0.439 . . . . 0.0 111.236 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.8 m -81.46 146.24 30.34 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.209 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.456 ' N ' ' O ' ' A' ' 103' ' ' LEU . 17.6 m-85 -140.63 171.55 13.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.414 0.626 . . . . 0.0 112.243 -179.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -143.65 104.88 4.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.843 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.405 ' CG2' ' CD1' ' A' ' 103' ' ' LEU . 18.7 t -105.16 114.08 63.92 Favored Pre-proline 0 C--N 1.33 -0.268 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 97.8 Cg_endo -84.79 126.98 3.52 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.454 2.103 . . . . 0.0 110.849 178.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.436 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -121.98 28.24 7.66 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -178.672 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -39.2 -32.46 0.1 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.054 0.454 . . . . 0.0 111.205 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -108.74 -34.44 6.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.122 179.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.2 t -70.68 -6.58 38.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.288 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 18' ' ' LEU . . . -42.56 -30.51 0.89 Allowed Glycine 0 C--N 1.337 0.593 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.727 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.3 p -83.01 -39.27 21.5 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.851 0.358 . . . . 0.0 110.528 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -78.61 -15.09 58.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.3 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.04 -46.37 1.39 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.645 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.465 ' O ' ' N ' ' A' ' 54' ' ' ALA . 8.2 tp 178.06 -31.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.7 0.286 . . . . 0.0 110.704 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.432 ' HA2' HD11 ' A' ' 50' ' ' ILE . . . 106.12 43.65 1.48 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.405 -0.903 . . . . 0.0 113.384 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.422 HG13 ' CG2' ' A' ' 49' ' ' ILE . 29.0 m -157.33 155.71 4.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.304 0.573 . . . . 0.0 112.073 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.74 116.91 30.85 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 19.6 m -105.93 143.34 17.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.237 0.541 . . . . 0.0 112.222 -178.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -146.54 129.01 15.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.056 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -104.85 159.66 15.72 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.47 -0.871 . . . . 0.0 112.782 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -134.71 154.03 51.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.8 0.333 . . . . 0.0 110.971 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.404 ' CG ' ' HB2' ' B' ' 5' ' ' ASP . 1.1 ptp180 -109.12 154.62 22.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.097 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -40.87 151.43 0.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.439 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.94 -56.1 11.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.101 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -59.52 -71.51 0.12 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.005 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -85.41 172.89 10.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.881 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -98.54 34.6 1.99 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.85 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.04 124.91 34.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.076 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -59.55 139.33 57.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.964 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 16.7 mt -100.79 -29.76 12.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.887 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 146.25 -176.8 24.99 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.296 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.422 ' N ' HD13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -105.98 140.12 25.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.675 0.274 . . . . 0.0 110.67 179.837 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -127.09 139.37 53.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.445 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.425 ' O ' HG11 ' A' ' 63' ' ' VAL . 53.2 t -58.03 106.5 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.166 179.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.7 tptp -76.08 -40.87 52.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.879 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.3 t -168.06 122.23 0.94 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.028 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.422 ' CG2' HG13 ' A' ' 28' ' ' VAL . 69.6 mt -88.59 123.02 40.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.19 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.432 HD11 ' HA2' ' A' ' 27' ' ' GLY . 1.8 mp -60.61 109.63 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.221 179.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.82 72.49 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.074 0.464 . . . . 0.0 110.963 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 163.36 -25.85 0.21 Allowed Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.383 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.427 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -71.19 -167.4 7.77 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.574 -0.822 . . . . 0.0 113.018 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 26' ' ' LEU . . . -65.41 -42.98 91.98 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.305 0.484 . . . . 0.0 112.305 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.419 ' CB ' ' CG1' ' A' ' 28' ' ' VAL . . . -64.52 -44.65 90.18 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.582 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.4 m -67.44 -29.95 69.56 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.289 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.3 mtpt -78.53 -30.84 47.22 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.293 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.86 -30.72 58.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.711 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.71 19.3 77.91 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.757 -0.735 . . . . 0.0 113.147 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.424 ' HG3' ' CD1' ' A' ' 14' ' ' PHE . 2.6 ptp180 -142.68 17.66 2.0 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.892 0.346 . . . . 0.0 110.997 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.34 130.75 56.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.638 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.42 ' HA ' HD11 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -139.51 142.56 37.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.116 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.582 ' O ' ' HB2' ' A' ' 64' ' ' ASN . 59.3 t -53.65 152.35 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.064 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.582 ' HB2' ' O ' ' A' ' 63' ' ' VAL . 9.1 m-80 78.27 13.78 1.52 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.498 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.71 114.31 26.81 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.448 ' O ' ' HA ' ' A' ' 105' ' ' VAL . 12.7 tm0? -71.31 140.41 50.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.008 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.7 mt -98.13 131.76 44.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.122 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.1 mp -116.15 -45.15 3.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.898 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -137.44 149.85 47.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.25 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.423 ' O ' ' HB2' ' A' ' 71' ' ' ASN . 7.1 p -140.91 123.22 15.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.605 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 70' ' ' VAL . 66.2 m-80 66.22 11.23 7.74 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.521 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 109.23 -18.28 30.84 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.831 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -94.05 117.29 29.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.919 0.39 . . . . 0.0 111.151 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.71 139.65 39.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.651 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.417 ' HB2' ' HB2' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -118.29 13.13 13.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.419 -179.835 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.1 tp -60.95 -20.88 62.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.654 0.264 . . . . 0.0 111.246 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -85.36 -24.87 41.72 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.91 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.431 ' HB3' ' HE2' ' A' ' 78' ' ' LYS . 5.6 ptpt -98.16 157.29 16.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.307 0.575 . . . . 0.0 111.305 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.33 166.47 1.18 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.253 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.42 ' OD1' ' N ' ' A' ' 81' ' ' GLN . 22.7 p30 -63.12 -38.97 93.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.095 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.451 ' HA ' ' HG2' ' A' ' 84' ' ' MET . 2.4 pp0? -67.18 -41.93 85.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.184 0.516 . . . . 0.0 110.469 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.94 -35.14 72.08 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.689 179.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.417 ' CB ' ' CD1' ' A' ' 44' ' ' ILE . . . -69.12 -46.51 67.48 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.581 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.507 ' HA ' ' CD2' ' A' ' 87' ' ' LEU . 4.4 ptp -62.47 -30.99 71.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.98 179.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.11 -33.91 56.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.727 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.3 m -69.81 -36.06 75.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.367 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.507 ' CD2' ' HA ' ' A' ' 84' ' ' MET . 3.7 pp -78.4 -33.91 48.47 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.442 ' HB2' ' O ' ' A' ' 84' ' ' MET . 0.6 OUTLIER -59.19 -49.98 75.79 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.342 179.108 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.85 -37.21 67.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.456 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.6 t -70.93 -29.36 65.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.399 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.427 ' HG2' ' O ' ' A' ' 88' ' ' ARG . 4.5 ptm -89.07 -22.75 22.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.64 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.0 21.92 14.39 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.488 ' O ' ' HG3' ' A' ' 97' ' ' LYS . 0.4 OUTLIER -154.23 -35.21 0.1 Allowed 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.757 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -111.86 -39.33 4.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.84 0.352 . . . . 0.0 111.362 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.462 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -70.94 -30.8 67.53 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.9 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.405 ' O ' ' ND2' ' A' ' 96' ' ' ASN . 0.9 OUTLIER -76.97 -34.09 57.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.787 0.327 . . . . 0.0 110.262 179.609 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' A' ' 93' ' ' THR . 46.2 mtpt -39.94 -45.77 1.92 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.79 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.37 -22.98 18.61 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.838 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 115.35 0.11 22.15 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.824 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.443 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -163.82 142.61 7.76 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.992 0.425 . . . . 0.0 111.193 -179.83 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.462 ' HB ' ' HA3' ' A' ' 95' ' ' GLY . 0.1 OUTLIER -112.12 142.69 23.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.326 -179.753 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.62 147.63 37.45 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.456 ' O ' ' N ' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -143.39 110.46 5.68 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -178.729 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 57.4 mt -101.36 112.54 34.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 177.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 66' ' ' GLN . 35.3 m -123.64 157.54 29.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.092 0.472 . . . . 0.0 112.091 -178.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -129.4 122.81 30.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.373 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.07 -179.35 5.5 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.953 0.406 . . . . 0.0 111.21 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -91.11 141.15 29.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.054 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 18.4 mt -73.44 110.27 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.933 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.0 t . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.94 -179.941 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 121.007 0.432 . . . . 0.0 110.935 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -105.3 166.16 10.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.95 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . 0.404 ' HB2' ' CG ' ' A' ' 34' ' ' ARG . 0.5 OUTLIER -100.79 36.28 1.98 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.755 179.893 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 67.33 -67.03 0.18 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.96 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -88.02 138.14 31.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.955 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.87 -160.78 1.09 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.81 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -163.37 126.46 2.69 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 1.6 mm -104.73 100.7 11.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.165 0.507 . . . . 0.0 111.228 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 99.0 m -77.61 102.47 7.03 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.356 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 1.3 tptp -68.78 122.33 18.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.293 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 18.3 m . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.559 -0.734 . . . . 0.0 110.758 179.748 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.245 0 N-CA-C 112.429 -0.268 . . . . 0.0 112.429 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 44.7 p 50.08 26.92 2.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.711 0.291 . . . . 0.0 111.241 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -91.5 119.81 31.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.74 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -128.91 151.06 50.06 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.094 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -92.05 148.37 22.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.572 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.422 ' HB3' ' CZ ' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -134.7 109.88 8.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.069 0.461 . . . . 0.0 111.229 -179.645 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 94.4 m -92.24 124.63 36.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.127 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.44 ' CG ' ' HB3' ' A' ' 60' ' ' ARG . 25.1 m-85 -134.83 151.36 50.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.358 0.599 . . . . 0.0 112.103 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.456 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.4 OUTLIER -111.98 110.67 21.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.097 178.948 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.438 ' CG2' ' CD1' ' A' ' 103' ' ' LEU . 11.7 t -100.33 116.52 64.33 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -177.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 84.6 Cg_endo -87.22 127.88 2.56 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.784 2.323 . . . . 0.0 111.086 178.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.609 ' HA ' ' HB1' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -127.49 28.49 5.66 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -178.987 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -39.08 -33.27 0.12 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.151 0.5 . . . . 0.0 111.179 179.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -108.04 -33.76 7.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.072 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.2 t -70.67 -6.82 39.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.141 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -41.61 -31.35 0.69 Allowed Glycine 0 C--N 1.338 0.653 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.789 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.3 p -82.52 -41.75 19.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.888 0.375 . . . . 0.0 110.386 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -77.5 -4.66 46.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.458 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.18 -50.16 3.32 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.867 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.457 ' O ' ' N ' ' A' ' 54' ' ' ALA . 9.9 tp 179.87 -33.0 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.722 0.296 . . . . 0.0 110.635 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.487 ' HA2' HD11 ' A' ' 50' ' ' ILE . . . 109.1 44.04 1.13 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.5 -0.857 . . . . 0.0 113.426 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.496 HG13 ' CB ' ' A' ' 55' ' ' ALA . 20.8 m -157.56 173.79 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.146 0.498 . . . . 0.0 112.077 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.422 ' O ' ' N ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -134.25 117.09 16.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.312 178.907 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.4 m -109.55 149.48 12.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.009 0.433 . . . . 0.0 111.937 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.421 ' O ' ' HG3' ' A' ' 31' ' ' LYS . 13.5 ptmt -143.63 133.47 23.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.595 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -95.15 150.94 19.86 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.919 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -112.16 165.69 11.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.813 0.339 . . . . 0.0 110.894 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -128.84 140.52 51.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.629 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.2 123.41 13.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.921 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.05 -32.56 74.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.955 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -75.31 -31.52 60.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.962 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -149.03 136.55 20.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.708 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -61.45 83.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.948 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.95 126.96 12.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.844 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -50.89 145.69 6.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.222 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 43.9 mt -111.34 -23.2 10.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.801 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.406 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 132.03 162.98 10.6 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.354 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.452 ' CD1' ' CB ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -98.69 136.22 30.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.059 0.457 . . . . 0.0 111.163 -179.866 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -123.69 147.16 47.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.663 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.496 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 35.0 t -60.3 104.59 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 29' ' ' SER . 24.5 tptt -72.25 -44.12 63.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.516 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 m -166.22 128.45 1.9 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.813 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.506 ' CD1' ' HB3' ' A' ' 61' ' ' LEU . 73.4 mt -94.03 121.61 44.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.145 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.487 HD11 ' HA2' ' A' ' 27' ' ' GLY . 1.6 mp -58.71 113.59 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.406 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -68.12 74.25 0.21 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.682 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 159.89 -27.22 0.34 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.112 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.425 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -69.12 -171.91 7.84 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.601 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.609 ' HB1' ' HA ' ' A' ' 18' ' ' LEU . . . -64.12 -40.54 96.41 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.187 0.439 . . . . 0.0 112.187 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.496 ' CB ' HG13 ' A' ' 28' ' ' VAL . . . -61.57 -51.13 69.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.321 -179.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.8 t -63.43 -30.09 71.27 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.104 0.478 . . . . 0.0 109.807 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.0 mtpt -74.86 -35.01 62.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.738 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -58.9 -27.12 64.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.774 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 63.3 25.25 68.23 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.57 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.44 ' HB3' ' CG ' ' A' ' 14' ' ' PHE . 19.4 mtm180 -127.44 -29.3 2.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.693 0.283 . . . . 0.0 111.224 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.506 ' HB3' ' CD1' ' A' ' 49' ' ' ILE . 2.3 mp -74.13 143.19 45.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.117 0.484 . . . . 0.0 111.291 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.83 134.83 23.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.313 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.496 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 58.1 t -53.68 143.05 6.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.587 -0.278 . . . . 0.0 110.908 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 30.5 m-20 89.7 -8.88 0.39 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.073 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -63.11 110.21 1.76 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.854 0.359 . . . . 0.0 110.725 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.402 ' NE2' ' O ' ' A' ' 67' ' ' LEU . 20.7 tm0? -74.28 112.93 10.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.915 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.445 ' HB2' HG12 ' A' ' 44' ' ' ILE . 45.7 mt -66.84 146.44 54.42 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.044 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 52.9 mt -135.77 -42.67 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.277 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.0 126.04 13.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.067 0.461 . . . . 0.0 111.621 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.4 p -118.56 127.55 75.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.152 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.422 ' ND2' ' HB3' ' A' ' 90' ' ' SER . 2.3 m-80 62.0 35.1 16.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.959 0.409 . . . . 0.0 110.293 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 68.64 24.1 75.38 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.166 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -126.34 98.11 5.32 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.73 0.3 . . . . 0.0 110.822 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.0 t -60.81 136.95 58.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.815 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.38 12.53 34.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.309 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 12.8 mt -63.89 -23.52 67.38 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.72 0.295 . . . . 0.0 111.011 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -93.05 21.16 41.41 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.736 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -150.73 167.02 28.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.176 0.512 . . . . 0.0 111.052 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.25 175.71 9.95 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.174 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -61.73 -55.83 26.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.239 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -53.9 -38.94 65.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.009 0.433 . . . . 0.0 111.222 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.62 -37.4 73.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.22 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.452 ' CB ' ' CD1' ' A' ' 44' ' ' ILE . . . -68.96 -47.6 65.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.821 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.467 ' HA ' ' CD2' ' A' ' 87' ' ' LEU . 9.1 ptp -62.88 -30.08 71.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.295 -0.412 . . . . 0.0 109.945 179.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -79.12 -35.66 41.83 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 178.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.8 m -67.68 -35.84 79.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.194 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.467 ' CD2' ' HA ' ' A' ' 84' ' ' MET . 4.4 pp -78.22 -33.88 49.64 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 178.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.446 ' O ' ' HG2' ' A' ' 91' ' ' MET . 0.0 OUTLIER -56.17 -50.05 72.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.007 178.962 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.677 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.35 -49.74 31.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.313 178.734 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.422 ' HB3' ' ND2' ' A' ' 71' ' ' ASN . 1.4 m -54.75 -29.38 53.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.602 179.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.446 ' HG2' ' O ' ' A' ' 88' ' ' ARG . 1.5 ptp -89.98 -37.85 14.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.306 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.21 37.91 2.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.988 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.677 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 72.3 m -162.56 -41.48 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.566 -0.454 . . . . 0.0 112.214 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -111.62 -48.58 3.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.058 0.456 . . . . 0.0 110.777 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.44 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -69.74 -20.45 75.86 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.146 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.428 ' O ' ' ND2' ' A' ' 96' ' ' ASN . 0.7 OUTLIER -83.09 -32.26 26.85 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.653 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -40.8 -35.88 0.55 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.383 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.25 -30.72 11.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.69 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 125.93 -6.14 7.83 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.689 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.456 ' SD ' ' HB3' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -153.97 143.64 21.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.983 0.42 . . . . 0.0 111.147 -179.924 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.44 ' HB ' ' HA3' ' A' ' 95' ' ' GLY . 0.1 OUTLIER -109.42 147.14 14.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.452 -179.707 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.47 143.47 34.92 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.438 ' CD1' ' CG2' ' A' ' 16' ' ' VAL . 0.3 OUTLIER -138.65 148.22 43.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.125 0.488 . . . . 0.0 111.902 -179.072 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.9 mt -144.63 113.33 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.047 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 30.0 m -124.3 179.32 2.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.468 -179.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -147.75 139.89 24.28 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.93 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.42 179.48 8.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.997 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -100.82 154.44 18.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.026 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 17.6 mt -100.77 -34.08 3.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.131 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.798 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 4.8 t70 . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.932 0.396 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -79.87 158.58 26.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.969 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -108.24 -76.03 0.62 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.892 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.8 -54.76 2.41 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.078 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 26.5 t-80 -146.3 145.82 30.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.047 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 54.4 p -105.62 -163.45 0.94 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.743 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 177.7 149.31 0.17 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.267 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 mm -118.27 148.71 20.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.038 0.446 . . . . 0.0 111.156 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 55.2 m -123.41 104.36 9.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.568 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.67 102.84 5.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.026 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 35.2 m . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.936 179.731 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.539 -0.224 . . . . 0.0 112.539 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.4 p -109.44 -15.99 14.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.622 0.248 . . . . 0.0 111.296 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.64 143.13 40.35 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.714 0.293 . . . . 0.0 110.665 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -163.97 161.99 23.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.005 0.431 . . . . 0.0 111.291 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -104.07 145.32 30.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.413 179.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.419 ' CD1' ' CG2' ' A' ' 105' ' ' VAL . 0.0 OUTLIER -134.32 119.58 18.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.025 0.44 . . . . 0.0 111.301 -179.676 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.409 ' O ' ' CD1' ' A' ' 14' ' ' PHE . 90.0 m -86.68 143.02 27.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.975 179.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.421 ' CE1' ' HG2' ' A' ' 60' ' ' ARG . 24.9 m-85 -139.59 169.41 17.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.286 0.565 . . . . 0.0 112.158 -179.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -139.52 107.54 5.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.173 -0.921 . . . . 0.0 108.923 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.437 ' CG2' ' CD1' ' A' ' 103' ' ' LEU . 17.6 t -104.28 111.43 65.17 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -177.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 84.6 Cg_endo -81.72 127.71 5.71 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.441 2.094 . . . . 0.0 110.794 178.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.658 ' HA ' ' HB3' ' A' ' 54' ' ' ALA . 0.5 OUTLIER -125.44 29.15 6.1 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.595 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -39.56 -32.75 0.14 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.112 0.482 . . . . 0.0 111.245 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -109.18 -35.26 6.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.105 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.9 t -67.83 -9.65 46.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.099 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.403 ' HA2' ' CD1' ' A' ' 18' ' ' LEU . . . -43.01 -29.76 0.92 Allowed Glycine 0 C--N 1.339 0.713 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.808 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.3 m -82.58 -39.09 22.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.884 0.373 . . . . 0.0 110.572 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -78.28 -20.85 50.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.197 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.29 -50.31 0.78 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.833 -0.698 . . . . 0.0 111.507 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.428 ' O ' ' N ' ' A' ' 54' ' ' ALA . 10.9 tp 179.0 -32.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.56 0.219 . . . . 0.0 110.836 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.424 ' HA3' ' HA3' ' A' ' 53' ' ' GLY . . . 110.79 37.74 1.67 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.342 -0.932 . . . . 0.0 113.171 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.488 HG11 ' CB ' ' A' ' 55' ' ' ALA . 14.4 m -156.51 164.37 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.229 0.538 . . . . 0.0 111.957 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.0 m -123.73 115.18 20.97 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.17 178.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.5 m -106.75 141.12 22.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.089 0.471 . . . . 0.0 111.93 -178.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.53 131.28 19.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.101 179.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -102.25 162.36 17.0 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.442 -0.885 . . . . 0.0 113.052 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -135.94 156.58 48.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.949 0.404 . . . . 0.0 111.019 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.454 ' HD2' ' HA ' ' A' ' 39' ' ' HIS . 0.0 OUTLIER -108.87 152.28 25.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.736 179.972 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.11 137.58 17.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.983 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.19 -23.81 65.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.494 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -71.14 -51.02 27.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.079 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -135.34 160.29 38.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.838 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.454 ' HA ' ' HD2' ' A' ' 34' ' ' ARG . 74.5 m-70 -70.39 66.0 0.3 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.87 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -126.17 121.34 32.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.172 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.411 ' CB ' ' ND2' ' A' ' 80' ' ' ASN . 3.4 p-10 -53.39 145.21 14.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.383 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 32.4 mt -109.71 -29.83 8.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.47 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.414 ' HA3' ' NE2' ' A' ' 66' ' ' GLN . . . 142.12 -178.58 20.67 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.995 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.44 ' CD1' ' CB ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -108.05 140.56 26.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.965 0.412 . . . . 0.0 111.219 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -128.6 142.3 51.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.708 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.529 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 40.0 t -57.58 104.33 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.784 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 36.4 tptt -72.66 -42.91 63.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.801 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.47 129.62 1.61 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.084 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.474 ' CD1' ' HB3' ' A' ' 61' ' ' LEU . 78.0 mt -95.16 118.31 41.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.212 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.42 ' O ' ' N ' ' A' ' 52' ' ' GLY . 1.8 mp -55.03 107.09 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.619 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.52 77.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.112 0.482 . . . . 0.0 110.593 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 155.27 -26.21 0.61 Allowed Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.872 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.424 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -67.73 -172.41 6.27 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.621 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.658 ' HB3' ' HA ' ' A' ' 18' ' ' LEU . . . -64.76 -39.35 93.47 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.488 ' CB ' HG11 ' A' ' 28' ' ' VAL . . . -64.79 -48.66 73.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.269 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 60.1 p -63.03 -31.51 72.67 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.864 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 34.6 mtpt -75.23 -34.43 61.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.911 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -59.53 -27.65 66.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.741 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.47 40.0 95.62 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.662 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.421 ' HG2' ' CE1' ' A' ' 14' ' ' PHE . 4.5 mtm180 -134.88 -40.96 0.76 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.857 0.361 . . . . 0.0 110.913 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.474 ' HB3' ' CD1' ' A' ' 49' ' ' ILE . 3.7 mp -58.22 166.89 1.47 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.294 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.6 mtm105 -162.15 118.78 2.04 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.301 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.529 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 34.1 t -47.98 143.12 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.385 -179.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.427 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 22.3 m-80 85.76 -5.36 0.83 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.326 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.15 127.41 32.53 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.754 0.311 . . . . 0.0 110.388 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.414 ' NE2' ' HA3' ' A' ' 43' ' ' GLY . 0.8 OUTLIER -79.66 136.37 36.79 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.678 -179.631 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.7 mt -89.0 133.04 34.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.274 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.8 mm -116.8 -30.09 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.994 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.86 159.02 32.0 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.06 0.457 . . . . 0.0 111.203 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.0 p -145.74 125.07 5.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.416 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 61.17 18.22 8.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.922 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.75 25.36 23.02 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.114 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -124.65 101.06 6.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.736 0.303 . . . . 0.0 110.692 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.5 p -62.67 138.26 58.46 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.018 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -104.39 -16.27 15.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.239 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.5 tp -55.27 89.72 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.913 0.387 . . . . 0.0 111.13 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 156.7 -27.92 0.53 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.294 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.458 ' HD3' ' HB3' ' A' ' 82' ' ' GLU . 0.5 OUTLIER -106.63 159.54 16.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.253 0.549 . . . . 0.0 111.048 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.13 158.0 12.08 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.135 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.411 ' ND2' ' CB ' ' A' ' 41' ' ' ASP . 26.7 m-80 -51.18 -57.38 8.91 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.164 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.429 ' NE2' ' CG ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -51.65 -37.72 51.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.562 -179.47 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.458 ' HB3' ' HD3' ' A' ' 78' ' ' LYS . 1.9 mt-10 -70.92 -40.9 71.83 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.055 0.455 . . . . 0.0 110.331 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.44 ' CB ' ' CD1' ' A' ' 44' ' ' ILE . . . -66.53 -50.07 64.41 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.835 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.45 ' HA ' ' CD2' ' A' ' 87' ' ' LEU . 5.6 ptp -60.92 -29.65 69.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.062 179.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -76.98 -33.73 57.61 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.4 m -67.95 -36.88 80.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.224 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.45 ' CD2' ' HA ' ' A' ' 84' ' ' MET . 4.4 pp -78.43 -33.36 48.59 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.462 ' O ' ' HG2' ' A' ' 91' ' ' MET . 0.0 OUTLIER -58.1 -49.03 78.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.262 178.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.467 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -73.15 -44.29 60.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.065 179.293 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.7 t -62.9 -29.8 71.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.178 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.462 ' HG2' ' O ' ' A' ' 88' ' ' ARG . 3.3 ptm -89.81 -25.25 21.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.701 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.21 31.72 6.55 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.467 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.3 OUTLIER -164.25 -33.31 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 179.849 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.411 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 7.7 mt-10 -111.09 -69.04 0.89 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.803 0.335 . . . . 0.0 111.37 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.415 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -48.8 -27.44 6.36 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.604 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.402 ' O ' ' ND2' ' A' ' 96' ' ' ASN . 0.7 OUTLIER -76.41 -33.13 58.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.626 0.25 . . . . 0.0 110.434 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 94' ' ' GLU . 38.0 mtpt -39.62 -41.51 1.06 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.066 0.46 . . . . 0.0 111.373 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.63 -26.99 15.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.061 179.092 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.434 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 120.5 -3.51 12.26 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.883 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.435 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.3 OUTLIER -154.0 141.32 19.61 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.89 0.376 . . . . 0.0 111.412 -179.628 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.437 ' CG2' ' CD2' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -110.27 141.69 24.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.036 179.82 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.61 150.47 36.45 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.437 ' CD1' ' CG2' ' A' ' 16' ' ' VAL . 0.4 OUTLIER -144.24 112.01 6.18 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.99 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 76.4 mt -103.39 113.27 39.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.419 ' CG2' ' CD1' ' A' ' 12' ' ' LEU . 16.9 m -120.99 174.99 5.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.857 0.36 . . . . 0.0 111.542 -179.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -147.36 142.82 27.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.206 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.4 ' HD2' HD12 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -159.38 -178.99 7.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.783 179.836 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 5.9 ttp85 -116.36 139.03 50.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.902 0.382 . . . . 0.0 111.124 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 28.9 mt -76.94 158.72 5.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.031 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.5 t . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.892 179.99 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.527 0.081 0 CA-C-O 120.849 0.356 . . . . 0.0 110.996 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -158.59 169.23 24.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.988 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -103.89 38.26 1.87 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.537 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 68.9 -65.17 0.3 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.045 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 14.1 p80 -107.51 98.26 7.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.119 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.85 -158.84 0.21 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.585 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -158.19 124.04 4.59 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 1.4 mm -102.26 120.29 51.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.185 0.516 . . . . 0.0 111.226 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 28.0 m -94.84 109.61 21.58 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.644 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 7.0 tppt? -70.99 126.72 30.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.095 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 4.1 m . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.554 -0.736 . . . . 0.0 110.862 179.747 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.255 0 N-CA-C 112.489 -0.245 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 108' ' ' ARG . 41.8 p -134.54 80.02 1.83 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.694 0.283 . . . . 0.0 110.832 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.91 127.07 33.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.838 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -128.27 136.97 51.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.178 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -86.96 147.5 25.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.891 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.77 110.46 7.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.204 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 71.2 m -103.89 128.03 51.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.489 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -140.95 172.65 12.38 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 121.354 0.597 . . . . 0.0 112.341 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -127.8 111.19 13.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.853 179.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.473 HG11 ' HA ' ' A' ' 55' ' ' ALA . 66.5 t -103.99 113.66 65.16 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -177.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.512 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 83.3 Cg_endo -84.13 127.58 4.06 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.373 2.049 . . . . 0.0 110.748 177.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.556 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -122.54 30.05 6.66 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -178.628 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -36.94 -33.87 0.06 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.172 0.511 . . . . 0.0 111.291 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -111.57 -34.47 6.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.16 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.407 ' HB3' ' HB2' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -66.26 -13.83 61.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.943 179.761 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.414 ' HA2' ' CD1' ' A' ' 18' ' ' LEU . . . -45.97 -28.01 2.69 Favored Glycine 0 C--N 1.337 0.608 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.78 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.33 -36.02 27.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.847 0.356 . . . . 0.0 110.78 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -82.64 -24.43 33.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.253 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.78 -54.59 0.64 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.932 -0.652 . . . . 0.0 111.481 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.475 ' O ' ' N ' ' A' ' 54' ' ' ALA . 10.0 tp 179.41 -35.3 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.616 0.246 . . . . 0.0 110.893 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 50' ' ' ILE . . . 117.28 32.69 1.45 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.296 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.513 HG12 ' CB ' ' A' ' 55' ' ' ALA . 33.4 m -157.88 157.04 3.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.121 0.486 . . . . 0.0 111.897 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.92 116.05 26.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.431 178.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.9 m -106.76 142.64 19.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.014 0.435 . . . . 0.0 111.691 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.5 135.18 33.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.617 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.477 ' HA3' ' HB2' ' A' ' 80' ' ' ASN . . . -89.73 152.42 22.43 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.013 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.44 ' ND2' ' CE1' ' A' ' 45' ' ' PHE . 91.2 m-20 -120.77 163.74 17.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.757 0.313 . . . . 0.0 110.873 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -116.44 151.76 35.38 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.752 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.97 167.71 0.11 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.207 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.11 -56.13 11.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.105 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -116.93 -38.22 3.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.031 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -55.06 -24.35 24.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.202 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 60.68 32.8 20.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.002 0.43 . . . . 0.0 110.737 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -107.87 135.43 49.28 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.009 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -58.17 122.3 12.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.809 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 16.0 mt -82.66 -30.23 29.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.2 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.465 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 140.99 177.85 16.68 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.017 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.425 ' CD1' ' CB ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -99.79 134.13 40.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.951 0.405 . . . . 0.0 111.297 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.468 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -123.15 143.29 50.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.54 -179.896 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.501 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 42.6 t -55.78 104.52 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.856 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.3 tptp -74.05 -42.17 60.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.644 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.42 125.57 1.53 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.949 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.532 ' CD1' ' HB3' ' A' ' 61' ' ' LEU . 69.8 mt -89.94 120.77 39.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.275 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.414 ' N ' ' O ' ' A' ' 27' ' ' GLY . 2.1 mp -61.88 108.87 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.794 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -66.68 74.24 0.1 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.926 0.393 . . . . 0.0 110.399 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 164.47 -28.04 0.21 Allowed Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.119 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.15 -176.33 23.28 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.601 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.556 ' HB2' ' HA ' ' A' ' 18' ' ' LEU . . . -61.27 -41.15 96.43 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.513 ' CB ' HG12 ' A' ' 28' ' ' VAL . . . -64.76 -48.0 76.16 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.9 0.381 . . . . 0.0 111.58 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.414 ' CB ' ' O ' ' A' ' 50' ' ' ILE . 5.6 t -63.36 -29.06 70.43 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.219 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 32.4 mtpt -75.1 -28.99 60.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.933 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.31 -26.99 69.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.016 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.11 20.24 57.89 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.282 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.9 mtm180 -118.52 -28.28 5.73 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.909 0.385 . . . . 0.0 110.791 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.532 ' HB3' ' CD1' ' A' ' 49' ' ' ILE . 0.6 OUTLIER -68.94 149.81 48.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.1 0.476 . . . . 0.0 111.271 -179.735 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 76.1 mtm-85 -146.98 128.64 15.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.722 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.501 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 46.6 t -55.39 143.91 7.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.042 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.438 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 19.2 m-20 85.21 10.37 0.31 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.136 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -88.67 115.79 26.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.822 0.344 . . . . 0.0 110.402 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 10.9 tm0? -75.31 123.28 25.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.9 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.407 HD12 ' CD2' ' A' ' 87' ' ' LEU . 9.4 mt -75.28 133.86 41.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.24 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 18.3 mt -114.47 -28.02 2.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.281 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -158.4 166.47 32.16 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.104 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.403 HG21 ' CD1' ' A' ' 103' ' ' LEU . 12.0 p -154.05 126.07 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.009 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 58.69 20.17 7.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.051 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.35 28.05 18.46 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.957 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -128.5 101.48 6.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.841 0.353 . . . . 0.0 110.747 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.1 t -66.81 133.26 49.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.816 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -93.8 -11.32 31.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.297 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.1 mt -54.01 91.52 0.01 OUTLIER 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.82 0.343 . . . . 0.0 111.118 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 151.21 -29.21 0.98 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.884 -0.675 . . . . 0.0 112.259 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.461 ' HD3' ' HB3' ' A' ' 82' ' ' GLU . 5.5 ptpp? -104.29 152.2 22.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.193 0.521 . . . . 0.0 110.943 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.85 149.73 6.05 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.108 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.477 ' HB2' ' HA3' ' A' ' 32' ' ' GLY . 25.1 p30 -52.8 -30.4 33.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.222 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.459 ' HA ' ' HG2' ' A' ' 84' ' ' MET . 1.1 pp0? -73.9 -38.28 64.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.274 0.559 . . . . 0.0 110.328 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.461 ' HB3' ' HD3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -70.23 -33.82 72.13 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.739 179.13 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.425 ' CB ' ' CD1' ' A' ' 44' ' ' ILE . . . -69.2 -44.96 71.07 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.77 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.459 ' HG2' ' HA ' ' A' ' 81' ' ' GLN . 6.1 ptp -63.53 -30.83 71.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.304 -0.407 . . . . 0.0 109.992 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -78.17 -32.98 50.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.518 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.527 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 1.9 m -69.81 -35.09 74.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.541 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.451 ' HA ' ' OG ' ' A' ' 90' ' ' SER . 4.2 pp -78.01 -34.22 50.82 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.42 ' N ' ' CD1' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -61.01 -51.11 70.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.926 -1.033 . . . . 0.0 110.964 179.464 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.527 ' HD3' ' O ' ' A' ' 86' ' ' THR . 0.0 OUTLIER -72.25 -33.39 67.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.373 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.451 ' OG ' ' HA ' ' A' ' 87' ' ' LEU . 66.6 p -71.95 -29.84 64.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.991 0.424 . . . . 0.0 110.49 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 2.9 ptp -85.42 -23.07 28.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.358 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.3 m -117.42 27.01 9.34 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.47 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.4 OUTLIER -156.81 -31.64 0.09 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.905 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.417 ' HG3' HG22 ' A' ' 93' ' ' THR . 7.0 mt-10 -115.98 -45.93 2.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.887 0.375 . . . . 0.0 111.518 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.485 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -72.23 -32.6 62.6 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.844 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.41 ' O ' ' ND2' ' A' ' 96' ' ' ASN . 0.8 OUTLIER -73.32 -32.83 64.82 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.577 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' A' ' 93' ' ' THR . 47.5 mtpt -41.12 -41.44 1.76 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.263 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.2 -27.58 16.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.688 178.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.509 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 115.77 0.82 21.39 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.696 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.512 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.2 OUTLIER -153.89 140.59 19.0 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 120.986 0.422 . . . . 0.0 111.429 -179.627 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.485 ' HB ' ' HA3' ' A' ' 95' ' ' GLY . 0.1 OUTLIER -113.29 144.15 21.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.733 179.615 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.51 142.3 31.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.04 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.452 HD21 HG12 ' A' ' 101' ' ' ILE . 2.9 mm? -131.25 136.09 47.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.98 0.419 . . . . 0.0 111.848 -179.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 73.4 mt -128.56 112.89 27.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.325 178.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.0 m -127.16 173.58 12.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.133 0.492 . . . . 0.0 111.441 -178.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -147.45 128.09 14.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.263 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.16 -178.81 5.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.977 0.418 . . . . 0.0 111.25 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.413 ' HA ' ' O ' ' A' ' 8' ' ' THR . 4.5 mtm180 -99.7 150.55 22.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.18 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 45.2 mt -78.09 -29.59 15.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.035 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.98 179.934 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.747 0.308 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -133.24 170.16 15.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.846 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -109.5 -80.57 0.58 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.864 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.67 -69.5 0.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.936 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 31.7 m80 -79.86 136.8 36.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.052 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 77.6 p -134.17 -171.09 2.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.665 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -177.84 130.17 0.15 Allowed 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . 0.448 HG22 HD13 ' B' ' 10' ' ' ILE . 3.2 mm -107.34 100.7 11.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.206 0.527 . . . . 0.0 111.006 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 92.1 m -73.16 99.51 2.84 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.852 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.1 110.75 14.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.922 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 15.7 m . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.343 -0.837 . . . . 0.0 111.039 179.875 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 N-CA-C 112.565 -0.214 . . . . 0.0 112.565 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -154.6 27.8 0.44 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.788 0.328 . . . . 0.0 111.145 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.1 137.47 33.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.548 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -152.83 154.5 35.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.905 0.383 . . . . 0.0 111.281 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -91.75 150.31 21.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.521 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.16 113.08 8.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.908 0.385 . . . . 0.0 111.62 -179.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 98.4 m -98.86 133.57 42.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.778 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.466 ' O ' ' HA ' ' A' ' 102' ' ' GLN . 52.0 m-85 -141.55 172.69 12.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.118 0.485 . . . . 0.0 111.939 -179.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.427 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.6 OUTLIER -128.53 109.51 11.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.547 179.272 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 34.2 t -104.55 109.21 62.5 Favored Pre-proline 0 C--N 1.33 -0.246 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.418 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 83.5 Cg_endo -81.48 127.64 5.85 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.418 2.079 . . . . 0.0 110.762 178.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.682 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -121.22 29.07 7.48 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -178.849 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -37.84 -31.4 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.366 179.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -112.95 -33.77 5.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.26 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.404 ' HB3' ' CB ' ' A' ' 18' ' ' LEU . 25.9 t -69.77 -9.87 56.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.209 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -45.57 -28.51 2.46 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.795 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.53 -35.12 25.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.85 0.357 . . . . 0.0 110.698 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -82.51 -24.45 34.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.129 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.44 -51.98 0.71 Allowed Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.448 ' O ' ' N ' ' A' ' 54' ' ' ALA . 10.5 tp 179.45 -35.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.658 0.266 . . . . 0.0 110.633 179.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.409 ' O ' ' N ' ' A' ' 50' ' ' ILE . . . 116.26 34.46 1.33 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.473 -0.87 . . . . 0.0 113.232 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.505 HG12 ' CB ' ' A' ' 55' ' ' ALA . 33.1 m -157.22 157.02 3.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 117.153 0.477 . . . . 0.0 112.0 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.4 ' O ' ' N ' ' A' ' 47' ' ' LYS . 0.9 OUTLIER -117.65 123.9 47.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.342 178.81 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.4 m -106.69 153.97 7.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.171 0.51 . . . . 0.0 112.32 -178.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.4 132.27 13.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.35 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' A' ' 44' ' ' ILE . . . -107.64 153.97 16.69 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.473 -0.87 . . . . 0.0 113.153 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.407 ' OD1' ' HB2' ' A' ' 42' ' ' LEU . 18.2 p-10 -106.73 -179.16 3.86 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.177 0.513 . . . . 0.0 111.318 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -135.86 127.54 29.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.53 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.6 t -38.61 134.67 0.9 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.739 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.13 -35.13 79.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.267 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -73.74 -57.34 4.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.012 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -119.26 161.07 21.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.932 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 40.6 m-70 -77.84 61.94 2.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.867 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.23 126.76 48.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.993 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -61.49 131.46 50.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.01 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.407 ' HB2' ' OD1' ' A' ' 33' ' ' ASN . 11.6 mt -89.54 -24.62 21.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.896 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.426 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 140.31 169.92 11.86 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.346 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.464 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -101.37 140.45 20.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.8 0.333 . . . . 0.0 111.309 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.436 ' CE2' ' HG3' ' A' ' 66' ' ' GLN . 0.1 OUTLIER -126.31 143.14 51.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.611 179.858 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.473 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 44.8 t -55.35 105.42 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.412 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.4 ' N ' ' O ' ' A' ' 29' ' ' SER . 18.3 tptt -72.6 -43.61 63.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.679 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.2 m -165.01 126.53 2.07 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.999 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.446 ' HA ' HG13 ' A' ' 28' ' ' VAL . 66.9 mt -91.82 119.04 38.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.324 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.45 ' O ' ' N ' ' A' ' 52' ' ' GLY . 1.9 mp -58.83 101.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.571 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -59.96 80.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.08 0.467 . . . . 0.0 110.584 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 153.63 -30.34 0.76 Allowed Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.624 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.37 -174.98 3.02 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.585 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.682 ' HB2' ' HA ' ' A' ' 18' ' ' LEU . . . -65.13 -36.22 83.58 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -179.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.505 ' CB ' HG12 ' A' ' 28' ' ' VAL . . . -68.74 -45.87 70.35 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.748 0.309 . . . . 0.0 111.551 -179.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.56 -29.9 70.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.104 0.478 . . . . 0.0 110.053 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.1 mtpt -72.77 -32.67 65.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.971 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.409 ' OD1' ' NH2' ' A' ' 60' ' ' ARG . 1.3 t0 -57.49 -29.78 64.56 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.787 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.16 16.84 75.37 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.045 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.409 ' NH2' ' OD1' ' A' ' 58' ' ' ASP . 0.6 OUTLIER -128.82 -2.03 5.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.933 0.366 . . . . 0.0 111.202 179.837 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.03 125.04 40.3 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.007 0.432 . . . . 0.0 111.472 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.41 ' HD2' ' N ' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -128.66 140.28 51.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.556 179.707 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.666 ' O ' ' HB2' ' A' ' 64' ' ' ASN . 39.7 t -61.41 150.86 7.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.461 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.666 ' HB2' ' O ' ' A' ' 63' ' ' VAL . 22.4 m-80 83.44 3.37 0.93 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.05 0.54 . . . . 0.0 111.95 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.1 117.76 21.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.852 0.358 . . . . 0.0 110.298 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.436 ' HG3' ' CE2' ' A' ' 45' ' ' PHE . 9.9 tm0? -75.73 115.03 14.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.248 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.407 HD11 ' CD2' ' A' ' 87' ' ' LEU . 32.8 mt -63.34 152.01 39.19 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.153 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 21.1 mt -136.77 -43.65 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.169 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -143.18 150.97 40.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.966 0.412 . . . . 0.0 111.399 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.403 ' CG2' HD13 ' A' ' 101' ' ' ILE . 10.3 p -140.62 116.28 7.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.819 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 55.79 55.36 7.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.789 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 60.89 18.69 54.53 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.435 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -118.11 88.72 2.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.881 0.372 . . . . 0.0 110.82 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.3 m -62.0 118.46 7.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.026 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.1 mt -73.59 -16.52 61.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.214 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -53.33 91.5 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.927 0.394 . . . . 0.0 111.133 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 152.77 -28.62 0.83 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.256 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.3 ptpp? -106.38 154.69 20.44 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.215 0.531 . . . . 0.0 110.963 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.36 156.42 3.29 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.303 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -53.85 -42.47 68.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.316 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -66.42 -38.01 86.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.966 0.412 . . . . 0.0 110.872 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.69 -33.18 72.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.185 0.517 . . . . 0.0 110.109 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.13 -46.69 67.01 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.782 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.413 ' HA ' ' CD2' ' A' ' 87' ' ' LEU . 6.1 ptp -63.26 -31.97 73.26 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.333 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -80.42 -32.05 37.46 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.6 m -68.73 -36.44 78.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.29 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.425 ' CD1' ' N ' ' A' ' 88' ' ' ARG . 4.3 pp -78.54 -35.05 46.7 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.369 0.604 . . . . 0.0 109.388 178.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.465 ' O ' ' HG2' ' A' ' 91' ' ' MET . 0.0 OUTLIER -60.04 -48.54 81.31 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.171 179.422 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.461 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.82 -42.33 63.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.964 179.329 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.0 t -62.75 -29.42 70.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.179 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.465 ' HG2' ' O ' ' A' ' 88' ' ' ARG . 3.2 ptp -85.47 -30.86 23.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.658 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.2 30.31 6.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.701 -179.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.461 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.4 OUTLIER -158.86 -28.98 0.07 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -179.79 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.455 ' HG3' HG22 ' A' ' 93' ' ' THR . 4.9 mt-10 -122.1 -38.98 2.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.959 0.409 . . . . 0.0 111.103 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.501 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -78.63 -31.45 45.05 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.724 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.43 ' O ' ' ND2' ' A' ' 96' ' ' ASN . 0.7 OUTLIER -75.02 -33.43 61.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.786 0.326 . . . . 0.0 110.14 179.493 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.453 ' HD3' ' O ' ' A' ' 93' ' ' THR . 26.2 mmmt -43.52 -44.8 6.23 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.157 0.504 . . . . 0.0 111.108 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.58 -23.57 21.94 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.715 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 113.69 -1.3 24.67 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.789 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.427 ' SD ' ' HB3' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -163.06 143.24 9.14 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.055 0.455 . . . . 0.0 111.341 -179.639 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.501 ' HB ' ' HA3' ' A' ' 95' ' ' GLY . 0.1 OUTLIER -116.47 139.77 41.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.277 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.466 ' HA ' ' O ' ' A' ' 14' ' ' PHE . 3.0 pp0? -87.25 135.32 33.36 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.441 HD22 ' O ' ' A' ' 101' ' ' ILE . 2.2 mm? -121.33 138.31 54.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.285 0.564 . . . . 0.0 112.286 -179.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 96.2 mt -120.02 112.67 37.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.278 178.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.5 m -125.98 154.06 34.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.448 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -125.63 135.31 52.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.417 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.04 -179.04 6.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.099 0.476 . . . . 0.0 111.52 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 2.6 tpp85 -100.05 124.21 45.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.826 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.7 mt -67.73 150.41 10.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.057 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.0 t . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.852 179.949 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 59.1 t0 . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.906 0.384 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -85.08 160.17 20.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.899 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -91.56 -67.89 0.83 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.959 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -136.66 -47.73 0.62 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.929 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -156.55 112.33 2.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.86 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 4.2 t -71.87 -165.49 0.17 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.766 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -170.55 129.11 0.83 Allowed 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 1.6 mm -100.75 125.78 54.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.223 0.535 . . . . 0.0 111.388 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 22.7 m -101.21 100.5 11.04 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.442 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.16 124.09 23.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.219 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 12.0 m . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.386 -0.816 . . . . 0.0 110.797 179.593 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.396 -0.281 . . . . 0.0 112.396 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 67.4 p -153.73 74.31 0.99 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.805 0.336 . . . . 0.0 110.87 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.7 mtm180 -148.25 121.15 8.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.691 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -114.51 121.89 44.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.091 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -78.43 136.06 37.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.638 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.58 111.08 11.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.902 0.382 . . . . 0.0 111.29 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.412 ' O ' ' CD1' ' A' ' 14' ' ' PHE . 99.2 m -99.93 132.12 45.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.346 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.432 ' CD1' ' HG2' ' A' ' 60' ' ' ARG . 28.4 m-85 -140.69 172.52 12.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.321 0.582 . . . . 0.0 112.202 -179.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.44 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.4 OUTLIER -130.74 111.24 11.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.276 179.295 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.2 t -103.65 117.01 60.91 Favored Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -178.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 82.9 Cg_endo -86.97 128.07 2.69 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.738 2.292 . . . . 0.0 110.898 178.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.694 ' HA ' ' HB3' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -122.71 28.75 7.16 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -178.899 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -38.38 -31.96 0.06 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.319 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -111.92 -32.5 6.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.123 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.418 ' HB3' ' CB ' ' A' ' 18' ' ' LEU . 25.0 t -71.74 -5.21 32.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.308 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.401 ' HA2' ' CD1' ' A' ' 18' ' ' LEU . . . -44.43 -29.37 1.75 Allowed Glycine 0 C--N 1.337 0.605 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.726 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.1 m -85.03 -35.1 22.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.001 0.429 . . . . 0.0 110.657 179.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.92 5.14 34.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.424 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.81 -56.35 5.04 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.958 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.447 ' O ' ' N ' ' A' ' 54' ' ' ALA . 8.4 tp -175.06 -36.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.635 0.255 . . . . 0.0 110.839 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.45 ' HA2' HD11 ' A' ' 50' ' ' ILE . . . 113.83 45.54 0.7 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.554 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.476 HG12 ' CB ' ' A' ' 55' ' ' ALA . 23.4 m -157.16 156.71 4.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.185 0.517 . . . . 0.0 112.122 179.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.414 ' O ' ' HB3' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -116.07 114.63 24.8 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.091 178.582 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.43 ' CG2' ' HG2' ' A' ' 84' ' ' MET . 0.0 OUTLIER -108.88 146.4 14.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.14 0.495 . . . . 0.0 111.993 -178.683 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.43 131.03 19.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.306 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' A' ' 44' ' ' ILE . . . -96.85 155.18 20.74 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.967 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -104.2 -171.19 1.89 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.864 0.364 . . . . 0.0 110.821 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.469 ' CD ' ' O ' ' A' ' 35' ' ' SER . 0.0 OUTLIER -145.17 141.27 28.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.505 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.469 ' O ' ' CD ' ' A' ' 34' ' ' ARG . 0.2 OUTLIER -43.7 146.68 0.52 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.119 0.485 . . . . 0.0 111.905 -179.246 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.03 -19.36 65.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.36 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -103.13 -82.27 0.49 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.692 0.282 . . . . 0.0 111.393 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -98.19 166.5 11.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.116 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.431 ' HA ' ' CG ' ' A' ' 34' ' ' ARG . 88.3 m-70 -66.74 73.52 0.1 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.917 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.65 88.34 2.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.866 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -37.97 121.93 0.97 Allowed 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.918 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 19.2 mt -88.92 6.67 38.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.04 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.437 ' HA3' ' NE2' ' A' ' 66' ' ' GLN . . . 103.16 -174.31 23.02 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.384 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.471 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -114.45 144.7 21.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.842 0.353 . . . . 0.0 111.478 -179.719 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -127.44 143.16 51.24 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.714 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.496 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 41.9 t -60.04 104.37 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.486 179.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.414 ' HB3' ' O ' ' A' ' 29' ' ' SER . 2.8 tptt -73.37 -42.35 62.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.881 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.0 m -168.66 122.6 0.86 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.028 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.514 ' CD1' ' HB3' ' A' ' 61' ' ' LEU . 75.1 mt -84.82 116.55 28.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.908 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.45 HD11 ' HA2' ' A' ' 27' ' ' GLY . 1.8 mp -52.65 101.91 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.742 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -60.1 80.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.129 0.49 . . . . 0.0 110.628 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 153.58 -30.0 0.76 Allowed Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.718 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.07 -171.19 2.82 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.366 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.694 ' HB3' ' HA ' ' A' ' 18' ' ' LEU . . . -68.43 -37.12 79.97 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.476 ' CB ' HG12 ' A' ' 28' ' ' VAL . . . -66.48 -43.54 85.15 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.468 -179.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.92 -32.11 70.24 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.049 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 26.7 mtpt -72.29 -33.21 67.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.852 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -62.16 -26.79 68.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.795 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.64 37.31 92.1 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.641 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.432 ' HG2' ' CD1' ' A' ' 14' ' ' PHE . 7.3 mtm180 -131.4 -33.48 1.46 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.674 0.273 . . . . 0.0 110.949 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.514 ' HB3' ' CD1' ' A' ' 49' ' ' ILE . 2.1 mp -64.45 157.89 25.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.048 0.451 . . . . 0.0 111.185 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -149.49 124.05 9.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.521 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.496 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 41.2 t -56.9 143.05 11.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.198 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.435 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 21.5 m-20 86.26 -2.78 0.73 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.238 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -78.43 124.03 27.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.718 0.295 . . . . 0.0 110.52 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.459 ' O ' ' HA ' ' A' ' 105' ' ' VAL . 0.7 OUTLIER -74.9 134.46 41.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.665 -179.86 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.3 mt -86.17 137.8 32.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.754 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 24.5 mt -120.99 -37.27 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.458 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.92 170.8 17.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.904 0.383 . . . . 0.0 111.275 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.43 HG21 ' OG ' ' A' ' 90' ' ' SER . 7.2 p -157.78 121.87 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.934 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 61.07 25.62 15.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.628 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.47 23.02 45.07 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.143 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -127.04 119.02 25.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.779 0.323 . . . . 0.0 110.71 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 60.9 p -69.8 153.31 43.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.097 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.8 mt -113.38 -15.4 12.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.314 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.7 mt -57.45 -18.3 17.61 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.521 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -87.87 21.28 24.05 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.079 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.423 ' HB2' ' HB3' ' A' ' 82' ' ' GLU . 1.9 ptpt -160.38 168.69 24.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.262 0.553 . . . . 0.0 111.221 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.37 174.31 7.52 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.641 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.401 ' HB3' ' HA3' ' A' ' 32' ' ' GLY . 21.1 m-80 -57.14 -58.29 8.84 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.496 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.1 pm0 -58.37 -34.12 70.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.045 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.423 ' HB3' ' HB2' ' A' ' 78' ' ' LYS . 2.8 mt-10 -70.77 -39.2 73.35 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.25 0.548 . . . . 0.0 109.867 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.402 ' CB ' ' CD1' ' A' ' 44' ' ' ILE . . . -69.13 -43.52 74.21 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.573 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.43 ' HG2' ' CG2' ' A' ' 30' ' ' VAL . 1.0 OUTLIER -64.61 -29.29 70.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.067 179.176 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -78.99 -35.76 42.4 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.408 ' HA ' ' HD2' ' A' ' 89' ' ' ARG . 1.6 m -65.36 -36.51 84.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.403 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.413 ' CD2' ' HA ' ' A' ' 84' ' ' MET . 4.4 pp -78.35 -34.26 48.55 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.428 ' O ' ' HG2' ' A' ' 91' ' ' MET . 0.2 OUTLIER -60.7 -49.45 77.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.744 179.349 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.5 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.15 -45.7 59.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.98 179.683 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.43 ' OG ' HG21 ' A' ' 70' ' ' VAL . 45.9 p -60.25 -29.35 68.72 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.763 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.428 ' HG2' ' O ' ' A' ' 88' ' ' ARG . 2.5 ptp -88.07 -29.36 20.71 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.493 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.58 35.46 4.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.761 -179.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.5 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.3 OUTLIER -166.42 -24.05 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.41 ' HG3' HG23 ' A' ' 93' ' ' THR . 6.6 mt-10 -123.92 -59.44 1.51 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.989 0.424 . . . . 0.0 111.175 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.416 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -66.59 -25.35 72.78 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.1 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.404 ' HB2' ' CD1' ' A' ' 18' ' ' LEU . 0.8 OUTLIER -78.28 -35.59 47.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.963 0.411 . . . . 0.0 110.185 179.671 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.463 ' HD3' ' O ' ' A' ' 93' ' ' THR . 27.7 mmmt -45.52 -42.28 10.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.985 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.91 -27.92 23.08 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.629 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 121.94 -6.67 10.25 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.934 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.44 ' SD ' ' HB3' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -158.33 142.38 15.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.013 0.435 . . . . 0.0 111.301 -179.759 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.431 HG12 HD23 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -109.45 144.79 17.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.996 -179.841 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.401 ' OE1' HG13 ' A' ' 104' ' ' ILE . 1.5 tm0? -85.83 140.35 30.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.168 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.431 HD23 HG12 ' A' ' 101' ' ' ILE . 2.7 mm? -130.4 139.81 50.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.039 0.447 . . . . 0.0 111.867 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.401 HG13 ' OE1' ' A' ' 102' ' ' GLN . 66.5 mt -128.6 112.91 27.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.596 178.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 66' ' ' GLN . 28.6 m -122.71 176.94 4.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.84 -178.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -147.71 117.53 7.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.475 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 5.6 ttm180 -105.73 142.05 36.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.928 0.394 . . . . 0.0 110.773 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 5.8 tpp180 -84.72 148.25 26.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.097 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 20.8 mt -99.24 -31.16 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.079 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.8 t . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.913 -179.959 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.935 0.398 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -91.56 170.17 10.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.953 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . 0.46 ' OD1' ' NH1' ' A' ' 34' ' ' ARG . 49.0 m-20 -98.26 35.78 1.71 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.533 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 77.09 -61.37 0.43 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.919 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -98.71 108.77 21.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.831 0.348 . . . . 0.0 110.986 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 60.4 p -104.13 -164.29 1.05 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.892 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -168.81 125.47 0.97 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 1.5 mm -99.97 100.77 11.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.177 0.513 . . . . 0.0 111.192 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 90.5 m -79.0 116.39 19.27 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.744 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt -79.11 129.0 33.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.861 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 21.3 m . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.126 -179.978 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.38 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 52.0 p -116.53 -20.33 9.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.567 0.223 . . . . 0.0 111.341 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.4 mtt85 -76.34 133.1 40.07 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.713 0.292 . . . . 0.0 110.643 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -162.38 161.3 27.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.028 0.442 . . . . 0.0 111.357 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.427 ' CD2' HG13 ' A' ' 68' ' ' ILE . 3.8 m-85 -101.95 145.03 29.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.405 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.6 137.36 22.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.126 0.489 . . . . 0.0 111.428 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.429 ' O ' ' CD1' ' A' ' 14' ' ' PHE . 86.8 m -88.77 145.9 25.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.242 179.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.456 ' CD1' ' HG3' ' A' ' 60' ' ' ARG . 21.3 m-85 -140.37 116.51 10.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.03 0.443 . . . . 0.0 111.979 -179.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.99 109.15 19.19 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.447 ' CG2' HD11 ' A' ' 103' ' ' LEU . 39.6 t -106.54 103.37 45.98 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -177.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.456 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 3.7 Cg_exo -75.42 128.01 10.83 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.606 2.204 . . . . 0.0 110.661 178.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.675 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -124.03 28.36 6.83 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.713 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -39.71 -31.2 0.1 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.069 0.461 . . . . 0.0 111.092 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -113.7 -32.69 6.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.234 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.406 ' HB3' ' CB ' ' A' ' 18' ' ' LEU . 45.9 t -70.65 -8.6 53.04 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.074 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.402 ' HA2' ' CD1' ' A' ' 18' ' ' LEU . . . -46.36 -27.64 2.91 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.603 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 52.4 m -84.9 -33.17 22.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.874 0.369 . . . . 0.0 110.693 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.78 11.13 20.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.49 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.14 -55.64 5.04 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.897 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.446 ' O ' ' N ' ' A' ' 54' ' ' ALA . 9.2 tp -178.49 -31.38 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.658 0.266 . . . . 0.0 110.96 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.418 ' HA3' ' HA3' ' A' ' 53' ' ' GLY . . . 112.73 32.49 2.26 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.421 -0.895 . . . . 0.0 113.286 179.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.512 HG13 ' CB ' ' A' ' 55' ' ' ALA . 35.2 m -156.34 150.55 10.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.1 0.476 . . . . 0.0 111.915 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.443 ' O ' ' N ' ' A' ' 47' ' ' LYS . 73.0 m -107.48 123.13 47.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.032 178.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.6 m -107.47 153.67 8.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 -178.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.505 ' O ' ' HG3' ' A' ' 31' ' ' LYS . 0.1 OUTLIER -155.62 129.93 8.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.206 179.303 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -103.97 160.46 16.09 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.181 -1.009 . . . . 0.0 113.101 -179.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -116.01 175.32 5.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.004 0.43 . . . . 0.0 111.133 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 29.5 mtt85 -121.41 153.05 38.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.749 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -47.7 156.87 0.28 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.484 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.87 -51.98 41.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.394 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.21 -51.74 28.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.704 -179.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -117.97 -177.12 3.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.752 0.31 . . . . 0.0 111.078 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 -92.34 40.38 1.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.049 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.18 110.2 17.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.829 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -48.37 124.5 8.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.443 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 17.0 mt -88.88 -36.25 16.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.72 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.46 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 154.44 -178.71 31.09 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.898 -0.667 . . . . 0.0 111.897 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.468 HG12 ' HB2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -106.58 137.82 35.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.845 0.355 . . . . 0.0 111.274 -179.854 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.461 ' CE2' ' NE2' ' A' ' 66' ' ' GLN . 0.5 OUTLIER -123.68 140.13 53.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.497 179.621 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.51 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 27.5 t -55.95 107.56 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.068 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 29' ' ' SER . 21.5 tptt -71.61 -46.87 57.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.625 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 27.2 t -166.42 123.83 1.36 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.857 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.446 ' HA ' HG11 ' A' ' 28' ' ' VAL . 66.9 mt -87.32 122.54 39.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.274 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.411 HD13 ' HA2' ' A' ' 27' ' ' GLY . 2.5 mp -64.84 111.77 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.289 179.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -68.06 72.63 0.18 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.212 0.53 . . . . 0.0 110.404 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 165.12 -28.89 0.21 Allowed Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.877 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.418 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -66.84 -170.56 4.2 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.662 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.675 ' HB2' ' HA ' ' A' ' 18' ' ' LEU . . . -69.24 -37.7 78.1 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.512 ' CB ' HG13 ' A' ' 28' ' ' VAL . . . -67.96 -44.26 77.15 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.792 0.33 . . . . 0.0 111.312 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.9 t -65.53 -34.79 79.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.224 0.535 . . . . 0.0 109.759 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -69.23 -31.41 69.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.766 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.59 -30.84 61.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.654 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 68.93 16.19 70.18 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.897 -0.668 . . . . 0.0 113.277 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.456 ' HG3' ' CD1' ' A' ' 14' ' ' PHE . 7.0 ptp180 -135.23 10.91 3.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.002 0.401 . . . . 0.0 111.143 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.414 ' HB3' ' CD1' ' A' ' 49' ' ' ILE . 0.1 OUTLIER -104.07 134.01 48.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.596 179.877 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.39 145.63 50.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.802 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.51 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 45.2 t -66.07 148.91 11.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.845 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.456 ' N ' HG12 ' A' ' 63' ' ' VAL . 15.9 m-80 84.65 -4.02 0.98 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.428 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.3 128.25 35.27 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.694 0.283 . . . . 0.0 110.697 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.461 ' NE2' ' CE2' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -85.55 130.01 34.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.937 -179.729 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.468 ' HB2' HG12 ' A' ' 44' ' ' ILE . 77.5 mt -81.13 135.95 35.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.575 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.427 HG13 ' CD2' ' A' ' 11' ' ' PHE . 18.7 mm -118.93 -29.14 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.298 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.04 148.73 17.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.983 0.42 . . . . 0.0 111.378 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.1 p -137.89 129.79 39.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.488 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 60.01 26.08 15.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.763 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.8 20.67 59.23 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.193 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -128.19 111.55 13.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.823 0.344 . . . . 0.0 110.723 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.47 149.83 20.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.158 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.411 ' HB3' ' CB ' ' A' ' 83' ' ' ALA . 4.2 mt -114.09 -20.2 11.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.347 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.1 tp -54.83 -24.35 22.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.674 0.273 . . . . 0.0 111.278 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.39 -2.17 83.48 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.031 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.6 ptpp? -135.83 161.13 36.47 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.293 0.568 . . . . 0.0 111.301 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.52 176.94 0.32 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.525 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.428 ' HB3' ' HA3' ' A' ' 32' ' ' GLY . 19.5 m-80 -67.14 -57.64 6.38 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.118 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.1 pp0? -58.36 -35.21 71.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.036 0.446 . . . . 0.0 110.591 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.53 -42.45 71.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.484 179.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.411 ' CB ' ' HB3' ' A' ' 75' ' ' LEU . . . -69.59 -30.99 68.88 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.934 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.462 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 0.5 OUTLIER -72.36 -33.32 67.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.596 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -77.63 -28.07 51.29 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.2 m -72.66 -36.85 68.03 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.528 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 84' ' ' MET . 4.4 pp -78.65 -34.24 46.57 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -61.4 -52.1 66.0 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.461 179.243 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.502 ' HD3' ' N ' ' A' ' 90' ' ' SER . 0.0 OUTLIER -72.17 -33.97 68.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.19 179.594 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.502 ' N ' ' HD3' ' A' ' 89' ' ' ARG . 41.7 m -72.57 -29.68 63.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.672 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.404 ' CB ' HD13 ' A' ' 101' ' ' ILE . 3.2 ptp -87.35 -22.4 25.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.31 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.0 t -112.81 22.65 14.26 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.946 0.351 . . . . 0.0 111.946 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.442 HG23 ' HG3' ' A' ' 94' ' ' GLU . 0.5 OUTLIER -154.77 -39.46 0.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.502 ' HA ' ' HG2' ' A' ' 97' ' ' LYS . 5.7 mt-10 -110.77 -22.06 11.76 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.868 0.366 . . . . 0.0 111.206 -179.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.489 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -93.27 -30.3 9.4 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 179.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -86.67 -37.05 18.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.791 0.329 . . . . 0.0 110.29 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.502 ' HG2' ' HA ' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -45.32 -28.53 0.85 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.31 179.627 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.415 ' N ' ' HD3' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -106.8 -27.04 11.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.534 178.964 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 118.36 -1.64 16.3 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.135 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.456 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -165.14 141.44 5.59 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.0 0.429 . . . . 0.0 111.649 -179.74 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.489 ' HB ' ' HA3' ' A' ' 95' ' ' GLY . 0.1 OUTLIER -115.47 134.56 58.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.043 179.848 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -81.55 140.32 34.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.001 178.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.447 HD11 ' CG2' ' A' ' 16' ' ' VAL . 1.8 mp -134.84 111.59 10.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.736 0.303 . . . . 0.0 111.686 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 62.6 mt -90.19 112.45 24.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 14.6 m -118.37 -179.2 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.882 0.373 . . . . 0.0 111.384 -179.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -147.01 134.99 21.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.755 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.93 -178.9 7.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.969 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 3.7 mtm180 -107.73 129.57 55.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.027 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 17.9 mt -63.08 115.75 2.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.923 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 35.9 t . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.822 179.878 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.049 0 CA-C-O 120.874 0.368 . . . . 0.0 110.807 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -75.26 144.79 42.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.945 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.41 -73.79 0.63 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.929 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 71.7 mm-40 -118.39 -66.48 1.07 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.816 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 68.1 m-70 -111.98 118.09 34.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.878 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' SER . . . . . 0.495 ' O ' ' HB2' ' B' ' 9' ' ' GLN . 77.1 p -62.76 -35.15 78.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.859 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . 0.495 ' HB2' ' O ' ' B' ' 8' ' ' SER . 0.0 OUTLIER 82.09 66.11 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.511 0.672 . . . . 0.0 109.689 -179.432 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 14.5 mm -77.67 142.18 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.079 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 1.9 m -162.05 122.37 2.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.584 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -80.46 145.1 32.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.15 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 27.2 m . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.175 -0.917 . . . . 0.0 111.093 179.808 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.404 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 31.2 p -94.63 42.05 1.09 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.855 0.359 . . . . 0.0 111.071 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.7 mtm180 -98.41 136.11 39.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.827 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -143.14 150.66 39.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.024 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -96.93 148.35 23.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.859 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.27 109.9 10.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.109 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 87.9 m -96.71 133.02 41.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.496 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.414 ' CE1' ' HG2' ' A' ' 60' ' ' ARG . 47.8 m-85 -140.59 172.67 12.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.164 0.506 . . . . 0.0 112.043 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.403 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.4 OUTLIER -129.67 112.22 13.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.228 179.105 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.8 t -105.31 111.53 64.99 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -177.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 1.2 Cg_endo -81.7 127.61 5.69 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.817 2.345 . . . . 0.0 111.049 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.519 ' HA ' ' HB1' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -122.09 28.67 7.4 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -179.002 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -38.72 -31.72 0.07 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.036 0.446 . . . . 0.0 111.195 179.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -112.26 -33.52 6.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.18 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.421 ' HB3' ' CB ' ' A' ' 18' ' ' LEU . 30.4 t -70.02 -7.57 42.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.2 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.406 ' HA2' ' CD1' ' A' ' 18' ' ' LEU . . . -45.3 -28.65 2.2 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.759 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.0 t -84.83 -34.23 22.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.783 0.325 . . . . 0.0 110.63 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.01 8.88 27.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.319 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.28 -55.26 4.94 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.969 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' A' ' 54' ' ' ALA . 8.2 tp -176.02 -34.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.508 0.194 . . . . 0.0 110.657 179.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.494 ' HA2' HD13 ' A' ' 50' ' ' ILE . . . 111.68 44.28 0.91 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.328 -0.939 . . . . 0.0 113.56 179.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.429 ' CG1' ' CB ' ' A' ' 55' ' ' ALA . 19.4 m -158.27 167.55 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.155 0.503 . . . . 0.0 111.902 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.67 116.67 21.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.276 178.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -111.18 144.47 19.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.013 0.435 . . . . 0.0 111.981 -178.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.407 ' O ' ' HG3' ' A' ' 31' ' ' LYS . 2.2 ptmt -138.05 134.06 34.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.365 179.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.495 ' HA3' ' HB3' ' A' ' 80' ' ' ASN . . . -100.07 147.6 18.19 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.939 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.404 ' ND2' ' CE1' ' A' ' 45' ' ' PHE . 76.6 m-20 -127.12 130.49 49.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.888 0.375 . . . . 0.0 110.866 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.16 145.74 26.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.468 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.3 m -44.1 130.61 6.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.269 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.13 -19.85 65.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.568 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -106.08 -44.09 4.67 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.825 0.345 . . . . 0.0 111.421 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -87.3 -16.91 33.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.522 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 30.2 m-70 61.47 21.3 11.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.746 0.308 . . . . 0.0 110.888 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -99.29 134.47 42.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.011 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -50.18 126.94 15.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.315 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 45.8 mt -94.39 -19.4 20.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.919 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.443 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 128.82 169.66 12.63 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.308 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.413 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -102.05 130.95 51.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.835 0.35 . . . . 0.0 111.29 179.85 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.463 ' CE2' ' NE2' ' A' ' 66' ' ' GLN . 0.1 OUTLIER -113.56 146.79 39.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.486 179.868 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.41 ' O ' HG12 ' A' ' 63' ' ' VAL . 49.1 t -60.53 104.66 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.563 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.1 tptt -75.48 -40.05 57.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.889 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -168.77 126.41 1.03 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.981 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.434 ' CD1' ' HB3' ' A' ' 61' ' ' LEU . 63.7 mt -94.44 121.21 44.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.048 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.494 HD13 ' HA2' ' A' ' 27' ' ' GLY . 1.5 mp -58.96 109.74 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.432 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -65.83 72.91 0.06 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.071 0.462 . . . . 0.0 110.691 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 163.76 -26.51 0.21 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.262 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.87 -165.41 6.05 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.777 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.519 ' HB1' ' HA ' ' A' ' 18' ' ' LEU . . . -69.09 -42.18 76.49 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.429 ' CB ' ' CG1' ' A' ' 28' ' ' VAL . . . -63.13 -43.84 97.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.342 -179.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.4 t -68.73 -33.56 74.13 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.132 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -72.2 -31.9 66.29 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.876 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -65.18 -25.17 67.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.709 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.12 29.7 65.9 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.575 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.414 ' HG2' ' CE1' ' A' ' 14' ' ' PHE . 15.0 mtm180 -124.9 -33.02 2.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.609 0.242 . . . . 0.0 111.254 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.434 ' HB3' ' CD1' ' A' ' 49' ' ' ILE . 5.5 mp -72.01 150.15 44.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.904 0.383 . . . . 0.0 111.055 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.11 135.71 20.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.082 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.548 ' O ' ' HB3' ' A' ' 64' ' ' ASN . 82.9 t -64.99 94.89 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.817 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.548 ' HB3' ' O ' ' A' ' 63' ' ' VAL . 12.2 p30 149.55 -4.45 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.92 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -84.22 131.78 34.71 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 121.096 0.474 . . . . 0.0 111.594 -179.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.463 ' NE2' ' CE2' ' A' ' 45' ' ' PHE . 0.3 OUTLIER -89.93 117.25 28.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.11 179.343 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.2 mt -71.91 133.52 45.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.929 0.395 . . . . 0.0 111.404 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 23.6 mt -122.12 -22.86 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.488 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.69 167.26 30.96 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.935 0.398 . . . . 0.0 111.466 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.427 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 10.3 p -158.18 126.34 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.694 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.417 ' HB2' ' O ' ' A' ' 70' ' ' VAL . 2.7 m-80 66.19 15.4 10.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.082 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 96.34 7.48 58.17 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.529 -0.843 . . . . 0.0 113.125 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.427 ' CG ' ' O ' ' A' ' 70' ' ' VAL . 2.4 pt-20 -121.13 109.15 14.66 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.889 0.376 . . . . 0.0 111.002 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.4 m -59.65 145.9 43.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.024 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.409 ' HB2' ' CB ' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -121.16 4.41 10.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.247 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.0 tp -61.21 -28.53 69.21 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.741 0.305 . . . . 0.0 111.029 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -74.87 -24.95 70.65 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.558 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -97.34 166.17 11.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.259 0.552 . . . . 0.0 111.212 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.21 165.2 16.59 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.245 -0.888 . . . . 0.0 111.418 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.495 ' HB3' ' HA3' ' A' ' 32' ' ' GLY . 20.3 m-80 -54.78 -57.77 10.24 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.269 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.0 pp0? -56.83 -34.49 67.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.83 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.72 -38.64 73.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.313 0.578 . . . . 0.0 109.625 179.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.409 ' CB ' ' HB2' ' A' ' 75' ' ' LEU . . . -69.08 -40.74 78.26 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.405 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.434 ' O ' ' HB2' ' A' ' 88' ' ' ARG . 1.1 mtm -66.3 -29.62 69.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.854 179.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -79.88 -35.88 37.37 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.421 ' HA ' ' HD2' ' A' ' 89' ' ' ARG . 2.9 m -65.21 -36.33 83.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.375 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.413 ' CD2' ' HA ' ' A' ' 84' ' ' MET . 4.4 pp -79.06 -34.6 43.57 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' A' ' 84' ' ' MET . 0.1 OUTLIER -62.32 -50.68 70.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.605 179.322 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.444 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.16 -37.34 69.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.233 179.634 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.8 m -67.11 -29.51 69.27 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.077 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.426 ' HB3' ' CD1' ' A' ' 101' ' ' ILE . 4.5 ptp -89.34 -30.28 18.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.624 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.0 23.46 13.97 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.452 ' O ' ' HG3' ' A' ' 97' ' ' LYS . 0.4 OUTLIER -155.04 -31.05 0.1 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.851 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.42 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 7.8 mt-10 -113.9 -63.89 1.39 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.894 0.378 . . . . 0.0 111.524 -179.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.457 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -58.11 -31.89 66.19 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.451 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.416 ' O ' ' ND2' ' A' ' 96' ' ' ASN . 0.7 OUTLIER -72.95 -33.71 66.07 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.715 0.293 . . . . 0.0 110.612 179.92 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 93' ' ' THR . 54.4 mtpt -43.56 -39.45 3.45 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.035 0.445 . . . . 0.0 111.325 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.31 -26.23 15.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.957 178.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 117.27 2.07 18.17 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.613 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.484 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -158.17 141.91 15.49 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.011 0.434 . . . . 0.0 111.28 -179.689 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.457 ' HB ' ' HA3' ' A' ' 95' ' ' GLY . 0.1 OUTLIER -112.86 146.15 17.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.967 179.915 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.412 ' OE1' HG13 ' A' ' 104' ' ' ILE . 1.5 tm0? -86.9 138.45 31.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.034 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.435 HD22 HG12 ' A' ' 101' ' ' ILE . 2.8 mm? -128.51 138.98 52.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.0 0.428 . . . . 0.0 111.961 -179.172 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.412 HG13 ' OE1' ' A' ' 102' ' ' GLN . 55.1 mt -127.67 112.79 28.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.745 178.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 34.7 m -121.76 175.88 4.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.048 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -147.52 141.77 26.21 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.842 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.38 -178.86 6.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.886 0.374 . . . . 0.0 111.175 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.39 144.29 31.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.858 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.6 mt -71.01 -52.96 23.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.992 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 47.4 t . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.999 179.992 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.776 0.322 . . . . 0.0 110.948 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -69.97 148.82 48.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.818 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -91.22 -39.82 11.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.021 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -150.11 -69.55 0.19 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.001 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -119.1 131.75 55.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.03 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 57.8 p -104.9 -162.34 0.88 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.776 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -180.0 145.64 0.22 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.259 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 1.6 mm -109.81 153.99 11.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.981 0.419 . . . . 0.0 111.146 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 27.3 m -138.06 97.8 3.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.795 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 8.1 ttpt -69.19 109.67 4.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.989 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 18.5 m . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.321 -0.847 . . . . 0.0 111.103 179.973 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.407 0 N-CA-C 112.448 -0.261 . . . . 0.0 112.448 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 35.6 p -158.28 62.86 0.44 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.865 0.364 . . . . 0.0 110.941 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 15.4 ttp85 -95.55 147.41 23.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.791 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -151.63 146.12 25.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.146 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -90.98 146.28 24.0 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.801 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -138.62 109.92 6.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.992 0.425 . . . . 0.0 111.088 -179.829 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 92.7 m -88.54 121.43 30.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.086 179.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.435 ' CG ' ' HG3' ' A' ' 60' ' ' ARG . 32.8 m-85 -131.14 150.53 52.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.214 0.53 . . . . 0.0 112.33 -179.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.456 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.6 OUTLIER -112.46 111.14 21.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.285 -0.87 . . . . 0.0 108.93 178.79 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.435 ' CG2' ' CD1' ' A' ' 103' ' ' LEU . 10.3 t -100.14 115.33 65.6 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -177.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 93.8 Cg_endo -85.98 128.2 3.19 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.758 2.305 . . . . 0.0 110.842 178.297 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.64 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -127.95 28.79 5.52 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -178.664 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -38.84 -33.35 0.11 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.061 0.458 . . . . 0.0 111.28 179.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -107.71 -33.87 7.15 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.231 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.406 ' HB3' ' CB ' ' A' ' 18' ' ' LEU . 7.6 t -70.51 -6.39 35.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.25 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.407 ' HA2' ' CD1' ' A' ' 18' ' ' LEU . . . -42.12 -30.49 0.75 Allowed Glycine 0 C--N 1.337 0.613 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.775 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.02 -38.81 20.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.866 0.365 . . . . 0.0 110.672 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -82.51 1.7 36.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.449 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.88 -53.81 4.86 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.978 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.43 ' O ' ' N ' ' A' ' 54' ' ' ALA . 7.7 tp -175.62 -36.06 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.735 0.302 . . . . 0.0 110.589 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.42 ' HA2' HD11 ' A' ' 50' ' ' ILE . . . 109.03 47.5 0.88 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.524 -0.846 . . . . 0.0 113.531 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.452 HG12 ' CB ' ' A' ' 55' ' ' ALA . 22.3 m -158.18 156.67 3.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 117.058 0.429 . . . . 0.0 111.75 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.401 ' O ' ' N ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -114.13 114.17 25.69 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.383 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.407 ' CG2' ' HG2' ' A' ' 84' ' ' MET . 0.4 OUTLIER -106.94 146.97 12.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.269 0.556 . . . . 0.0 111.979 -178.659 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.18 130.9 15.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.321 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -100.08 176.97 28.57 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.941 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.483 ' OD1' ' HB2' ' A' ' 42' ' ' LEU . 50.8 p30 -125.15 -174.8 3.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.303 0.573 . . . . 0.0 111.637 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.426 ' O ' ' C ' ' A' ' 35' ' ' SER . 4.5 mtm180 -144.27 126.13 15.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.698 179.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.462 ' CA ' HD23 ' A' ' 42' ' ' LEU . 57.7 m -28.68 142.77 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.22 -178.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -37.21 83.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.354 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.78 -63.16 1.42 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.933 0.397 . . . . 0.0 110.925 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -112.78 -179.92 3.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.882 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 53.1 m-70 -87.56 53.62 2.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.968 0.413 . . . . 0.0 110.857 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -104.24 105.0 14.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.074 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -49.06 139.75 10.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.554 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.483 ' HB2' ' OD1' ' A' ' 33' ' ' ASN . 5.4 mt -103.66 -16.37 15.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.737 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 137.5 -177.94 19.46 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.036 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.414 ' CD1' ' HB2' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -115.98 136.59 52.42 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-O 120.819 0.342 . . . . 0.0 110.672 179.749 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -126.47 144.08 50.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.87 0.366 . . . . 0.0 110.827 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.45 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 40.1 t -57.06 113.79 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.825 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 29' ' ' SER . 30.1 tptt -83.03 -38.16 22.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.653 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -168.3 120.09 0.82 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.082 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.419 ' CD1' ' HB3' ' A' ' 61' ' ' LEU . 70.4 mt -85.75 120.61 36.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.971 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.44 HD12 ' N ' ' A' ' 28' ' ' VAL . 1.4 mp -57.55 103.95 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.623 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -60.24 83.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.484 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 148.97 -28.03 1.27 Allowed Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.664 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.42 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -67.09 -176.15 7.98 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.543 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.64 ' HB2' ' HA ' ' A' ' 18' ' ' LEU . . . -61.77 -39.29 91.16 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.452 ' CB ' HG12 ' A' ' 28' ' ' VAL . . . -64.65 -48.6 74.2 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.98 0.419 . . . . 0.0 111.486 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.69 -28.52 69.95 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.113 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.7 mtpt -77.46 -29.03 52.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.948 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.407 ' OD1' ' NH2' ' A' ' 60' ' ' ARG . 4.5 t0 -56.13 -31.7 63.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.412 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.77 13.51 80.5 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.887 -0.673 . . . . 0.0 113.35 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.435 ' HG3' ' CG ' ' A' ' 14' ' ' PHE . 2.9 ptp180 -135.62 7.09 3.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 117.089 0.445 . . . . 0.0 111.373 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.419 ' HB3' ' CD1' ' A' ' 49' ' ' ILE . 0.1 OUTLIER -98.99 133.49 43.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.46 179.827 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.9 142.16 38.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.911 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.45 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 52.3 t -59.3 147.35 8.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.912 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.434 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 16.3 m-20 85.36 12.99 0.21 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.3 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -85.26 109.53 18.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.854 0.359 . . . . 0.0 110.611 179.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -73.59 111.17 8.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.841 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.8 mt -66.08 141.47 58.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.66 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.487 HD12 HG21 ' A' ' 68' ' ' ILE . 34.8 mt -129.51 -39.69 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.437 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.0 124.03 11.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.991 0.424 . . . . 0.0 111.227 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.4 p -120.33 124.93 73.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.437 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 60.93 42.74 12.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.905 0.383 . . . . 0.0 110.477 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 64.8 21.51 67.47 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.225 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -126.94 118.61 24.87 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.771 0.319 . . . . 0.0 110.767 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.3 t -60.5 152.43 25.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.941 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 36.2 mt -118.39 -31.89 4.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.233 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.5 mt -53.96 -29.73 43.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.22 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.03 -11.6 63.81 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.837 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.0 ptpp? -126.01 156.26 40.16 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.252 0.548 . . . . 0.0 111.206 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.07 162.45 0.66 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.882 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -54.66 -57.62 10.74 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.079 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -59.55 -35.4 74.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.061 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.49 -40.53 73.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.153 0.502 . . . . 0.0 109.655 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.414 ' HB2' ' CD1' ' A' ' 44' ' ' ILE . . . -69.13 -38.83 79.07 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.45 179.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.407 ' HG2' ' CG2' ' A' ' 30' ' ' VAL . 0.5 OUTLIER -65.95 -30.67 71.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.865 179.239 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -79.72 -31.95 41.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.341 178.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.419 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 1.7 m -69.48 -35.39 75.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.33 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.409 ' CD1' ' N ' ' A' ' 88' ' ' ARG . 4.3 pp -78.72 -34.61 45.81 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.409 ' N ' ' CD1' ' A' ' 87' ' ' LEU . 5.0 mtp180 -61.4 -52.11 65.98 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 114.937 -1.028 . . . . 0.0 110.616 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.468 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.42 -33.48 67.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.993 179.613 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.456 ' N ' ' HD3' ' A' ' 89' ' ' ARG . 28.6 m -70.99 -29.54 65.55 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.46 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.426 ' HB3' ' CD1' ' A' ' 101' ' ' ILE . 2.3 ptp -88.94 -21.34 23.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.386 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.5 31.81 6.29 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.468 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.4 OUTLIER -160.01 -31.68 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 179.899 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.411 ' HG3' HG21 ' A' ' 93' ' ' THR . 5.1 mt-10 -115.88 -45.94 2.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.885 0.374 . . . . 0.0 111.239 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.47 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -73.34 -35.25 56.73 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.665 -0.778 . . . . 0.0 111.945 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.422 ' O ' ' ND2' ' A' ' 96' ' ' ASN . 0.8 OUTLIER -71.25 -33.82 70.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.898 0.38 . . . . 0.0 110.089 179.568 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' A' ' 93' ' ' THR . 49.3 mtpt -40.85 -32.59 0.23 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.739 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.15 -28.21 10.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.797 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 128.22 -8.88 6.66 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.731 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.456 ' SD ' ' HB3' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -154.38 144.44 21.9 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.962 0.411 . . . . 0.0 110.852 -179.847 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.47 ' HB ' ' HA3' ' A' ' 95' ' ' GLY . 0.1 OUTLIER -107.2 144.63 15.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.597 -179.483 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -77.01 137.17 38.82 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.435 ' CD1' ' CG2' ' A' ' 16' ' ' VAL . 0.3 OUTLIER -135.57 147.12 48.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.335 0.588 . . . . 0.0 112.198 -178.807 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 8.5 mt -140.45 112.63 4.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.311 178.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.1 m -122.47 176.61 4.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.056 0.455 . . . . 0.0 111.677 -178.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -147.48 132.67 18.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.561 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.33 -179.7 6.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.842 0.353 . . . . 0.0 111.212 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 15.5 mtm-85 -95.8 142.88 27.54 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.125 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.402 HG22 HD13 ' A' ' 109' ' ' ILE . 44.0 mt -68.26 -22.48 27.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.074 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.332 -0.195 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.901 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.813 0.339 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -99.12 167.57 10.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.083 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.22 -65.7 0.64 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.914 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -130.57 -75.53 0.53 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.927 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -126.42 22.17 7.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.196 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 55.68 -159.7 0.2 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.095 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -164.44 121.0 1.58 Allowed 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mm -94.45 145.94 7.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.197 0.522 . . . . 0.0 111.774 -178.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 55.0 m -140.36 106.63 5.25 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.484 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 9.2 ttmt -68.89 112.8 5.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.269 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.404 ' CG1' ' HG3' ' A' ' 88' ' ' ARG . 30.8 m . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.979 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 N-CA-C 112.484 -0.247 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 69.1 p 51.68 94.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.025 0.441 . . . . 0.0 111.191 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.3 mtp85 -153.38 136.33 15.46 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.596 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -156.86 152.58 26.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.917 0.389 . . . . 0.0 111.467 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -94.88 144.06 25.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.264 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.46 127.78 32.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.942 0.401 . . . . 0.0 111.606 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 99.2 m -97.47 133.99 41.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.741 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.464 ' O ' ' N ' ' A' ' 103' ' ' LEU . 21.6 m-85 -140.71 148.19 40.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.268 0.556 . . . . 0.0 112.404 -179.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -112.39 111.5 22.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.401 -0.818 . . . . 0.0 108.928 178.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.438 ' CG2' ' CD1' ' A' ' 103' ' ' LEU . 21.2 t -103.41 111.22 64.97 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -177.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 86.4 Cg_endo -81.03 128.18 6.39 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.427 2.085 . . . . 0.0 111.014 178.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.606 ' HA ' ' HB1' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -126.22 29.39 5.83 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -178.85 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -37.43 -32.33 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.411 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -112.32 -34.1 6.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.248 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.41 ' HB3' ' CB ' ' A' ' 18' ' ' LEU . 10.5 t -67.03 -11.92 58.43 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.147 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.406 ' HA2' ' CD1' ' A' ' 18' ' ' LEU . . . -45.86 -28.58 2.8 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.737 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.1 t -81.68 -36.77 28.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.89 0.376 . . . . 0.0 110.67 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.17 -24.54 37.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.062 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.9 -52.59 0.7 Allowed Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.508 ' HB2' ' HE3' ' A' ' 91' ' ' MET . 9.3 tp 179.15 -32.82 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.654 0.264 . . . . 0.0 110.796 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.418 ' HA2' HD12 ' A' ' 50' ' ' ILE . . . 107.13 43.11 1.42 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.969 179.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.42 ' N ' HD13 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -164.77 151.44 2.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.068 0.461 . . . . 0.0 111.343 179.738 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.41 ' O ' ' N ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -111.85 123.32 49.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.931 179.356 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -112.43 141.36 28.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.895 0.379 . . . . 0.0 111.501 -179.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.04 130.29 25.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.648 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -96.75 144.18 17.18 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.851 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.401 ' O ' ' HA ' ' A' ' 41' ' ' ASP . 1.5 m-80 -94.4 -176.3 3.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.711 0.291 . . . . 0.0 110.624 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.3 mtt180 -142.67 148.86 38.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.906 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.3 t -66.59 137.05 56.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.938 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -67.09 -29.14 68.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.154 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -70.2 -50.36 40.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.976 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -141.28 165.32 27.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.756 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -70.48 66.05 0.31 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.908 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -120.33 119.06 32.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.94 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.401 ' HA ' ' O ' ' A' ' 33' ' ' ASN . 9.2 p-10 -53.4 142.57 21.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.175 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 43.2 mt -107.27 3.94 26.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.392 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.427 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 113.92 160.33 13.59 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.524 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.402 ' HA ' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -98.73 130.59 47.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.733 0.301 . . . . 0.0 111.063 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.15 142.4 47.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.808 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.473 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 39.5 t -57.8 105.84 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.903 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 29' ' ' SER . 6.3 tptt -73.92 -41.42 62.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.106 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.2 m -171.89 123.35 0.52 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.913 0.387 . . . . 0.0 111.371 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.531 ' CD1' ' HB3' ' A' ' 61' ' ' LEU . 76.1 mt -85.66 110.95 20.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.068 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.456 ' O ' ' N ' ' A' ' 52' ' ' GLY . 1.9 mp -48.74 104.01 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.774 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -62.16 75.38 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.778 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 160.33 -28.79 0.34 Allowed Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.655 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.11 -161.71 3.49 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.476 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.606 ' HB1' ' HA ' ' A' ' 18' ' ' LEU . . . -76.41 -38.13 56.08 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.919 0.341 . . . . 0.0 111.919 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.64 -38.29 89.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.889 0.376 . . . . 0.0 111.022 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.6 t -78.03 -35.49 49.72 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.149 0.5 . . . . 0.0 109.736 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.5 mtpt -69.69 -31.34 69.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.813 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -64.47 -25.43 68.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.668 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.31 28.99 65.27 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.58 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.424 ' HG2' ' CE1' ' A' ' 14' ' ' PHE . 12.7 mtm180 -125.76 -32.33 2.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.729 0.3 . . . . 0.0 111.012 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.531 ' HB3' ' CD1' ' A' ' 49' ' ' ILE . 2.7 mp -68.94 147.26 51.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.093 0.473 . . . . 0.0 111.371 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 48.8 mtm-85 -142.96 123.74 14.21 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.508 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.473 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 41.3 t -52.75 142.76 5.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.339 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.429 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 20.2 m-20 85.22 18.66 0.12 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.237 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -99.21 118.39 35.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.35 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 16.7 tm0? -74.39 126.16 30.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.945 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 73.5 mt -76.06 141.77 41.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.296 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.9 mt -123.85 -39.64 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.704 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -150.95 154.98 38.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.886 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.417 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 8.0 p -142.34 125.6 14.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.633 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 64.83 12.89 8.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.65 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.21 13.22 36.86 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.205 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.417 ' CG ' ' O ' ' A' ' 70' ' ' VAL . 4.9 pt-20 -128.18 112.2 14.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 117.036 0.418 . . . . 0.0 111.018 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.4 p -65.15 170.41 4.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.947 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.68 16.59 1.81 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.216 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.8 tp -66.18 -21.31 66.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.628 0.251 . . . . 0.0 111.052 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -91.18 14.76 62.75 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.962 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -139.35 163.76 31.65 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.403 0.621 . . . . 0.0 111.235 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.15 162.38 22.57 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.486 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -55.9 -52.51 63.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.109 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.6 pp0? -59.29 -36.29 75.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.971 0.415 . . . . 0.0 110.524 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.58 -38.65 74.07 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.344 179.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.18 -34.92 75.68 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.128 179.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.49 ' HA ' ' CD2' ' A' ' 87' ' ' LEU . 1.0 OUTLIER -69.94 -29.45 66.59 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.9 179.043 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -78.01 -39.54 41.82 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.405 ' O ' ' HB2' ' A' ' 90' ' ' SER . 1.8 m -61.79 -37.47 84.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.082 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.49 ' CD2' ' HA ' ' A' ' 84' ' ' MET . 3.5 pp -78.18 -33.54 50.06 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.434 ' O ' ' HG2' ' A' ' 91' ' ' MET . 0.6 OUTLIER -59.78 -52.0 67.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.668 179.074 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.455 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.85 -35.37 67.21 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.671 -179.909 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.44 ' N ' ' HD3' ' A' ' 89' ' ' ARG . 5.1 t -72.96 -29.85 63.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.851 0.357 . . . . 0.0 110.953 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.508 ' HE3' ' HB2' ' A' ' 26' ' ' LEU . 4.1 ptm -89.33 -18.23 27.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.283 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.28 29.71 6.59 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.469 ' O ' ' HG3' ' A' ' 97' ' ' LYS . 0.4 OUTLIER -162.26 -30.24 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 179.897 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -116.82 -44.84 2.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.905 0.383 . . . . 0.0 111.197 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -69.98 -30.22 70.21 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.908 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.59 -35.13 58.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.885 0.374 . . . . 0.0 110.173 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 93' ' ' THR . 26.9 mtpt -42.57 -40.12 2.56 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.421 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.08 -25.59 16.39 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.529 179.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 117.56 -3.1 17.95 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.907 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.85 144.06 13.12 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.895 0.379 . . . . 0.0 111.156 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.417 ' CG2' ' CD2' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -111.81 145.1 18.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.423 -179.666 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.0 150.42 33.9 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' A' ' 14' ' ' PHE . 0.4 OUTLIER -146.65 113.51 6.1 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.85 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 36.1 mt -107.32 112.91 42.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.784 178.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 22.1 m -123.27 -179.44 2.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.501 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -147.76 132.4 17.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.488 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.23 -178.75 6.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.962 0.411 . . . . 0.0 111.412 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -80.22 141.16 35.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.889 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 24.2 mt -73.19 -40.13 57.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.015 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.3 t . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.991 179.84 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.938 0.399 . . . . 0.0 110.843 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.11 168.96 8.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.819 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -102.73 36.63 2.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.7 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . 0.416 ' O ' ' HB2' ' B' ' 7' ' ' HIS . 20.6 mp0 63.83 129.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.746 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . 0.416 ' HB2' ' O ' ' B' ' 6' ' ' GLN . 51.6 m-70 68.06 -63.68 0.32 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.192 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 71.32 -156.86 0.11 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.75 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.13 147.15 2.02 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . 0.432 HD12 HG22 ' B' ' 10' ' ' ILE . 1.6 mm -115.01 124.39 71.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.392 0.615 . . . . 0.0 111.264 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 20.5 m -96.47 97.76 9.69 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.665 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 13.6 ttmt -69.52 139.54 53.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.003 0.43 . . . . 0.0 111.145 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 13.8 m . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.908 179.885 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 121.046 0.451 . . . . 0.0 111.6 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.498 ' CE2' HD13 ' A' ' 68' ' ' ILE . 19.8 m-85 -79.02 149.93 32.06 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.238 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.618 HD12 HG23 ' A' ' 105' ' ' VAL . 0.3 OUTLIER -140.09 109.71 6.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.057 0.456 . . . . 0.0 111.649 -179.449 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.683 HG23 ' OE1' ' A' ' 102' ' ' GLN . 85.1 m -99.52 120.81 40.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.715 178.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.435 ' O ' ' N ' ' A' ' 103' ' ' LEU . 28.8 m-85 -134.61 153.87 51.76 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.466 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.2 OUTLIER -110.91 111.95 23.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.901 178.86 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.489 HG11 ' HG ' ' A' ' 26' ' ' LEU . 17.6 t -101.32 112.4 65.01 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -177.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.56 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 94.9 Cg_endo -83.5 127.5 4.43 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.591 2.194 . . . . 0.0 110.847 178.229 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.794 HD22 HD13 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -122.41 28.5 7.38 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -178.778 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.429 ' ND2' ' OD2' ' A' ' 20' ' ' ASP . 8.6 p-10 -39.02 -32.15 0.08 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.089 0.471 . . . . 0.0 111.17 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.429 ' OD2' ' ND2' ' A' ' 19' ' ' ASN . 27.7 m-20 -109.44 -34.81 6.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.255 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.417 ' HB3' ' CB ' ' A' ' 18' ' ' LEU . 39.9 t -71.97 -5.71 36.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.236 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.775 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -43.99 -30.18 1.68 Allowed Glycine 0 C--N 1.338 0.649 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.531 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.0 t -82.72 -38.52 23.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.915 0.388 . . . . 0.0 110.314 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -82.51 -1.74 51.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.395 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.1 -48.5 3.65 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.705 -0.759 . . . . 0.0 111.794 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.984 HD22 ' HE2' ' A' ' 91' ' ' MET . 8.1 tp -179.72 -32.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.585 0.231 . . . . 0.0 110.55 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.471 ' HA3' ' HA3' ' A' ' 53' ' ' GLY . . . 106.9 46.45 1.1 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.457 -0.877 . . . . 0.0 113.453 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.781 HG12 HG23 ' A' ' 49' ' ' ILE . 30.1 m -157.85 154.12 5.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.037 0.446 . . . . 0.0 111.831 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.07 121.72 45.74 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.2 m -106.04 148.02 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -155.48 129.15 8.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.071 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' A' ' 44' ' ' ILE . . . -107.88 166.53 13.14 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.864 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -113.2 -178.61 3.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.954 0.407 . . . . 0.0 110.93 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.04 135.82 24.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.242 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.489 ' OG ' HD21 ' A' ' 42' ' ' LEU . 1.6 m -48.35 143.58 4.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.823 0.345 . . . . 0.0 110.896 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.37 -49.16 67.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.532 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -95.33 -50.02 5.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.384 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 36.8 m-20 -66.04 -23.87 66.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.35 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 58.04 21.47 7.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.807 0.337 . . . . 0.0 110.964 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -94.18 135.52 35.47 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.871 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -46.57 132.05 10.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.536 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.489 HD21 ' OG ' ' A' ' 35' ' ' SER . 38.7 mt -100.79 17.98 20.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.041 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.83 177.67 46.49 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.616 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.902 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -105.78 152.49 7.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.918 0.389 . . . . 0.0 111.202 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.444 ' CE1' ' NE2' ' A' ' 66' ' ' GLN . 2.2 m-85 -135.39 138.21 43.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.708 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.697 ' O ' HG13 ' A' ' 63' ' ' VAL . 31.1 t -54.94 104.46 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.345 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.426 ' HD3' HD12 ' B' ' 10' ' ' ILE . 37.8 tptt -73.74 -42.71 60.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.757 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.5 t -168.95 119.16 0.72 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.182 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.781 HG23 HG12 ' A' ' 28' ' ' VAL . 80.8 mt -85.3 121.97 37.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.244 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.463 HD13 ' HA2' ' A' ' 27' ' ' GLY . 1.9 mp -59.52 107.17 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.371 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -61.17 78.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.887 0.375 . . . . 0.0 110.776 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 155.97 -28.68 0.59 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.194 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.471 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -67.19 -171.59 5.11 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.853 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.56 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -63.09 -40.72 98.5 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.578 ' HA ' HD13 ' A' ' 61' ' ' LEU . . . -64.91 -44.86 88.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.813 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.09 -28.48 66.53 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.592 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.4 mtpt -79.55 -28.23 41.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.061 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.2 -29.94 67.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.603 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.17 14.04 76.53 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.944 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -130.4 1.41 4.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.915 0.357 . . . . 0.0 111.34 179.866 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.689 ' HB3' HD13 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -103.38 128.43 50.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.882 0.372 . . . . 0.0 111.241 -179.755 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.612 HH21 HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -138.14 141.88 40.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.753 179.362 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.697 HG13 ' O ' ' A' ' 46' ' ' VAL . 39.0 t -55.91 146.15 5.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.213 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 18.0 m-20 87.27 13.56 0.11 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.378 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.454 ' O ' HG23 ' A' ' 46' ' ' VAL . 5.0 m-20 -93.4 120.6 33.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.721 0.296 . . . . 0.0 110.39 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.444 ' NE2' ' CE1' ' A' ' 45' ' ' PHE . 0.8 OUTLIER -78.2 135.05 37.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.763 -179.8 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.965 HD23 HG12 ' A' ' 105' ' ' VAL . 80.0 mt -85.25 140.9 30.5 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.841 0.353 . . . . 0.0 110.799 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.944 HD11 ' HB2' ' A' ' 106' ' ' ALA . 24.0 mt -123.17 -40.27 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.219 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.871 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -155.18 138.43 15.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.355 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.752 HG11 ' HA ' ' A' ' 87' ' ' LEU . 12.3 p -127.74 125.58 65.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.78 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.48 HD22 ' CA ' ' A' ' 95' ' ' GLY . 20.6 m120 61.21 27.0 16.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.724 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.53 25.32 56.96 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.002 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -130.4 104.38 7.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.692 0.282 . . . . 0.0 110.779 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.8 t -58.54 155.56 12.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.013 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.472 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . 1.0 OUTLIER -118.32 -9.55 10.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.697 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 30.0 mt -57.01 -20.66 25.4 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.666 0.27 . . . . 0.0 111.408 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -92.75 27.41 11.01 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.788 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.42 ' HD2' ' HA ' ' A' ' 83' ' ' ALA . 1.1 ptpm? -160.71 162.78 32.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.288 0.566 . . . . 0.0 111.189 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.12 164.03 16.38 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.391 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.408 ' O ' ' HG2' ' A' ' 84' ' ' MET . 20.3 m-80 -56.0 -57.51 11.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.812 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.408 ' HA ' ' HG2' ' A' ' 84' ' ' MET . 0.0 OUTLIER -54.76 -38.61 67.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.955 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.38 -36.16 73.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.007 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.578 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -69.17 -51.07 41.82 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.783 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.432 ' HA ' ' CD2' ' A' ' 87' ' ' LEU . 6.6 ptp -60.39 -29.04 68.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.801 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.39 -31.9 42.91 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.555 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.414 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 2.1 m -70.13 -35.79 74.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.291 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.853 HD12 ' N ' ' A' ' 88' ' ' ARG . 4.2 pp -78.0 -34.26 50.89 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.853 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -57.26 -50.45 72.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.339 178.988 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.488 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.33 -38.06 68.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.171 179.697 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 63.7 m -67.4 -29.1 68.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.929 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.984 ' HE2' HD22 ' A' ' 26' ' ' LEU . 2.6 ptp -88.25 -28.23 21.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.678 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -110.77 26.58 10.54 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.488 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.4 OUTLIER -156.06 -33.04 0.09 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.441 ' HG3' HG22 ' A' ' 93' ' ' THR . 7.6 mt-10 -115.56 -36.68 4.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.822 0.344 . . . . 0.0 111.138 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.48 ' CA ' HD22 ' A' ' 71' ' ' ASN . . . -80.44 -32.09 35.44 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.884 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.717 ' HB2' HD11 ' A' ' 18' ' ' LEU . 3.1 t30 -76.73 -34.33 58.11 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 93' ' ' THR . 48.4 mtpt -42.12 -32.49 0.47 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.473 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.97 -25.03 12.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.875 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 121.58 -7.63 10.34 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.789 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.467 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -157.02 144.66 19.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.89 0.376 . . . . 0.0 110.914 -179.895 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.557 HG22 HD21 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -108.3 143.69 18.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.412 -179.71 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.683 ' OE1' HG23 ' A' ' 13' ' ' THR . 1.1 tm0? -76.94 142.18 40.17 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -137.59 145.88 43.34 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.115 0.483 . . . . 0.0 112.115 -178.757 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.871 HD12 ' HB3' ' A' ' 69' ' ' ALA . 22.8 mt -139.1 112.77 6.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.468 178.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.965 HG12 HD23 ' A' ' 67' ' ' LEU . 27.4 m -132.15 150.14 33.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.855 0.36 . . . . 0.0 111.578 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.944 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -114.77 129.27 56.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.686 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.465 ' HB3' HD11 ' A' ' 12' ' ' LEU . 1.8 tmm_? . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.888 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.426 HD12 ' HD3' ' A' ' 47' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.454 -0.231 0 CA-C-O 120.929 0.395 . . . . 0.0 111.203 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 66.1 m -138.3 115.91 11.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.732 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -69.94 115.23 8.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.836 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.721 HG12 ' HG3' ' A' ' 88' ' ' ARG . 15.3 m . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.298 -0.858 . . . . 0.0 111.121 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.696 0.284 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -88.01 146.18 25.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.604 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.918 HD12 HG23 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -140.82 109.86 6.14 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.9 0.381 . . . . 0.0 111.333 -179.504 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.5 m -80.55 145.49 31.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.979 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.438 ' CD1' ' HG3' ' A' ' 60' ' ' ARG . 12.8 m-85 -140.28 171.41 14.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.368 0.604 . . . . 0.0 112.132 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -143.55 103.43 4.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.028 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.6 HG11 ' HG ' ' A' ' 26' ' ' LEU . 17.8 t -104.83 112.05 65.26 Favored Pre-proline 0 C--N 1.329 -0.302 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -177.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.593 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 93.7 Cg_endo -83.46 127.53 4.46 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.413 2.076 . . . . 0.0 110.798 178.398 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.744 HD22 HD13 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -120.85 27.96 8.2 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.848 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -40.93 -30.2 0.12 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.999 0.428 . . . . 0.0 110.744 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -114.87 -31.47 6.1 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.174 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.582 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 43.0 t -72.65 -7.55 50.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.139 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.637 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -45.27 -28.3 2.05 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.624 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.6 m -85.44 -34.86 21.58 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.942 0.401 . . . . 0.0 110.677 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.14 8.97 24.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.526 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.62 -56.23 5.02 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.932 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.799 HD22 ' HE2' ' A' ' 91' ' ' MET . 9.7 tp -178.8 -27.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.518 0.199 . . . . 0.0 111.155 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.485 ' HA3' ' HA3' ' A' ' 53' ' ' GLY . . . 109.75 35.54 2.2 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.31 -0.948 . . . . 0.0 113.536 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.702 HG12 HG23 ' A' ' 49' ' ' ILE . 13.0 m -158.95 157.75 3.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 117.08 0.44 . . . . 0.0 111.538 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.533 ' O ' ' N ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -114.15 134.94 54.55 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.711 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.614 HG11 HD11 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -120.65 143.56 32.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.119 0.485 . . . . 0.0 111.896 -178.809 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.56 ' HB3' HD13 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -142.12 129.71 21.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.587 179.666 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -102.7 153.3 18.32 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.991 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -125.28 175.25 7.57 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.009 0.433 . . . . 0.0 111.252 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.5 mtt85 -122.57 157.42 32.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.736 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.729 ' CA ' HD21 ' A' ' 42' ' ' LEU . 19.5 m -51.28 155.86 1.3 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.269 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.05 -39.59 86.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.111 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.58 -78.68 0.18 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.958 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -81.64 -175.77 5.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.834 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -98.32 29.91 3.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.942 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.24 115.84 14.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.098 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.41 ' CB ' ' ND2' ' A' ' 80' ' ' ASN . 1.2 p30 -59.08 119.62 7.63 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.951 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.729 HD21 ' CA ' ' A' ' 35' ' ' SER . 17.4 mt -75.58 -26.42 57.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.872 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.466 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 133.21 -176.69 19.45 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.121 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.906 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -107.32 134.53 48.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.876 0.369 . . . . 0.0 111.262 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.464 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -117.55 144.08 45.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.565 -179.79 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.674 ' O ' HG13 ' A' ' 63' ' ' VAL . 21.3 t -54.54 106.36 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.124 0.488 . . . . 0.0 110.941 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.599 ' HG3' HG23 ' B' ' 10' ' ' ILE . 0.5 OUTLIER -65.99 -52.58 48.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.638 179.86 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.6 t -169.41 133.86 1.4 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.388 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.709 HD13 ' HB3' ' A' ' 61' ' ' LEU . 65.8 mt -95.06 116.55 36.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.083 0.468 . . . . 0.0 111.826 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.505 HD12 ' N ' ' A' ' 28' ' ' VAL . 2.3 mp -58.09 115.9 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.199 178.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -68.23 69.86 0.15 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.068 0.461 . . . . 0.0 110.69 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 168.21 -29.62 0.16 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.375 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.485 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -68.02 -172.33 6.6 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.907 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.593 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -62.98 -40.87 99.03 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.646 ' CB ' HD13 ' A' ' 61' ' ' LEU . . . -64.69 -48.06 76.09 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.936 0.398 . . . . 0.0 111.561 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.3 t -63.35 -30.66 71.75 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.216 0.531 . . . . 0.0 110.09 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 39.5 mtpt -76.68 -28.85 56.09 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.055 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.72 -29.26 64.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.882 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 68.05 16.51 68.71 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.202 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.438 ' HG3' ' CD1' ' A' ' 14' ' ' PHE . 0.8 OUTLIER -138.47 11.57 2.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.908 0.354 . . . . 0.0 111.274 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.709 ' HB3' HD13 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -106.68 134.92 49.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.689 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.854 ' NH2' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -139.12 144.57 38.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.85 179.774 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.674 HG13 ' O ' ' A' ' 46' ' ' VAL . 46.2 t -61.89 148.69 9.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.085 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 23.7 m-20 88.11 -10.46 0.51 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.431 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.659 ' O ' HG23 ' A' ' 46' ' ' VAL . 1.2 m-20 -66.5 115.05 5.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.769 0.318 . . . . 0.0 110.626 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.468 ' O ' ' HA ' ' A' ' 105' ' ' VAL . 18.3 tm0? -69.16 135.86 51.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.699 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.908 HD23 HG12 ' A' ' 105' ' ' VAL . 93.2 mt -87.75 139.85 30.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.849 0.357 . . . . 0.0 111.148 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.629 HD11 ' HB2' ' A' ' 106' ' ' ALA . 2.4 mt -122.28 -44.36 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.888 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 1.028 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -147.83 145.57 28.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.702 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.765 HG22 HD22 ' A' ' 71' ' ' ASN . 7.1 p -132.68 130.0 58.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.313 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.765 HD22 HG22 ' A' ' 70' ' ' VAL . 23.7 m-80 61.2 26.95 16.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.819 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.97 23.69 59.05 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.389 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -131.89 108.7 9.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.804 0.335 . . . . 0.0 110.864 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.0 t -59.21 154.67 15.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.711 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.508 HD21 HG12 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -115.8 -15.59 11.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.582 -179.723 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.414 ' CD2' HG23 ' A' ' 68' ' ' ILE . 4.1 mm? -46.66 -44.13 18.25 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.942 0.401 . . . . 0.0 111.173 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -57.51 -35.47 72.86 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.574 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.4 ptpm? -101.31 168.12 9.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.286 0.565 . . . . 0.0 111.297 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.45 ' HB3' HE22 ' A' ' 81' ' ' GLN . . . -71.34 174.73 6.12 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.542 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.432 ' HB2' ' HA3' ' A' ' 32' ' ' GLY . 8.1 p30 -67.0 -52.26 44.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.581 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.45 HE22 ' HB3' ' A' ' 79' ' ' ALA . 5.1 pm0 -58.12 -41.26 83.24 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.931 0.396 . . . . 0.0 110.483 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -70.45 -37.85 74.38 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.505 ' HB3' ' CD1' ' A' ' 44' ' ' ILE . . . -66.77 -33.49 75.73 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.229 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.462 ' O ' ' HB2' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -72.54 -32.32 66.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.981 179.236 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -78.48 -35.38 46.62 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.38 178.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.445 ' HA ' ' HD2' ' A' ' 89' ' ' ARG . 1.5 m -67.28 -35.72 80.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.311 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.74 HD12 ' N ' ' A' ' 88' ' ' ARG . 4.4 pp -78.31 -33.71 49.18 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.74 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -63.24 -50.84 68.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.788 179.312 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.445 ' HD2' ' HA ' ' A' ' 86' ' ' THR . 0.0 OUTLIER -73.03 -34.62 66.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.065 179.771 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.415 ' O ' ' ND2' ' A' ' 71' ' ' ASN . 55.9 m -72.19 -31.64 66.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.77 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.799 ' HE2' HD22 ' A' ' 26' ' ' LEU . 3.8 ptm -88.08 -18.72 28.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.614 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.01 18.14 14.73 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.472 HG22 ' HG3' ' A' ' 94' ' ' GLU . 0.4 OUTLIER -153.28 -37.99 0.1 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.898 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.52 ' HA ' ' CG ' ' A' ' 97' ' ' LYS . 8.6 mt-10 -104.15 -42.01 5.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.003 0.43 . . . . 0.0 111.742 -178.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.424 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -68.44 -37.94 86.25 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.806 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.677 ' HB2' HD11 ' A' ' 18' ' ' LEU . 4.2 t30 -67.13 -33.76 76.14 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.52 ' CG ' ' HA ' ' A' ' 94' ' ' GLU . 4.2 mmmt -31.42 -51.8 0.2 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.464 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.95 -27.48 16.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.757 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 122.8 1.11 9.84 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.813 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.482 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -161.77 142.55 10.76 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 121.038 0.447 . . . . 0.0 111.371 -179.743 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.565 HD11 HG23 ' A' ' 70' ' ' VAL . 0.1 OUTLIER -114.81 138.64 44.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.853 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.42 ' HA ' ' O ' ' A' ' 14' ' ' PHE . 2.2 pp0? -76.54 149.91 36.63 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.463 HD13 HG21 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -140.99 111.16 6.67 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.778 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 1.028 HD12 ' HB3' ' A' ' 69' ' ' ALA . 45.6 mt -98.35 112.77 31.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.323 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.918 HG23 HD12 ' A' ' 12' ' ' LEU . 18.1 m -124.28 152.42 30.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.454 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.629 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -124.95 148.11 48.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.113 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.769 ' HG3' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.98 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.599 HG23 ' HG3' ' A' ' 47' ' ' LYS . 4.2 mm . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 120.976 0.417 . . . . 0.0 111.333 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 11' ' ' THR . . . . . 0.42 ' CB ' ' HG2' ' A' ' 84' ' ' MET . 3.5 m -94.33 97.93 10.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.664 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -73.93 127.81 33.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.121 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 18.4 m . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.562 -0.732 . . . . 0.0 110.693 179.683 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.711 0.291 . . . . 0.0 111.069 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.568 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 2.4 p90 -112.36 148.34 34.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.645 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.889 HD11 ' HD2' ' A' ' 107' ' ' ARG . 0.1 OUTLIER -129.14 120.72 26.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.36 -178.988 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.0 m -83.15 145.43 29.21 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.336 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.435 ' CD1' ' HB3' ' A' ' 60' ' ' ARG . 63.8 m-85 -140.67 171.35 14.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.383 0.611 . . . . 0.0 112.219 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -140.13 106.99 5.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.214 -0.903 . . . . 0.0 108.902 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.776 ' CG2' HD11 ' A' ' 61' ' ' LEU . 17.3 t -105.61 117.75 57.2 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 -177.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.727 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 90.2 Cg_endo -86.69 128.18 2.84 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.764 2.309 . . . . 0.0 110.936 178.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.746 HD11 ' HB2' ' A' ' 96' ' ' ASN . 0.5 OUTLIER -122.77 28.63 7.19 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -178.717 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -40.91 -30.57 0.13 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.167 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -113.01 -32.53 6.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.14 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.706 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 41.7 t -70.74 -6.56 38.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.182 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.603 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -42.97 -30.03 0.95 Allowed Glycine 0 C--N 1.337 0.605 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.664 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.8 m -83.16 -40.37 19.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.885 0.374 . . . . 0.0 110.434 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.98 -5.79 56.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.266 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.92 -46.8 3.12 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.953 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.888 HD22 ' HE2' ' A' ' 91' ' ' MET . 6.2 tp 178.79 -33.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.661 0.267 . . . . 0.0 110.677 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.452 ' HA3' ' HA3' ' A' ' 53' ' ' GLY . . . 102.96 49.86 1.12 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.442 -0.885 . . . . 0.0 113.565 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.785 HG12 HG23 ' A' ' 49' ' ' ILE . 34.2 m -158.41 154.81 4.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 117.053 0.426 . . . . 0.0 111.78 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.439 ' O ' ' HB3' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -112.24 111.12 21.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.343 178.606 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.535 HG11 HD11 ' A' ' 67' ' ' LEU . 2.3 m -106.93 141.93 20.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.09 0.471 . . . . 0.0 111.843 -178.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.417 ' HB3' HG23 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -145.94 129.68 17.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.199 179.423 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -91.33 158.09 25.28 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.017 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -114.0 -178.76 3.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.9 0.381 . . . . 0.0 110.929 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 67.9 mtt180 -135.96 152.67 51.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.541 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.469 ' OG ' HD21 ' A' ' 42' ' ' LEU . 50.1 m -54.36 144.38 20.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.041 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.75 -33.39 75.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.981 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.14 -68.47 0.7 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.891 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -94.3 -173.41 3.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.85 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 65.2 m-70 -101.53 31.1 3.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.036 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.74 128.34 34.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.953 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.401 ' CB ' ' ND2' ' A' ' 80' ' ' ASN . 3.7 p-10 -57.18 149.0 20.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.137 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.469 HD21 ' OG ' ' A' ' 35' ' ' SER . 35.7 mt -113.14 -1.0 14.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.323 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.475 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 113.7 169.83 17.07 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.313 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.762 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -102.82 131.23 51.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.709 0.29 . . . . 0.0 110.951 179.757 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.445 ' N ' ' CD1' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -119.54 144.95 46.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.866 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.715 ' O ' HG13 ' A' ' 63' ' ' VAL . 39.0 t -60.78 104.57 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.641 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.439 ' HB3' ' O ' ' A' ' 29' ' ' SER . 2.2 tptt -73.71 -42.26 61.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.569 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.48 119.64 1.05 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.113 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.785 HG23 HG12 ' A' ' 28' ' ' VAL . 68.0 mt -85.18 117.8 30.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.015 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.556 HD12 ' N ' ' A' ' 28' ' ' VAL . 1.6 mp -55.72 106.6 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.462 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -64.64 74.2 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.014 0.435 . . . . 0.0 110.73 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 162.6 -26.4 0.23 Allowed Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.326 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.452 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -71.19 -163.46 5.41 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.85 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.727 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -71.28 -41.61 69.8 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.65 ' HB1' HD22 ' A' ' 61' ' ' LEU . . . -65.34 -43.4 91.02 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.317 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.652 ' OG ' HG22 ' A' ' 49' ' ' ILE . 1.2 m -67.5 -36.13 80.48 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.889 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -68.85 -33.95 74.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.597 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -60.24 -26.78 66.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.756 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 58.54 26.76 60.16 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.368 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.435 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 8.7 mtm180 -121.39 -28.52 4.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.63 0.252 . . . . 0.0 111.109 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.776 HD11 ' CG2' ' A' ' 16' ' ' VAL . 4.2 mp -75.91 151.1 37.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.136 0.493 . . . . 0.0 111.677 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.765 HH22 HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -146.56 131.53 18.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.172 179.701 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.715 HG13 ' O ' ' A' ' 46' ' ' VAL . 47.3 t -57.69 141.69 14.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.121 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.466 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 28.4 m-20 89.91 17.41 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.577 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -103.28 123.44 46.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.327 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.427 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -81.52 136.41 35.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.789 0.328 . . . . 0.0 110.793 -179.583 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.762 HD12 HG13 ' A' ' 44' ' ' ILE . 7.9 mt -87.51 131.21 34.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.569 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 1.021 HD11 ' HB2' ' A' ' 106' ' ' ALA . 34.5 mt -110.98 -33.97 2.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.614 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.934 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -153.34 157.47 40.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.132 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.804 HG22 ' ND2' ' A' ' 71' ' ' ASN . 8.4 p -142.25 126.42 15.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.387 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.804 ' ND2' HG22 ' A' ' 70' ' ' VAL . 66.1 m-80 60.68 18.87 8.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.74 0.305 . . . . 0.0 110.931 -179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.0 27.46 23.58 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.118 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -129.04 101.27 5.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.826 0.346 . . . . 0.0 110.828 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.0 t -65.33 148.5 51.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.05 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.62 HD22 ' HB1' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -130.61 14.43 5.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.234 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.5 tp -60.47 -22.5 63.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.725 0.297 . . . . 0.0 111.04 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -82.06 -27.21 46.01 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.662 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.4 ' HD3' ' HB3' ' A' ' 82' ' ' GLU . 1.6 ptpm? -96.05 171.31 8.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.174 0.512 . . . . 0.0 111.24 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.81 165.02 25.27 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.467 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.402 ' HB2' ' HA3' ' A' ' 32' ' ' GLY . 8.4 p30 -57.0 -47.95 79.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.252 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.402 ' N ' ' OD1' ' A' ' 80' ' ' ASN . 0.0 OUTLIER -59.77 -43.86 94.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.907 0.384 . . . . 0.0 110.938 -179.893 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.4 ' HB3' ' HD3' ' A' ' 78' ' ' LYS . 1.7 mm-40 -70.01 -32.57 70.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.853 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.62 ' HB1' HD22 ' A' ' 75' ' ' LEU . . . -69.16 -47.42 65.05 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.619 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.546 ' HB3' HG21 ' A' ' 44' ' ' ILE . 6.8 ptp -61.96 -31.64 71.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.101 0.477 . . . . 0.0 109.863 178.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.11 -34.75 66.34 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.442 ' HB ' ' O ' ' A' ' 83' ' ' ALA . 2.1 m -62.97 -34.21 77.03 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.141 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.703 HD13 HD13 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -76.24 -35.05 59.17 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.868 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.4 ' HG3' ' CG1' ' B' ' 13' ' ' VAL . 0.0 OUTLIER -58.06 -51.84 68.03 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.772 179.416 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.482 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -71.57 -43.42 66.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.612 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.435 ' HB2' ' O ' ' A' ' 86' ' ' THR . 1.6 t -65.6 -29.55 70.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.174 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.888 ' HE2' HD22 ' A' ' 26' ' ' LEU . 2.2 ptp -89.58 -19.88 24.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.629 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.21 27.56 8.75 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 -179.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.3 OUTLIER -162.19 -31.23 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.956 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.435 ' HA ' ' HG3' ' A' ' 97' ' ' LYS . 7.4 mt-10 -111.62 -72.49 0.71 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.788 0.328 . . . . 0.0 111.55 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.435 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -49.2 -29.67 9.89 Favored Glycine 0 CA--C 1.517 0.204 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.633 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.746 ' HB2' HD11 ' A' ' 18' ' ' LEU . 2.4 t30 -73.68 -34.59 64.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.856 0.36 . . . . 0.0 110.257 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.435 ' HG3' ' HA ' ' A' ' 94' ' ' GLU . 8.9 mtpp -40.01 -34.6 0.3 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.47 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.87 -25.05 12.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.705 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 122.64 -8.3 9.44 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.006 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.435 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -154.48 144.2 21.6 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.924 0.392 . . . . 0.0 111.53 -179.636 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.481 HG22 HD21 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -110.52 140.54 29.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.034 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.408 ' HB3' ' HA ' ' A' ' 71' ' ' ASN . 5.2 tt0 -76.88 150.48 36.03 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.534 HD12 HG23 ' A' ' 16' ' ' VAL . 0.5 OUTLIER -143.54 111.03 5.86 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -178.999 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.934 HD12 ' HB3' ' A' ' 69' ' ' ALA . 36.5 mt -102.0 113.33 38.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.732 178.418 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.752 HG23 HD12 ' A' ' 12' ' ' LEU . 4.4 m -116.83 174.9 3.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.058 0.456 . . . . 0.0 111.664 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 1.021 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -147.38 137.02 22.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.998 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.889 ' HD2' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.388 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.709 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.417 HG23 ' HB3' ' A' ' 31' ' ' LYS . 1.6 mm . . . . . 0 N--CA 1.452 -0.342 0 CA-C-O 120.991 0.424 . . . . 0.0 111.237 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 99.0 m -119.27 99.48 6.72 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.687 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 9.3 ttmt -72.66 122.63 21.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.001 0.429 . . . . 0.0 110.946 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.4 ' CG1' ' HG3' ' A' ' 88' ' ' ARG . 35.4 m . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.123 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.785 0.326 . . . . 0.0 111.373 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -83.85 149.91 26.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.539 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.836 HD22 ' NH2' ' A' ' 62' ' ' ARG . 0.2 OUTLIER -136.72 109.83 7.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.97 0.414 . . . . 0.0 111.273 -179.639 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.78 HG23 ' OE1' ' A' ' 102' ' ' GLN . 39.6 m -101.15 127.85 47.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.584 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.463 ' CZ ' ' HB3' ' A' ' 60' ' ' ARG . 29.5 m-85 -140.86 172.62 12.44 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.424 0.63 . . . . 0.0 112.327 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.495 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.4 OUTLIER -126.38 112.43 15.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.021 179.131 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.917 HG23 HD23 ' A' ' 103' ' ' LEU . 21.9 t -104.77 111.7 65.24 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -177.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.562 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 85.8 Cg_endo -83.3 127.64 4.6 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.431 2.087 . . . . 0.0 110.738 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.888 HD11 ' HB2' ' A' ' 96' ' ' ASN . 0.5 OUTLIER -121.54 27.99 7.95 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -178.893 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -39.86 -31.06 0.1 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.289 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -112.23 -32.04 6.66 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.163 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.516 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 12.6 t -70.51 -6.0 33.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.181 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.617 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -43.83 -29.85 1.48 Allowed Glycine 0 C--N 1.337 0.621 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.732 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.39 -36.09 22.68 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.971 0.415 . . . . 0.0 110.598 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.79 -6.71 59.49 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.377 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.25 -47.47 2.87 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.948 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.959 HD22 ' HE2' ' A' ' 91' ' ' MET . 6.8 tp 178.47 -29.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.589 0.233 . . . . 0.0 110.824 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.494 ' HA3' ' HA3' ' A' ' 53' ' ' GLY . . . 104.58 42.67 1.82 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.501 -0.857 . . . . 0.0 113.3 179.173 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.779 HG12 HG23 ' A' ' 49' ' ' ILE . 33.1 m -157.15 158.5 3.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.206 0.527 . . . . 0.0 111.988 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -117.1 118.03 31.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.208 178.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.626 HG11 HD11 ' A' ' 67' ' ' LEU . 2.5 m -106.35 149.61 9.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.228 0.537 . . . . 0.0 112.379 -178.4 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.404 ' HG2' ' CD ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -148.38 130.77 15.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.026 179.415 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' A' ' 44' ' ' ILE . . . -104.76 161.59 15.04 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.266 -0.969 . . . . 0.0 113.115 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 -130.67 170.93 13.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.968 0.413 . . . . 0.0 110.907 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.26 154.24 31.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.621 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.845 ' HA ' HD21 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -47.45 149.21 1.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.302 -179.884 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.42 -47.97 68.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.359 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.477 ' HG3' ' ND2' ' A' ' 38' ' ' ASN . 3.6 pt-20 -73.59 -50.07 23.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.328 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.477 ' ND2' ' HG3' ' A' ' 37' ' ' GLU . 1.4 p30 -121.14 168.36 11.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.746 0.308 . . . . 0.0 111.039 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -83.41 57.78 4.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.143 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.548 ' HB3' ' HB2' ' A' ' 35' ' ' SER . . . -103.04 109.49 21.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.765 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.404 ' HB3' ' ND2' ' A' ' 80' ' ' ASN . 37.4 m-20 -45.91 119.29 2.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.722 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.845 HD21 ' HA ' ' A' ' 35' ' ' SER . 8.8 mt -88.24 -1.3 57.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.009 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.426 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 106.91 -174.62 20.12 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.172 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.796 ' CG1' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -111.41 138.34 40.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.907 0.384 . . . . 0.0 111.284 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.71 141.5 49.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.629 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.672 ' O ' HG13 ' A' ' 63' ' ' VAL . 38.6 t -54.7 107.2 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.841 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.475 ' HD3' HD12 ' B' ' 10' ' ' ILE . 21.2 tptt -77.21 -41.47 41.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.627 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.6 m -167.5 123.91 1.13 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.06 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.779 HG23 HG12 ' A' ' 28' ' ' VAL . 69.3 mt -90.92 124.26 43.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.359 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.446 HD12 ' N ' ' A' ' 28' ' ' VAL . 2.1 mp -63.89 110.28 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.379 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.13 70.98 0.06 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.084 0.469 . . . . 0.0 110.892 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 166.98 -27.45 0.16 Allowed Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.111 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.494 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -70.04 -166.85 5.92 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.944 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.562 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -68.64 -41.09 79.89 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.711 ' HB1' HD22 ' A' ' 61' ' ' LEU . . . -66.65 -41.12 88.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.57 -179.154 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 t -70.07 -33.3 71.74 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.139 0.495 . . . . 0.0 110.116 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.3 mtpt -73.62 -29.05 62.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.076 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.78 -29.96 67.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.565 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 68.52 15.74 68.74 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.824 -0.703 . . . . 0.0 113.005 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.463 ' HB3' ' CZ ' ' A' ' 14' ' ' PHE . 0.5 OUTLIER -129.0 -0.72 5.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.764 0.282 . . . . 0.0 111.222 179.832 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.711 HD22 ' HB1' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -99.23 132.98 44.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.91 0.386 . . . . 0.0 111.18 -179.67 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.836 ' NH2' HD22 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -138.27 142.47 39.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.769 179.546 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.672 HG13 ' O ' ' A' ' 46' ' ' VAL . 55.0 t -56.41 147.04 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.175 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 29.9 m-20 89.76 -10.47 0.37 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.371 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -63.62 107.26 1.11 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.821 0.343 . . . . 0.0 110.729 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 21.4 tm0? -71.5 114.0 9.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.608 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.94 HD23 ' CG1' ' A' ' 105' ' ' VAL . 7.9 mt -68.07 142.7 55.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.958 0.408 . . . . 0.0 111.561 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.711 HD11 ' CB ' ' A' ' 106' ' ' ALA . 36.6 mt -129.18 -34.92 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.374 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.976 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -148.65 166.26 28.86 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.896 0.379 . . . . 0.0 111.288 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.631 HG22 ' ND2' ' A' ' 71' ' ' ASN . 12.3 p -155.19 118.85 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.903 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.631 ' ND2' HG22 ' A' ' 70' ' ' VAL . 68.5 m-80 56.72 43.82 24.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.556 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 70.93 23.54 77.94 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.722 -0.752 . . . . 0.0 111.966 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -122.55 97.37 5.43 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.778 0.323 . . . . 0.0 110.862 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.82 119.37 13.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.929 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.635 HD13 ' HB1' ' A' ' 83' ' ' ALA . 9.8 mt -72.27 -15.65 61.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.175 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 21.6 mt -52.2 93.13 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.892 0.377 . . . . 0.0 111.013 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 151.51 -24.16 0.95 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.415 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.5 ptpm? -111.93 167.75 10.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.165 0.507 . . . . 0.0 111.072 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.4 ' HB3' ' NE2' ' A' ' 81' ' ' GLN . . . -74.02 165.13 25.67 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.279 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.43 ' HB3' ' HA3' ' A' ' 32' ' ' GLY . 22.2 m-80 -52.29 -57.47 9.65 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.258 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.413 ' HA ' ' HG2' ' A' ' 84' ' ' MET . 2.6 pp0? -53.82 -38.75 64.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.399 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.85 -38.88 73.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.277 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.635 ' HB1' HD13 ' A' ' 75' ' ' LEU . . . -66.76 -47.88 70.82 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.746 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.498 ' HB3' HG21 ' A' ' 44' ' ' ILE . 5.0 ptp -63.13 -29.7 71.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.977 179.082 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.66 -32.36 47.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.385 178.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.444 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 1.4 m -69.03 -36.59 77.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.348 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.479 ' CD2' ' HA ' ' A' ' 84' ' ' MET . 4.4 pp -78.46 -33.82 48.13 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.75 ' HG3' HG12 ' B' ' 13' ' ' VAL . 1.1 ttt180 -58.4 -51.69 68.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.465 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.575 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.27 -33.88 67.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.195 179.814 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.435 ' HB2' ' O ' ' A' ' 86' ' ' THR . 5.3 t -70.45 -29.17 65.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.25 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.959 ' HE2' HD22 ' A' ' 26' ' ' LEU . 4.2 ptp -88.77 -20.27 24.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.533 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.75 39.57 3.93 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.165 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.575 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.5 OUTLIER -171.71 -22.22 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 179.696 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.479 ' HG3' HG22 ' A' ' 93' ' ' THR . 12.0 mt-10 -127.9 -59.0 1.21 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.91 0.386 . . . . 0.0 111.091 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.438 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -67.52 -25.28 73.87 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.998 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.888 ' HB2' HD11 ' A' ' 18' ' ' LEU . 1.3 t30 -78.44 -32.93 48.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.966 0.412 . . . . 0.0 110.24 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.497 ' HD3' ' O ' ' A' ' 93' ' ' THR . 10.5 mmmt -44.22 -40.14 4.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.258 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.63 -28.29 19.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.743 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 122.74 -7.43 9.51 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.951 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.495 ' SD ' ' HB3' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -157.05 143.45 18.14 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.061 0.458 . . . . 0.0 111.29 -179.709 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.91 HD11 HD11 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -113.94 146.99 17.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.188 -179.713 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.78 ' OE1' HG23 ' A' ' 13' ' ' THR . 1.2 tm0? -87.86 139.94 30.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.095 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.917 HD23 HG23 ' A' ' 16' ' ' VAL . 2.5 mm? -131.73 141.87 49.64 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.131 0.491 . . . . 0.0 112.046 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.976 HD12 ' HB3' ' A' ' 69' ' ' ALA . 73.5 mt -127.09 112.31 28.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.94 ' CG1' HD23 ' A' ' 67' ' ' LEU . 29.8 m -132.5 133.08 60.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.825 -178.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.711 ' CB ' HD11 ' A' ' 68' ' ' ILE . . . -108.93 139.48 43.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.254 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.655 ' CG ' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.991 0.424 . . . . 0.0 111.382 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.475 HD12 ' HD3' ' A' ' 47' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.453 -0.316 0 CA-C-O 120.893 0.378 . . . . 0.0 111.128 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 11' ' ' THR . . . . . 0.402 HG22 HG13 ' B' ' 13' ' ' VAL . 53.2 m -126.75 134.56 50.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.974 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.27 109.48 16.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.63 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.75 HG12 ' HG3' ' A' ' 88' ' ' ARG . 16.8 m . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.151 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 121.013 0.435 . . . . 0.0 111.596 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.4 ' CE2' HG12 ' A' ' 68' ' ' ILE . 13.6 m-85 -95.99 151.21 19.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.695 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.997 HD12 HG23 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -137.3 110.99 8.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.885 -179.757 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.635 HG23 ' OE1' ' A' ' 102' ' ' GLN . 97.2 m -97.6 130.63 44.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.639 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.463 ' CZ ' ' HB3' ' A' ' 12' ' ' LEU . 28.4 m-85 -140.87 172.47 12.64 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.26 0.553 . . . . 0.0 112.416 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.439 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.5 OUTLIER -126.98 111.7 14.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.051 179.086 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.906 HG23 HD23 ' A' ' 103' ' ' LEU . 34.3 t -104.26 116.66 60.97 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -177.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.523 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 89.7 Cg_endo -88.57 126.53 1.86 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.47 2.113 . . . . 0.0 110.846 178.194 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.815 HD11 ' HB2' ' A' ' 96' ' ' ASN . 0.3 OUTLIER -116.16 29.09 8.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.716 0.293 . . . . 0.0 111.547 -178.823 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -38.6 -31.72 0.06 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.434 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -112.2 -32.07 6.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.312 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 t -74.39 -5.49 42.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.181 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.782 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -43.88 -28.77 1.26 Allowed Glycine 0 C--N 1.336 0.561 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.942 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.1 p -88.26 -33.04 18.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.762 0.315 . . . . 0.0 110.897 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.47 9.02 28.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.531 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.62 -54.39 4.95 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.966 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.933 HD22 ' HE2' ' A' ' 91' ' ' MET . 8.4 tp -175.12 -36.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.628 0.252 . . . . 0.0 110.811 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.494 ' HA3' ' HA3' ' A' ' 53' ' ' GLY . . . 114.83 44.91 0.67 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.4 -0.905 . . . . 0.0 113.295 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.803 HG12 HG23 ' A' ' 49' ' ' ILE . 33.1 m -157.24 160.56 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.189 0.518 . . . . 0.0 111.727 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.42 ' O ' ' HB3' ' A' ' 47' ' ' LYS . 0.7 OUTLIER -117.44 110.3 17.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.31 178.774 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.618 HG11 HD11 ' A' ' 67' ' ' LEU . 4.3 m -106.9 137.97 35.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.949 0.404 . . . . 0.0 111.717 -178.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.505 ' CB ' HD13 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -141.46 129.63 22.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.431 179.452 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -89.23 156.92 26.47 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.539 -0.838 . . . . 0.0 113.055 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -128.29 145.22 51.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.827 0.346 . . . . 0.0 110.93 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 45.3 mtt85 -96.22 147.63 23.56 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.646 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.862 ' HA ' HD21 ' A' ' 42' ' ' LEU . 12.4 t -45.64 141.93 2.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.405 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -25.15 64.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.049 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -85.46 -72.18 0.5 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.8 0.333 . . . . 0.0 111.023 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.41 ' OD1' ' HB2' ' A' ' 40' ' ' ALA . 5.5 p30 -106.23 -162.45 0.86 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.744 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 53.5 m-70 -93.76 33.11 1.33 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.013 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.635 ' HB3' ' HB2' ' A' ' 35' ' ' SER . . . -73.48 105.46 4.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.977 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -54.6 106.46 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.154 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.862 HD21 ' HA ' ' A' ' 35' ' ' SER . 21.6 mt -67.79 -25.52 65.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.794 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.463 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 129.14 -178.63 17.2 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.06 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.691 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -104.23 133.05 49.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.911 0.386 . . . . 0.0 111.301 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -122.47 145.48 48.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.833 -179.935 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.724 ' O ' HG13 ' A' ' 63' ' ' VAL . 42.8 t -60.9 104.9 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.691 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.42 ' HB3' ' O ' ' A' ' 29' ' ' SER . 5.2 tppt? -76.68 -37.82 55.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.721 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.64 122.76 0.87 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.871 0.367 . . . . 0.0 111.422 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.803 HG23 HG12 ' A' ' 28' ' ' VAL . 63.9 mt -89.46 127.41 42.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.166 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.44 HD12 ' N ' ' A' ' 28' ' ' VAL . 1.6 mp -66.33 109.06 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.52 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.28 76.64 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.086 0.47 . . . . 0.0 110.33 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 159.76 -26.71 0.34 Allowed Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.494 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -76.81 174.47 54.18 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.367 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.662 ' HB1' HG12 ' A' ' 16' ' ' VAL . . . -47.19 -46.52 23.92 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.645 ' HB1' HD22 ' A' ' 61' ' ' LEU . . . -61.81 -38.18 87.15 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.735 0.303 . . . . 0.0 111.763 -178.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.7 t -70.45 -43.11 70.52 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.938 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.467 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -66.49 -25.94 66.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.995 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.815 ' OD1' HG13 ' A' ' 16' ' ' VAL . 0.5 OUTLIER -55.03 -52.88 61.78 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.83 0.347 . . . . 0.0 111.33 -179.711 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.87 4.71 69.18 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.401 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.446 ' HD2' ' CD1' ' A' ' 14' ' ' PHE . 1.3 mtm180 -122.15 0.96 9.69 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.761 0.315 . . . . 0.0 110.662 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.729 ' HB3' HD13 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -100.5 136.34 40.53 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.98 -179.807 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.33 143.99 29.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.844 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.724 HG13 ' O ' ' A' ' 46' ' ' VAL . 58.5 t -59.18 142.85 14.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.046 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 29.1 m-20 90.26 12.45 0.05 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.694 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.74 120.93 34.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.721 0.296 . . . . 0.0 110.274 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.413 ' O ' ' HA ' ' A' ' 105' ' ' VAL . 0.0 OUTLIER -78.05 137.18 38.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.7 -179.831 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.903 HD23 HG12 ' A' ' 105' ' ' VAL . 6.6 mt -93.52 140.95 29.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.024 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.603 HD12 ' HA ' ' A' ' 105' ' ' VAL . 4.5 mp -124.89 -41.44 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.393 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.943 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -139.17 151.03 46.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.018 0.437 . . . . 0.0 111.371 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.602 HG11 ' HA ' ' A' ' 87' ' ' LEU . 14.7 p -140.38 119.56 11.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.025 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 60.96 27.95 17.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.652 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.0 22.53 54.9 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.153 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -125.51 115.07 19.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.861 0.362 . . . . 0.0 110.78 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.5 p -60.22 149.96 31.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.129 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.612 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . 12.0 mt -115.55 -29.72 6.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.064 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.0 mt -51.6 -35.21 40.67 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.236 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.35 -21.38 47.86 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.335 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -120.64 162.14 20.17 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.367 0.603 . . . . 0.0 110.977 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.48 161.73 5.56 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.154 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.42 ' HB2' ' HA3' ' A' ' 32' ' ' GLY . 10.3 p30 -56.87 -43.81 81.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.158 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.417 ' N ' ' OD1' ' A' ' 80' ' ' ASN . 0.0 OUTLIER -64.58 -42.62 95.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.092 0.472 . . . . 0.0 110.55 179.781 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.68 -32.1 70.52 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.649 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.612 ' HB1' ' HB3' ' A' ' 75' ' ' LEU . . . -69.4 -49.04 58.98 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.685 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.611 ' HB3' HG21 ' A' ' 44' ' ' ILE . 6.9 ptp -59.64 -32.93 70.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.481 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -78.15 -31.28 49.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.22 0.533 . . . . 0.0 109.832 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.4 ' HA ' ' HD2' ' A' ' 89' ' ' ARG . 1.3 m -69.88 -36.44 75.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.521 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.851 HD12 ' N ' ' A' ' 88' ' ' ARG . 4.3 pp -78.77 -34.6 45.5 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.418 0.627 . . . . 0.0 109.478 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.851 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -61.11 -47.37 86.59 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.5 179.46 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.458 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -73.18 -43.27 61.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.424 179.544 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.3 p -61.36 -29.54 69.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.381 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.933 ' HE2' HD22 ' A' ' 26' ' ' LEU . 3.5 ptp -86.37 -34.93 20.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.84 -179.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -102.56 25.64 8.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.833 -179.132 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.552 HG23 ' HG2' ' A' ' 94' ' ' GLU . 0.5 OUTLIER -152.38 -36.66 0.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.796 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.552 ' HG2' HG23 ' A' ' 93' ' ' THR . 4.0 mt-10 -111.37 -60.04 1.89 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.813 0.34 . . . . 0.0 111.408 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.606 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -56.17 -27.31 51.89 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.378 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.815 ' HB2' HD11 ' A' ' 18' ' ' LEU . 2.6 t30 -77.09 -33.73 56.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.712 0.291 . . . . 0.0 110.565 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 94' ' ' GLU . 60.9 mtpt -39.33 -39.53 0.66 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.674 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.77 -27.28 13.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.191 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 121.75 -3.2 10.95 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.7 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.523 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -155.63 143.38 19.7 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.981 0.419 . . . . 0.0 111.257 -179.639 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.665 HD11 HD11 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -112.71 145.11 19.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.023 179.839 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.635 ' OE1' HG23 ' A' ' 13' ' ' THR . 1.3 tm0? -82.04 143.76 31.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.725 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.906 HD23 HG23 ' A' ' 16' ' ' VAL . 2.5 mm? -133.82 149.56 51.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.293 0.568 . . . . 0.0 112.008 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.943 HD12 ' HB3' ' A' ' 69' ' ' ALA . 74.7 mt -139.34 112.35 6.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.361 178.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.997 HG23 HD12 ' A' ' 12' ' ' LEU . 35.2 m -123.66 172.93 10.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.473 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -147.85 132.52 17.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.41 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.671 ' HG3' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.343 0 CA-C-O 120.919 0.39 . . . . 0.0 111.007 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.505 HD13 ' CB ' ' A' ' 31' ' ' LYS . 1.1 mm . . . . . 0 N--CA 1.453 -0.286 0 CA-C-O 121.181 0.515 . . . . 0.0 111.514 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 11' ' ' THR . . . . . 0.599 HG22 HG13 ' B' ' 13' ' ' VAL . 43.9 m -98.08 102.97 14.87 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.527 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.75 102.75 1.59 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.641 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.599 HG13 HG22 ' B' ' 11' ' ' THR . 34.8 m . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.175 -0.917 . . . . 0.0 111.247 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 . . . . . 0 C--O 1.233 0.234 0 CA-C-O 120.886 0.374 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.448 ' CE2' HD13 ' A' ' 68' ' ' ILE . 4.4 m-85 -100.51 147.07 26.31 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.516 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 1.083 HD12 HG23 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -139.51 121.43 15.57 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.958 0.408 . . . . 0.0 111.303 -179.783 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.3 m -94.74 142.7 27.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.249 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.506 ' O ' ' HA ' ' A' ' 102' ' ' GLN . 26.6 m-85 -142.03 172.64 12.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.975 0.417 . . . . 0.0 111.587 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.423 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.7 OUTLIER -132.27 107.63 8.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.55 179.219 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.971 HG23 HD23 ' A' ' 103' ' ' LEU . 32.2 t -104.3 114.36 64.32 Favored Pre-proline 0 C--N 1.33 -0.248 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -178.286 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.614 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 93.1 Cg_endo -84.58 128.12 3.92 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.645 2.23 . . . . 0.0 110.958 178.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.789 HD11 ' HB2' ' A' ' 96' ' ' ASN . 0.4 OUTLIER -122.26 28.78 7.29 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -178.856 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -39.37 -31.11 0.08 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.101 0.477 . . . . 0.0 111.15 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -112.94 -32.94 6.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.24 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.588 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 43.9 t -71.31 -6.62 41.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.174 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.71 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -44.23 -29.79 1.74 Allowed Glycine 0 C--N 1.336 0.567 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.692 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.21 -37.93 22.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.982 0.42 . . . . 0.0 110.553 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.29 -1.03 54.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.427 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.07 -48.91 3.91 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.879 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.005 HD22 ' HE2' ' A' ' 91' ' ' MET . 6.1 tp 179.78 -31.34 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.611 0.243 . . . . 0.0 110.553 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.449 ' HA2' HD13 ' A' ' 50' ' ' ILE . . . 105.96 48.31 1.02 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.297 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.785 HG12 HG23 ' A' ' 49' ' ' ILE . 20.0 m -157.08 163.97 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.164 0.506 . . . . 0.0 111.94 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.417 ' O ' ' HB3' ' A' ' 47' ' ' LYS . 49.7 m -124.7 117.37 24.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.238 178.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.785 HG11 HD11 ' A' ' 67' ' ' LEU . 4.4 m -111.58 145.62 17.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.079 0.466 . . . . 0.0 112.163 -178.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.492 ' HB3' HD13 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -143.81 130.25 19.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.37 179.331 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 44' ' ' ILE . . . -103.71 156.99 17.57 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.442 -0.885 . . . . 0.0 113.142 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.907 ' ND2' HD12 ' A' ' 42' ' ' LEU . 6.7 p-10 -105.16 178.21 4.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.909 0.385 . . . . 0.0 111.163 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -136.27 126.47 26.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.76 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.664 ' OG ' HD21 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -50.43 121.45 5.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.149 -179.752 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.46 -10.89 55.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.552 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -77.91 -64.39 1.17 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.734 0.302 . . . . 0.0 111.325 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.574 ' OD1' ' HB2' ' A' ' 40' ' ' ALA . 10.8 p30 -124.12 25.87 7.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.498 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 52.46 54.2 11.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.898 0.38 . . . . 0.0 111.153 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.574 ' HB2' ' OD1' ' A' ' 38' ' ' ASN . . . -110.3 120.86 43.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.989 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -48.06 118.56 2.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.3 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.907 HD12 ' ND2' ' A' ' 33' ' ' ASN . 21.3 mt -81.31 -28.29 34.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.62 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 138.53 173.96 13.21 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.494 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.876 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -101.68 153.5 5.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.869 0.366 . . . . 0.0 111.38 -180.0 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -140.19 141.75 35.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.662 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.747 ' O ' HG13 ' A' ' 63' ' ' VAL . 42.2 t -57.74 104.64 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.59 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.482 ' HD3' HD12 ' B' ' 10' ' ' ILE . 21.9 tptt -75.26 -41.49 57.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.749 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.97 124.52 1.08 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.857 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.803 HD13 ' HB3' ' A' ' 61' ' ' LEU . 77.2 mt -91.62 119.95 39.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.218 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.472 HD12 ' N ' ' A' ' 28' ' ' VAL . 1.7 mp -56.0 108.14 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.376 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.15 72.94 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.873 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 162.45 -26.95 0.24 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.176 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.422 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -69.86 -170.6 8.14 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.901 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.614 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -64.15 -41.49 97.15 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.953 ' HB1' HD13 ' A' ' 61' ' ' LEU . . . -62.87 -47.58 82.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.703 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.0 t -67.85 -29.04 68.08 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.497 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 37.4 mtpt -74.87 -32.31 61.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.151 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -61.18 -27.94 68.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.808 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 66.59 20.76 70.27 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.779 -0.724 . . . . 0.0 113.132 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.429 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 12.5 mtm180 -125.19 -16.57 5.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.778 0.323 . . . . 0.0 110.979 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.953 HD13 ' HB1' ' A' ' 55' ' ' ALA . 0.5 OUTLIER -88.27 135.53 33.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.195 -179.668 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.664 HH21 HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -143.16 137.87 29.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.692 179.671 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.747 HG13 ' O ' ' A' ' 46' ' ' VAL . 48.1 t -52.52 145.91 2.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.267 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.444 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 28.2 m-80 86.98 11.09 0.15 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.613 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.439 ' OD2' HG21 ' A' ' 105' ' ' VAL . 3.0 m-20 -91.82 115.69 28.27 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.435 ' O ' ' HA ' ' A' ' 105' ' ' VAL . 0.0 OUTLIER -72.89 128.97 37.06 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.779 -179.632 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.876 HD12 HG13 ' A' ' 44' ' ' ILE . 42.6 mt -83.09 152.2 25.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.772 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.474 HD11 ' CB ' ' A' ' 106' ' ' ALA . 30.6 mt -143.63 -40.98 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.637 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.743 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -138.12 158.5 44.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.83 0.348 . . . . 0.0 111.457 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.492 HG23 HD11 ' A' ' 101' ' ' ILE . 12.8 p -151.51 120.6 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.951 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.484 HD22 HG22 ' A' ' 70' ' ' VAL . 70.4 m-80 57.12 29.65 16.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.87 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.19 23.75 50.52 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.308 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -127.75 118.61 24.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.741 0.305 . . . . 0.0 110.753 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.8 t -70.65 150.19 46.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.115 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.499 HD22 ' HA ' ' A' ' 83' ' ' ALA . 22.5 mt -111.16 -19.34 12.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.102 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.8 tp -54.41 -21.99 11.25 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.32 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -91.2 28.74 7.71 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.863 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.413 ' HD2' ' HA ' ' A' ' 83' ' ' ALA . 8.6 ptpp? -164.81 152.04 11.22 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.27 0.557 . . . . 0.0 110.921 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.96 156.45 2.05 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.329 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -54.16 -47.85 71.52 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.044 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.42 -40.0 89.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.016 0.436 . . . . 0.0 110.635 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.1 -34.22 72.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.678 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.563 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -66.5 -50.6 62.71 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.366 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.429 ' HA ' ' CD2' ' A' ' 87' ' ' LEU . 6.9 ptp -60.67 -30.5 69.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.927 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -79.51 -32.94 42.44 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.412 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 2.1 m -68.08 -35.67 78.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.277 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.871 HD11 HG11 ' B' ' 13' ' ' VAL . 4.4 pp -78.31 -34.35 48.73 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.81 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -60.21 -52.14 66.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.655 179.293 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.481 ' O ' HG22 ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.5 -33.91 67.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.295 179.651 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.414 ' N ' ' HD3' ' A' ' 89' ' ' ARG . 24.0 t -71.6 -29.99 65.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.958 0.409 . . . . 0.0 110.424 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' MET . . . . . 1.005 ' HE2' HD22 ' A' ' 26' ' ' LEU . 1.5 ptp -89.2 -25.14 21.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.163 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.3 t -109.22 23.18 14.87 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.481 HG22 ' O ' ' A' ' 89' ' ' ARG . 0.5 OUTLIER -153.37 -36.19 0.11 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.902 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.455 ' HA ' ' HG3' ' A' ' 97' ' ' LYS . 4.1 mt-10 -107.61 -64.3 1.22 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.828 0.347 . . . . 0.0 111.346 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.545 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -52.92 -33.63 44.06 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.656 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.789 ' HB2' HD11 ' A' ' 18' ' ' LEU . 2.6 t30 -70.49 -34.78 72.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.702 0.287 . . . . 0.0 110.382 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.455 ' HG3' ' HA ' ' A' ' 94' ' ' GLU . 20.7 mtpt -38.23 -47.29 1.16 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.475 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.31 -25.32 19.49 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.662 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 118.97 -3.05 14.58 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.819 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.423 ' SD ' ' HB3' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -159.48 143.43 14.84 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.076 0.465 . . . . 0.0 111.383 -179.744 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.776 HD11 HD11 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -114.33 141.48 30.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.529 179.932 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.506 ' HA ' ' O ' ' A' ' 14' ' ' PHE . 2.2 pp0? -86.88 131.13 34.19 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.981 -0.287 . . . . 0.0 110.403 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.971 HD23 HG23 ' A' ' 16' ' ' VAL . 2.8 mm? -115.87 134.39 55.04 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.275 0.559 . . . . 0.0 112.114 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.743 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 96.7 mt -118.07 112.59 39.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.611 178.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 1.083 HG23 HD12 ' A' ' 12' ' ' LEU . 28.9 m -121.53 177.21 3.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.265 -179.242 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.474 ' CB ' HD11 ' A' ' 68' ' ' ILE . . . -147.29 139.18 24.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.826 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.566 ' HD2' HD21 ' A' ' 12' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.429 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.149 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.492 HD13 ' HB3' ' A' ' 31' ' ' LYS . 1.6 mm . . . . . 0 CA--C 1.521 -0.172 0 CA-C-O 121.135 0.493 . . . . 0.0 111.123 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 2.5 m -110.5 116.4 31.32 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.661 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 27.2 ttmt -78.13 109.2 12.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.925 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.871 HG11 HD11 ' A' ' 87' ' ' LEU . 17.3 m . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.277 -0.868 . . . . 0.0 111.275 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.921 0.391 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.689 ' HE2' HG21 ' A' ' 68' ' ' ILE . 11.0 m-85 -100.7 148.93 24.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.802 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.892 HD12 HG23 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -133.68 110.88 10.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.026 -179.838 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.842 HG23 ' OE1' ' A' ' 102' ' ' GLN . 89.3 m -96.1 132.47 41.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.577 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.436 ' CZ ' ' HB3' ' A' ' 12' ' ' LEU . 54.9 m-85 -140.73 172.43 12.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.301 0.572 . . . . 0.0 112.113 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.427 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.3 OUTLIER -129.07 112.09 13.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.152 179.174 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.932 HG23 HD23 ' A' ' 103' ' ' LEU . 34.8 t -103.19 112.2 65.58 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -178.145 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.768 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 84.2 Cg_endo -82.22 127.82 5.4 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.365 2.043 . . . . 0.0 110.886 178.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.866 HD22 ' CD1' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -122.62 28.52 7.3 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -178.724 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -39.12 -31.49 0.07 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.172 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -113.33 -32.83 6.14 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.282 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.716 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 46.7 t -70.96 -7.7 47.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.163 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.744 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -45.25 -28.46 2.09 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.744 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.8 p -85.27 -34.28 21.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.797 0.332 . . . . 0.0 110.563 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.66 7.21 31.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.526 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.03 -54.99 4.78 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.644 -0.789 . . . . 0.0 111.985 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.934 HD22 ' HE2' ' A' ' 91' ' ' MET . 9.8 tp -178.89 -32.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.592 0.234 . . . . 0.0 110.948 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 50' ' ' ILE . . . 114.47 31.91 2.07 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.381 -0.914 . . . . 0.0 113.413 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.809 HG12 HG23 ' A' ' 49' ' ' ILE . 33.7 m -150.83 161.01 3.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 117.164 0.482 . . . . 0.0 111.75 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.42 ' O ' ' N ' ' A' ' 47' ' ' LYS . 0.9 OUTLIER -122.41 118.16 27.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.556 178.942 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.828 HG11 HD11 ' A' ' 67' ' ' LEU . 3.3 m -110.77 141.67 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.9 0.381 . . . . 0.0 111.937 -178.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.56 ' CB ' HD13 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -140.66 130.54 24.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.545 179.397 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.56 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -90.94 160.75 27.6 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.397 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.454 ' ND2' ' CE1' ' A' ' 45' ' ' PHE . 89.3 m-20 -119.57 179.91 4.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.837 0.351 . . . . 0.0 110.915 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.59 155.66 40.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.624 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.801 ' CA ' HD21 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -57.14 140.49 49.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.063 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.2 mtmm -64.51 -28.25 69.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.984 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -84.96 -74.88 0.38 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.944 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -94.41 177.26 6.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.903 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -93.07 58.42 2.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.881 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -116.78 131.63 56.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.998 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -59.37 144.31 47.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.915 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.801 HD21 ' CA ' ' A' ' 35' ' ' SER . 17.0 mt -105.38 -30.98 9.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.862 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.56 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 148.51 -173.99 28.31 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.098 -0.572 . . . . 0.0 111.866 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.87 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -110.23 148.11 14.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 120.988 0.423 . . . . 0.0 111.735 -179.739 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.454 ' CE1' ' ND2' ' A' ' 33' ' ' ASN . 0.4 OUTLIER -134.4 138.43 44.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.557 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.604 ' O ' HG13 ' A' ' 63' ' ' VAL . 40.0 t -54.17 104.41 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.564 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.511 ' HG2' HG21 ' B' ' 10' ' ' ILE . 5.9 tptm -73.03 -43.01 62.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.841 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 m -168.18 125.02 1.07 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.107 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.809 HG23 HG12 ' A' ' 28' ' ' VAL . 62.7 mt -88.93 116.66 30.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.297 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.531 HD12 ' N ' ' A' ' 28' ' ' VAL . 1.9 mp -55.42 105.26 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.629 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.11 76.4 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.141 0.496 . . . . 0.0 110.588 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 158.95 -27.17 0.39 Allowed Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.907 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.45 -170.62 6.07 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.691 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.768 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -67.94 -38.58 83.0 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.779 ' HB1' HD13 ' A' ' 61' ' ' LEU . . . -67.66 -43.86 79.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.393 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.43 ' HB3' HG22 ' A' ' 49' ' ' ILE . 53.6 p -66.85 -33.28 75.25 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.204 0.526 . . . . 0.0 110.109 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -70.74 -33.53 70.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.171 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -58.05 -28.0 64.13 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.786 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.87 25.0 67.26 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.783 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.411 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 22.1 mtm180 -125.31 -24.22 4.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.812 0.339 . . . . 0.0 111.017 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.785 HD22 HG11 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -71.62 164.06 26.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.444 -179.729 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.461 ' N ' ' HD2' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -160.46 138.83 10.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.713 179.876 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.604 HG13 ' O ' ' A' ' 46' ' ' VAL . 37.0 t -70.5 144.75 13.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.594 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 25.4 m-20 88.75 -2.53 0.43 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.642 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.95 133.14 35.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.96 0.409 . . . . 0.0 110.599 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.63 139.02 33.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.692 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.954 HD23 HG12 ' A' ' 105' ' ' VAL . 28.7 mt -88.99 131.81 35.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.839 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.689 HG21 ' HE2' ' A' ' 11' ' ' PHE . 19.3 mm -113.13 -32.19 2.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.473 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.781 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -157.03 170.91 21.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.884 0.373 . . . . 0.0 111.585 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.433 HG11 ' HA ' ' A' ' 87' ' ' LEU . 7.3 p -158.17 127.39 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.767 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.3 m120 60.24 22.83 12.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.668 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.07 25.53 31.32 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.993 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -130.55 108.45 9.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.796 0.332 . . . . 0.0 110.831 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.418 ' HA ' ' HB2' ' A' ' 69' ' ' ALA . 33.2 t -71.23 138.27 49.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.087 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.777 HD22 ' HB1' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -98.57 -13.24 20.5 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.163 179.906 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.415 ' CD1' HG23 ' A' ' 68' ' ' ILE . 0.1 OUTLIER -52.82 94.7 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.913 0.387 . . . . 0.0 111.058 -179.906 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 145.3 -31.09 1.71 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.185 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -97.56 156.89 16.3 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.239 0.542 . . . . 0.0 110.903 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.12 139.45 28.58 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.33 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.9 p30 -50.63 -28.14 8.25 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.172 0.511 . . . . 0.0 109.927 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.4 ' O ' ' HG2' ' A' ' 84' ' ' MET . 0.7 OUTLIER -74.18 -42.04 60.49 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.013 178.958 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -70.11 -32.99 71.27 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.868 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.777 ' HB1' HD22 ' A' ' 75' ' ' LEU . . . -68.92 -45.46 70.8 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.487 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.434 ' HB3' HG21 ' A' ' 44' ' ' ILE . 6.5 ptp -63.49 -30.05 71.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.816 178.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -78.59 -33.46 47.51 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.502 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 3.4 m -68.34 -35.65 78.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.343 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.749 HD12 ' N ' ' A' ' 88' ' ' ARG . 4.4 pp -78.32 -33.83 48.99 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 178.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.749 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -60.23 -51.24 70.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.65 179.332 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.502 ' HD3' ' O ' ' A' ' 86' ' ' THR . 0.0 OUTLIER -72.26 -34.93 68.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.618 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.421 ' N ' ' HD3' ' A' ' 89' ' ' ARG . 24.7 p -72.92 -29.8 63.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.852 0.358 . . . . 0.0 110.735 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.934 ' HE2' HD22 ' A' ' 26' ' ' LEU . 1.7 ptm -88.85 -17.43 29.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.288 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.85 25.45 9.68 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.522 ' O ' ' HD3' ' A' ' 97' ' ' LYS . 0.4 OUTLIER -157.14 -31.97 0.08 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.458 ' HG3' HG22 ' A' ' 93' ' ' THR . 5.7 mt-10 -117.59 -35.56 3.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.856 0.36 . . . . 0.0 111.443 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.494 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -78.26 -31.25 47.62 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.614 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.771 ' HB2' HD11 ' A' ' 18' ' ' LEU . 1.8 t30 -75.29 -31.89 60.83 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.584 -0.308 . . . . 0.0 110.176 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.522 ' HD3' ' O ' ' A' ' 93' ' ' THR . 27.1 mmmt -39.54 -47.19 1.86 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.968 0.414 . . . . 0.0 111.096 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.92 -25.49 19.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.889 178.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 114.19 1.09 23.74 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.908 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.485 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -154.66 141.0 18.66 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 120.975 0.417 . . . . 0.0 111.197 -179.588 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.8 HD11 HD11 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -112.85 145.31 18.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.657 179.538 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.842 ' OE1' HG23 ' A' ' 13' ' ' THR . 1.3 tm0? -84.99 139.64 31.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.978 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.932 HD23 HG23 ' A' ' 16' ' ' VAL . 2.7 mm? -129.99 137.66 50.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.045 0.45 . . . . 0.0 111.801 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.781 HD12 ' HB3' ' A' ' 69' ' ' ALA . 72.6 mt -126.5 113.1 31.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.563 178.421 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.954 HG12 HD23 ' A' ' 67' ' ' LEU . 31.9 m -123.62 174.69 7.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.472 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -147.73 137.43 22.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.841 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.607 ' CG ' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.946 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.56 HD13 ' CB ' ' A' ' 31' ' ' LYS . 1.1 mm . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 121.413 0.625 . . . . 0.0 111.495 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 11' ' ' THR . . . . . 0.781 HG22 HG13 ' B' ' 13' ' ' VAL . 16.5 m -92.15 114.9 27.57 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.325 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -75.09 102.85 5.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.507 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.781 HG13 HG22 ' B' ' 11' ' ' THR . 30.0 m . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.726 -0.655 . . . . 0.0 110.532 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.791 0.329 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.625 ' CD1' ' HB2' ' A' ' 106' ' ' ALA . 30.3 m-85 -77.75 140.48 39.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.462 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.863 HD12 HG23 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -147.16 134.42 20.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.123 0.487 . . . . 0.0 111.238 -179.66 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.428 ' O ' ' CD1' ' A' ' 14' ' ' PHE . 25.4 m -92.63 150.8 20.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.295 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' ' 102' ' ' GLN . 15.5 m-85 -140.08 170.37 15.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.105 0.479 . . . . 0.0 111.683 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -143.43 104.95 4.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.096 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.768 HG21 HD11 ' A' ' 61' ' ' LEU . 20.7 t -109.49 110.86 59.79 Favored Pre-proline 0 CA--C 1.531 0.226 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -177.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.728 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 91.2 Cg_endo -82.49 128.11 5.3 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.527 2.151 . . . . 0.0 110.736 178.026 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.862 HD22 ' CD1' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -121.82 29.5 7.09 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -178.582 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.417 ' ND2' ' OD2' ' A' ' 20' ' ' ASP . 6.7 p-10 -40.92 -31.7 0.19 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.103 0.478 . . . . 0.0 111.031 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.417 ' OD2' ' ND2' ' A' ' 19' ' ' ASN . 23.6 m-20 -111.32 -33.65 6.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.203 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.736 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 29.9 t -70.52 -8.55 52.12 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.111 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.707 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -44.96 -28.05 1.66 Allowed Glycine 0 C--N 1.337 0.613 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.691 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -85.69 -33.44 21.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.834 0.349 . . . . 0.0 110.737 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.37 8.33 28.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.441 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.96 -55.64 4.99 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.629 -0.795 . . . . 0.0 111.908 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.862 ' CD1' HD22 ' A' ' 18' ' ' LEU . 10.2 tp -179.0 -34.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.601 0.239 . . . . 0.0 111.12 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.4 ' HA3' ' HA3' ' A' ' 53' ' ' GLY . . . 115.79 35.02 1.31 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.537 -0.839 . . . . 0.0 113.295 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.736 HG12 HG23 ' A' ' 49' ' ' ILE . 34.2 m -156.3 162.2 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.282 0.563 . . . . 0.0 112.082 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -122.65 116.4 23.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.179 178.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.67 HG11 HD11 ' A' ' 67' ' ' LEU . 3.4 m -106.56 146.35 13.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.143 0.497 . . . . 0.0 111.938 -178.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.528 ' HB3' HD13 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -143.34 131.08 21.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.58 179.705 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' A' ' 44' ' ' ILE . . . -97.32 145.69 17.95 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.697 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.555 ' ND2' ' CE1' ' A' ' 45' ' ' PHE . 72.9 m-20 -107.84 -179.17 3.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.828 0.347 . . . . 0.0 111.028 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.4 mtt180 -134.53 156.12 49.2 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.691 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.462 ' HA ' HD21 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -48.92 150.97 1.34 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.194 -179.947 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -66.48 -40.33 89.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.116 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -108.24 -35.46 6.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.127 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -91.67 168.94 11.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.925 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 -103.25 31.03 4.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.79 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.66 129.5 44.73 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.089 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.436 ' CB ' ' ND2' ' A' ' 80' ' ' ASN . 1.7 p30 -57.1 142.27 43.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.079 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.462 HD21 ' HA ' ' A' ' 35' ' ' SER . 24.2 mt -104.06 12.6 33.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.11 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.423 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 98.47 170.67 31.8 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.586 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.88 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -102.02 135.78 37.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.851 0.358 . . . . 0.0 110.995 179.831 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.555 ' CE1' ' ND2' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -121.02 141.33 50.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.792 -179.834 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.635 ' O ' HG13 ' A' ' 63' ' ' VAL . 46.7 t -56.35 104.64 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.638 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.44 ' HG2' HD12 ' B' ' 10' ' ' ILE . 0.9 OUTLIER -74.9 -40.94 60.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.758 -179.753 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.0 p -166.9 124.72 1.31 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.162 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.736 HG23 HG12 ' A' ' 28' ' ' VAL . 67.6 mt -91.25 111.86 24.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.059 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.629 HD12 ' N ' ' A' ' 28' ' ' VAL . 2.1 mp -51.8 106.41 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.801 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.34 75.52 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.023 0.44 . . . . 0.0 110.675 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 162.56 -29.99 0.28 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.082 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.4 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -66.61 -170.43 3.93 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.686 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.736 ' HB2' ' HB3' ' A' ' 21' ' ' SER . . . -68.54 -38.18 80.59 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.649 ' HB3' HG13 ' A' ' 28' ' ' VAL . . . -66.84 -45.04 79.46 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.455 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.632 ' OG ' HG22 ' A' ' 49' ' ' ILE . 0.4 OUTLIER -66.21 -34.8 78.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.27 0.557 . . . . 0.0 109.861 179.341 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.7 mtpt -68.47 -30.33 69.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.947 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.41 ' OD1' ' CD ' ' A' ' 17' ' ' PRO . 0.8 OUTLIER -64.09 -25.87 68.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.944 179.753 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.01 26.18 65.27 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.643 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.7 mtm180 -122.26 -34.79 3.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.968 0.413 . . . . 0.0 110.769 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.768 HD11 HG21 ' A' ' 16' ' ' VAL . 2.1 mp -66.74 141.86 57.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.473 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -138.45 134.22 33.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.269 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.635 HG13 ' O ' ' A' ' 46' ' ' VAL . 46.3 t -59.51 145.36 11.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.014 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.444 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 22.3 m-20 87.85 -7.3 0.58 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.392 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -76.07 125.66 29.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.787 0.327 . . . . 0.0 110.766 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.435 ' HG3' ' CE2' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -81.51 140.48 34.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.916 -179.906 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.911 HD23 HG12 ' A' ' 105' ' ' VAL . 30.8 mt -87.17 139.57 30.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.924 0.392 . . . . 0.0 111.183 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 19.6 mm -120.65 -31.52 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.241 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 1.012 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -161.72 134.73 6.18 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.973 0.416 . . . . 0.0 111.573 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.476 HG23 HD11 ' A' ' 101' ' ' ILE . 7.5 p -121.57 129.36 75.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.366 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.43 ' ND2' ' O ' ' A' ' 90' ' ' SER . 9.3 m-80 64.95 13.96 8.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.538 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.77 -14.72 53.03 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.005 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.639 ' OE1' HG23 ' A' ' 86' ' ' THR . 5.7 pt-20 -99.27 125.64 44.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.879 0.371 . . . . 0.0 111.07 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 21.3 p -75.04 165.1 25.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.901 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.515 HD22 ' HB1' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -128.9 4.38 5.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.267 -179.828 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.88 -41.43 78.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.909 0.385 . . . . 0.0 110.934 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.23 -25.84 73.49 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.691 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.431 ' HD2' ' HA ' ' A' ' 83' ' ' ALA . 1.3 ptpm? -101.7 166.78 10.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.287 0.565 . . . . 0.0 111.179 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.24 168.04 20.41 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.189 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.489 ' HB2' ' HA3' ' A' ' 32' ' ' GLY . 7.2 p30 -58.66 -50.48 73.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.055 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.421 ' N ' ' OD1' ' A' ' 80' ' ' ASN . 0.0 OUTLIER -58.84 -39.69 82.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.116 0.484 . . . . 0.0 110.516 179.942 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.13 -34.48 73.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.9 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.55 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -69.03 -47.66 64.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.785 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.498 ' HB3' HG21 ' A' ' 44' ' ' ILE . 5.6 ptp -61.93 -31.52 71.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.205 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.07 -33.8 65.86 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.639 HG23 ' OE1' ' A' ' 73' ' ' GLU . 1.8 m -64.66 -33.91 77.04 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.26 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.62 HD13 HD13 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -76.02 -36.02 59.3 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.099 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.58 ' HG3' HG11 ' B' ' 13' ' ' VAL . 0.0 OUTLIER -59.14 -51.99 67.62 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.843 179.51 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.5 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.42 -44.86 61.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.429 179.665 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.43 ' O ' ' ND2' ' A' ' 71' ' ' ASN . 40.4 p -64.23 -30.38 71.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.489 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.808 ' HE2' HD22 ' A' ' 26' ' ' LEU . 2.1 ptm -89.01 -22.29 23.06 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.683 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.26 28.87 8.31 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.5 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.3 OUTLIER -164.96 -23.15 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -179.664 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.453 ' HG3' HG22 ' A' ' 93' ' ' THR . 8.7 mt-10 -122.06 -54.96 1.9 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.893 0.378 . . . . 0.0 111.317 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.446 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -66.59 -26.6 72.91 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.016 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.733 ' HB2' HD11 ' A' ' 18' ' ' LEU . 3.7 t30 -77.86 -36.04 50.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.834 0.349 . . . . 0.0 110.207 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.48 ' HD3' ' O ' ' A' ' 93' ' ' THR . 25.8 mmmt -45.46 -43.04 11.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.969 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.08 -24.53 22.26 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.51 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 111.61 1.9 27.46 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.856 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.546 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -165.17 140.23 5.16 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 121.172 0.51 . . . . 0.0 111.744 -179.818 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.554 HG22 HD21 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -114.38 133.54 60.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.902 179.932 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.462 ' HA ' ' O ' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -76.72 150.2 36.29 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.992 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.421 HD12 HG23 ' A' ' 16' ' ' VAL . 0.5 OUTLIER -138.79 112.82 8.57 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.919 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 1.012 HD12 ' HB3' ' A' ' 69' ' ' ALA . 32.6 mt -98.86 112.84 31.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.911 HG12 HD23 ' A' ' 67' ' ' LEU . 34.5 m -128.25 161.92 35.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.942 0.401 . . . . 0.0 111.48 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.625 ' HB2' ' CD1' ' A' ' 11' ' ' PHE . . . -123.55 120.38 32.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.558 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.86 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.528 HD13 ' HB3' ' A' ' 31' ' ' LYS . 1.4 mm . . . . . 0 CA--C 1.52 -0.204 0 CA-C-O 121.254 0.549 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 55.9 m -70.51 102.82 2.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.578 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.6 120.07 20.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.92 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.58 HG11 ' HG3' ' A' ' 88' ' ' ARG . 11.1 m . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.151 -0.928 . . . . 0.0 110.818 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.445 ' OE2' HD21 ' A' ' 12' ' ' LEU . 7.3 pt-20 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.953 0.406 . . . . 0.0 111.063 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -94.61 147.46 23.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.604 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.786 HD12 HG23 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -134.23 110.17 9.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.363 -179.711 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 76.5 m -96.59 130.25 43.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.282 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.438 ' CZ ' ' HB3' ' A' ' 12' ' ' LEU . 32.0 m-85 -140.21 172.37 12.84 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.467 0.651 . . . . 0.0 112.249 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.47 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.2 OUTLIER -128.93 111.71 13.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.328 179.354 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.9 HG23 HD23 ' A' ' 103' ' ' LEU . 8.8 t -103.39 117.17 60.77 Favored Pre-proline 0 C--N 1.33 -0.274 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -178.115 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.53 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 80.7 Cg_endo -86.36 127.22 2.83 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.461 2.108 . . . . 0.0 111.184 178.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.849 HD11 ' HB2' ' A' ' 96' ' ' ASN . 0.4 OUTLIER -119.04 28.12 8.45 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -178.989 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -39.23 -30.76 0.06 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.209 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -114.63 -31.27 6.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.138 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.439 ' CB ' ' HB2' ' A' ' 54' ' ' ALA . 1.9 t -72.15 -7.6 50.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.095 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.629 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -44.74 -28.49 1.67 Allowed Glycine 0 C--N 1.337 0.602 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.741 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.73 -35.43 20.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.8 0.333 . . . . 0.0 110.824 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.21 8.74 25.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.455 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.87 -54.39 4.95 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.92 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.996 HD22 ' HE2' ' A' ' 91' ' ' MET . 8.8 tp -178.03 -36.1 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.636 0.255 . . . . 0.0 110.657 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.472 ' HA3' ' HA3' ' A' ' 53' ' ' GLY . . . 115.66 41.13 0.81 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.378 -0.915 . . . . 0.0 113.373 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.808 HG12 HG23 ' A' ' 49' ' ' ILE . 14.2 m -156.93 157.69 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 117.147 0.474 . . . . 0.0 111.917 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.422 ' O ' ' HB3' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -116.38 117.2 29.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.279 178.596 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.477 HG11 HD11 ' A' ' 67' ' ' LEU . 2.5 m -110.33 148.24 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.148 0.499 . . . . 0.0 112.159 -178.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.541 ' HB3' HD13 ' B' ' 10' ' ' ILE . 0.2 OUTLIER -147.82 129.67 15.24 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.292 179.28 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.488 ' HA2' ' HA ' ' A' ' 44' ' ' ILE . . . -90.57 163.65 29.96 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.43 -179.208 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.408 ' HB2' ' CZ ' ' A' ' 45' ' ' PHE . 2.5 m120 -124.2 179.15 5.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.819 0.343 . . . . 0.0 110.637 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 11.0 ttm180 -135.15 148.75 49.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.574 ' CA ' HD21 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -55.84 128.84 36.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.917 -179.88 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.23 -28.77 69.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.139 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -80.02 -62.83 1.56 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.875 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -117.05 164.64 14.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.831 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -75.05 63.05 1.21 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.939 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -119.56 117.82 29.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.061 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -51.08 142.71 11.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.174 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.574 HD21 ' CA ' ' A' ' 35' ' ' SER . 23.0 mt -107.86 -2.16 20.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.341 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.414 ' HA3' ' NE2' ' A' ' 66' ' ' GLN . . . 111.0 179.93 20.16 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.326 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.768 ' CG1' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -109.27 139.4 32.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.978 0.418 . . . . 0.0 111.491 -179.824 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.42 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -120.47 144.84 47.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.589 179.952 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.57 ' O ' HG13 ' A' ' 63' ' ' VAL . 35.7 t -62.93 104.44 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.677 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.437 ' HD3' HD12 ' B' ' 10' ' ' ILE . 10.8 tptt -69.8 -45.4 68.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.813 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -167.88 127.91 1.34 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.009 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.808 HG23 HG12 ' A' ' 28' ' ' VAL . 61.8 mt -90.17 122.44 41.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.056 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.541 HD12 ' N ' ' A' ' 28' ' ' VAL . 1.8 mp -61.36 110.08 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.247 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -65.19 75.73 0.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.02 0.438 . . . . 0.0 110.597 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 160.67 -28.33 0.32 Allowed Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.807 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.472 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -74.65 167.53 54.77 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.798 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.53 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -40.76 -45.33 2.41 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.746 ' HB1' HD22 ' A' ' 61' ' ' LEU . . . -61.6 -42.36 98.76 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.178 -0.465 . . . . 0.0 112.164 -178.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.432 ' OG ' HG22 ' A' ' 49' ' ' ILE . 0.4 OUTLIER -74.23 -24.69 59.35 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.021 0.439 . . . . 0.0 110.588 -179.718 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.423 ' HG3' ' HA ' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -77.53 -34.39 53.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.795 -179.894 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -60.33 -33.81 72.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.727 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.78 22.09 79.28 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.811 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.437 ' HB3' ' CG ' ' A' ' 14' ' ' PHE . 17.4 mtm180 -125.19 -20.1 4.95 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.777 0.322 . . . . 0.0 111.08 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.78 HD11 HG21 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -77.39 138.81 39.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.979 0.418 . . . . 0.0 111.295 -179.771 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.411 ' NH2' HD13 ' A' ' 12' ' ' LEU . 0.1 OUTLIER -136.82 139.92 42.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.417 179.9 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.57 HG13 ' O ' ' A' ' 46' ' ' VAL . 41.7 t -67.74 144.03 14.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.066 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.503 ' HB2' ' O ' ' A' ' 63' ' ' VAL . 22.2 m120 83.4 8.12 0.65 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.119 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.489 ' OD2' HG21 ' A' ' 105' ' ' VAL . 6.9 t0 -84.83 126.05 33.12 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.158 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.414 ' NE2' ' HA3' ' A' ' 43' ' ' GLY . 1.2 tt0 -78.15 131.93 37.42 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.734 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.914 HD23 HG12 ' A' ' 105' ' ' VAL . 14.4 mt -87.28 141.41 28.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.749 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.75 HD11 ' HB2' ' A' ' 106' ' ' ALA . 22.6 mt -124.91 -36.87 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.494 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.72 ' HB3' ' CD1' ' A' ' 104' ' ' ILE . . . -153.29 145.47 23.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.047 0.451 . . . . 0.0 111.666 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.71 HG11 ' HA ' ' A' ' 87' ' ' LEU . 14.9 p -133.54 130.25 56.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.588 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.526 HD22 ' CA ' ' A' ' 95' ' ' GLY . 3.0 m120 63.2 18.48 11.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.692 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.48 25.27 36.54 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.663 -0.779 . . . . 0.0 111.728 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -133.03 104.11 6.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.873 0.368 . . . . 0.0 110.633 -179.538 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 0.4 OUTLIER -62.95 157.23 22.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.231 -179.712 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.623 HD22 ' HB1' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -123.95 9.49 8.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.104 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.43 -25.61 67.33 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.848 0.356 . . . . 0.0 110.984 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -94.52 25.65 21.82 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.613 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.461 ' HD2' ' HA ' ' A' ' 83' ' ' ALA . 0.5 OUTLIER -151.34 160.71 43.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.25 0.548 . . . . 0.0 111.213 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.47 ' HB1' ' OE1' ' A' ' 81' ' ' GLN . . . -65.08 158.63 25.27 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.104 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.459 ' HB2' ' HA3' ' A' ' 32' ' ' GLY . 7.8 p30 -57.35 -47.73 80.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.311 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.47 ' OE1' ' HB1' ' A' ' 79' ' ' ALA . 5.8 pm0 -58.51 -37.98 76.74 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.996 0.427 . . . . 0.0 110.776 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.406 ' HB3' ' HD3' ' A' ' 78' ' ' LYS . 3.7 mm-40 -70.67 -38.08 73.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.998 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.623 ' HB1' HD22 ' A' ' 75' ' ' LEU . . . -67.24 -46.16 74.59 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.823 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.502 ' HB3' HG21 ' A' ' 44' ' ' ILE . 5.5 ptp -64.26 -29.66 70.75 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -81.09 -30.28 34.69 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.425 178.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.494 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 7.3 m -71.58 -35.08 70.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.209 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.859 HD12 ' N ' ' A' ' 88' ' ' ARG . 4.2 pp -78.44 -34.29 47.93 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.859 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -59.5 -52.0 67.43 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.628 179.203 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.548 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.82 -33.62 66.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.017 179.474 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.448 ' N ' ' HD3' ' A' ' 89' ' ' ARG . 49.5 m -70.5 -29.79 66.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.486 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.996 ' HE2' HD22 ' A' ' 26' ' ' LEU . 2.9 ptp -86.41 -23.38 26.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.248 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.5 33.12 5.76 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.548 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.4 OUTLIER -162.91 -28.35 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.498 ' HG3' HG22 ' A' ' 93' ' ' THR . 5.3 mt-10 -122.62 -37.27 2.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.912 0.387 . . . . 0.0 111.196 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.526 ' CA ' HD22 ' A' ' 71' ' ' ASN . . . -82.27 -33.06 26.88 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.458 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.849 ' HB2' HD11 ' A' ' 18' ' ' LEU . 1.9 t30 -72.83 -33.25 66.04 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.469 ' HD3' ' O ' ' A' ' 93' ' ' THR . 10.5 mmmt -40.56 -46.12 2.44 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.098 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.8 -24.31 20.36 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.816 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 118.32 -4.91 15.42 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.784 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.47 ' SD ' ' HB3' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -156.03 143.99 19.7 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.935 0.398 . . . . 0.0 111.097 -179.748 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.858 HD11 HD11 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -111.76 145.28 18.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.225 -179.643 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.643 ' O ' HD13 ' A' ' 103' ' ' LEU . 2.1 tt0 -86.24 142.55 28.49 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.128 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.9 HD23 HG23 ' A' ' 16' ' ' VAL . 2.8 mm? -133.77 139.23 46.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.1 0.476 . . . . 0.0 111.749 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.72 ' CD1' ' HB3' ' A' ' 69' ' ' ALA . 7.4 mt -126.99 112.62 29.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.506 178.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.914 HG12 HD23 ' A' ' 67' ' ' LEU . 32.6 m -125.41 176.02 6.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.513 -179.002 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.75 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -147.65 136.55 22.07 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.865 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.564 ' HD2' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-O 120.912 0.387 . . . . 0.0 111.212 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.541 HD13 ' HB3' ' A' ' 31' ' ' LYS . 3.3 mm . . . . . 0 N--CA 1.453 -0.302 0 CA-C-O 120.994 0.426 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 7.9 m -120.72 113.97 20.98 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.958 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.12 131.61 42.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.591 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.436 ' CG1' ' HG3' ' A' ' 88' ' ' ARG . 10.4 m . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.316 -0.85 . . . . 0.0 111.304 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.912 0.387 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.506 ' CE2' HD13 ' A' ' 68' ' ' ILE . 37.3 m-85 -74.92 144.42 43.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.214 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.839 HD12 HG23 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -145.49 109.86 4.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.034 0.445 . . . . 0.0 111.644 -179.415 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.437 ' O ' ' CD1' ' A' ' 14' ' ' PHE . 11.8 m -81.09 141.4 34.35 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.706 178.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.448 ' CD2' ' CD2' ' A' ' 61' ' ' LEU . 19.5 m-85 -136.38 171.84 13.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.414 0.626 . . . . 0.0 112.595 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -143.05 102.29 3.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.242 178.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.603 HG21 HD13 ' A' ' 103' ' ' LEU . 40.4 t -104.39 106.77 55.49 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -177.095 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.791 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 5.3 Cg_exo -77.89 127.69 8.77 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.492 2.128 . . . . 0.0 110.623 178.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.871 HD22 ' CD1' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -125.78 28.93 6.05 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.748 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -38.96 -33.11 0.1 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.15 0.5 . . . . 0.0 111.139 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -108.82 -34.07 6.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.071 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.739 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 4.7 t -69.3 -8.3 44.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.056 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.796 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -42.44 -30.52 0.86 Allowed Glycine 0 C--N 1.337 0.619 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.837 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.2 p -82.88 -39.98 20.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.859 0.361 . . . . 0.0 110.438 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -78.63 -3.31 43.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.407 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.87 -50.75 2.87 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.005 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.924 HD22 ' HE2' ' A' ' 91' ' ' MET . 10.2 tp -179.13 -35.28 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.708 0.29 . . . . 0.0 110.785 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.423 ' C ' HD12 ' A' ' 50' ' ' ILE . . . 113.83 31.03 2.4 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.535 -0.84 . . . . 0.0 113.271 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.798 HG12 HG23 ' A' ' 49' ' ' ILE . 27.8 m -150.07 154.0 9.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.045 0.45 . . . . 0.0 112.0 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.41 ' O ' ' HB3' ' A' ' 47' ' ' LYS . 0.9 OUTLIER -111.02 115.61 29.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.315 178.627 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.867 HG11 HD11 ' A' ' 67' ' ' LEU . 3.1 m -108.23 142.4 20.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.046 0.45 . . . . 0.0 111.9 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.567 ' HB3' HD13 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -144.67 131.17 19.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.15 179.556 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -92.01 157.82 24.48 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.478 -0.867 . . . . 0.0 113.351 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -117.33 -176.76 3.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.723 0.297 . . . . 0.0 110.693 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.21 152.15 47.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.684 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.16 139.51 52.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.102 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.22 -29.22 70.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.999 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -83.85 -70.41 0.57 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.998 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 34.2 p30 -100.78 -174.83 2.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.978 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -93.59 45.68 1.17 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.948 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.23 114.3 26.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.082 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -56.07 133.14 51.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.002 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 47.7 mt -94.34 16.94 13.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.274 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.465 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 86.99 179.14 48.87 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.367 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.918 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -103.89 136.26 37.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 120.933 0.397 . . . . 0.0 111.251 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -123.98 147.77 47.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.713 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.728 ' O ' HG13 ' A' ' 63' ' ' VAL . 43.0 t -58.33 105.04 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.796 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.462 ' HG2' HG21 ' B' ' 10' ' ' ILE . 4.0 tptt -75.88 -40.59 54.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.689 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -168.8 115.16 0.62 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.207 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.798 HG23 HG12 ' A' ' 28' ' ' VAL . 52.9 mt -81.31 118.75 29.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.206 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.52 HD12 ' N ' ' A' ' 28' ' ' VAL . 2.0 mp -59.07 104.9 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.565 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.47 76.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.037 0.446 . . . . 0.0 110.615 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 159.82 -27.35 0.35 Allowed Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.022 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.402 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -69.06 -170.03 6.46 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.473 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.791 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -68.67 -39.14 80.76 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.783 ' HB3' HG13 ' A' ' 28' ' ' VAL . . . -65.96 -46.34 78.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.158 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 40.1 p -63.38 -35.38 80.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.215 0.531 . . . . 0.0 109.878 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.0 mtpt -66.68 -32.14 73.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.816 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.24 -30.3 64.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.461 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.66 27.49 66.38 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.836 -0.62 . . . . 0.0 113.406 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.431 ' HG3' ' CD1' ' A' ' 14' ' ' PHE . 15.8 ptp180 -134.85 1.74 3.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 117.162 0.481 . . . . 0.0 111.592 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.448 ' CD2' ' CD2' ' A' ' 14' ' ' PHE . 3.4 mm? -108.85 152.19 25.24 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.9 0.381 . . . . 0.0 111.06 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.44 145.48 26.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.785 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.728 HG13 ' O ' ' A' ' 46' ' ' VAL . 60.1 t -52.96 144.32 3.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.07 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.486 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 37.9 m-20 93.37 -14.11 0.14 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.331 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -60.99 110.0 1.23 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.767 0.317 . . . . 0.0 110.726 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.435 ' HG3' ' CE2' ' A' ' 45' ' ' PHE . 0.8 OUTLIER -75.34 111.24 10.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.999 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.945 HD23 HG12 ' A' ' 105' ' ' VAL . 42.6 mt -61.02 136.97 58.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.003 0.43 . . . . 0.0 111.085 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 1.045 HD11 ' HB2' ' A' ' 106' ' ' ALA . 29.9 mt -119.84 -34.78 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.139 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.955 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -155.4 143.84 20.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.457 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.64 HG11 ' HA ' ' A' ' 87' ' ' LEU . 7.4 p -133.04 132.04 58.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.431 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 61.88 26.21 15.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.927 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.44 24.43 63.15 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.312 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -129.98 103.86 7.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.853 0.358 . . . . 0.0 110.82 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.6 t -57.23 141.07 47.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.888 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.474 ' HB3' ' CB ' ' A' ' 83' ' ' ALA . 0.7 OUTLIER -101.23 3.19 40.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.572 -179.753 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.2 tp -63.76 -15.79 59.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.574 0.226 . . . . 0.0 111.304 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -88.92 14.34 60.66 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.127 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.41 ' CE ' HD23 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -156.52 177.34 11.58 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.251 0.548 . . . . 0.0 111.333 179.851 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.801 ' HB3' ' OE1' ' A' ' 81' ' ' GLN . . . -81.62 174.05 11.76 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.748 -179.054 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.402 ' OD1' ' N ' ' A' ' 81' ' ' GLN . 7.3 p30 -60.13 -51.52 69.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.347 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.801 ' OE1' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -60.64 -38.48 84.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.873 0.368 . . . . 0.0 110.619 -179.754 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.3 -40.04 74.47 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.52 ' HB3' ' CD1' ' A' ' 44' ' ' ILE . . . -69.56 -30.91 68.81 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.873 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.638 ' SD ' HG23 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -72.58 -33.26 66.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.73 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.403 ' HG2' ' N ' ' A' ' 86' ' ' THR . 1.9 pt-20 -78.07 -30.38 49.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.114 0.483 . . . . 0.0 109.775 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.403 ' N ' ' HG2' ' A' ' 85' ' ' GLU . 1.5 m -70.65 -35.96 73.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.361 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.865 HD12 ' N ' ' A' ' 88' ' ' ARG . 4.3 pp -78.58 -34.85 46.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.401 0.62 . . . . 0.0 109.472 178.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.865 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -62.49 -51.46 67.36 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.272 179.368 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.508 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -71.82 -35.42 69.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.119 179.602 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.7 m -67.23 -35.61 79.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.926 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.924 ' HE2' HD22 ' A' ' 26' ' ' LEU . 3.5 ptp -83.92 -27.98 28.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.868 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.13 23.58 14.28 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.508 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.4 OUTLIER -155.38 -32.18 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.42 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 5.0 mt-10 -112.94 -65.49 1.18 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.916 0.389 . . . . 0.0 111.513 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.498 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -54.2 -27.57 39.56 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.575 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.54 ' HB2' HD11 ' A' ' 18' ' ' LEU . 1.6 t30 -77.49 -32.79 54.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.692 0.282 . . . . 0.0 110.59 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' A' ' 93' ' ' THR . 40.6 mtpt -41.49 -40.06 1.7 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.005 0.431 . . . . 0.0 111.521 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.77 -25.24 15.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.182 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 117.33 1.55 18.3 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.788 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.499 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -158.36 142.04 15.35 Favored 'General case' 0 N--CA 1.457 -0.089 0 CA-C-O 121.07 0.462 . . . . 0.0 111.845 -179.568 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.591 HG22 HD21 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -115.62 136.25 53.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.6 179.496 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.448 ' HA ' ' O ' ' A' ' 14' ' ' PHE . 2.0 pp0? -76.55 140.85 41.26 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.718 HD11 HD21 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -134.8 112.59 10.84 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -178.715 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.955 HD12 ' HB3' ' A' ' 69' ' ' ALA . 43.1 mt -98.3 112.67 30.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.059 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.945 HG12 HD23 ' A' ' 67' ' ' LEU . 35.7 m -124.81 143.14 39.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.978 0.418 . . . . 0.0 111.462 -178.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 1.045 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -110.83 124.78 52.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.731 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.04 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.567 HD13 ' HB3' ' A' ' 31' ' ' LYS . 1.8 mm . . . . . 0 CA--C 1.518 -0.284 0 CA-C-O 121.204 0.526 . . . . 0.0 111.085 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 11' ' ' THR . . . . . 0.582 HG22 HG13 ' B' ' 13' ' ' VAL . 88.9 m -71.47 99.41 2.01 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.732 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -69.51 108.02 3.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.093 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.736 HG11 ' HG3' ' A' ' 88' ' ' ARG . 30.1 m . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.65 -0.691 . . . . 0.0 110.651 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.599 ' HG3' HD21 ' A' ' 12' ' ' LEU . 24.4 pt-20 . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.721 0.296 . . . . 0.0 110.937 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.519 ' HD2' HD13 ' A' ' 68' ' ' ILE . 51.7 m-85 -81.43 151.47 27.87 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.785 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.751 HD12 HG23 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -155.02 122.39 5.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.022 0.439 . . . . 0.0 111.236 -179.836 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.419 HG23 HG12 ' A' ' 104' ' ' ILE . 6.8 m -81.46 146.24 30.34 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.209 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.456 ' N ' ' O ' ' A' ' 103' ' ' LEU . 17.6 m-85 -140.63 171.55 13.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.414 0.626 . . . . 0.0 112.243 -179.238 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -143.65 104.88 4.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.843 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.562 HG12 ' HB1' ' A' ' 54' ' ' ALA . 18.7 t -105.16 114.08 63.92 Favored Pre-proline 0 C--N 1.33 -0.268 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.529 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 97.8 Cg_endo -84.79 126.98 3.52 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.454 2.103 . . . . 0.0 110.849 178.287 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.802 HD22 ' CD1' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -121.98 28.24 7.66 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -178.672 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -39.2 -32.46 0.1 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.054 0.454 . . . . 0.0 111.205 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -108.74 -34.44 6.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.122 179.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.2 t -70.68 -6.58 38.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.288 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.755 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -42.56 -30.51 0.89 Allowed Glycine 0 C--N 1.337 0.593 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.727 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.3 p -83.01 -39.27 21.5 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.851 0.358 . . . . 0.0 110.528 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -78.61 -15.09 58.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.3 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.04 -46.37 1.39 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.645 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.802 ' CD1' HD22 ' A' ' 18' ' ' LEU . 8.2 tp 178.06 -31.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.7 0.286 . . . . 0.0 110.704 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.455 ' HA3' ' HA3' ' A' ' 53' ' ' GLY . . . 106.12 43.65 1.48 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.405 -0.903 . . . . 0.0 113.384 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.814 HG12 HG23 ' A' ' 49' ' ' ILE . 29.0 m -157.33 155.71 4.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.304 0.573 . . . . 0.0 112.073 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.74 116.91 30.85 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.302 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 19.6 m -105.93 143.34 17.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.237 0.541 . . . . 0.0 112.222 -178.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.662 ' HB2' HD13 ' B' ' 10' ' ' ILE . 0.4 OUTLIER -146.54 129.01 15.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.056 179.443 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' A' ' 44' ' ' ILE . . . -104.85 159.66 15.72 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.47 -0.871 . . . . 0.0 112.782 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -134.71 154.03 51.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.8 0.333 . . . . 0.0 110.971 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.41 ' HB3' ' HA ' ' A' ' 41' ' ' ASP . 1.1 ptp180 -109.12 154.62 22.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.097 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.534 ' N ' HD21 ' A' ' 42' ' ' LEU . 0.6 OUTLIER -40.87 151.43 0.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.439 -179.692 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.94 -56.1 11.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.101 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -59.52 -71.51 0.12 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.005 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -85.41 172.89 10.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.881 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -98.54 34.6 1.99 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.85 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.04 124.91 34.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.076 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.588 ' OD2' ' HB1' ' A' ' 79' ' ' ALA . 75.1 m-20 -59.55 139.33 57.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.964 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.534 HD21 ' N ' ' A' ' 35' ' ' SER . 16.7 mt -100.79 -29.76 12.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.887 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 146.25 -176.8 24.99 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.296 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.825 HG21 ' HB3' ' A' ' 84' ' ' MET . 0.0 OUTLIER -105.98 140.12 25.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.675 0.274 . . . . 0.0 110.67 179.837 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -127.09 139.37 53.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.445 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.732 ' O ' HG13 ' A' ' 63' ' ' VAL . 53.2 t -58.03 106.5 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.166 179.212 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.535 ' HG2' HD12 ' B' ' 10' ' ' ILE . 9.7 tptp -76.08 -40.87 52.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.879 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.3 t -168.06 122.23 0.94 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.028 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.814 HG23 HG12 ' A' ' 28' ' ' VAL . 69.6 mt -88.59 123.02 40.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.19 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.443 HD13 ' HA2' ' A' ' 27' ' ' GLY . 1.8 mp -60.61 109.63 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.221 179.196 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.82 72.49 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.074 0.464 . . . . 0.0 110.963 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 163.36 -25.85 0.21 Allowed Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.383 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.455 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -71.19 -167.4 7.77 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.574 -0.822 . . . . 0.0 113.018 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.562 ' HB1' HG12 ' A' ' 16' ' ' VAL . . . -65.41 -42.98 91.98 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.305 0.484 . . . . 0.0 112.305 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.577 ' CB ' HD13 ' A' ' 61' ' ' LEU . . . -64.52 -44.65 90.18 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.582 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.561 ' OG ' HG22 ' A' ' 49' ' ' ILE . 1.4 m -67.44 -29.95 69.56 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.289 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.3 mtpt -78.53 -30.84 47.22 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.293 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.86 -30.72 58.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.711 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.71 19.3 77.91 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.757 -0.735 . . . . 0.0 113.147 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.413 ' HG3' ' CD1' ' A' ' 14' ' ' PHE . 2.6 ptp180 -142.68 17.66 2.0 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.892 0.346 . . . . 0.0 110.997 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.699 ' HB3' HD13 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -114.34 130.75 56.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.638 179.713 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.51 142.56 37.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.116 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.732 HG13 ' O ' ' A' ' 46' ' ' VAL . 59.3 t -53.65 152.35 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.064 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.6 ' HB2' ' O ' ' A' ' 63' ' ' VAL . 9.1 m-80 78.27 13.78 1.52 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.498 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.447 ' O ' HG23 ' A' ' 46' ' ' VAL . 0.8 OUTLIER -91.71 114.31 26.81 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.024 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.421 ' O ' ' HA ' ' A' ' 105' ' ' VAL . 12.7 tm0? -71.31 140.41 50.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.008 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.992 HD23 HG12 ' A' ' 105' ' ' VAL . 18.7 mt -98.13 131.76 44.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.122 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.635 ' O ' HD12 ' A' ' 75' ' ' LEU . 2.1 mp -116.15 -45.15 3.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.898 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 1.004 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -137.44 149.85 47.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.25 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.704 HG11 ' HA ' ' A' ' 87' ' ' LEU . 7.1 p -140.91 123.22 15.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.605 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.617 HD22 HG22 ' A' ' 70' ' ' VAL . 66.2 m-80 66.22 11.23 7.74 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.521 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 109.23 -18.28 30.84 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.831 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -94.05 117.29 29.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.919 0.39 . . . . 0.0 111.151 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.71 139.65 39.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.651 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.635 HD12 ' O ' ' A' ' 68' ' ' ILE . 0.1 OUTLIER -118.29 13.13 13.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.419 -179.835 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.438 HD13 HG23 ' A' ' 68' ' ' ILE . 3.1 tp -60.95 -20.88 62.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.654 0.264 . . . . 0.0 111.246 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -85.36 -24.87 41.72 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.91 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.427 ' HE2' ' HB3' ' A' ' 78' ' ' LYS . 5.6 ptpt -98.16 157.29 16.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.307 0.575 . . . . 0.0 111.305 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.588 ' HB1' ' OD2' ' A' ' 41' ' ' ASP . . . -57.33 166.47 1.18 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.253 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.42 ' OD1' ' N ' ' A' ' 81' ' ' GLN . 22.7 p30 -63.12 -38.97 93.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.095 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.454 ' HA ' ' HG2' ' A' ' 84' ' ' MET . 0.0 OUTLIER -67.18 -41.93 85.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.184 0.516 . . . . 0.0 110.469 179.823 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.4 ' HB3' ' HD3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -70.94 -35.14 72.08 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.689 179.093 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.598 ' HB3' ' CD1' ' A' ' 44' ' ' ILE . . . -69.12 -46.51 67.48 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.581 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.825 ' HB3' HG21 ' A' ' 44' ' ' ILE . 4.4 ptp -62.47 -30.99 71.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.98 179.004 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.11 -33.91 56.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.727 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.403 ' HA ' ' HD2' ' A' ' 89' ' ' ARG . 1.3 m -69.81 -36.06 75.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.367 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.808 HD22 HD13 ' A' ' 67' ' ' LEU . 3.7 pp -78.4 -33.91 48.47 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.555 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -59.19 -49.98 75.79 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.342 179.108 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.442 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.85 -37.21 67.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.456 179.648 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.6 t -70.93 -29.36 65.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.399 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.774 ' HE2' HD22 ' A' ' 26' ' ' LEU . 4.5 ptm -89.07 -22.75 22.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.64 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.0 21.92 14.39 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.493 ' O ' ' HG3' ' A' ' 97' ' ' LYS . 0.4 OUTLIER -154.23 -35.21 0.1 Allowed 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.757 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.411 ' HG3' HG22 ' A' ' 93' ' ' THR . 3.7 mt-10 -111.86 -39.33 4.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.84 0.352 . . . . 0.0 111.362 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.476 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -70.94 -30.8 67.53 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.9 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.723 ' HB2' HD11 ' A' ' 18' ' ' LEU . 2.9 t30 -76.97 -34.09 57.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.787 0.327 . . . . 0.0 110.262 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.493 ' HG3' ' O ' ' A' ' 93' ' ' THR . 46.2 mtpt -39.94 -45.77 1.92 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.79 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.37 -22.98 18.61 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.838 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 115.35 0.11 22.15 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.824 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.473 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -163.82 142.61 7.76 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.992 0.425 . . . . 0.0 111.193 -179.83 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.54 HG22 HD21 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -112.12 142.69 23.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.326 -179.753 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -76.62 147.63 37.45 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.456 ' O ' ' N ' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -143.39 110.46 5.68 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -178.729 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 1.004 HD12 ' HB3' ' A' ' 69' ' ' ALA . 57.4 mt -101.36 112.54 34.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 177.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.992 HG12 HD23 ' A' ' 67' ' ' LEU . 35.3 m -123.64 157.54 29.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.092 0.472 . . . . 0.0 112.091 -178.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.606 ' CB ' HD11 ' A' ' 68' ' ' ILE . . . -129.4 122.81 30.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.373 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.41 0 CA-C-O 120.953 0.406 . . . . 0.0 111.21 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.662 HD13 ' HB2' ' A' ' 31' ' ' LYS . 1.6 mm . . . . . 0 CA--C 1.519 -0.218 0 CA-C-O 121.165 0.507 . . . . 0.0 111.228 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 99.0 m -77.61 102.47 7.03 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.356 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 1.3 tptp -68.78 122.33 18.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.293 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 18.3 m . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.559 -0.734 . . . . 0.0 110.758 179.748 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.896 0.379 . . . . 0.0 111.094 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -92.05 148.37 22.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.572 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.637 HD12 HG23 ' A' ' 105' ' ' VAL . 0.3 OUTLIER -134.7 109.88 8.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.069 0.461 . . . . 0.0 111.229 -179.645 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.534 HG23 ' OE1' ' A' ' 102' ' ' GLN . 94.4 m -92.24 124.63 36.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.127 179.296 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.451 ' CG ' ' HB3' ' A' ' 60' ' ' ARG . 25.1 m-85 -134.83 151.36 50.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.358 0.599 . . . . 0.0 112.103 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.486 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.4 OUTLIER -111.98 110.67 21.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.097 178.948 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.749 ' CG2' HD11 ' A' ' 61' ' ' LEU . 11.7 t -100.33 116.52 64.33 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -177.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.735 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 84.6 Cg_endo -87.22 127.88 2.56 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.784 2.323 . . . . 0.0 111.086 178.439 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.861 HD22 HD13 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -127.49 28.49 5.66 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -178.987 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -39.08 -33.27 0.12 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.151 0.5 . . . . 0.0 111.179 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -108.04 -33.76 7.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.072 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.697 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 7.2 t -70.67 -6.82 39.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.141 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.806 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -41.61 -31.35 0.69 Allowed Glycine 0 C--N 1.338 0.653 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.789 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.3 p -82.52 -41.75 19.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.888 0.375 . . . . 0.0 110.386 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -77.5 -4.66 46.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.458 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.18 -50.16 3.32 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.867 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.943 HD22 ' HE2' ' A' ' 91' ' ' MET . 9.9 tp 179.87 -33.0 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.722 0.296 . . . . 0.0 110.635 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.448 ' HA3' ' HA3' ' A' ' 53' ' ' GLY . . . 109.1 44.04 1.13 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.5 -0.857 . . . . 0.0 113.426 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.73 HG12 HG23 ' A' ' 49' ' ' ILE . 20.8 m -157.56 173.79 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.146 0.498 . . . . 0.0 112.077 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.422 ' O ' ' N ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -134.25 117.09 16.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.312 178.907 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.7 HG11 HD11 ' A' ' 67' ' ' LEU . 3.4 m -109.55 149.48 12.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.009 0.433 . . . . 0.0 111.937 -178.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.427 ' O ' ' HG3' ' A' ' 31' ' ' LYS . 13.5 ptmt -143.63 133.47 23.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.595 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.44 ' HA2' ' HA ' ' A' ' 44' ' ' ILE . . . -95.15 150.94 19.86 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.919 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -112.16 165.69 11.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.813 0.339 . . . . 0.0 110.894 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -128.84 140.52 51.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.629 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.2 123.41 13.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.921 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.05 -32.56 74.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.955 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -75.31 -31.52 60.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.962 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -149.03 136.55 20.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.708 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -61.45 83.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.948 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.95 126.96 12.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.844 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -50.89 145.69 6.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.222 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 43.9 mt -111.34 -23.2 10.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.801 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.421 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 132.03 162.98 10.6 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.354 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.935 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -98.69 136.22 30.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.059 0.457 . . . . 0.0 111.163 -179.866 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -123.69 147.16 47.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.663 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.668 ' O ' HG13 ' A' ' 63' ' ' VAL . 35.0 t -60.3 104.59 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 29' ' ' SER . 24.5 tptt -72.25 -44.12 63.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.516 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 m -166.22 128.45 1.9 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.813 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.73 HG23 HG12 ' A' ' 28' ' ' VAL . 73.4 mt -94.03 121.61 44.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.145 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.585 HD12 ' N ' ' A' ' 28' ' ' VAL . 1.6 mp -58.71 113.59 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.406 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -68.12 74.25 0.21 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.682 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 159.89 -27.22 0.34 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.112 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.448 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -69.12 -171.91 7.84 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.601 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.735 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -64.12 -40.54 96.41 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.187 0.439 . . . . 0.0 112.187 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.645 ' HA ' HD13 ' A' ' 61' ' ' LEU . . . -61.57 -51.13 69.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.321 -179.345 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.8 t -63.43 -30.09 71.27 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.104 0.478 . . . . 0.0 109.807 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.0 mtpt -74.86 -35.01 62.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.738 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -58.9 -27.12 64.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.774 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 63.3 25.25 68.23 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.57 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.451 ' HB3' ' CG ' ' A' ' 14' ' ' PHE . 19.4 mtm180 -127.44 -29.3 2.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.693 0.283 . . . . 0.0 111.224 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.749 HD11 ' CG2' ' A' ' 16' ' ' VAL . 2.3 mp -74.13 143.19 45.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.117 0.484 . . . . 0.0 111.291 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.41 ' NH2' HD13 ' A' ' 12' ' ' LEU . 0.1 OUTLIER -144.83 134.83 23.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.313 179.84 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.668 HG13 ' O ' ' A' ' 46' ' ' VAL . 58.1 t -53.68 143.05 6.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.587 -0.278 . . . . 0.0 110.908 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 30.5 m-20 89.7 -8.88 0.39 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.073 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -63.11 110.21 1.76 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.854 0.359 . . . . 0.0 110.725 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.402 ' NE2' ' O ' ' A' ' 67' ' ' LEU . 20.7 tm0? -74.28 112.93 10.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.915 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.935 HD12 HG13 ' A' ' 44' ' ' ILE . 45.7 mt -66.84 146.44 54.42 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.044 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.735 HD11 ' CB ' ' A' ' 106' ' ' ALA . 52.9 mt -135.77 -42.67 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.277 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.878 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -146.0 126.04 13.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.067 0.461 . . . . 0.0 111.621 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.463 HG11 ' HA ' ' A' ' 87' ' ' LEU . 11.4 p -118.56 127.55 75.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.152 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.5 m120 62.0 35.1 16.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.959 0.409 . . . . 0.0 110.293 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 68.64 24.1 75.38 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.166 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -126.34 98.11 5.32 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.73 0.3 . . . . 0.0 110.822 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.0 t -60.81 136.95 58.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.815 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.62 HD22 ' HB1' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -98.38 12.53 34.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.309 -179.851 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 12.8 mt -63.89 -23.52 67.38 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.72 0.295 . . . . 0.0 111.011 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -93.05 21.16 41.41 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.736 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -150.73 167.02 28.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.176 0.512 . . . . 0.0 111.052 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.566 ' HB3' HE22 ' A' ' 81' ' ' GLN . . . -78.25 175.71 9.95 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.174 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -61.73 -55.83 26.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.239 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.566 HE22 ' HB3' ' A' ' 79' ' ' ALA . 4.8 pm0 -53.9 -38.94 65.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.009 0.433 . . . . 0.0 111.222 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.62 -37.4 73.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.22 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.62 ' HB1' HD22 ' A' ' 75' ' ' LEU . . . -68.96 -47.6 65.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.821 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.475 ' HA ' ' CD2' ' A' ' 87' ' ' LEU . 9.1 ptp -62.88 -30.08 71.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.295 -0.412 . . . . 0.0 109.945 179.242 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -79.12 -35.66 41.83 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 178.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.8 m -67.68 -35.84 79.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.194 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.745 HD12 ' N ' ' A' ' 88' ' ' ARG . 4.4 pp -78.22 -33.88 49.64 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 178.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.745 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -56.17 -50.05 72.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.007 178.962 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.705 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.35 -49.74 31.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.313 178.734 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 m -54.75 -29.38 53.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.602 179.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.943 ' HE2' HD22 ' A' ' 26' ' ' LEU . 1.5 ptp -89.98 -37.85 14.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.306 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.21 37.91 2.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.988 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.705 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 72.3 m -162.56 -41.48 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.566 -0.454 . . . . 0.0 112.214 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -111.62 -48.58 3.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.058 0.456 . . . . 0.0 110.777 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.454 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -69.74 -20.45 75.86 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.146 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.526 ' HB2' HD11 ' A' ' 18' ' ' LEU . 1.7 t30 -83.09 -32.26 26.85 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -40.8 -35.88 0.55 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.383 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.25 -30.72 11.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.69 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 125.93 -6.14 7.83 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.689 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.491 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -153.97 143.64 21.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.983 0.42 . . . . 0.0 111.147 -179.924 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.617 HG22 HD21 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -109.42 147.14 14.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.452 -179.707 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.534 ' OE1' HG23 ' A' ' 13' ' ' THR . 0.0 OUTLIER -79.47 143.47 34.92 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.714 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.473 HD12 HG23 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -138.65 148.22 43.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.125 0.488 . . . . 0.0 111.902 -179.072 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.878 HD12 ' HB3' ' A' ' 69' ' ' ALA . 68.9 mt -144.63 113.33 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.047 179.013 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.931 HG12 HD23 ' A' ' 67' ' ' LEU . 30.0 m -124.3 179.32 2.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.468 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.735 ' CB ' HD11 ' A' ' 68' ' ' ILE . . . -147.75 139.89 24.28 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.93 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.625 ' CG ' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.997 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.411 HD12 ' HD3' ' A' ' 47' ' ' LYS . 2.1 mm . . . . . 0 N--CA 1.453 -0.309 0 CA-C-O 121.038 0.446 . . . . 0.0 111.156 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 11' ' ' THR . . . . . 0.8 HG22 HG13 ' B' ' 13' ' ' VAL . 55.2 m -123.41 104.36 9.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.568 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.67 102.84 5.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.026 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.8 HG13 HG22 ' B' ' 11' ' ' THR . 35.2 m . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.936 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.031 0 CA-C-O 121.005 0.431 . . . . 0.0 111.291 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -104.07 145.32 30.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.413 179.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 1.093 HD12 HG23 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -134.32 119.58 18.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.025 0.44 . . . . 0.0 111.301 -179.676 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.409 ' O ' ' CD1' ' A' ' 14' ' ' PHE . 90.0 m -86.68 143.02 27.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.975 179.204 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.417 ' CE1' ' HG2' ' A' ' 60' ' ' ARG . 24.9 m-85 -139.59 169.41 17.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.286 0.565 . . . . 0.0 112.158 -179.065 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -139.52 107.54 5.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.173 -0.921 . . . . 0.0 108.923 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.7 HG21 HD11 ' A' ' 61' ' ' LEU . 17.6 t -104.28 111.43 65.17 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -177.62 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.785 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 84.6 Cg_endo -81.72 127.71 5.71 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.441 2.094 . . . . 0.0 110.794 178.455 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.828 HD22 HD13 ' A' ' 26' ' ' LEU . 0.5 OUTLIER -125.44 29.15 6.1 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.595 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -39.56 -32.75 0.14 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.112 0.482 . . . . 0.0 111.245 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -109.18 -35.26 6.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.105 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.704 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 9.9 t -67.83 -9.65 46.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.099 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.731 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -43.01 -29.76 0.92 Allowed Glycine 0 C--N 1.339 0.713 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.808 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.3 m -82.58 -39.09 22.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.884 0.373 . . . . 0.0 110.572 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -78.28 -20.85 50.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.197 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.29 -50.31 0.78 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.833 -0.698 . . . . 0.0 111.507 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.828 HD13 HD22 ' A' ' 18' ' ' LEU . 10.9 tp 179.0 -32.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.56 0.219 . . . . 0.0 110.836 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.453 ' HA3' ' HA3' ' A' ' 53' ' ' GLY . . . 110.79 37.74 1.67 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.342 -0.932 . . . . 0.0 113.171 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.744 HG12 HG23 ' A' ' 49' ' ' ILE . 14.4 m -156.51 164.37 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.229 0.538 . . . . 0.0 111.957 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.405 ' O ' ' HB3' ' A' ' 47' ' ' LYS . 2.0 m -123.73 115.18 20.97 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.17 178.682 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.561 HG11 HD11 ' A' ' 67' ' ' LEU . 4.5 m -106.75 141.12 22.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.089 0.471 . . . . 0.0 111.93 -178.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.522 ' CB ' HD13 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -145.53 131.28 19.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.101 179.452 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 44' ' ' ILE . . . -102.25 162.36 17.0 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.442 -0.885 . . . . 0.0 113.052 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -135.94 156.58 48.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.949 0.404 . . . . 0.0 111.019 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.467 ' HD2' ' HA ' ' A' ' 39' ' ' HIS . 0.0 OUTLIER -108.87 152.28 25.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.736 179.972 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.593 ' CB ' HD21 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -50.11 137.58 17.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.983 179.954 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.19 -23.81 65.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.494 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -71.14 -51.02 27.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.079 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -135.34 160.29 38.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.838 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.467 ' HA ' ' HD2' ' A' ' 34' ' ' ARG . 74.5 m-70 -70.39 66.0 0.3 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.87 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -126.17 121.34 32.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.172 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.411 ' CB ' ' ND2' ' A' ' 80' ' ' ASN . 3.4 p-10 -53.39 145.21 14.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.383 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.593 HD21 ' CB ' ' A' ' 35' ' ' SER . 32.4 mt -109.71 -29.83 8.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.47 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.416 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 142.12 -178.58 20.67 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.995 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.827 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -108.05 140.56 26.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.965 0.412 . . . . 0.0 111.219 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -128.6 142.3 51.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.708 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.58 ' O ' HG13 ' A' ' 63' ' ' VAL . 40.0 t -57.58 104.33 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.784 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' A' ' 29' ' ' SER . 36.4 tptt -72.66 -42.91 63.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.801 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.47 129.62 1.61 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.084 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.744 HG23 HG12 ' A' ' 28' ' ' VAL . 78.0 mt -95.16 118.31 41.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.212 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.564 HD12 ' N ' ' A' ' 28' ' ' VAL . 1.8 mp -55.03 107.09 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.619 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.52 77.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.112 0.482 . . . . 0.0 110.593 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 155.27 -26.21 0.61 Allowed Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.872 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.453 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -67.73 -172.41 6.27 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.621 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.785 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -64.76 -39.35 93.47 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.513 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.684 ' HB1' HD13 ' A' ' 61' ' ' LEU . . . -64.79 -48.66 73.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.269 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 60.1 p -63.03 -31.51 72.67 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.864 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 34.6 mtpt -75.23 -34.43 61.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.911 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -59.53 -27.65 66.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.741 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.47 40.0 95.62 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.662 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.417 ' HG2' ' CE1' ' A' ' 14' ' ' PHE . 4.5 mtm180 -134.88 -40.96 0.76 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.857 0.361 . . . . 0.0 110.913 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.7 HD11 HG21 ' A' ' 16' ' ' VAL . 3.7 mp -58.22 166.89 1.47 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.294 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.6 mtm105 -162.15 118.78 2.04 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.301 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.58 HG13 ' O ' ' A' ' 46' ' ' VAL . 34.1 t -47.98 143.12 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.385 -179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.427 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 22.3 m-80 85.76 -5.36 0.83 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.326 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.15 127.41 32.53 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.754 0.311 . . . . 0.0 110.388 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -79.66 136.37 36.79 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.678 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.852 HD23 HG12 ' A' ' 105' ' ' VAL . 49.7 mt -89.0 133.04 34.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.274 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.8 mm -116.8 -30.09 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.994 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.831 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -159.86 159.02 32.0 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.06 0.457 . . . . 0.0 111.203 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.803 HG22 ' ND2' ' A' ' 71' ' ' ASN . 8.0 p -145.74 125.07 5.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.416 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.803 ' ND2' HG22 ' A' ' 70' ' ' VAL . 66.7 m-80 61.17 18.22 8.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.922 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.75 25.36 23.02 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.114 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -124.65 101.06 6.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.736 0.303 . . . . 0.0 110.692 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.5 p -62.67 138.26 58.46 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.018 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -104.39 -16.27 15.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.239 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.5 tp -55.27 89.72 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.913 0.387 . . . . 0.0 111.13 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 156.7 -27.92 0.53 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.294 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.47 ' HD3' ' HB3' ' A' ' 82' ' ' GLU . 0.5 OUTLIER -106.63 159.54 16.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.253 0.549 . . . . 0.0 111.048 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.13 158.0 12.08 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.135 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.411 ' ND2' ' CB ' ' A' ' 41' ' ' ASP . 26.7 m-80 -51.18 -57.38 8.91 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.164 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.423 ' HA ' ' HG2' ' A' ' 84' ' ' MET . 0.0 OUTLIER -51.65 -37.72 51.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.562 -179.47 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.47 ' HB3' ' HD3' ' A' ' 78' ' ' LYS . 1.9 mt-10 -70.92 -40.9 71.83 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.055 0.455 . . . . 0.0 110.331 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.521 ' HB3' ' CD1' ' A' ' 44' ' ' ILE . . . -66.53 -50.07 64.41 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.835 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.575 ' HB3' HG21 ' A' ' 44' ' ' ILE . 5.6 ptp -60.92 -29.65 69.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.062 179.112 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -76.98 -33.73 57.61 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.555 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.4 m -67.95 -36.88 80.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.224 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.692 HD12 ' N ' ' A' ' 88' ' ' ARG . 4.4 pp -78.43 -33.36 48.59 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.692 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -58.1 -49.03 78.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.262 178.988 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.529 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -73.15 -44.29 60.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.065 179.293 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.7 t -62.9 -29.8 71.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.178 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.768 ' HE2' HD22 ' A' ' 26' ' ' LEU . 3.3 ptm -89.81 -25.25 21.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.701 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.21 31.72 6.55 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.529 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.3 OUTLIER -164.25 -33.31 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 179.849 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.409 ' HG3' HG22 ' A' ' 93' ' ' THR . 7.7 mt-10 -111.09 -69.04 0.89 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.803 0.335 . . . . 0.0 111.37 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.427 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -48.8 -27.44 6.36 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.604 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.714 ' HB2' HD11 ' A' ' 18' ' ' LEU . 1.6 t30 -76.41 -33.13 58.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.626 0.25 . . . . 0.0 110.434 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 94' ' ' GLU . 38.0 mtpt -39.62 -41.51 1.06 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.066 0.46 . . . . 0.0 111.373 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.63 -26.99 15.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.061 179.092 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 120.5 -3.51 12.26 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.883 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.457 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.3 OUTLIER -154.0 141.32 19.61 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.89 0.376 . . . . 0.0 111.412 -179.628 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.571 HG22 HD21 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -110.27 141.69 24.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.036 179.82 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -76.61 150.47 36.45 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.514 HD12 HG23 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -144.24 112.01 6.18 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.99 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.831 HD12 ' HB3' ' A' ' 69' ' ' ALA . 76.4 mt -103.39 113.27 39.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.274 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 1.093 HG23 HD12 ' A' ' 12' ' ' LEU . 16.9 m -120.99 174.99 5.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.857 0.36 . . . . 0.0 111.542 -179.109 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -147.36 142.82 27.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.206 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.475 ' HD2' HD21 ' A' ' 12' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.783 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.522 HD13 ' CB ' ' A' ' 31' ' ' LYS . 1.4 mm . . . . . 0 N--CA 1.454 -0.248 0 CA-C-O 121.185 0.516 . . . . 0.0 111.226 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 28.0 m -94.84 109.61 21.58 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.644 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 7.0 tppt? -70.99 126.72 30.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.095 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.551 HG11 ' HG3' ' A' ' 88' ' ' ARG . 4.1 m . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.554 -0.736 . . . . 0.0 110.862 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.801 0.334 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -86.96 147.5 25.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.891 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.994 HD12 HG23 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -137.77 110.46 7.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.204 -179.656 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 71.2 m -103.89 128.03 51.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.489 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -140.95 172.65 12.38 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 121.354 0.597 . . . . 0.0 112.341 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.404 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.5 OUTLIER -127.8 111.19 13.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.853 179.26 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.845 HG13 ' OD1' ' A' ' 58' ' ' ASP . 66.5 t -103.99 113.66 65.16 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -177.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.624 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 83.3 Cg_endo -84.13 127.58 4.06 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.373 2.049 . . . . 0.0 110.748 177.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.882 HD22 ' CD1' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -122.54 30.05 6.66 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -178.628 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.453 ' ND2' ' OD2' ' A' ' 20' ' ' ASP . 8.4 p-10 -36.94 -33.87 0.06 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.172 0.511 . . . . 0.0 111.291 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.453 ' OD2' ' ND2' ' A' ' 19' ' ' ASN . 35.8 m-20 -111.57 -34.47 6.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.16 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.503 ' HB2' ' HB2' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -66.26 -13.83 61.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.943 179.761 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.743 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -45.97 -28.01 2.69 Favored Glycine 0 C--N 1.337 0.608 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.78 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.33 -36.02 27.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.847 0.356 . . . . 0.0 110.78 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -82.64 -24.43 33.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.253 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.78 -54.59 0.64 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.932 -0.652 . . . . 0.0 111.481 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.986 HD22 ' HE2' ' A' ' 91' ' ' MET . 10.0 tp 179.41 -35.3 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.616 0.246 . . . . 0.0 110.893 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 50' ' ' ILE . . . 117.28 32.69 1.45 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.296 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.775 HG11 HD22 ' A' ' 61' ' ' LEU . 33.4 m -157.88 157.04 3.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.121 0.486 . . . . 0.0 111.897 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.92 116.05 26.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.431 178.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.958 HG11 HD11 ' A' ' 67' ' ' LEU . 3.9 m -106.76 142.64 19.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.014 0.435 . . . . 0.0 111.691 -179.021 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.584 ' HB3' HD13 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -139.5 135.18 33.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.617 179.821 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.501 ' HA3' ' HB2' ' A' ' 80' ' ' ASN . . . -89.73 152.42 22.43 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.013 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.44 ' ND2' ' CE1' ' A' ' 45' ' ' PHE . 91.2 m-20 -120.77 163.74 17.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.757 0.313 . . . . 0.0 110.873 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -116.44 151.76 35.38 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.752 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.606 ' HA ' HD21 ' A' ' 42' ' ' LEU . 0.9 OUTLIER -51.97 167.71 0.11 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.207 -179.909 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.11 -56.13 11.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.105 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -116.93 -38.22 3.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.031 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -55.06 -24.35 24.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.202 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 35.1 m80 60.68 32.8 20.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.002 0.43 . . . . 0.0 110.737 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -107.87 135.43 49.28 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.009 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -58.17 122.3 12.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.809 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.606 HD21 ' HA ' ' A' ' 35' ' ' SER . 16.0 mt -82.66 -30.23 29.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.2 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.481 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 140.99 177.85 16.68 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.017 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.849 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -99.79 134.13 40.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.951 0.405 . . . . 0.0 111.297 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.468 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -123.15 143.29 50.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.54 -179.896 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.623 ' O ' HG13 ' A' ' 63' ' ' VAL . 42.6 t -55.78 104.52 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.856 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.548 ' HD3' HD12 ' B' ' 10' ' ' ILE . 6.3 tptp -74.05 -42.17 60.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.644 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.42 125.57 1.53 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.949 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.723 HG23 HG12 ' A' ' 28' ' ' VAL . 69.8 mt -89.94 120.77 39.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.275 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.64 HD12 ' N ' ' A' ' 28' ' ' VAL . 2.1 mp -61.88 108.87 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.794 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -66.68 74.24 0.1 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.926 0.393 . . . . 0.0 110.399 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 164.47 -28.04 0.21 Allowed Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.119 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.15 -176.33 23.28 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.601 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.624 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -61.27 -41.15 96.43 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.809 ' HB1' HD13 ' A' ' 61' ' ' LEU . . . -64.76 -48.0 76.16 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.9 0.381 . . . . 0.0 111.58 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.464 ' HB2' HG22 ' A' ' 49' ' ' ILE . 5.6 t -63.36 -29.06 70.43 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.219 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 32.4 mtpt -75.1 -28.99 60.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.933 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.845 ' OD1' HG13 ' A' ' 16' ' ' VAL . 1.2 m-20 -63.31 -26.99 69.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.016 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.11 20.24 57.89 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.282 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.9 mtm180 -118.52 -28.28 5.73 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.909 0.385 . . . . 0.0 110.791 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.809 HD13 ' HB1' ' A' ' 55' ' ' ALA . 0.6 OUTLIER -68.94 149.81 48.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.1 0.476 . . . . 0.0 111.271 -179.735 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.645 HH21 HD22 ' A' ' 12' ' ' LEU . 76.1 mtm-85 -146.98 128.64 15.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.722 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.623 HG13 ' O ' ' A' ' 46' ' ' VAL . 46.6 t -55.39 143.91 7.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.042 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.438 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 19.2 m-20 85.21 10.37 0.31 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.136 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -88.67 115.79 26.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.822 0.344 . . . . 0.0 110.402 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.31 123.28 25.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.9 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.958 HD11 HG11 ' A' ' 30' ' ' VAL . 9.4 mt -75.28 133.86 41.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.24 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.905 HD11 ' HB2' ' A' ' 106' ' ' ALA . 18.3 mt -114.47 -28.02 2.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.281 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.855 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -158.4 166.47 32.16 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.104 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.685 HG11 ' HA ' ' A' ' 87' ' ' LEU . 12.0 p -154.05 126.07 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.009 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.597 ' ND2' HG22 ' A' ' 70' ' ' VAL . 68.6 m-80 58.69 20.17 7.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.051 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.35 28.05 18.46 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.957 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 70' ' ' VAL . 0.4 OUTLIER -128.5 101.48 6.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.841 0.353 . . . . 0.0 110.747 -179.638 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.1 t -66.81 133.26 49.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.816 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.595 HD22 ' HA ' ' A' ' 83' ' ' ALA . 0.9 OUTLIER -93.8 -11.32 31.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.297 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.1 mt -54.01 91.52 0.01 OUTLIER 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.82 0.343 . . . . 0.0 111.118 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 151.21 -29.21 0.98 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.884 -0.675 . . . . 0.0 112.259 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.474 ' HD3' ' HB3' ' A' ' 82' ' ' GLU . 5.5 ptpp? -104.29 152.2 22.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.193 0.521 . . . . 0.0 110.943 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.85 149.73 6.05 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.108 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.501 ' HB2' ' HA3' ' A' ' 32' ' ' GLY . 25.1 p30 -52.8 -30.4 33.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.222 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.466 ' HA ' ' HG2' ' A' ' 84' ' ' MET . 0.0 OUTLIER -73.9 -38.28 64.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.274 0.559 . . . . 0.0 110.328 179.454 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.474 ' HB3' ' HD3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -70.23 -33.82 72.13 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.739 179.13 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.595 ' HA ' HD22 ' A' ' 75' ' ' LEU . . . -69.2 -44.96 71.07 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.77 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.677 ' HB3' HG21 ' A' ' 44' ' ' ILE . 6.1 ptp -63.53 -30.83 71.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.304 -0.407 . . . . 0.0 109.992 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -78.17 -32.98 50.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.518 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.55 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 1.9 m -69.81 -35.09 74.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.541 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.854 HD12 ' N ' ' A' ' 88' ' ' ARG . 4.2 pp -78.01 -34.22 50.82 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.854 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -61.01 -51.11 70.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.926 -1.033 . . . . 0.0 110.964 179.464 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.55 ' HD3' ' O ' ' A' ' 86' ' ' THR . 0.0 OUTLIER -72.25 -33.39 67.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.373 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.445 ' OG ' ' HA ' ' A' ' 87' ' ' LEU . 66.6 p -71.95 -29.84 64.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.991 0.424 . . . . 0.0 110.49 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.986 ' HE2' HD22 ' A' ' 26' ' ' LEU . 2.9 ptp -85.42 -23.07 28.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.358 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.3 m -117.42 27.01 9.34 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.511 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.4 OUTLIER -156.81 -31.64 0.09 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.905 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.412 ' HG3' HG22 ' A' ' 93' ' ' THR . 7.0 mt-10 -115.98 -45.93 2.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.887 0.375 . . . . 0.0 111.518 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.496 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -72.23 -32.6 62.6 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.844 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.592 ' HB2' HD11 ' A' ' 18' ' ' LEU . 2.0 t30 -73.32 -32.83 64.82 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' A' ' 93' ' ' THR . 47.5 mtpt -41.12 -41.44 1.76 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.263 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.2 -27.58 16.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.688 178.498 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.542 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 115.77 0.82 21.39 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.696 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.531 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.2 OUTLIER -153.89 140.59 19.0 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 120.986 0.422 . . . . 0.0 111.429 -179.627 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.731 HD11 HD11 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -113.29 144.15 21.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.733 179.615 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.559 ' O ' HD13 ' A' ' 103' ' ' LEU . 1.9 tt0 -83.51 142.3 31.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.04 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.731 HD11 HD11 ' A' ' 101' ' ' ILE . 2.9 mm? -131.25 136.09 47.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.98 0.419 . . . . 0.0 111.848 -179.157 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.855 HD12 ' HB3' ' A' ' 69' ' ' ALA . 73.4 mt -128.56 112.89 27.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.325 178.099 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.994 HG23 HD12 ' A' ' 12' ' ' LEU . 27.0 m -127.16 173.58 12.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.133 0.492 . . . . 0.0 111.441 -178.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.905 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -147.45 128.09 14.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.263 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.718 ' HG3' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 120.977 0.418 . . . . 0.0 111.25 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.584 HD13 ' HB3' ' A' ' 31' ' ' LYS . 3.2 mm . . . . . 0 CA--C 1.521 -0.147 0 CA-C-O 121.206 0.527 . . . . 0.0 111.006 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 92.1 m -73.16 99.51 2.84 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.852 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.1 110.75 14.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.922 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.738 HG11 ' CG ' ' A' ' 88' ' ' ARG . 15.7 m . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.343 -0.837 . . . . 0.0 111.039 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 . . . . . 0 C--O 1.233 0.189 0 CA-C-O 120.905 0.383 . . . . 0.0 111.281 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -91.75 150.31 21.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.521 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.763 HD12 HG23 ' A' ' 105' ' ' VAL . 0.5 OUTLIER -139.16 113.08 8.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.908 0.385 . . . . 0.0 111.62 -179.42 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.485 HG23 ' OE1' ' A' ' 102' ' ' GLN . 98.4 m -98.86 133.57 42.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.778 178.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 102' ' ' GLN . 52.0 m-85 -141.55 172.69 12.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.118 0.485 . . . . 0.0 111.939 -179.01 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.448 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.6 OUTLIER -128.53 109.51 11.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.547 179.272 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.907 HG23 HD23 ' A' ' 103' ' ' LEU . 34.2 t -104.55 109.21 62.5 Favored Pre-proline 0 C--N 1.33 -0.246 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.242 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.75 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 83.5 Cg_endo -81.48 127.64 5.85 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.418 2.079 . . . . 0.0 110.762 178.358 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.823 HD22 ' CD1' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -121.22 29.07 7.48 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -178.849 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -37.84 -31.4 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.366 179.318 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -112.95 -33.77 5.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.26 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.655 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 25.9 t -69.77 -9.87 56.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.209 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.755 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -45.57 -28.51 2.46 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.795 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.53 -35.12 25.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.85 0.357 . . . . 0.0 110.698 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -82.51 -24.45 34.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.129 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.44 -51.98 0.71 Allowed Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.931 HD22 ' HE2' ' A' ' 91' ' ' MET . 10.5 tp 179.45 -35.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.658 0.266 . . . . 0.0 110.633 179.024 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.409 ' O ' ' N ' ' A' ' 50' ' ' ILE . . . 116.26 34.46 1.33 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.473 -0.87 . . . . 0.0 113.232 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.778 HG11 HD22 ' A' ' 61' ' ' LEU . 33.1 m -157.22 157.02 3.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 117.153 0.477 . . . . 0.0 112.0 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.4 ' O ' ' N ' ' A' ' 47' ' ' LYS . 0.9 OUTLIER -117.65 123.9 47.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.342 178.81 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.928 HG11 HD11 ' A' ' 67' ' ' LEU . 5.4 m -106.69 153.97 7.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.171 0.51 . . . . 0.0 112.32 -178.6 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.506 ' HB3' HD13 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -152.4 132.27 13.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.35 179.513 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.504 ' HA2' ' HA ' ' A' ' 44' ' ' ILE . . . -107.64 153.97 16.69 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.473 -0.87 . . . . 0.0 113.153 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.925 ' ND2' HD12 ' A' ' 42' ' ' LEU . 18.2 p-10 -106.73 -179.16 3.86 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.177 0.513 . . . . 0.0 111.318 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -135.86 127.54 29.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.53 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.732 ' CA ' HD21 ' A' ' 42' ' ' LEU . 10.6 t -38.61 134.67 0.9 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.739 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.13 -35.13 79.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.267 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -73.74 -57.34 4.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.012 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -119.26 161.07 21.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.932 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 40.6 m-70 -77.84 61.94 2.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.867 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.23 126.76 48.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.993 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -61.49 131.46 50.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.01 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.925 HD12 ' ND2' ' A' ' 33' ' ' ASN . 11.6 mt -89.54 -24.62 21.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.896 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.448 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 140.31 169.92 11.86 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.346 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.915 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -101.37 140.45 20.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.8 0.333 . . . . 0.0 111.309 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.46 ' CE2' ' HG3' ' A' ' 66' ' ' GLN . 0.1 OUTLIER -126.31 143.14 51.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.611 179.858 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.645 ' O ' HG13 ' A' ' 63' ' ' VAL . 44.8 t -55.35 105.42 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.412 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.473 ' HD3' HD12 ' B' ' 10' ' ' ILE . 18.3 tptt -72.6 -43.61 63.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.679 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.2 m -165.01 126.53 2.07 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.999 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.742 HG23 HG12 ' A' ' 28' ' ' VAL . 66.9 mt -91.82 119.04 38.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.324 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.558 HD12 ' N ' ' A' ' 28' ' ' VAL . 1.9 mp -58.83 101.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.571 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -59.96 80.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.08 0.467 . . . . 0.0 110.584 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 153.63 -30.34 0.76 Allowed Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.624 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.402 ' H ' HG22 ' A' ' 50' ' ' ILE . . . -63.37 -174.98 3.02 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.585 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.75 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -65.13 -36.22 83.58 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.741 ' HB1' HD13 ' A' ' 61' ' ' LEU . . . -68.74 -45.87 70.35 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.748 0.309 . . . . 0.0 111.551 -179.278 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.56 -29.9 70.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.104 0.478 . . . . 0.0 110.053 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.1 mtpt -72.77 -32.67 65.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.971 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.409 ' OD1' ' NH2' ' A' ' 60' ' ' ARG . 1.3 t0 -57.49 -29.78 64.56 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.787 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.16 16.84 75.37 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.045 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.409 ' NH2' ' OD1' ' A' ' 58' ' ' ASP . 0.6 OUTLIER -128.82 -2.03 5.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.933 0.366 . . . . 0.0 111.202 179.837 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.778 HD22 HG11 ' A' ' 28' ' ' VAL . 0.1 OUTLIER -96.03 125.04 40.3 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.007 0.432 . . . . 0.0 111.472 -179.642 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.412 ' N ' ' HD2' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -128.66 140.28 51.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.556 179.707 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.678 ' O ' ' HB2' ' A' ' 64' ' ' ASN . 39.7 t -61.41 150.86 7.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.461 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.678 ' HB2' ' O ' ' A' ' 63' ' ' VAL . 22.4 m-80 83.44 3.37 0.93 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.05 0.54 . . . . 0.0 111.95 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.511 ' OD2' HG21 ' A' ' 105' ' ' VAL . 1.2 m-20 -81.1 117.76 21.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.852 0.358 . . . . 0.0 110.298 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.46 ' HG3' ' CE2' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -75.73 115.03 14.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.248 -179.387 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.928 HD11 HG11 ' A' ' 30' ' ' VAL . 32.8 mt -63.34 152.01 39.19 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.153 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.943 HD11 ' HB2' ' A' ' 106' ' ' ALA . 21.1 mt -136.77 -43.65 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.169 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.9 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -143.18 150.97 40.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.966 0.412 . . . . 0.0 111.399 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.582 HG11 ' HA ' ' A' ' 87' ' ' LEU . 10.3 p -140.62 116.28 7.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.819 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.539 ' ND2' HG22 ' A' ' 70' ' ' VAL . 69.3 m-80 55.79 55.36 7.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.789 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 60.89 18.69 54.53 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.435 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -118.11 88.72 2.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.881 0.372 . . . . 0.0 110.82 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.3 m -62.0 118.46 7.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.026 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.482 HD22 ' HA ' ' A' ' 83' ' ' ALA . 2.1 mt -73.59 -16.52 61.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.214 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.599 HD13 HG23 ' A' ' 68' ' ' ILE . 1.0 OUTLIER -53.33 91.5 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.927 0.394 . . . . 0.0 111.133 -179.906 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 152.77 -28.62 0.83 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.256 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.3 ptpp? -106.38 154.69 20.44 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.215 0.531 . . . . 0.0 110.963 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.36 156.42 3.29 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.303 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -53.85 -42.47 68.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.316 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.41 ' HA ' ' HG2' ' A' ' 84' ' ' MET . 0.0 OUTLIER -66.42 -38.01 86.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.966 0.412 . . . . 0.0 110.872 -179.936 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.69 -33.18 72.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.185 0.517 . . . . 0.0 110.109 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.602 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -69.13 -46.69 67.01 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.782 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.42 ' HA ' ' CD2' ' A' ' 87' ' ' LEU . 6.1 ptp -63.26 -31.97 73.26 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.333 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -80.42 -32.05 37.46 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.6 m -68.73 -36.44 78.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.29 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.852 HD12 ' N ' ' A' ' 88' ' ' ARG . 4.3 pp -78.54 -35.05 46.7 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.369 0.604 . . . . 0.0 109.388 178.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.852 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -60.04 -48.54 81.31 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.171 179.422 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.516 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.82 -42.33 63.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.964 179.329 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.0 t -62.75 -29.42 70.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.179 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.931 ' HE2' HD22 ' A' ' 26' ' ' LEU . 3.2 ptp -85.47 -30.86 23.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.658 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.2 30.31 6.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.701 -179.253 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.516 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.4 OUTLIER -158.86 -28.98 0.07 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -179.79 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.5 ' HG3' HG22 ' A' ' 93' ' ' THR . 4.9 mt-10 -122.1 -38.98 2.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.959 0.409 . . . . 0.0 111.103 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.513 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -78.63 -31.45 45.05 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.724 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.741 ' HB2' HD11 ' A' ' 18' ' ' LEU . 2.2 t30 -75.02 -33.43 61.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.786 0.326 . . . . 0.0 110.14 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.45 ' HD3' ' O ' ' A' ' 93' ' ' THR . 26.2 mmmt -43.52 -44.8 6.23 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.157 0.504 . . . . 0.0 111.108 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.58 -23.57 21.94 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.715 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 113.69 -1.3 24.67 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.789 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.448 ' SD ' ' HB3' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -163.06 143.24 9.14 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.055 0.455 . . . . 0.0 111.341 -179.639 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.884 HD11 HD11 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -116.47 139.77 41.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.277 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.533 ' C ' HD22 ' A' ' 103' ' ' LEU . 3.0 pp0? -87.25 135.32 33.36 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.907 HD23 HG23 ' A' ' 16' ' ' VAL . 2.2 mm? -121.33 138.31 54.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.285 0.564 . . . . 0.0 112.286 -179.161 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.9 HD12 ' HB3' ' A' ' 69' ' ' ALA . 96.2 mt -120.02 112.67 37.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.278 178.242 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.829 HG12 HD23 ' A' ' 67' ' ' LEU . 28.5 m -125.98 154.06 34.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.448 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.943 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -125.63 135.31 52.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.417 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.563 ' HG3' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 CA-C-O 121.099 0.476 . . . . 0.0 111.52 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.506 HD13 ' HB3' ' A' ' 31' ' ' LYS . 1.6 mm . . . . . 0 N--CA 1.456 -0.172 0 CA-C-O 121.223 0.535 . . . . 0.0 111.388 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 22.7 m -101.21 100.5 11.04 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.442 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.16 124.09 23.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.219 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.53 HG23 ' O ' ' B' ' 13' ' ' VAL . 12.0 m . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.386 -0.816 . . . . 0.0 110.797 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.875 0.369 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -78.43 136.06 37.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.638 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.967 HD12 HG23 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -130.58 111.08 11.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.902 0.382 . . . . 0.0 111.29 -179.746 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.598 HG23 ' OE1' ' A' ' 102' ' ' GLN . 99.2 m -99.93 132.12 45.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.346 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.427 ' CG ' ' HB3' ' A' ' 60' ' ' ARG . 28.4 m-85 -140.69 172.52 12.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.321 0.582 . . . . 0.0 112.202 -179.174 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.468 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.4 OUTLIER -130.74 111.24 11.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.276 179.295 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.892 HG23 HD23 ' A' ' 103' ' ' LEU . 24.2 t -103.65 117.01 60.91 Favored Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -178.071 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.775 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 82.9 Cg_endo -86.97 128.07 2.69 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.738 2.292 . . . . 0.0 110.898 178.317 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.901 HD11 ' HB2' ' A' ' 96' ' ' ASN . 0.4 OUTLIER -122.71 28.75 7.16 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -178.899 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -38.38 -31.96 0.06 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.319 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -111.92 -32.5 6.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.123 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.762 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 25.0 t -71.74 -5.21 32.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.308 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.771 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -44.43 -29.37 1.75 Allowed Glycine 0 C--N 1.337 0.605 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.726 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.1 m -85.03 -35.1 22.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.001 0.429 . . . . 0.0 110.657 179.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.92 5.14 34.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.424 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.81 -56.35 5.04 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.958 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.918 HD22 ' HE2' ' A' ' 91' ' ' MET . 8.4 tp -175.06 -36.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.635 0.255 . . . . 0.0 110.839 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.83 45.54 0.7 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.554 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.775 HG12 HG23 ' A' ' 49' ' ' ILE . 23.4 m -157.16 156.71 4.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.185 0.517 . . . . 0.0 112.122 179.353 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.43 ' O ' ' HB3' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -116.07 114.63 24.8 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.091 178.582 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.88 HG11 HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -108.88 146.4 14.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.14 0.495 . . . . 0.0 111.993 -178.683 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.494 ' HB3' HD13 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -144.43 131.03 19.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.306 179.621 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.507 ' HA2' ' HA ' ' A' ' 44' ' ' ILE . . . -96.85 155.18 20.74 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.967 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -104.2 -171.19 1.89 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.864 0.364 . . . . 0.0 110.821 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.469 ' CD ' ' O ' ' A' ' 35' ' ' SER . 0.0 OUTLIER -145.17 141.27 28.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.505 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.764 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 0.2 OUTLIER -43.7 146.68 0.52 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.119 0.485 . . . . 0.0 111.905 -179.246 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.03 -19.36 65.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.36 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -103.13 -82.27 0.49 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.692 0.282 . . . . 0.0 111.393 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -98.19 166.5 11.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.116 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.442 ' HA ' ' CG ' ' A' ' 34' ' ' ARG . 88.3 m-70 -66.74 73.52 0.1 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.917 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.764 ' HB3' ' HB2' ' A' ' 35' ' ' SER . . . -115.65 88.34 2.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.866 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.404 ' HB3' ' ND2' ' A' ' 80' ' ' ASN . 2.0 p-10 -37.97 121.93 0.97 Allowed 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.918 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.645 HD21 ' HA ' ' A' ' 35' ' ' SER . 19.2 mt -88.92 6.67 38.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.04 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.457 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 103.16 -174.31 23.02 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.384 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.827 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -114.45 144.7 21.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.842 0.353 . . . . 0.0 111.478 -179.719 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -127.44 143.16 51.24 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.714 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.589 ' O ' HG13 ' A' ' 63' ' ' VAL . 41.9 t -60.04 104.37 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.486 179.507 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.43 ' HB3' ' O ' ' A' ' 29' ' ' SER . 2.8 tptt -73.37 -42.35 62.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.881 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.0 m -168.66 122.6 0.86 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.028 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.775 HG23 HG12 ' A' ' 28' ' ' VAL . 75.1 mt -84.82 116.55 28.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.908 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.619 HD12 ' N ' ' A' ' 28' ' ' VAL . 1.8 mp -52.65 101.91 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.742 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -60.1 80.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.129 0.49 . . . . 0.0 110.628 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 153.58 -30.0 0.76 Allowed Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.718 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.477 ' H ' HG22 ' A' ' 50' ' ' ILE . . . -65.07 -171.19 2.82 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.366 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.775 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -68.43 -37.12 79.97 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.734 ' HB1' HD13 ' A' ' 61' ' ' LEU . . . -66.48 -43.54 85.15 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.468 -179.386 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.419 ' OG ' HG22 ' A' ' 49' ' ' ILE . 0.5 OUTLIER -69.92 -32.11 70.24 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.049 179.702 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 26.7 mtpt -72.29 -33.21 67.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.852 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -62.16 -26.79 68.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.795 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.64 37.31 92.1 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.641 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.427 ' HB3' ' CG ' ' A' ' 14' ' ' PHE . 7.3 mtm180 -131.4 -33.48 1.46 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.674 0.273 . . . . 0.0 110.949 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.795 HD11 HG21 ' A' ' 16' ' ' VAL . 2.1 mp -64.45 157.89 25.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.048 0.451 . . . . 0.0 111.185 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -149.49 124.05 9.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.521 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.589 HG13 ' O ' ' A' ' 46' ' ' VAL . 41.2 t -56.9 143.05 11.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.198 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.435 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 21.5 m-20 86.26 -2.78 0.73 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.238 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -78.43 124.03 27.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.718 0.295 . . . . 0.0 110.52 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.438 ' O ' ' HA ' ' A' ' 105' ' ' VAL . 0.7 OUTLIER -74.9 134.46 41.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.665 -179.86 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.904 HD23 HG12 ' A' ' 105' ' ' VAL . 19.3 mt -86.17 137.8 32.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.754 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.971 HD11 ' HB2' ' A' ' 106' ' ' ALA . 24.5 mt -120.99 -37.27 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.458 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.79 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -149.92 170.8 17.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.904 0.383 . . . . 0.0 111.275 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.711 HG23 ' CD1' ' A' ' 103' ' ' LEU . 7.2 p -157.78 121.87 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.934 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.512 ' ND2' HG22 ' A' ' 70' ' ' VAL . 70.0 m-80 61.07 25.62 15.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.628 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.47 23.02 45.07 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.143 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -127.04 119.02 25.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.779 0.323 . . . . 0.0 110.71 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 60.9 p -69.8 153.31 43.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.097 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.439 HD22 ' HB1' ' A' ' 83' ' ' ALA . 6.8 mt -113.38 -15.4 12.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.314 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.7 mt -57.45 -18.3 17.61 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.521 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -87.87 21.28 24.05 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.079 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.448 ' HB2' ' HB3' ' A' ' 82' ' ' GLU . 1.9 ptpt -160.38 168.69 24.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.262 0.553 . . . . 0.0 111.221 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.44 ' HB3' HE22 ' A' ' 81' ' ' GLN . . . -72.37 174.31 7.52 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.641 -179.299 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.464 ' O ' ' HE2' ' A' ' 84' ' ' MET . 21.1 m-80 -57.14 -58.29 8.84 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.496 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.44 HE22 ' HB3' ' A' ' 79' ' ' ALA . 6.1 pm0 -58.37 -34.12 70.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.045 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.448 ' HB3' ' HB2' ' A' ' 78' ' ' LYS . 2.8 mt-10 -70.77 -39.2 73.35 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.25 0.548 . . . . 0.0 109.867 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.6 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -69.13 -43.52 74.21 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.573 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.481 ' HG3' HG21 ' A' ' 44' ' ' ILE . 1.0 OUTLIER -64.61 -29.29 70.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.067 179.176 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -78.99 -35.76 42.4 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.433 ' HA ' ' HD2' ' A' ' 89' ' ' ARG . 1.6 m -65.36 -36.51 84.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.403 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.775 HD12 ' N ' ' A' ' 88' ' ' ARG . 4.4 pp -78.35 -34.26 48.55 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.775 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -60.7 -49.45 77.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.744 179.349 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.558 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.15 -45.7 59.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.98 179.683 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 45.9 p -60.25 -29.35 68.72 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.763 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.918 ' HE2' HD22 ' A' ' 26' ' ' LEU . 2.5 ptp -88.07 -29.36 20.71 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.493 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.58 35.46 4.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.761 -179.354 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.558 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.3 OUTLIER -166.42 -24.05 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.474 ' HG3' HG22 ' A' ' 93' ' ' THR . 6.6 mt-10 -123.92 -59.44 1.51 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.989 0.424 . . . . 0.0 111.175 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.428 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -66.59 -25.35 72.78 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.1 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.901 ' HB2' HD11 ' A' ' 18' ' ' LEU . 3.0 t30 -78.28 -35.59 47.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.963 0.411 . . . . 0.0 110.185 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.46 ' HD3' ' O ' ' A' ' 93' ' ' THR . 27.7 mmmt -45.52 -42.28 10.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.985 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.91 -27.92 23.08 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.629 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 121.94 -6.67 10.25 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.934 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.468 ' SD ' ' HB3' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -158.33 142.38 15.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.013 0.435 . . . . 0.0 111.301 -179.759 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.786 HD11 HD11 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -109.45 144.79 17.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.996 -179.841 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.598 ' OE1' HG23 ' A' ' 13' ' ' THR . 1.5 tm0? -85.83 140.35 30.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.168 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.892 HD23 HG23 ' A' ' 16' ' ' VAL . 2.7 mm? -130.4 139.81 50.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.039 0.447 . . . . 0.0 111.867 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.79 HD12 ' HB3' ' A' ' 69' ' ' ALA . 66.5 mt -128.6 112.91 27.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.596 178.221 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.967 HG23 HD12 ' A' ' 12' ' ' LEU . 28.6 m -122.71 176.94 4.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.84 -178.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.971 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -147.71 117.53 7.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.475 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 5.6 ttm180 . . . . . 0 C--N 1.326 -0.433 0 CA-C-O 120.928 0.394 . . . . 0.0 110.773 -179.878 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.494 HD13 ' HB3' ' A' ' 31' ' ' LYS . 1.5 mm . . . . . 0 CA--C 1.52 -0.174 0 CA-C-O 121.177 0.513 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 90.5 m -79.0 116.39 19.27 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.744 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt -79.11 129.0 33.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.861 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.75 HG11 HD11 ' A' ' 87' ' ' LEU . 21.3 m . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.126 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 121.028 0.442 . . . . 0.0 111.357 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.429 ' CD2' HG13 ' A' ' 68' ' ' ILE . 3.8 m-85 -101.95 145.03 29.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.405 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.69 HD13 ' CZ ' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -147.6 137.36 22.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.126 0.489 . . . . 0.0 111.428 -179.652 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.469 HG23 ' OE1' ' A' ' 102' ' ' GLN . 86.8 m -88.77 145.9 25.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.242 179.399 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.69 ' CZ ' HD13 ' A' ' 12' ' ' LEU . 21.3 m-85 -140.37 116.51 10.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.03 0.443 . . . . 0.0 111.979 -179.251 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.411 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.6 OUTLIER -86.99 109.15 19.19 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.565 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.509 HG11 ' HG ' ' A' ' 26' ' ' LEU . 39.6 t -106.54 103.37 45.98 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -177.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.749 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 3.7 Cg_exo -75.42 128.01 10.83 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.606 2.204 . . . . 0.0 110.661 178.352 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.78 HD11 ' HB2' ' A' ' 96' ' ' ASN . 0.4 OUTLIER -124.03 28.36 6.83 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.713 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -39.71 -31.2 0.1 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.069 0.461 . . . . 0.0 111.092 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -113.7 -32.69 6.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.234 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.747 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 45.9 t -70.65 -8.6 53.04 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.074 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.678 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -46.36 -27.64 2.91 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.603 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 52.4 m -84.9 -33.17 22.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.874 0.369 . . . . 0.0 110.693 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.78 11.13 20.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.49 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.14 -55.64 5.04 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.897 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.954 HD22 ' HE2' ' A' ' 91' ' ' MET . 9.2 tp -178.49 -31.38 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.658 0.266 . . . . 0.0 110.96 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.443 ' HA3' ' HA3' ' A' ' 53' ' ' GLY . . . 112.73 32.49 2.26 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.421 -0.895 . . . . 0.0 113.286 179.433 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.75 HG12 HG23 ' A' ' 49' ' ' ILE . 35.2 m -156.34 150.55 10.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.1 0.476 . . . . 0.0 111.915 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.443 ' O ' ' N ' ' A' ' 47' ' ' LYS . 73.0 m -107.48 123.13 47.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.032 178.302 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.6 m -107.47 153.67 8.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 -178.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.513 ' O ' ' HG3' ' A' ' 31' ' ' LYS . 0.1 OUTLIER -155.62 129.93 8.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.206 179.303 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -103.97 160.46 16.09 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.181 -1.009 . . . . 0.0 113.101 -179.486 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -116.01 175.32 5.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.004 0.43 . . . . 0.0 111.133 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 29.5 mtt85 -121.41 153.05 38.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.749 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.894 ' HA ' HD21 ' A' ' 42' ' ' LEU . 0.5 OUTLIER -47.7 156.87 0.28 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.484 -179.866 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.87 -51.98 41.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.394 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.21 -51.74 28.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.704 -179.34 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -117.97 -177.12 3.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.752 0.31 . . . . 0.0 111.078 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 -92.34 40.38 1.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.049 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.18 110.2 17.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.829 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.603 ' OD2' ' HB1' ' A' ' 79' ' ' ALA . 1.2 m-20 -48.37 124.5 8.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.443 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.894 HD21 ' HA ' ' A' ' 35' ' ' SER . 17.0 mt -88.88 -36.25 16.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.72 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.484 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 154.44 -178.71 31.09 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.898 -0.667 . . . . 0.0 111.897 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.741 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -106.58 137.82 35.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.845 0.355 . . . . 0.0 111.274 -179.854 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -123.68 140.13 53.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.497 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.609 ' O ' HG13 ' A' ' 63' ' ' VAL . 27.5 t -55.95 107.56 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.068 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 29' ' ' SER . 21.5 tptt -71.61 -46.87 57.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.625 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 27.2 t -166.42 123.83 1.36 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.857 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.75 HG23 HG12 ' A' ' 28' ' ' VAL . 66.9 mt -87.32 122.54 39.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.274 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.51 HD12 ' N ' ' A' ' 28' ' ' VAL . 2.5 mp -64.84 111.77 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.289 179.249 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -68.06 72.63 0.18 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.212 0.53 . . . . 0.0 110.404 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 165.12 -28.89 0.21 Allowed Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.877 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.443 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -66.84 -170.56 4.2 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.662 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.749 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -69.24 -37.7 78.1 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.744 ' HB1' HD13 ' A' ' 61' ' ' LEU . . . -67.96 -44.26 77.15 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.792 0.33 . . . . 0.0 111.312 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.416 ' HB2' HG22 ' A' ' 49' ' ' ILE . 6.9 t -65.53 -34.79 79.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.224 0.535 . . . . 0.0 109.759 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -69.23 -31.41 69.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.766 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.59 -30.84 61.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.654 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 68.93 16.19 70.18 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.897 -0.668 . . . . 0.0 113.277 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.441 ' HG3' ' CD1' ' A' ' 14' ' ' PHE . 7.0 ptp180 -135.23 10.91 3.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.002 0.401 . . . . 0.0 111.143 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.744 HD13 ' HB1' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -104.07 134.01 48.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.596 179.877 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.39 145.63 50.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.802 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.609 HG13 ' O ' ' A' ' 46' ' ' VAL . 45.2 t -66.07 148.91 11.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.845 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.43 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 15.9 m-80 84.65 -4.02 0.98 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.428 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.3 128.25 35.27 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.694 0.283 . . . . 0.0 110.697 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.55 130.01 34.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.937 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.907 HD23 HG12 ' A' ' 105' ' ' VAL . 77.5 mt -81.13 135.95 35.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.575 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.429 HG13 ' CD2' ' A' ' 11' ' ' PHE . 18.7 mm -118.93 -29.14 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.298 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.744 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -160.04 148.73 17.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.983 0.42 . . . . 0.0 111.378 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.432 HG11 ' HA ' ' A' ' 87' ' ' LEU . 7.1 p -137.89 129.79 39.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.488 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.9 m120 60.01 26.08 15.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.763 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.8 20.67 59.23 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.193 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -128.19 111.55 13.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.823 0.344 . . . . 0.0 110.723 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.47 149.83 20.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.158 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.586 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . 4.2 mt -114.09 -20.2 11.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.347 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.1 tp -54.83 -24.35 22.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.674 0.273 . . . . 0.0 111.278 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.39 -2.17 83.48 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.031 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.433 ' HG3' ' HB2' ' A' ' 83' ' ' ALA . 4.6 ptpp? -135.83 161.13 36.47 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.293 0.568 . . . . 0.0 111.301 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.603 ' HB1' ' OD2' ' A' ' 41' ' ' ASP . . . -60.52 176.94 0.32 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.525 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.435 ' HB3' ' HA3' ' A' ' 32' ' ' GLY . 19.5 m-80 -67.14 -57.64 6.38 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.118 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.438 ' HA ' ' HE3' ' A' ' 84' ' ' MET . 0.0 OUTLIER -58.36 -35.21 71.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.036 0.446 . . . . 0.0 110.591 -179.826 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.53 -42.45 71.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.484 179.09 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.586 ' HB1' ' HB3' ' A' ' 75' ' ' LEU . . . -69.59 -30.99 68.88 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.934 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.47 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 0.5 OUTLIER -72.36 -33.32 67.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.596 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -77.63 -28.07 51.29 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.2 m -72.66 -36.85 68.03 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.528 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 84' ' ' MET . 4.4 pp -78.65 -34.24 46.57 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -61.4 -52.1 66.0 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.461 179.243 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.5 ' O ' HG22 ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.17 -33.97 68.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.19 179.594 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.491 ' N ' ' HD3' ' A' ' 89' ' ' ARG . 41.7 m -72.57 -29.68 63.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.672 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.954 ' HE2' HD22 ' A' ' 26' ' ' LEU . 3.2 ptp -87.35 -22.4 25.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.31 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.0 t -112.81 22.65 14.26 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.946 0.351 . . . . 0.0 111.946 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.558 HG23 ' HG2' ' A' ' 94' ' ' GLU . 0.5 OUTLIER -154.77 -39.46 0.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.558 ' HG2' HG23 ' A' ' 93' ' ' THR . 5.7 mt-10 -110.77 -22.06 11.76 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.868 0.366 . . . . 0.0 111.206 -179.448 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.505 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -93.27 -30.3 9.4 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 179.188 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.78 ' HB2' HD11 ' A' ' 18' ' ' LEU . 5.3 t30 -86.67 -37.05 18.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.791 0.329 . . . . 0.0 110.29 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.551 ' HG2' ' HA ' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -45.32 -28.53 0.85 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.31 179.627 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.427 ' HD3' ' HD2' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -106.8 -27.04 11.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.534 178.964 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 118.36 -1.64 16.3 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.135 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.49 ' HE2' ' O ' ' A' ' 100' ' ' MET . 0.0 OUTLIER -165.14 141.44 5.59 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.0 0.429 . . . . 0.0 111.649 -179.74 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.545 HG22 HD21 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -115.47 134.56 58.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.043 179.848 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.469 ' OE1' HG23 ' A' ' 13' ' ' THR . 1.7 pp0? -81.55 140.32 34.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.001 178.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.451 HD13 HG21 ' A' ' 16' ' ' VAL . 1.8 mp -134.84 111.59 10.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.736 0.303 . . . . 0.0 111.686 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.744 HD12 ' HB3' ' A' ' 69' ' ' ALA . 62.6 mt -90.19 112.45 24.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.255 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.907 HG12 HD23 ' A' ' 67' ' ' LEU . 14.6 m -118.37 -179.2 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.882 0.373 . . . . 0.0 111.384 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -147.01 134.99 21.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.755 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.616 ' HD2' HD21 ' A' ' 12' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.969 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.472 HD13 ' HB3' ' A' ' 31' ' ' LYS . 14.5 mm . . . . . 0 N--CA 1.449 -0.495 0 CA-C-O 120.839 0.352 . . . . 0.0 111.079 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 1.9 m -162.05 122.37 2.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.584 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -80.46 145.1 32.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.15 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.402 ' CG1' ' HG3' ' A' ' 88' ' ' ARG . 27.2 m . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.175 -0.917 . . . . 0.0 111.093 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.848 0.356 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -96.93 148.35 23.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.859 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.86 HD12 HG23 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -132.27 109.9 10.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.109 -179.848 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.689 HG23 ' OE1' ' A' ' 102' ' ' GLN . 87.9 m -96.71 133.02 41.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.496 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.407 ' CE1' ' HG2' ' A' ' 60' ' ' ARG . 47.8 m-85 -140.59 172.67 12.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.164 0.506 . . . . 0.0 112.043 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.427 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.4 OUTLIER -129.67 112.22 13.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.228 179.105 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.901 HG23 HD23 ' A' ' 103' ' ' LEU . 25.8 t -105.31 111.53 64.99 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -177.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.578 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 1.2 Cg_endo -81.7 127.61 5.69 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.817 2.345 . . . . 0.0 111.049 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.775 HD11 ' HB2' ' A' ' 96' ' ' ASN . 0.4 OUTLIER -122.09 28.67 7.4 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -179.002 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -38.72 -31.72 0.07 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.036 0.446 . . . . 0.0 111.195 179.414 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -112.26 -33.52 6.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.18 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.472 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 30.4 t -70.02 -7.57 42.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.2 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.745 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -45.3 -28.65 2.2 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.759 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.0 t -84.83 -34.23 22.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.783 0.325 . . . . 0.0 110.63 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.01 8.88 27.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.319 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.28 -55.26 4.94 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.969 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.864 HD22 ' HE2' ' A' ' 91' ' ' MET . 8.2 tp -176.02 -34.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.508 0.194 . . . . 0.0 110.657 179.346 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.42 ' HA2' HD13 ' A' ' 50' ' ' ILE . . . 111.68 44.28 0.91 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.328 -0.939 . . . . 0.0 113.56 179.085 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.782 HG12 HG23 ' A' ' 49' ' ' ILE . 19.4 m -158.27 167.55 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.155 0.503 . . . . 0.0 111.902 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' B' ' 12' ' ' LYS . 0.0 OUTLIER -126.67 116.67 21.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.276 178.636 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.961 HG11 HD11 ' A' ' 67' ' ' LEU . 1.0 OUTLIER -111.18 144.47 19.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.013 0.435 . . . . 0.0 111.981 -178.836 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.417 ' O ' ' HG3' ' A' ' 31' ' ' LYS . 2.2 ptmt -138.05 134.06 34.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.365 179.478 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.514 ' HA3' ' HB3' ' A' ' 80' ' ' ASN . . . -100.07 147.6 18.19 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.939 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.404 ' ND2' ' CE1' ' A' ' 45' ' ' PHE . 76.6 m-20 -127.12 130.49 49.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.888 0.375 . . . . 0.0 110.866 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.16 145.74 26.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.468 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.85 ' OG ' HD21 ' A' ' 42' ' ' LEU . 8.3 m -44.1 130.61 6.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.269 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.13 -19.85 65.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.568 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -106.08 -44.09 4.67 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.825 0.345 . . . . 0.0 111.421 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -87.3 -16.91 33.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.522 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 30.2 m-70 61.47 21.3 11.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.746 0.308 . . . . 0.0 110.888 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -99.29 134.47 42.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.011 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -50.18 126.94 15.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.315 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.85 HD21 ' OG ' ' A' ' 35' ' ' SER . 45.8 mt -94.39 -19.4 20.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.919 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.464 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 128.82 169.66 12.63 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.308 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.755 ' CG1' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -102.05 130.95 51.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.835 0.35 . . . . 0.0 111.29 179.85 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.425 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -113.56 146.79 39.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.486 179.868 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.534 ' O ' HG13 ' A' ' 63' ' ' VAL . 49.1 t -60.53 104.66 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.563 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.437 ' HD3' HD12 ' B' ' 10' ' ' ILE . 18.1 tptt -75.48 -40.05 57.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.889 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -168.77 126.41 1.03 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.981 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.782 HG23 HG12 ' A' ' 28' ' ' VAL . 63.7 mt -94.44 121.21 44.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.048 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.52 HD12 ' N ' ' A' ' 28' ' ' VAL . 1.5 mp -58.96 109.74 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.432 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -65.83 72.91 0.06 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.071 0.462 . . . . 0.0 110.691 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 163.76 -26.51 0.21 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.262 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.404 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -70.87 -165.41 6.05 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.777 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.578 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -69.09 -42.18 76.49 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.756 ' HB1' HD22 ' A' ' 61' ' ' LEU . . . -63.13 -43.84 97.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.342 -179.278 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.4 t -68.73 -33.56 74.13 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.132 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -72.2 -31.9 66.29 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.876 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -65.18 -25.17 67.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.709 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.12 29.7 65.9 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.575 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.407 ' HG2' ' CE1' ' A' ' 14' ' ' PHE . 15.0 mtm180 -124.9 -33.02 2.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.609 0.242 . . . . 0.0 111.254 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.756 HD22 ' HB1' ' A' ' 55' ' ' ALA . 5.5 mp -72.01 150.15 44.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.904 0.383 . . . . 0.0 111.055 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.11 135.71 20.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.082 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.54 ' O ' ' HB3' ' A' ' 64' ' ' ASN . 82.9 t -64.99 94.89 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.817 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.54 ' HB3' ' O ' ' A' ' 63' ' ' VAL . 12.2 p30 149.55 -4.45 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.92 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -84.22 131.78 34.71 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 121.096 0.474 . . . . 0.0 111.594 -179.009 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.93 117.25 28.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.11 179.343 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.961 HD11 HG11 ' A' ' 30' ' ' VAL . 5.2 mt -71.91 133.52 45.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.929 0.395 . . . . 0.0 111.404 -179.531 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.725 HD11 ' CB ' ' A' ' 106' ' ' ALA . 23.6 mt -122.12 -22.86 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.488 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.703 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -155.69 167.26 30.96 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.935 0.398 . . . . 0.0 111.466 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.83 HG22 HD22 ' A' ' 71' ' ' ASN . 10.3 p -158.18 126.34 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.694 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.83 HD22 HG22 ' A' ' 70' ' ' VAL . 2.7 m-80 66.19 15.4 10.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.082 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 96.34 7.48 58.17 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.529 -0.843 . . . . 0.0 113.125 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.427 ' CG ' ' O ' ' A' ' 70' ' ' VAL . 2.4 pt-20 -121.13 109.15 14.66 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.889 0.376 . . . . 0.0 111.002 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.4 m -59.65 145.9 43.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.024 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.423 ' HB2' ' CB ' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -121.16 4.41 10.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.247 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.598 HD13 HG23 ' A' ' 68' ' ' ILE . 5.0 tp -61.21 -28.53 69.21 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.741 0.305 . . . . 0.0 111.029 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -74.87 -24.95 70.65 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.558 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -97.34 166.17 11.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.259 0.552 . . . . 0.0 111.212 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.21 165.2 16.59 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.245 -0.888 . . . . 0.0 111.418 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.514 ' HB3' ' HA3' ' A' ' 32' ' ' GLY . 20.3 m-80 -54.78 -57.77 10.24 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.269 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.83 -34.49 67.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.83 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.72 -38.64 73.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.313 0.578 . . . . 0.0 109.625 179.237 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.534 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -69.08 -40.74 78.26 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.405 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.462 ' HG2' HG23 ' A' ' 30' ' ' VAL . 1.1 mtm -66.3 -29.62 69.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.854 179.144 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -79.88 -35.88 37.37 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.432 ' HA ' ' HD2' ' A' ' 89' ' ' ARG . 2.9 m -65.21 -36.33 83.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.375 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.809 HD12 ' N ' ' A' ' 88' ' ' ARG . 4.4 pp -79.06 -34.6 43.57 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.809 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -62.32 -50.68 70.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.605 179.322 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.499 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.16 -37.34 69.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.233 179.634 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.413 ' HB3' ' ND2' ' A' ' 71' ' ' ASN . 34.8 m -67.11 -29.51 69.27 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.077 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.864 ' HE2' HD22 ' A' ' 26' ' ' LEU . 4.5 ptp -89.34 -30.28 18.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.624 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.0 23.46 13.97 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.499 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.4 OUTLIER -155.04 -31.05 0.1 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.851 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.418 ' HG3' HG22 ' A' ' 93' ' ' THR . 7.8 mt-10 -113.9 -63.89 1.39 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.894 0.378 . . . . 0.0 111.524 -179.314 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.459 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -58.11 -31.89 66.19 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.451 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.775 ' HB2' HD11 ' A' ' 18' ' ' LEU . 1.8 t30 -72.95 -33.71 66.07 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.715 0.293 . . . . 0.0 110.612 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 93' ' ' THR . 54.4 mtpt -43.56 -39.45 3.45 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.035 0.445 . . . . 0.0 111.325 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.31 -26.23 15.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.957 178.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 117.27 2.07 18.17 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.613 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.512 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -158.17 141.91 15.49 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.011 0.434 . . . . 0.0 111.28 -179.689 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.828 HD11 HD11 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -112.86 146.15 17.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.967 179.915 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.689 ' OE1' HG23 ' A' ' 13' ' ' THR . 1.5 tm0? -86.9 138.45 31.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.034 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.901 HD23 HG23 ' A' ' 16' ' ' VAL . 2.8 mm? -128.51 138.98 52.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.0 0.428 . . . . 0.0 111.961 -179.172 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.703 HD12 ' HB3' ' A' ' 69' ' ' ALA . 55.1 mt -127.67 112.79 28.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.745 178.429 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.86 HG23 HD12 ' A' ' 12' ' ' LEU . 34.7 m -121.76 175.88 4.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.048 -179.438 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.725 ' CB ' HD11 ' A' ' 68' ' ' ILE . . . -147.52 141.77 26.21 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.842 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.668 ' CG ' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.333 0 CA-C-O 120.886 0.374 . . . . 0.0 111.175 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.437 HD12 ' HD3' ' A' ' 47' ' ' LYS . 1.6 mm . . . . . 0 N--CA 1.454 -0.253 0 CA-C-O 120.981 0.419 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 27.3 m -138.06 97.8 3.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.795 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 12' ' ' LYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 29' ' ' SER . 8.1 ttpt -69.19 109.67 4.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.989 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.755 HG11 HD11 ' A' ' 87' ' ' LEU . 18.5 m . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.321 -0.847 . . . . 0.0 111.103 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 . . . . . 0 C--O 1.231 0.132 0 CA-C-O 120.843 0.354 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -90.98 146.28 24.0 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.801 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.609 HD11 ' CG ' ' A' ' 107' ' ' ARG . 0.3 OUTLIER -138.62 109.92 6.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.992 0.425 . . . . 0.0 111.088 -179.829 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.703 HG23 ' OE1' ' A' ' 102' ' ' GLN . 92.7 m -88.54 121.43 30.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.086 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.439 ' CZ ' ' HB3' ' A' ' 12' ' ' LEU . 32.8 m-85 -131.14 150.53 52.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.214 0.53 . . . . 0.0 112.33 -179.125 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.486 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.6 OUTLIER -112.46 111.14 21.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.285 -0.87 . . . . 0.0 108.93 178.79 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.546 HG11 ' HG ' ' A' ' 26' ' ' LEU . 10.3 t -100.14 115.33 65.6 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -177.625 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.776 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 93.8 Cg_endo -85.98 128.2 3.19 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.758 2.305 . . . . 0.0 110.842 178.297 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.808 HD12 ' HA2' ' A' ' 22' ' ' GLY . 0.4 OUTLIER -127.95 28.79 5.52 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -178.664 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -38.84 -33.35 0.11 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.061 0.458 . . . . 0.0 111.28 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -107.71 -33.87 7.15 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.231 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.758 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 7.6 t -70.51 -6.39 35.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.25 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.808 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -42.12 -30.49 0.75 Allowed Glycine 0 C--N 1.337 0.613 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.775 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.02 -38.81 20.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.866 0.365 . . . . 0.0 110.672 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -82.51 1.7 36.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.449 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.88 -53.81 4.86 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.978 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.942 HD22 ' HE2' ' A' ' 91' ' ' MET . 7.7 tp -175.62 -36.06 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.735 0.302 . . . . 0.0 110.589 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.443 ' HA3' ' HA3' ' A' ' 53' ' ' GLY . . . 109.03 47.5 0.88 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.524 -0.846 . . . . 0.0 113.531 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.8 HG12 HG23 ' A' ' 49' ' ' ILE . 22.3 m -158.18 156.67 3.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 117.058 0.429 . . . . 0.0 111.75 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.414 ' O ' ' HB3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -114.13 114.17 25.69 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.383 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.606 HG11 HD11 ' A' ' 67' ' ' LEU . 0.4 OUTLIER -106.94 146.97 12.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.269 0.556 . . . . 0.0 111.979 -178.659 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.466 ' HB3' HD13 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -148.18 130.9 15.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.321 179.41 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 44' ' ' ILE . . . -100.08 176.97 28.57 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.941 -179.356 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.708 ' ND2' HD12 ' A' ' 42' ' ' LEU . 50.8 p30 -125.15 -174.8 3.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.303 0.573 . . . . 0.0 111.637 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.426 ' O ' ' C ' ' A' ' 35' ' ' SER . 4.5 mtm180 -144.27 126.13 15.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.698 179.138 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.456 ' CA ' HD21 ' A' ' 42' ' ' LEU . 57.7 m -28.68 142.77 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.22 -178.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -37.21 83.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.354 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.78 -63.16 1.42 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.933 0.397 . . . . 0.0 110.925 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -112.78 -179.92 3.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.882 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 53.1 m-70 -87.56 53.62 2.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.968 0.413 . . . . 0.0 110.857 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.497 ' O ' HD23 ' A' ' 42' ' ' LEU . . . -104.24 105.0 14.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.074 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -49.06 139.75 10.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.554 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.708 HD12 ' ND2' ' A' ' 33' ' ' ASN . 5.4 mt -103.66 -16.37 15.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.737 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 137.5 -177.94 19.46 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.036 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.687 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -115.98 136.59 52.42 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-O 120.819 0.342 . . . . 0.0 110.672 179.749 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -126.47 144.08 50.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.87 0.366 . . . . 0.0 110.827 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.606 ' O ' HG13 ' A' ' 63' ' ' VAL . 40.1 t -57.06 113.79 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.825 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.51 ' HG2' HD12 ' B' ' 10' ' ' ILE . 30.1 tptt -83.03 -38.16 22.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.653 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -168.3 120.09 0.82 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.082 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.8 HG23 HG12 ' A' ' 28' ' ' VAL . 70.4 mt -85.75 120.61 36.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.971 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.545 HD12 ' N ' ' A' ' 28' ' ' VAL . 1.4 mp -57.55 103.95 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.623 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -60.24 83.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.484 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 148.97 -28.03 1.27 Allowed Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.664 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.505 ' H ' HG22 ' A' ' 50' ' ' ILE . . . -67.09 -176.15 7.98 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.543 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.776 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -61.77 -39.29 91.16 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.713 ' HB1' HD13 ' A' ' 61' ' ' LEU . . . -64.65 -48.6 74.2 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.98 0.419 . . . . 0.0 111.486 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.69 -28.52 69.95 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.113 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.7 mtpt -77.46 -29.03 52.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.948 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.407 ' OD1' ' NH2' ' A' ' 60' ' ' ARG . 4.5 t0 -56.13 -31.7 63.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.412 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.77 13.51 80.5 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.887 -0.673 . . . . 0.0 113.35 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.428 ' HG3' ' CG ' ' A' ' 14' ' ' PHE . 2.9 ptp180 -135.62 7.09 3.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 117.089 0.445 . . . . 0.0 111.373 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.772 ' HB3' HD13 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -98.99 133.49 43.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.46 179.827 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.9 142.16 38.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.911 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.606 HG13 ' O ' ' A' ' 46' ' ' VAL . 52.3 t -59.3 147.35 8.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.912 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.434 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 16.3 m-20 85.36 12.99 0.21 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.3 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.441 ' CG ' HG21 ' A' ' 105' ' ' VAL . 1.3 m-20 -85.26 109.53 18.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.854 0.359 . . . . 0.0 110.611 179.53 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -73.59 111.17 8.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.841 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.888 HD23 HG12 ' A' ' 105' ' ' VAL . 14.8 mt -66.08 141.47 58.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.66 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.824 HG23 HD12 ' A' ' 76' ' ' LEU . 34.8 mt -129.51 -39.69 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.437 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.73 ' HB3' ' CD1' ' A' ' 104' ' ' ILE . . . -147.0 124.03 11.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.991 0.424 . . . . 0.0 111.227 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.651 HG11 ' HA ' ' A' ' 87' ' ' LEU . 8.4 p -120.33 124.93 73.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.437 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.1 m120 60.93 42.74 12.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.905 0.383 . . . . 0.0 110.477 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 64.8 21.51 67.47 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.225 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -126.94 118.61 24.87 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.771 0.319 . . . . 0.0 110.767 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.3 t -60.5 152.43 25.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.941 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.686 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . 36.2 mt -118.39 -31.89 4.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.233 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.824 HD12 HG23 ' A' ' 68' ' ' ILE . 1.5 mt -53.96 -29.73 43.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.22 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.03 -11.6 63.81 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.837 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.428 ' HG3' ' HB2' ' A' ' 83' ' ' ALA . 7.0 ptpp? -126.01 156.26 40.16 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.252 0.548 . . . . 0.0 111.206 -179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.07 162.45 0.66 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.882 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -54.66 -57.62 10.74 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.079 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -59.55 -35.4 74.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.061 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.407 ' HB3' ' HB2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -70.49 -40.53 73.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.153 0.502 . . . . 0.0 109.655 179.458 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.686 ' HB1' ' HB3' ' A' ' 75' ' ' LEU . . . -69.13 -38.83 79.07 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.45 179.621 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.435 ' HG3' HG21 ' A' ' 44' ' ' ILE . 0.5 OUTLIER -65.95 -30.67 71.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.865 179.239 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -79.72 -31.95 41.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.341 178.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.437 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 1.7 m -69.48 -35.39 75.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.33 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.833 HD12 ' N ' ' A' ' 88' ' ' ARG . 4.3 pp -78.72 -34.61 45.81 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.833 ' N ' HD12 ' A' ' 87' ' ' LEU . 5.0 mtp180 -61.4 -52.11 65.98 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 114.937 -1.028 . . . . 0.0 110.616 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.517 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.42 -33.48 67.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.993 179.613 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.443 ' N ' ' HD3' ' A' ' 89' ' ' ARG . 28.6 m -70.99 -29.54 65.55 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.46 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.942 ' HE2' HD22 ' A' ' 26' ' ' LEU . 2.3 ptp -88.94 -21.34 23.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.386 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.5 31.81 6.29 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.517 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.4 OUTLIER -160.01 -31.68 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 179.899 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.457 ' HG3' HG22 ' A' ' 93' ' ' THR . 5.1 mt-10 -115.88 -45.94 2.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.885 0.374 . . . . 0.0 111.239 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.478 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -73.34 -35.25 56.73 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.665 -0.778 . . . . 0.0 111.945 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.678 ' HB2' HD11 ' A' ' 18' ' ' LEU . 2.7 t30 -71.25 -33.82 70.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.898 0.38 . . . . 0.0 110.089 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 93' ' ' THR . 49.3 mtpt -40.85 -32.59 0.23 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.739 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.15 -28.21 10.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.797 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 128.22 -8.88 6.66 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.731 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.486 ' SD ' ' HB3' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -154.38 144.44 21.9 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.962 0.411 . . . . 0.0 110.852 -179.847 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.615 HG22 HD21 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -107.2 144.63 15.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.597 -179.483 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.703 ' OE1' HG23 ' A' ' 13' ' ' THR . 0.8 OUTLIER -77.01 137.17 38.82 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.429 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.465 HD12 HG23 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -135.57 147.12 48.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.335 0.588 . . . . 0.0 112.198 -178.807 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.73 ' CD1' ' HB3' ' A' ' 69' ' ' ALA . 8.5 mt -140.45 112.63 4.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.311 178.563 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.888 HG12 HD23 ' A' ' 67' ' ' LEU . 28.1 m -122.47 176.61 4.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.056 0.455 . . . . 0.0 111.677 -178.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.686 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -147.48 132.67 18.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.561 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.609 ' CG ' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.343 0 CA-C-O 120.842 0.353 . . . . 0.0 111.212 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.51 HD12 ' HG2' ' A' ' 47' ' ' LYS . 2.7 mm . . . . . 0 CA--C 1.522 -0.097 0 CA-C-O 121.197 0.522 . . . . 0.0 111.774 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 55.0 m -140.36 106.63 5.25 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.484 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 9.2 ttmt -68.89 112.8 5.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.269 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.758 HG11 HD11 ' A' ' 87' ' ' LEU . 30.8 m . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.979 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.917 0.389 . . . . 0.0 111.467 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.57 ' HD1' ' HB2' ' A' ' 106' ' ' ALA . 17.4 m-85 -94.88 144.06 25.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.264 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.59 HD11 ' HD2' ' A' ' 107' ' ' ARG . 0.1 OUTLIER -134.46 127.78 32.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.942 0.401 . . . . 0.0 111.606 -179.476 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 99.2 m -97.47 133.99 41.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.741 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.464 ' O ' ' N ' ' A' ' 103' ' ' LEU . 21.6 m-85 -140.71 148.19 40.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.268 0.556 . . . . 0.0 112.404 -179.007 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.425 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.2 OUTLIER -112.39 111.5 22.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.401 -0.818 . . . . 0.0 108.928 178.727 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.801 HG21 HD11 ' A' ' 61' ' ' LEU . 21.2 t -103.41 111.22 64.97 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -177.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.735 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 86.4 Cg_endo -81.03 128.18 6.39 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.427 2.085 . . . . 0.0 111.014 178.566 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.926 HD22 HD13 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -126.22 29.39 5.83 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -178.85 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -37.43 -32.33 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.411 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -112.32 -34.1 6.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.248 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.606 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 10.5 t -67.03 -11.92 58.43 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.147 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.678 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -45.86 -28.58 2.8 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.737 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.1 t -81.68 -36.77 28.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.89 0.376 . . . . 0.0 110.67 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.17 -24.54 37.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.062 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.9 -52.59 0.7 Allowed Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.926 HD13 HD22 ' A' ' 18' ' ' LEU . 9.3 tp 179.15 -32.82 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.654 0.264 . . . . 0.0 110.796 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.13 43.11 1.42 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.969 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.62 ' N ' HD12 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -164.77 151.44 2.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.068 0.461 . . . . 0.0 111.343 179.738 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' B' ' 12' ' ' LYS . 0.0 OUTLIER -111.85 123.32 49.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.931 179.356 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.75 HG11 HD11 ' A' ' 67' ' ' LEU . 0.9 OUTLIER -112.43 141.36 28.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.895 0.379 . . . . 0.0 111.501 -179.534 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.04 130.29 25.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.648 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -96.75 144.18 17.18 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.851 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.415 ' O ' ' HA ' ' A' ' 41' ' ' ASP . 2.6 m120 -94.4 -176.3 3.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.711 0.291 . . . . 0.0 110.624 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.3 mtt180 -142.67 148.86 38.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.906 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.473 ' HB2' HD21 ' A' ' 42' ' ' LEU . 8.3 t -66.59 137.05 56.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.938 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -67.09 -29.14 68.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.154 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -70.2 -50.36 40.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.976 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.574 ' OD1' ' HB2' ' A' ' 40' ' ' ALA . 10.4 p30 -141.28 165.32 27.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.756 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -70.48 66.05 0.31 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.908 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.574 ' HB2' ' OD1' ' A' ' 38' ' ' ASN . . . -120.33 119.06 32.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.94 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.415 ' HA ' ' O ' ' A' ' 33' ' ' ASN . 9.2 p-10 -53.4 142.57 21.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.175 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.473 HD21 ' HB2' ' A' ' 35' ' ' SER . 43.2 mt -107.27 3.94 26.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.392 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.444 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 113.92 160.33 13.59 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.524 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.677 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -98.73 130.59 47.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.733 0.301 . . . . 0.0 111.063 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.15 142.4 47.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.808 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.611 ' O ' HG13 ' A' ' 63' ' ' VAL . 39.5 t -57.8 105.84 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.903 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.48 ' HG2' HG21 ' B' ' 10' ' ' ILE . 6.3 tptt -73.92 -41.42 62.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.106 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.2 m -171.89 123.35 0.52 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.913 0.387 . . . . 0.0 111.371 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.554 ' CD1' ' HB3' ' A' ' 61' ' ' LEU . 76.1 mt -85.66 110.95 20.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.068 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.62 HD12 ' N ' ' A' ' 28' ' ' VAL . 1.9 mp -48.74 104.01 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.774 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -62.16 75.38 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.778 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 160.33 -28.79 0.34 Allowed Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.655 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.478 ' H ' HG22 ' A' ' 50' ' ' ILE . . . -70.11 -161.71 3.49 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.476 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.735 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -76.41 -38.13 56.08 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.919 0.341 . . . . 0.0 111.919 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.736 ' HA ' HD13 ' A' ' 61' ' ' LEU . . . -62.64 -38.29 89.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.889 0.376 . . . . 0.0 111.022 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.6 t -78.03 -35.49 49.72 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.149 0.5 . . . . 0.0 109.736 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.5 mtpt -69.69 -31.34 69.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.813 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -64.47 -25.43 68.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.668 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.31 28.99 65.27 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.58 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.424 ' HB3' ' CG ' ' A' ' 14' ' ' PHE . 12.7 mtm180 -125.76 -32.33 2.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.729 0.3 . . . . 0.0 111.012 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.801 HD11 HG21 ' A' ' 16' ' ' VAL . 2.7 mp -68.94 147.26 51.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.093 0.473 . . . . 0.0 111.371 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 48.8 mtm-85 -142.96 123.74 14.21 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.508 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.611 HG13 ' O ' ' A' ' 46' ' ' VAL . 41.3 t -52.75 142.76 5.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.339 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.429 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 20.2 m-20 85.22 18.66 0.12 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.237 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.43 ' O ' HG23 ' A' ' 46' ' ' VAL . 3.4 m-20 -99.21 118.39 35.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.35 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.39 126.16 30.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.945 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.912 HD23 HG12 ' A' ' 105' ' ' VAL . 73.5 mt -76.06 141.77 41.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.296 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.704 HD11 ' HB2' ' A' ' 106' ' ' ALA . 28.9 mt -123.85 -39.64 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.704 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 1.025 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -150.95 154.98 38.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.886 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.761 HG22 ' ND2' ' A' ' 71' ' ' ASN . 8.0 p -142.34 125.6 14.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.633 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.761 ' ND2' HG22 ' A' ' 70' ' ' VAL . 67.0 m-80 64.83 12.89 8.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.65 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.21 13.22 36.86 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.205 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.417 ' CG ' ' O ' ' A' ' 70' ' ' VAL . 4.9 pt-20 -128.18 112.2 14.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 117.036 0.418 . . . . 0.0 111.018 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.4 p -65.15 170.41 4.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.947 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.644 HD22 ' HB1' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -143.68 16.59 1.81 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.216 -179.799 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.8 tp -66.18 -21.31 66.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.628 0.251 . . . . 0.0 111.052 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -91.18 14.76 62.75 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.962 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.403 ' HD2' ' HB3' ' A' ' 75' ' ' LEU . 1.0 OUTLIER -139.35 163.76 31.65 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.403 0.621 . . . . 0.0 111.235 179.845 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.15 162.38 22.57 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.486 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -55.9 -52.51 63.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.109 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.409 ' HA ' ' HE3' ' A' ' 84' ' ' MET . 0.0 OUTLIER -59.29 -36.29 75.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.971 0.415 . . . . 0.0 110.524 179.646 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.58 -38.65 74.07 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.344 179.019 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.644 ' HB1' HD22 ' A' ' 75' ' ' LEU . . . -69.18 -34.92 75.68 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.128 179.148 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.594 ' HA ' HD21 ' A' ' 87' ' ' LEU . 1.0 OUTLIER -69.94 -29.45 66.59 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.9 179.043 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -78.01 -39.54 41.82 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.432 ' O ' ' HB2' ' A' ' 90' ' ' SER . 1.8 m -61.79 -37.47 84.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.082 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.684 ' HA ' HG11 ' A' ' 70' ' ' VAL . 3.5 pp -78.18 -33.54 50.06 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.533 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -59.78 -52.0 67.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.668 179.074 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.508 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.85 -35.37 67.21 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.671 -179.909 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' ' 86' ' ' THR . 5.1 t -72.96 -29.85 63.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.851 0.357 . . . . 0.0 110.953 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.685 ' HE2' HD22 ' A' ' 26' ' ' LEU . 4.1 ptm -89.33 -18.23 27.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.283 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.28 29.71 6.59 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.021 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.508 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.4 OUTLIER -162.26 -30.24 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 179.897 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.426 ' HG3' HG22 ' A' ' 93' ' ' THR . 6.6 mt-10 -116.82 -44.84 2.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.905 0.383 . . . . 0.0 111.197 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.4 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -69.98 -30.22 70.21 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.908 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.74 ' HB2' HD11 ' A' ' 18' ' ' LEU . 3.2 t30 -76.59 -35.13 58.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.885 0.374 . . . . 0.0 110.173 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' A' ' 93' ' ' THR . 26.9 mtpt -42.57 -40.12 2.56 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.421 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.08 -25.59 16.39 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.529 179.332 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 117.56 -3.1 17.95 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.907 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.425 ' SD ' ' HB3' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -160.85 144.06 13.12 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.895 0.379 . . . . 0.0 111.156 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.562 HG22 HD21 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -111.81 145.1 18.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.423 -179.666 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.0 150.42 33.9 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.476 HD12 HG23 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -146.65 113.51 6.1 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.85 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 1.025 HD12 ' HB3' ' A' ' 69' ' ' ALA . 36.1 mt -107.32 112.91 42.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.784 178.296 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.912 HG12 HD23 ' A' ' 67' ' ' LEU . 22.1 m -123.27 -179.44 2.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.501 -179.078 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.704 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -147.76 132.4 17.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.488 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.59 ' HD2' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.323 0 CA-C-O 120.962 0.411 . . . . 0.0 111.412 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.48 HG21 ' HG2' ' A' ' 47' ' ' LYS . 1.6 mm . . . . . 0 N--CA 1.453 -0.285 0 CA-C-O 121.392 0.615 . . . . 0.0 111.264 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 20.5 m -96.47 97.76 9.69 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.665 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 12' ' ' LYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 29' ' ' SER . 13.6 ttmt -69.52 139.54 53.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.003 0.43 . . . . 0.0 111.145 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.564 HG23 ' O ' ' B' ' 13' ' ' VAL . 13.8 m . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.908 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.791 ' HA ' HD12 ' A' ' 109' ' ' ILE . 65.7 p -118.28 48.68 1.37 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.803 0.335 . . . . 0.0 110.867 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 13.5 mtm180 -144.34 132.35 21.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.477 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -142.7 134.67 27.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.046 0.451 . . . . 0.0 111.6 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.498 ' CE2' HD13 ' A' ' 68' ' ' ILE . 19.8 m-85 -79.02 149.93 32.06 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.238 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.618 HD12 HG23 ' A' ' 105' ' ' VAL . 0.3 OUTLIER -140.09 109.71 6.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.057 0.456 . . . . 0.0 111.649 -179.449 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.683 HG23 ' OE1' ' A' ' 102' ' ' GLN . 85.1 m -99.52 120.81 40.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.715 178.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.435 ' O ' ' N ' ' A' ' 103' ' ' LEU . 28.8 m-85 -134.61 153.87 51.76 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.466 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.2 OUTLIER -110.91 111.95 23.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.901 178.86 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.489 HG11 ' HG ' ' A' ' 26' ' ' LEU . 17.6 t -101.32 112.4 65.01 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -177.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.56 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 94.9 Cg_endo -83.5 127.5 4.43 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.591 2.194 . . . . 0.0 110.847 178.229 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.794 HD22 HD13 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -122.41 28.5 7.38 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -178.778 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.429 ' ND2' ' OD2' ' A' ' 20' ' ' ASP . 8.6 p-10 -39.02 -32.15 0.08 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.089 0.471 . . . . 0.0 111.17 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.429 ' OD2' ' ND2' ' A' ' 19' ' ' ASN . 27.7 m-20 -109.44 -34.81 6.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.255 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.417 ' HB3' ' CB ' ' A' ' 18' ' ' LEU . 39.9 t -71.97 -5.71 36.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.236 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.775 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -43.99 -30.18 1.68 Allowed Glycine 0 C--N 1.338 0.649 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.531 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.0 t -82.72 -38.52 23.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.915 0.388 . . . . 0.0 110.314 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -82.51 -1.74 51.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.395 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.1 -48.5 3.65 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.705 -0.759 . . . . 0.0 111.794 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.984 HD22 ' HE2' ' A' ' 91' ' ' MET . 8.1 tp -179.72 -32.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.585 0.231 . . . . 0.0 110.55 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.471 ' HA3' ' HA3' ' A' ' 53' ' ' GLY . . . 106.9 46.45 1.1 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.457 -0.877 . . . . 0.0 113.453 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.781 HG12 HG23 ' A' ' 49' ' ' ILE . 30.1 m -157.85 154.12 5.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.037 0.446 . . . . 0.0 111.831 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.07 121.72 45.74 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.2 m -106.04 148.02 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -155.48 129.15 8.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.071 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' A' ' 44' ' ' ILE . . . -107.88 166.53 13.14 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.864 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -113.2 -178.61 3.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.954 0.407 . . . . 0.0 110.93 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.04 135.82 24.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.242 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.489 ' OG ' HD21 ' A' ' 42' ' ' LEU . 1.6 m -48.35 143.58 4.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.823 0.345 . . . . 0.0 110.896 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.37 -49.16 67.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.532 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -95.33 -50.02 5.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.384 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 36.8 m-20 -66.04 -23.87 66.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.35 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 58.04 21.47 7.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.807 0.337 . . . . 0.0 110.964 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -94.18 135.52 35.47 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.871 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -46.57 132.05 10.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.536 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.489 HD21 ' OG ' ' A' ' 35' ' ' SER . 38.7 mt -100.79 17.98 20.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.041 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.83 177.67 46.49 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.616 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.902 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -105.78 152.49 7.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.918 0.389 . . . . 0.0 111.202 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.444 ' CE1' ' NE2' ' A' ' 66' ' ' GLN . 2.2 m-85 -135.39 138.21 43.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.708 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.697 ' O ' HG13 ' A' ' 63' ' ' VAL . 31.1 t -54.94 104.46 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.345 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.426 ' HD3' HD12 ' B' ' 10' ' ' ILE . 37.8 tptt -73.74 -42.71 60.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.757 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.5 t -168.95 119.16 0.72 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.182 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.781 HG23 HG12 ' A' ' 28' ' ' VAL . 80.8 mt -85.3 121.97 37.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.244 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.463 HD13 ' HA2' ' A' ' 27' ' ' GLY . 1.9 mp -59.52 107.17 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.371 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -61.17 78.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.887 0.375 . . . . 0.0 110.776 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 155.97 -28.68 0.59 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.194 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.471 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -67.19 -171.59 5.11 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.853 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.56 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -63.09 -40.72 98.5 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.578 ' HA ' HD13 ' A' ' 61' ' ' LEU . . . -64.91 -44.86 88.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.813 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.09 -28.48 66.53 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.592 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.4 mtpt -79.55 -28.23 41.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.061 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.2 -29.94 67.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.603 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.17 14.04 76.53 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.944 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -130.4 1.41 4.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.915 0.357 . . . . 0.0 111.34 179.866 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.689 ' HB3' HD13 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -103.38 128.43 50.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.882 0.372 . . . . 0.0 111.241 -179.755 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.612 HH21 HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -138.14 141.88 40.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.753 179.362 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.697 HG13 ' O ' ' A' ' 46' ' ' VAL . 39.0 t -55.91 146.15 5.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.213 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 18.0 m-20 87.27 13.56 0.11 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.378 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.454 ' O ' HG23 ' A' ' 46' ' ' VAL . 5.0 m-20 -93.4 120.6 33.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.721 0.296 . . . . 0.0 110.39 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.444 ' NE2' ' CE1' ' A' ' 45' ' ' PHE . 0.8 OUTLIER -78.2 135.05 37.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.763 -179.8 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.965 HD23 HG12 ' A' ' 105' ' ' VAL . 80.0 mt -85.25 140.9 30.5 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.841 0.353 . . . . 0.0 110.799 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.944 HD11 ' HB2' ' A' ' 106' ' ' ALA . 24.0 mt -123.17 -40.27 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.219 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.871 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -155.18 138.43 15.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.355 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.752 HG11 ' HA ' ' A' ' 87' ' ' LEU . 12.3 p -127.74 125.58 65.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.78 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.48 HD22 ' CA ' ' A' ' 95' ' ' GLY . 20.6 m120 61.21 27.0 16.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.724 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.53 25.32 56.96 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.002 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -130.4 104.38 7.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.692 0.282 . . . . 0.0 110.779 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.8 t -58.54 155.56 12.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.013 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.472 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . 1.0 OUTLIER -118.32 -9.55 10.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.697 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 30.0 mt -57.01 -20.66 25.4 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.666 0.27 . . . . 0.0 111.408 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -92.75 27.41 11.01 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.788 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.42 ' HD2' ' HA ' ' A' ' 83' ' ' ALA . 1.1 ptpm? -160.71 162.78 32.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.288 0.566 . . . . 0.0 111.189 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.12 164.03 16.38 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.391 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.408 ' O ' ' HG2' ' A' ' 84' ' ' MET . 20.3 m-80 -56.0 -57.51 11.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.812 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.408 ' HA ' ' HG2' ' A' ' 84' ' ' MET . 0.0 OUTLIER -54.76 -38.61 67.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.955 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.38 -36.16 73.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.007 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.578 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -69.17 -51.07 41.82 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.783 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.432 ' HA ' ' CD2' ' A' ' 87' ' ' LEU . 6.6 ptp -60.39 -29.04 68.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.801 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.39 -31.9 42.91 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.414 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 2.1 m -70.13 -35.79 74.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.291 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.853 HD12 ' N ' ' A' ' 88' ' ' ARG . 4.2 pp -78.0 -34.26 50.89 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.853 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -57.26 -50.45 72.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.339 178.988 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.488 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.33 -38.06 68.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.171 179.697 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 63.7 m -67.4 -29.1 68.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.929 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.984 ' HE2' HD22 ' A' ' 26' ' ' LEU . 2.6 ptp -88.25 -28.23 21.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.678 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -110.77 26.58 10.54 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.488 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.4 OUTLIER -156.06 -33.04 0.09 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.441 ' HG3' HG22 ' A' ' 93' ' ' THR . 7.6 mt-10 -115.56 -36.68 4.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.822 0.344 . . . . 0.0 111.138 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.48 ' CA ' HD22 ' A' ' 71' ' ' ASN . . . -80.44 -32.09 35.44 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.884 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.717 ' HB2' HD11 ' A' ' 18' ' ' LEU . 3.1 t30 -76.73 -34.33 58.11 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 93' ' ' THR . 48.4 mtpt -42.12 -32.49 0.47 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.473 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.97 -25.03 12.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.875 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 121.58 -7.63 10.34 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.789 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.467 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -157.02 144.66 19.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.89 0.376 . . . . 0.0 110.914 -179.895 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.557 HG22 HD21 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -108.3 143.69 18.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.412 -179.71 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.683 ' OE1' HG23 ' A' ' 13' ' ' THR . 1.1 tm0? -76.94 142.18 40.17 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -137.59 145.88 43.34 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.115 0.483 . . . . 0.0 112.115 -178.757 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.871 HD12 ' HB3' ' A' ' 69' ' ' ALA . 22.8 mt -139.1 112.77 6.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.468 178.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.965 HG12 HD23 ' A' ' 67' ' ' LEU . 27.4 m -132.15 150.14 33.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.855 0.36 . . . . 0.0 111.578 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.944 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -114.77 129.27 56.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.686 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.465 ' HB3' HD11 ' A' ' 12' ' ' LEU . 1.8 tmm_? -129.61 143.58 50.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.888 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 8' ' ' THR . 72.3 mtm-85 -85.59 148.28 26.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.971 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.791 HD12 ' HA ' ' A' ' 8' ' ' THR . 31.5 mt -73.41 108.7 5.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.114 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.829 -179.985 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.911 0.386 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -84.72 170.33 13.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.859 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -94.43 23.98 4.84 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.128 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 59.47 28.97 18.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.853 0.359 . . . . 0.0 110.968 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -139.66 30.85 2.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.83 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.31 -165.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.902 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? 178.75 147.14 0.17 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.145 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.426 HD12 ' HD3' ' A' ' 47' ' ' LYS . 1.0 OUTLIER -108.23 155.29 9.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.929 0.395 . . . . 0.0 111.203 -179.386 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 66.1 m -138.3 115.91 11.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.732 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -69.94 115.23 8.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.836 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.721 HG12 ' HG3' ' A' ' 88' ' ' ARG . 15.3 m . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.298 -0.858 . . . . 0.0 111.121 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.378 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.5 p -143.03 24.16 1.84 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.627 0.251 . . . . 0.0 110.981 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.6 ttp180 -78.06 146.99 34.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.923 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -155.11 148.09 24.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.04 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -88.01 146.18 25.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.604 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.918 HD12 HG23 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -140.82 109.86 6.14 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.9 0.381 . . . . 0.0 111.333 -179.504 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.5 m -80.55 145.49 31.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.979 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.438 ' CD1' ' HG3' ' A' ' 60' ' ' ARG . 12.8 m-85 -140.28 171.41 14.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.368 0.604 . . . . 0.0 112.132 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -143.55 103.43 4.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.028 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.6 HG11 ' HG ' ' A' ' 26' ' ' LEU . 17.8 t -104.83 112.05 65.26 Favored Pre-proline 0 C--N 1.329 -0.302 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -177.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.593 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 93.7 Cg_endo -83.46 127.53 4.46 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.413 2.076 . . . . 0.0 110.798 178.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.744 HD22 HD13 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -120.85 27.96 8.2 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.848 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -40.93 -30.2 0.12 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.999 0.428 . . . . 0.0 110.744 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -114.87 -31.47 6.1 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.174 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.582 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 43.0 t -72.65 -7.55 50.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.139 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.637 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -45.27 -28.3 2.05 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.624 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.6 m -85.44 -34.86 21.58 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.942 0.401 . . . . 0.0 110.677 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.14 8.97 24.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.526 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.62 -56.23 5.02 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.932 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.799 HD22 ' HE2' ' A' ' 91' ' ' MET . 9.7 tp -178.8 -27.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.518 0.199 . . . . 0.0 111.155 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.485 ' HA3' ' HA3' ' A' ' 53' ' ' GLY . . . 109.75 35.54 2.2 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.31 -0.948 . . . . 0.0 113.536 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.702 HG12 HG23 ' A' ' 49' ' ' ILE . 13.0 m -158.95 157.75 3.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 117.08 0.44 . . . . 0.0 111.538 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.533 ' O ' ' N ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -114.15 134.94 54.55 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.711 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.614 HG11 HD11 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -120.65 143.56 32.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.119 0.485 . . . . 0.0 111.896 -178.809 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.56 ' HB3' HD13 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -142.12 129.71 21.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.587 179.666 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -102.7 153.3 18.32 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.991 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.746 HD21 ' HE2' ' A' ' 45' ' ' PHE . 82.5 m-20 -125.28 175.25 7.57 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.009 0.433 . . . . 0.0 111.252 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.5 mtt85 -122.57 157.42 32.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.736 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.729 ' CA ' HD21 ' A' ' 42' ' ' LEU . 19.5 m -51.28 155.86 1.3 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.269 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.05 -39.59 86.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.111 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.58 -78.68 0.18 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.958 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -81.64 -175.77 5.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.834 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -98.32 29.91 3.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.942 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.24 115.84 14.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.098 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.41 ' CB ' ' ND2' ' A' ' 80' ' ' ASN . 1.2 p30 -59.08 119.62 7.63 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.951 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.729 HD21 ' CA ' ' A' ' 35' ' ' SER . 17.4 mt -75.58 -26.42 57.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.872 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.466 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 133.21 -176.69 19.45 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.121 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.906 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -107.32 134.53 48.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.876 0.369 . . . . 0.0 111.262 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.746 ' HE2' HD21 ' A' ' 33' ' ' ASN . 0.2 OUTLIER -117.55 144.08 45.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.565 -179.79 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.674 ' O ' HG13 ' A' ' 63' ' ' VAL . 21.3 t -54.54 106.36 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.124 0.488 . . . . 0.0 110.941 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.599 ' HG3' HG23 ' B' ' 10' ' ' ILE . 0.5 OUTLIER -65.99 -52.58 48.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.638 179.86 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.6 t -169.41 133.86 1.4 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.388 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.709 HD13 ' HB3' ' A' ' 61' ' ' LEU . 65.8 mt -95.06 116.55 36.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.083 0.468 . . . . 0.0 111.826 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.505 HD12 ' N ' ' A' ' 28' ' ' VAL . 2.3 mp -58.09 115.9 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.199 178.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -68.23 69.86 0.15 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.068 0.461 . . . . 0.0 110.69 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 168.21 -29.62 0.16 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.375 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.485 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -68.02 -172.33 6.6 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.907 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.593 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -62.98 -40.87 99.03 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.646 ' CB ' HD13 ' A' ' 61' ' ' LEU . . . -64.69 -48.06 76.09 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.936 0.398 . . . . 0.0 111.561 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.3 t -63.35 -30.66 71.75 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.216 0.531 . . . . 0.0 110.09 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 39.5 mtpt -76.68 -28.85 56.09 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.055 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.72 -29.26 64.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.882 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 68.05 16.51 68.71 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.202 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.438 ' HG3' ' CD1' ' A' ' 14' ' ' PHE . 0.8 OUTLIER -138.47 11.57 2.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.908 0.354 . . . . 0.0 111.274 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.709 ' HB3' HD13 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -106.68 134.92 49.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.689 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.854 ' NH2' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -139.12 144.57 38.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.85 179.774 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.674 HG13 ' O ' ' A' ' 46' ' ' VAL . 46.2 t -61.89 148.69 9.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.085 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 23.7 m-20 88.11 -10.46 0.51 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.431 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.659 ' O ' HG23 ' A' ' 46' ' ' VAL . 1.2 m-20 -66.5 115.05 5.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.769 0.318 . . . . 0.0 110.626 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.468 ' O ' ' HA ' ' A' ' 105' ' ' VAL . 18.3 tm0? -69.16 135.86 51.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.699 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.908 HD23 HG12 ' A' ' 105' ' ' VAL . 93.2 mt -87.75 139.85 30.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.849 0.357 . . . . 0.0 111.148 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.629 HD11 ' HB2' ' A' ' 106' ' ' ALA . 2.4 mt -122.28 -44.36 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.888 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 1.028 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -147.83 145.57 28.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.702 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.765 HG22 HD22 ' A' ' 71' ' ' ASN . 7.1 p -132.68 130.0 58.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.313 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.765 HD22 HG22 ' A' ' 70' ' ' VAL . 23.7 m-80 61.2 26.95 16.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.819 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.97 23.69 59.05 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.389 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -131.89 108.7 9.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.804 0.335 . . . . 0.0 110.864 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.0 t -59.21 154.67 15.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.711 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.508 HD21 HG12 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -115.8 -15.59 11.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.582 -179.723 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.414 ' CD2' HG23 ' A' ' 68' ' ' ILE . 4.1 mm? -46.66 -44.13 18.25 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.942 0.401 . . . . 0.0 111.173 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -57.51 -35.47 72.86 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.574 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.4 ptpm? -101.31 168.12 9.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.286 0.565 . . . . 0.0 111.297 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.45 ' HB3' HE22 ' A' ' 81' ' ' GLN . . . -71.34 174.73 6.12 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.542 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.432 ' HB2' ' HA3' ' A' ' 32' ' ' GLY . 8.1 p30 -67.0 -52.26 44.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.581 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.45 HE22 ' HB3' ' A' ' 79' ' ' ALA . 5.1 pm0 -58.12 -41.26 83.24 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.931 0.396 . . . . 0.0 110.483 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -70.45 -37.85 74.38 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.505 ' HB3' ' CD1' ' A' ' 44' ' ' ILE . . . -66.77 -33.49 75.73 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.229 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.522 ' HE2' ' HB2' ' A' ' 84' ' ' MET . 0.0 OUTLIER -72.54 -32.32 66.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.981 179.236 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -78.48 -35.38 46.62 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.38 178.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.445 ' HA ' ' HD2' ' A' ' 89' ' ' ARG . 1.5 m -67.28 -35.72 80.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.311 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.74 HD12 ' N ' ' A' ' 88' ' ' ARG . 4.4 pp -78.31 -33.71 49.18 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.74 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -63.24 -50.84 68.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.788 179.312 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.445 ' HD2' ' HA ' ' A' ' 86' ' ' THR . 0.0 OUTLIER -73.03 -34.62 66.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.065 179.771 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.415 ' O ' ' ND2' ' A' ' 71' ' ' ASN . 55.9 m -72.19 -31.64 66.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.77 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.799 ' HE2' HD22 ' A' ' 26' ' ' LEU . 3.8 ptm -88.08 -18.72 28.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.614 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.01 18.14 14.73 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.472 HG22 ' HG3' ' A' ' 94' ' ' GLU . 0.4 OUTLIER -153.28 -37.99 0.1 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.898 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.52 ' HA ' ' CG ' ' A' ' 97' ' ' LYS . 8.6 mt-10 -104.15 -42.01 5.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.003 0.43 . . . . 0.0 111.742 -178.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.424 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -68.44 -37.94 86.25 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.806 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.677 ' HB2' HD11 ' A' ' 18' ' ' LEU . 4.2 t30 -67.13 -33.76 76.14 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.52 ' CG ' ' HA ' ' A' ' 94' ' ' GLU . 4.2 mmmt -31.42 -51.8 0.2 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.464 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.95 -27.48 16.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.757 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 122.8 1.11 9.84 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.813 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.482 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -161.77 142.55 10.76 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 121.038 0.447 . . . . 0.0 111.371 -179.743 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.565 HD11 HG23 ' A' ' 70' ' ' VAL . 0.1 OUTLIER -114.81 138.64 44.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.853 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.42 ' HA ' ' O ' ' A' ' 14' ' ' PHE . 2.2 pp0? -76.54 149.91 36.63 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.463 HD13 HG21 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -140.99 111.16 6.67 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.778 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 1.028 HD12 ' HB3' ' A' ' 69' ' ' ALA . 45.6 mt -98.35 112.77 31.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.918 HG23 HD12 ' A' ' 12' ' ' LEU . 18.1 m -124.28 152.42 30.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.454 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.629 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -124.95 148.11 48.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.113 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.769 ' HG3' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -160.59 171.85 18.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.98 179.797 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 21.4 mtm180 -94.22 135.08 35.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.009 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 7.1 mt -62.61 115.22 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.02 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 46.6 t . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.896 -179.998 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.848 0.356 . . . . 0.0 110.755 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -78.75 170.07 17.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.964 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.41 39.1 1.73 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.536 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 74.34 114.8 0.06 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.695 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 63.02 80.58 0.23 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.75 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 1.1 m -81.46 -93.58 0.05 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.93 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 167.15 154.79 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.599 HG23 ' HG3' ' A' ' 47' ' ' LYS . 4.2 mm -136.36 109.18 8.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.976 0.417 . . . . 0.0 111.333 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 11' ' ' THR . . . . . 0.42 ' CB ' ' HG2' ' A' ' 84' ' ' MET . 3.5 m -94.33 97.93 10.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.664 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -73.93 127.81 33.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.121 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 18.4 m . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.562 -0.732 . . . . 0.0 110.693 179.683 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.422 -0.271 . . . . 0.0 112.422 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.3 p -124.05 20.89 9.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.679 0.276 . . . . 0.0 111.029 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 12.0 mtm180 -104.63 121.37 43.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.872 0.368 . . . . 0.0 110.708 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.27 169.1 18.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.069 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.568 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 2.4 p90 -112.36 148.34 34.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.645 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.889 HD11 ' HD2' ' A' ' 107' ' ' ARG . 0.1 OUTLIER -129.14 120.72 26.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.36 -178.988 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.0 m -83.15 145.43 29.21 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.336 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.435 ' CD1' ' HB3' ' A' ' 60' ' ' ARG . 63.8 m-85 -140.67 171.35 14.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.383 0.611 . . . . 0.0 112.219 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -140.13 106.99 5.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.214 -0.903 . . . . 0.0 108.902 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.776 ' CG2' HD11 ' A' ' 61' ' ' LEU . 17.3 t -105.61 117.75 57.2 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 -177.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.727 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 90.2 Cg_endo -86.69 128.18 2.84 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.764 2.309 . . . . 0.0 110.936 178.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.746 HD11 ' HB2' ' A' ' 96' ' ' ASN . 0.5 OUTLIER -122.77 28.63 7.19 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -178.717 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -40.91 -30.57 0.13 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.167 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -113.01 -32.53 6.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.14 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.706 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 41.7 t -70.74 -6.56 38.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.182 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.603 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -42.97 -30.03 0.95 Allowed Glycine 0 C--N 1.337 0.605 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.664 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.8 m -83.16 -40.37 19.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.885 0.374 . . . . 0.0 110.434 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.98 -5.79 56.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.266 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.92 -46.8 3.12 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.953 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.888 HD22 ' HE2' ' A' ' 91' ' ' MET . 6.2 tp 178.79 -33.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.661 0.267 . . . . 0.0 110.677 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.452 ' HA3' ' HA3' ' A' ' 53' ' ' GLY . . . 102.96 49.86 1.12 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.442 -0.885 . . . . 0.0 113.565 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.785 HG12 HG23 ' A' ' 49' ' ' ILE . 34.2 m -158.41 154.81 4.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 117.053 0.426 . . . . 0.0 111.78 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.439 ' O ' ' HB3' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -112.24 111.12 21.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.343 178.606 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.535 HG11 HD11 ' A' ' 67' ' ' LEU . 2.3 m -106.93 141.93 20.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.09 0.471 . . . . 0.0 111.843 -178.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.417 ' HB3' HG23 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -145.94 129.68 17.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.199 179.423 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -91.33 158.09 25.28 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.017 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.46 ' ND2' ' HG2' ' B' ' 4' ' ' GLU . 3.4 m120 -114.0 -178.76 3.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.9 0.381 . . . . 0.0 110.929 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 67.9 mtt180 -135.96 152.67 51.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.541 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.469 ' OG ' HD21 ' A' ' 42' ' ' LEU . 50.1 m -54.36 144.38 20.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.041 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.75 -33.39 75.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.981 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.14 -68.47 0.7 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.891 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -94.3 -173.41 3.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.85 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 65.2 m-70 -101.53 31.1 3.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.036 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.74 128.34 34.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.953 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.401 ' CB ' ' ND2' ' A' ' 80' ' ' ASN . 3.7 p-10 -57.18 149.0 20.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.137 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.469 HD21 ' OG ' ' A' ' 35' ' ' SER . 35.7 mt -113.14 -1.0 14.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.323 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.475 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 113.7 169.83 17.07 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.313 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.762 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -102.82 131.23 51.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.709 0.29 . . . . 0.0 110.951 179.757 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.445 ' N ' ' CD1' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -119.54 144.95 46.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.866 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.715 ' O ' HG13 ' A' ' 63' ' ' VAL . 39.0 t -60.78 104.57 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.641 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.439 ' HB3' ' O ' ' A' ' 29' ' ' SER . 2.2 tptt -73.71 -42.26 61.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.569 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.48 119.64 1.05 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.113 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.785 HG23 HG12 ' A' ' 28' ' ' VAL . 68.0 mt -85.18 117.8 30.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.015 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.556 HD12 ' N ' ' A' ' 28' ' ' VAL . 1.6 mp -55.72 106.6 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.462 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -64.64 74.2 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.014 0.435 . . . . 0.0 110.73 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 162.6 -26.4 0.23 Allowed Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.326 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.452 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -71.19 -163.46 5.41 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.85 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.727 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -71.28 -41.61 69.8 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.65 ' HB1' HD22 ' A' ' 61' ' ' LEU . . . -65.34 -43.4 91.02 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.317 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.652 ' OG ' HG22 ' A' ' 49' ' ' ILE . 1.2 m -67.5 -36.13 80.48 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.889 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -68.85 -33.95 74.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.597 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -60.24 -26.78 66.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.756 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 58.54 26.76 60.16 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.368 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.435 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 8.7 mtm180 -121.39 -28.52 4.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.63 0.252 . . . . 0.0 111.109 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.776 HD11 ' CG2' ' A' ' 16' ' ' VAL . 4.2 mp -75.91 151.1 37.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.136 0.493 . . . . 0.0 111.677 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.765 HH22 HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -146.56 131.53 18.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.172 179.701 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.715 HG13 ' O ' ' A' ' 46' ' ' VAL . 47.3 t -57.69 141.69 14.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.121 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.466 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 28.4 m-20 89.91 17.41 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.577 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -103.28 123.44 46.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.327 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.427 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -81.52 136.41 35.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.789 0.328 . . . . 0.0 110.793 -179.583 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.762 HD12 HG13 ' A' ' 44' ' ' ILE . 7.9 mt -87.51 131.21 34.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.569 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 1.021 HD11 ' HB2' ' A' ' 106' ' ' ALA . 34.5 mt -110.98 -33.97 2.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.614 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.934 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -153.34 157.47 40.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.132 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.804 HG22 ' ND2' ' A' ' 71' ' ' ASN . 8.4 p -142.25 126.42 15.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.387 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.804 ' ND2' HG22 ' A' ' 70' ' ' VAL . 66.1 m-80 60.68 18.87 8.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.74 0.305 . . . . 0.0 110.931 -179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.0 27.46 23.58 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.118 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -129.04 101.27 5.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.826 0.346 . . . . 0.0 110.828 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.0 t -65.33 148.5 51.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.05 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.62 HD22 ' HB1' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -130.61 14.43 5.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.234 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.5 tp -60.47 -22.5 63.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.725 0.297 . . . . 0.0 111.04 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -82.06 -27.21 46.01 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.662 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.4 ' HD3' ' HB3' ' A' ' 82' ' ' GLU . 1.6 ptpm? -96.05 171.31 8.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.174 0.512 . . . . 0.0 111.24 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.81 165.02 25.27 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.467 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.402 ' HB2' ' HA3' ' A' ' 32' ' ' GLY . 8.4 p30 -57.0 -47.95 79.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.252 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.402 ' N ' ' OD1' ' A' ' 80' ' ' ASN . 0.0 OUTLIER -59.77 -43.86 94.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.907 0.384 . . . . 0.0 110.938 -179.893 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.4 ' HB3' ' HD3' ' A' ' 78' ' ' LYS . 1.7 mm-40 -70.01 -32.57 70.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.853 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.62 ' HB1' HD22 ' A' ' 75' ' ' LEU . . . -69.16 -47.42 65.05 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.619 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.546 ' HB3' HG21 ' A' ' 44' ' ' ILE . 6.8 ptp -61.96 -31.64 71.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.101 0.477 . . . . 0.0 109.863 178.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.11 -34.75 66.34 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.442 ' HB ' ' O ' ' A' ' 83' ' ' ALA . 2.1 m -62.97 -34.21 77.03 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.141 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.703 HD13 HD13 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -76.24 -35.05 59.17 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.868 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.4 ' HG3' ' CG1' ' B' ' 13' ' ' VAL . 0.0 OUTLIER -58.06 -51.84 68.03 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.772 179.416 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.482 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -71.57 -43.42 66.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.612 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.435 ' HB2' ' O ' ' A' ' 86' ' ' THR . 1.6 t -65.6 -29.55 70.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.174 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.888 ' HE2' HD22 ' A' ' 26' ' ' LEU . 2.2 ptp -89.58 -19.88 24.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.629 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.21 27.56 8.75 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 -179.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.3 OUTLIER -162.19 -31.23 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.956 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.435 ' HA ' ' HG3' ' A' ' 97' ' ' LYS . 7.4 mt-10 -111.62 -72.49 0.71 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.788 0.328 . . . . 0.0 111.55 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.435 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -49.2 -29.67 9.89 Favored Glycine 0 CA--C 1.517 0.204 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.633 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.746 ' HB2' HD11 ' A' ' 18' ' ' LEU . 2.4 t30 -73.68 -34.59 64.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.856 0.36 . . . . 0.0 110.257 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.435 ' HG3' ' HA ' ' A' ' 94' ' ' GLU . 8.9 mtpp -40.01 -34.6 0.3 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.47 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.87 -25.05 12.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.705 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 122.64 -8.3 9.44 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.006 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.435 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -154.48 144.2 21.6 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.924 0.392 . . . . 0.0 111.53 -179.636 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.481 HG22 HD21 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -110.52 140.54 29.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.034 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.408 ' HB3' ' HA ' ' A' ' 71' ' ' ASN . 5.2 tt0 -76.88 150.48 36.03 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.534 HD12 HG23 ' A' ' 16' ' ' VAL . 0.5 OUTLIER -143.54 111.03 5.86 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -178.999 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.934 HD12 ' HB3' ' A' ' 69' ' ' ALA . 36.5 mt -102.0 113.33 38.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.732 178.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.752 HG23 HD12 ' A' ' 12' ' ' LEU . 4.4 m -116.83 174.9 3.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.058 0.456 . . . . 0.0 111.664 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 1.021 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -147.38 137.02 22.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.998 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.889 ' HD2' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -156.5 -178.18 7.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.709 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -107.58 133.73 51.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.906 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 47.1 mt -64.81 105.38 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.93 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.7 t . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.868 179.99 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.828 0.347 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 4' ' ' GLU . . . . . 0.46 ' HG2' ' ND2' ' A' ' 33' ' ' ASN . 1.7 mt-10 -112.45 163.48 14.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.967 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -98.9 31.75 2.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.746 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 60.94 81.53 0.19 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.801 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 26.8 m170 58.89 102.63 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.702 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.72 -87.96 0.39 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.134 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? 170.21 151.71 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.417 HG23 ' HB3' ' A' ' 31' ' ' LYS . 1.6 mm -112.09 144.54 19.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.991 0.424 . . . . 0.0 111.237 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 99.0 m -119.27 99.48 6.72 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.687 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 9.3 ttmt -72.66 122.63 21.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.001 0.429 . . . . 0.0 110.946 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.4 ' CG1' ' HG3' ' A' ' 88' ' ' ARG . 35.4 m . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.123 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 N-CA-C 112.544 -0.222 . . . . 0.0 112.544 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.402 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 28.8 p -135.54 69.57 1.44 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.891 0.376 . . . . 0.0 110.895 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.02 123.15 9.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.728 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -136.82 137.53 39.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.373 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -83.85 149.91 26.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.539 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.836 HD22 ' NH2' ' A' ' 62' ' ' ARG . 0.2 OUTLIER -136.72 109.83 7.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.97 0.414 . . . . 0.0 111.273 -179.639 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.78 HG23 ' OE1' ' A' ' 102' ' ' GLN . 39.6 m -101.15 127.85 47.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.584 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.463 ' CZ ' ' HB3' ' A' ' 60' ' ' ARG . 29.5 m-85 -140.86 172.62 12.44 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.424 0.63 . . . . 0.0 112.327 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.495 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.4 OUTLIER -126.38 112.43 15.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.021 179.131 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.917 HG23 HD23 ' A' ' 103' ' ' LEU . 21.9 t -104.77 111.7 65.24 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -177.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.562 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 85.8 Cg_endo -83.3 127.64 4.6 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.431 2.087 . . . . 0.0 110.738 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.888 HD11 ' HB2' ' A' ' 96' ' ' ASN . 0.5 OUTLIER -121.54 27.99 7.95 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -178.893 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -39.86 -31.06 0.1 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.289 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -112.23 -32.04 6.66 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.163 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.516 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 12.6 t -70.51 -6.0 33.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.181 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.617 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -43.83 -29.85 1.48 Allowed Glycine 0 C--N 1.337 0.621 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.732 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.39 -36.09 22.68 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.971 0.415 . . . . 0.0 110.598 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.79 -6.71 59.49 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.377 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.25 -47.47 2.87 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.948 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.959 HD22 ' HE2' ' A' ' 91' ' ' MET . 6.8 tp 178.47 -29.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.589 0.233 . . . . 0.0 110.824 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.494 ' HA3' ' HA3' ' A' ' 53' ' ' GLY . . . 104.58 42.67 1.82 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.501 -0.857 . . . . 0.0 113.3 179.173 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.779 HG12 HG23 ' A' ' 49' ' ' ILE . 33.1 m -157.15 158.5 3.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.206 0.527 . . . . 0.0 111.988 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -117.1 118.03 31.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.208 178.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.626 HG11 HD11 ' A' ' 67' ' ' LEU . 2.5 m -106.35 149.61 9.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.228 0.537 . . . . 0.0 112.379 -178.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.404 ' HG2' ' CD ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -148.38 130.77 15.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.026 179.415 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' A' ' 44' ' ' ILE . . . -104.76 161.59 15.04 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.266 -0.969 . . . . 0.0 113.115 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 -130.67 170.93 13.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.968 0.413 . . . . 0.0 110.907 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.26 154.24 31.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.621 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.845 ' HA ' HD21 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -47.45 149.21 1.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.302 -179.884 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.42 -47.97 68.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.359 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.477 ' HG3' ' ND2' ' A' ' 38' ' ' ASN . 3.6 pt-20 -73.59 -50.07 23.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.328 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.477 ' ND2' ' HG3' ' A' ' 37' ' ' GLU . 1.4 p30 -121.14 168.36 11.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.746 0.308 . . . . 0.0 111.039 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -83.41 57.78 4.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.143 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.548 ' HB3' ' HB2' ' A' ' 35' ' ' SER . . . -103.04 109.49 21.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.765 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.404 ' HB3' ' ND2' ' A' ' 80' ' ' ASN . 37.4 m-20 -45.91 119.29 2.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.722 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.845 HD21 ' HA ' ' A' ' 35' ' ' SER . 8.8 mt -88.24 -1.3 57.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.009 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.426 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 106.91 -174.62 20.12 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.172 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.796 ' CG1' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -111.41 138.34 40.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.907 0.384 . . . . 0.0 111.284 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.71 141.5 49.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.629 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.672 ' O ' HG13 ' A' ' 63' ' ' VAL . 38.6 t -54.7 107.2 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.841 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.475 ' HD3' HD12 ' B' ' 10' ' ' ILE . 21.2 tptt -77.21 -41.47 41.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.627 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.6 m -167.5 123.91 1.13 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.06 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.779 HG23 HG12 ' A' ' 28' ' ' VAL . 69.3 mt -90.92 124.26 43.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.359 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.446 HD12 ' N ' ' A' ' 28' ' ' VAL . 2.1 mp -63.89 110.28 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.379 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.13 70.98 0.06 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.084 0.469 . . . . 0.0 110.892 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 166.98 -27.45 0.16 Allowed Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.111 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.494 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -70.04 -166.85 5.92 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.944 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.562 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -68.64 -41.09 79.89 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.711 ' HB1' HD22 ' A' ' 61' ' ' LEU . . . -66.65 -41.12 88.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.57 -179.154 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 t -70.07 -33.3 71.74 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.139 0.495 . . . . 0.0 110.116 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.3 mtpt -73.62 -29.05 62.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.076 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.78 -29.96 67.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.565 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 68.52 15.74 68.74 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.824 -0.703 . . . . 0.0 113.005 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.463 ' HB3' ' CZ ' ' A' ' 14' ' ' PHE . 0.5 OUTLIER -129.0 -0.72 5.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.764 0.282 . . . . 0.0 111.222 179.832 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.711 HD22 ' HB1' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -99.23 132.98 44.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.91 0.386 . . . . 0.0 111.18 -179.67 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.836 ' NH2' HD22 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -138.27 142.47 39.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.769 179.546 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.672 HG13 ' O ' ' A' ' 46' ' ' VAL . 55.0 t -56.41 147.04 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.175 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 29.9 m-20 89.76 -10.47 0.37 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.371 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -63.62 107.26 1.11 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.821 0.343 . . . . 0.0 110.729 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 21.4 tm0? -71.5 114.0 9.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.608 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.94 HD23 ' CG1' ' A' ' 105' ' ' VAL . 7.9 mt -68.07 142.7 55.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.958 0.408 . . . . 0.0 111.561 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.711 HD11 ' CB ' ' A' ' 106' ' ' ALA . 36.6 mt -129.18 -34.92 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.374 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.976 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -148.65 166.26 28.86 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.896 0.379 . . . . 0.0 111.288 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.631 HG22 ' ND2' ' A' ' 71' ' ' ASN . 12.3 p -155.19 118.85 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.903 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.631 ' ND2' HG22 ' A' ' 70' ' ' VAL . 68.5 m-80 56.72 43.82 24.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.556 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 70.93 23.54 77.94 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.722 -0.752 . . . . 0.0 111.966 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -122.55 97.37 5.43 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.778 0.323 . . . . 0.0 110.862 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.82 119.37 13.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.929 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.635 HD13 ' HB1' ' A' ' 83' ' ' ALA . 9.8 mt -72.27 -15.65 61.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.175 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 21.6 mt -52.2 93.13 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.892 0.377 . . . . 0.0 111.013 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 151.51 -24.16 0.95 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.415 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.5 ptpm? -111.93 167.75 10.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.165 0.507 . . . . 0.0 111.072 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.4 ' HB3' ' NE2' ' A' ' 81' ' ' GLN . . . -74.02 165.13 25.67 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.279 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.43 ' HB3' ' HA3' ' A' ' 32' ' ' GLY . 22.2 m-80 -52.29 -57.47 9.65 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.258 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.413 ' HA ' ' HG2' ' A' ' 84' ' ' MET . 2.6 pp0? -53.82 -38.75 64.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.399 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.85 -38.88 73.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.277 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.635 ' HB1' HD13 ' A' ' 75' ' ' LEU . . . -66.76 -47.88 70.82 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.746 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.498 ' HB3' HG21 ' A' ' 44' ' ' ILE . 5.0 ptp -63.13 -29.7 71.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.977 179.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.66 -32.36 47.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.385 178.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.444 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 1.4 m -69.03 -36.59 77.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.348 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.479 ' CD2' ' HA ' ' A' ' 84' ' ' MET . 4.4 pp -78.46 -33.82 48.13 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.75 ' HG3' HG12 ' B' ' 13' ' ' VAL . 1.1 ttt180 -58.4 -51.69 68.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.465 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.575 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.27 -33.88 67.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.195 179.814 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.435 ' HB2' ' O ' ' A' ' 86' ' ' THR . 5.3 t -70.45 -29.17 65.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.25 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.959 ' HE2' HD22 ' A' ' 26' ' ' LEU . 4.2 ptp -88.77 -20.27 24.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.533 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.75 39.57 3.93 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.165 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.575 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.5 OUTLIER -171.71 -22.22 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 179.696 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.479 ' HG3' HG22 ' A' ' 93' ' ' THR . 12.0 mt-10 -127.9 -59.0 1.21 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.91 0.386 . . . . 0.0 111.091 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.438 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -67.52 -25.28 73.87 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.998 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.888 ' HB2' HD11 ' A' ' 18' ' ' LEU . 1.3 t30 -78.44 -32.93 48.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.966 0.412 . . . . 0.0 110.24 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.497 ' HD3' ' O ' ' A' ' 93' ' ' THR . 10.5 mmmt -44.22 -40.14 4.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.258 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.63 -28.29 19.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.743 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 122.74 -7.43 9.51 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.951 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.495 ' SD ' ' HB3' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -157.05 143.45 18.14 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.061 0.458 . . . . 0.0 111.29 -179.709 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.91 HD11 HD11 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -113.94 146.99 17.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.188 -179.713 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.78 ' OE1' HG23 ' A' ' 13' ' ' THR . 1.2 tm0? -87.86 139.94 30.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.095 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.917 HD23 HG23 ' A' ' 16' ' ' VAL . 2.5 mm? -131.73 141.87 49.64 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.131 0.491 . . . . 0.0 112.046 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.976 HD12 ' HB3' ' A' ' 69' ' ' ALA . 73.5 mt -127.09 112.31 28.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.94 ' CG1' HD23 ' A' ' 67' ' ' LEU . 29.8 m -132.5 133.08 60.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.825 -178.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.711 ' CB ' HD11 ' A' ' 68' ' ' ILE . . . -108.93 139.48 43.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.254 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.655 ' CG ' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -134.52 175.77 9.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.991 0.424 . . . . 0.0 111.382 -179.699 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' A' ' 8' ' ' THR . 5.1 mtm180 -97.76 143.77 28.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.175 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 19.4 mt -87.15 109.85 19.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.937 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 76.6 p . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.013 -179.89 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.886 0.374 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -102.34 166.17 10.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.844 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.82 34.45 4.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.904 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 60.83 169.33 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.808 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 59.2 m170 60.95 30.21 19.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.934 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.0 -175.0 0.53 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.839 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 9' ' ' GLN . . . . . 0.408 ' O ' ' NE2' ' B' ' 9' ' ' GLN . 1.2 pp0? -178.67 156.61 0.89 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.044 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.475 HD12 ' HD3' ' A' ' 47' ' ' LYS . 1.0 OUTLIER -116.53 155.15 18.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.893 0.378 . . . . 0.0 111.128 -179.536 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 11' ' ' THR . . . . . 0.402 HG22 HG13 ' B' ' 13' ' ' VAL . 53.2 m -126.75 134.56 50.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.974 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.27 109.48 16.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.63 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.75 HG12 ' HG3' ' A' ' 88' ' ' ARG . 16.8 m . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.151 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 N-CA-C 112.523 -0.231 . . . . 0.0 112.523 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.407 ' O ' HG13 ' A' ' 109' ' ' ILE . 82.8 p -88.3 -27.22 21.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.773 0.321 . . . . 0.0 111.071 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.406 ' HA ' ' O ' ' A' ' 107' ' ' ARG . 3.3 ttt180 -76.76 113.37 14.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.821 0.343 . . . . 0.0 110.611 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -130.19 156.8 43.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.013 0.435 . . . . 0.0 111.596 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.4 ' CE2' HG12 ' A' ' 68' ' ' ILE . 13.6 m-85 -95.99 151.21 19.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.695 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.997 HD12 HG23 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -137.3 110.99 8.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.885 -179.757 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.635 HG23 ' OE1' ' A' ' 102' ' ' GLN . 97.2 m -97.6 130.63 44.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.639 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.463 ' CZ ' ' HB3' ' A' ' 12' ' ' LEU . 28.4 m-85 -140.87 172.47 12.64 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.26 0.553 . . . . 0.0 112.416 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.439 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.5 OUTLIER -126.98 111.7 14.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.051 179.086 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.906 HG23 HD23 ' A' ' 103' ' ' LEU . 34.3 t -104.26 116.66 60.97 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -177.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.523 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 89.7 Cg_endo -88.57 126.53 1.86 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.47 2.113 . . . . 0.0 110.846 178.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.815 HD11 ' HB2' ' A' ' 96' ' ' ASN . 0.3 OUTLIER -116.16 29.09 8.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.716 0.293 . . . . 0.0 111.547 -178.823 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -38.6 -31.72 0.06 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.434 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -112.2 -32.07 6.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.312 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 t -74.39 -5.49 42.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.181 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.782 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -43.88 -28.77 1.26 Allowed Glycine 0 C--N 1.336 0.561 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.942 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.1 p -88.26 -33.04 18.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.762 0.315 . . . . 0.0 110.897 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.47 9.02 28.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.531 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.62 -54.39 4.95 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.966 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.933 HD22 ' HE2' ' A' ' 91' ' ' MET . 8.4 tp -175.12 -36.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.628 0.252 . . . . 0.0 110.811 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.494 ' HA3' ' HA3' ' A' ' 53' ' ' GLY . . . 114.83 44.91 0.67 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.4 -0.905 . . . . 0.0 113.295 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.803 HG12 HG23 ' A' ' 49' ' ' ILE . 33.1 m -157.24 160.56 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.189 0.518 . . . . 0.0 111.727 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.42 ' O ' ' HB3' ' A' ' 47' ' ' LYS . 0.7 OUTLIER -117.44 110.3 17.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.31 178.774 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.618 HG11 HD11 ' A' ' 67' ' ' LEU . 4.3 m -106.9 137.97 35.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.949 0.404 . . . . 0.0 111.717 -178.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.505 ' CB ' HD13 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -141.46 129.63 22.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.431 179.452 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -89.23 156.92 26.47 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.539 -0.838 . . . . 0.0 113.055 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -128.29 145.22 51.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.827 0.346 . . . . 0.0 110.93 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 45.3 mtt85 -96.22 147.63 23.56 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.646 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.862 ' HA ' HD21 ' A' ' 42' ' ' LEU . 12.4 t -45.64 141.93 2.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.405 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -25.15 64.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.049 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -85.46 -72.18 0.5 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.8 0.333 . . . . 0.0 111.023 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.41 ' OD1' ' HB2' ' A' ' 40' ' ' ALA . 5.5 p30 -106.23 -162.45 0.86 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.744 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 53.5 m-70 -93.76 33.11 1.33 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.013 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.635 ' HB3' ' HB2' ' A' ' 35' ' ' SER . . . -73.48 105.46 4.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.977 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -54.6 106.46 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.154 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.862 HD21 ' HA ' ' A' ' 35' ' ' SER . 21.6 mt -67.79 -25.52 65.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.794 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.463 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 129.14 -178.63 17.2 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.06 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.691 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -104.23 133.05 49.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.911 0.386 . . . . 0.0 111.301 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -122.47 145.48 48.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.833 -179.935 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.724 ' O ' HG13 ' A' ' 63' ' ' VAL . 42.8 t -60.9 104.9 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.691 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.42 ' HB3' ' O ' ' A' ' 29' ' ' SER . 5.2 tppt? -76.68 -37.82 55.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.721 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.64 122.76 0.87 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.871 0.367 . . . . 0.0 111.422 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.803 HG23 HG12 ' A' ' 28' ' ' VAL . 63.9 mt -89.46 127.41 42.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.166 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.44 HD12 ' N ' ' A' ' 28' ' ' VAL . 1.6 mp -66.33 109.06 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.52 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.28 76.64 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.086 0.47 . . . . 0.0 110.33 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 159.76 -26.71 0.34 Allowed Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.494 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -76.81 174.47 54.18 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.367 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.662 ' HB1' HG12 ' A' ' 16' ' ' VAL . . . -47.19 -46.52 23.92 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.645 ' HB1' HD22 ' A' ' 61' ' ' LEU . . . -61.81 -38.18 87.15 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.735 0.303 . . . . 0.0 111.763 -178.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.7 t -70.45 -43.11 70.52 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.938 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.467 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -66.49 -25.94 66.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.995 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.815 ' OD1' HG13 ' A' ' 16' ' ' VAL . 0.5 OUTLIER -55.03 -52.88 61.78 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.83 0.347 . . . . 0.0 111.33 -179.711 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.87 4.71 69.18 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.401 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.446 ' HD2' ' CD1' ' A' ' 14' ' ' PHE . 1.3 mtm180 -122.15 0.96 9.69 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.761 0.315 . . . . 0.0 110.662 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.729 ' HB3' HD13 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -100.5 136.34 40.53 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.98 -179.807 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.33 143.99 29.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.844 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.724 HG13 ' O ' ' A' ' 46' ' ' VAL . 58.5 t -59.18 142.85 14.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.046 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 29.1 m-20 90.26 12.45 0.05 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.694 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.74 120.93 34.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.721 0.296 . . . . 0.0 110.274 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.413 ' O ' ' HA ' ' A' ' 105' ' ' VAL . 0.0 OUTLIER -78.05 137.18 38.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.7 -179.831 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.903 HD23 HG12 ' A' ' 105' ' ' VAL . 6.6 mt -93.52 140.95 29.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.024 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.603 HD12 ' HA ' ' A' ' 105' ' ' VAL . 4.5 mp -124.89 -41.44 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.393 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.943 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -139.17 151.03 46.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.018 0.437 . . . . 0.0 111.371 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.602 HG11 ' HA ' ' A' ' 87' ' ' LEU . 14.7 p -140.38 119.56 11.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.025 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 60.96 27.95 17.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.652 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.0 22.53 54.9 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.153 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -125.51 115.07 19.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.861 0.362 . . . . 0.0 110.78 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.5 p -60.22 149.96 31.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.129 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.612 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . 12.0 mt -115.55 -29.72 6.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.064 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.0 mt -51.6 -35.21 40.67 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.236 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.35 -21.38 47.86 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.335 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -120.64 162.14 20.17 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.367 0.603 . . . . 0.0 110.977 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.48 161.73 5.56 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.154 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.42 ' HB2' ' HA3' ' A' ' 32' ' ' GLY . 10.3 p30 -56.87 -43.81 81.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.158 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.417 ' N ' ' OD1' ' A' ' 80' ' ' ASN . 0.0 OUTLIER -64.58 -42.62 95.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.092 0.472 . . . . 0.0 110.55 179.781 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.68 -32.1 70.52 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.649 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.612 ' HB1' ' HB3' ' A' ' 75' ' ' LEU . . . -69.4 -49.04 58.98 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.685 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.611 ' HB3' HG21 ' A' ' 44' ' ' ILE . 6.9 ptp -59.64 -32.93 70.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.481 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -78.15 -31.28 49.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.22 0.533 . . . . 0.0 109.832 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.4 ' HA ' ' HD2' ' A' ' 89' ' ' ARG . 1.3 m -69.88 -36.44 75.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.521 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.851 HD12 ' N ' ' A' ' 88' ' ' ARG . 4.3 pp -78.77 -34.6 45.5 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.418 0.627 . . . . 0.0 109.478 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.851 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -61.11 -47.37 86.59 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.5 179.46 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.458 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -73.18 -43.27 61.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.424 179.544 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.3 p -61.36 -29.54 69.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.381 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.933 ' HE2' HD22 ' A' ' 26' ' ' LEU . 3.5 ptp -86.37 -34.93 20.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.84 -179.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -102.56 25.64 8.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.833 -179.132 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.552 HG23 ' HG2' ' A' ' 94' ' ' GLU . 0.5 OUTLIER -152.38 -36.66 0.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.796 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.552 ' HG2' HG23 ' A' ' 93' ' ' THR . 4.0 mt-10 -111.37 -60.04 1.89 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.813 0.34 . . . . 0.0 111.408 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.606 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -56.17 -27.31 51.89 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.378 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.815 ' HB2' HD11 ' A' ' 18' ' ' LEU . 2.6 t30 -77.09 -33.73 56.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.712 0.291 . . . . 0.0 110.565 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 94' ' ' GLU . 60.9 mtpt -39.33 -39.53 0.66 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.674 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.77 -27.28 13.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.191 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 121.75 -3.2 10.95 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.7 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.523 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -155.63 143.38 19.7 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.981 0.419 . . . . 0.0 111.257 -179.639 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.665 HD11 HD11 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -112.71 145.11 19.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.023 179.839 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.635 ' OE1' HG23 ' A' ' 13' ' ' THR . 1.3 tm0? -82.04 143.76 31.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.725 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.906 HD23 HG23 ' A' ' 16' ' ' VAL . 2.5 mm? -133.82 149.56 51.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.293 0.568 . . . . 0.0 112.008 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.943 HD12 ' HB3' ' A' ' 69' ' ' ALA . 74.7 mt -139.34 112.35 6.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.361 178.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.997 HG23 HD12 ' A' ' 12' ' ' LEU . 35.2 m -123.66 172.93 10.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.473 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -147.85 132.52 17.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.41 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.671 ' HG3' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -138.55 -179.99 6.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.919 0.39 . . . . 0.0 111.007 -179.803 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 2.1 tpp85 -116.49 132.29 56.72 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.01 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 8' ' ' THR . 47.9 mt -59.68 -25.75 32.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.962 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.834 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.879 0.371 . . . . 0.0 110.986 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -97.56 170.14 9.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.763 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -124.58 -50.13 1.75 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.127 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.88 93.01 1.41 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.781 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 60.99 -175.39 0.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.792 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 33.2 t -166.67 -156.28 0.23 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.657 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -161.37 129.91 4.43 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.505 HD13 ' CB ' ' A' ' 31' ' ' LYS . 1.1 mm -102.38 120.19 51.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.181 0.515 . . . . 0.0 111.514 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 11' ' ' THR . . . . . 0.599 HG22 HG13 ' B' ' 13' ' ' VAL . 43.9 m -98.08 102.97 14.87 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.527 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.75 102.75 1.59 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.641 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.599 HG13 HG22 ' B' ' 11' ' ' THR . 34.8 m . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.175 -0.917 . . . . 0.0 111.247 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.267 -0.333 . . . . 0.0 112.267 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 69.4 p -74.76 -6.69 50.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.642 0.258 . . . . 0.0 111.597 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -76.7 109.74 10.71 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.807 0.337 . . . . 0.0 110.676 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -126.71 163.59 23.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.135 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.448 ' CE2' HD13 ' A' ' 68' ' ' ILE . 4.4 m-85 -100.51 147.07 26.31 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.516 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 1.083 HD12 HG23 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -139.51 121.43 15.57 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.958 0.408 . . . . 0.0 111.303 -179.783 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.3 m -94.74 142.7 27.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.249 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.506 ' O ' ' HA ' ' A' ' 102' ' ' GLN . 26.6 m-85 -142.03 172.64 12.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.975 0.417 . . . . 0.0 111.587 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.423 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.7 OUTLIER -132.27 107.63 8.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.55 179.219 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.971 HG23 HD23 ' A' ' 103' ' ' LEU . 32.2 t -104.3 114.36 64.32 Favored Pre-proline 0 C--N 1.33 -0.248 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -178.286 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.614 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 93.1 Cg_endo -84.58 128.12 3.92 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.645 2.23 . . . . 0.0 110.958 178.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.789 HD11 ' HB2' ' A' ' 96' ' ' ASN . 0.4 OUTLIER -122.26 28.78 7.29 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -178.856 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -39.37 -31.11 0.08 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.101 0.477 . . . . 0.0 111.15 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -112.94 -32.94 6.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.24 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.588 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 43.9 t -71.31 -6.62 41.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.174 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.71 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -44.23 -29.79 1.74 Allowed Glycine 0 C--N 1.336 0.567 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.692 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.21 -37.93 22.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.982 0.42 . . . . 0.0 110.553 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.29 -1.03 54.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.427 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.07 -48.91 3.91 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.879 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.005 HD22 ' HE2' ' A' ' 91' ' ' MET . 6.1 tp 179.78 -31.34 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.611 0.243 . . . . 0.0 110.553 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.449 ' HA2' HD13 ' A' ' 50' ' ' ILE . . . 105.96 48.31 1.02 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.297 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.785 HG12 HG23 ' A' ' 49' ' ' ILE . 20.0 m -157.08 163.97 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.164 0.506 . . . . 0.0 111.94 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.417 ' O ' ' HB3' ' A' ' 47' ' ' LYS . 49.7 m -124.7 117.37 24.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.238 178.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.785 HG11 HD11 ' A' ' 67' ' ' LEU . 4.4 m -111.58 145.62 17.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.079 0.466 . . . . 0.0 112.163 -178.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.492 ' HB3' HD13 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -143.81 130.25 19.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.37 179.331 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 44' ' ' ILE . . . -103.71 156.99 17.57 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.442 -0.885 . . . . 0.0 113.142 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.907 ' ND2' HD12 ' A' ' 42' ' ' LEU . 6.7 p-10 -105.16 178.21 4.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.909 0.385 . . . . 0.0 111.163 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -136.27 126.47 26.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.76 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.664 ' OG ' HD21 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -50.43 121.45 5.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.149 -179.752 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.46 -10.89 55.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.552 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -77.91 -64.39 1.17 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.734 0.302 . . . . 0.0 111.325 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.574 ' OD1' ' HB2' ' A' ' 40' ' ' ALA . 10.8 p30 -124.12 25.87 7.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.498 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 52.46 54.2 11.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.898 0.38 . . . . 0.0 111.153 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.574 ' HB2' ' OD1' ' A' ' 38' ' ' ASN . . . -110.3 120.86 43.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.989 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -48.06 118.56 2.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.3 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.907 HD12 ' ND2' ' A' ' 33' ' ' ASN . 21.3 mt -81.31 -28.29 34.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.62 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 138.53 173.96 13.21 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.494 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.876 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -101.68 153.5 5.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.869 0.366 . . . . 0.0 111.38 -180.0 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -140.19 141.75 35.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.662 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.747 ' O ' HG13 ' A' ' 63' ' ' VAL . 42.2 t -57.74 104.64 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.59 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.482 ' HD3' HD12 ' B' ' 10' ' ' ILE . 21.9 tptt -75.26 -41.49 57.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.749 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.97 124.52 1.08 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.857 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.803 HD13 ' HB3' ' A' ' 61' ' ' LEU . 77.2 mt -91.62 119.95 39.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.218 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.472 HD12 ' N ' ' A' ' 28' ' ' VAL . 1.7 mp -56.0 108.14 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.376 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.15 72.94 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.873 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 162.45 -26.95 0.24 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.176 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.422 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -69.86 -170.6 8.14 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.901 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.614 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -64.15 -41.49 97.15 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.953 ' HB1' HD13 ' A' ' 61' ' ' LEU . . . -62.87 -47.58 82.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.703 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.0 t -67.85 -29.04 68.08 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.497 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 37.4 mtpt -74.87 -32.31 61.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.151 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -61.18 -27.94 68.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.808 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 66.59 20.76 70.27 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.779 -0.724 . . . . 0.0 113.132 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.429 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 12.5 mtm180 -125.19 -16.57 5.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.778 0.323 . . . . 0.0 110.979 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.953 HD13 ' HB1' ' A' ' 55' ' ' ALA . 0.5 OUTLIER -88.27 135.53 33.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.195 -179.668 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.664 HH21 HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -143.16 137.87 29.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.692 179.671 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.747 HG13 ' O ' ' A' ' 46' ' ' VAL . 48.1 t -52.52 145.91 2.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.267 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.444 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 28.2 m-80 86.98 11.09 0.15 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.613 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.439 ' OD2' HG21 ' A' ' 105' ' ' VAL . 3.0 m-20 -91.82 115.69 28.27 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.435 ' O ' ' HA ' ' A' ' 105' ' ' VAL . 0.0 OUTLIER -72.89 128.97 37.06 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.779 -179.632 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.876 HD12 HG13 ' A' ' 44' ' ' ILE . 42.6 mt -83.09 152.2 25.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.772 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.474 HD11 ' CB ' ' A' ' 106' ' ' ALA . 30.6 mt -143.63 -40.98 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.637 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.743 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -138.12 158.5 44.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.83 0.348 . . . . 0.0 111.457 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.492 HG23 HD11 ' A' ' 101' ' ' ILE . 12.8 p -151.51 120.6 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.951 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.484 HD22 HG22 ' A' ' 70' ' ' VAL . 70.4 m-80 57.12 29.65 16.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.87 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.19 23.75 50.52 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.308 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -127.75 118.61 24.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.741 0.305 . . . . 0.0 110.753 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.8 t -70.65 150.19 46.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.115 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.499 HD22 ' HA ' ' A' ' 83' ' ' ALA . 22.5 mt -111.16 -19.34 12.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.102 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.8 tp -54.41 -21.99 11.25 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.32 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -91.2 28.74 7.71 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.863 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.413 ' HD2' ' HA ' ' A' ' 83' ' ' ALA . 8.6 ptpp? -164.81 152.04 11.22 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.27 0.557 . . . . 0.0 110.921 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.96 156.45 2.05 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.329 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -54.16 -47.85 71.52 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.044 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.42 -40.0 89.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.016 0.436 . . . . 0.0 110.635 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.1 -34.22 72.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.678 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.563 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -66.5 -50.6 62.71 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.366 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.429 ' HA ' ' CD2' ' A' ' 87' ' ' LEU . 6.9 ptp -60.67 -30.5 69.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.927 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -79.51 -32.94 42.44 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.412 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 2.1 m -68.08 -35.67 78.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.277 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.871 HD11 HG11 ' B' ' 13' ' ' VAL . 4.4 pp -78.31 -34.35 48.73 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.81 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -60.21 -52.14 66.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.655 179.293 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.481 ' O ' HG22 ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.5 -33.91 67.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.295 179.651 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.414 ' N ' ' HD3' ' A' ' 89' ' ' ARG . 24.0 t -71.6 -29.99 65.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.958 0.409 . . . . 0.0 110.424 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' MET . . . . . 1.005 ' HE2' HD22 ' A' ' 26' ' ' LEU . 1.5 ptp -89.2 -25.14 21.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.163 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.3 t -109.22 23.18 14.87 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.481 HG22 ' O ' ' A' ' 89' ' ' ARG . 0.5 OUTLIER -153.37 -36.19 0.11 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.902 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.455 ' HA ' ' HG3' ' A' ' 97' ' ' LYS . 4.1 mt-10 -107.61 -64.3 1.22 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.828 0.347 . . . . 0.0 111.346 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.545 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -52.92 -33.63 44.06 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.656 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.789 ' HB2' HD11 ' A' ' 18' ' ' LEU . 2.6 t30 -70.49 -34.78 72.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.702 0.287 . . . . 0.0 110.382 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.455 ' HG3' ' HA ' ' A' ' 94' ' ' GLU . 20.7 mtpt -38.23 -47.29 1.16 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.475 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.31 -25.32 19.49 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.662 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 118.97 -3.05 14.58 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.819 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.423 ' SD ' ' HB3' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -159.48 143.43 14.84 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.076 0.465 . . . . 0.0 111.383 -179.744 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.776 HD11 HD11 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -114.33 141.48 30.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.529 179.932 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.506 ' HA ' ' O ' ' A' ' 14' ' ' PHE . 2.2 pp0? -86.88 131.13 34.19 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.981 -0.287 . . . . 0.0 110.403 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.971 HD23 HG23 ' A' ' 16' ' ' VAL . 2.8 mm? -115.87 134.39 55.04 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.275 0.559 . . . . 0.0 112.114 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.743 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 96.7 mt -118.07 112.59 39.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.611 178.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 1.083 HG23 HD12 ' A' ' 12' ' ' LEU . 28.9 m -121.53 177.21 3.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.265 -179.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.474 ' CB ' HD11 ' A' ' 68' ' ' ILE . . . -147.29 139.18 24.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.826 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.566 ' HD2' HD21 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -155.2 177.04 11.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.149 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 15.7 mtm180 -94.46 127.88 40.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.079 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.2 mt -64.04 -41.03 91.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.798 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.938 179.928 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 3' ' ' ASP . . . . . 0.566 ' HB3' HD11 ' A' ' 42' ' ' LEU . 2.2 m-20 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.837 0.351 . . . . 0.0 110.902 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.25 155.77 16.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.923 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -98.3 34.25 2.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.814 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 64.08 129.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.92 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 27.2 m170 60.64 85.01 0.12 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.866 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.71 -165.55 0.83 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.902 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 9' ' ' GLN . . . . . 0.46 ' NE2' ' O ' ' B' ' 10' ' ' ILE . 12.3 tm0? -168.94 127.62 1.04 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.492 HD13 ' HB3' ' A' ' 31' ' ' LYS . 1.6 mm -101.97 134.92 41.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.135 0.493 . . . . 0.0 111.123 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 2.5 m -110.5 116.4 31.32 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.661 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 27.2 ttmt -78.13 109.2 12.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.925 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.871 HG11 HD11 ' A' ' 87' ' ' LEU . 17.3 m . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.277 -0.868 . . . . 0.0 111.275 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 N-CA-C 112.566 -0.214 . . . . 0.0 112.566 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.2 p -111.74 48.27 0.97 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.903 0.382 . . . . 0.0 110.931 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -112.98 146.54 38.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.692 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -151.73 155.25 37.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.211 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.689 ' HE2' HG21 ' A' ' 68' ' ' ILE . 11.0 m-85 -100.7 148.93 24.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.802 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.892 HD12 HG23 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -133.68 110.88 10.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.026 -179.838 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.842 HG23 ' OE1' ' A' ' 102' ' ' GLN . 89.3 m -96.1 132.47 41.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.577 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.436 ' CZ ' ' HB3' ' A' ' 12' ' ' LEU . 54.9 m-85 -140.73 172.43 12.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.301 0.572 . . . . 0.0 112.113 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.427 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.3 OUTLIER -129.07 112.09 13.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.152 179.174 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.932 HG23 HD23 ' A' ' 103' ' ' LEU . 34.8 t -103.19 112.2 65.58 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -178.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.768 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 84.2 Cg_endo -82.22 127.82 5.4 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.365 2.043 . . . . 0.0 110.886 178.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.866 HD22 ' CD1' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -122.62 28.52 7.3 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -178.724 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -39.12 -31.49 0.07 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.172 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -113.33 -32.83 6.14 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.282 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.716 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 46.7 t -70.96 -7.7 47.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.163 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.744 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -45.25 -28.46 2.09 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.744 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.8 p -85.27 -34.28 21.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.797 0.332 . . . . 0.0 110.563 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.66 7.21 31.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.526 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.03 -54.99 4.78 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.644 -0.789 . . . . 0.0 111.985 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.934 HD22 ' HE2' ' A' ' 91' ' ' MET . 9.8 tp -178.89 -32.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.592 0.234 . . . . 0.0 110.948 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 50' ' ' ILE . . . 114.47 31.91 2.07 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.381 -0.914 . . . . 0.0 113.413 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.809 HG12 HG23 ' A' ' 49' ' ' ILE . 33.7 m -150.83 161.01 3.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 117.164 0.482 . . . . 0.0 111.75 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.42 ' O ' ' N ' ' A' ' 47' ' ' LYS . 0.9 OUTLIER -122.41 118.16 27.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.556 178.942 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.828 HG11 HD11 ' A' ' 67' ' ' LEU . 3.3 m -110.77 141.67 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.9 0.381 . . . . 0.0 111.937 -178.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.56 ' CB ' HD13 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -140.66 130.54 24.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.545 179.397 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.56 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -90.94 160.75 27.6 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.397 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.454 ' ND2' ' CE1' ' A' ' 45' ' ' PHE . 89.3 m-20 -119.57 179.91 4.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.837 0.351 . . . . 0.0 110.915 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.59 155.66 40.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.624 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.801 ' CA ' HD21 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -57.14 140.49 49.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.063 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.2 mtmm -64.51 -28.25 69.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.984 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -84.96 -74.88 0.38 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.944 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -94.41 177.26 6.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.903 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -93.07 58.42 2.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.881 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -116.78 131.63 56.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.998 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -59.37 144.31 47.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.915 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.801 HD21 ' CA ' ' A' ' 35' ' ' SER . 17.0 mt -105.38 -30.98 9.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.862 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.56 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 148.51 -173.99 28.31 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.098 -0.572 . . . . 0.0 111.866 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.87 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -110.23 148.11 14.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 120.988 0.423 . . . . 0.0 111.735 -179.739 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.454 ' CE1' ' ND2' ' A' ' 33' ' ' ASN . 0.4 OUTLIER -134.4 138.43 44.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.557 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.604 ' O ' HG13 ' A' ' 63' ' ' VAL . 40.0 t -54.17 104.41 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.564 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.511 ' HG2' HG21 ' B' ' 10' ' ' ILE . 5.9 tptm -73.03 -43.01 62.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.841 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 m -168.18 125.02 1.07 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.107 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.809 HG23 HG12 ' A' ' 28' ' ' VAL . 62.7 mt -88.93 116.66 30.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.297 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.531 HD12 ' N ' ' A' ' 28' ' ' VAL . 1.9 mp -55.42 105.26 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.629 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.11 76.4 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.141 0.496 . . . . 0.0 110.588 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 158.95 -27.17 0.39 Allowed Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.907 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.45 -170.62 6.07 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.691 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.768 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -67.94 -38.58 83.0 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.779 ' HB1' HD13 ' A' ' 61' ' ' LEU . . . -67.66 -43.86 79.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.393 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.43 ' HB3' HG22 ' A' ' 49' ' ' ILE . 53.6 p -66.85 -33.28 75.25 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.204 0.526 . . . . 0.0 110.109 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -70.74 -33.53 70.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.171 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -58.05 -28.0 64.13 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.786 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.87 25.0 67.26 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.783 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.411 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 22.1 mtm180 -125.31 -24.22 4.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.812 0.339 . . . . 0.0 111.017 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.785 HD22 HG11 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -71.62 164.06 26.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.444 -179.729 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.461 ' N ' ' HD2' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -160.46 138.83 10.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.713 179.876 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.604 HG13 ' O ' ' A' ' 46' ' ' VAL . 37.0 t -70.5 144.75 13.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.594 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 25.4 m-20 88.75 -2.53 0.43 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.642 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.95 133.14 35.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.96 0.409 . . . . 0.0 110.599 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.63 139.02 33.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.692 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.954 HD23 HG12 ' A' ' 105' ' ' VAL . 28.7 mt -88.99 131.81 35.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.839 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.689 HG21 ' HE2' ' A' ' 11' ' ' PHE . 19.3 mm -113.13 -32.19 2.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.473 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.781 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -157.03 170.91 21.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.884 0.373 . . . . 0.0 111.585 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.433 HG11 ' HA ' ' A' ' 87' ' ' LEU . 7.3 p -158.17 127.39 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.767 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.3 m120 60.24 22.83 12.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.668 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.07 25.53 31.32 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.993 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -130.55 108.45 9.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.796 0.332 . . . . 0.0 110.831 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.418 ' HA ' ' HB2' ' A' ' 69' ' ' ALA . 33.2 t -71.23 138.27 49.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.087 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.777 HD22 ' HB1' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -98.57 -13.24 20.5 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.163 179.906 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.415 ' CD1' HG23 ' A' ' 68' ' ' ILE . 0.1 OUTLIER -52.82 94.7 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.913 0.387 . . . . 0.0 111.058 -179.906 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 145.3 -31.09 1.71 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.185 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -97.56 156.89 16.3 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.239 0.542 . . . . 0.0 110.903 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.12 139.45 28.58 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.33 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.9 p30 -50.63 -28.14 8.25 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.172 0.511 . . . . 0.0 109.927 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.4 ' O ' ' HG2' ' A' ' 84' ' ' MET . 0.7 OUTLIER -74.18 -42.04 60.49 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.013 178.958 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -70.11 -32.99 71.27 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.868 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.777 ' HB1' HD22 ' A' ' 75' ' ' LEU . . . -68.92 -45.46 70.8 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.487 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.434 ' HB3' HG21 ' A' ' 44' ' ' ILE . 6.5 ptp -63.49 -30.05 71.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.816 178.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -78.59 -33.46 47.51 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.502 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 3.4 m -68.34 -35.65 78.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.343 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.749 HD12 ' N ' ' A' ' 88' ' ' ARG . 4.4 pp -78.32 -33.83 48.99 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 178.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.749 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -60.23 -51.24 70.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.65 179.332 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.502 ' HD3' ' O ' ' A' ' 86' ' ' THR . 0.0 OUTLIER -72.26 -34.93 68.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.618 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.421 ' N ' ' HD3' ' A' ' 89' ' ' ARG . 24.7 p -72.92 -29.8 63.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.852 0.358 . . . . 0.0 110.735 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.934 ' HE2' HD22 ' A' ' 26' ' ' LEU . 1.7 ptm -88.85 -17.43 29.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.288 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.85 25.45 9.68 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.522 ' O ' ' HD3' ' A' ' 97' ' ' LYS . 0.4 OUTLIER -157.14 -31.97 0.08 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.458 ' HG3' HG22 ' A' ' 93' ' ' THR . 5.7 mt-10 -117.59 -35.56 3.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.856 0.36 . . . . 0.0 111.443 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.494 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -78.26 -31.25 47.62 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.614 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.771 ' HB2' HD11 ' A' ' 18' ' ' LEU . 1.8 t30 -75.29 -31.89 60.83 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.584 -0.308 . . . . 0.0 110.176 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.522 ' HD3' ' O ' ' A' ' 93' ' ' THR . 27.1 mmmt -39.54 -47.19 1.86 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.968 0.414 . . . . 0.0 111.096 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.92 -25.49 19.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.889 178.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 114.19 1.09 23.74 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.908 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.485 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -154.66 141.0 18.66 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 120.975 0.417 . . . . 0.0 111.197 -179.588 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.8 HD11 HD11 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -112.85 145.31 18.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.657 179.538 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.842 ' OE1' HG23 ' A' ' 13' ' ' THR . 1.3 tm0? -84.99 139.64 31.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.978 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.932 HD23 HG23 ' A' ' 16' ' ' VAL . 2.7 mm? -129.99 137.66 50.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.045 0.45 . . . . 0.0 111.801 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.781 HD12 ' HB3' ' A' ' 69' ' ' ALA . 72.6 mt -126.5 113.1 31.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.563 178.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.954 HG12 HD23 ' A' ' 67' ' ' LEU . 31.9 m -123.62 174.69 7.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.472 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -147.73 137.43 22.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.841 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.607 ' CG ' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -147.37 -178.62 6.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.946 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.54 151.6 24.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.02 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 31.1 mt -93.61 -39.84 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.074 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.914 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.755 0.312 . . . . 0.0 110.972 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -90.76 135.53 33.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.726 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -113.36 -41.16 3.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.922 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.85 -175.98 3.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.732 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.22 98.03 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.926 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 31.8 t -59.59 -160.77 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.859 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -159.77 130.66 5.82 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.56 HD13 ' CB ' ' A' ' 31' ' ' LYS . 1.1 mm -104.43 121.8 56.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.413 0.625 . . . . 0.0 111.495 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 11' ' ' THR . . . . . 0.781 HG22 HG13 ' B' ' 13' ' ' VAL . 16.5 m -92.15 114.9 27.57 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.325 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -75.09 102.85 5.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.507 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.781 HG13 HG22 ' B' ' 11' ' ' THR . 30.0 m . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.726 -0.655 . . . . 0.0 110.532 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.21 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.1 p -133.77 41.33 3.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.867 0.365 . . . . 0.0 110.911 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 18.5 mtm-85 -108.85 135.28 50.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.699 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -123.95 122.74 38.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.217 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.625 ' CD1' ' HB2' ' A' ' 106' ' ' ALA . 30.3 m-85 -77.75 140.48 39.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.462 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.863 HD12 HG23 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -147.16 134.42 20.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.123 0.487 . . . . 0.0 111.238 -179.66 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.428 ' O ' ' CD1' ' A' ' 14' ' ' PHE . 25.4 m -92.63 150.8 20.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.295 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' ' 102' ' ' GLN . 15.5 m-85 -140.08 170.37 15.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.105 0.479 . . . . 0.0 111.683 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -143.43 104.95 4.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.096 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.768 HG21 HD11 ' A' ' 61' ' ' LEU . 20.7 t -109.49 110.86 59.79 Favored Pre-proline 0 CA--C 1.531 0.226 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -177.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.728 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 91.2 Cg_endo -82.49 128.11 5.3 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.527 2.151 . . . . 0.0 110.736 178.026 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.862 HD22 ' CD1' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -121.82 29.5 7.09 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -178.582 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.417 ' ND2' ' OD2' ' A' ' 20' ' ' ASP . 6.7 p-10 -40.92 -31.7 0.19 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.103 0.478 . . . . 0.0 111.031 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.417 ' OD2' ' ND2' ' A' ' 19' ' ' ASN . 23.6 m-20 -111.32 -33.65 6.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.203 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.736 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 29.9 t -70.52 -8.55 52.12 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.111 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.707 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -44.96 -28.05 1.66 Allowed Glycine 0 C--N 1.337 0.613 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.691 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -85.69 -33.44 21.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.834 0.349 . . . . 0.0 110.737 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.37 8.33 28.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.441 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.96 -55.64 4.99 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.629 -0.795 . . . . 0.0 111.908 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.862 ' CD1' HD22 ' A' ' 18' ' ' LEU . 10.2 tp -179.0 -34.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.601 0.239 . . . . 0.0 111.12 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.4 ' HA3' ' HA3' ' A' ' 53' ' ' GLY . . . 115.79 35.02 1.31 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.537 -0.839 . . . . 0.0 113.295 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.736 HG12 HG23 ' A' ' 49' ' ' ILE . 34.2 m -156.3 162.2 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.282 0.563 . . . . 0.0 112.082 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -122.65 116.4 23.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.179 178.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.67 HG11 HD11 ' A' ' 67' ' ' LEU . 3.4 m -106.56 146.35 13.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.143 0.497 . . . . 0.0 111.938 -178.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.528 ' HB3' HD13 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -143.34 131.08 21.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.58 179.705 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' A' ' 44' ' ' ILE . . . -97.32 145.69 17.95 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.697 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.555 ' ND2' ' CE1' ' A' ' 45' ' ' PHE . 72.9 m-20 -107.84 -179.17 3.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.828 0.347 . . . . 0.0 111.028 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.4 mtt180 -134.53 156.12 49.2 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.691 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.462 ' HA ' HD21 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -48.92 150.97 1.34 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.194 -179.947 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -66.48 -40.33 89.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.116 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -108.24 -35.46 6.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.127 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -91.67 168.94 11.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.925 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 -103.25 31.03 4.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.79 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.66 129.5 44.73 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.089 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.436 ' CB ' ' ND2' ' A' ' 80' ' ' ASN . 1.7 p30 -57.1 142.27 43.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.079 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.462 HD21 ' HA ' ' A' ' 35' ' ' SER . 24.2 mt -104.06 12.6 33.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.11 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.423 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 98.47 170.67 31.8 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.586 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.88 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -102.02 135.78 37.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.851 0.358 . . . . 0.0 110.995 179.831 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.555 ' CE1' ' ND2' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -121.02 141.33 50.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.792 -179.834 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.635 ' O ' HG13 ' A' ' 63' ' ' VAL . 46.7 t -56.35 104.64 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.638 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.44 ' HG2' HD12 ' B' ' 10' ' ' ILE . 0.9 OUTLIER -74.9 -40.94 60.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.758 -179.753 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.0 p -166.9 124.72 1.31 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.162 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.736 HG23 HG12 ' A' ' 28' ' ' VAL . 67.6 mt -91.25 111.86 24.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.059 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.629 HD12 ' N ' ' A' ' 28' ' ' VAL . 2.1 mp -51.8 106.41 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.801 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.34 75.52 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.023 0.44 . . . . 0.0 110.675 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 162.56 -29.99 0.28 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.082 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.4 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -66.61 -170.43 3.93 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.686 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.736 ' HB2' ' HB3' ' A' ' 21' ' ' SER . . . -68.54 -38.18 80.59 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.649 ' HB3' HG13 ' A' ' 28' ' ' VAL . . . -66.84 -45.04 79.46 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.455 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.632 ' OG ' HG22 ' A' ' 49' ' ' ILE . 0.4 OUTLIER -66.21 -34.8 78.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.27 0.557 . . . . 0.0 109.861 179.341 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.7 mtpt -68.47 -30.33 69.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.947 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.41 ' OD1' ' CD ' ' A' ' 17' ' ' PRO . 0.8 OUTLIER -64.09 -25.87 68.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.944 179.753 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.01 26.18 65.27 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.643 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.7 mtm180 -122.26 -34.79 3.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.968 0.413 . . . . 0.0 110.769 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.768 HD11 HG21 ' A' ' 16' ' ' VAL . 2.1 mp -66.74 141.86 57.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.473 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -138.45 134.22 33.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.269 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.635 HG13 ' O ' ' A' ' 46' ' ' VAL . 46.3 t -59.51 145.36 11.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.014 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.444 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 22.3 m-20 87.85 -7.3 0.58 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.392 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -76.07 125.66 29.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.787 0.327 . . . . 0.0 110.766 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.435 ' HG3' ' CE2' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -81.51 140.48 34.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.916 -179.906 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.911 HD23 HG12 ' A' ' 105' ' ' VAL . 30.8 mt -87.17 139.57 30.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.924 0.392 . . . . 0.0 111.183 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 19.6 mm -120.65 -31.52 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.241 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 1.012 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -161.72 134.73 6.18 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.973 0.416 . . . . 0.0 111.573 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.476 HG23 HD11 ' A' ' 101' ' ' ILE . 7.5 p -121.57 129.36 75.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.366 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.43 ' ND2' ' O ' ' A' ' 90' ' ' SER . 9.3 m-80 64.95 13.96 8.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.538 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.77 -14.72 53.03 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.005 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.639 ' OE1' HG23 ' A' ' 86' ' ' THR . 5.7 pt-20 -99.27 125.64 44.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.879 0.371 . . . . 0.0 111.07 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 21.3 p -75.04 165.1 25.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.901 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.515 HD22 ' HB1' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -128.9 4.38 5.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.267 -179.828 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.88 -41.43 78.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.909 0.385 . . . . 0.0 110.934 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.23 -25.84 73.49 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.691 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.431 ' HD2' ' HA ' ' A' ' 83' ' ' ALA . 1.3 ptpm? -101.7 166.78 10.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.287 0.565 . . . . 0.0 111.179 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.24 168.04 20.41 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.189 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.489 ' HB2' ' HA3' ' A' ' 32' ' ' GLY . 7.2 p30 -58.66 -50.48 73.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.055 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.421 ' N ' ' OD1' ' A' ' 80' ' ' ASN . 0.0 OUTLIER -58.84 -39.69 82.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.116 0.484 . . . . 0.0 110.516 179.942 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.13 -34.48 73.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.9 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.55 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -69.03 -47.66 64.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.785 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.498 ' HB3' HG21 ' A' ' 44' ' ' ILE . 5.6 ptp -61.93 -31.52 71.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.205 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.07 -33.8 65.86 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.639 HG23 ' OE1' ' A' ' 73' ' ' GLU . 1.8 m -64.66 -33.91 77.04 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.26 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.62 HD13 HD13 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -76.02 -36.02 59.3 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.099 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.58 ' HG3' HG11 ' B' ' 13' ' ' VAL . 0.0 OUTLIER -59.14 -51.99 67.62 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.843 179.51 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.5 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.42 -44.86 61.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.429 179.665 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.43 ' O ' ' ND2' ' A' ' 71' ' ' ASN . 40.4 p -64.23 -30.38 71.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.489 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.808 ' HE2' HD22 ' A' ' 26' ' ' LEU . 2.1 ptm -89.01 -22.29 23.06 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.683 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.26 28.87 8.31 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.5 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.3 OUTLIER -164.96 -23.15 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -179.664 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.453 ' HG3' HG22 ' A' ' 93' ' ' THR . 8.7 mt-10 -122.06 -54.96 1.9 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.893 0.378 . . . . 0.0 111.317 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.446 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -66.59 -26.6 72.91 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.016 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.733 ' HB2' HD11 ' A' ' 18' ' ' LEU . 3.7 t30 -77.86 -36.04 50.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.834 0.349 . . . . 0.0 110.207 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.48 ' HD3' ' O ' ' A' ' 93' ' ' THR . 25.8 mmmt -45.46 -43.04 11.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.969 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.08 -24.53 22.26 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.51 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 111.61 1.9 27.46 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.856 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.546 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -165.17 140.23 5.16 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 121.172 0.51 . . . . 0.0 111.744 -179.818 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.554 HG22 HD21 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -114.38 133.54 60.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.902 179.932 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.462 ' HA ' ' O ' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -76.72 150.2 36.29 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.992 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.421 HD12 HG23 ' A' ' 16' ' ' VAL . 0.5 OUTLIER -138.79 112.82 8.57 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.919 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 1.012 HD12 ' HB3' ' A' ' 69' ' ' ALA . 32.6 mt -98.86 112.84 31.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.911 HG12 HD23 ' A' ' 67' ' ' LEU . 34.5 m -128.25 161.92 35.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.942 0.401 . . . . 0.0 111.48 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.625 ' HB2' ' CD1' ' A' ' 11' ' ' PHE . . . -123.55 120.38 32.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.558 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.401 ' HG2' ' N ' ' A' ' 108' ' ' ARG . 0.0 OUTLIER -110.6 146.34 36.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.86 -179.664 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.401 ' N ' ' HG2' ' A' ' 107' ' ' ARG . 0.4 OUTLIER -76.55 126.02 30.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.98 -179.856 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 9.6 mt -62.86 -51.7 68.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.093 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 27.2 t . . . . . 0 C--N 1.326 -0.425 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.928 179.95 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.892 0.377 . . . . 0.0 110.916 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -149.03 170.03 19.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.882 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -106.67 -70.15 0.8 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.879 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -152.53 -56.9 0.13 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.663 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -132.29 145.17 51.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.686 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 32.8 t -120.38 -164.13 1.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.965 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -167.84 127.81 1.34 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.528 HD13 ' HB3' ' A' ' 31' ' ' LYS . 1.4 mm -99.87 100.58 10.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.254 0.549 . . . . 0.0 111.161 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 55.9 m -70.51 102.82 2.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.578 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.6 120.07 20.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.92 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.58 HG11 ' HG3' ' A' ' 88' ' ' ARG . 11.1 m . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.151 -0.928 . . . . 0.0 110.818 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.461 ' C ' ' HG1' ' A' ' 8' ' ' THR . . . . . . . . 0 N--CA 1.452 -0.292 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.482 ' HG1' ' HG3' ' A' ' 108' ' ' ARG . 13.3 p 49.44 34.71 6.99 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.718 0.294 . . . . 0.0 111.277 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.3 mtt85 -92.42 116.59 29.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.65 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.445 ' OE2' HD21 ' A' ' 12' ' ' LEU . 7.3 pt-20 -124.12 152.39 42.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.063 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -94.61 147.46 23.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.604 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.786 HD12 HG23 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -134.23 110.17 9.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.363 -179.711 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 76.5 m -96.59 130.25 43.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.282 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.438 ' CZ ' ' HB3' ' A' ' 12' ' ' LEU . 32.0 m-85 -140.21 172.37 12.84 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.467 0.651 . . . . 0.0 112.249 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.47 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.2 OUTLIER -128.93 111.71 13.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.328 179.354 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.9 HG23 HD23 ' A' ' 103' ' ' LEU . 8.8 t -103.39 117.17 60.77 Favored Pre-proline 0 C--N 1.33 -0.274 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -178.115 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.53 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 80.7 Cg_endo -86.36 127.22 2.83 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.461 2.108 . . . . 0.0 111.184 178.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.849 HD11 ' HB2' ' A' ' 96' ' ' ASN . 0.4 OUTLIER -119.04 28.12 8.45 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -178.989 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -39.23 -30.76 0.06 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.209 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -114.63 -31.27 6.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.138 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.439 ' CB ' ' HB2' ' A' ' 54' ' ' ALA . 1.9 t -72.15 -7.6 50.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.095 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.629 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -44.74 -28.49 1.67 Allowed Glycine 0 C--N 1.337 0.602 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.741 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.73 -35.43 20.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.8 0.333 . . . . 0.0 110.824 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.21 8.74 25.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.455 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.87 -54.39 4.95 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.92 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.996 HD22 ' HE2' ' A' ' 91' ' ' MET . 8.8 tp -178.03 -36.1 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.636 0.255 . . . . 0.0 110.657 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.472 ' HA3' ' HA3' ' A' ' 53' ' ' GLY . . . 115.66 41.13 0.81 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.378 -0.915 . . . . 0.0 113.373 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.808 HG12 HG23 ' A' ' 49' ' ' ILE . 14.2 m -156.93 157.69 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 117.147 0.474 . . . . 0.0 111.917 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.422 ' O ' ' HB3' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -116.38 117.2 29.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.279 178.596 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.477 HG11 HD11 ' A' ' 67' ' ' LEU . 2.5 m -110.33 148.24 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.148 0.499 . . . . 0.0 112.159 -178.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.541 ' HB3' HD13 ' B' ' 10' ' ' ILE . 0.2 OUTLIER -147.82 129.67 15.24 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.292 179.28 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.488 ' HA2' ' HA ' ' A' ' 44' ' ' ILE . . . -90.57 163.65 29.96 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.43 -179.208 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.468 ' ND2' ' HG3' ' B' ' 4' ' ' GLU . 2.5 m120 -124.2 179.15 5.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.819 0.343 . . . . 0.0 110.637 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 11.0 ttm180 -135.15 148.75 49.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.574 ' CA ' HD21 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -55.84 128.84 36.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.917 -179.88 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.23 -28.77 69.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.139 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -80.02 -62.83 1.56 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.875 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -117.05 164.64 14.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.831 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -75.05 63.05 1.21 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.939 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -119.56 117.82 29.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.061 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -51.08 142.71 11.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.174 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.574 HD21 ' CA ' ' A' ' 35' ' ' SER . 23.0 mt -107.86 -2.16 20.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.341 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.414 ' HA3' ' NE2' ' A' ' 66' ' ' GLN . . . 111.0 179.93 20.16 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.326 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.768 ' CG1' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -109.27 139.4 32.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.978 0.418 . . . . 0.0 111.491 -179.824 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.42 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -120.47 144.84 47.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.589 179.952 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.57 ' O ' HG13 ' A' ' 63' ' ' VAL . 35.7 t -62.93 104.44 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.677 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.437 ' HD3' HD12 ' B' ' 10' ' ' ILE . 10.8 tptt -69.8 -45.4 68.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.813 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -167.88 127.91 1.34 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.009 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.808 HG23 HG12 ' A' ' 28' ' ' VAL . 61.8 mt -90.17 122.44 41.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.056 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.541 HD12 ' N ' ' A' ' 28' ' ' VAL . 1.8 mp -61.36 110.08 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.247 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -65.19 75.73 0.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.02 0.438 . . . . 0.0 110.597 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 160.67 -28.33 0.32 Allowed Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.807 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.472 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -74.65 167.53 54.77 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.798 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.53 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -40.76 -45.33 2.41 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.746 ' HB1' HD22 ' A' ' 61' ' ' LEU . . . -61.6 -42.36 98.76 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.178 -0.465 . . . . 0.0 112.164 -178.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.432 ' OG ' HG22 ' A' ' 49' ' ' ILE . 0.4 OUTLIER -74.23 -24.69 59.35 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.021 0.439 . . . . 0.0 110.588 -179.718 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.423 ' HG3' ' HA ' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -77.53 -34.39 53.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.795 -179.894 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -60.33 -33.81 72.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.727 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.78 22.09 79.28 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.811 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.437 ' HB3' ' CG ' ' A' ' 14' ' ' PHE . 17.4 mtm180 -125.19 -20.1 4.95 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.777 0.322 . . . . 0.0 111.08 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.78 HD11 HG21 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -77.39 138.81 39.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.979 0.418 . . . . 0.0 111.295 -179.771 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.411 ' NH2' HD13 ' A' ' 12' ' ' LEU . 0.1 OUTLIER -136.82 139.92 42.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.417 179.9 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.57 HG13 ' O ' ' A' ' 46' ' ' VAL . 41.7 t -67.74 144.03 14.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.066 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.503 ' HB2' ' O ' ' A' ' 63' ' ' VAL . 22.2 m120 83.4 8.12 0.65 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.119 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.489 ' OD2' HG21 ' A' ' 105' ' ' VAL . 6.9 t0 -84.83 126.05 33.12 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.158 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.414 ' NE2' ' HA3' ' A' ' 43' ' ' GLY . 1.2 tt0 -78.15 131.93 37.42 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.734 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.914 HD23 HG12 ' A' ' 105' ' ' VAL . 14.4 mt -87.28 141.41 28.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.749 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.75 HD11 ' HB2' ' A' ' 106' ' ' ALA . 22.6 mt -124.91 -36.87 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.494 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.72 ' HB3' ' CD1' ' A' ' 104' ' ' ILE . . . -153.29 145.47 23.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.047 0.451 . . . . 0.0 111.666 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.71 HG11 ' HA ' ' A' ' 87' ' ' LEU . 14.9 p -133.54 130.25 56.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.588 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.526 HD22 ' CA ' ' A' ' 95' ' ' GLY . 3.0 m120 63.2 18.48 11.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.692 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.48 25.27 36.54 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.663 -0.779 . . . . 0.0 111.728 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -133.03 104.11 6.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.873 0.368 . . . . 0.0 110.633 -179.538 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 0.4 OUTLIER -62.95 157.23 22.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.231 -179.712 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.623 HD22 ' HB1' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -123.95 9.49 8.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.104 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.43 -25.61 67.33 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.848 0.356 . . . . 0.0 110.984 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -94.52 25.65 21.82 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.613 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.461 ' HD2' ' HA ' ' A' ' 83' ' ' ALA . 0.5 OUTLIER -151.34 160.71 43.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.25 0.548 . . . . 0.0 111.213 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.47 ' HB1' ' OE1' ' A' ' 81' ' ' GLN . . . -65.08 158.63 25.27 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.104 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.459 ' HB2' ' HA3' ' A' ' 32' ' ' GLY . 7.8 p30 -57.35 -47.73 80.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.311 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.47 ' OE1' ' HB1' ' A' ' 79' ' ' ALA . 5.8 pm0 -58.51 -37.98 76.74 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.996 0.427 . . . . 0.0 110.776 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.406 ' HB3' ' HD3' ' A' ' 78' ' ' LYS . 3.7 mm-40 -70.67 -38.08 73.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.998 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.623 ' HB1' HD22 ' A' ' 75' ' ' LEU . . . -67.24 -46.16 74.59 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.823 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.502 ' HB3' HG21 ' A' ' 44' ' ' ILE . 5.5 ptp -64.26 -29.66 70.75 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -81.09 -30.28 34.69 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.425 178.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.494 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 7.3 m -71.58 -35.08 70.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.209 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.859 HD12 ' N ' ' A' ' 88' ' ' ARG . 4.2 pp -78.44 -34.29 47.93 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.859 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -59.5 -52.0 67.43 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.628 179.203 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.548 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.82 -33.62 66.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.017 179.474 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.448 ' N ' ' HD3' ' A' ' 89' ' ' ARG . 49.5 m -70.5 -29.79 66.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.486 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.996 ' HE2' HD22 ' A' ' 26' ' ' LEU . 2.9 ptp -86.41 -23.38 26.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.248 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.5 33.12 5.76 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.548 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.4 OUTLIER -162.91 -28.35 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.498 ' HG3' HG22 ' A' ' 93' ' ' THR . 5.3 mt-10 -122.62 -37.27 2.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.912 0.387 . . . . 0.0 111.196 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.526 ' CA ' HD22 ' A' ' 71' ' ' ASN . . . -82.27 -33.06 26.88 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.458 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.849 ' HB2' HD11 ' A' ' 18' ' ' LEU . 1.9 t30 -72.83 -33.25 66.04 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.469 ' HD3' ' O ' ' A' ' 93' ' ' THR . 10.5 mmmt -40.56 -46.12 2.44 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.098 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.8 -24.31 20.36 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.816 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 118.32 -4.91 15.42 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.784 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.47 ' SD ' ' HB3' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -156.03 143.99 19.7 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.935 0.398 . . . . 0.0 111.097 -179.748 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.858 HD11 HD11 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -111.76 145.28 18.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.225 -179.643 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.643 ' O ' HD13 ' A' ' 103' ' ' LEU . 2.1 tt0 -86.24 142.55 28.49 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.128 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.9 HD23 HG23 ' A' ' 16' ' ' VAL . 2.8 mm? -133.77 139.23 46.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.1 0.476 . . . . 0.0 111.749 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.72 ' CD1' ' HB3' ' A' ' 69' ' ' ALA . 7.4 mt -126.99 112.62 29.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.506 178.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.914 HG12 HD23 ' A' ' 67' ' ' LEU . 32.6 m -125.41 176.02 6.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.513 -179.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.75 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -147.65 136.55 22.07 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.865 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.564 ' HD2' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -150.32 -178.88 6.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.912 0.387 . . . . 0.0 111.212 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.482 ' HG3' ' HG1' ' A' ' 8' ' ' THR . 0.0 OUTLIER -94.02 146.32 24.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.934 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 34.4 mt -75.47 -62.59 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.11 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.876 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.941 0.4 . . . . 0.0 111.129 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' GLU . . . . . 0.468 ' HG3' ' ND2' ' A' ' 33' ' ' ASN . 2.4 tt0 -134.46 169.02 17.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.966 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -109.63 39.18 2.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.802 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 18.0 mp0 65.73 -72.91 0.07 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.054 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 4.6 m80 -78.86 119.53 22.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.068 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.12 -169.47 1.47 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.646 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -174.32 125.1 0.32 Allowed 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.541 HD13 ' HB3' ' A' ' 31' ' ' LYS . 3.3 mm -101.2 137.02 30.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.994 0.426 . . . . 0.0 110.903 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 7.9 m -120.72 113.97 20.98 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.958 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.12 131.61 42.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.591 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.436 ' CG1' ' HG3' ' A' ' 88' ' ' ARG . 10.4 m . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.316 -0.85 . . . . 0.0 111.304 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 67.5 p -149.09 87.6 1.55 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.824 0.345 . . . . 0.0 110.99 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 48.0 mtt-85 -150.55 114.6 5.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.651 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -110.89 122.27 47.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.912 0.387 . . . . 0.0 111.138 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.506 ' CE2' HD13 ' A' ' 68' ' ' ILE . 37.3 m-85 -74.92 144.42 43.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.214 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.839 HD12 HG23 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -145.49 109.86 4.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.034 0.445 . . . . 0.0 111.644 -179.415 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.437 ' O ' ' CD1' ' A' ' 14' ' ' PHE . 11.8 m -81.09 141.4 34.35 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.706 178.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.448 ' CD2' ' CD2' ' A' ' 61' ' ' LEU . 19.5 m-85 -136.38 171.84 13.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.414 0.626 . . . . 0.0 112.595 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -143.05 102.29 3.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.242 178.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.603 HG21 HD13 ' A' ' 103' ' ' LEU . 40.4 t -104.39 106.77 55.49 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -177.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.791 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 5.3 Cg_exo -77.89 127.69 8.77 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.492 2.128 . . . . 0.0 110.623 178.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.871 HD22 ' CD1' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -125.78 28.93 6.05 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.748 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -38.96 -33.11 0.1 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.15 0.5 . . . . 0.0 111.139 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -108.82 -34.07 6.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.071 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.739 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 4.7 t -69.3 -8.3 44.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.056 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.796 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -42.44 -30.52 0.86 Allowed Glycine 0 C--N 1.337 0.619 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.837 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.2 p -82.88 -39.98 20.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.859 0.361 . . . . 0.0 110.438 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -78.63 -3.31 43.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.407 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.87 -50.75 2.87 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.005 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.924 HD22 ' HE2' ' A' ' 91' ' ' MET . 10.2 tp -179.13 -35.28 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.708 0.29 . . . . 0.0 110.785 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.423 ' C ' HD12 ' A' ' 50' ' ' ILE . . . 113.83 31.03 2.4 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.535 -0.84 . . . . 0.0 113.271 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.798 HG12 HG23 ' A' ' 49' ' ' ILE . 27.8 m -150.07 154.0 9.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.045 0.45 . . . . 0.0 112.0 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.41 ' O ' ' HB3' ' A' ' 47' ' ' LYS . 0.9 OUTLIER -111.02 115.61 29.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.315 178.627 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.867 HG11 HD11 ' A' ' 67' ' ' LEU . 3.1 m -108.23 142.4 20.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.046 0.45 . . . . 0.0 111.9 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.567 ' HB3' HD13 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -144.67 131.17 19.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.15 179.556 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -92.01 157.82 24.48 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.478 -0.867 . . . . 0.0 113.351 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.477 ' ND2' ' HG3' ' B' ' 4' ' ' GLU . 3.5 m120 -117.33 -176.76 3.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.723 0.297 . . . . 0.0 110.693 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.21 152.15 47.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.684 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.16 139.51 52.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.102 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.22 -29.22 70.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.999 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -83.85 -70.41 0.57 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.998 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 34.2 p30 -100.78 -174.83 2.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.978 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -93.59 45.68 1.17 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.948 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.23 114.3 26.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.082 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -56.07 133.14 51.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.002 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 47.7 mt -94.34 16.94 13.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.274 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.465 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 86.99 179.14 48.87 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.367 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.918 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -103.89 136.26 37.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 120.933 0.397 . . . . 0.0 111.251 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -123.98 147.77 47.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.713 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.728 ' O ' HG13 ' A' ' 63' ' ' VAL . 43.0 t -58.33 105.04 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.796 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.462 ' HG2' HG21 ' B' ' 10' ' ' ILE . 4.0 tptt -75.88 -40.59 54.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.689 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -168.8 115.16 0.62 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.207 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.798 HG23 HG12 ' A' ' 28' ' ' VAL . 52.9 mt -81.31 118.75 29.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.206 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.52 HD12 ' N ' ' A' ' 28' ' ' VAL . 2.0 mp -59.07 104.9 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.565 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.47 76.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.037 0.446 . . . . 0.0 110.615 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 159.82 -27.35 0.35 Allowed Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.022 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.402 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -69.06 -170.03 6.46 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.473 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.791 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -68.67 -39.14 80.76 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.783 ' HB3' HG13 ' A' ' 28' ' ' VAL . . . -65.96 -46.34 78.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.158 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 40.1 p -63.38 -35.38 80.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.215 0.531 . . . . 0.0 109.878 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.0 mtpt -66.68 -32.14 73.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.816 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.24 -30.3 64.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.461 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.66 27.49 66.38 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.836 -0.62 . . . . 0.0 113.406 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.431 ' HG3' ' CD1' ' A' ' 14' ' ' PHE . 15.8 ptp180 -134.85 1.74 3.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 117.162 0.481 . . . . 0.0 111.592 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.448 ' CD2' ' CD2' ' A' ' 14' ' ' PHE . 3.4 mm? -108.85 152.19 25.24 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.9 0.381 . . . . 0.0 111.06 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.44 145.48 26.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.785 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.728 HG13 ' O ' ' A' ' 46' ' ' VAL . 60.1 t -52.96 144.32 3.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.07 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.486 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 37.9 m-20 93.37 -14.11 0.14 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.331 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -60.99 110.0 1.23 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.767 0.317 . . . . 0.0 110.726 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.435 ' HG3' ' CE2' ' A' ' 45' ' ' PHE . 0.8 OUTLIER -75.34 111.24 10.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.999 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.945 HD23 HG12 ' A' ' 105' ' ' VAL . 42.6 mt -61.02 136.97 58.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.003 0.43 . . . . 0.0 111.085 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 1.045 HD11 ' HB2' ' A' ' 106' ' ' ALA . 29.9 mt -119.84 -34.78 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.139 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.955 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -155.4 143.84 20.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.457 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.64 HG11 ' HA ' ' A' ' 87' ' ' LEU . 7.4 p -133.04 132.04 58.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.431 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 61.88 26.21 15.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.927 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.44 24.43 63.15 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.312 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -129.98 103.86 7.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.853 0.358 . . . . 0.0 110.82 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.6 t -57.23 141.07 47.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.888 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.474 ' HB3' ' CB ' ' A' ' 83' ' ' ALA . 0.7 OUTLIER -101.23 3.19 40.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.572 -179.753 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.2 tp -63.76 -15.79 59.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.574 0.226 . . . . 0.0 111.304 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -88.92 14.34 60.66 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.127 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.41 ' CE ' HD23 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -156.52 177.34 11.58 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.251 0.548 . . . . 0.0 111.333 179.851 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.801 ' HB3' ' OE1' ' A' ' 81' ' ' GLN . . . -81.62 174.05 11.76 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.748 -179.054 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.402 ' OD1' ' N ' ' A' ' 81' ' ' GLN . 7.3 p30 -60.13 -51.52 69.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.347 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.801 ' OE1' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -60.64 -38.48 84.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.873 0.368 . . . . 0.0 110.619 -179.754 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.3 -40.04 74.47 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.52 ' HB3' ' CD1' ' A' ' 44' ' ' ILE . . . -69.56 -30.91 68.81 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.873 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.638 ' SD ' HG23 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -72.58 -33.26 66.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.73 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.403 ' HG2' ' N ' ' A' ' 86' ' ' THR . 1.9 pt-20 -78.07 -30.38 49.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.114 0.483 . . . . 0.0 109.775 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.403 ' N ' ' HG2' ' A' ' 85' ' ' GLU . 1.5 m -70.65 -35.96 73.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.361 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.865 HD12 ' N ' ' A' ' 88' ' ' ARG . 4.3 pp -78.58 -34.85 46.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.401 0.62 . . . . 0.0 109.472 178.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.865 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -62.49 -51.46 67.36 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.272 179.368 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.508 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -71.82 -35.42 69.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.119 179.602 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.7 m -67.23 -35.61 79.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.926 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.924 ' HE2' HD22 ' A' ' 26' ' ' LEU . 3.5 ptp -83.92 -27.98 28.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.868 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.13 23.58 14.28 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.508 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.4 OUTLIER -155.38 -32.18 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.42 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 5.0 mt-10 -112.94 -65.49 1.18 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.916 0.389 . . . . 0.0 111.513 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.498 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -54.2 -27.57 39.56 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.575 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.54 ' HB2' HD11 ' A' ' 18' ' ' LEU . 1.6 t30 -77.49 -32.79 54.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.692 0.282 . . . . 0.0 110.59 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' A' ' 93' ' ' THR . 40.6 mtpt -41.49 -40.06 1.7 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.005 0.431 . . . . 0.0 111.521 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.77 -25.24 15.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.182 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 117.33 1.55 18.3 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.788 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.499 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -158.36 142.04 15.35 Favored 'General case' 0 N--CA 1.457 -0.089 0 CA-C-O 121.07 0.462 . . . . 0.0 111.845 -179.568 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.591 HG22 HD21 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -115.62 136.25 53.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.6 179.496 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.448 ' HA ' ' O ' ' A' ' 14' ' ' PHE . 2.0 pp0? -76.55 140.85 41.26 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.718 HD11 HD21 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -134.8 112.59 10.84 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -178.715 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.955 HD12 ' HB3' ' A' ' 69' ' ' ALA . 43.1 mt -98.3 112.67 30.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.059 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.945 HG12 HD23 ' A' ' 67' ' ' LEU . 35.7 m -124.81 143.14 39.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.978 0.418 . . . . 0.0 111.462 -178.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 1.045 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -110.83 124.78 52.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.731 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.56 146.58 39.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.04 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.08 124.81 26.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.718 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 44.8 mt -69.15 -32.7 55.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.226 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 25.9 t . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.824 -179.857 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.914 0.388 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 4' ' ' GLU . . . . . 0.477 ' HG3' ' ND2' ' A' ' 33' ' ' ASN . 4.5 mt-10 -74.01 132.7 42.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.987 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -105.05 -31.84 9.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.774 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -113.0 -172.86 2.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.914 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.31 -22.8 65.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.072 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 11.7 t 64.22 -162.38 0.27 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.765 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -176.03 126.9 0.22 Allowed 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.567 HD13 ' HB3' ' A' ' 31' ' ' LYS . 1.8 mm -95.74 100.51 11.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.204 0.526 . . . . 0.0 111.085 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 11' ' ' THR . . . . . 0.582 HG22 HG13 ' B' ' 13' ' ' VAL . 88.9 m -71.47 99.41 2.01 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.732 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -69.51 108.02 3.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.093 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.736 HG11 ' HG3' ' A' ' 88' ' ' ARG . 30.1 m . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.65 -0.691 . . . . 0.0 110.651 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.383 0 N-CA-C 112.573 -0.211 . . . . 0.0 112.573 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 35.8 p -121.94 29.83 6.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.778 0.323 . . . . 0.0 110.878 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.81 125.88 30.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.951 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.599 ' HG3' HD21 ' A' ' 12' ' ' LEU . 24.4 pt-20 -133.55 133.94 42.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.937 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.519 ' HD2' HD13 ' A' ' 68' ' ' ILE . 51.7 m-85 -81.43 151.47 27.87 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.785 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.751 HD12 HG23 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -155.02 122.39 5.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.022 0.439 . . . . 0.0 111.236 -179.836 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.419 HG23 HG12 ' A' ' 104' ' ' ILE . 6.8 m -81.46 146.24 30.34 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.209 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.456 ' N ' ' O ' ' A' ' 103' ' ' LEU . 17.6 m-85 -140.63 171.55 13.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.414 0.626 . . . . 0.0 112.243 -179.238 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -143.65 104.88 4.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.843 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.562 HG12 ' HB1' ' A' ' 54' ' ' ALA . 18.7 t -105.16 114.08 63.92 Favored Pre-proline 0 C--N 1.33 -0.268 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.529 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 97.8 Cg_endo -84.79 126.98 3.52 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.454 2.103 . . . . 0.0 110.849 178.287 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.802 HD22 ' CD1' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -121.98 28.24 7.66 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -178.672 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -39.2 -32.46 0.1 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.054 0.454 . . . . 0.0 111.205 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -108.74 -34.44 6.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.122 179.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.2 t -70.68 -6.58 38.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.288 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.755 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -42.56 -30.51 0.89 Allowed Glycine 0 C--N 1.337 0.593 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.727 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.3 p -83.01 -39.27 21.5 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.851 0.358 . . . . 0.0 110.528 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -78.61 -15.09 58.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.3 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.04 -46.37 1.39 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.645 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.802 ' CD1' HD22 ' A' ' 18' ' ' LEU . 8.2 tp 178.06 -31.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.7 0.286 . . . . 0.0 110.704 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.455 ' HA3' ' HA3' ' A' ' 53' ' ' GLY . . . 106.12 43.65 1.48 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.405 -0.903 . . . . 0.0 113.384 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.814 HG12 HG23 ' A' ' 49' ' ' ILE . 29.0 m -157.33 155.71 4.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.304 0.573 . . . . 0.0 112.073 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.74 116.91 30.85 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.302 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 19.6 m -105.93 143.34 17.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.237 0.541 . . . . 0.0 112.222 -178.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.662 ' HB2' HD13 ' B' ' 10' ' ' ILE . 0.4 OUTLIER -146.54 129.01 15.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.056 179.443 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' A' ' 44' ' ' ILE . . . -104.85 159.66 15.72 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.47 -0.871 . . . . 0.0 112.782 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -134.71 154.03 51.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.8 0.333 . . . . 0.0 110.971 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.41 ' HB3' ' HA ' ' A' ' 41' ' ' ASP . 1.1 ptp180 -109.12 154.62 22.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.097 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.534 ' N ' HD21 ' A' ' 42' ' ' LEU . 0.6 OUTLIER -40.87 151.43 0.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.439 -179.692 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.94 -56.1 11.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.101 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -59.52 -71.51 0.12 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.005 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -85.41 172.89 10.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.881 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -98.54 34.6 1.99 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.85 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.04 124.91 34.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.076 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.588 ' OD2' ' HB1' ' A' ' 79' ' ' ALA . 75.1 m-20 -59.55 139.33 57.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.964 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.534 HD21 ' N ' ' A' ' 35' ' ' SER . 16.7 mt -100.79 -29.76 12.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.887 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 146.25 -176.8 24.99 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.296 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.825 HG21 ' HB3' ' A' ' 84' ' ' MET . 0.0 OUTLIER -105.98 140.12 25.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.675 0.274 . . . . 0.0 110.67 179.837 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -127.09 139.37 53.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.445 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.732 ' O ' HG13 ' A' ' 63' ' ' VAL . 53.2 t -58.03 106.5 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.166 179.212 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.535 ' HG2' HD12 ' B' ' 10' ' ' ILE . 9.7 tptp -76.08 -40.87 52.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.879 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.3 t -168.06 122.23 0.94 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.028 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.814 HG23 HG12 ' A' ' 28' ' ' VAL . 69.6 mt -88.59 123.02 40.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.19 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.443 HD13 ' HA2' ' A' ' 27' ' ' GLY . 1.8 mp -60.61 109.63 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.221 179.196 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.82 72.49 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.074 0.464 . . . . 0.0 110.963 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 163.36 -25.85 0.21 Allowed Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.383 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.455 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -71.19 -167.4 7.77 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.574 -0.822 . . . . 0.0 113.018 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.562 ' HB1' HG12 ' A' ' 16' ' ' VAL . . . -65.41 -42.98 91.98 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.305 0.484 . . . . 0.0 112.305 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.577 ' CB ' HD13 ' A' ' 61' ' ' LEU . . . -64.52 -44.65 90.18 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.582 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.561 ' OG ' HG22 ' A' ' 49' ' ' ILE . 1.4 m -67.44 -29.95 69.56 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.289 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.3 mtpt -78.53 -30.84 47.22 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.293 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.86 -30.72 58.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.711 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.71 19.3 77.91 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.757 -0.735 . . . . 0.0 113.147 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.413 ' HG3' ' CD1' ' A' ' 14' ' ' PHE . 2.6 ptp180 -142.68 17.66 2.0 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.892 0.346 . . . . 0.0 110.997 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.699 ' HB3' HD13 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -114.34 130.75 56.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.638 179.713 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.51 142.56 37.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.116 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.732 HG13 ' O ' ' A' ' 46' ' ' VAL . 59.3 t -53.65 152.35 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.064 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.6 ' HB2' ' O ' ' A' ' 63' ' ' VAL . 9.1 m-80 78.27 13.78 1.52 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.498 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.447 ' O ' HG23 ' A' ' 46' ' ' VAL . 0.8 OUTLIER -91.71 114.31 26.81 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.024 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.421 ' O ' ' HA ' ' A' ' 105' ' ' VAL . 12.7 tm0? -71.31 140.41 50.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.008 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.992 HD23 HG12 ' A' ' 105' ' ' VAL . 18.7 mt -98.13 131.76 44.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.122 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.635 ' O ' HD12 ' A' ' 75' ' ' LEU . 2.1 mp -116.15 -45.15 3.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.898 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 1.004 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -137.44 149.85 47.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.25 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.704 HG11 ' HA ' ' A' ' 87' ' ' LEU . 7.1 p -140.91 123.22 15.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.605 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.617 HD22 HG22 ' A' ' 70' ' ' VAL . 66.2 m-80 66.22 11.23 7.74 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.521 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 109.23 -18.28 30.84 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.831 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -94.05 117.29 29.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.919 0.39 . . . . 0.0 111.151 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.71 139.65 39.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.651 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.635 HD12 ' O ' ' A' ' 68' ' ' ILE . 0.1 OUTLIER -118.29 13.13 13.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.419 -179.835 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.438 HD13 HG23 ' A' ' 68' ' ' ILE . 3.1 tp -60.95 -20.88 62.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.654 0.264 . . . . 0.0 111.246 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -85.36 -24.87 41.72 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.91 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.427 ' HE2' ' HB3' ' A' ' 78' ' ' LYS . 5.6 ptpt -98.16 157.29 16.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.307 0.575 . . . . 0.0 111.305 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.588 ' HB1' ' OD2' ' A' ' 41' ' ' ASP . . . -57.33 166.47 1.18 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.253 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.42 ' OD1' ' N ' ' A' ' 81' ' ' GLN . 22.7 p30 -63.12 -38.97 93.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.095 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.454 ' HA ' ' HG2' ' A' ' 84' ' ' MET . 0.0 OUTLIER -67.18 -41.93 85.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.184 0.516 . . . . 0.0 110.469 179.823 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.4 ' HB3' ' HD3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -70.94 -35.14 72.08 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.689 179.093 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.598 ' HB3' ' CD1' ' A' ' 44' ' ' ILE . . . -69.12 -46.51 67.48 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.581 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.825 ' HB3' HG21 ' A' ' 44' ' ' ILE . 4.4 ptp -62.47 -30.99 71.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.98 179.004 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.11 -33.91 56.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.727 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.403 ' HA ' ' HD2' ' A' ' 89' ' ' ARG . 1.3 m -69.81 -36.06 75.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.367 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.808 HD22 HD13 ' A' ' 67' ' ' LEU . 3.7 pp -78.4 -33.91 48.47 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.555 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -59.19 -49.98 75.79 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.342 179.108 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.442 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.85 -37.21 67.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.456 179.648 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.6 t -70.93 -29.36 65.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.399 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.774 ' HE2' HD22 ' A' ' 26' ' ' LEU . 4.5 ptm -89.07 -22.75 22.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.64 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.0 21.92 14.39 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.493 ' O ' ' HG3' ' A' ' 97' ' ' LYS . 0.4 OUTLIER -154.23 -35.21 0.1 Allowed 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.757 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.411 ' HG3' HG22 ' A' ' 93' ' ' THR . 3.7 mt-10 -111.86 -39.33 4.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.84 0.352 . . . . 0.0 111.362 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.476 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -70.94 -30.8 67.53 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.9 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.723 ' HB2' HD11 ' A' ' 18' ' ' LEU . 2.9 t30 -76.97 -34.09 57.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.787 0.327 . . . . 0.0 110.262 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.493 ' HG3' ' O ' ' A' ' 93' ' ' THR . 46.2 mtpt -39.94 -45.77 1.92 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.79 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.37 -22.98 18.61 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.838 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 115.35 0.11 22.15 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.824 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.473 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -163.82 142.61 7.76 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.992 0.425 . . . . 0.0 111.193 -179.83 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.54 HG22 HD21 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -112.12 142.69 23.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.326 -179.753 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -76.62 147.63 37.45 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.456 ' O ' ' N ' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -143.39 110.46 5.68 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -178.729 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 1.004 HD12 ' HB3' ' A' ' 69' ' ' ALA . 57.4 mt -101.36 112.54 34.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 177.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.992 HG12 HD23 ' A' ' 67' ' ' LEU . 35.3 m -123.64 157.54 29.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.092 0.472 . . . . 0.0 112.091 -178.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.606 ' CB ' HD11 ' A' ' 68' ' ' ILE . . . -129.4 122.81 30.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.373 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.07 -179.35 5.5 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.953 0.406 . . . . 0.0 111.21 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -91.11 141.15 29.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.054 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 18.4 mt -73.44 110.27 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.933 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.0 t . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.94 -179.941 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 121.007 0.432 . . . . 0.0 110.935 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -105.3 166.16 10.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.95 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 5' ' ' ASP . . . . . 0.405 ' HB2' ' CG ' ' A' ' 34' ' ' ARG . 0.5 OUTLIER -100.79 36.28 1.98 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.755 179.893 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 16.3 mp0 67.33 -67.03 0.18 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.96 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -88.02 138.14 31.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.955 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.87 -160.78 1.09 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.81 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -163.37 126.46 2.69 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.662 HD13 ' HB2' ' A' ' 31' ' ' LYS . 1.6 mm -104.73 100.7 11.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.165 0.507 . . . . 0.0 111.228 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 99.0 m -77.61 102.47 7.03 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.356 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 1.3 tptp -68.78 122.33 18.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.293 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 18.3 m . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.559 -0.734 . . . . 0.0 110.758 179.748 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.245 0 N-CA-C 112.429 -0.268 . . . . 0.0 112.429 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.44 ' HG1' ' HG2' ' A' ' 108' ' ' ARG . 44.7 p 50.08 26.92 2.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.711 0.291 . . . . 0.0 111.241 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -91.5 119.81 31.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.74 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.408 ' OE1' HD11 ' A' ' 109' ' ' ILE . 23.7 pt-20 -128.91 151.06 50.06 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.094 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -92.05 148.37 22.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.572 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.637 HD12 HG23 ' A' ' 105' ' ' VAL . 0.3 OUTLIER -134.7 109.88 8.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.069 0.461 . . . . 0.0 111.229 -179.645 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.534 HG23 ' OE1' ' A' ' 102' ' ' GLN . 94.4 m -92.24 124.63 36.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.127 179.296 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.451 ' CG ' ' HB3' ' A' ' 60' ' ' ARG . 25.1 m-85 -134.83 151.36 50.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.358 0.599 . . . . 0.0 112.103 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.486 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.4 OUTLIER -111.98 110.67 21.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.097 178.948 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.749 ' CG2' HD11 ' A' ' 61' ' ' LEU . 11.7 t -100.33 116.52 64.33 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -177.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.735 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 84.6 Cg_endo -87.22 127.88 2.56 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.784 2.323 . . . . 0.0 111.086 178.439 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.861 HD22 HD13 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -127.49 28.49 5.66 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -178.987 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -39.08 -33.27 0.12 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.151 0.5 . . . . 0.0 111.179 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -108.04 -33.76 7.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.072 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.697 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 7.2 t -70.67 -6.82 39.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.141 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.806 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -41.61 -31.35 0.69 Allowed Glycine 0 C--N 1.338 0.653 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.789 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.3 p -82.52 -41.75 19.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.888 0.375 . . . . 0.0 110.386 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -77.5 -4.66 46.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.458 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.18 -50.16 3.32 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.867 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.943 HD22 ' HE2' ' A' ' 91' ' ' MET . 9.9 tp 179.87 -33.0 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.722 0.296 . . . . 0.0 110.635 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.448 ' HA3' ' HA3' ' A' ' 53' ' ' GLY . . . 109.1 44.04 1.13 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.5 -0.857 . . . . 0.0 113.426 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.73 HG12 HG23 ' A' ' 49' ' ' ILE . 20.8 m -157.56 173.79 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.146 0.498 . . . . 0.0 112.077 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.422 ' O ' ' N ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -134.25 117.09 16.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.312 178.907 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.7 HG11 HD11 ' A' ' 67' ' ' LEU . 3.4 m -109.55 149.48 12.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.009 0.433 . . . . 0.0 111.937 -178.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.427 ' O ' ' HG3' ' A' ' 31' ' ' LYS . 13.5 ptmt -143.63 133.47 23.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.595 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.521 ' H ' HE22 ' B' ' 9' ' ' GLN . . . -95.15 150.94 19.86 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.919 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -112.16 165.69 11.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.813 0.339 . . . . 0.0 110.894 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.434 ' HB3' ' HB2' ' B' ' 5' ' ' ASP . 6.8 ttm180 -128.84 140.52 51.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.629 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.2 123.41 13.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.921 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.05 -32.56 74.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.955 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -75.31 -31.52 60.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.962 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -149.03 136.55 20.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.708 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.542 ' CE1' HE22 ' B' ' 6' ' ' GLN . 46.8 m170 -61.45 83.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.948 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.95 126.96 12.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.844 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -50.89 145.69 6.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.222 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.62 HD11 ' OD1' ' B' ' 3' ' ' ASP . 43.9 mt -111.34 -23.2 10.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.801 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.421 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 132.03 162.98 10.6 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.354 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.935 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -98.69 136.22 30.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.059 0.457 . . . . 0.0 111.163 -179.866 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -123.69 147.16 47.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.663 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.668 ' O ' HG13 ' A' ' 63' ' ' VAL . 35.0 t -60.3 104.59 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 29' ' ' SER . 24.5 tptt -72.25 -44.12 63.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.516 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 m -166.22 128.45 1.9 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.813 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.73 HG23 HG12 ' A' ' 28' ' ' VAL . 73.4 mt -94.03 121.61 44.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.145 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.585 HD12 ' N ' ' A' ' 28' ' ' VAL . 1.6 mp -58.71 113.59 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.406 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -68.12 74.25 0.21 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.682 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 159.89 -27.22 0.34 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.112 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.448 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -69.12 -171.91 7.84 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.601 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.735 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -64.12 -40.54 96.41 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.187 0.439 . . . . 0.0 112.187 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.645 ' HA ' HD13 ' A' ' 61' ' ' LEU . . . -61.57 -51.13 69.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.321 -179.345 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.8 t -63.43 -30.09 71.27 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.104 0.478 . . . . 0.0 109.807 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.0 mtpt -74.86 -35.01 62.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.738 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -58.9 -27.12 64.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.774 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 63.3 25.25 68.23 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.57 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.451 ' HB3' ' CG ' ' A' ' 14' ' ' PHE . 19.4 mtm180 -127.44 -29.3 2.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.693 0.283 . . . . 0.0 111.224 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.749 HD11 ' CG2' ' A' ' 16' ' ' VAL . 2.3 mp -74.13 143.19 45.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.117 0.484 . . . . 0.0 111.291 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.41 ' NH2' HD13 ' A' ' 12' ' ' LEU . 0.1 OUTLIER -144.83 134.83 23.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.313 179.84 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.668 HG13 ' O ' ' A' ' 46' ' ' VAL . 58.1 t -53.68 143.05 6.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.587 -0.278 . . . . 0.0 110.908 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 30.5 m-20 89.7 -8.88 0.39 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.073 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -63.11 110.21 1.76 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.854 0.359 . . . . 0.0 110.725 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.402 ' NE2' ' O ' ' A' ' 67' ' ' LEU . 20.7 tm0? -74.28 112.93 10.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.915 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.935 HD12 HG13 ' A' ' 44' ' ' ILE . 45.7 mt -66.84 146.44 54.42 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.044 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.735 HD11 ' CB ' ' A' ' 106' ' ' ALA . 52.9 mt -135.77 -42.67 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.277 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.878 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -146.0 126.04 13.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.067 0.461 . . . . 0.0 111.621 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.463 HG11 ' HA ' ' A' ' 87' ' ' LEU . 11.4 p -118.56 127.55 75.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.152 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.5 m120 62.0 35.1 16.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.959 0.409 . . . . 0.0 110.293 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 68.64 24.1 75.38 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.166 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -126.34 98.11 5.32 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.73 0.3 . . . . 0.0 110.822 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.0 t -60.81 136.95 58.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.815 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.62 HD22 ' HB1' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -98.38 12.53 34.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.309 -179.851 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 12.8 mt -63.89 -23.52 67.38 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.72 0.295 . . . . 0.0 111.011 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -93.05 21.16 41.41 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.736 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -150.73 167.02 28.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.176 0.512 . . . . 0.0 111.052 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.566 ' HB3' HE22 ' A' ' 81' ' ' GLN . . . -78.25 175.71 9.95 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.174 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -61.73 -55.83 26.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.239 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.566 HE22 ' HB3' ' A' ' 79' ' ' ALA . 4.8 pm0 -53.9 -38.94 65.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.009 0.433 . . . . 0.0 111.222 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.62 -37.4 73.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.22 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.62 ' HB1' HD22 ' A' ' 75' ' ' LEU . . . -68.96 -47.6 65.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.821 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.475 ' HA ' ' CD2' ' A' ' 87' ' ' LEU . 9.1 ptp -62.88 -30.08 71.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.295 -0.412 . . . . 0.0 109.945 179.242 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -79.12 -35.66 41.83 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 178.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.8 m -67.68 -35.84 79.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.194 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.745 HD12 ' N ' ' A' ' 88' ' ' ARG . 4.4 pp -78.22 -33.88 49.64 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 178.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.745 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -56.17 -50.05 72.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.007 178.962 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.705 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.35 -49.74 31.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.313 178.734 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 m -54.75 -29.38 53.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.602 179.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.943 ' HE2' HD22 ' A' ' 26' ' ' LEU . 1.5 ptp -89.98 -37.85 14.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.306 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.21 37.91 2.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.988 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.705 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 72.3 m -162.56 -41.48 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.566 -0.454 . . . . 0.0 112.214 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -111.62 -48.58 3.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.058 0.456 . . . . 0.0 110.777 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.454 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -69.74 -20.45 75.86 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.146 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.526 ' HB2' HD11 ' A' ' 18' ' ' LEU . 1.7 t30 -83.09 -32.26 26.85 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -40.8 -35.88 0.55 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.383 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.25 -30.72 11.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.69 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 125.93 -6.14 7.83 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.689 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.491 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -153.97 143.64 21.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.983 0.42 . . . . 0.0 111.147 -179.924 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.617 HG22 HD21 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -109.42 147.14 14.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.452 -179.707 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.534 ' OE1' HG23 ' A' ' 13' ' ' THR . 0.0 OUTLIER -79.47 143.47 34.92 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.714 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.473 HD12 HG23 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -138.65 148.22 43.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.125 0.488 . . . . 0.0 111.902 -179.072 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.878 HD12 ' HB3' ' A' ' 69' ' ' ALA . 68.9 mt -144.63 113.33 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.047 179.013 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.931 HG12 HD23 ' A' ' 67' ' ' LEU . 30.0 m -124.3 179.32 2.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.468 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.735 ' CB ' HD11 ' A' ' 68' ' ' ILE . . . -147.75 139.89 24.28 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.93 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.625 ' CG ' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -152.42 179.48 8.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.997 179.872 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.44 ' HG2' ' HG1' ' A' ' 8' ' ' THR . 3.2 mtm180 -100.82 154.44 18.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.026 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.408 HD11 ' OE1' ' A' ' 10' ' ' GLU . 17.6 mt -100.77 -34.08 3.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.131 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.798 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 3' ' ' ASP . . . . . 0.62 ' OD1' HD11 ' A' ' 42' ' ' LEU . 4.8 t70 . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.932 0.396 . . . . 0.0 110.88 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -79.87 158.58 26.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.969 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 5' ' ' ASP . . . . . 0.434 ' HB2' ' HB3' ' A' ' 34' ' ' ARG . 19.7 t70 -108.24 -76.03 0.62 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.892 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 6' ' ' GLN . . . . . 0.542 HE22 ' CE1' ' A' ' 39' ' ' HIS . 0.0 OUTLIER -116.8 -54.76 2.41 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.078 -179.948 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 26.5 t-80 -146.3 145.82 30.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.047 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 54.4 p -105.62 -163.45 0.94 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.743 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 9' ' ' GLN . . . . . 0.521 HE22 ' H ' ' A' ' 32' ' ' GLY . 2.2 pp0? 177.7 149.31 0.17 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.267 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.411 HD12 ' HD3' ' A' ' 47' ' ' LYS . 2.1 mm -118.27 148.71 20.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.038 0.446 . . . . 0.0 111.156 -179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 11' ' ' THR . . . . . 0.8 HG22 HG13 ' B' ' 13' ' ' VAL . 55.2 m -123.41 104.36 9.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.568 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.67 102.84 5.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.026 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.8 HG13 HG22 ' B' ' 11' ' ' THR . 35.2 m . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.936 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.539 -0.224 . . . . 0.0 112.539 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.4 p -109.44 -15.99 14.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.622 0.248 . . . . 0.0 111.296 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.64 143.13 40.35 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.714 0.293 . . . . 0.0 110.665 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -163.97 161.99 23.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.005 0.431 . . . . 0.0 111.291 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -104.07 145.32 30.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.413 179.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 1.093 HD12 HG23 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -134.32 119.58 18.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.025 0.44 . . . . 0.0 111.301 -179.676 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.409 ' O ' ' CD1' ' A' ' 14' ' ' PHE . 90.0 m -86.68 143.02 27.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.975 179.204 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.417 ' CE1' ' HG2' ' A' ' 60' ' ' ARG . 24.9 m-85 -139.59 169.41 17.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.286 0.565 . . . . 0.0 112.158 -179.065 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -139.52 107.54 5.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.173 -0.921 . . . . 0.0 108.923 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.7 HG21 HD11 ' A' ' 61' ' ' LEU . 17.6 t -104.28 111.43 65.17 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -177.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.785 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 84.6 Cg_endo -81.72 127.71 5.71 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.441 2.094 . . . . 0.0 110.794 178.455 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.828 HD22 HD13 ' A' ' 26' ' ' LEU . 0.5 OUTLIER -125.44 29.15 6.1 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.595 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -39.56 -32.75 0.14 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.112 0.482 . . . . 0.0 111.245 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -109.18 -35.26 6.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.105 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.704 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 9.9 t -67.83 -9.65 46.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.099 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.731 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -43.01 -29.76 0.92 Allowed Glycine 0 C--N 1.339 0.713 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.808 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.3 m -82.58 -39.09 22.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.884 0.373 . . . . 0.0 110.572 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -78.28 -20.85 50.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.197 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.29 -50.31 0.78 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.833 -0.698 . . . . 0.0 111.507 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.828 HD13 HD22 ' A' ' 18' ' ' LEU . 10.9 tp 179.0 -32.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.56 0.219 . . . . 0.0 110.836 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.453 ' HA3' ' HA3' ' A' ' 53' ' ' GLY . . . 110.79 37.74 1.67 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.342 -0.932 . . . . 0.0 113.171 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.744 HG12 HG23 ' A' ' 49' ' ' ILE . 14.4 m -156.51 164.37 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.229 0.538 . . . . 0.0 111.957 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.405 ' O ' ' HB3' ' A' ' 47' ' ' LYS . 2.0 m -123.73 115.18 20.97 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.17 178.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.561 HG11 HD11 ' A' ' 67' ' ' LEU . 4.5 m -106.75 141.12 22.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.089 0.471 . . . . 0.0 111.93 -178.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.551 ' HE3' HD22 ' A' ' 33' ' ' ASN . 0.0 OUTLIER -145.53 131.28 19.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.101 179.452 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 44' ' ' ILE . . . -102.25 162.36 17.0 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.442 -0.885 . . . . 0.0 113.052 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.551 HD22 ' HE3' ' A' ' 31' ' ' LYS . 43.8 m-20 -135.94 156.58 48.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.949 0.404 . . . . 0.0 111.019 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.467 ' HD2' ' HA ' ' A' ' 39' ' ' HIS . 0.0 OUTLIER -108.87 152.28 25.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.736 179.972 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.593 ' CB ' HD21 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -50.11 137.58 17.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.983 179.954 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.19 -23.81 65.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.494 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -71.14 -51.02 27.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.079 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -135.34 160.29 38.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.838 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.467 ' HA ' ' HD2' ' A' ' 34' ' ' ARG . 74.5 m-70 -70.39 66.0 0.3 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.87 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -126.17 121.34 32.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.172 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.411 ' CB ' ' ND2' ' A' ' 80' ' ' ASN . 3.4 p-10 -53.39 145.21 14.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.383 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.593 HD21 ' CB ' ' A' ' 35' ' ' SER . 32.4 mt -109.71 -29.83 8.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.47 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.416 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 142.12 -178.58 20.67 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.995 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.827 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -108.05 140.56 26.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.965 0.412 . . . . 0.0 111.219 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -128.6 142.3 51.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.708 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.58 ' O ' HG13 ' A' ' 63' ' ' VAL . 40.0 t -57.58 104.33 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.784 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' A' ' 29' ' ' SER . 36.4 tptt -72.66 -42.91 63.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.801 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.47 129.62 1.61 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.084 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.744 HG23 HG12 ' A' ' 28' ' ' VAL . 78.0 mt -95.16 118.31 41.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.212 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.564 HD12 ' N ' ' A' ' 28' ' ' VAL . 1.8 mp -55.03 107.09 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.619 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.52 77.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.112 0.482 . . . . 0.0 110.593 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 155.27 -26.21 0.61 Allowed Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.872 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.453 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -67.73 -172.41 6.27 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.621 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.785 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -64.76 -39.35 93.47 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.513 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.684 ' HB1' HD13 ' A' ' 61' ' ' LEU . . . -64.79 -48.66 73.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.269 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 60.1 p -63.03 -31.51 72.67 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.864 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 34.6 mtpt -75.23 -34.43 61.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.911 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -59.53 -27.65 66.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.741 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.47 40.0 95.62 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.662 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.417 ' HG2' ' CE1' ' A' ' 14' ' ' PHE . 4.5 mtm180 -134.88 -40.96 0.76 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.857 0.361 . . . . 0.0 110.913 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.7 HD11 HG21 ' A' ' 16' ' ' VAL . 3.7 mp -58.22 166.89 1.47 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.294 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.6 mtm105 -162.15 118.78 2.04 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.301 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.58 HG13 ' O ' ' A' ' 46' ' ' VAL . 34.1 t -47.98 143.12 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.385 -179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.427 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 22.3 m-80 85.76 -5.36 0.83 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.326 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.15 127.41 32.53 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.754 0.311 . . . . 0.0 110.388 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -79.66 136.37 36.79 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.678 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.852 HD23 HG12 ' A' ' 105' ' ' VAL . 49.7 mt -89.0 133.04 34.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.274 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.8 mm -116.8 -30.09 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.994 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.831 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -159.86 159.02 32.0 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.06 0.457 . . . . 0.0 111.203 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.803 HG22 ' ND2' ' A' ' 71' ' ' ASN . 8.0 p -145.74 125.07 5.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.416 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.803 ' ND2' HG22 ' A' ' 70' ' ' VAL . 66.7 m-80 61.17 18.22 8.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.922 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.75 25.36 23.02 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.114 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -124.65 101.06 6.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.736 0.303 . . . . 0.0 110.692 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.5 p -62.67 138.26 58.46 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.018 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -104.39 -16.27 15.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.239 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.5 tp -55.27 89.72 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.913 0.387 . . . . 0.0 111.13 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 156.7 -27.92 0.53 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.294 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.47 ' HD3' ' HB3' ' A' ' 82' ' ' GLU . 0.5 OUTLIER -106.63 159.54 16.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.253 0.549 . . . . 0.0 111.048 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.13 158.0 12.08 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.135 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.411 ' ND2' ' CB ' ' A' ' 41' ' ' ASP . 26.7 m-80 -51.18 -57.38 8.91 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.164 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.423 ' HA ' ' HG2' ' A' ' 84' ' ' MET . 0.0 OUTLIER -51.65 -37.72 51.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.562 -179.47 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.47 ' HB3' ' HD3' ' A' ' 78' ' ' LYS . 1.9 mt-10 -70.92 -40.9 71.83 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.055 0.455 . . . . 0.0 110.331 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.521 ' HB3' ' CD1' ' A' ' 44' ' ' ILE . . . -66.53 -50.07 64.41 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.835 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.575 ' HB3' HG21 ' A' ' 44' ' ' ILE . 5.6 ptp -60.92 -29.65 69.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.062 179.112 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -76.98 -33.73 57.61 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.555 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.4 m -67.95 -36.88 80.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.224 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.692 HD12 ' N ' ' A' ' 88' ' ' ARG . 4.4 pp -78.43 -33.36 48.59 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.692 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -58.1 -49.03 78.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.262 178.988 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.529 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -73.15 -44.29 60.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.065 179.293 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.7 t -62.9 -29.8 71.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.178 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.768 ' HE2' HD22 ' A' ' 26' ' ' LEU . 3.3 ptm -89.81 -25.25 21.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.701 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.21 31.72 6.55 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.529 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.3 OUTLIER -164.25 -33.31 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 179.849 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.409 ' HG3' HG22 ' A' ' 93' ' ' THR . 7.7 mt-10 -111.09 -69.04 0.89 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.803 0.335 . . . . 0.0 111.37 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.427 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -48.8 -27.44 6.36 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.604 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.714 ' HB2' HD11 ' A' ' 18' ' ' LEU . 1.6 t30 -76.41 -33.13 58.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.626 0.25 . . . . 0.0 110.434 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 94' ' ' GLU . 38.0 mtpt -39.62 -41.51 1.06 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.066 0.46 . . . . 0.0 111.373 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.63 -26.99 15.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.061 179.092 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 120.5 -3.51 12.26 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.883 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.457 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.3 OUTLIER -154.0 141.32 19.61 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.89 0.376 . . . . 0.0 111.412 -179.628 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.571 HG22 HD21 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -110.27 141.69 24.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.036 179.82 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -76.61 150.47 36.45 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.514 HD12 HG23 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -144.24 112.01 6.18 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.99 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.831 HD12 ' HB3' ' A' ' 69' ' ' ALA . 76.4 mt -103.39 113.27 39.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.274 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 1.093 HG23 HD12 ' A' ' 12' ' ' LEU . 16.9 m -120.99 174.99 5.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.857 0.36 . . . . 0.0 111.542 -179.109 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -147.36 142.82 27.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.206 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.475 ' HD2' HD21 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -159.38 -178.99 7.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.783 179.836 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 5.9 ttp85 -116.36 139.03 50.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.902 0.382 . . . . 0.0 111.124 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.495 HG22 ' N ' ' A' ' 110' ' ' SER . 28.9 mt -76.94 158.72 5.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.031 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.495 ' N ' HG22 ' A' ' 109' ' ' ILE . 32.5 t . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.892 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 3' ' ' ASP . . . . . 0.479 ' OD1' HD11 ' A' ' 42' ' ' LEU . 0.7 OUTLIER . . . . . 0 CA--C 1.527 0.081 0 CA-C-O 120.849 0.356 . . . . 0.0 110.996 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -158.59 169.23 24.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.988 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -103.89 38.26 1.87 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.537 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 68.9 -65.17 0.3 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.045 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 14.1 p80 -107.51 98.26 7.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.119 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.85 -158.84 0.21 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.585 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -158.19 124.04 4.59 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.522 HD13 ' CB ' ' A' ' 31' ' ' LYS . 1.4 mm -102.26 120.29 51.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.185 0.516 . . . . 0.0 111.226 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 28.0 m -94.84 109.61 21.58 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.644 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 7.0 tppt? -70.99 126.72 30.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.095 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.551 HG11 ' HG3' ' A' ' 88' ' ' ARG . 4.1 m . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.554 -0.736 . . . . 0.0 110.862 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.255 0 N-CA-C 112.489 -0.245 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 108' ' ' ARG . 41.8 p -134.54 80.02 1.83 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.694 0.283 . . . . 0.0 110.832 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.91 127.07 33.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.838 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -128.27 136.97 51.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.178 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -86.96 147.5 25.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.891 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.994 HD12 HG23 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -137.77 110.46 7.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.204 -179.656 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 71.2 m -103.89 128.03 51.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.489 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -140.95 172.65 12.38 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 121.354 0.597 . . . . 0.0 112.341 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.404 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.5 OUTLIER -127.8 111.19 13.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.853 179.26 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.845 HG13 ' OD1' ' A' ' 58' ' ' ASP . 66.5 t -103.99 113.66 65.16 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -177.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.624 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 83.3 Cg_endo -84.13 127.58 4.06 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.373 2.049 . . . . 0.0 110.748 177.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.882 HD22 ' CD1' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -122.54 30.05 6.66 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -178.628 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.453 ' ND2' ' OD2' ' A' ' 20' ' ' ASP . 8.4 p-10 -36.94 -33.87 0.06 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.172 0.511 . . . . 0.0 111.291 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.453 ' OD2' ' ND2' ' A' ' 19' ' ' ASN . 35.8 m-20 -111.57 -34.47 6.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.16 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.503 ' HB2' ' HB2' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -66.26 -13.83 61.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.943 179.761 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.743 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -45.97 -28.01 2.69 Favored Glycine 0 C--N 1.337 0.608 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.78 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.33 -36.02 27.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.847 0.356 . . . . 0.0 110.78 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -82.64 -24.43 33.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.253 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.78 -54.59 0.64 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.932 -0.652 . . . . 0.0 111.481 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.986 HD22 ' HE2' ' A' ' 91' ' ' MET . 10.0 tp 179.41 -35.3 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.616 0.246 . . . . 0.0 110.893 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 50' ' ' ILE . . . 117.28 32.69 1.45 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.296 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.775 HG11 HD22 ' A' ' 61' ' ' LEU . 33.4 m -157.88 157.04 3.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.121 0.486 . . . . 0.0 111.897 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.92 116.05 26.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.431 178.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.958 HG11 HD11 ' A' ' 67' ' ' LEU . 3.9 m -106.76 142.64 19.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.014 0.435 . . . . 0.0 111.691 -179.021 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.584 ' HB3' HD13 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -139.5 135.18 33.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.617 179.821 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.501 ' HA3' ' HB2' ' A' ' 80' ' ' ASN . . . -89.73 152.42 22.43 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.013 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.44 ' ND2' ' CE1' ' A' ' 45' ' ' PHE . 91.2 m-20 -120.77 163.74 17.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.757 0.313 . . . . 0.0 110.873 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -116.44 151.76 35.38 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.752 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.606 ' HA ' HD21 ' A' ' 42' ' ' LEU . 0.9 OUTLIER -51.97 167.71 0.11 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.207 -179.909 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.11 -56.13 11.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.105 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -116.93 -38.22 3.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.031 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -55.06 -24.35 24.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.202 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 60.68 32.8 20.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.002 0.43 . . . . 0.0 110.737 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -107.87 135.43 49.28 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.009 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -58.17 122.3 12.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.809 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.606 HD21 ' HA ' ' A' ' 35' ' ' SER . 16.0 mt -82.66 -30.23 29.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.2 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.481 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 140.99 177.85 16.68 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.017 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.849 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -99.79 134.13 40.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.951 0.405 . . . . 0.0 111.297 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.468 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -123.15 143.29 50.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.54 -179.896 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.623 ' O ' HG13 ' A' ' 63' ' ' VAL . 42.6 t -55.78 104.52 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.856 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.548 ' HD3' HD12 ' B' ' 10' ' ' ILE . 6.3 tptp -74.05 -42.17 60.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.644 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.42 125.57 1.53 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.949 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.723 HG23 HG12 ' A' ' 28' ' ' VAL . 69.8 mt -89.94 120.77 39.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.275 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.64 HD12 ' N ' ' A' ' 28' ' ' VAL . 2.1 mp -61.88 108.87 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.794 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -66.68 74.24 0.1 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.926 0.393 . . . . 0.0 110.399 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 164.47 -28.04 0.21 Allowed Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.119 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.15 -176.33 23.28 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.601 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.624 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -61.27 -41.15 96.43 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.809 ' HB1' HD13 ' A' ' 61' ' ' LEU . . . -64.76 -48.0 76.16 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.9 0.381 . . . . 0.0 111.58 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.464 ' HB2' HG22 ' A' ' 49' ' ' ILE . 5.6 t -63.36 -29.06 70.43 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.219 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 32.4 mtpt -75.1 -28.99 60.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.933 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.845 ' OD1' HG13 ' A' ' 16' ' ' VAL . 1.2 m-20 -63.31 -26.99 69.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.016 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.11 20.24 57.89 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.282 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.9 mtm180 -118.52 -28.28 5.73 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.909 0.385 . . . . 0.0 110.791 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.809 HD13 ' HB1' ' A' ' 55' ' ' ALA . 0.6 OUTLIER -68.94 149.81 48.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.1 0.476 . . . . 0.0 111.271 -179.735 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.645 HH21 HD22 ' A' ' 12' ' ' LEU . 76.1 mtm-85 -146.98 128.64 15.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.722 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.623 HG13 ' O ' ' A' ' 46' ' ' VAL . 46.6 t -55.39 143.91 7.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.042 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.438 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 19.2 m-20 85.21 10.37 0.31 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.136 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -88.67 115.79 26.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.822 0.344 . . . . 0.0 110.402 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.31 123.28 25.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.9 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.958 HD11 HG11 ' A' ' 30' ' ' VAL . 9.4 mt -75.28 133.86 41.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.24 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.905 HD11 ' HB2' ' A' ' 106' ' ' ALA . 18.3 mt -114.47 -28.02 2.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.281 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.855 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -158.4 166.47 32.16 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.104 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.685 HG11 ' HA ' ' A' ' 87' ' ' LEU . 12.0 p -154.05 126.07 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.009 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.597 ' ND2' HG22 ' A' ' 70' ' ' VAL . 68.6 m-80 58.69 20.17 7.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.051 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.35 28.05 18.46 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.957 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 70' ' ' VAL . 0.4 OUTLIER -128.5 101.48 6.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.841 0.353 . . . . 0.0 110.747 -179.638 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.1 t -66.81 133.26 49.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.816 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.595 HD22 ' HA ' ' A' ' 83' ' ' ALA . 0.9 OUTLIER -93.8 -11.32 31.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.297 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.1 mt -54.01 91.52 0.01 OUTLIER 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.82 0.343 . . . . 0.0 111.118 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 151.21 -29.21 0.98 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.884 -0.675 . . . . 0.0 112.259 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.474 ' HD3' ' HB3' ' A' ' 82' ' ' GLU . 5.5 ptpp? -104.29 152.2 22.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.193 0.521 . . . . 0.0 110.943 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.85 149.73 6.05 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.108 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.501 ' HB2' ' HA3' ' A' ' 32' ' ' GLY . 25.1 p30 -52.8 -30.4 33.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.222 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.466 ' HA ' ' HG2' ' A' ' 84' ' ' MET . 0.0 OUTLIER -73.9 -38.28 64.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.274 0.559 . . . . 0.0 110.328 179.454 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.474 ' HB3' ' HD3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -70.23 -33.82 72.13 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.739 179.13 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.595 ' HA ' HD22 ' A' ' 75' ' ' LEU . . . -69.2 -44.96 71.07 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.77 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.677 ' HB3' HG21 ' A' ' 44' ' ' ILE . 6.1 ptp -63.53 -30.83 71.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.304 -0.407 . . . . 0.0 109.992 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -78.17 -32.98 50.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.518 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.55 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 1.9 m -69.81 -35.09 74.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.541 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.854 HD12 ' N ' ' A' ' 88' ' ' ARG . 4.2 pp -78.01 -34.22 50.82 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.854 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -61.01 -51.11 70.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.926 -1.033 . . . . 0.0 110.964 179.464 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.55 ' HD3' ' O ' ' A' ' 86' ' ' THR . 0.0 OUTLIER -72.25 -33.39 67.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.373 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.445 ' OG ' ' HA ' ' A' ' 87' ' ' LEU . 66.6 p -71.95 -29.84 64.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.991 0.424 . . . . 0.0 110.49 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.986 ' HE2' HD22 ' A' ' 26' ' ' LEU . 2.9 ptp -85.42 -23.07 28.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.358 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.3 m -117.42 27.01 9.34 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.511 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.4 OUTLIER -156.81 -31.64 0.09 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.905 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.412 ' HG3' HG22 ' A' ' 93' ' ' THR . 7.0 mt-10 -115.98 -45.93 2.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.887 0.375 . . . . 0.0 111.518 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.496 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -72.23 -32.6 62.6 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.844 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.592 ' HB2' HD11 ' A' ' 18' ' ' LEU . 2.0 t30 -73.32 -32.83 64.82 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' A' ' 93' ' ' THR . 47.5 mtpt -41.12 -41.44 1.76 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.263 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.2 -27.58 16.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.688 178.498 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.542 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 115.77 0.82 21.39 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.696 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.531 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.2 OUTLIER -153.89 140.59 19.0 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 120.986 0.422 . . . . 0.0 111.429 -179.627 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.731 HD11 HD11 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -113.29 144.15 21.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.733 179.615 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.559 ' O ' HD13 ' A' ' 103' ' ' LEU . 1.9 tt0 -83.51 142.3 31.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.04 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.731 HD11 HD11 ' A' ' 101' ' ' ILE . 2.9 mm? -131.25 136.09 47.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.98 0.419 . . . . 0.0 111.848 -179.157 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.855 HD12 ' HB3' ' A' ' 69' ' ' ALA . 73.4 mt -128.56 112.89 27.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.325 178.099 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.994 HG23 HD12 ' A' ' 12' ' ' LEU . 27.0 m -127.16 173.58 12.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.133 0.492 . . . . 0.0 111.441 -178.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.905 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -147.45 128.09 14.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.263 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.718 ' HG3' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -131.16 -178.81 5.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.977 0.418 . . . . 0.0 111.25 -179.564 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.423 ' HA ' ' O ' ' A' ' 8' ' ' THR . 4.5 mtm180 -99.7 150.55 22.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.18 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 45.2 mt -78.09 -29.59 15.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.035 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.98 179.934 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.747 0.308 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -133.24 170.16 15.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.846 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -109.5 -80.57 0.58 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.864 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.67 -69.5 0.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.936 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 31.7 m80 -79.86 136.8 36.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.052 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 77.6 p -134.17 -171.09 2.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.665 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -177.84 130.17 0.15 Allowed 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.584 HD13 ' HB3' ' A' ' 31' ' ' LYS . 3.2 mm -107.34 100.7 11.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.206 0.527 . . . . 0.0 111.006 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 92.1 m -73.16 99.51 2.84 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.852 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.1 110.75 14.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.922 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.738 HG11 ' CG ' ' A' ' 88' ' ' ARG . 15.7 m . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.343 -0.837 . . . . 0.0 111.039 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 N-CA-C 112.565 -0.214 . . . . 0.0 112.565 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -154.6 27.8 0.44 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.788 0.328 . . . . 0.0 111.145 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.1 137.47 33.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.548 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -152.83 154.5 35.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.905 0.383 . . . . 0.0 111.281 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -91.75 150.31 21.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.521 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.763 HD12 HG23 ' A' ' 105' ' ' VAL . 0.5 OUTLIER -139.16 113.08 8.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.908 0.385 . . . . 0.0 111.62 -179.42 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.485 HG23 ' OE1' ' A' ' 102' ' ' GLN . 98.4 m -98.86 133.57 42.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.778 178.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 102' ' ' GLN . 52.0 m-85 -141.55 172.69 12.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.118 0.485 . . . . 0.0 111.939 -179.01 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.448 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.6 OUTLIER -128.53 109.51 11.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.547 179.272 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.907 HG23 HD23 ' A' ' 103' ' ' LEU . 34.2 t -104.55 109.21 62.5 Favored Pre-proline 0 C--N 1.33 -0.246 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.242 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.75 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 83.5 Cg_endo -81.48 127.64 5.85 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.418 2.079 . . . . 0.0 110.762 178.358 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.823 HD22 ' CD1' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -121.22 29.07 7.48 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -178.849 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -37.84 -31.4 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.366 179.318 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -112.95 -33.77 5.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.26 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.655 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 25.9 t -69.77 -9.87 56.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.209 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.755 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -45.57 -28.51 2.46 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.795 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.53 -35.12 25.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.85 0.357 . . . . 0.0 110.698 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -82.51 -24.45 34.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.129 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.44 -51.98 0.71 Allowed Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.931 HD22 ' HE2' ' A' ' 91' ' ' MET . 10.5 tp 179.45 -35.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.658 0.266 . . . . 0.0 110.633 179.024 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.409 ' O ' ' N ' ' A' ' 50' ' ' ILE . . . 116.26 34.46 1.33 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.473 -0.87 . . . . 0.0 113.232 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.778 HG11 HD22 ' A' ' 61' ' ' LEU . 33.1 m -157.22 157.02 3.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 117.153 0.477 . . . . 0.0 112.0 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.4 ' O ' ' N ' ' A' ' 47' ' ' LYS . 0.9 OUTLIER -117.65 123.9 47.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.342 178.81 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.928 HG11 HD11 ' A' ' 67' ' ' LEU . 5.4 m -106.69 153.97 7.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.171 0.51 . . . . 0.0 112.32 -178.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.506 ' HB3' HD13 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -152.4 132.27 13.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.35 179.513 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.504 ' HA2' ' HA ' ' A' ' 44' ' ' ILE . . . -107.64 153.97 16.69 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.473 -0.87 . . . . 0.0 113.153 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.925 ' ND2' HD12 ' A' ' 42' ' ' LEU . 18.2 p-10 -106.73 -179.16 3.86 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.177 0.513 . . . . 0.0 111.318 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -135.86 127.54 29.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.53 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.732 ' CA ' HD21 ' A' ' 42' ' ' LEU . 10.6 t -38.61 134.67 0.9 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.739 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.13 -35.13 79.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.267 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -73.74 -57.34 4.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.012 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -119.26 161.07 21.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.932 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 40.6 m-70 -77.84 61.94 2.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.867 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.23 126.76 48.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.993 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -61.49 131.46 50.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.01 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.925 HD12 ' ND2' ' A' ' 33' ' ' ASN . 11.6 mt -89.54 -24.62 21.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.896 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.448 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 140.31 169.92 11.86 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.346 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.915 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -101.37 140.45 20.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.8 0.333 . . . . 0.0 111.309 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.46 ' CE2' ' HG3' ' A' ' 66' ' ' GLN . 0.1 OUTLIER -126.31 143.14 51.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.611 179.858 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.645 ' O ' HG13 ' A' ' 63' ' ' VAL . 44.8 t -55.35 105.42 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.412 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.473 ' HD3' HD12 ' B' ' 10' ' ' ILE . 18.3 tptt -72.6 -43.61 63.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.679 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.2 m -165.01 126.53 2.07 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.999 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.742 HG23 HG12 ' A' ' 28' ' ' VAL . 66.9 mt -91.82 119.04 38.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.324 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.558 HD12 ' N ' ' A' ' 28' ' ' VAL . 1.9 mp -58.83 101.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.571 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -59.96 80.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.08 0.467 . . . . 0.0 110.584 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 153.63 -30.34 0.76 Allowed Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.624 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.402 ' H ' HG22 ' A' ' 50' ' ' ILE . . . -63.37 -174.98 3.02 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.585 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.75 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -65.13 -36.22 83.58 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.741 ' HB1' HD13 ' A' ' 61' ' ' LEU . . . -68.74 -45.87 70.35 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.748 0.309 . . . . 0.0 111.551 -179.278 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.56 -29.9 70.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.104 0.478 . . . . 0.0 110.053 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.1 mtpt -72.77 -32.67 65.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.971 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.409 ' OD1' ' NH2' ' A' ' 60' ' ' ARG . 1.3 t0 -57.49 -29.78 64.56 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.787 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.16 16.84 75.37 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.045 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.409 ' NH2' ' OD1' ' A' ' 58' ' ' ASP . 0.6 OUTLIER -128.82 -2.03 5.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.933 0.366 . . . . 0.0 111.202 179.837 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.778 HD22 HG11 ' A' ' 28' ' ' VAL . 0.1 OUTLIER -96.03 125.04 40.3 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.007 0.432 . . . . 0.0 111.472 -179.642 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.412 ' N ' ' HD2' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -128.66 140.28 51.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.556 179.707 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.678 ' O ' ' HB2' ' A' ' 64' ' ' ASN . 39.7 t -61.41 150.86 7.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.461 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.678 ' HB2' ' O ' ' A' ' 63' ' ' VAL . 22.4 m-80 83.44 3.37 0.93 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.05 0.54 . . . . 0.0 111.95 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.511 ' OD2' HG21 ' A' ' 105' ' ' VAL . 1.2 m-20 -81.1 117.76 21.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.852 0.358 . . . . 0.0 110.298 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.46 ' HG3' ' CE2' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -75.73 115.03 14.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.248 -179.387 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.928 HD11 HG11 ' A' ' 30' ' ' VAL . 32.8 mt -63.34 152.01 39.19 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.153 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.943 HD11 ' HB2' ' A' ' 106' ' ' ALA . 21.1 mt -136.77 -43.65 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.169 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.9 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -143.18 150.97 40.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.966 0.412 . . . . 0.0 111.399 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.582 HG11 ' HA ' ' A' ' 87' ' ' LEU . 10.3 p -140.62 116.28 7.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.819 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.539 ' ND2' HG22 ' A' ' 70' ' ' VAL . 69.3 m-80 55.79 55.36 7.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.789 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 60.89 18.69 54.53 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.435 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -118.11 88.72 2.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.881 0.372 . . . . 0.0 110.82 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.3 m -62.0 118.46 7.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.026 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.482 HD22 ' HA ' ' A' ' 83' ' ' ALA . 2.1 mt -73.59 -16.52 61.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.214 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.599 HD13 HG23 ' A' ' 68' ' ' ILE . 1.0 OUTLIER -53.33 91.5 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.927 0.394 . . . . 0.0 111.133 -179.906 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 152.77 -28.62 0.83 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.256 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.3 ptpp? -106.38 154.69 20.44 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.215 0.531 . . . . 0.0 110.963 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.36 156.42 3.29 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.303 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -53.85 -42.47 68.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.316 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.41 ' HA ' ' HG2' ' A' ' 84' ' ' MET . 0.0 OUTLIER -66.42 -38.01 86.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.966 0.412 . . . . 0.0 110.872 -179.936 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.69 -33.18 72.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.185 0.517 . . . . 0.0 110.109 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.602 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -69.13 -46.69 67.01 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.782 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.42 ' HA ' ' CD2' ' A' ' 87' ' ' LEU . 6.1 ptp -63.26 -31.97 73.26 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.333 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -80.42 -32.05 37.46 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.6 m -68.73 -36.44 78.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.29 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.852 HD12 ' N ' ' A' ' 88' ' ' ARG . 4.3 pp -78.54 -35.05 46.7 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.369 0.604 . . . . 0.0 109.388 178.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.852 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -60.04 -48.54 81.31 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.171 179.422 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.516 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.82 -42.33 63.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.964 179.329 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.0 t -62.75 -29.42 70.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.179 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.931 ' HE2' HD22 ' A' ' 26' ' ' LEU . 3.2 ptp -85.47 -30.86 23.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.658 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.2 30.31 6.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.701 -179.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.516 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.4 OUTLIER -158.86 -28.98 0.07 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -179.79 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.5 ' HG3' HG22 ' A' ' 93' ' ' THR . 4.9 mt-10 -122.1 -38.98 2.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.959 0.409 . . . . 0.0 111.103 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.513 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -78.63 -31.45 45.05 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.724 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.741 ' HB2' HD11 ' A' ' 18' ' ' LEU . 2.2 t30 -75.02 -33.43 61.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.786 0.326 . . . . 0.0 110.14 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.45 ' HD3' ' O ' ' A' ' 93' ' ' THR . 26.2 mmmt -43.52 -44.8 6.23 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.157 0.504 . . . . 0.0 111.108 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.58 -23.57 21.94 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.715 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 113.69 -1.3 24.67 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.789 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.448 ' SD ' ' HB3' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -163.06 143.24 9.14 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.055 0.455 . . . . 0.0 111.341 -179.639 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.884 HD11 HD11 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -116.47 139.77 41.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.277 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.533 ' C ' HD22 ' A' ' 103' ' ' LEU . 3.0 pp0? -87.25 135.32 33.36 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.907 HD23 HG23 ' A' ' 16' ' ' VAL . 2.2 mm? -121.33 138.31 54.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.285 0.564 . . . . 0.0 112.286 -179.161 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.9 HD12 ' HB3' ' A' ' 69' ' ' ALA . 96.2 mt -120.02 112.67 37.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.278 178.242 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.829 HG12 HD23 ' A' ' 67' ' ' LEU . 28.5 m -125.98 154.06 34.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.448 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.943 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -125.63 135.31 52.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.417 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.563 ' HG3' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -148.04 -179.04 6.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.099 0.476 . . . . 0.0 111.52 -179.41 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 2.6 tpp85 -100.05 124.21 45.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.826 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.7 mt -67.73 150.41 10.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.057 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.0 t . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.852 179.949 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 59.1 t0 . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.906 0.384 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -85.08 160.17 20.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.899 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -91.56 -67.89 0.83 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.959 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -136.66 -47.73 0.62 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.929 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -156.55 112.33 2.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.86 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 4.2 t -71.87 -165.49 0.17 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.766 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -170.55 129.11 0.83 Allowed 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.506 HD13 ' HB3' ' A' ' 31' ' ' LYS . 1.6 mm -100.75 125.78 54.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.223 0.535 . . . . 0.0 111.388 -179.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 22.7 m -101.21 100.5 11.04 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.442 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.16 124.09 23.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.219 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.53 HG23 ' O ' ' B' ' 13' ' ' VAL . 12.0 m . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.386 -0.816 . . . . 0.0 110.797 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.396 -0.281 . . . . 0.0 112.396 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 67.4 p -153.73 74.31 0.99 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.805 0.336 . . . . 0.0 110.87 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.7 mtm180 -148.25 121.15 8.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.691 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -114.51 121.89 44.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.091 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -78.43 136.06 37.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.638 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.967 HD12 HG23 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -130.58 111.08 11.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.902 0.382 . . . . 0.0 111.29 -179.746 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.598 HG23 ' OE1' ' A' ' 102' ' ' GLN . 99.2 m -99.93 132.12 45.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.346 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.427 ' CG ' ' HB3' ' A' ' 60' ' ' ARG . 28.4 m-85 -140.69 172.52 12.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.321 0.582 . . . . 0.0 112.202 -179.174 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.468 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.4 OUTLIER -130.74 111.24 11.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.276 179.295 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.892 HG23 HD23 ' A' ' 103' ' ' LEU . 24.2 t -103.65 117.01 60.91 Favored Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -178.071 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.775 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 82.9 Cg_endo -86.97 128.07 2.69 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.738 2.292 . . . . 0.0 110.898 178.317 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.901 HD11 ' HB2' ' A' ' 96' ' ' ASN . 0.4 OUTLIER -122.71 28.75 7.16 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -178.899 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -38.38 -31.96 0.06 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.319 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -111.92 -32.5 6.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.123 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.762 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 25.0 t -71.74 -5.21 32.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.308 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.771 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -44.43 -29.37 1.75 Allowed Glycine 0 C--N 1.337 0.605 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.726 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.1 m -85.03 -35.1 22.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.001 0.429 . . . . 0.0 110.657 179.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.92 5.14 34.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.424 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.81 -56.35 5.04 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.958 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.918 HD22 ' HE2' ' A' ' 91' ' ' MET . 8.4 tp -175.06 -36.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.635 0.255 . . . . 0.0 110.839 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.83 45.54 0.7 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.554 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.775 HG12 HG23 ' A' ' 49' ' ' ILE . 23.4 m -157.16 156.71 4.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.185 0.517 . . . . 0.0 112.122 179.353 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.43 ' O ' ' HB3' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -116.07 114.63 24.8 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.091 178.582 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.88 HG11 HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -108.88 146.4 14.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.14 0.495 . . . . 0.0 111.993 -178.683 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.494 ' HB3' HD13 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -144.43 131.03 19.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.306 179.621 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.507 ' HA2' ' HA ' ' A' ' 44' ' ' ILE . . . -96.85 155.18 20.74 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.967 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -104.2 -171.19 1.89 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.864 0.364 . . . . 0.0 110.821 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.469 ' CD ' ' O ' ' A' ' 35' ' ' SER . 0.0 OUTLIER -145.17 141.27 28.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.505 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.764 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 0.2 OUTLIER -43.7 146.68 0.52 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.119 0.485 . . . . 0.0 111.905 -179.246 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.03 -19.36 65.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.36 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -103.13 -82.27 0.49 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.692 0.282 . . . . 0.0 111.393 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -98.19 166.5 11.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.116 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.442 ' HA ' ' CG ' ' A' ' 34' ' ' ARG . 88.3 m-70 -66.74 73.52 0.1 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.917 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.764 ' HB3' ' HB2' ' A' ' 35' ' ' SER . . . -115.65 88.34 2.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.866 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.404 ' HB3' ' ND2' ' A' ' 80' ' ' ASN . 2.0 p-10 -37.97 121.93 0.97 Allowed 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.918 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.645 HD21 ' HA ' ' A' ' 35' ' ' SER . 19.2 mt -88.92 6.67 38.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.04 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.457 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 103.16 -174.31 23.02 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.384 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.827 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -114.45 144.7 21.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.842 0.353 . . . . 0.0 111.478 -179.719 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -127.44 143.16 51.24 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.714 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.589 ' O ' HG13 ' A' ' 63' ' ' VAL . 41.9 t -60.04 104.37 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.486 179.507 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.43 ' HB3' ' O ' ' A' ' 29' ' ' SER . 2.8 tptt -73.37 -42.35 62.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.881 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.0 m -168.66 122.6 0.86 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.028 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.775 HG23 HG12 ' A' ' 28' ' ' VAL . 75.1 mt -84.82 116.55 28.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.908 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.619 HD12 ' N ' ' A' ' 28' ' ' VAL . 1.8 mp -52.65 101.91 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.742 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -60.1 80.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.129 0.49 . . . . 0.0 110.628 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 153.58 -30.0 0.76 Allowed Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.718 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.477 ' H ' HG22 ' A' ' 50' ' ' ILE . . . -65.07 -171.19 2.82 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.366 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.775 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -68.43 -37.12 79.97 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.734 ' HB1' HD13 ' A' ' 61' ' ' LEU . . . -66.48 -43.54 85.15 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.468 -179.386 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.419 ' OG ' HG22 ' A' ' 49' ' ' ILE . 0.5 OUTLIER -69.92 -32.11 70.24 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.049 179.702 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 26.7 mtpt -72.29 -33.21 67.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.852 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -62.16 -26.79 68.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.795 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.64 37.31 92.1 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.641 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.427 ' HB3' ' CG ' ' A' ' 14' ' ' PHE . 7.3 mtm180 -131.4 -33.48 1.46 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.674 0.273 . . . . 0.0 110.949 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.795 HD11 HG21 ' A' ' 16' ' ' VAL . 2.1 mp -64.45 157.89 25.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.048 0.451 . . . . 0.0 111.185 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -149.49 124.05 9.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.521 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.589 HG13 ' O ' ' A' ' 46' ' ' VAL . 41.2 t -56.9 143.05 11.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.198 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.435 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 21.5 m-20 86.26 -2.78 0.73 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.238 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -78.43 124.03 27.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.718 0.295 . . . . 0.0 110.52 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.438 ' O ' ' HA ' ' A' ' 105' ' ' VAL . 0.7 OUTLIER -74.9 134.46 41.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.665 -179.86 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.904 HD23 HG12 ' A' ' 105' ' ' VAL . 19.3 mt -86.17 137.8 32.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.754 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.971 HD11 ' HB2' ' A' ' 106' ' ' ALA . 24.5 mt -120.99 -37.27 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.458 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.79 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -149.92 170.8 17.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.904 0.383 . . . . 0.0 111.275 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.711 HG23 ' CD1' ' A' ' 103' ' ' LEU . 7.2 p -157.78 121.87 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.934 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.512 ' ND2' HG22 ' A' ' 70' ' ' VAL . 70.0 m-80 61.07 25.62 15.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.628 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.47 23.02 45.07 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.143 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -127.04 119.02 25.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.779 0.323 . . . . 0.0 110.71 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 60.9 p -69.8 153.31 43.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.097 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.439 HD22 ' HB1' ' A' ' 83' ' ' ALA . 6.8 mt -113.38 -15.4 12.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.314 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.7 mt -57.45 -18.3 17.61 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.521 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -87.87 21.28 24.05 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.079 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.448 ' HB2' ' HB3' ' A' ' 82' ' ' GLU . 1.9 ptpt -160.38 168.69 24.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.262 0.553 . . . . 0.0 111.221 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.44 ' HB3' HE22 ' A' ' 81' ' ' GLN . . . -72.37 174.31 7.52 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.641 -179.299 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.464 ' O ' ' HE2' ' A' ' 84' ' ' MET . 21.1 m-80 -57.14 -58.29 8.84 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.496 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.44 HE22 ' HB3' ' A' ' 79' ' ' ALA . 6.1 pm0 -58.37 -34.12 70.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.045 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.448 ' HB3' ' HB2' ' A' ' 78' ' ' LYS . 2.8 mt-10 -70.77 -39.2 73.35 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.25 0.548 . . . . 0.0 109.867 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.6 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -69.13 -43.52 74.21 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.573 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.481 ' HG3' HG21 ' A' ' 44' ' ' ILE . 1.0 OUTLIER -64.61 -29.29 70.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.067 179.176 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -78.99 -35.76 42.4 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.433 ' HA ' ' HD2' ' A' ' 89' ' ' ARG . 1.6 m -65.36 -36.51 84.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.403 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.775 HD12 ' N ' ' A' ' 88' ' ' ARG . 4.4 pp -78.35 -34.26 48.55 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.775 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -60.7 -49.45 77.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.744 179.349 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.558 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.15 -45.7 59.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.98 179.683 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 45.9 p -60.25 -29.35 68.72 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.763 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.918 ' HE2' HD22 ' A' ' 26' ' ' LEU . 2.5 ptp -88.07 -29.36 20.71 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.493 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.58 35.46 4.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.761 -179.354 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.558 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.3 OUTLIER -166.42 -24.05 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.474 ' HG3' HG22 ' A' ' 93' ' ' THR . 6.6 mt-10 -123.92 -59.44 1.51 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.989 0.424 . . . . 0.0 111.175 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.428 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -66.59 -25.35 72.78 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.1 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.901 ' HB2' HD11 ' A' ' 18' ' ' LEU . 3.0 t30 -78.28 -35.59 47.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.963 0.411 . . . . 0.0 110.185 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.46 ' HD3' ' O ' ' A' ' 93' ' ' THR . 27.7 mmmt -45.52 -42.28 10.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.985 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.91 -27.92 23.08 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.629 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 121.94 -6.67 10.25 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.934 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.468 ' SD ' ' HB3' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -158.33 142.38 15.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.013 0.435 . . . . 0.0 111.301 -179.759 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.786 HD11 HD11 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -109.45 144.79 17.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.996 -179.841 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.598 ' OE1' HG23 ' A' ' 13' ' ' THR . 1.5 tm0? -85.83 140.35 30.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.168 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.892 HD23 HG23 ' A' ' 16' ' ' VAL . 2.7 mm? -130.4 139.81 50.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.039 0.447 . . . . 0.0 111.867 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.79 HD12 ' HB3' ' A' ' 69' ' ' ALA . 66.5 mt -128.6 112.91 27.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.596 178.221 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.967 HG23 HD12 ' A' ' 12' ' ' LEU . 28.6 m -122.71 176.94 4.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.84 -178.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.971 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -147.71 117.53 7.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.475 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 5.6 ttm180 -105.73 142.05 36.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.928 0.394 . . . . 0.0 110.773 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 5.8 tpp180 -84.72 148.25 26.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.097 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 20.8 mt -99.24 -31.16 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.079 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.8 t . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.913 -179.959 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.935 0.398 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -91.56 170.17 10.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.953 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 5' ' ' ASP . . . . . 0.46 ' OD1' ' NH1' ' A' ' 34' ' ' ARG . 49.0 m-20 -98.26 35.78 1.71 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.533 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 77.09 -61.37 0.43 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.919 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -98.71 108.77 21.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.831 0.348 . . . . 0.0 110.986 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 60.4 p -104.13 -164.29 1.05 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.892 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -168.81 125.47 0.97 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.494 HD13 ' HB3' ' A' ' 31' ' ' LYS . 1.5 mm -99.97 100.77 11.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.177 0.513 . . . . 0.0 111.192 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 90.5 m -79.0 116.39 19.27 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.744 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt -79.11 129.0 33.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.861 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.75 HG11 HD11 ' A' ' 87' ' ' LEU . 21.3 m . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.126 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.38 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.494 ' HA ' HD12 ' A' ' 109' ' ' ILE . 52.0 p -116.53 -20.33 9.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.567 0.223 . . . . 0.0 111.341 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.4 mtt85 -76.34 133.1 40.07 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.713 0.292 . . . . 0.0 110.643 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -162.38 161.3 27.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.028 0.442 . . . . 0.0 111.357 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.429 ' CD2' HG13 ' A' ' 68' ' ' ILE . 3.8 m-85 -101.95 145.03 29.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.405 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.69 HD13 ' CZ ' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -147.6 137.36 22.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.126 0.489 . . . . 0.0 111.428 -179.652 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.469 HG23 ' OE1' ' A' ' 102' ' ' GLN . 86.8 m -88.77 145.9 25.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.242 179.399 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.69 ' CZ ' HD13 ' A' ' 12' ' ' LEU . 21.3 m-85 -140.37 116.51 10.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.03 0.443 . . . . 0.0 111.979 -179.251 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.411 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.6 OUTLIER -86.99 109.15 19.19 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.565 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.509 HG11 ' HG ' ' A' ' 26' ' ' LEU . 39.6 t -106.54 103.37 45.98 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -177.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.749 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 3.7 Cg_exo -75.42 128.01 10.83 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.606 2.204 . . . . 0.0 110.661 178.352 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.78 HD11 ' HB2' ' A' ' 96' ' ' ASN . 0.4 OUTLIER -124.03 28.36 6.83 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.713 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -39.71 -31.2 0.1 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.069 0.461 . . . . 0.0 111.092 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -113.7 -32.69 6.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.234 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.747 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 45.9 t -70.65 -8.6 53.04 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.074 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.678 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -46.36 -27.64 2.91 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.603 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 52.4 m -84.9 -33.17 22.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.874 0.369 . . . . 0.0 110.693 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.78 11.13 20.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.49 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.14 -55.64 5.04 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.897 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.954 HD22 ' HE2' ' A' ' 91' ' ' MET . 9.2 tp -178.49 -31.38 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.658 0.266 . . . . 0.0 110.96 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.443 ' HA3' ' HA3' ' A' ' 53' ' ' GLY . . . 112.73 32.49 2.26 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.421 -0.895 . . . . 0.0 113.286 179.433 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.75 HG12 HG23 ' A' ' 49' ' ' ILE . 35.2 m -156.34 150.55 10.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.1 0.476 . . . . 0.0 111.915 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.443 ' O ' ' N ' ' A' ' 47' ' ' LYS . 73.0 m -107.48 123.13 47.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.032 178.302 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.6 m -107.47 153.67 8.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 -178.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.513 ' O ' ' HG3' ' A' ' 31' ' ' LYS . 0.1 OUTLIER -155.62 129.93 8.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.206 179.303 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -103.97 160.46 16.09 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.181 -1.009 . . . . 0.0 113.101 -179.486 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -116.01 175.32 5.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.004 0.43 . . . . 0.0 111.133 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 29.5 mtt85 -121.41 153.05 38.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.749 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.894 ' HA ' HD21 ' A' ' 42' ' ' LEU . 0.5 OUTLIER -47.7 156.87 0.28 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.484 -179.866 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.87 -51.98 41.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.394 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.21 -51.74 28.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.704 -179.34 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -117.97 -177.12 3.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.752 0.31 . . . . 0.0 111.078 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 -92.34 40.38 1.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.049 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.18 110.2 17.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.829 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.603 ' OD2' ' HB1' ' A' ' 79' ' ' ALA . 1.2 m-20 -48.37 124.5 8.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.443 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.894 HD21 ' HA ' ' A' ' 35' ' ' SER . 17.0 mt -88.88 -36.25 16.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.72 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.484 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 154.44 -178.71 31.09 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.898 -0.667 . . . . 0.0 111.897 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.741 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -106.58 137.82 35.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.845 0.355 . . . . 0.0 111.274 -179.854 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -123.68 140.13 53.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.497 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.609 ' O ' HG13 ' A' ' 63' ' ' VAL . 27.5 t -55.95 107.56 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.068 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 29' ' ' SER . 21.5 tptt -71.61 -46.87 57.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.625 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 27.2 t -166.42 123.83 1.36 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.857 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.75 HG23 HG12 ' A' ' 28' ' ' VAL . 66.9 mt -87.32 122.54 39.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.274 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.51 HD12 ' N ' ' A' ' 28' ' ' VAL . 2.5 mp -64.84 111.77 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.289 179.249 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -68.06 72.63 0.18 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.212 0.53 . . . . 0.0 110.404 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 165.12 -28.89 0.21 Allowed Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.877 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.443 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -66.84 -170.56 4.2 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.662 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.749 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -69.24 -37.7 78.1 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.744 ' HB1' HD13 ' A' ' 61' ' ' LEU . . . -67.96 -44.26 77.15 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.792 0.33 . . . . 0.0 111.312 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.416 ' HB2' HG22 ' A' ' 49' ' ' ILE . 6.9 t -65.53 -34.79 79.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.224 0.535 . . . . 0.0 109.759 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -69.23 -31.41 69.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.766 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.59 -30.84 61.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.654 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 68.93 16.19 70.18 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.897 -0.668 . . . . 0.0 113.277 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.441 ' HG3' ' CD1' ' A' ' 14' ' ' PHE . 7.0 ptp180 -135.23 10.91 3.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.002 0.401 . . . . 0.0 111.143 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.744 HD13 ' HB1' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -104.07 134.01 48.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.596 179.877 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.39 145.63 50.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.802 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.609 HG13 ' O ' ' A' ' 46' ' ' VAL . 45.2 t -66.07 148.91 11.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.845 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.43 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 15.9 m-80 84.65 -4.02 0.98 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.428 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.3 128.25 35.27 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.694 0.283 . . . . 0.0 110.697 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.55 130.01 34.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.937 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.907 HD23 HG12 ' A' ' 105' ' ' VAL . 77.5 mt -81.13 135.95 35.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.575 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.429 HG13 ' CD2' ' A' ' 11' ' ' PHE . 18.7 mm -118.93 -29.14 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.298 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.744 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -160.04 148.73 17.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.983 0.42 . . . . 0.0 111.378 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.432 HG11 ' HA ' ' A' ' 87' ' ' LEU . 7.1 p -137.89 129.79 39.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.488 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.9 m120 60.01 26.08 15.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.763 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.8 20.67 59.23 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.193 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -128.19 111.55 13.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.823 0.344 . . . . 0.0 110.723 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.47 149.83 20.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.158 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.586 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . 4.2 mt -114.09 -20.2 11.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.347 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.1 tp -54.83 -24.35 22.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.674 0.273 . . . . 0.0 111.278 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.39 -2.17 83.48 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.031 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.433 ' HG3' ' HB2' ' A' ' 83' ' ' ALA . 4.6 ptpp? -135.83 161.13 36.47 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.293 0.568 . . . . 0.0 111.301 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.603 ' HB1' ' OD2' ' A' ' 41' ' ' ASP . . . -60.52 176.94 0.32 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.525 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.435 ' HB3' ' HA3' ' A' ' 32' ' ' GLY . 19.5 m-80 -67.14 -57.64 6.38 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.118 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.438 ' HA ' ' HE3' ' A' ' 84' ' ' MET . 0.0 OUTLIER -58.36 -35.21 71.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.036 0.446 . . . . 0.0 110.591 -179.826 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.53 -42.45 71.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.484 179.09 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.586 ' HB1' ' HB3' ' A' ' 75' ' ' LEU . . . -69.59 -30.99 68.88 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.934 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.47 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 0.5 OUTLIER -72.36 -33.32 67.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.596 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -77.63 -28.07 51.29 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.2 m -72.66 -36.85 68.03 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.528 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 84' ' ' MET . 4.4 pp -78.65 -34.24 46.57 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -61.4 -52.1 66.0 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.461 179.243 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.5 ' O ' HG22 ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.17 -33.97 68.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.19 179.594 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.491 ' N ' ' HD3' ' A' ' 89' ' ' ARG . 41.7 m -72.57 -29.68 63.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.672 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.954 ' HE2' HD22 ' A' ' 26' ' ' LEU . 3.2 ptp -87.35 -22.4 25.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.31 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.0 t -112.81 22.65 14.26 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.946 0.351 . . . . 0.0 111.946 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.558 HG23 ' HG2' ' A' ' 94' ' ' GLU . 0.5 OUTLIER -154.77 -39.46 0.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.558 ' HG2' HG23 ' A' ' 93' ' ' THR . 5.7 mt-10 -110.77 -22.06 11.76 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.868 0.366 . . . . 0.0 111.206 -179.448 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.505 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -93.27 -30.3 9.4 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 179.188 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.78 ' HB2' HD11 ' A' ' 18' ' ' LEU . 5.3 t30 -86.67 -37.05 18.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.791 0.329 . . . . 0.0 110.29 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.551 ' HG2' ' HA ' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -45.32 -28.53 0.85 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.31 179.627 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.427 ' HD3' ' HD2' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -106.8 -27.04 11.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.534 178.964 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 118.36 -1.64 16.3 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.135 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.49 ' HE2' ' O ' ' A' ' 100' ' ' MET . 0.0 OUTLIER -165.14 141.44 5.59 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.0 0.429 . . . . 0.0 111.649 -179.74 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.545 HG22 HD21 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -115.47 134.56 58.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.043 179.848 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.469 ' OE1' HG23 ' A' ' 13' ' ' THR . 1.7 pp0? -81.55 140.32 34.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.001 178.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.451 HD13 HG21 ' A' ' 16' ' ' VAL . 1.8 mp -134.84 111.59 10.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.736 0.303 . . . . 0.0 111.686 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.744 HD12 ' HB3' ' A' ' 69' ' ' ALA . 62.6 mt -90.19 112.45 24.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.255 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.907 HG12 HD23 ' A' ' 67' ' ' LEU . 14.6 m -118.37 -179.2 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.882 0.373 . . . . 0.0 111.384 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -147.01 134.99 21.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.755 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.616 ' HD2' HD21 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -151.93 -178.9 7.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.969 -179.864 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 3.7 mtm180 -107.73 129.57 55.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.027 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.494 HD12 ' HA ' ' A' ' 8' ' ' THR . 17.9 mt -63.08 115.75 2.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.923 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 35.9 t . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.822 179.878 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.049 0 CA-C-O 120.874 0.368 . . . . 0.0 110.807 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -75.26 144.79 42.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.945 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.41 -73.79 0.63 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.929 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 71.7 mm-40 -118.39 -66.48 1.07 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.816 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 68.1 m-70 -111.98 118.09 34.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.878 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 8' ' ' SER . . . . . 0.516 ' O ' ' HB2' ' B' ' 9' ' ' GLN . 77.1 p -62.76 -35.15 78.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.859 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 9' ' ' GLN . . . . . 0.516 ' HB2' ' O ' ' B' ' 8' ' ' SER . 0.0 OUTLIER 82.09 66.11 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.511 0.672 . . . . 0.0 109.689 -179.432 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.472 HD13 ' HB3' ' A' ' 31' ' ' LYS . 14.5 mm -77.67 142.18 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.079 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 1.9 m -162.05 122.37 2.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.584 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -80.46 145.1 32.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.15 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.402 ' CG1' ' HG3' ' A' ' 88' ' ' ARG . 27.2 m . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.175 -0.917 . . . . 0.0 111.093 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.404 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 31.2 p -94.63 42.05 1.09 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.855 0.359 . . . . 0.0 111.071 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.7 mtm180 -98.41 136.11 39.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.827 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -143.14 150.66 39.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.024 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -96.93 148.35 23.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.859 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.86 HD12 HG23 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -132.27 109.9 10.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.109 -179.848 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.689 HG23 ' OE1' ' A' ' 102' ' ' GLN . 87.9 m -96.71 133.02 41.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.496 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.407 ' CE1' ' HG2' ' A' ' 60' ' ' ARG . 47.8 m-85 -140.59 172.67 12.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.164 0.506 . . . . 0.0 112.043 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.427 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.4 OUTLIER -129.67 112.22 13.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.228 179.105 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.901 HG23 HD23 ' A' ' 103' ' ' LEU . 25.8 t -105.31 111.53 64.99 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -177.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.578 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 1.2 Cg_endo -81.7 127.61 5.69 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.817 2.345 . . . . 0.0 111.049 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.775 HD11 ' HB2' ' A' ' 96' ' ' ASN . 0.4 OUTLIER -122.09 28.67 7.4 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -179.002 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -38.72 -31.72 0.07 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.036 0.446 . . . . 0.0 111.195 179.414 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -112.26 -33.52 6.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.18 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.472 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 30.4 t -70.02 -7.57 42.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.2 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.745 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -45.3 -28.65 2.2 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.759 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.0 t -84.83 -34.23 22.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.783 0.325 . . . . 0.0 110.63 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.01 8.88 27.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.319 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.28 -55.26 4.94 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.969 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.864 HD22 ' HE2' ' A' ' 91' ' ' MET . 8.2 tp -176.02 -34.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.508 0.194 . . . . 0.0 110.657 179.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.42 ' HA2' HD13 ' A' ' 50' ' ' ILE . . . 111.68 44.28 0.91 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.328 -0.939 . . . . 0.0 113.56 179.085 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.782 HG12 HG23 ' A' ' 49' ' ' ILE . 19.4 m -158.27 167.55 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.155 0.503 . . . . 0.0 111.902 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' B' ' 12' ' ' LYS . 0.0 OUTLIER -126.67 116.67 21.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.276 178.636 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.961 HG11 HD11 ' A' ' 67' ' ' LEU . 1.0 OUTLIER -111.18 144.47 19.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.013 0.435 . . . . 0.0 111.981 -178.836 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.417 ' O ' ' HG3' ' A' ' 31' ' ' LYS . 2.2 ptmt -138.05 134.06 34.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.365 179.478 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.514 ' HA3' ' HB3' ' A' ' 80' ' ' ASN . . . -100.07 147.6 18.19 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.939 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.404 ' ND2' ' CE1' ' A' ' 45' ' ' PHE . 76.6 m-20 -127.12 130.49 49.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.888 0.375 . . . . 0.0 110.866 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.16 145.74 26.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.468 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.85 ' OG ' HD21 ' A' ' 42' ' ' LEU . 8.3 m -44.1 130.61 6.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.269 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.13 -19.85 65.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.568 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -106.08 -44.09 4.67 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.825 0.345 . . . . 0.0 111.421 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -87.3 -16.91 33.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.522 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 30.2 m-70 61.47 21.3 11.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.746 0.308 . . . . 0.0 110.888 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -99.29 134.47 42.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.011 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -50.18 126.94 15.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.315 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.85 HD21 ' OG ' ' A' ' 35' ' ' SER . 45.8 mt -94.39 -19.4 20.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.919 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.464 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 128.82 169.66 12.63 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.308 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.755 ' CG1' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -102.05 130.95 51.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.835 0.35 . . . . 0.0 111.29 179.85 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.425 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -113.56 146.79 39.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.486 179.868 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.534 ' O ' HG13 ' A' ' 63' ' ' VAL . 49.1 t -60.53 104.66 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.563 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.437 ' HD3' HD12 ' B' ' 10' ' ' ILE . 18.1 tptt -75.48 -40.05 57.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.889 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -168.77 126.41 1.03 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.981 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.782 HG23 HG12 ' A' ' 28' ' ' VAL . 63.7 mt -94.44 121.21 44.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.048 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.52 HD12 ' N ' ' A' ' 28' ' ' VAL . 1.5 mp -58.96 109.74 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.432 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -65.83 72.91 0.06 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.071 0.462 . . . . 0.0 110.691 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 163.76 -26.51 0.21 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.262 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.404 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -70.87 -165.41 6.05 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.777 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.578 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -69.09 -42.18 76.49 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.756 ' HB1' HD22 ' A' ' 61' ' ' LEU . . . -63.13 -43.84 97.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.342 -179.278 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.4 t -68.73 -33.56 74.13 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.132 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -72.2 -31.9 66.29 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.876 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -65.18 -25.17 67.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.709 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.12 29.7 65.9 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.575 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.407 ' HG2' ' CE1' ' A' ' 14' ' ' PHE . 15.0 mtm180 -124.9 -33.02 2.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.609 0.242 . . . . 0.0 111.254 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.756 HD22 ' HB1' ' A' ' 55' ' ' ALA . 5.5 mp -72.01 150.15 44.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.904 0.383 . . . . 0.0 111.055 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.11 135.71 20.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.082 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.54 ' O ' ' HB3' ' A' ' 64' ' ' ASN . 82.9 t -64.99 94.89 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.817 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.54 ' HB3' ' O ' ' A' ' 63' ' ' VAL . 12.2 p30 149.55 -4.45 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.92 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -84.22 131.78 34.71 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 121.096 0.474 . . . . 0.0 111.594 -179.009 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.93 117.25 28.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.11 179.343 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.961 HD11 HG11 ' A' ' 30' ' ' VAL . 5.2 mt -71.91 133.52 45.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.929 0.395 . . . . 0.0 111.404 -179.531 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.725 HD11 ' CB ' ' A' ' 106' ' ' ALA . 23.6 mt -122.12 -22.86 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.488 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.703 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -155.69 167.26 30.96 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.935 0.398 . . . . 0.0 111.466 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.83 HG22 HD22 ' A' ' 71' ' ' ASN . 10.3 p -158.18 126.34 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.694 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.83 HD22 HG22 ' A' ' 70' ' ' VAL . 2.7 m-80 66.19 15.4 10.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.082 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 96.34 7.48 58.17 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.529 -0.843 . . . . 0.0 113.125 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.427 ' CG ' ' O ' ' A' ' 70' ' ' VAL . 2.4 pt-20 -121.13 109.15 14.66 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.889 0.376 . . . . 0.0 111.002 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.4 m -59.65 145.9 43.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.024 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.423 ' HB2' ' CB ' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -121.16 4.41 10.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.247 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.598 HD13 HG23 ' A' ' 68' ' ' ILE . 5.0 tp -61.21 -28.53 69.21 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.741 0.305 . . . . 0.0 111.029 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -74.87 -24.95 70.65 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.558 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -97.34 166.17 11.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.259 0.552 . . . . 0.0 111.212 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.21 165.2 16.59 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.245 -0.888 . . . . 0.0 111.418 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.514 ' HB3' ' HA3' ' A' ' 32' ' ' GLY . 20.3 m-80 -54.78 -57.77 10.24 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.269 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.83 -34.49 67.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.83 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.72 -38.64 73.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.313 0.578 . . . . 0.0 109.625 179.237 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.534 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -69.08 -40.74 78.26 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.405 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.462 ' HG2' HG23 ' A' ' 30' ' ' VAL . 1.1 mtm -66.3 -29.62 69.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.854 179.144 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -79.88 -35.88 37.37 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.432 ' HA ' ' HD2' ' A' ' 89' ' ' ARG . 2.9 m -65.21 -36.33 83.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.375 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.809 HD12 ' N ' ' A' ' 88' ' ' ARG . 4.4 pp -79.06 -34.6 43.57 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.809 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -62.32 -50.68 70.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.605 179.322 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.499 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.16 -37.34 69.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.233 179.634 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.413 ' HB3' ' ND2' ' A' ' 71' ' ' ASN . 34.8 m -67.11 -29.51 69.27 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.077 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.864 ' HE2' HD22 ' A' ' 26' ' ' LEU . 4.5 ptp -89.34 -30.28 18.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.624 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.0 23.46 13.97 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.499 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.4 OUTLIER -155.04 -31.05 0.1 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.851 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.418 ' HG3' HG22 ' A' ' 93' ' ' THR . 7.8 mt-10 -113.9 -63.89 1.39 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.894 0.378 . . . . 0.0 111.524 -179.314 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.459 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -58.11 -31.89 66.19 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.451 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.775 ' HB2' HD11 ' A' ' 18' ' ' LEU . 1.8 t30 -72.95 -33.71 66.07 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.715 0.293 . . . . 0.0 110.612 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 93' ' ' THR . 54.4 mtpt -43.56 -39.45 3.45 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.035 0.445 . . . . 0.0 111.325 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.31 -26.23 15.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.957 178.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 117.27 2.07 18.17 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.613 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.512 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -158.17 141.91 15.49 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.011 0.434 . . . . 0.0 111.28 -179.689 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.828 HD11 HD11 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -112.86 146.15 17.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.967 179.915 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.689 ' OE1' HG23 ' A' ' 13' ' ' THR . 1.5 tm0? -86.9 138.45 31.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.034 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.901 HD23 HG23 ' A' ' 16' ' ' VAL . 2.8 mm? -128.51 138.98 52.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.0 0.428 . . . . 0.0 111.961 -179.172 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.703 HD12 ' HB3' ' A' ' 69' ' ' ALA . 55.1 mt -127.67 112.79 28.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.745 178.429 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.86 HG23 HD12 ' A' ' 12' ' ' LEU . 34.7 m -121.76 175.88 4.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.048 -179.438 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.725 ' CB ' HD11 ' A' ' 68' ' ' ILE . . . -147.52 141.77 26.21 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.842 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.668 ' CG ' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -150.38 -178.86 6.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.886 0.374 . . . . 0.0 111.175 -179.836 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.39 144.29 31.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.858 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.6 mt -71.01 -52.96 23.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.992 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 47.4 t . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.999 179.992 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.776 0.322 . . . . 0.0 110.948 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -69.97 148.82 48.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.818 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -91.22 -39.82 11.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.021 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -150.11 -69.55 0.19 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.001 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -119.1 131.75 55.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.03 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 57.8 p -104.9 -162.34 0.88 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.776 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -180.0 145.64 0.22 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.259 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.437 HD12 ' HD3' ' A' ' 47' ' ' LYS . 1.6 mm -109.81 153.99 11.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.981 0.419 . . . . 0.0 111.146 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 27.3 m -138.06 97.8 3.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.795 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 12' ' ' LYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 29' ' ' SER . 8.1 ttpt -69.19 109.67 4.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.989 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.755 HG11 HD11 ' A' ' 87' ' ' LEU . 18.5 m . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.321 -0.847 . . . . 0.0 111.103 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.443 ' O ' HG23 ' A' ' 8' ' ' THR . . . . . . . . 0 N--CA 1.45 -0.407 0 N-CA-C 112.448 -0.261 . . . . 0.0 112.448 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.443 HG23 ' O ' ' A' ' 7' ' ' GLY . 35.6 p -158.28 62.86 0.44 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.865 0.364 . . . . 0.0 110.941 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 15.4 ttp85 -95.55 147.41 23.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.791 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -151.63 146.12 25.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.146 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -90.98 146.28 24.0 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.801 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.609 HD11 ' CG ' ' A' ' 107' ' ' ARG . 0.3 OUTLIER -138.62 109.92 6.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.992 0.425 . . . . 0.0 111.088 -179.829 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.703 HG23 ' OE1' ' A' ' 102' ' ' GLN . 92.7 m -88.54 121.43 30.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.086 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.439 ' CZ ' ' HB3' ' A' ' 12' ' ' LEU . 32.8 m-85 -131.14 150.53 52.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.214 0.53 . . . . 0.0 112.33 -179.125 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.486 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.6 OUTLIER -112.46 111.14 21.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.285 -0.87 . . . . 0.0 108.93 178.79 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.546 HG11 ' HG ' ' A' ' 26' ' ' LEU . 10.3 t -100.14 115.33 65.6 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -177.625 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.776 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 93.8 Cg_endo -85.98 128.2 3.19 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.758 2.305 . . . . 0.0 110.842 178.297 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.808 HD12 ' HA2' ' A' ' 22' ' ' GLY . 0.4 OUTLIER -127.95 28.79 5.52 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -178.664 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -38.84 -33.35 0.11 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.061 0.458 . . . . 0.0 111.28 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -107.71 -33.87 7.15 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.231 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.758 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 7.6 t -70.51 -6.39 35.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.25 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.808 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -42.12 -30.49 0.75 Allowed Glycine 0 C--N 1.337 0.613 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.775 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.02 -38.81 20.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.866 0.365 . . . . 0.0 110.672 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -82.51 1.7 36.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.449 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.88 -53.81 4.86 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.978 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.942 HD22 ' HE2' ' A' ' 91' ' ' MET . 7.7 tp -175.62 -36.06 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.735 0.302 . . . . 0.0 110.589 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.443 ' HA3' ' HA3' ' A' ' 53' ' ' GLY . . . 109.03 47.5 0.88 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.524 -0.846 . . . . 0.0 113.531 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.8 HG12 HG23 ' A' ' 49' ' ' ILE . 22.3 m -158.18 156.67 3.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 117.058 0.429 . . . . 0.0 111.75 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.414 ' O ' ' HB3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -114.13 114.17 25.69 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.383 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.606 HG11 HD11 ' A' ' 67' ' ' LEU . 0.4 OUTLIER -106.94 146.97 12.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.269 0.556 . . . . 0.0 111.979 -178.659 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.466 ' HB3' HD13 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -148.18 130.9 15.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.321 179.41 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 44' ' ' ILE . . . -100.08 176.97 28.57 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.941 -179.356 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.708 ' ND2' HD12 ' A' ' 42' ' ' LEU . 50.8 p30 -125.15 -174.8 3.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.303 0.573 . . . . 0.0 111.637 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.426 ' O ' ' C ' ' A' ' 35' ' ' SER . 4.5 mtm180 -144.27 126.13 15.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.698 179.138 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.456 ' CA ' HD21 ' A' ' 42' ' ' LEU . 57.7 m -28.68 142.77 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.22 -178.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.407 ' HD2' ' CB ' ' B' ' 3' ' ' ASP . 0.0 OUTLIER -67.09 -37.21 83.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.354 -179.838 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.78 -63.16 1.42 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.933 0.397 . . . . 0.0 110.925 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -112.78 -179.92 3.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.882 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 53.1 m-70 -87.56 53.62 2.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.968 0.413 . . . . 0.0 110.857 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.497 ' O ' HD23 ' A' ' 42' ' ' LEU . . . -104.24 105.0 14.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.074 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -49.06 139.75 10.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.554 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.708 HD12 ' ND2' ' A' ' 33' ' ' ASN . 5.4 mt -103.66 -16.37 15.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.737 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 137.5 -177.94 19.46 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.036 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.687 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -115.98 136.59 52.42 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-O 120.819 0.342 . . . . 0.0 110.672 179.749 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -126.47 144.08 50.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.87 0.366 . . . . 0.0 110.827 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.606 ' O ' HG13 ' A' ' 63' ' ' VAL . 40.1 t -57.06 113.79 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.825 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.51 ' HG2' HD12 ' B' ' 10' ' ' ILE . 30.1 tptt -83.03 -38.16 22.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.653 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -168.3 120.09 0.82 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.082 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.8 HG23 HG12 ' A' ' 28' ' ' VAL . 70.4 mt -85.75 120.61 36.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.971 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.545 HD12 ' N ' ' A' ' 28' ' ' VAL . 1.4 mp -57.55 103.95 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.623 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -60.24 83.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.484 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 148.97 -28.03 1.27 Allowed Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.664 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.505 ' H ' HG22 ' A' ' 50' ' ' ILE . . . -67.09 -176.15 7.98 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.543 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.776 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -61.77 -39.29 91.16 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.713 ' HB1' HD13 ' A' ' 61' ' ' LEU . . . -64.65 -48.6 74.2 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.98 0.419 . . . . 0.0 111.486 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.69 -28.52 69.95 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.113 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.7 mtpt -77.46 -29.03 52.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.948 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.407 ' OD1' ' NH2' ' A' ' 60' ' ' ARG . 4.5 t0 -56.13 -31.7 63.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.412 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.77 13.51 80.5 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.887 -0.673 . . . . 0.0 113.35 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.428 ' HG3' ' CG ' ' A' ' 14' ' ' PHE . 2.9 ptp180 -135.62 7.09 3.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 117.089 0.445 . . . . 0.0 111.373 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.772 ' HB3' HD13 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -98.99 133.49 43.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.46 179.827 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.9 142.16 38.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.911 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.606 HG13 ' O ' ' A' ' 46' ' ' VAL . 52.3 t -59.3 147.35 8.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.912 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.434 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 16.3 m-20 85.36 12.99 0.21 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.3 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.441 ' CG ' HG21 ' A' ' 105' ' ' VAL . 1.3 m-20 -85.26 109.53 18.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.854 0.359 . . . . 0.0 110.611 179.53 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -73.59 111.17 8.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.841 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.888 HD23 HG12 ' A' ' 105' ' ' VAL . 14.8 mt -66.08 141.47 58.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.66 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.824 HG23 HD12 ' A' ' 76' ' ' LEU . 34.8 mt -129.51 -39.69 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.437 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.73 ' HB3' ' CD1' ' A' ' 104' ' ' ILE . . . -147.0 124.03 11.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.991 0.424 . . . . 0.0 111.227 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.651 HG11 ' HA ' ' A' ' 87' ' ' LEU . 8.4 p -120.33 124.93 73.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.437 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.1 m120 60.93 42.74 12.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.905 0.383 . . . . 0.0 110.477 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 64.8 21.51 67.47 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.225 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -126.94 118.61 24.87 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.771 0.319 . . . . 0.0 110.767 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.3 t -60.5 152.43 25.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.941 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.686 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . 36.2 mt -118.39 -31.89 4.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.233 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.824 HD12 HG23 ' A' ' 68' ' ' ILE . 1.5 mt -53.96 -29.73 43.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.22 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.03 -11.6 63.81 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.837 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.428 ' HG3' ' HB2' ' A' ' 83' ' ' ALA . 7.0 ptpp? -126.01 156.26 40.16 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.252 0.548 . . . . 0.0 111.206 -179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.07 162.45 0.66 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.882 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -54.66 -57.62 10.74 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.079 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -59.55 -35.4 74.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.061 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.407 ' HB3' ' HB2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -70.49 -40.53 73.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.153 0.502 . . . . 0.0 109.655 179.458 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.686 ' HB1' ' HB3' ' A' ' 75' ' ' LEU . . . -69.13 -38.83 79.07 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.45 179.621 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.435 ' HG3' HG21 ' A' ' 44' ' ' ILE . 0.5 OUTLIER -65.95 -30.67 71.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.865 179.239 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -79.72 -31.95 41.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.341 178.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.437 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 1.7 m -69.48 -35.39 75.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.33 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.833 HD12 ' N ' ' A' ' 88' ' ' ARG . 4.3 pp -78.72 -34.61 45.81 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.833 ' N ' HD12 ' A' ' 87' ' ' LEU . 5.0 mtp180 -61.4 -52.11 65.98 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 114.937 -1.028 . . . . 0.0 110.616 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.517 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.42 -33.48 67.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.993 179.613 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.443 ' N ' ' HD3' ' A' ' 89' ' ' ARG . 28.6 m -70.99 -29.54 65.55 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.46 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.942 ' HE2' HD22 ' A' ' 26' ' ' LEU . 2.3 ptp -88.94 -21.34 23.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.386 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.5 31.81 6.29 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.517 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.4 OUTLIER -160.01 -31.68 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 179.899 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.457 ' HG3' HG22 ' A' ' 93' ' ' THR . 5.1 mt-10 -115.88 -45.94 2.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.885 0.374 . . . . 0.0 111.239 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.478 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -73.34 -35.25 56.73 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.665 -0.778 . . . . 0.0 111.945 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.678 ' HB2' HD11 ' A' ' 18' ' ' LEU . 2.7 t30 -71.25 -33.82 70.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.898 0.38 . . . . 0.0 110.089 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 93' ' ' THR . 49.3 mtpt -40.85 -32.59 0.23 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.739 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.15 -28.21 10.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.797 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 128.22 -8.88 6.66 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.731 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.486 ' SD ' ' HB3' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -154.38 144.44 21.9 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.962 0.411 . . . . 0.0 110.852 -179.847 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.615 HG22 HD21 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -107.2 144.63 15.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.597 -179.483 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.703 ' OE1' HG23 ' A' ' 13' ' ' THR . 0.8 OUTLIER -77.01 137.17 38.82 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.429 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.465 HD12 HG23 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -135.57 147.12 48.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.335 0.588 . . . . 0.0 112.198 -178.807 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.73 ' CD1' ' HB3' ' A' ' 69' ' ' ALA . 8.5 mt -140.45 112.63 4.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.311 178.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.888 HG12 HD23 ' A' ' 67' ' ' LEU . 28.1 m -122.47 176.61 4.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.056 0.455 . . . . 0.0 111.677 -178.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.686 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -147.48 132.67 18.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.561 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.609 ' CG ' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -142.33 -179.7 6.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.842 0.353 . . . . 0.0 111.212 -179.919 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.408 ' HA ' ' O ' ' A' ' 8' ' ' THR . 15.5 mtm-85 -95.8 142.88 27.54 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.125 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 44.0 mt -68.26 -22.48 27.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.074 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.332 -0.195 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.901 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 3' ' ' ASP . . . . . 0.407 ' CB ' ' HD2' ' A' ' 36' ' ' LYS . 39.7 m-20 . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.813 0.339 . . . . 0.0 110.915 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 4' ' ' GLU . . . . . 0.416 ' HA ' ' HB2' ' A' ' 33' ' ' ASN . 5.6 pt-20 -99.12 167.57 10.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.083 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.22 -65.7 0.64 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.914 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -130.57 -75.53 0.53 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.927 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -126.42 22.17 7.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.196 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 55.68 -159.7 0.2 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.095 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 9' ' ' GLN . . . . . 0.495 ' NE2' ' O ' ' B' ' 10' ' ' ILE . 13.7 tm0? -164.44 121.0 1.58 Allowed 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.51 HD12 ' HG2' ' A' ' 47' ' ' LYS . 2.7 mm -94.45 145.94 7.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.197 0.522 . . . . 0.0 111.774 -178.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 55.0 m -140.36 106.63 5.25 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.484 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 9.2 ttmt -68.89 112.8 5.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.269 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.758 HG11 HD11 ' A' ' 87' ' ' LEU . 30.8 m . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.979 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 N-CA-C 112.484 -0.247 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.467 ' HG1' ' HG3' ' A' ' 108' ' ' ARG . 69.1 p 51.68 94.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.025 0.441 . . . . 0.0 111.191 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.3 mtp85 -153.38 136.33 15.46 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.596 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -156.86 152.58 26.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.917 0.389 . . . . 0.0 111.467 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.57 ' HD1' ' HB2' ' A' ' 106' ' ' ALA . 17.4 m-85 -94.88 144.06 25.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.264 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.59 HD11 ' HD2' ' A' ' 107' ' ' ARG . 0.1 OUTLIER -134.46 127.78 32.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.942 0.401 . . . . 0.0 111.606 -179.476 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 99.2 m -97.47 133.99 41.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.741 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.464 ' O ' ' N ' ' A' ' 103' ' ' LEU . 21.6 m-85 -140.71 148.19 40.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.268 0.556 . . . . 0.0 112.404 -179.007 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.425 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.2 OUTLIER -112.39 111.5 22.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.401 -0.818 . . . . 0.0 108.928 178.727 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.801 HG21 HD11 ' A' ' 61' ' ' LEU . 21.2 t -103.41 111.22 64.97 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -177.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.735 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 86.4 Cg_endo -81.03 128.18 6.39 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.427 2.085 . . . . 0.0 111.014 178.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.926 HD22 HD13 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -126.22 29.39 5.83 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -178.85 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -37.43 -32.33 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.411 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -112.32 -34.1 6.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.248 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.606 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 10.5 t -67.03 -11.92 58.43 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.147 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.678 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -45.86 -28.58 2.8 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.737 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.1 t -81.68 -36.77 28.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.89 0.376 . . . . 0.0 110.67 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.17 -24.54 37.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.062 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.9 -52.59 0.7 Allowed Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.926 HD13 HD22 ' A' ' 18' ' ' LEU . 9.3 tp 179.15 -32.82 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.654 0.264 . . . . 0.0 110.796 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.13 43.11 1.42 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.969 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.62 ' N ' HD12 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -164.77 151.44 2.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.068 0.461 . . . . 0.0 111.343 179.738 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' B' ' 12' ' ' LYS . 0.0 OUTLIER -111.85 123.32 49.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.931 179.356 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.75 HG11 HD11 ' A' ' 67' ' ' LEU . 0.9 OUTLIER -112.43 141.36 28.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.895 0.379 . . . . 0.0 111.501 -179.534 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.04 130.29 25.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.648 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -96.75 144.18 17.18 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.851 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.415 ' O ' ' HA ' ' A' ' 41' ' ' ASP . 1.5 m-80 -94.4 -176.3 3.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.711 0.291 . . . . 0.0 110.624 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.3 mtt180 -142.67 148.86 38.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.906 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.473 ' HB2' HD21 ' A' ' 42' ' ' LEU . 8.3 t -66.59 137.05 56.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.938 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -67.09 -29.14 68.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.154 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -70.2 -50.36 40.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.976 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.574 ' OD1' ' HB2' ' A' ' 40' ' ' ALA . 10.4 p30 -141.28 165.32 27.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.756 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -70.48 66.05 0.31 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.908 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.574 ' HB2' ' OD1' ' A' ' 38' ' ' ASN . . . -120.33 119.06 32.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.94 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.415 ' HA ' ' O ' ' A' ' 33' ' ' ASN . 9.2 p-10 -53.4 142.57 21.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.175 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.473 HD21 ' HB2' ' A' ' 35' ' ' SER . 43.2 mt -107.27 3.94 26.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.392 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.444 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 113.92 160.33 13.59 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.524 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.677 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -98.73 130.59 47.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.733 0.301 . . . . 0.0 111.063 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.15 142.4 47.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.808 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.611 ' O ' HG13 ' A' ' 63' ' ' VAL . 39.5 t -57.8 105.84 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.903 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.48 ' HG2' HG21 ' B' ' 10' ' ' ILE . 6.3 tptt -73.92 -41.42 62.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.106 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.2 m -171.89 123.35 0.52 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.913 0.387 . . . . 0.0 111.371 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.554 ' CD1' ' HB3' ' A' ' 61' ' ' LEU . 76.1 mt -85.66 110.95 20.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.068 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.62 HD12 ' N ' ' A' ' 28' ' ' VAL . 1.9 mp -48.74 104.01 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.774 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -62.16 75.38 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.778 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 160.33 -28.79 0.34 Allowed Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.655 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.478 ' H ' HG22 ' A' ' 50' ' ' ILE . . . -70.11 -161.71 3.49 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.476 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.735 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -76.41 -38.13 56.08 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.919 0.341 . . . . 0.0 111.919 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.736 ' HA ' HD13 ' A' ' 61' ' ' LEU . . . -62.64 -38.29 89.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.889 0.376 . . . . 0.0 111.022 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.6 t -78.03 -35.49 49.72 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.149 0.5 . . . . 0.0 109.736 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.5 mtpt -69.69 -31.34 69.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.813 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -64.47 -25.43 68.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.668 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.31 28.99 65.27 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.58 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.424 ' HB3' ' CG ' ' A' ' 14' ' ' PHE . 12.7 mtm180 -125.76 -32.33 2.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.729 0.3 . . . . 0.0 111.012 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.801 HD11 HG21 ' A' ' 16' ' ' VAL . 2.7 mp -68.94 147.26 51.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.093 0.473 . . . . 0.0 111.371 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 48.8 mtm-85 -142.96 123.74 14.21 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.508 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.611 HG13 ' O ' ' A' ' 46' ' ' VAL . 41.3 t -52.75 142.76 5.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.339 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.429 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 20.2 m-20 85.22 18.66 0.12 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.237 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.43 ' O ' HG23 ' A' ' 46' ' ' VAL . 3.4 m-20 -99.21 118.39 35.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.35 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.39 126.16 30.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.945 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.912 HD23 HG12 ' A' ' 105' ' ' VAL . 73.5 mt -76.06 141.77 41.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.296 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.704 HD11 ' HB2' ' A' ' 106' ' ' ALA . 28.9 mt -123.85 -39.64 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.704 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 1.025 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -150.95 154.98 38.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.886 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.761 HG22 ' ND2' ' A' ' 71' ' ' ASN . 8.0 p -142.34 125.6 14.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.633 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.761 ' ND2' HG22 ' A' ' 70' ' ' VAL . 67.0 m-80 64.83 12.89 8.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.65 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.21 13.22 36.86 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.205 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.417 ' CG ' ' O ' ' A' ' 70' ' ' VAL . 4.9 pt-20 -128.18 112.2 14.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 117.036 0.418 . . . . 0.0 111.018 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.4 p -65.15 170.41 4.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.947 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.644 HD22 ' HB1' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -143.68 16.59 1.81 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.216 -179.799 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.8 tp -66.18 -21.31 66.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.628 0.251 . . . . 0.0 111.052 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -91.18 14.76 62.75 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.962 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.403 ' HD2' ' HB3' ' A' ' 75' ' ' LEU . 1.0 OUTLIER -139.35 163.76 31.65 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.403 0.621 . . . . 0.0 111.235 179.845 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.15 162.38 22.57 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.486 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -55.9 -52.51 63.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.109 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.409 ' HA ' ' HE3' ' A' ' 84' ' ' MET . 0.0 OUTLIER -59.29 -36.29 75.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.971 0.415 . . . . 0.0 110.524 179.646 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.58 -38.65 74.07 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.344 179.019 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.644 ' HB1' HD22 ' A' ' 75' ' ' LEU . . . -69.18 -34.92 75.68 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.128 179.148 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.594 ' HA ' HD21 ' A' ' 87' ' ' LEU . 1.0 OUTLIER -69.94 -29.45 66.59 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.9 179.043 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -78.01 -39.54 41.82 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.432 ' O ' ' HB2' ' A' ' 90' ' ' SER . 1.8 m -61.79 -37.47 84.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.082 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.684 ' HA ' HG11 ' A' ' 70' ' ' VAL . 3.5 pp -78.18 -33.54 50.06 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.533 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -59.78 -52.0 67.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.668 179.074 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.508 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.85 -35.37 67.21 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.671 -179.909 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' ' 86' ' ' THR . 5.1 t -72.96 -29.85 63.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.851 0.357 . . . . 0.0 110.953 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.685 ' HE2' HD22 ' A' ' 26' ' ' LEU . 4.1 ptm -89.33 -18.23 27.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.283 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.28 29.71 6.59 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.021 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.508 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.4 OUTLIER -162.26 -30.24 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 179.897 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.426 ' HG3' HG22 ' A' ' 93' ' ' THR . 6.6 mt-10 -116.82 -44.84 2.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.905 0.383 . . . . 0.0 111.197 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.4 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -69.98 -30.22 70.21 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.908 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.74 ' HB2' HD11 ' A' ' 18' ' ' LEU . 3.2 t30 -76.59 -35.13 58.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.885 0.374 . . . . 0.0 110.173 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' A' ' 93' ' ' THR . 26.9 mtpt -42.57 -40.12 2.56 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.421 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.08 -25.59 16.39 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.529 179.332 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 117.56 -3.1 17.95 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.907 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.425 ' SD ' ' HB3' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -160.85 144.06 13.12 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.895 0.379 . . . . 0.0 111.156 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.562 HG22 HD21 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -111.81 145.1 18.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.423 -179.666 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.0 150.42 33.9 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.476 HD12 HG23 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -146.65 113.51 6.1 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.85 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 1.025 HD12 ' HB3' ' A' ' 69' ' ' ALA . 36.1 mt -107.32 112.91 42.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.784 178.296 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.912 HG12 HD23 ' A' ' 67' ' ' LEU . 22.1 m -123.27 -179.44 2.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.501 -179.078 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.704 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -147.76 132.4 17.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.488 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.59 ' HD2' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -150.23 -178.75 6.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.962 0.411 . . . . 0.0 111.412 -179.614 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.467 ' HG3' ' HG1' ' A' ' 8' ' ' THR . 0.3 OUTLIER -80.22 141.16 35.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.889 -179.904 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 24.2 mt -73.19 -40.13 57.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.015 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.3 t . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.991 179.84 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.938 0.399 . . . . 0.0 110.843 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.11 168.96 8.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.819 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -102.73 36.63 2.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.7 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 6' ' ' GLN . . . . . 0.416 ' O ' ' HB2' ' B' ' 7' ' ' HIS . 20.6 mp0 63.83 129.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.746 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 7' ' ' HIS . . . . . 0.416 ' HB2' ' O ' ' B' ' 6' ' ' GLN . 51.6 m-70 68.06 -63.68 0.32 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.192 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 71.32 -156.86 0.11 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.75 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -172.13 147.15 2.02 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.48 HG21 ' HG2' ' A' ' 47' ' ' LYS . 1.6 mm -115.01 124.39 71.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.392 0.615 . . . . 0.0 111.264 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 20.5 m -96.47 97.76 9.69 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.665 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 12' ' ' LYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 29' ' ' SER . 13.6 ttmt -69.52 139.54 53.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.003 0.43 . . . . 0.0 111.145 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.564 HG23 ' O ' ' B' ' 13' ' ' VAL . 13.8 m . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.908 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 121.046 0.451 . . . . 0.0 111.6 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.498 ' CE2' HD13 ' A' ' 68' ' ' ILE . 19.8 m-85 -79.02 149.93 32.06 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.238 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.618 HD12 HG23 ' A' ' 105' ' ' VAL . 0.3 OUTLIER -140.09 109.71 6.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.057 0.456 . . . . 0.0 111.649 -179.449 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.683 HG23 ' OE1' ' A' ' 102' ' ' GLN . 85.1 m -99.52 120.81 40.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.715 178.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.435 ' O ' ' N ' ' A' ' 103' ' ' LEU . 28.8 m-85 -134.61 153.87 51.76 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.466 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.2 OUTLIER -110.91 111.95 23.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.901 178.86 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.489 HG11 ' HG ' ' A' ' 26' ' ' LEU . 17.6 t -101.32 112.4 65.01 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -177.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.56 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 94.9 Cg_endo -83.5 127.5 4.43 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.591 2.194 . . . . 0.0 110.847 178.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.794 HD22 HD13 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -122.41 28.5 7.38 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -178.778 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -39.02 -32.15 0.08 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.089 0.471 . . . . 0.0 111.17 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -109.44 -34.81 6.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.255 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.417 ' HB3' ' CB ' ' A' ' 18' ' ' LEU . 39.9 t -71.97 -5.71 36.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.236 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.775 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -43.99 -30.18 1.68 Allowed Glycine 0 C--N 1.338 0.649 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.531 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.0 t -82.72 -38.52 23.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.915 0.388 . . . . 0.0 110.314 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -82.51 -1.74 51.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.395 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.1 -48.5 3.65 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.705 -0.759 . . . . 0.0 111.794 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.984 HD22 ' HE2' ' A' ' 91' ' ' MET . 8.1 tp -179.72 -32.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.585 0.231 . . . . 0.0 110.55 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.471 ' HA3' ' HA3' ' A' ' 53' ' ' GLY . . . 106.9 46.45 1.1 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.457 -0.877 . . . . 0.0 113.453 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.781 HG12 HG23 ' A' ' 49' ' ' ILE . 30.1 m -157.85 154.12 5.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.037 0.446 . . . . 0.0 111.831 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.07 121.72 45.74 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.2 m -106.04 148.02 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -155.48 129.15 8.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.071 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' A' ' 44' ' ' ILE . . . -107.88 166.53 13.14 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.864 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -113.2 -178.61 3.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.954 0.407 . . . . 0.0 110.93 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.04 135.82 24.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.242 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.489 ' OG ' HD21 ' A' ' 42' ' ' LEU . 1.6 m -48.35 143.58 4.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.823 0.345 . . . . 0.0 110.896 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.37 -49.16 67.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.532 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -95.33 -50.02 5.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.384 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 36.8 m-20 -66.04 -23.87 66.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.35 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 58.04 21.47 7.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.807 0.337 . . . . 0.0 110.964 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -94.18 135.52 35.47 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.871 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -46.57 132.05 10.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.536 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.489 HD21 ' OG ' ' A' ' 35' ' ' SER . 38.7 mt -100.79 17.98 20.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.041 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.83 177.67 46.49 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.616 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.902 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -105.78 152.49 7.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.918 0.389 . . . . 0.0 111.202 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.444 ' CE1' ' NE2' ' A' ' 66' ' ' GLN . 2.2 m-85 -135.39 138.21 43.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.708 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.697 ' O ' HG13 ' A' ' 63' ' ' VAL . 31.1 t -54.94 104.46 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.345 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.426 ' HD3' HD12 ' B' ' 10' ' ' ILE . 37.8 tptt -73.74 -42.71 60.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.757 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.5 t -168.95 119.16 0.72 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.182 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.781 HG23 HG12 ' A' ' 28' ' ' VAL . 80.8 mt -85.3 121.97 37.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.244 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.463 HD13 ' HA2' ' A' ' 27' ' ' GLY . 1.9 mp -59.52 107.17 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.371 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -61.17 78.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.887 0.375 . . . . 0.0 110.776 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 155.97 -28.68 0.59 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.194 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.471 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -67.19 -171.59 5.11 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.853 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.56 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -63.09 -40.72 98.5 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.578 ' HA ' HD13 ' A' ' 61' ' ' LEU . . . -64.91 -44.86 88.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.813 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.09 -28.48 66.53 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.592 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.4 mtpt -79.55 -28.23 41.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.061 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.2 -29.94 67.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.603 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.17 14.04 76.53 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.944 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -130.4 1.41 4.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.915 0.357 . . . . 0.0 111.34 179.866 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.689 ' HB3' HD13 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -103.38 128.43 50.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.882 0.372 . . . . 0.0 111.241 -179.755 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.612 HH21 HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -138.14 141.88 40.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.753 179.362 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.697 HG13 ' O ' ' A' ' 46' ' ' VAL . 39.0 t -55.91 146.15 5.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.213 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 18.0 m-20 87.27 13.56 0.11 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.378 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.454 ' O ' HG23 ' A' ' 46' ' ' VAL . 5.0 m-20 -93.4 120.6 33.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.721 0.296 . . . . 0.0 110.39 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.444 ' NE2' ' CE1' ' A' ' 45' ' ' PHE . 0.8 OUTLIER -78.2 135.05 37.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.763 -179.8 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.965 HD23 HG12 ' A' ' 105' ' ' VAL . 80.0 mt -85.25 140.9 30.5 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.841 0.353 . . . . 0.0 110.799 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.944 HD11 ' HB2' ' A' ' 106' ' ' ALA . 24.0 mt -123.17 -40.27 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.219 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.871 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -155.18 138.43 15.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.355 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.771 HG22 HD22 ' A' ' 71' ' ' ASN . 12.3 p -127.74 125.58 65.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.78 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.771 HD22 HG22 ' A' ' 70' ' ' VAL . 58.7 m-80 61.21 27.0 16.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.724 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.53 25.32 56.96 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.002 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -130.4 104.38 7.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.692 0.282 . . . . 0.0 110.779 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.8 t -58.54 155.56 12.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.013 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.472 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . 1.0 OUTLIER -118.32 -9.55 10.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.697 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 30.0 mt -57.01 -20.66 25.4 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.666 0.27 . . . . 0.0 111.408 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -92.75 27.41 11.01 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.788 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.42 ' HD2' ' HA ' ' A' ' 83' ' ' ALA . 1.1 ptpm? -160.71 162.78 32.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.288 0.566 . . . . 0.0 111.189 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.642 ' HB3' HE21 ' A' ' 81' ' ' GLN . . . -66.12 164.03 16.38 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.391 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.408 ' O ' ' HG2' ' A' ' 84' ' ' MET . 20.3 m-80 -56.0 -57.51 11.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.812 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.642 HE21 ' HB3' ' A' ' 79' ' ' ALA . 2.3 pp0? -54.76 -38.61 67.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.955 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.38 -36.16 73.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.007 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.578 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -69.17 -51.07 41.82 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.783 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.432 ' HA ' ' CD2' ' A' ' 87' ' ' LEU . 6.6 ptp -60.39 -29.04 68.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.801 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.39 -31.9 42.91 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.414 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 2.1 m -70.13 -35.79 74.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.291 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.853 HD12 ' N ' ' A' ' 88' ' ' ARG . 4.2 pp -78.0 -34.26 50.89 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.853 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -57.26 -50.45 72.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.339 178.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.488 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.33 -38.06 68.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.171 179.697 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 63.7 m -67.4 -29.1 68.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.929 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.984 ' HE2' HD22 ' A' ' 26' ' ' LEU . 2.6 ptp -88.25 -28.23 21.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.678 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -110.77 26.58 10.54 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.488 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.4 OUTLIER -156.06 -33.04 0.09 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.441 ' HG3' HG22 ' A' ' 93' ' ' THR . 7.6 mt-10 -115.56 -36.68 4.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.822 0.344 . . . . 0.0 111.138 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.475 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -80.44 -32.09 35.44 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.884 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.717 ' HB2' HD11 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -76.73 -34.33 58.11 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 179.543 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 93' ' ' THR . 48.4 mtpt -42.12 -32.49 0.47 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.473 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.97 -25.03 12.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.875 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 121.58 -7.63 10.34 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.789 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.467 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -157.02 144.66 19.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.89 0.376 . . . . 0.0 110.914 -179.895 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.557 HG22 HD21 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -108.3 143.69 18.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.412 -179.71 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.683 ' OE1' HG23 ' A' ' 13' ' ' THR . 1.1 tm0? -76.94 142.18 40.17 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -137.59 145.88 43.34 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.115 0.483 . . . . 0.0 112.115 -178.757 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.871 HD12 ' HB3' ' A' ' 69' ' ' ALA . 22.8 mt -139.1 112.77 6.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.468 178.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.965 HG12 HD23 ' A' ' 67' ' ' LEU . 27.4 m -132.15 150.14 33.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.855 0.36 . . . . 0.0 111.578 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.944 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -114.77 129.27 56.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.686 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.465 ' HB3' HD11 ' A' ' 12' ' ' LEU . 1.8 tmm_? . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.888 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.426 HD12 ' HD3' ' A' ' 47' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.454 -0.231 0 CA-C-O 120.929 0.395 . . . . 0.0 111.203 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 66.1 m -138.3 115.91 11.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.732 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -69.94 115.23 8.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.836 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.721 HG12 ' HG3' ' A' ' 88' ' ' ARG . 15.3 m . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.298 -0.858 . . . . 0.0 111.121 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.696 0.284 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -88.01 146.18 25.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.604 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.918 HD12 HG23 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -140.82 109.86 6.14 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.9 0.381 . . . . 0.0 111.333 -179.504 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.5 m -80.55 145.49 31.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.979 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.438 ' CD1' ' HG3' ' A' ' 60' ' ' ARG . 12.8 m-85 -140.28 171.41 14.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.368 0.604 . . . . 0.0 112.132 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -143.55 103.43 4.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.028 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.6 HG11 ' HG ' ' A' ' 26' ' ' LEU . 17.8 t -104.83 112.05 65.26 Favored Pre-proline 0 C--N 1.329 -0.302 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -177.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.593 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 93.7 Cg_endo -83.46 127.53 4.46 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.413 2.076 . . . . 0.0 110.798 178.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.744 HD22 HD13 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -120.85 27.96 8.2 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.848 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -40.93 -30.2 0.12 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.999 0.428 . . . . 0.0 110.744 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -114.87 -31.47 6.1 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.174 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.582 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 43.0 t -72.65 -7.55 50.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.139 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.637 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -45.27 -28.3 2.05 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.624 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.6 m -85.44 -34.86 21.58 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.942 0.401 . . . . 0.0 110.677 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.14 8.97 24.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.526 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.62 -56.23 5.02 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.932 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.799 HD22 ' HE2' ' A' ' 91' ' ' MET . 9.7 tp -178.8 -27.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.518 0.199 . . . . 0.0 111.155 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.485 ' HA3' ' HA3' ' A' ' 53' ' ' GLY . . . 109.75 35.54 2.2 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.31 -0.948 . . . . 0.0 113.536 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.702 HG12 HG23 ' A' ' 49' ' ' ILE . 13.0 m -158.95 157.75 3.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 117.08 0.44 . . . . 0.0 111.538 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.533 ' O ' ' N ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -114.15 134.94 54.55 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.711 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.614 HG11 HD11 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -120.65 143.56 32.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.119 0.485 . . . . 0.0 111.896 -178.809 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.56 ' HB3' HD13 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -142.12 129.71 21.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.587 179.666 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -102.7 153.3 18.32 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.991 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -125.28 175.25 7.57 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.009 0.433 . . . . 0.0 111.252 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.5 mtt85 -122.57 157.42 32.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.736 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.729 ' CA ' HD21 ' A' ' 42' ' ' LEU . 19.5 m -51.28 155.86 1.3 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.269 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.05 -39.59 86.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.111 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.58 -78.68 0.18 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.958 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -81.64 -175.77 5.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.834 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -98.32 29.91 3.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.942 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.24 115.84 14.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.098 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.41 ' CB ' ' ND2' ' A' ' 80' ' ' ASN . 1.2 p30 -59.08 119.62 7.63 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.951 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.729 HD21 ' CA ' ' A' ' 35' ' ' SER . 17.4 mt -75.58 -26.42 57.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.872 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.466 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 133.21 -176.69 19.45 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.121 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.906 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -107.32 134.53 48.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.876 0.369 . . . . 0.0 111.262 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.464 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -117.55 144.08 45.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.565 -179.79 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.674 ' O ' HG13 ' A' ' 63' ' ' VAL . 21.3 t -54.54 106.36 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.124 0.488 . . . . 0.0 110.941 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.599 ' HG3' HG23 ' B' ' 10' ' ' ILE . 0.5 OUTLIER -65.99 -52.58 48.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.638 179.86 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.6 t -169.41 133.86 1.4 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.388 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.709 HD13 ' HB3' ' A' ' 61' ' ' LEU . 65.8 mt -95.06 116.55 36.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.083 0.468 . . . . 0.0 111.826 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.505 HD12 ' N ' ' A' ' 28' ' ' VAL . 2.3 mp -58.09 115.9 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.199 178.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -68.23 69.86 0.15 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.068 0.461 . . . . 0.0 110.69 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 168.21 -29.62 0.16 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.375 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.485 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -68.02 -172.33 6.6 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.907 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.593 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -62.98 -40.87 99.03 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.646 ' CB ' HD13 ' A' ' 61' ' ' LEU . . . -64.69 -48.06 76.09 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.936 0.398 . . . . 0.0 111.561 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.3 t -63.35 -30.66 71.75 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.216 0.531 . . . . 0.0 110.09 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 39.5 mtpt -76.68 -28.85 56.09 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.055 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.72 -29.26 64.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.882 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 68.05 16.51 68.71 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.202 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.438 ' HG3' ' CD1' ' A' ' 14' ' ' PHE . 0.8 OUTLIER -138.47 11.57 2.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.908 0.354 . . . . 0.0 111.274 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.709 ' HB3' HD13 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -106.68 134.92 49.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.689 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.854 ' NH2' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -139.12 144.57 38.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.85 179.774 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.674 HG13 ' O ' ' A' ' 46' ' ' VAL . 46.2 t -61.89 148.69 9.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.085 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 23.7 m-20 88.11 -10.46 0.51 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.431 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.659 ' O ' HG23 ' A' ' 46' ' ' VAL . 1.2 m-20 -66.5 115.05 5.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.769 0.318 . . . . 0.0 110.626 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.468 ' O ' ' HA ' ' A' ' 105' ' ' VAL . 18.3 tm0? -69.16 135.86 51.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.699 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.908 HD23 HG12 ' A' ' 105' ' ' VAL . 93.2 mt -87.75 139.85 30.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.849 0.357 . . . . 0.0 111.148 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.629 HD11 ' HB2' ' A' ' 106' ' ' ALA . 2.4 mt -122.28 -44.36 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.888 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 1.028 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -147.83 145.57 28.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.702 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.765 HG22 HD22 ' A' ' 71' ' ' ASN . 7.1 p -132.68 130.0 58.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.313 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.765 HD22 HG22 ' A' ' 70' ' ' VAL . 23.7 m-80 61.2 26.95 16.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.819 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.97 23.69 59.05 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.389 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -131.89 108.7 9.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.804 0.335 . . . . 0.0 110.864 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.0 t -59.21 154.67 15.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.711 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.508 HD21 HG12 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -115.8 -15.59 11.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.582 -179.723 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.414 ' CD2' HG23 ' A' ' 68' ' ' ILE . 4.1 mm? -46.66 -44.13 18.25 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.942 0.401 . . . . 0.0 111.173 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -57.51 -35.47 72.86 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.574 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.4 ptpm? -101.31 168.12 9.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.286 0.565 . . . . 0.0 111.297 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.45 ' HB3' HE22 ' A' ' 81' ' ' GLN . . . -71.34 174.73 6.12 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.542 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.432 ' HB2' ' HA3' ' A' ' 32' ' ' GLY . 8.1 p30 -67.0 -52.26 44.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.581 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.45 HE22 ' HB3' ' A' ' 79' ' ' ALA . 5.1 pm0 -58.12 -41.26 83.24 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.931 0.396 . . . . 0.0 110.483 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -70.45 -37.85 74.38 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.505 ' HB3' ' CD1' ' A' ' 44' ' ' ILE . . . -66.77 -33.49 75.73 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.229 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.462 ' O ' ' HB2' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -72.54 -32.32 66.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.981 179.236 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -78.48 -35.38 46.62 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.38 178.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.445 ' HA ' ' HD2' ' A' ' 89' ' ' ARG . 1.5 m -67.28 -35.72 80.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.311 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.74 HD12 ' N ' ' A' ' 88' ' ' ARG . 4.4 pp -78.31 -33.71 49.18 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.74 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -63.24 -50.84 68.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.788 179.312 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.445 ' HD2' ' HA ' ' A' ' 86' ' ' THR . 0.0 OUTLIER -73.03 -34.62 66.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.065 179.771 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.415 ' O ' ' ND2' ' A' ' 71' ' ' ASN . 55.9 m -72.19 -31.64 66.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.77 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.799 ' HE2' HD22 ' A' ' 26' ' ' LEU . 3.8 ptm -88.08 -18.72 28.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.614 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.01 18.14 14.73 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.472 HG22 ' HG3' ' A' ' 94' ' ' GLU . 0.4 OUTLIER -153.28 -37.99 0.1 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.898 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.52 ' HA ' ' CG ' ' A' ' 97' ' ' LYS . 8.6 mt-10 -104.15 -42.01 5.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.003 0.43 . . . . 0.0 111.742 -178.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.424 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -68.44 -37.94 86.25 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.806 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.677 ' HB2' HD11 ' A' ' 18' ' ' LEU . 1.1 t-20 -67.13 -33.76 76.14 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.52 ' CG ' ' HA ' ' A' ' 94' ' ' GLU . 4.2 mmmt -31.42 -51.8 0.2 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.464 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.95 -27.48 16.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.757 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 122.8 1.11 9.84 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.813 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.482 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -161.77 142.55 10.76 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 121.038 0.447 . . . . 0.0 111.371 -179.743 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.565 HD11 HG23 ' A' ' 70' ' ' VAL . 0.1 OUTLIER -114.81 138.64 44.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.853 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.42 ' HA ' ' O ' ' A' ' 14' ' ' PHE . 2.2 pp0? -76.54 149.91 36.63 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.463 HD13 HG21 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -140.99 111.16 6.67 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.778 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 1.028 HD12 ' HB3' ' A' ' 69' ' ' ALA . 45.6 mt -98.35 112.77 31.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.918 HG23 HD12 ' A' ' 12' ' ' LEU . 18.1 m -124.28 152.42 30.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.454 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.629 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -124.95 148.11 48.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.113 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.769 ' HG3' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.98 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.599 HG23 ' HG3' ' A' ' 47' ' ' LYS . 4.2 mm . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 120.976 0.417 . . . . 0.0 111.333 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . 0.42 ' CB ' ' HG2' ' A' ' 84' ' ' MET . 3.5 m -94.33 97.93 10.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.664 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -73.93 127.81 33.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.121 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 18.4 m . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.562 -0.732 . . . . 0.0 110.693 179.683 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.711 0.291 . . . . 0.0 111.069 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.568 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 2.4 p90 -112.36 148.34 34.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.645 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.889 HD11 ' HD2' ' A' ' 107' ' ' ARG . 0.1 OUTLIER -129.14 120.72 26.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.36 -178.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.0 m -83.15 145.43 29.21 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.336 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.435 ' CD1' ' HB3' ' A' ' 60' ' ' ARG . 63.8 m-85 -140.67 171.35 14.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.383 0.611 . . . . 0.0 112.219 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -140.13 106.99 5.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.214 -0.903 . . . . 0.0 108.902 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.776 ' CG2' HD11 ' A' ' 61' ' ' LEU . 17.3 t -105.61 117.75 57.2 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 -177.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.727 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 90.2 Cg_endo -86.69 128.18 2.84 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.764 2.309 . . . . 0.0 110.936 178.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.746 HD11 ' HB2' ' A' ' 96' ' ' ASN . 0.5 OUTLIER -122.77 28.63 7.19 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -178.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -40.91 -30.57 0.13 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.167 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -113.01 -32.53 6.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.14 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.706 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 41.7 t -70.74 -6.56 38.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.182 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.603 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -42.97 -30.03 0.95 Allowed Glycine 0 C--N 1.337 0.605 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.664 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.8 m -83.16 -40.37 19.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.885 0.374 . . . . 0.0 110.434 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.98 -5.79 56.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.266 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.92 -46.8 3.12 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.953 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.888 HD22 ' HE2' ' A' ' 91' ' ' MET . 6.2 tp 178.79 -33.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.661 0.267 . . . . 0.0 110.677 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.452 ' HA3' ' HA3' ' A' ' 53' ' ' GLY . . . 102.96 49.86 1.12 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.442 -0.885 . . . . 0.0 113.565 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.785 HG12 HG23 ' A' ' 49' ' ' ILE . 34.2 m -158.41 154.81 4.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 117.053 0.426 . . . . 0.0 111.78 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.439 ' O ' ' HB3' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -112.24 111.12 21.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.343 178.606 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.535 HG11 HD11 ' A' ' 67' ' ' LEU . 2.3 m -106.93 141.93 20.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.09 0.471 . . . . 0.0 111.843 -178.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.417 ' HB3' HG23 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -145.94 129.68 17.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.199 179.423 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -91.33 158.09 25.28 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.017 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -114.0 -178.76 3.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.9 0.381 . . . . 0.0 110.929 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 67.9 mtt180 -135.96 152.67 51.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.541 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.469 ' OG ' HD21 ' A' ' 42' ' ' LEU . 50.1 m -54.36 144.38 20.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.041 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.75 -33.39 75.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.981 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.14 -68.47 0.7 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.891 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -94.3 -173.41 3.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.85 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 65.2 m-70 -101.53 31.1 3.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.036 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.74 128.34 34.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.953 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.401 ' CB ' ' ND2' ' A' ' 80' ' ' ASN . 3.7 p-10 -57.18 149.0 20.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.137 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.469 HD21 ' OG ' ' A' ' 35' ' ' SER . 35.7 mt -113.14 -1.0 14.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.323 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.475 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 113.7 169.83 17.07 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.313 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.762 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -102.82 131.23 51.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.709 0.29 . . . . 0.0 110.951 179.757 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.445 ' N ' ' CD1' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -119.54 144.95 46.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.866 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.715 ' O ' HG13 ' A' ' 63' ' ' VAL . 39.0 t -60.78 104.57 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.641 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.439 ' HB3' ' O ' ' A' ' 29' ' ' SER . 2.2 tptt -73.71 -42.26 61.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.569 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.48 119.64 1.05 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.113 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.785 HG23 HG12 ' A' ' 28' ' ' VAL . 68.0 mt -85.18 117.8 30.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.015 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.556 HD12 ' N ' ' A' ' 28' ' ' VAL . 1.6 mp -55.72 106.6 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.462 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -64.64 74.2 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.014 0.435 . . . . 0.0 110.73 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 162.6 -26.4 0.23 Allowed Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.326 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.452 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -71.19 -163.46 5.41 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.85 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.727 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -71.28 -41.61 69.8 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.65 ' HB1' HD22 ' A' ' 61' ' ' LEU . . . -65.34 -43.4 91.02 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.317 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.652 ' OG ' HG22 ' A' ' 49' ' ' ILE . 1.2 m -67.5 -36.13 80.48 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.889 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -68.85 -33.95 74.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.597 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -60.24 -26.78 66.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.756 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 58.54 26.76 60.16 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.368 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.435 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 8.7 mtm180 -121.39 -28.52 4.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.63 0.252 . . . . 0.0 111.109 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.776 HD11 ' CG2' ' A' ' 16' ' ' VAL . 4.2 mp -75.91 151.1 37.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.136 0.493 . . . . 0.0 111.677 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.765 HH22 HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -146.56 131.53 18.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.172 179.701 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.715 HG13 ' O ' ' A' ' 46' ' ' VAL . 47.3 t -57.69 141.69 14.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.121 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.466 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 28.4 m-20 89.91 17.41 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.577 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -103.28 123.44 46.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.327 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.427 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -81.52 136.41 35.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.789 0.328 . . . . 0.0 110.793 -179.583 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.762 HD12 HG13 ' A' ' 44' ' ' ILE . 7.9 mt -87.51 131.21 34.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.569 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 1.021 HD11 ' HB2' ' A' ' 106' ' ' ALA . 34.5 mt -110.98 -33.97 2.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.614 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.934 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -153.34 157.47 40.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.132 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.804 HG22 ' ND2' ' A' ' 71' ' ' ASN . 8.4 p -142.25 126.42 15.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.387 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.804 ' ND2' HG22 ' A' ' 70' ' ' VAL . 66.1 m-80 60.68 18.87 8.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.74 0.305 . . . . 0.0 110.931 -179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.0 27.46 23.58 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.118 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -129.04 101.27 5.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.826 0.346 . . . . 0.0 110.828 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.0 t -65.33 148.5 51.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.05 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.62 HD22 ' HB1' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -130.61 14.43 5.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.234 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.5 tp -60.47 -22.5 63.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.725 0.297 . . . . 0.0 111.04 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -82.06 -27.21 46.01 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.662 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.4 ' HD3' ' HB3' ' A' ' 82' ' ' GLU . 1.6 ptpm? -96.05 171.31 8.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.174 0.512 . . . . 0.0 111.24 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.621 ' HB3' HE21 ' A' ' 81' ' ' GLN . . . -76.81 165.02 25.27 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.467 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.402 ' HB2' ' HA3' ' A' ' 32' ' ' GLY . 8.4 p30 -57.0 -47.95 79.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.252 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.621 HE21 ' HB3' ' A' ' 79' ' ' ALA . 2.1 pp0? -59.77 -43.86 94.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.907 0.384 . . . . 0.0 110.938 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.4 ' HB3' ' HD3' ' A' ' 78' ' ' LYS . 1.7 mm-40 -70.01 -32.57 70.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.853 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.62 ' HB1' HD22 ' A' ' 75' ' ' LEU . . . -69.16 -47.42 65.05 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.619 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.546 ' HB3' HG21 ' A' ' 44' ' ' ILE . 6.8 ptp -61.96 -31.64 71.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.101 0.477 . . . . 0.0 109.863 178.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.11 -34.75 66.34 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.442 ' HB ' ' O ' ' A' ' 83' ' ' ALA . 2.1 m -62.97 -34.21 77.03 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.141 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.703 HD13 HD13 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -76.24 -35.05 59.17 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.868 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.4 ' HG3' ' CG1' ' B' ' 13' ' ' VAL . 0.0 OUTLIER -58.06 -51.84 68.03 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.772 179.416 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.482 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -71.57 -43.42 66.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.612 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.435 ' HB2' ' O ' ' A' ' 86' ' ' THR . 1.6 t -65.6 -29.55 70.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.174 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.888 ' HE2' HD22 ' A' ' 26' ' ' LEU . 2.2 ptp -89.58 -19.88 24.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.629 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.21 27.56 8.75 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 -179.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.3 OUTLIER -162.19 -31.23 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.435 ' HA ' ' HG3' ' A' ' 97' ' ' LYS . 7.4 mt-10 -111.62 -72.49 0.71 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.788 0.328 . . . . 0.0 111.55 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.435 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -49.2 -29.67 9.89 Favored Glycine 0 CA--C 1.517 0.204 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.633 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.746 ' HB2' HD11 ' A' ' 18' ' ' LEU . 0.8 OUTLIER -73.68 -34.59 64.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.856 0.36 . . . . 0.0 110.257 179.711 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.435 ' HG3' ' HA ' ' A' ' 94' ' ' GLU . 8.9 mtpp -40.01 -34.6 0.3 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.47 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.87 -25.05 12.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.705 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 122.64 -8.3 9.44 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.006 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.435 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -154.48 144.2 21.6 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.924 0.392 . . . . 0.0 111.53 -179.636 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.481 HG22 HD21 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -110.52 140.54 29.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.034 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.408 ' HB3' ' HA ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -76.88 150.48 36.03 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.922 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.534 HD12 HG23 ' A' ' 16' ' ' VAL . 0.5 OUTLIER -143.54 111.03 5.86 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -178.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.934 HD12 ' HB3' ' A' ' 69' ' ' ALA . 36.5 mt -102.0 113.33 38.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.732 178.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.752 HG23 HD12 ' A' ' 12' ' ' LEU . 4.4 m -116.83 174.9 3.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.058 0.456 . . . . 0.0 111.664 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 1.021 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -147.38 137.02 22.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.998 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.889 ' HD2' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.388 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.709 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.417 HG23 ' HB3' ' A' ' 31' ' ' LYS . 1.6 mm . . . . . 0 N--CA 1.452 -0.342 0 CA-C-O 120.991 0.424 . . . . 0.0 111.237 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 99.0 m -119.27 99.48 6.72 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.687 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 9.3 ttmt -72.66 122.63 21.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.001 0.429 . . . . 0.0 110.946 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.4 ' CG1' ' HG3' ' A' ' 88' ' ' ARG . 35.4 m . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.123 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.785 0.326 . . . . 0.0 111.373 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -83.85 149.91 26.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.539 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.836 HD22 ' NH2' ' A' ' 62' ' ' ARG . 0.2 OUTLIER -136.72 109.83 7.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.97 0.414 . . . . 0.0 111.273 -179.639 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.78 HG23 ' OE1' ' A' ' 102' ' ' GLN . 39.6 m -101.15 127.85 47.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.584 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.463 ' CZ ' ' HB3' ' A' ' 60' ' ' ARG . 29.5 m-85 -140.86 172.62 12.44 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.424 0.63 . . . . 0.0 112.327 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.495 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.4 OUTLIER -126.38 112.43 15.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.021 179.131 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.917 HG23 HD23 ' A' ' 103' ' ' LEU . 21.9 t -104.77 111.7 65.24 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -177.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.562 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 85.8 Cg_endo -83.3 127.64 4.6 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.431 2.087 . . . . 0.0 110.738 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.888 HD11 ' HB2' ' A' ' 96' ' ' ASN . 0.5 OUTLIER -121.54 27.99 7.95 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -178.893 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -39.86 -31.06 0.1 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.289 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -112.23 -32.04 6.66 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.163 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.516 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 12.6 t -70.51 -6.0 33.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.181 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.617 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -43.83 -29.85 1.48 Allowed Glycine 0 C--N 1.337 0.621 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.732 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.39 -36.09 22.68 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.971 0.415 . . . . 0.0 110.598 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.79 -6.71 59.49 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.377 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.25 -47.47 2.87 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.948 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.959 HD22 ' HE2' ' A' ' 91' ' ' MET . 6.8 tp 178.47 -29.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.589 0.233 . . . . 0.0 110.824 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.494 ' HA3' ' HA3' ' A' ' 53' ' ' GLY . . . 104.58 42.67 1.82 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.501 -0.857 . . . . 0.0 113.3 179.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.779 HG12 HG23 ' A' ' 49' ' ' ILE . 33.1 m -157.15 158.5 3.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.206 0.527 . . . . 0.0 111.988 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -117.1 118.03 31.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.208 178.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.626 HG11 HD11 ' A' ' 67' ' ' LEU . 2.5 m -106.35 149.61 9.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.228 0.537 . . . . 0.0 112.379 -178.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.404 ' HG2' ' CD ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -148.38 130.77 15.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.026 179.415 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' A' ' 44' ' ' ILE . . . -104.76 161.59 15.04 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.266 -0.969 . . . . 0.0 113.115 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 -130.67 170.93 13.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.968 0.413 . . . . 0.0 110.907 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.26 154.24 31.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.621 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.845 ' HA ' HD21 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -47.45 149.21 1.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.302 -179.884 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.42 -47.97 68.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.359 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -73.59 -50.07 23.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.328 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -121.14 168.36 11.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.746 0.308 . . . . 0.0 111.039 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -83.41 57.78 4.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.143 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.548 ' HB3' ' HB2' ' A' ' 35' ' ' SER . . . -103.04 109.49 21.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.765 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.404 ' HB3' ' ND2' ' A' ' 80' ' ' ASN . 37.4 m-20 -45.91 119.29 2.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.722 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.845 HD21 ' HA ' ' A' ' 35' ' ' SER . 8.8 mt -88.24 -1.3 57.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.009 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.426 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 106.91 -174.62 20.12 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.172 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.796 ' CG1' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -111.41 138.34 40.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.907 0.384 . . . . 0.0 111.284 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.71 141.5 49.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.629 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.672 ' O ' HG13 ' A' ' 63' ' ' VAL . 38.6 t -54.7 107.2 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.841 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.475 ' HD3' HD12 ' B' ' 10' ' ' ILE . 21.2 tptt -77.21 -41.47 41.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.627 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.6 m -167.5 123.91 1.13 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.06 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.779 HG23 HG12 ' A' ' 28' ' ' VAL . 69.3 mt -90.92 124.26 43.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.359 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.446 HD12 ' N ' ' A' ' 28' ' ' VAL . 2.1 mp -63.89 110.28 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.379 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.13 70.98 0.06 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.084 0.469 . . . . 0.0 110.892 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 166.98 -27.45 0.16 Allowed Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.111 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.494 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -70.04 -166.85 5.92 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.944 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.562 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -68.64 -41.09 79.89 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.711 ' HB1' HD22 ' A' ' 61' ' ' LEU . . . -66.65 -41.12 88.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.57 -179.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 t -70.07 -33.3 71.74 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.139 0.495 . . . . 0.0 110.116 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.3 mtpt -73.62 -29.05 62.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.076 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.78 -29.96 67.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.565 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 68.52 15.74 68.74 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.824 -0.703 . . . . 0.0 113.005 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.463 ' HB3' ' CZ ' ' A' ' 14' ' ' PHE . 0.5 OUTLIER -129.0 -0.72 5.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.764 0.282 . . . . 0.0 111.222 179.832 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.711 HD22 ' HB1' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -99.23 132.98 44.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.91 0.386 . . . . 0.0 111.18 -179.67 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.836 ' NH2' HD22 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -138.27 142.47 39.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.769 179.546 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.672 HG13 ' O ' ' A' ' 46' ' ' VAL . 55.0 t -56.41 147.04 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.175 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 29.9 m-20 89.76 -10.47 0.37 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.371 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -63.62 107.26 1.11 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.821 0.343 . . . . 0.0 110.729 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 21.4 tm0? -71.5 114.0 9.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.608 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.94 HD23 ' CG1' ' A' ' 105' ' ' VAL . 7.9 mt -68.07 142.7 55.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.958 0.408 . . . . 0.0 111.561 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.711 HD11 ' CB ' ' A' ' 106' ' ' ALA . 36.6 mt -129.18 -34.92 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.374 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.976 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -148.65 166.26 28.86 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.896 0.379 . . . . 0.0 111.288 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.631 HG22 ' ND2' ' A' ' 71' ' ' ASN . 12.3 p -155.19 118.85 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.903 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.631 ' ND2' HG22 ' A' ' 70' ' ' VAL . 68.5 m-80 56.72 43.82 24.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.556 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 70.93 23.54 77.94 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.722 -0.752 . . . . 0.0 111.966 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -122.55 97.37 5.43 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.778 0.323 . . . . 0.0 110.862 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.82 119.37 13.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.929 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.635 HD13 ' HB1' ' A' ' 83' ' ' ALA . 9.8 mt -72.27 -15.65 61.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.175 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 21.6 mt -52.2 93.13 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.892 0.377 . . . . 0.0 111.013 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 151.51 -24.16 0.95 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.415 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.5 ptpm? -111.93 167.75 10.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.165 0.507 . . . . 0.0 111.072 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.4 ' HB3' ' NE2' ' A' ' 81' ' ' GLN . . . -74.02 165.13 25.67 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.279 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.43 ' HB3' ' HA3' ' A' ' 32' ' ' GLY . 22.2 m-80 -52.29 -57.47 9.65 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.258 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.413 ' HA ' ' HG2' ' A' ' 84' ' ' MET . 2.6 pp0? -53.82 -38.75 64.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.399 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.85 -38.88 73.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.277 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.635 ' HB1' HD13 ' A' ' 75' ' ' LEU . . . -66.76 -47.88 70.82 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.746 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.498 ' HB3' HG21 ' A' ' 44' ' ' ILE . 5.0 ptp -63.13 -29.7 71.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.977 179.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.66 -32.36 47.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.385 178.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.444 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 1.4 m -69.03 -36.59 77.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.348 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.479 ' CD2' ' HA ' ' A' ' 84' ' ' MET . 4.4 pp -78.46 -33.82 48.13 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.75 ' HG3' HG12 ' B' ' 13' ' ' VAL . 1.1 ttt180 -58.4 -51.69 68.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.465 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.575 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.27 -33.88 67.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.195 179.814 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.435 ' HB2' ' O ' ' A' ' 86' ' ' THR . 5.3 t -70.45 -29.17 65.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.25 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.959 ' HE2' HD22 ' A' ' 26' ' ' LEU . 4.2 ptp -88.77 -20.27 24.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.533 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.75 39.57 3.93 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.575 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.5 OUTLIER -171.71 -22.22 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 179.696 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.479 ' HG3' HG22 ' A' ' 93' ' ' THR . 12.0 mt-10 -127.9 -59.0 1.21 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.91 0.386 . . . . 0.0 111.091 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.438 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -67.52 -25.28 73.87 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.998 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.888 ' HB2' HD11 ' A' ' 18' ' ' LEU . 0.6 OUTLIER -78.44 -32.93 48.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.966 0.412 . . . . 0.0 110.24 179.517 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.497 ' HD3' ' O ' ' A' ' 93' ' ' THR . 10.5 mmmt -44.22 -40.14 4.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.258 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.63 -28.29 19.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.743 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 122.74 -7.43 9.51 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.951 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.495 ' SD ' ' HB3' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -157.05 143.45 18.14 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.061 0.458 . . . . 0.0 111.29 -179.709 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.91 HD11 HD11 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -113.94 146.99 17.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.188 -179.713 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.78 ' OE1' HG23 ' A' ' 13' ' ' THR . 1.2 tm0? -87.86 139.94 30.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.095 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.917 HD23 HG23 ' A' ' 16' ' ' VAL . 2.5 mm? -131.73 141.87 49.64 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.131 0.491 . . . . 0.0 112.046 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.976 HD12 ' HB3' ' A' ' 69' ' ' ALA . 73.5 mt -127.09 112.31 28.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.94 ' CG1' HD23 ' A' ' 67' ' ' LEU . 29.8 m -132.5 133.08 60.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.825 -178.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.711 ' CB ' HD11 ' A' ' 68' ' ' ILE . . . -108.93 139.48 43.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.254 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.655 ' CG ' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.991 0.424 . . . . 0.0 111.382 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.475 HD12 ' HD3' ' A' ' 47' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.453 -0.316 0 CA-C-O 120.893 0.378 . . . . 0.0 111.128 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . 0.402 HG22 HG13 ' B' ' 13' ' ' VAL . 53.2 m -126.75 134.56 50.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.974 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.27 109.48 16.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.63 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.75 HG12 ' HG3' ' A' ' 88' ' ' ARG . 16.8 m . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.151 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 121.013 0.435 . . . . 0.0 111.596 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.4 ' CE2' HG12 ' A' ' 68' ' ' ILE . 13.6 m-85 -95.99 151.21 19.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.695 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.997 HD12 HG23 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -137.3 110.99 8.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.885 -179.757 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.635 HG23 ' OE1' ' A' ' 102' ' ' GLN . 97.2 m -97.6 130.63 44.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.639 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.463 ' CZ ' ' HB3' ' A' ' 12' ' ' LEU . 28.4 m-85 -140.87 172.47 12.64 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.26 0.553 . . . . 0.0 112.416 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.439 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.5 OUTLIER -126.98 111.7 14.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.051 179.086 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.906 HG23 HD23 ' A' ' 103' ' ' LEU . 34.3 t -104.26 116.66 60.97 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -177.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.523 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 89.7 Cg_endo -88.57 126.53 1.86 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.47 2.113 . . . . 0.0 110.846 178.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.815 HD11 ' HB2' ' A' ' 96' ' ' ASN . 0.3 OUTLIER -116.16 29.09 8.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.716 0.293 . . . . 0.0 111.547 -178.823 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -38.6 -31.72 0.06 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.434 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -112.2 -32.07 6.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.312 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 t -74.39 -5.49 42.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.181 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.782 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -43.88 -28.77 1.26 Allowed Glycine 0 C--N 1.336 0.561 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.942 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.1 p -88.26 -33.04 18.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.762 0.315 . . . . 0.0 110.897 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.47 9.02 28.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.531 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.62 -54.39 4.95 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.966 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.933 HD22 ' HE2' ' A' ' 91' ' ' MET . 8.4 tp -175.12 -36.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.628 0.252 . . . . 0.0 110.811 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.494 ' HA3' ' HA3' ' A' ' 53' ' ' GLY . . . 114.83 44.91 0.67 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.4 -0.905 . . . . 0.0 113.295 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.803 HG12 HG23 ' A' ' 49' ' ' ILE . 33.1 m -157.24 160.56 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.189 0.518 . . . . 0.0 111.727 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.42 ' O ' ' HB3' ' A' ' 47' ' ' LYS . 0.7 OUTLIER -117.44 110.3 17.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.31 178.774 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.618 HG11 HD11 ' A' ' 67' ' ' LEU . 4.3 m -106.9 137.97 35.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.949 0.404 . . . . 0.0 111.717 -178.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.505 ' CB ' HD13 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -141.46 129.63 22.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.431 179.452 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -89.23 156.92 26.47 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.539 -0.838 . . . . 0.0 113.055 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -128.29 145.22 51.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.827 0.346 . . . . 0.0 110.93 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 45.3 mtt85 -96.22 147.63 23.56 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.646 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.862 ' HA ' HD21 ' A' ' 42' ' ' LEU . 12.4 t -45.64 141.93 2.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.405 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -25.15 64.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.049 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -85.46 -72.18 0.5 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.8 0.333 . . . . 0.0 111.023 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.41 ' OD1' ' HB2' ' A' ' 40' ' ' ALA . 5.5 p30 -106.23 -162.45 0.86 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.744 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 53.5 m-70 -93.76 33.11 1.33 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.013 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.635 ' HB3' ' HB2' ' A' ' 35' ' ' SER . . . -73.48 105.46 4.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.977 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -54.6 106.46 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.154 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.862 HD21 ' HA ' ' A' ' 35' ' ' SER . 21.6 mt -67.79 -25.52 65.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.794 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.463 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 129.14 -178.63 17.2 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.06 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.691 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -104.23 133.05 49.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.911 0.386 . . . . 0.0 111.301 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.455 ' CE2' ' NE2' ' A' ' 66' ' ' GLN . 0.1 OUTLIER -122.47 145.48 48.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.833 -179.935 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.724 ' O ' HG13 ' A' ' 63' ' ' VAL . 42.8 t -60.9 104.9 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.691 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.42 ' HB3' ' O ' ' A' ' 29' ' ' SER . 5.2 tppt? -76.68 -37.82 55.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.721 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.64 122.76 0.87 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.871 0.367 . . . . 0.0 111.422 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.803 HG23 HG12 ' A' ' 28' ' ' VAL . 63.9 mt -89.46 127.41 42.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.166 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.44 HD12 ' N ' ' A' ' 28' ' ' VAL . 1.6 mp -66.33 109.06 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.52 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.28 76.64 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.086 0.47 . . . . 0.0 110.33 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 159.76 -26.71 0.34 Allowed Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.494 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -76.81 174.47 54.18 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.367 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.662 ' HB1' HG12 ' A' ' 16' ' ' VAL . . . -47.19 -46.52 23.92 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.645 ' HB1' HD22 ' A' ' 61' ' ' LEU . . . -61.81 -38.18 87.15 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.735 0.303 . . . . 0.0 111.763 -178.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.7 t -70.45 -43.11 70.52 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.938 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.467 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -66.49 -25.94 66.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.995 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.815 ' OD1' HG13 ' A' ' 16' ' ' VAL . 0.5 OUTLIER -55.03 -52.88 61.78 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.83 0.347 . . . . 0.0 111.33 -179.711 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.87 4.71 69.18 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.401 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.446 ' HD2' ' CD1' ' A' ' 14' ' ' PHE . 1.3 mtm180 -122.15 0.96 9.69 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.761 0.315 . . . . 0.0 110.662 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.729 ' HB3' HD13 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -100.5 136.34 40.53 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.98 -179.807 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.33 143.99 29.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.844 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.724 HG13 ' O ' ' A' ' 46' ' ' VAL . 58.5 t -59.18 142.85 14.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.046 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 29.1 m-20 90.26 12.45 0.05 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.694 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.74 120.93 34.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.721 0.296 . . . . 0.0 110.274 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.455 ' NE2' ' CE2' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -78.05 137.18 38.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.7 -179.831 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.903 HD23 HG12 ' A' ' 105' ' ' VAL . 6.6 mt -93.52 140.95 29.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.024 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.603 HD12 ' HA ' ' A' ' 105' ' ' VAL . 4.5 mp -124.89 -41.44 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.393 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.943 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -139.17 151.03 46.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.018 0.437 . . . . 0.0 111.371 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.602 HG11 ' HA ' ' A' ' 87' ' ' LEU . 14.7 p -140.38 119.56 11.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.025 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 60.96 27.95 17.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.652 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.0 22.53 54.9 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.153 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -125.51 115.07 19.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.861 0.362 . . . . 0.0 110.78 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.5 p -60.22 149.96 31.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.129 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.612 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . 12.0 mt -115.55 -29.72 6.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.064 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.0 mt -51.6 -35.21 40.67 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.236 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.35 -21.38 47.86 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.335 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -120.64 162.14 20.17 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.367 0.603 . . . . 0.0 110.977 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.6 ' HB3' HE21 ' A' ' 81' ' ' GLN . . . -59.48 161.73 5.56 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.154 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.42 ' HB2' ' HA3' ' A' ' 32' ' ' GLY . 10.3 p30 -56.87 -43.81 81.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.158 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.6 HE21 ' HB3' ' A' ' 79' ' ' ALA . 1.9 pp0? -64.58 -42.62 95.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.092 0.472 . . . . 0.0 110.55 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.68 -32.1 70.52 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.649 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.612 ' HB1' ' HB3' ' A' ' 75' ' ' LEU . . . -69.4 -49.04 58.98 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.685 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.611 ' HB3' HG21 ' A' ' 44' ' ' ILE . 6.9 ptp -59.64 -32.93 70.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.481 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -78.15 -31.28 49.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.22 0.533 . . . . 0.0 109.832 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.4 ' HA ' ' HD2' ' A' ' 89' ' ' ARG . 1.3 m -69.88 -36.44 75.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.521 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.851 HD12 ' N ' ' A' ' 88' ' ' ARG . 4.3 pp -78.77 -34.6 45.5 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.418 0.627 . . . . 0.0 109.478 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.851 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -61.11 -47.37 86.59 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.5 179.46 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.458 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -73.18 -43.27 61.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.424 179.544 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.3 p -61.36 -29.54 69.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.381 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.933 ' HE2' HD22 ' A' ' 26' ' ' LEU . 3.5 ptp -86.37 -34.93 20.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.84 -179.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -102.56 25.64 8.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.833 -179.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.552 HG23 ' HG2' ' A' ' 94' ' ' GLU . 0.5 OUTLIER -152.38 -36.66 0.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.796 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.552 ' HG2' HG23 ' A' ' 93' ' ' THR . 4.0 mt-10 -111.37 -60.04 1.89 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.813 0.34 . . . . 0.0 111.408 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.606 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -56.17 -27.31 51.89 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.378 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.815 ' HB2' HD11 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -77.09 -33.73 56.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.712 0.291 . . . . 0.0 110.565 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 94' ' ' GLU . 60.9 mtpt -39.33 -39.53 0.66 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.674 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.77 -27.28 13.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.191 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 121.75 -3.2 10.95 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.7 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.523 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -155.63 143.38 19.7 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.981 0.419 . . . . 0.0 111.257 -179.639 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.665 HD11 HD11 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -112.71 145.11 19.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.023 179.839 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.635 ' OE1' HG23 ' A' ' 13' ' ' THR . 1.3 tm0? -82.04 143.76 31.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.725 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.906 HD23 HG23 ' A' ' 16' ' ' VAL . 2.5 mm? -133.82 149.56 51.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.293 0.568 . . . . 0.0 112.008 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.943 HD12 ' HB3' ' A' ' 69' ' ' ALA . 74.7 mt -139.34 112.35 6.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.361 178.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.997 HG23 HD12 ' A' ' 12' ' ' LEU . 35.2 m -123.66 172.93 10.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.473 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -147.85 132.52 17.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.41 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.671 ' HG3' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.343 0 CA-C-O 120.919 0.39 . . . . 0.0 111.007 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.505 HD13 ' CB ' ' A' ' 31' ' ' LYS . 1.1 mm . . . . . 0 N--CA 1.453 -0.286 0 CA-C-O 121.181 0.515 . . . . 0.0 111.514 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . 0.599 HG22 HG13 ' B' ' 13' ' ' VAL . 43.9 m -98.08 102.97 14.87 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.527 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.75 102.75 1.59 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.641 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.599 HG13 HG22 ' B' ' 11' ' ' THR . 34.8 m . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.175 -0.917 . . . . 0.0 111.247 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 . . . . . 0 C--O 1.233 0.234 0 CA-C-O 120.886 0.374 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.448 ' CE2' HD13 ' A' ' 68' ' ' ILE . 4.4 m-85 -100.51 147.07 26.31 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.516 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 1.083 HD12 HG23 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -139.51 121.43 15.57 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.958 0.408 . . . . 0.0 111.303 -179.783 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.3 m -94.74 142.7 27.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.249 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.506 ' O ' ' HA ' ' A' ' 102' ' ' GLN . 26.6 m-85 -142.03 172.64 12.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.975 0.417 . . . . 0.0 111.587 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.423 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.7 OUTLIER -132.27 107.63 8.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.55 179.219 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.971 HG23 HD23 ' A' ' 103' ' ' LEU . 32.2 t -104.3 114.36 64.32 Favored Pre-proline 0 C--N 1.33 -0.248 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -178.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.614 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 93.1 Cg_endo -84.58 128.12 3.92 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.645 2.23 . . . . 0.0 110.958 178.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.789 HD11 ' HB2' ' A' ' 96' ' ' ASN . 0.4 OUTLIER -122.26 28.78 7.29 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -178.856 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -39.37 -31.11 0.08 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.101 0.477 . . . . 0.0 111.15 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -112.94 -32.94 6.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.24 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.588 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 43.9 t -71.31 -6.62 41.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.174 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.71 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -44.23 -29.79 1.74 Allowed Glycine 0 C--N 1.336 0.567 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.692 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.21 -37.93 22.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.982 0.42 . . . . 0.0 110.553 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.29 -1.03 54.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.427 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.07 -48.91 3.91 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.879 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.005 HD22 ' HE2' ' A' ' 91' ' ' MET . 6.1 tp 179.78 -31.34 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.611 0.243 . . . . 0.0 110.553 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.449 ' HA2' HD13 ' A' ' 50' ' ' ILE . . . 105.96 48.31 1.02 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.297 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.785 HG12 HG23 ' A' ' 49' ' ' ILE . 20.0 m -157.08 163.97 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.164 0.506 . . . . 0.0 111.94 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.417 ' O ' ' HB3' ' A' ' 47' ' ' LYS . 49.7 m -124.7 117.37 24.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.238 178.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.785 HG11 HD11 ' A' ' 67' ' ' LEU . 4.4 m -111.58 145.62 17.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.079 0.466 . . . . 0.0 112.163 -178.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.492 ' HB3' HD13 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -143.81 130.25 19.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.37 179.331 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 44' ' ' ILE . . . -103.71 156.99 17.57 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.442 -0.885 . . . . 0.0 113.142 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.907 ' ND2' HD12 ' A' ' 42' ' ' LEU . 6.7 p-10 -105.16 178.21 4.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.909 0.385 . . . . 0.0 111.163 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -136.27 126.47 26.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.76 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.664 ' OG ' HD21 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -50.43 121.45 5.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.149 -179.752 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.46 -10.89 55.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.552 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -77.91 -64.39 1.17 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.734 0.302 . . . . 0.0 111.325 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.574 ' OD1' ' HB2' ' A' ' 40' ' ' ALA . 10.8 p30 -124.12 25.87 7.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.498 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 52.46 54.2 11.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.898 0.38 . . . . 0.0 111.153 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.574 ' HB2' ' OD1' ' A' ' 38' ' ' ASN . . . -110.3 120.86 43.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.989 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -48.06 118.56 2.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.3 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.907 HD12 ' ND2' ' A' ' 33' ' ' ASN . 21.3 mt -81.31 -28.29 34.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.62 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 138.53 173.96 13.21 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.494 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.876 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -101.68 153.5 5.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.869 0.366 . . . . 0.0 111.38 -180.0 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.458 ' CE2' ' NE2' ' A' ' 66' ' ' GLN . 0.4 OUTLIER -140.19 141.75 35.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.662 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.747 ' O ' HG13 ' A' ' 63' ' ' VAL . 42.2 t -57.74 104.64 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.59 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.482 ' HD3' HD12 ' B' ' 10' ' ' ILE . 21.9 tptt -75.26 -41.49 57.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.749 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.97 124.52 1.08 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.857 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.803 HD13 ' HB3' ' A' ' 61' ' ' LEU . 77.2 mt -91.62 119.95 39.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.218 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.472 HD12 ' N ' ' A' ' 28' ' ' VAL . 1.7 mp -56.0 108.14 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.376 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.15 72.94 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.873 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 162.45 -26.95 0.24 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.176 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.422 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -69.86 -170.6 8.14 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.901 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.614 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -64.15 -41.49 97.15 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.953 ' HB1' HD13 ' A' ' 61' ' ' LEU . . . -62.87 -47.58 82.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.703 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.0 t -67.85 -29.04 68.08 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.497 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 37.4 mtpt -74.87 -32.31 61.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.151 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -61.18 -27.94 68.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.808 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 66.59 20.76 70.27 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.779 -0.724 . . . . 0.0 113.132 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.429 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 12.5 mtm180 -125.19 -16.57 5.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.778 0.323 . . . . 0.0 110.979 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.953 HD13 ' HB1' ' A' ' 55' ' ' ALA . 0.5 OUTLIER -88.27 135.53 33.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.195 -179.668 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.664 HH21 HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -143.16 137.87 29.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.692 179.671 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.747 HG13 ' O ' ' A' ' 46' ' ' VAL . 48.1 t -52.52 145.91 2.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.267 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.444 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 28.2 m-80 86.98 11.09 0.15 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.613 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.439 ' OD2' HG21 ' A' ' 105' ' ' VAL . 3.0 m-20 -91.82 115.69 28.27 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.458 ' NE2' ' CE2' ' A' ' 45' ' ' PHE . 0.9 OUTLIER -72.89 128.97 37.06 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.779 -179.632 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.876 HD12 HG13 ' A' ' 44' ' ' ILE . 42.6 mt -83.09 152.2 25.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.772 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.474 HD11 ' CB ' ' A' ' 106' ' ' ALA . 30.6 mt -143.63 -40.98 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.637 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.743 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -138.12 158.5 44.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.83 0.348 . . . . 0.0 111.457 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.492 HG23 HD11 ' A' ' 101' ' ' ILE . 12.8 p -151.51 120.6 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.951 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.484 HD22 HG22 ' A' ' 70' ' ' VAL . 70.4 m-80 57.12 29.65 16.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.87 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.19 23.75 50.52 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.308 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -127.75 118.61 24.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.741 0.305 . . . . 0.0 110.753 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.8 t -70.65 150.19 46.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.115 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.499 HD22 ' HA ' ' A' ' 83' ' ' ALA . 22.5 mt -111.16 -19.34 12.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.102 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.8 tp -54.41 -21.99 11.25 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.32 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -91.2 28.74 7.71 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.863 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.413 ' HD2' ' HA ' ' A' ' 83' ' ' ALA . 8.6 ptpp? -164.81 152.04 11.22 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.27 0.557 . . . . 0.0 110.921 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.716 ' HB3' HE21 ' A' ' 81' ' ' GLN . . . -52.96 156.45 2.05 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.329 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -54.16 -47.85 71.52 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.044 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.716 HE21 ' HB3' ' A' ' 79' ' ' ALA . 2.9 pp0? -60.42 -40.0 89.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.016 0.436 . . . . 0.0 110.635 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.1 -34.22 72.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.678 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.563 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -66.5 -50.6 62.71 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.366 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.429 ' HA ' ' CD2' ' A' ' 87' ' ' LEU . 6.9 ptp -60.67 -30.5 69.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.927 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -79.51 -32.94 42.44 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.412 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 2.1 m -68.08 -35.67 78.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.277 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.871 HD11 HG11 ' B' ' 13' ' ' VAL . 4.4 pp -78.31 -34.35 48.73 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.81 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -60.21 -52.14 66.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.655 179.293 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.481 ' O ' HG22 ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.5 -33.91 67.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.295 179.651 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.414 ' N ' ' HD3' ' A' ' 89' ' ' ARG . 24.0 t -71.6 -29.99 65.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.958 0.409 . . . . 0.0 110.424 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 1.005 ' HE2' HD22 ' A' ' 26' ' ' LEU . 1.5 ptp -89.2 -25.14 21.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.163 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.3 t -109.22 23.18 14.87 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.481 HG22 ' O ' ' A' ' 89' ' ' ARG . 0.5 OUTLIER -153.37 -36.19 0.11 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.902 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.455 ' HA ' ' HG3' ' A' ' 97' ' ' LYS . 4.1 mt-10 -107.61 -64.3 1.22 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.828 0.347 . . . . 0.0 111.346 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.545 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -52.92 -33.63 44.06 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.656 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.789 ' HB2' HD11 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -70.49 -34.78 72.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.702 0.287 . . . . 0.0 110.382 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.455 ' HG3' ' HA ' ' A' ' 94' ' ' GLU . 20.7 mtpt -38.23 -47.29 1.16 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.475 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.31 -25.32 19.49 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.662 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 118.97 -3.05 14.58 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.819 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.423 ' SD ' ' HB3' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -159.48 143.43 14.84 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.076 0.465 . . . . 0.0 111.383 -179.744 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.776 HD11 HD11 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -114.33 141.48 30.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.529 179.932 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.506 ' HA ' ' O ' ' A' ' 14' ' ' PHE . 2.2 pp0? -86.88 131.13 34.19 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.981 -0.287 . . . . 0.0 110.403 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.971 HD23 HG23 ' A' ' 16' ' ' VAL . 2.8 mm? -115.87 134.39 55.04 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.275 0.559 . . . . 0.0 112.114 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.743 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 96.7 mt -118.07 112.59 39.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.611 178.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 1.083 HG23 HD12 ' A' ' 12' ' ' LEU . 28.9 m -121.53 177.21 3.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.265 -179.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.474 ' CB ' HD11 ' A' ' 68' ' ' ILE . . . -147.29 139.18 24.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.826 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.566 ' HD2' HD21 ' A' ' 12' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.429 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.149 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.492 HD13 ' HB3' ' A' ' 31' ' ' LYS . 1.6 mm . . . . . 0 CA--C 1.521 -0.172 0 CA-C-O 121.135 0.493 . . . . 0.0 111.123 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 2.5 m -110.5 116.4 31.32 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.661 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 27.2 ttmt -78.13 109.2 12.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.925 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.871 HG11 HD11 ' A' ' 87' ' ' LEU . 17.3 m . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.277 -0.868 . . . . 0.0 111.275 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.921 0.391 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.689 ' HE2' HG21 ' A' ' 68' ' ' ILE . 11.0 m-85 -100.7 148.93 24.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.802 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.892 HD12 HG23 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -133.68 110.88 10.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.026 -179.838 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.842 HG23 ' OE1' ' A' ' 102' ' ' GLN . 89.3 m -96.1 132.47 41.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.577 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.436 ' CZ ' ' HB3' ' A' ' 12' ' ' LEU . 54.9 m-85 -140.73 172.43 12.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.301 0.572 . . . . 0.0 112.113 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.427 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.3 OUTLIER -129.07 112.09 13.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.152 179.174 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.932 HG23 HD23 ' A' ' 103' ' ' LEU . 34.8 t -103.19 112.2 65.58 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -178.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.768 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 84.2 Cg_endo -82.22 127.82 5.4 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.365 2.043 . . . . 0.0 110.886 178.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.866 HD22 ' CD1' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -122.62 28.52 7.3 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -178.724 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -39.12 -31.49 0.07 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.172 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -113.33 -32.83 6.14 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.282 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.716 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 46.7 t -70.96 -7.7 47.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.163 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.744 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -45.25 -28.46 2.09 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.744 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.8 p -85.27 -34.28 21.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.797 0.332 . . . . 0.0 110.563 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.66 7.21 31.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.526 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.03 -54.99 4.78 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.644 -0.789 . . . . 0.0 111.985 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.934 HD22 ' HE2' ' A' ' 91' ' ' MET . 9.8 tp -178.89 -32.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.592 0.234 . . . . 0.0 110.948 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 50' ' ' ILE . . . 114.47 31.91 2.07 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.381 -0.914 . . . . 0.0 113.413 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.809 HG12 HG23 ' A' ' 49' ' ' ILE . 33.7 m -150.83 161.01 3.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 117.164 0.482 . . . . 0.0 111.75 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.42 ' O ' ' N ' ' A' ' 47' ' ' LYS . 0.9 OUTLIER -122.41 118.16 27.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.556 178.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.828 HG11 HD11 ' A' ' 67' ' ' LEU . 3.3 m -110.77 141.67 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.9 0.381 . . . . 0.0 111.937 -178.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.56 ' CB ' HD13 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -140.66 130.54 24.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.545 179.397 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.56 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -90.94 160.75 27.6 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.397 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.454 ' ND2' ' CE1' ' A' ' 45' ' ' PHE . 89.3 m-20 -119.57 179.91 4.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.837 0.351 . . . . 0.0 110.915 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.59 155.66 40.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.624 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.801 ' CA ' HD21 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -57.14 140.49 49.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.063 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.2 mtmm -64.51 -28.25 69.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.984 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -84.96 -74.88 0.38 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.944 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -94.41 177.26 6.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.903 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -93.07 58.42 2.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.881 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -116.78 131.63 56.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.998 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -59.37 144.31 47.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.915 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.801 HD21 ' CA ' ' A' ' 35' ' ' SER . 17.0 mt -105.38 -30.98 9.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.862 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.56 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 148.51 -173.99 28.31 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.098 -0.572 . . . . 0.0 111.866 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.87 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -110.23 148.11 14.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 120.988 0.423 . . . . 0.0 111.735 -179.739 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.454 ' CE1' ' ND2' ' A' ' 33' ' ' ASN . 0.4 OUTLIER -134.4 138.43 44.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.557 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.604 ' O ' HG13 ' A' ' 63' ' ' VAL . 40.0 t -54.17 104.41 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.564 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.511 ' HG2' HG21 ' B' ' 10' ' ' ILE . 5.9 tptm -73.03 -43.01 62.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.841 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 m -168.18 125.02 1.07 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.107 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.809 HG23 HG12 ' A' ' 28' ' ' VAL . 62.7 mt -88.93 116.66 30.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.297 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.531 HD12 ' N ' ' A' ' 28' ' ' VAL . 1.9 mp -55.42 105.26 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.629 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.11 76.4 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.141 0.496 . . . . 0.0 110.588 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 158.95 -27.17 0.39 Allowed Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.907 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.45 -170.62 6.07 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.691 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.768 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -67.94 -38.58 83.0 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.779 ' HB1' HD13 ' A' ' 61' ' ' LEU . . . -67.66 -43.86 79.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.393 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.43 ' HB3' HG22 ' A' ' 49' ' ' ILE . 53.6 p -66.85 -33.28 75.25 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.204 0.526 . . . . 0.0 110.109 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -70.74 -33.53 70.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.171 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -58.05 -28.0 64.13 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.786 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.87 25.0 67.26 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.783 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.411 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 22.1 mtm180 -125.31 -24.22 4.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.812 0.339 . . . . 0.0 111.017 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.785 HD22 HG11 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -71.62 164.06 26.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.444 -179.729 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.461 ' N ' ' HD2' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -160.46 138.83 10.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.713 179.876 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.604 HG13 ' O ' ' A' ' 46' ' ' VAL . 37.0 t -70.5 144.75 13.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.594 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 25.4 m-20 88.75 -2.53 0.43 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.642 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.95 133.14 35.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.96 0.409 . . . . 0.0 110.599 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.424 ' NE2' ' HA3' ' A' ' 43' ' ' GLY . 1.0 OUTLIER -82.63 139.02 33.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.692 -179.806 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.954 HD23 HG12 ' A' ' 105' ' ' VAL . 28.7 mt -88.99 131.81 35.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.839 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.689 HG21 ' HE2' ' A' ' 11' ' ' PHE . 19.3 mm -113.13 -32.19 2.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.473 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.781 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -157.03 170.91 21.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.884 0.373 . . . . 0.0 111.585 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.433 HG11 ' HA ' ' A' ' 87' ' ' LEU . 7.3 p -158.17 127.39 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.767 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 60.24 22.83 12.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.668 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.07 25.53 31.32 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.993 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -130.55 108.45 9.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.796 0.332 . . . . 0.0 110.831 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.418 ' HA ' ' HB2' ' A' ' 69' ' ' ALA . 33.2 t -71.23 138.27 49.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.087 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.777 HD22 ' HB1' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -98.57 -13.24 20.5 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.163 179.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.415 ' CD1' HG23 ' A' ' 68' ' ' ILE . 0.1 OUTLIER -52.82 94.7 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.913 0.387 . . . . 0.0 111.058 -179.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 145.3 -31.09 1.71 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.185 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -97.56 156.89 16.3 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.239 0.542 . . . . 0.0 110.903 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.12 139.45 28.58 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.33 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.9 p30 -50.63 -28.14 8.25 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.172 0.511 . . . . 0.0 109.927 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.4 ' O ' ' HG2' ' A' ' 84' ' ' MET . 0.0 OUTLIER -74.18 -42.04 60.49 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.013 178.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -70.11 -32.99 71.27 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.868 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.777 ' HB1' HD22 ' A' ' 75' ' ' LEU . . . -68.92 -45.46 70.8 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.487 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.434 ' HB3' HG21 ' A' ' 44' ' ' ILE . 6.5 ptp -63.49 -30.05 71.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.816 178.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -78.59 -33.46 47.51 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.502 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 3.4 m -68.34 -35.65 78.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.343 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.749 HD12 ' N ' ' A' ' 88' ' ' ARG . 4.4 pp -78.32 -33.83 48.99 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 178.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.749 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -60.23 -51.24 70.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.65 179.332 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.502 ' HD3' ' O ' ' A' ' 86' ' ' THR . 0.0 OUTLIER -72.26 -34.93 68.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.618 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.421 ' N ' ' HD3' ' A' ' 89' ' ' ARG . 24.7 p -72.92 -29.8 63.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.852 0.358 . . . . 0.0 110.735 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.934 ' HE2' HD22 ' A' ' 26' ' ' LEU . 1.7 ptm -88.85 -17.43 29.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.288 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.85 25.45 9.68 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.522 ' O ' ' HD3' ' A' ' 97' ' ' LYS . 0.4 OUTLIER -157.14 -31.97 0.08 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.458 ' HG3' HG22 ' A' ' 93' ' ' THR . 5.7 mt-10 -117.59 -35.56 3.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.856 0.36 . . . . 0.0 111.443 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.494 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -78.26 -31.25 47.62 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.614 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.771 ' HB2' HD11 ' A' ' 18' ' ' LEU . 0.7 OUTLIER -75.29 -31.89 60.83 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.584 -0.308 . . . . 0.0 110.176 179.576 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.522 ' HD3' ' O ' ' A' ' 93' ' ' THR . 27.1 mmmt -39.54 -47.19 1.86 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.968 0.414 . . . . 0.0 111.096 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.92 -25.49 19.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.889 178.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 114.19 1.09 23.74 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.908 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.485 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -154.66 141.0 18.66 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 120.975 0.417 . . . . 0.0 111.197 -179.588 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.8 HD11 HD11 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -112.85 145.31 18.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.657 179.538 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.842 ' OE1' HG23 ' A' ' 13' ' ' THR . 1.3 tm0? -84.99 139.64 31.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.978 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.932 HD23 HG23 ' A' ' 16' ' ' VAL . 2.7 mm? -129.99 137.66 50.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.045 0.45 . . . . 0.0 111.801 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.781 HD12 ' HB3' ' A' ' 69' ' ' ALA . 72.6 mt -126.5 113.1 31.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.563 178.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.954 HG12 HD23 ' A' ' 67' ' ' LEU . 31.9 m -123.62 174.69 7.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.472 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -147.73 137.43 22.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.841 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.607 ' CG ' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.946 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.56 HD13 ' CB ' ' A' ' 31' ' ' LYS . 1.1 mm . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 121.413 0.625 . . . . 0.0 111.495 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . 0.781 HG22 HG13 ' B' ' 13' ' ' VAL . 16.5 m -92.15 114.9 27.57 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.325 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -75.09 102.85 5.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.507 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.781 HG13 HG22 ' B' ' 11' ' ' THR . 30.0 m . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.726 -0.655 . . . . 0.0 110.532 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.791 0.329 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.625 ' CD1' ' HB2' ' A' ' 106' ' ' ALA . 30.3 m-85 -77.75 140.48 39.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.462 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.863 HD12 HG23 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -147.16 134.42 20.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.123 0.487 . . . . 0.0 111.238 -179.66 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.428 ' O ' ' CD1' ' A' ' 14' ' ' PHE . 25.4 m -92.63 150.8 20.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.295 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' ' 102' ' ' GLN . 15.5 m-85 -140.08 170.37 15.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.105 0.479 . . . . 0.0 111.683 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -143.43 104.95 4.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.096 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.768 HG21 HD11 ' A' ' 61' ' ' LEU . 20.7 t -109.49 110.86 59.79 Favored Pre-proline 0 CA--C 1.531 0.226 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -177.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.728 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 91.2 Cg_endo -82.49 128.11 5.3 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.527 2.151 . . . . 0.0 110.736 178.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.862 HD22 ' CD1' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -121.82 29.5 7.09 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -178.582 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -40.92 -31.7 0.19 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.103 0.478 . . . . 0.0 111.031 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -111.32 -33.65 6.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.203 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.736 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 29.9 t -70.52 -8.55 52.12 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.111 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.707 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -44.96 -28.05 1.66 Allowed Glycine 0 C--N 1.337 0.613 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.691 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -85.69 -33.44 21.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.834 0.349 . . . . 0.0 110.737 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.37 8.33 28.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.441 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.96 -55.64 4.99 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.629 -0.795 . . . . 0.0 111.908 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.862 ' CD1' HD22 ' A' ' 18' ' ' LEU . 10.2 tp -179.0 -34.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.601 0.239 . . . . 0.0 111.12 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.4 ' HA3' ' HA3' ' A' ' 53' ' ' GLY . . . 115.79 35.02 1.31 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.537 -0.839 . . . . 0.0 113.295 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.736 HG12 HG23 ' A' ' 49' ' ' ILE . 34.2 m -156.3 162.2 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.282 0.563 . . . . 0.0 112.082 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -122.65 116.4 23.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.179 178.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.67 HG11 HD11 ' A' ' 67' ' ' LEU . 3.4 m -106.56 146.35 13.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.143 0.497 . . . . 0.0 111.938 -178.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.528 ' HB3' HD13 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -143.34 131.08 21.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.58 179.705 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' A' ' 44' ' ' ILE . . . -97.32 145.69 17.95 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.697 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.405 ' OD1' ' CE1' ' A' ' 45' ' ' PHE . 21.9 m120 -107.84 -179.17 3.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.828 0.347 . . . . 0.0 111.028 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.4 mtt180 -134.53 156.12 49.2 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.691 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.462 ' HA ' HD21 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -48.92 150.97 1.34 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.194 -179.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -66.48 -40.33 89.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.116 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -108.24 -35.46 6.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.127 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -91.67 168.94 11.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.925 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 -103.25 31.03 4.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.79 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.66 129.5 44.73 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.089 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.436 ' CB ' ' ND2' ' A' ' 80' ' ' ASN . 1.7 p30 -57.1 142.27 43.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.079 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.462 HD21 ' HA ' ' A' ' 35' ' ' SER . 24.2 mt -104.06 12.6 33.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.11 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.423 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 98.47 170.67 31.8 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.586 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.88 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -102.02 135.78 37.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.851 0.358 . . . . 0.0 110.995 179.831 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.435 ' CE2' ' HG3' ' A' ' 66' ' ' GLN . 0.1 OUTLIER -121.02 141.33 50.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.792 -179.834 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.635 ' O ' HG13 ' A' ' 63' ' ' VAL . 46.7 t -56.35 104.64 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.638 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.44 ' HG2' HD12 ' B' ' 10' ' ' ILE . 0.9 OUTLIER -74.9 -40.94 60.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.758 -179.753 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.0 p -166.9 124.72 1.31 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.162 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.736 HG23 HG12 ' A' ' 28' ' ' VAL . 67.6 mt -91.25 111.86 24.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.059 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.629 HD12 ' N ' ' A' ' 28' ' ' VAL . 2.1 mp -51.8 106.41 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.801 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.34 75.52 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.023 0.44 . . . . 0.0 110.675 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 162.56 -29.99 0.28 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.082 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.4 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -66.61 -170.43 3.93 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.686 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.736 ' HB2' ' HB3' ' A' ' 21' ' ' SER . . . -68.54 -38.18 80.59 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.649 ' HB3' HG13 ' A' ' 28' ' ' VAL . . . -66.84 -45.04 79.46 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.455 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.632 ' OG ' HG22 ' A' ' 49' ' ' ILE . 0.4 OUTLIER -66.21 -34.8 78.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.27 0.557 . . . . 0.0 109.861 179.341 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.7 mtpt -68.47 -30.33 69.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.947 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.41 ' OD1' ' CD ' ' A' ' 17' ' ' PRO . 0.8 OUTLIER -64.09 -25.87 68.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.944 179.753 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.01 26.18 65.27 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.643 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.7 mtm180 -122.26 -34.79 3.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.968 0.413 . . . . 0.0 110.769 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.768 HD11 HG21 ' A' ' 16' ' ' VAL . 2.1 mp -66.74 141.86 57.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.473 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -138.45 134.22 33.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.269 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.635 HG13 ' O ' ' A' ' 46' ' ' VAL . 46.3 t -59.51 145.36 11.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.014 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.444 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 22.3 m-20 87.85 -7.3 0.58 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.392 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -76.07 125.66 29.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.787 0.327 . . . . 0.0 110.766 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.435 ' HG3' ' CE2' ' A' ' 45' ' ' PHE . 1.8 tm0? -81.51 140.48 34.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.916 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.911 HD23 HG12 ' A' ' 105' ' ' VAL . 30.8 mt -87.17 139.57 30.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.924 0.392 . . . . 0.0 111.183 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 19.6 mm -120.65 -31.52 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.241 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 1.012 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -161.72 134.73 6.18 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.973 0.416 . . . . 0.0 111.573 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.476 HG23 HD11 ' A' ' 101' ' ' ILE . 7.5 p -121.57 129.36 75.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.366 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.43 ' ND2' ' O ' ' A' ' 90' ' ' SER . 9.3 m-80 64.95 13.96 8.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.538 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.77 -14.72 53.03 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.005 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.639 ' OE1' HG23 ' A' ' 86' ' ' THR . 5.7 pt-20 -99.27 125.64 44.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.879 0.371 . . . . 0.0 111.07 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 21.3 p -75.04 165.1 25.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.901 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.515 HD22 ' HB1' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -128.9 4.38 5.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.267 -179.828 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.88 -41.43 78.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.909 0.385 . . . . 0.0 110.934 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.23 -25.84 73.49 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.691 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.431 ' HD2' ' HA ' ' A' ' 83' ' ' ALA . 1.3 ptpm? -101.7 166.78 10.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.287 0.565 . . . . 0.0 111.179 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.584 ' HB3' HE21 ' A' ' 81' ' ' GLN . . . -74.24 168.04 20.41 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.189 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.489 ' HB2' ' HA3' ' A' ' 32' ' ' GLY . 7.2 p30 -58.66 -50.48 73.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.055 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.584 HE21 ' HB3' ' A' ' 79' ' ' ALA . 2.2 pp0? -58.84 -39.69 82.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.116 0.484 . . . . 0.0 110.516 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.13 -34.48 73.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.9 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.55 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -69.03 -47.66 64.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.785 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.498 ' HB3' HG21 ' A' ' 44' ' ' ILE . 5.6 ptp -61.93 -31.52 71.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.205 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.07 -33.8 65.86 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.639 HG23 ' OE1' ' A' ' 73' ' ' GLU . 1.8 m -64.66 -33.91 77.04 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.26 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.62 HD13 HD13 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -76.02 -36.02 59.3 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.099 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.58 ' HG3' HG11 ' B' ' 13' ' ' VAL . 0.0 OUTLIER -59.14 -51.99 67.62 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.843 179.51 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.5 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.42 -44.86 61.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.429 179.665 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.43 ' O ' ' ND2' ' A' ' 71' ' ' ASN . 40.4 p -64.23 -30.38 71.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.489 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.808 ' HE2' HD22 ' A' ' 26' ' ' LEU . 2.1 ptm -89.01 -22.29 23.06 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.683 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.26 28.87 8.31 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.5 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.3 OUTLIER -164.96 -23.15 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -179.664 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.453 ' HG3' HG22 ' A' ' 93' ' ' THR . 8.7 mt-10 -122.06 -54.96 1.9 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.893 0.378 . . . . 0.0 111.317 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.446 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -66.59 -26.6 72.91 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.016 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.733 ' HB2' HD11 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -77.86 -36.04 50.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.834 0.349 . . . . 0.0 110.207 179.673 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.48 ' HD3' ' O ' ' A' ' 93' ' ' THR . 25.8 mmmt -45.46 -43.04 11.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.969 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.08 -24.53 22.26 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.51 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 111.61 1.9 27.46 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.856 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.546 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -165.17 140.23 5.16 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 121.172 0.51 . . . . 0.0 111.744 -179.818 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.554 HG22 HD21 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -114.38 133.54 60.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.902 179.932 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.462 ' HA ' ' O ' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -76.72 150.2 36.29 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.421 HD12 HG23 ' A' ' 16' ' ' VAL . 0.5 OUTLIER -138.79 112.82 8.57 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.919 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 1.012 HD12 ' HB3' ' A' ' 69' ' ' ALA . 32.6 mt -98.86 112.84 31.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.911 HG12 HD23 ' A' ' 67' ' ' LEU . 34.5 m -128.25 161.92 35.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.942 0.401 . . . . 0.0 111.48 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.625 ' HB2' ' CD1' ' A' ' 11' ' ' PHE . . . -123.55 120.38 32.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.558 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.86 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.528 HD13 ' HB3' ' A' ' 31' ' ' LYS . 1.4 mm . . . . . 0 CA--C 1.52 -0.204 0 CA-C-O 121.254 0.549 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 55.9 m -70.51 102.82 2.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.578 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.6 120.07 20.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.92 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.58 HG11 ' HG3' ' A' ' 88' ' ' ARG . 11.1 m . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.151 -0.928 . . . . 0.0 110.818 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.445 ' OE2' HD21 ' A' ' 12' ' ' LEU . 7.3 pt-20 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.953 0.406 . . . . 0.0 111.063 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -94.61 147.46 23.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.604 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.786 HD12 HG23 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -134.23 110.17 9.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.363 -179.711 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 76.5 m -96.59 130.25 43.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.282 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.438 ' CZ ' ' HB3' ' A' ' 12' ' ' LEU . 32.0 m-85 -140.21 172.37 12.84 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.467 0.651 . . . . 0.0 112.249 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.47 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.2 OUTLIER -128.93 111.71 13.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.328 179.354 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.9 HG23 HD23 ' A' ' 103' ' ' LEU . 8.8 t -103.39 117.17 60.77 Favored Pre-proline 0 C--N 1.33 -0.274 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -178.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.53 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 80.7 Cg_endo -86.36 127.22 2.83 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.461 2.108 . . . . 0.0 111.184 178.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.849 HD11 ' HB2' ' A' ' 96' ' ' ASN . 0.4 OUTLIER -119.04 28.12 8.45 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -178.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -39.23 -30.76 0.06 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.209 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -114.63 -31.27 6.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.138 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.439 ' CB ' ' HB2' ' A' ' 54' ' ' ALA . 1.9 t -72.15 -7.6 50.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.095 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.629 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -44.74 -28.49 1.67 Allowed Glycine 0 C--N 1.337 0.602 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.741 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.73 -35.43 20.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.8 0.333 . . . . 0.0 110.824 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.21 8.74 25.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.455 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.87 -54.39 4.95 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.92 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.996 HD22 ' HE2' ' A' ' 91' ' ' MET . 8.8 tp -178.03 -36.1 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.636 0.255 . . . . 0.0 110.657 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.472 ' HA3' ' HA3' ' A' ' 53' ' ' GLY . . . 115.66 41.13 0.81 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.378 -0.915 . . . . 0.0 113.373 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.808 HG12 HG23 ' A' ' 49' ' ' ILE . 14.2 m -156.93 157.69 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 117.147 0.474 . . . . 0.0 111.917 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.422 ' O ' ' HB3' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -116.38 117.2 29.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.279 178.596 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.477 HG11 HD11 ' A' ' 67' ' ' LEU . 2.5 m -110.33 148.24 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.148 0.499 . . . . 0.0 112.159 -178.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.541 ' HB3' HD13 ' B' ' 10' ' ' ILE . 0.2 OUTLIER -147.82 129.67 15.24 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.292 179.28 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.488 ' HA2' ' HA ' ' A' ' 44' ' ' ILE . . . -90.57 163.65 29.96 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.43 -179.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.408 ' HB2' ' CZ ' ' A' ' 45' ' ' PHE . 1.7 m-80 -124.2 179.15 5.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.819 0.343 . . . . 0.0 110.637 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 11.0 ttm180 -135.15 148.75 49.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.574 ' CA ' HD21 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -55.84 128.84 36.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.917 -179.88 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.23 -28.77 69.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.139 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -80.02 -62.83 1.56 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.875 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -117.05 164.64 14.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.831 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -75.05 63.05 1.21 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.939 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -119.56 117.82 29.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.061 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -51.08 142.71 11.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.174 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.574 HD21 ' CA ' ' A' ' 35' ' ' SER . 23.0 mt -107.86 -2.16 20.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.341 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.414 ' HA3' ' NE2' ' A' ' 66' ' ' GLN . . . 111.0 179.93 20.16 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.326 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.768 ' CG1' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -109.27 139.4 32.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.978 0.418 . . . . 0.0 111.491 -179.824 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.42 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -120.47 144.84 47.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.589 179.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.57 ' O ' HG13 ' A' ' 63' ' ' VAL . 35.7 t -62.93 104.44 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.677 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.437 ' HD3' HD12 ' B' ' 10' ' ' ILE . 10.8 tptt -69.8 -45.4 68.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.813 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -167.88 127.91 1.34 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.009 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.808 HG23 HG12 ' A' ' 28' ' ' VAL . 61.8 mt -90.17 122.44 41.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.056 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.541 HD12 ' N ' ' A' ' 28' ' ' VAL . 1.8 mp -61.36 110.08 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.247 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -65.19 75.73 0.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.02 0.438 . . . . 0.0 110.597 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 160.67 -28.33 0.32 Allowed Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.807 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.472 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -74.65 167.53 54.77 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.798 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.53 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -40.76 -45.33 2.41 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.746 ' HB1' HD22 ' A' ' 61' ' ' LEU . . . -61.6 -42.36 98.76 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.178 -0.465 . . . . 0.0 112.164 -178.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.432 ' OG ' HG22 ' A' ' 49' ' ' ILE . 0.4 OUTLIER -74.23 -24.69 59.35 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.021 0.439 . . . . 0.0 110.588 -179.718 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.423 ' HG3' ' HA ' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -77.53 -34.39 53.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.795 -179.894 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -60.33 -33.81 72.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.727 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.78 22.09 79.28 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.811 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.437 ' HB3' ' CG ' ' A' ' 14' ' ' PHE . 17.4 mtm180 -125.19 -20.1 4.95 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.777 0.322 . . . . 0.0 111.08 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.78 HD11 HG21 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -77.39 138.81 39.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.979 0.418 . . . . 0.0 111.295 -179.771 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.411 ' NH2' HD13 ' A' ' 12' ' ' LEU . 0.1 OUTLIER -136.82 139.92 42.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.417 179.9 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.57 HG13 ' O ' ' A' ' 46' ' ' VAL . 41.7 t -67.74 144.03 14.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.066 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.503 ' HB2' ' O ' ' A' ' 63' ' ' VAL . 43.9 m-80 83.4 8.12 0.65 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.119 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.489 ' OD2' HG21 ' A' ' 105' ' ' VAL . 6.9 t0 -84.83 126.05 33.12 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.414 ' NE2' ' HA3' ' A' ' 43' ' ' GLY . 1.2 tt0 -78.15 131.93 37.42 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.734 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.914 HD23 HG12 ' A' ' 105' ' ' VAL . 14.4 mt -87.28 141.41 28.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.749 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.75 HD11 ' HB2' ' A' ' 106' ' ' ALA . 22.6 mt -124.91 -36.87 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.494 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.72 ' HB3' ' CD1' ' A' ' 104' ' ' ILE . . . -153.29 145.47 23.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.047 0.451 . . . . 0.0 111.666 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.71 HG11 ' HA ' ' A' ' 87' ' ' LEU . 14.9 p -133.54 130.25 56.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.588 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.447 HD22 HG22 ' A' ' 70' ' ' VAL . 9.8 m-80 63.2 18.48 11.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.692 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.48 25.27 36.54 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.663 -0.779 . . . . 0.0 111.728 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -133.03 104.11 6.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.873 0.368 . . . . 0.0 110.633 -179.538 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 0.4 OUTLIER -62.95 157.23 22.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.231 -179.712 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.623 HD22 ' HB1' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -123.95 9.49 8.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.104 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.43 -25.61 67.33 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.848 0.356 . . . . 0.0 110.984 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -94.52 25.65 21.82 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.613 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.461 ' HD2' ' HA ' ' A' ' 83' ' ' ALA . 0.5 OUTLIER -151.34 160.71 43.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.25 0.548 . . . . 0.0 111.213 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.47 ' HB1' ' OE1' ' A' ' 81' ' ' GLN . . . -65.08 158.63 25.27 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.104 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.459 ' HB2' ' HA3' ' A' ' 32' ' ' GLY . 7.8 p30 -57.35 -47.73 80.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.311 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.47 ' OE1' ' HB1' ' A' ' 79' ' ' ALA . 5.8 pm0 -58.51 -37.98 76.74 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.996 0.427 . . . . 0.0 110.776 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.406 ' HB3' ' HD3' ' A' ' 78' ' ' LYS . 3.7 mm-40 -70.67 -38.08 73.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.998 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.623 ' HB1' HD22 ' A' ' 75' ' ' LEU . . . -67.24 -46.16 74.59 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.823 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.502 ' HB3' HG21 ' A' ' 44' ' ' ILE . 5.5 ptp -64.26 -29.66 70.75 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -81.09 -30.28 34.69 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.425 178.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.494 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 7.3 m -71.58 -35.08 70.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.209 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.859 HD12 ' N ' ' A' ' 88' ' ' ARG . 4.2 pp -78.44 -34.29 47.93 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.859 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -59.5 -52.0 67.43 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.628 179.203 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.548 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.82 -33.62 66.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.017 179.474 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.448 ' N ' ' HD3' ' A' ' 89' ' ' ARG . 49.5 m -70.5 -29.79 66.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.486 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.996 ' HE2' HD22 ' A' ' 26' ' ' LEU . 2.9 ptp -86.41 -23.38 26.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.248 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.5 33.12 5.76 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.548 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.4 OUTLIER -162.91 -28.35 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.498 ' HG3' HG22 ' A' ' 93' ' ' THR . 5.3 mt-10 -122.62 -37.27 2.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.912 0.387 . . . . 0.0 111.196 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.445 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -82.27 -33.06 26.88 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.458 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.849 ' HB2' HD11 ' A' ' 18' ' ' LEU . 0.7 OUTLIER -72.83 -33.25 66.04 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.313 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.469 ' HD3' ' O ' ' A' ' 93' ' ' THR . 10.5 mmmt -40.56 -46.12 2.44 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.098 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.8 -24.31 20.36 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.816 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 118.32 -4.91 15.42 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.784 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.47 ' SD ' ' HB3' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -156.03 143.99 19.7 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.935 0.398 . . . . 0.0 111.097 -179.748 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.858 HD11 HD11 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -111.76 145.28 18.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.225 -179.643 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.643 ' O ' HD13 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -86.24 142.55 28.49 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.128 179.416 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.9 HD23 HG23 ' A' ' 16' ' ' VAL . 2.8 mm? -133.77 139.23 46.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.1 0.476 . . . . 0.0 111.749 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.72 ' CD1' ' HB3' ' A' ' 69' ' ' ALA . 7.4 mt -126.99 112.62 29.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.506 178.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.914 HG12 HD23 ' A' ' 67' ' ' LEU . 32.6 m -125.41 176.02 6.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.513 -179.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.75 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -147.65 136.55 22.07 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.865 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.564 ' HD2' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-O 120.912 0.387 . . . . 0.0 111.212 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.541 HD13 ' HB3' ' A' ' 31' ' ' LYS . 3.3 mm . . . . . 0 N--CA 1.453 -0.302 0 CA-C-O 120.994 0.426 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 7.9 m -120.72 113.97 20.98 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.958 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.12 131.61 42.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.591 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.436 ' CG1' ' HG3' ' A' ' 88' ' ' ARG . 10.4 m . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.316 -0.85 . . . . 0.0 111.304 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.912 0.387 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.506 ' CE2' HD13 ' A' ' 68' ' ' ILE . 37.3 m-85 -74.92 144.42 43.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.214 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.839 HD12 HG23 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -145.49 109.86 4.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.034 0.445 . . . . 0.0 111.644 -179.415 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.437 ' O ' ' CD1' ' A' ' 14' ' ' PHE . 11.8 m -81.09 141.4 34.35 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.706 178.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.448 ' CD2' ' CD2' ' A' ' 61' ' ' LEU . 19.5 m-85 -136.38 171.84 13.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.414 0.626 . . . . 0.0 112.595 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -143.05 102.29 3.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.242 178.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.603 HG21 HD13 ' A' ' 103' ' ' LEU . 40.4 t -104.39 106.77 55.49 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -177.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.791 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 5.3 Cg_exo -77.89 127.69 8.77 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.492 2.128 . . . . 0.0 110.623 178.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.871 HD22 ' CD1' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -125.78 28.93 6.05 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.748 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -38.96 -33.11 0.1 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.15 0.5 . . . . 0.0 111.139 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -108.82 -34.07 6.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.071 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.739 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 4.7 t -69.3 -8.3 44.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.056 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.796 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -42.44 -30.52 0.86 Allowed Glycine 0 C--N 1.337 0.619 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.837 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.2 p -82.88 -39.98 20.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.859 0.361 . . . . 0.0 110.438 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -78.63 -3.31 43.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.407 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.87 -50.75 2.87 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.005 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.924 HD22 ' HE2' ' A' ' 91' ' ' MET . 10.2 tp -179.13 -35.28 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.708 0.29 . . . . 0.0 110.785 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.423 ' C ' HD12 ' A' ' 50' ' ' ILE . . . 113.83 31.03 2.4 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.535 -0.84 . . . . 0.0 113.271 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.798 HG12 HG23 ' A' ' 49' ' ' ILE . 27.8 m -150.07 154.0 9.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.045 0.45 . . . . 0.0 112.0 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.41 ' O ' ' HB3' ' A' ' 47' ' ' LYS . 0.9 OUTLIER -111.02 115.61 29.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.315 178.627 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.867 HG11 HD11 ' A' ' 67' ' ' LEU . 3.1 m -108.23 142.4 20.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.046 0.45 . . . . 0.0 111.9 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.567 ' HB3' HD13 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -144.67 131.17 19.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.15 179.556 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -92.01 157.82 24.48 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.478 -0.867 . . . . 0.0 113.351 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -117.33 -176.76 3.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.723 0.297 . . . . 0.0 110.693 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.21 152.15 47.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.684 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.16 139.51 52.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.102 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.22 -29.22 70.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.999 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -83.85 -70.41 0.57 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.998 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 34.2 p30 -100.78 -174.83 2.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.978 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -93.59 45.68 1.17 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.948 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.23 114.3 26.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.082 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -56.07 133.14 51.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.002 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 47.7 mt -94.34 16.94 13.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.274 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.465 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 86.99 179.14 48.87 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.367 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.918 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -103.89 136.26 37.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 120.933 0.397 . . . . 0.0 111.251 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -123.98 147.77 47.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.713 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.728 ' O ' HG13 ' A' ' 63' ' ' VAL . 43.0 t -58.33 105.04 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.796 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.462 ' HG2' HG21 ' B' ' 10' ' ' ILE . 4.0 tptt -75.88 -40.59 54.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.689 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -168.8 115.16 0.62 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.207 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.798 HG23 HG12 ' A' ' 28' ' ' VAL . 52.9 mt -81.31 118.75 29.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.206 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.52 HD12 ' N ' ' A' ' 28' ' ' VAL . 2.0 mp -59.07 104.9 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.565 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.47 76.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.037 0.446 . . . . 0.0 110.615 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 159.82 -27.35 0.35 Allowed Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.022 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.402 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -69.06 -170.03 6.46 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.473 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.791 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -68.67 -39.14 80.76 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.783 ' HB3' HG13 ' A' ' 28' ' ' VAL . . . -65.96 -46.34 78.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.158 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 40.1 p -63.38 -35.38 80.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.215 0.531 . . . . 0.0 109.878 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.0 mtpt -66.68 -32.14 73.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.816 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.24 -30.3 64.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.461 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.66 27.49 66.38 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.836 -0.62 . . . . 0.0 113.406 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.431 ' HG3' ' CD1' ' A' ' 14' ' ' PHE . 15.8 ptp180 -134.85 1.74 3.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 117.162 0.481 . . . . 0.0 111.592 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.448 ' CD2' ' CD2' ' A' ' 14' ' ' PHE . 3.4 mm? -108.85 152.19 25.24 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.9 0.381 . . . . 0.0 111.06 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.44 145.48 26.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.785 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.728 HG13 ' O ' ' A' ' 46' ' ' VAL . 60.1 t -52.96 144.32 3.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.07 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.486 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 37.9 m-20 93.37 -14.11 0.14 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.331 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -60.99 110.0 1.23 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.767 0.317 . . . . 0.0 110.726 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.435 ' HG3' ' CE2' ' A' ' 45' ' ' PHE . 11.8 tm0? -75.34 111.24 10.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.999 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.945 HD23 HG12 ' A' ' 105' ' ' VAL . 42.6 mt -61.02 136.97 58.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.003 0.43 . . . . 0.0 111.085 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 1.045 HD11 ' HB2' ' A' ' 106' ' ' ALA . 29.9 mt -119.84 -34.78 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.139 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.955 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -155.4 143.84 20.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.457 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.64 HG11 ' HA ' ' A' ' 87' ' ' LEU . 7.4 p -133.04 132.04 58.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.431 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 61.88 26.21 15.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.927 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.44 24.43 63.15 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.312 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -129.98 103.86 7.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.853 0.358 . . . . 0.0 110.82 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.6 t -57.23 141.07 47.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.888 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.474 ' HB3' ' CB ' ' A' ' 83' ' ' ALA . 0.7 OUTLIER -101.23 3.19 40.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.572 -179.753 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.2 tp -63.76 -15.79 59.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.574 0.226 . . . . 0.0 111.304 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -88.92 14.34 60.66 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.127 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.41 ' CE ' HD23 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -156.52 177.34 11.58 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.251 0.548 . . . . 0.0 111.333 179.851 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.801 ' HB3' ' OE1' ' A' ' 81' ' ' GLN . . . -81.62 174.05 11.76 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.748 -179.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.402 ' OD1' ' N ' ' A' ' 81' ' ' GLN . 7.3 p30 -60.13 -51.52 69.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.347 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.801 ' OE1' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -60.64 -38.48 84.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.873 0.368 . . . . 0.0 110.619 -179.754 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.3 -40.04 74.47 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.52 ' HB3' ' CD1' ' A' ' 44' ' ' ILE . . . -69.56 -30.91 68.81 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.873 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.638 ' SD ' HG23 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -72.58 -33.26 66.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.73 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.403 ' HG2' ' N ' ' A' ' 86' ' ' THR . 1.9 pt-20 -78.07 -30.38 49.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.114 0.483 . . . . 0.0 109.775 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.403 ' N ' ' HG2' ' A' ' 85' ' ' GLU . 1.5 m -70.65 -35.96 73.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.361 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.865 HD12 ' N ' ' A' ' 88' ' ' ARG . 4.3 pp -78.58 -34.85 46.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.401 0.62 . . . . 0.0 109.472 178.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.865 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -62.49 -51.46 67.36 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.272 179.368 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.508 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -71.82 -35.42 69.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.119 179.602 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.7 m -67.23 -35.61 79.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.926 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.924 ' HE2' HD22 ' A' ' 26' ' ' LEU . 3.5 ptp -83.92 -27.98 28.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.868 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.13 23.58 14.28 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.508 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.4 OUTLIER -155.38 -32.18 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.42 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 5.0 mt-10 -112.94 -65.49 1.18 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.916 0.389 . . . . 0.0 111.513 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.498 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -54.2 -27.57 39.56 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.575 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.54 ' HB2' HD11 ' A' ' 18' ' ' LEU . 0.7 OUTLIER -77.49 -32.79 54.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.692 0.282 . . . . 0.0 110.59 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' A' ' 93' ' ' THR . 40.6 mtpt -41.49 -40.06 1.7 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.005 0.431 . . . . 0.0 111.521 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.77 -25.24 15.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.182 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 117.33 1.55 18.3 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.788 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.499 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -158.36 142.04 15.35 Favored 'General case' 0 N--CA 1.457 -0.089 0 CA-C-O 121.07 0.462 . . . . 0.0 111.845 -179.568 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.591 HG22 HD21 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -115.62 136.25 53.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.6 179.496 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.448 ' HA ' ' O ' ' A' ' 14' ' ' PHE . 2.0 pp0? -76.55 140.85 41.26 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.718 HD11 HD21 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -134.8 112.59 10.84 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -178.715 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.955 HD12 ' HB3' ' A' ' 69' ' ' ALA . 43.1 mt -98.3 112.67 30.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.945 HG12 HD23 ' A' ' 67' ' ' LEU . 35.7 m -124.81 143.14 39.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.978 0.418 . . . . 0.0 111.462 -178.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 1.045 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -110.83 124.78 52.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.731 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.04 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.567 HD13 ' HB3' ' A' ' 31' ' ' LYS . 1.8 mm . . . . . 0 CA--C 1.518 -0.284 0 CA-C-O 121.204 0.526 . . . . 0.0 111.085 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . 0.582 HG22 HG13 ' B' ' 13' ' ' VAL . 88.9 m -71.47 99.41 2.01 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.732 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -69.51 108.02 3.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.093 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.736 HG11 ' HG3' ' A' ' 88' ' ' ARG . 30.1 m . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.65 -0.691 . . . . 0.0 110.651 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.599 ' HG3' HD21 ' A' ' 12' ' ' LEU . 24.4 pt-20 . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.721 0.296 . . . . 0.0 110.937 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.519 ' HD2' HD13 ' A' ' 68' ' ' ILE . 51.7 m-85 -81.43 151.47 27.87 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.785 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.751 HD12 HG23 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -155.02 122.39 5.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.022 0.439 . . . . 0.0 111.236 -179.836 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.419 HG23 HG12 ' A' ' 104' ' ' ILE . 6.8 m -81.46 146.24 30.34 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.209 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.456 ' N ' ' O ' ' A' ' 103' ' ' LEU . 17.6 m-85 -140.63 171.55 13.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.414 0.626 . . . . 0.0 112.243 -179.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -143.65 104.88 4.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.843 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.562 HG12 ' HB1' ' A' ' 54' ' ' ALA . 18.7 t -105.16 114.08 63.92 Favored Pre-proline 0 C--N 1.33 -0.268 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.529 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 97.8 Cg_endo -84.79 126.98 3.52 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.454 2.103 . . . . 0.0 110.849 178.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.802 HD22 ' CD1' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -121.98 28.24 7.66 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -178.672 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -39.2 -32.46 0.1 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.054 0.454 . . . . 0.0 111.205 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -108.74 -34.44 6.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.122 179.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.2 t -70.68 -6.58 38.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.288 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.755 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -42.56 -30.51 0.89 Allowed Glycine 0 C--N 1.337 0.593 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.727 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.3 p -83.01 -39.27 21.5 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.851 0.358 . . . . 0.0 110.528 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -78.61 -15.09 58.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.3 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.04 -46.37 1.39 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.645 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.802 ' CD1' HD22 ' A' ' 18' ' ' LEU . 8.2 tp 178.06 -31.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.7 0.286 . . . . 0.0 110.704 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.455 ' HA3' ' HA3' ' A' ' 53' ' ' GLY . . . 106.12 43.65 1.48 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.405 -0.903 . . . . 0.0 113.384 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.814 HG12 HG23 ' A' ' 49' ' ' ILE . 29.0 m -157.33 155.71 4.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.304 0.573 . . . . 0.0 112.073 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.74 116.91 30.85 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 19.6 m -105.93 143.34 17.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.237 0.541 . . . . 0.0 112.222 -178.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.662 ' HB2' HD13 ' B' ' 10' ' ' ILE . 0.4 OUTLIER -146.54 129.01 15.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.056 179.443 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' A' ' 44' ' ' ILE . . . -104.85 159.66 15.72 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.47 -0.871 . . . . 0.0 112.782 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -134.71 154.03 51.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.8 0.333 . . . . 0.0 110.971 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.41 ' HB3' ' HA ' ' A' ' 41' ' ' ASP . 1.1 ptp180 -109.12 154.62 22.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.097 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.534 ' N ' HD21 ' A' ' 42' ' ' LEU . 0.6 OUTLIER -40.87 151.43 0.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.439 -179.692 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.94 -56.1 11.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.101 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -59.52 -71.51 0.12 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.005 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -85.41 172.89 10.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.881 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -98.54 34.6 1.99 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.85 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.04 124.91 34.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.076 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.588 ' OD2' ' HB1' ' A' ' 79' ' ' ALA . 75.1 m-20 -59.55 139.33 57.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.964 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.534 HD21 ' N ' ' A' ' 35' ' ' SER . 16.7 mt -100.79 -29.76 12.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.887 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 146.25 -176.8 24.99 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.296 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.825 HG21 ' HB3' ' A' ' 84' ' ' MET . 0.0 OUTLIER -105.98 140.12 25.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.675 0.274 . . . . 0.0 110.67 179.837 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -127.09 139.37 53.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.445 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.732 ' O ' HG13 ' A' ' 63' ' ' VAL . 53.2 t -58.03 106.5 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.166 179.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.535 ' HG2' HD12 ' B' ' 10' ' ' ILE . 9.7 tptp -76.08 -40.87 52.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.879 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.3 t -168.06 122.23 0.94 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.028 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.814 HG23 HG12 ' A' ' 28' ' ' VAL . 69.6 mt -88.59 123.02 40.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.19 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.443 HD13 ' HA2' ' A' ' 27' ' ' GLY . 1.8 mp -60.61 109.63 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.221 179.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.82 72.49 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.074 0.464 . . . . 0.0 110.963 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 163.36 -25.85 0.21 Allowed Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.383 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.455 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -71.19 -167.4 7.77 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.574 -0.822 . . . . 0.0 113.018 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.562 ' HB1' HG12 ' A' ' 16' ' ' VAL . . . -65.41 -42.98 91.98 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.305 0.484 . . . . 0.0 112.305 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.577 ' CB ' HD13 ' A' ' 61' ' ' LEU . . . -64.52 -44.65 90.18 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.582 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.561 ' OG ' HG22 ' A' ' 49' ' ' ILE . 1.4 m -67.44 -29.95 69.56 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.289 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.3 mtpt -78.53 -30.84 47.22 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.293 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.86 -30.72 58.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.711 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.71 19.3 77.91 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.757 -0.735 . . . . 0.0 113.147 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.413 ' HG3' ' CD1' ' A' ' 14' ' ' PHE . 2.6 ptp180 -142.68 17.66 2.0 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.892 0.346 . . . . 0.0 110.997 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.699 ' HB3' HD13 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -114.34 130.75 56.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.638 179.713 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.51 142.56 37.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.116 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.732 HG13 ' O ' ' A' ' 46' ' ' VAL . 59.3 t -53.65 152.35 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.064 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.6 ' HB2' ' O ' ' A' ' 63' ' ' VAL . 9.1 m-80 78.27 13.78 1.52 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.498 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.447 ' O ' HG23 ' A' ' 46' ' ' VAL . 0.8 OUTLIER -91.71 114.31 26.81 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.024 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.421 ' O ' ' HA ' ' A' ' 105' ' ' VAL . 12.7 tm0? -71.31 140.41 50.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.008 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.992 HD23 HG12 ' A' ' 105' ' ' VAL . 18.7 mt -98.13 131.76 44.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.122 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.635 ' O ' HD12 ' A' ' 75' ' ' LEU . 2.1 mp -116.15 -45.15 3.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.898 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 1.004 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -137.44 149.85 47.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.25 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.704 HG11 ' HA ' ' A' ' 87' ' ' LEU . 7.1 p -140.91 123.22 15.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.605 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.617 HD22 HG22 ' A' ' 70' ' ' VAL . 66.2 m-80 66.22 11.23 7.74 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.521 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 109.23 -18.28 30.84 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.831 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -94.05 117.29 29.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.919 0.39 . . . . 0.0 111.151 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.71 139.65 39.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.651 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.635 HD12 ' O ' ' A' ' 68' ' ' ILE . 0.1 OUTLIER -118.29 13.13 13.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.419 -179.835 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.438 HD13 HG23 ' A' ' 68' ' ' ILE . 3.1 tp -60.95 -20.88 62.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.654 0.264 . . . . 0.0 111.246 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -85.36 -24.87 41.72 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.91 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.427 ' HE2' ' HB3' ' A' ' 78' ' ' LYS . 5.6 ptpt -98.16 157.29 16.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.307 0.575 . . . . 0.0 111.305 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.588 ' HB1' ' OD2' ' A' ' 41' ' ' ASP . . . -57.33 166.47 1.18 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.253 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.42 ' OD1' ' N ' ' A' ' 81' ' ' GLN . 22.7 p30 -63.12 -38.97 93.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.095 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.564 HE21 ' HB3' ' A' ' 79' ' ' ALA . 2.4 pp0? -67.18 -41.93 85.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.184 0.516 . . . . 0.0 110.469 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.4 ' HB3' ' HD3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -70.94 -35.14 72.08 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.689 179.093 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.598 ' HB3' ' CD1' ' A' ' 44' ' ' ILE . . . -69.12 -46.51 67.48 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.581 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.825 ' HB3' HG21 ' A' ' 44' ' ' ILE . 4.4 ptp -62.47 -30.99 71.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.98 179.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.11 -33.91 56.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.727 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.403 ' HA ' ' HD2' ' A' ' 89' ' ' ARG . 1.3 m -69.81 -36.06 75.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.367 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.808 HD22 HD13 ' A' ' 67' ' ' LEU . 3.7 pp -78.4 -33.91 48.47 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.555 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -59.19 -49.98 75.79 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.342 179.108 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.442 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.85 -37.21 67.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.456 179.648 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.6 t -70.93 -29.36 65.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.399 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.774 ' HE2' HD22 ' A' ' 26' ' ' LEU . 4.5 ptm -89.07 -22.75 22.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.64 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.0 21.92 14.39 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.493 ' O ' ' HG3' ' A' ' 97' ' ' LYS . 0.4 OUTLIER -154.23 -35.21 0.1 Allowed 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.757 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.411 ' HG3' HG22 ' A' ' 93' ' ' THR . 3.7 mt-10 -111.86 -39.33 4.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.84 0.352 . . . . 0.0 111.362 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.476 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -70.94 -30.8 67.53 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.9 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.723 ' HB2' HD11 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -76.97 -34.09 57.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.787 0.327 . . . . 0.0 110.262 179.609 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.493 ' HG3' ' O ' ' A' ' 93' ' ' THR . 46.2 mtpt -39.94 -45.77 1.92 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.79 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.37 -22.98 18.61 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.838 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 115.35 0.11 22.15 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.824 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.473 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -163.82 142.61 7.76 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.992 0.425 . . . . 0.0 111.193 -179.83 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.54 HG22 HD21 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -112.12 142.69 23.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.326 -179.753 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.62 147.63 37.45 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.456 ' O ' ' N ' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -143.39 110.46 5.68 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -178.729 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 1.004 HD12 ' HB3' ' A' ' 69' ' ' ALA . 57.4 mt -101.36 112.54 34.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 177.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.992 HG12 HD23 ' A' ' 67' ' ' LEU . 35.3 m -123.64 157.54 29.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.092 0.472 . . . . 0.0 112.091 -178.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.606 ' CB ' HD11 ' A' ' 68' ' ' ILE . . . -129.4 122.81 30.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.373 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.41 0 CA-C-O 120.953 0.406 . . . . 0.0 111.21 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.662 HD13 ' HB2' ' A' ' 31' ' ' LYS . 1.6 mm . . . . . 0 CA--C 1.519 -0.218 0 CA-C-O 121.165 0.507 . . . . 0.0 111.228 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 99.0 m -77.61 102.47 7.03 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.356 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 1.3 tptp -68.78 122.33 18.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.293 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 18.3 m . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.559 -0.734 . . . . 0.0 110.758 179.748 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.896 0.379 . . . . 0.0 111.094 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -92.05 148.37 22.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.572 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.637 HD12 HG23 ' A' ' 105' ' ' VAL . 0.3 OUTLIER -134.7 109.88 8.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.069 0.461 . . . . 0.0 111.229 -179.645 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.534 HG23 ' OE1' ' A' ' 102' ' ' GLN . 94.4 m -92.24 124.63 36.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.127 179.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.451 ' CG ' ' HB3' ' A' ' 60' ' ' ARG . 25.1 m-85 -134.83 151.36 50.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.358 0.599 . . . . 0.0 112.103 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.486 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.4 OUTLIER -111.98 110.67 21.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.097 178.948 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.749 ' CG2' HD11 ' A' ' 61' ' ' LEU . 11.7 t -100.33 116.52 64.33 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -177.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.735 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 84.6 Cg_endo -87.22 127.88 2.56 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.784 2.323 . . . . 0.0 111.086 178.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.861 HD22 HD13 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -127.49 28.49 5.66 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -178.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -39.08 -33.27 0.12 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.151 0.5 . . . . 0.0 111.179 179.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -108.04 -33.76 7.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.072 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.697 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 7.2 t -70.67 -6.82 39.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.141 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.806 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -41.61 -31.35 0.69 Allowed Glycine 0 C--N 1.338 0.653 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.789 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.3 p -82.52 -41.75 19.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.888 0.375 . . . . 0.0 110.386 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -77.5 -4.66 46.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.458 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.18 -50.16 3.32 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.867 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.943 HD22 ' HE2' ' A' ' 91' ' ' MET . 9.9 tp 179.87 -33.0 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.722 0.296 . . . . 0.0 110.635 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.448 ' HA3' ' HA3' ' A' ' 53' ' ' GLY . . . 109.1 44.04 1.13 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.5 -0.857 . . . . 0.0 113.426 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.73 HG12 HG23 ' A' ' 49' ' ' ILE . 20.8 m -157.56 173.79 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.146 0.498 . . . . 0.0 112.077 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.422 ' O ' ' N ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -134.25 117.09 16.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.312 178.907 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.7 HG11 HD11 ' A' ' 67' ' ' LEU . 3.4 m -109.55 149.48 12.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.009 0.433 . . . . 0.0 111.937 -178.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.427 ' O ' ' HG3' ' A' ' 31' ' ' LYS . 13.5 ptmt -143.63 133.47 23.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.595 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.44 ' HA2' ' HA ' ' A' ' 44' ' ' ILE . . . -95.15 150.94 19.86 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.919 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -112.16 165.69 11.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.813 0.339 . . . . 0.0 110.894 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -128.84 140.52 51.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.629 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.2 123.41 13.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.921 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.05 -32.56 74.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.955 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -75.31 -31.52 60.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.962 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -149.03 136.55 20.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.708 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -61.45 83.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.948 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.95 126.96 12.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.844 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -50.89 145.69 6.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.222 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 43.9 mt -111.34 -23.2 10.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.801 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.421 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 132.03 162.98 10.6 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.354 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.935 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -98.69 136.22 30.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.059 0.457 . . . . 0.0 111.163 -179.866 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -123.69 147.16 47.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.663 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.668 ' O ' HG13 ' A' ' 63' ' ' VAL . 35.0 t -60.3 104.59 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 29' ' ' SER . 24.5 tptt -72.25 -44.12 63.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.516 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 m -166.22 128.45 1.9 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.813 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.73 HG23 HG12 ' A' ' 28' ' ' VAL . 73.4 mt -94.03 121.61 44.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.145 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.585 HD12 ' N ' ' A' ' 28' ' ' VAL . 1.6 mp -58.71 113.59 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.406 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -68.12 74.25 0.21 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.682 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 159.89 -27.22 0.34 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.112 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.448 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -69.12 -171.91 7.84 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.601 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.735 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -64.12 -40.54 96.41 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.187 0.439 . . . . 0.0 112.187 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.645 ' HA ' HD13 ' A' ' 61' ' ' LEU . . . -61.57 -51.13 69.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.321 -179.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.8 t -63.43 -30.09 71.27 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.104 0.478 . . . . 0.0 109.807 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.0 mtpt -74.86 -35.01 62.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.738 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -58.9 -27.12 64.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.774 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 63.3 25.25 68.23 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.57 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.451 ' HB3' ' CG ' ' A' ' 14' ' ' PHE . 19.4 mtm180 -127.44 -29.3 2.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.693 0.283 . . . . 0.0 111.224 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.749 HD11 ' CG2' ' A' ' 16' ' ' VAL . 2.3 mp -74.13 143.19 45.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.117 0.484 . . . . 0.0 111.291 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.41 ' NH2' HD13 ' A' ' 12' ' ' LEU . 0.1 OUTLIER -144.83 134.83 23.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.313 179.84 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.668 HG13 ' O ' ' A' ' 46' ' ' VAL . 58.1 t -53.68 143.05 6.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.587 -0.278 . . . . 0.0 110.908 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 30.5 m-20 89.7 -8.88 0.39 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.073 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -63.11 110.21 1.76 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.854 0.359 . . . . 0.0 110.725 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.402 ' NE2' ' O ' ' A' ' 67' ' ' LEU . 20.7 tm0? -74.28 112.93 10.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.915 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.935 HD12 HG13 ' A' ' 44' ' ' ILE . 45.7 mt -66.84 146.44 54.42 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.044 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.735 HD11 ' CB ' ' A' ' 106' ' ' ALA . 52.9 mt -135.77 -42.67 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.277 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.878 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -146.0 126.04 13.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.067 0.461 . . . . 0.0 111.621 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.706 HG22 HD22 ' A' ' 71' ' ' ASN . 11.4 p -118.56 127.55 75.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.152 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.706 HD22 HG22 ' A' ' 70' ' ' VAL . 2.3 m-80 62.0 35.1 16.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.959 0.409 . . . . 0.0 110.293 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 68.64 24.1 75.38 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.166 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -126.34 98.11 5.32 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.73 0.3 . . . . 0.0 110.822 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.0 t -60.81 136.95 58.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.815 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.62 HD22 ' HB1' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -98.38 12.53 34.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.309 -179.851 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 12.8 mt -63.89 -23.52 67.38 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.72 0.295 . . . . 0.0 111.011 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -93.05 21.16 41.41 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.736 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -150.73 167.02 28.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.176 0.512 . . . . 0.0 111.052 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.566 ' HB3' HE22 ' A' ' 81' ' ' GLN . . . -78.25 175.71 9.95 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.174 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -61.73 -55.83 26.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.239 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.566 HE22 ' HB3' ' A' ' 79' ' ' ALA . 4.8 pm0 -53.9 -38.94 65.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.009 0.433 . . . . 0.0 111.222 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.62 -37.4 73.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.22 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.62 ' HB1' HD22 ' A' ' 75' ' ' LEU . . . -68.96 -47.6 65.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.821 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.475 ' HA ' ' CD2' ' A' ' 87' ' ' LEU . 9.1 ptp -62.88 -30.08 71.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.295 -0.412 . . . . 0.0 109.945 179.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -79.12 -35.66 41.83 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 178.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.8 m -67.68 -35.84 79.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.194 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.745 HD12 ' N ' ' A' ' 88' ' ' ARG . 4.4 pp -78.22 -33.88 49.64 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 178.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.745 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -56.17 -50.05 72.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.007 178.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.705 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.35 -49.74 31.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.313 178.734 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.431 ' HB3' ' ND2' ' A' ' 71' ' ' ASN . 1.4 m -54.75 -29.38 53.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.602 179.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.943 ' HE2' HD22 ' A' ' 26' ' ' LEU . 1.5 ptp -89.98 -37.85 14.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.306 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.21 37.91 2.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.988 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.705 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 72.3 m -162.56 -41.48 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.566 -0.454 . . . . 0.0 112.214 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -111.62 -48.58 3.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.058 0.456 . . . . 0.0 110.777 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.454 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -69.74 -20.45 75.86 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.146 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.526 ' HB2' HD11 ' A' ' 18' ' ' LEU . 0.7 OUTLIER -83.09 -32.26 26.85 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.653 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -40.8 -35.88 0.55 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.383 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.25 -30.72 11.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.69 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 125.93 -6.14 7.83 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.689 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.491 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -153.97 143.64 21.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.983 0.42 . . . . 0.0 111.147 -179.924 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.617 HG22 HD21 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -109.42 147.14 14.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.452 -179.707 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.534 ' OE1' HG23 ' A' ' 13' ' ' THR . 0.0 OUTLIER -79.47 143.47 34.92 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.714 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.473 HD12 HG23 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -138.65 148.22 43.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.125 0.488 . . . . 0.0 111.902 -179.072 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.878 HD12 ' HB3' ' A' ' 69' ' ' ALA . 68.9 mt -144.63 113.33 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.047 179.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.931 HG12 HD23 ' A' ' 67' ' ' LEU . 30.0 m -124.3 179.32 2.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.468 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.735 ' CB ' HD11 ' A' ' 68' ' ' ILE . . . -147.75 139.89 24.28 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.93 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.625 ' CG ' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.997 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.411 HD12 ' HD3' ' A' ' 47' ' ' LYS . 2.1 mm . . . . . 0 N--CA 1.453 -0.309 0 CA-C-O 121.038 0.446 . . . . 0.0 111.156 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . 0.8 HG22 HG13 ' B' ' 13' ' ' VAL . 55.2 m -123.41 104.36 9.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.568 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.67 102.84 5.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.026 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.8 HG13 HG22 ' B' ' 11' ' ' THR . 35.2 m . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.936 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.031 0 CA-C-O 121.005 0.431 . . . . 0.0 111.291 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -104.07 145.32 30.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.413 179.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 1.093 HD12 HG23 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -134.32 119.58 18.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.025 0.44 . . . . 0.0 111.301 -179.676 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.409 ' O ' ' CD1' ' A' ' 14' ' ' PHE . 90.0 m -86.68 143.02 27.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.975 179.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.417 ' CE1' ' HG2' ' A' ' 60' ' ' ARG . 24.9 m-85 -139.59 169.41 17.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.286 0.565 . . . . 0.0 112.158 -179.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -139.52 107.54 5.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.173 -0.921 . . . . 0.0 108.923 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.7 HG21 HD11 ' A' ' 61' ' ' LEU . 17.6 t -104.28 111.43 65.17 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -177.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.785 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 84.6 Cg_endo -81.72 127.71 5.71 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.441 2.094 . . . . 0.0 110.794 178.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.828 HD22 HD13 ' A' ' 26' ' ' LEU . 0.5 OUTLIER -125.44 29.15 6.1 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.595 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -39.56 -32.75 0.14 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.112 0.482 . . . . 0.0 111.245 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -109.18 -35.26 6.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.105 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.704 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 9.9 t -67.83 -9.65 46.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.099 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.731 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -43.01 -29.76 0.92 Allowed Glycine 0 C--N 1.339 0.713 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.808 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.3 m -82.58 -39.09 22.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.884 0.373 . . . . 0.0 110.572 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -78.28 -20.85 50.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.197 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.29 -50.31 0.78 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.833 -0.698 . . . . 0.0 111.507 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.828 HD13 HD22 ' A' ' 18' ' ' LEU . 10.9 tp 179.0 -32.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.56 0.219 . . . . 0.0 110.836 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.453 ' HA3' ' HA3' ' A' ' 53' ' ' GLY . . . 110.79 37.74 1.67 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.342 -0.932 . . . . 0.0 113.171 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.744 HG12 HG23 ' A' ' 49' ' ' ILE . 14.4 m -156.51 164.37 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.229 0.538 . . . . 0.0 111.957 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.405 ' O ' ' HB3' ' A' ' 47' ' ' LYS . 2.0 m -123.73 115.18 20.97 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.17 178.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.561 HG11 HD11 ' A' ' 67' ' ' LEU . 4.5 m -106.75 141.12 22.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.089 0.471 . . . . 0.0 111.93 -178.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.522 ' CB ' HD13 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -145.53 131.28 19.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.101 179.452 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 44' ' ' ILE . . . -102.25 162.36 17.0 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.442 -0.885 . . . . 0.0 113.052 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -135.94 156.58 48.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.949 0.404 . . . . 0.0 111.019 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.467 ' HD2' ' HA ' ' A' ' 39' ' ' HIS . 0.0 OUTLIER -108.87 152.28 25.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.736 179.972 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.593 ' CB ' HD21 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -50.11 137.58 17.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.983 179.954 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.19 -23.81 65.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.494 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -71.14 -51.02 27.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.079 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -135.34 160.29 38.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.838 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.467 ' HA ' ' HD2' ' A' ' 34' ' ' ARG . 74.5 m-70 -70.39 66.0 0.3 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.87 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -126.17 121.34 32.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.172 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.411 ' CB ' ' ND2' ' A' ' 80' ' ' ASN . 3.4 p-10 -53.39 145.21 14.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.383 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.593 HD21 ' CB ' ' A' ' 35' ' ' SER . 32.4 mt -109.71 -29.83 8.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.47 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.416 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 142.12 -178.58 20.67 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.995 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.827 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -108.05 140.56 26.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.965 0.412 . . . . 0.0 111.219 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -128.6 142.3 51.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.708 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.58 ' O ' HG13 ' A' ' 63' ' ' VAL . 40.0 t -57.58 104.33 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.784 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' A' ' 29' ' ' SER . 36.4 tptt -72.66 -42.91 63.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.801 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.47 129.62 1.61 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.084 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.744 HG23 HG12 ' A' ' 28' ' ' VAL . 78.0 mt -95.16 118.31 41.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.212 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.564 HD12 ' N ' ' A' ' 28' ' ' VAL . 1.8 mp -55.03 107.09 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.619 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.52 77.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.112 0.482 . . . . 0.0 110.593 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 155.27 -26.21 0.61 Allowed Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.872 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.453 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -67.73 -172.41 6.27 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.621 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.785 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -64.76 -39.35 93.47 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.684 ' HB1' HD13 ' A' ' 61' ' ' LEU . . . -64.79 -48.66 73.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.269 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 60.1 p -63.03 -31.51 72.67 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.864 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 34.6 mtpt -75.23 -34.43 61.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.911 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -59.53 -27.65 66.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.741 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.47 40.0 95.62 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.662 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.417 ' HG2' ' CE1' ' A' ' 14' ' ' PHE . 4.5 mtm180 -134.88 -40.96 0.76 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.857 0.361 . . . . 0.0 110.913 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.7 HD11 HG21 ' A' ' 16' ' ' VAL . 3.7 mp -58.22 166.89 1.47 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.294 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.6 mtm105 -162.15 118.78 2.04 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.301 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.58 HG13 ' O ' ' A' ' 46' ' ' VAL . 34.1 t -47.98 143.12 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.385 -179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.427 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 22.3 m-80 85.76 -5.36 0.83 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.326 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.15 127.41 32.53 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.754 0.311 . . . . 0.0 110.388 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.412 ' NE2' ' HA3' ' A' ' 43' ' ' GLY . 0.8 OUTLIER -79.66 136.37 36.79 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.678 -179.631 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.852 HD23 HG12 ' A' ' 105' ' ' VAL . 49.7 mt -89.0 133.04 34.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.274 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.8 mm -116.8 -30.09 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.994 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.831 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -159.86 159.02 32.0 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.06 0.457 . . . . 0.0 111.203 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.803 HG22 ' ND2' ' A' ' 71' ' ' ASN . 8.0 p -145.74 125.07 5.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.416 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.803 ' ND2' HG22 ' A' ' 70' ' ' VAL . 66.7 m-80 61.17 18.22 8.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.922 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.75 25.36 23.02 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.114 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -124.65 101.06 6.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.736 0.303 . . . . 0.0 110.692 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.5 p -62.67 138.26 58.46 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.018 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -104.39 -16.27 15.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.239 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.5 tp -55.27 89.72 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.913 0.387 . . . . 0.0 111.13 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 156.7 -27.92 0.53 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.294 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.47 ' HD3' ' HB3' ' A' ' 82' ' ' GLU . 0.5 OUTLIER -106.63 159.54 16.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.253 0.549 . . . . 0.0 111.048 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.13 158.0 12.08 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.135 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.411 ' ND2' ' CB ' ' A' ' 41' ' ' ASP . 26.7 m-80 -51.18 -57.38 8.91 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.164 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.429 ' NE2' ' CG ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -51.65 -37.72 51.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.562 -179.47 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.47 ' HB3' ' HD3' ' A' ' 78' ' ' LYS . 1.9 mt-10 -70.92 -40.9 71.83 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.055 0.455 . . . . 0.0 110.331 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.521 ' HB3' ' CD1' ' A' ' 44' ' ' ILE . . . -66.53 -50.07 64.41 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.835 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.575 ' HB3' HG21 ' A' ' 44' ' ' ILE . 5.6 ptp -60.92 -29.65 69.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.062 179.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -76.98 -33.73 57.61 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.4 m -67.95 -36.88 80.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.224 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.692 HD12 ' N ' ' A' ' 88' ' ' ARG . 4.4 pp -78.43 -33.36 48.59 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.692 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -58.1 -49.03 78.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.262 178.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.529 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -73.15 -44.29 60.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.065 179.293 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.7 t -62.9 -29.8 71.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.178 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.768 ' HE2' HD22 ' A' ' 26' ' ' LEU . 3.3 ptm -89.81 -25.25 21.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.701 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.21 31.72 6.55 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.529 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.3 OUTLIER -164.25 -33.31 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 179.849 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.409 ' HG3' HG22 ' A' ' 93' ' ' THR . 7.7 mt-10 -111.09 -69.04 0.89 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.803 0.335 . . . . 0.0 111.37 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.427 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -48.8 -27.44 6.36 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.604 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.714 ' HB2' HD11 ' A' ' 18' ' ' LEU . 0.7 OUTLIER -76.41 -33.13 58.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.626 0.25 . . . . 0.0 110.434 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 94' ' ' GLU . 38.0 mtpt -39.62 -41.51 1.06 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.066 0.46 . . . . 0.0 111.373 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.63 -26.99 15.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.061 179.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 120.5 -3.51 12.26 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.883 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.457 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.3 OUTLIER -154.0 141.32 19.61 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.89 0.376 . . . . 0.0 111.412 -179.628 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.571 HG22 HD21 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -110.27 141.69 24.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.036 179.82 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.61 150.47 36.45 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.514 HD12 HG23 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -144.24 112.01 6.18 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.831 HD12 ' HB3' ' A' ' 69' ' ' ALA . 76.4 mt -103.39 113.27 39.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 1.093 HG23 HD12 ' A' ' 12' ' ' LEU . 16.9 m -120.99 174.99 5.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.857 0.36 . . . . 0.0 111.542 -179.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -147.36 142.82 27.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.206 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.475 ' HD2' HD21 ' A' ' 12' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.783 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.522 HD13 ' CB ' ' A' ' 31' ' ' LYS . 1.4 mm . . . . . 0 N--CA 1.454 -0.248 0 CA-C-O 121.185 0.516 . . . . 0.0 111.226 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 28.0 m -94.84 109.61 21.58 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.644 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 7.0 tppt? -70.99 126.72 30.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.095 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.551 HG11 ' HG3' ' A' ' 88' ' ' ARG . 4.1 m . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.554 -0.736 . . . . 0.0 110.862 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.801 0.334 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -86.96 147.5 25.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.891 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.994 HD12 HG23 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -137.77 110.46 7.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.204 -179.656 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 71.2 m -103.89 128.03 51.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.489 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -140.95 172.65 12.38 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 121.354 0.597 . . . . 0.0 112.341 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.404 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.5 OUTLIER -127.8 111.19 13.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.853 179.26 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.845 HG13 ' OD1' ' A' ' 58' ' ' ASP . 66.5 t -103.99 113.66 65.16 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -177.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.624 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 83.3 Cg_endo -84.13 127.58 4.06 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.373 2.049 . . . . 0.0 110.748 177.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.882 HD22 ' CD1' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -122.54 30.05 6.66 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -178.628 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -36.94 -33.87 0.06 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.172 0.511 . . . . 0.0 111.291 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -111.57 -34.47 6.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.16 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.503 ' HB2' ' HB2' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -66.26 -13.83 61.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.943 179.761 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.743 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -45.97 -28.01 2.69 Favored Glycine 0 C--N 1.337 0.608 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.78 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.33 -36.02 27.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.847 0.356 . . . . 0.0 110.78 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -82.64 -24.43 33.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.253 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.78 -54.59 0.64 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.932 -0.652 . . . . 0.0 111.481 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.986 HD22 ' HE2' ' A' ' 91' ' ' MET . 10.0 tp 179.41 -35.3 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.616 0.246 . . . . 0.0 110.893 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 50' ' ' ILE . . . 117.28 32.69 1.45 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.296 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.775 HG11 HD22 ' A' ' 61' ' ' LEU . 33.4 m -157.88 157.04 3.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.121 0.486 . . . . 0.0 111.897 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.92 116.05 26.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.431 178.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.958 HG11 HD11 ' A' ' 67' ' ' LEU . 3.9 m -106.76 142.64 19.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.014 0.435 . . . . 0.0 111.691 -179.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.584 ' HB3' HD13 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -139.5 135.18 33.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.617 179.821 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.501 ' HA3' ' HB2' ' A' ' 80' ' ' ASN . . . -89.73 152.42 22.43 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.013 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.44 ' ND2' ' CE1' ' A' ' 45' ' ' PHE . 91.2 m-20 -120.77 163.74 17.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.757 0.313 . . . . 0.0 110.873 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -116.44 151.76 35.38 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.752 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.606 ' HA ' HD21 ' A' ' 42' ' ' LEU . 0.9 OUTLIER -51.97 167.71 0.11 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.207 -179.909 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.11 -56.13 11.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.105 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -116.93 -38.22 3.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.031 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -55.06 -24.35 24.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.202 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 60.68 32.8 20.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.002 0.43 . . . . 0.0 110.737 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -107.87 135.43 49.28 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.009 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -58.17 122.3 12.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.809 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.606 HD21 ' HA ' ' A' ' 35' ' ' SER . 16.0 mt -82.66 -30.23 29.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.2 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.481 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 140.99 177.85 16.68 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.017 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.849 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -99.79 134.13 40.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.951 0.405 . . . . 0.0 111.297 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.468 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -123.15 143.29 50.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.54 -179.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.623 ' O ' HG13 ' A' ' 63' ' ' VAL . 42.6 t -55.78 104.52 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.856 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.548 ' HD3' HD12 ' B' ' 10' ' ' ILE . 6.3 tptp -74.05 -42.17 60.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.644 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.42 125.57 1.53 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.949 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.723 HG23 HG12 ' A' ' 28' ' ' VAL . 69.8 mt -89.94 120.77 39.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.275 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.64 HD12 ' N ' ' A' ' 28' ' ' VAL . 2.1 mp -61.88 108.87 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.794 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -66.68 74.24 0.1 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.926 0.393 . . . . 0.0 110.399 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 164.47 -28.04 0.21 Allowed Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.119 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.15 -176.33 23.28 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.601 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.624 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -61.27 -41.15 96.43 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.809 ' HB1' HD13 ' A' ' 61' ' ' LEU . . . -64.76 -48.0 76.16 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.9 0.381 . . . . 0.0 111.58 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.464 ' HB2' HG22 ' A' ' 49' ' ' ILE . 5.6 t -63.36 -29.06 70.43 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.219 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 32.4 mtpt -75.1 -28.99 60.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.933 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.845 ' OD1' HG13 ' A' ' 16' ' ' VAL . 1.2 m-20 -63.31 -26.99 69.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.016 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.11 20.24 57.89 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.282 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.9 mtm180 -118.52 -28.28 5.73 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.909 0.385 . . . . 0.0 110.791 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.809 HD13 ' HB1' ' A' ' 55' ' ' ALA . 0.6 OUTLIER -68.94 149.81 48.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.1 0.476 . . . . 0.0 111.271 -179.735 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.645 HH21 HD22 ' A' ' 12' ' ' LEU . 76.1 mtm-85 -146.98 128.64 15.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.722 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.623 HG13 ' O ' ' A' ' 46' ' ' VAL . 46.6 t -55.39 143.91 7.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.042 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.438 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 19.2 m-20 85.21 10.37 0.31 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.136 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -88.67 115.79 26.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.822 0.344 . . . . 0.0 110.402 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 10.9 tm0? -75.31 123.28 25.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.9 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.958 HD11 HG11 ' A' ' 30' ' ' VAL . 9.4 mt -75.28 133.86 41.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.24 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.905 HD11 ' HB2' ' A' ' 106' ' ' ALA . 18.3 mt -114.47 -28.02 2.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.281 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.855 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -158.4 166.47 32.16 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.104 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.685 HG11 ' HA ' ' A' ' 87' ' ' LEU . 12.0 p -154.05 126.07 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.009 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.597 ' ND2' HG22 ' A' ' 70' ' ' VAL . 68.6 m-80 58.69 20.17 7.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.051 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.35 28.05 18.46 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.957 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 70' ' ' VAL . 0.4 OUTLIER -128.5 101.48 6.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.841 0.353 . . . . 0.0 110.747 -179.638 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.1 t -66.81 133.26 49.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.816 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.595 HD22 ' HA ' ' A' ' 83' ' ' ALA . 0.9 OUTLIER -93.8 -11.32 31.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.297 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.1 mt -54.01 91.52 0.01 OUTLIER 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.82 0.343 . . . . 0.0 111.118 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 151.21 -29.21 0.98 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.884 -0.675 . . . . 0.0 112.259 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.474 ' HD3' ' HB3' ' A' ' 82' ' ' GLU . 5.5 ptpp? -104.29 152.2 22.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.193 0.521 . . . . 0.0 110.943 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.85 149.73 6.05 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.108 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.501 ' HB2' ' HA3' ' A' ' 32' ' ' GLY . 25.1 p30 -52.8 -30.4 33.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.222 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.466 ' HA ' ' HG2' ' A' ' 84' ' ' MET . 1.1 pp0? -73.9 -38.28 64.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.274 0.559 . . . . 0.0 110.328 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.474 ' HB3' ' HD3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -70.23 -33.82 72.13 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.739 179.13 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.595 ' HA ' HD22 ' A' ' 75' ' ' LEU . . . -69.2 -44.96 71.07 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.77 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.677 ' HB3' HG21 ' A' ' 44' ' ' ILE . 6.1 ptp -63.53 -30.83 71.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.304 -0.407 . . . . 0.0 109.992 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -78.17 -32.98 50.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.518 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.55 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 1.9 m -69.81 -35.09 74.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.541 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.854 HD12 ' N ' ' A' ' 88' ' ' ARG . 4.2 pp -78.01 -34.22 50.82 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.854 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -61.01 -51.11 70.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.926 -1.033 . . . . 0.0 110.964 179.464 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.55 ' HD3' ' O ' ' A' ' 86' ' ' THR . 0.0 OUTLIER -72.25 -33.39 67.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.373 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.445 ' OG ' ' HA ' ' A' ' 87' ' ' LEU . 66.6 p -71.95 -29.84 64.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.991 0.424 . . . . 0.0 110.49 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.986 ' HE2' HD22 ' A' ' 26' ' ' LEU . 2.9 ptp -85.42 -23.07 28.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.358 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.3 m -117.42 27.01 9.34 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.511 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.4 OUTLIER -156.81 -31.64 0.09 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.905 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.412 ' HG3' HG22 ' A' ' 93' ' ' THR . 7.0 mt-10 -115.98 -45.93 2.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.887 0.375 . . . . 0.0 111.518 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.496 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -72.23 -32.6 62.6 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.844 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.592 ' HB2' HD11 ' A' ' 18' ' ' LEU . 0.8 OUTLIER -73.32 -32.83 64.82 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.577 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' A' ' 93' ' ' THR . 47.5 mtpt -41.12 -41.44 1.76 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.263 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.2 -27.58 16.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.688 178.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.542 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 115.77 0.82 21.39 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.696 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.531 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.2 OUTLIER -153.89 140.59 19.0 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 120.986 0.422 . . . . 0.0 111.429 -179.627 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.731 HD11 HD11 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -113.29 144.15 21.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.733 179.615 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.559 ' O ' HD13 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -83.51 142.3 31.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.04 179.266 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.731 HD11 HD11 ' A' ' 101' ' ' ILE . 2.9 mm? -131.25 136.09 47.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.98 0.419 . . . . 0.0 111.848 -179.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.855 HD12 ' HB3' ' A' ' 69' ' ' ALA . 73.4 mt -128.56 112.89 27.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.325 178.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.994 HG23 HD12 ' A' ' 12' ' ' LEU . 27.0 m -127.16 173.58 12.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.133 0.492 . . . . 0.0 111.441 -178.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.905 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -147.45 128.09 14.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.263 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.718 ' HG3' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 120.977 0.418 . . . . 0.0 111.25 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.584 HD13 ' HB3' ' A' ' 31' ' ' LYS . 3.2 mm . . . . . 0 CA--C 1.521 -0.147 0 CA-C-O 121.206 0.527 . . . . 0.0 111.006 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 92.1 m -73.16 99.51 2.84 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.852 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.1 110.75 14.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.922 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.738 HG11 ' CG ' ' A' ' 88' ' ' ARG . 15.7 m . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.343 -0.837 . . . . 0.0 111.039 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 . . . . . 0 C--O 1.233 0.189 0 CA-C-O 120.905 0.383 . . . . 0.0 111.281 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -91.75 150.31 21.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.521 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.763 HD12 HG23 ' A' ' 105' ' ' VAL . 0.5 OUTLIER -139.16 113.08 8.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.908 0.385 . . . . 0.0 111.62 -179.42 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.485 HG23 ' OE1' ' A' ' 102' ' ' GLN . 98.4 m -98.86 133.57 42.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.778 178.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 102' ' ' GLN . 52.0 m-85 -141.55 172.69 12.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.118 0.485 . . . . 0.0 111.939 -179.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.448 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.6 OUTLIER -128.53 109.51 11.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.547 179.272 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.907 HG23 HD23 ' A' ' 103' ' ' LEU . 34.2 t -104.55 109.21 62.5 Favored Pre-proline 0 C--N 1.33 -0.246 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.75 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 83.5 Cg_endo -81.48 127.64 5.85 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.418 2.079 . . . . 0.0 110.762 178.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.823 HD22 ' CD1' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -121.22 29.07 7.48 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -178.849 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -37.84 -31.4 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.366 179.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -112.95 -33.77 5.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.26 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.655 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 25.9 t -69.77 -9.87 56.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.209 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.755 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -45.57 -28.51 2.46 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.795 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.53 -35.12 25.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.85 0.357 . . . . 0.0 110.698 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -82.51 -24.45 34.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.129 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.44 -51.98 0.71 Allowed Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.931 HD22 ' HE2' ' A' ' 91' ' ' MET . 10.5 tp 179.45 -35.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.658 0.266 . . . . 0.0 110.633 179.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.409 ' O ' ' N ' ' A' ' 50' ' ' ILE . . . 116.26 34.46 1.33 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.473 -0.87 . . . . 0.0 113.232 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.778 HG11 HD22 ' A' ' 61' ' ' LEU . 33.1 m -157.22 157.02 3.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 117.153 0.477 . . . . 0.0 112.0 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.4 ' O ' ' N ' ' A' ' 47' ' ' LYS . 0.9 OUTLIER -117.65 123.9 47.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.342 178.81 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.928 HG11 HD11 ' A' ' 67' ' ' LEU . 5.4 m -106.69 153.97 7.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.171 0.51 . . . . 0.0 112.32 -178.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.506 ' HB3' HD13 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -152.4 132.27 13.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.35 179.513 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.504 ' HA2' ' HA ' ' A' ' 44' ' ' ILE . . . -107.64 153.97 16.69 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.473 -0.87 . . . . 0.0 113.153 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.925 ' ND2' HD12 ' A' ' 42' ' ' LEU . 18.2 p-10 -106.73 -179.16 3.86 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.177 0.513 . . . . 0.0 111.318 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -135.86 127.54 29.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.53 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.732 ' CA ' HD21 ' A' ' 42' ' ' LEU . 10.6 t -38.61 134.67 0.9 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.739 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.13 -35.13 79.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.267 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -73.74 -57.34 4.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.012 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -119.26 161.07 21.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.932 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 40.6 m-70 -77.84 61.94 2.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.867 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.23 126.76 48.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.993 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -61.49 131.46 50.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.01 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.925 HD12 ' ND2' ' A' ' 33' ' ' ASN . 11.6 mt -89.54 -24.62 21.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.896 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.448 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 140.31 169.92 11.86 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.346 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.915 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -101.37 140.45 20.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.8 0.333 . . . . 0.0 111.309 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.46 ' CE2' ' HG3' ' A' ' 66' ' ' GLN . 0.1 OUTLIER -126.31 143.14 51.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.611 179.858 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.645 ' O ' HG13 ' A' ' 63' ' ' VAL . 44.8 t -55.35 105.42 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.412 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.473 ' HD3' HD12 ' B' ' 10' ' ' ILE . 18.3 tptt -72.6 -43.61 63.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.679 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.2 m -165.01 126.53 2.07 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.999 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.742 HG23 HG12 ' A' ' 28' ' ' VAL . 66.9 mt -91.82 119.04 38.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.324 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.558 HD12 ' N ' ' A' ' 28' ' ' VAL . 1.9 mp -58.83 101.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.571 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -59.96 80.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.08 0.467 . . . . 0.0 110.584 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 153.63 -30.34 0.76 Allowed Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.624 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.402 ' H ' HG22 ' A' ' 50' ' ' ILE . . . -63.37 -174.98 3.02 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.585 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.75 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -65.13 -36.22 83.58 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.741 ' HB1' HD13 ' A' ' 61' ' ' LEU . . . -68.74 -45.87 70.35 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.748 0.309 . . . . 0.0 111.551 -179.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.56 -29.9 70.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.104 0.478 . . . . 0.0 110.053 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.1 mtpt -72.77 -32.67 65.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.971 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.409 ' OD1' ' NH2' ' A' ' 60' ' ' ARG . 1.3 t0 -57.49 -29.78 64.56 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.787 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.16 16.84 75.37 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.045 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.409 ' NH2' ' OD1' ' A' ' 58' ' ' ASP . 0.6 OUTLIER -128.82 -2.03 5.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.933 0.366 . . . . 0.0 111.202 179.837 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.778 HD22 HG11 ' A' ' 28' ' ' VAL . 0.1 OUTLIER -96.03 125.04 40.3 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.007 0.432 . . . . 0.0 111.472 -179.642 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.412 ' N ' ' HD2' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -128.66 140.28 51.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.556 179.707 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.678 ' O ' ' HB2' ' A' ' 64' ' ' ASN . 39.7 t -61.41 150.86 7.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.461 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.678 ' HB2' ' O ' ' A' ' 63' ' ' VAL . 22.4 m-80 83.44 3.37 0.93 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.05 0.54 . . . . 0.0 111.95 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.511 ' OD2' HG21 ' A' ' 105' ' ' VAL . 1.2 m-20 -81.1 117.76 21.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.852 0.358 . . . . 0.0 110.298 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.46 ' HG3' ' CE2' ' A' ' 45' ' ' PHE . 9.9 tm0? -75.73 115.03 14.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.248 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.928 HD11 HG11 ' A' ' 30' ' ' VAL . 32.8 mt -63.34 152.01 39.19 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.153 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.943 HD11 ' HB2' ' A' ' 106' ' ' ALA . 21.1 mt -136.77 -43.65 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.169 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.9 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -143.18 150.97 40.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.966 0.412 . . . . 0.0 111.399 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.582 HG11 ' HA ' ' A' ' 87' ' ' LEU . 10.3 p -140.62 116.28 7.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.819 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.539 ' ND2' HG22 ' A' ' 70' ' ' VAL . 69.3 m-80 55.79 55.36 7.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.789 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 60.89 18.69 54.53 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.435 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -118.11 88.72 2.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.881 0.372 . . . . 0.0 110.82 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.3 m -62.0 118.46 7.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.026 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.482 HD22 ' HA ' ' A' ' 83' ' ' ALA . 2.1 mt -73.59 -16.52 61.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.214 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.599 HD13 HG23 ' A' ' 68' ' ' ILE . 1.0 OUTLIER -53.33 91.5 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.927 0.394 . . . . 0.0 111.133 -179.906 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 152.77 -28.62 0.83 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.256 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.3 ptpp? -106.38 154.69 20.44 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.215 0.531 . . . . 0.0 110.963 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.677 ' HB3' HE21 ' A' ' 81' ' ' GLN . . . -54.36 156.42 3.29 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.303 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -53.85 -42.47 68.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.316 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.677 HE21 ' HB3' ' A' ' 79' ' ' ALA . 4.7 pp0? -66.42 -38.01 86.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.966 0.412 . . . . 0.0 110.872 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.69 -33.18 72.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.185 0.517 . . . . 0.0 110.109 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.602 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -69.13 -46.69 67.01 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.782 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.42 ' HA ' ' CD2' ' A' ' 87' ' ' LEU . 6.1 ptp -63.26 -31.97 73.26 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.333 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -80.42 -32.05 37.46 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.6 m -68.73 -36.44 78.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.29 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.852 HD12 ' N ' ' A' ' 88' ' ' ARG . 4.3 pp -78.54 -35.05 46.7 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.369 0.604 . . . . 0.0 109.388 178.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.852 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -60.04 -48.54 81.31 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.171 179.422 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.516 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.82 -42.33 63.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.964 179.329 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.0 t -62.75 -29.42 70.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.179 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.931 ' HE2' HD22 ' A' ' 26' ' ' LEU . 3.2 ptp -85.47 -30.86 23.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.658 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.2 30.31 6.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.701 -179.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.516 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.4 OUTLIER -158.86 -28.98 0.07 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -179.79 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.5 ' HG3' HG22 ' A' ' 93' ' ' THR . 4.9 mt-10 -122.1 -38.98 2.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.959 0.409 . . . . 0.0 111.103 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.513 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -78.63 -31.45 45.05 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.724 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.741 ' HB2' HD11 ' A' ' 18' ' ' LEU . 0.7 OUTLIER -75.02 -33.43 61.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.786 0.326 . . . . 0.0 110.14 179.493 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.45 ' HD3' ' O ' ' A' ' 93' ' ' THR . 26.2 mmmt -43.52 -44.8 6.23 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.157 0.504 . . . . 0.0 111.108 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.58 -23.57 21.94 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.715 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 113.69 -1.3 24.67 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.789 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.448 ' SD ' ' HB3' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -163.06 143.24 9.14 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.055 0.455 . . . . 0.0 111.341 -179.639 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.884 HD11 HD11 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -116.47 139.77 41.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.277 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.533 ' C ' HD22 ' A' ' 103' ' ' LEU . 3.0 pp0? -87.25 135.32 33.36 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.907 HD23 HG23 ' A' ' 16' ' ' VAL . 2.2 mm? -121.33 138.31 54.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.285 0.564 . . . . 0.0 112.286 -179.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.9 HD12 ' HB3' ' A' ' 69' ' ' ALA . 96.2 mt -120.02 112.67 37.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.278 178.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.829 HG12 HD23 ' A' ' 67' ' ' LEU . 28.5 m -125.98 154.06 34.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.448 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.943 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -125.63 135.31 52.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.417 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.563 ' HG3' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 CA-C-O 121.099 0.476 . . . . 0.0 111.52 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.506 HD13 ' HB3' ' A' ' 31' ' ' LYS . 1.6 mm . . . . . 0 N--CA 1.456 -0.172 0 CA-C-O 121.223 0.535 . . . . 0.0 111.388 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 22.7 m -101.21 100.5 11.04 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.442 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.16 124.09 23.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.219 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.53 HG23 ' O ' ' B' ' 13' ' ' VAL . 12.0 m . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.386 -0.816 . . . . 0.0 110.797 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.875 0.369 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -78.43 136.06 37.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.638 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.967 HD12 HG23 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -130.58 111.08 11.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.902 0.382 . . . . 0.0 111.29 -179.746 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.598 HG23 ' OE1' ' A' ' 102' ' ' GLN . 99.2 m -99.93 132.12 45.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.346 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.427 ' CG ' ' HB3' ' A' ' 60' ' ' ARG . 28.4 m-85 -140.69 172.52 12.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.321 0.582 . . . . 0.0 112.202 -179.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.468 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.4 OUTLIER -130.74 111.24 11.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.276 179.295 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.892 HG23 HD23 ' A' ' 103' ' ' LEU . 24.2 t -103.65 117.01 60.91 Favored Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -178.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.775 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 82.9 Cg_endo -86.97 128.07 2.69 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.738 2.292 . . . . 0.0 110.898 178.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.901 HD11 ' HB2' ' A' ' 96' ' ' ASN . 0.4 OUTLIER -122.71 28.75 7.16 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -178.899 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -38.38 -31.96 0.06 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.319 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -111.92 -32.5 6.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.123 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.762 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 25.0 t -71.74 -5.21 32.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.308 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.771 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -44.43 -29.37 1.75 Allowed Glycine 0 C--N 1.337 0.605 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.726 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.1 m -85.03 -35.1 22.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.001 0.429 . . . . 0.0 110.657 179.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.92 5.14 34.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.424 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.81 -56.35 5.04 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.958 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.918 HD22 ' HE2' ' A' ' 91' ' ' MET . 8.4 tp -175.06 -36.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.635 0.255 . . . . 0.0 110.839 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.83 45.54 0.7 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.554 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.775 HG12 HG23 ' A' ' 49' ' ' ILE . 23.4 m -157.16 156.71 4.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.185 0.517 . . . . 0.0 112.122 179.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.43 ' O ' ' HB3' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -116.07 114.63 24.8 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.091 178.582 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.88 HG11 HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -108.88 146.4 14.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.14 0.495 . . . . 0.0 111.993 -178.683 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.494 ' HB3' HD13 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -144.43 131.03 19.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.306 179.621 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.507 ' HA2' ' HA ' ' A' ' 44' ' ' ILE . . . -96.85 155.18 20.74 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.967 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -104.2 -171.19 1.89 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.864 0.364 . . . . 0.0 110.821 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.469 ' CD ' ' O ' ' A' ' 35' ' ' SER . 0.0 OUTLIER -145.17 141.27 28.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.505 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.764 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 0.2 OUTLIER -43.7 146.68 0.52 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.119 0.485 . . . . 0.0 111.905 -179.246 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.03 -19.36 65.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.36 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -103.13 -82.27 0.49 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.692 0.282 . . . . 0.0 111.393 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -98.19 166.5 11.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.116 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.442 ' HA ' ' CG ' ' A' ' 34' ' ' ARG . 88.3 m-70 -66.74 73.52 0.1 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.917 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.764 ' HB3' ' HB2' ' A' ' 35' ' ' SER . . . -115.65 88.34 2.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.866 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.404 ' HB3' ' ND2' ' A' ' 80' ' ' ASN . 2.0 p-10 -37.97 121.93 0.97 Allowed 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.918 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.645 HD21 ' HA ' ' A' ' 35' ' ' SER . 19.2 mt -88.92 6.67 38.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.04 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.457 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 103.16 -174.31 23.02 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.384 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.827 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -114.45 144.7 21.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.842 0.353 . . . . 0.0 111.478 -179.719 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -127.44 143.16 51.24 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.714 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.589 ' O ' HG13 ' A' ' 63' ' ' VAL . 41.9 t -60.04 104.37 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.486 179.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.43 ' HB3' ' O ' ' A' ' 29' ' ' SER . 2.8 tptt -73.37 -42.35 62.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.881 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.0 m -168.66 122.6 0.86 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.028 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.775 HG23 HG12 ' A' ' 28' ' ' VAL . 75.1 mt -84.82 116.55 28.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.908 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.619 HD12 ' N ' ' A' ' 28' ' ' VAL . 1.8 mp -52.65 101.91 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.742 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -60.1 80.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.129 0.49 . . . . 0.0 110.628 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 153.58 -30.0 0.76 Allowed Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.718 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.477 ' H ' HG22 ' A' ' 50' ' ' ILE . . . -65.07 -171.19 2.82 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.366 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.775 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -68.43 -37.12 79.97 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.734 ' HB1' HD13 ' A' ' 61' ' ' LEU . . . -66.48 -43.54 85.15 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.468 -179.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.419 ' OG ' HG22 ' A' ' 49' ' ' ILE . 0.5 OUTLIER -69.92 -32.11 70.24 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.049 179.702 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 26.7 mtpt -72.29 -33.21 67.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.852 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -62.16 -26.79 68.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.795 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.64 37.31 92.1 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.641 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.427 ' HB3' ' CG ' ' A' ' 14' ' ' PHE . 7.3 mtm180 -131.4 -33.48 1.46 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.674 0.273 . . . . 0.0 110.949 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.795 HD11 HG21 ' A' ' 16' ' ' VAL . 2.1 mp -64.45 157.89 25.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.048 0.451 . . . . 0.0 111.185 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -149.49 124.05 9.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.521 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.589 HG13 ' O ' ' A' ' 46' ' ' VAL . 41.2 t -56.9 143.05 11.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.198 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.435 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 21.5 m-20 86.26 -2.78 0.73 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.238 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -78.43 124.03 27.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.718 0.295 . . . . 0.0 110.52 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.438 ' O ' ' HA ' ' A' ' 105' ' ' VAL . 0.7 OUTLIER -74.9 134.46 41.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.665 -179.86 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.904 HD23 HG12 ' A' ' 105' ' ' VAL . 19.3 mt -86.17 137.8 32.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.754 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.971 HD11 ' HB2' ' A' ' 106' ' ' ALA . 24.5 mt -120.99 -37.27 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.458 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.79 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -149.92 170.8 17.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.904 0.383 . . . . 0.0 111.275 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.711 HG23 ' CD1' ' A' ' 103' ' ' LEU . 7.2 p -157.78 121.87 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.934 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.512 ' ND2' HG22 ' A' ' 70' ' ' VAL . 70.0 m-80 61.07 25.62 15.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.628 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.47 23.02 45.07 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.143 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -127.04 119.02 25.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.779 0.323 . . . . 0.0 110.71 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 60.9 p -69.8 153.31 43.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.097 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.439 HD22 ' HB1' ' A' ' 83' ' ' ALA . 6.8 mt -113.38 -15.4 12.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.314 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.7 mt -57.45 -18.3 17.61 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.521 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -87.87 21.28 24.05 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.079 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.448 ' HB2' ' HB3' ' A' ' 82' ' ' GLU . 1.9 ptpt -160.38 168.69 24.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.262 0.553 . . . . 0.0 111.221 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.44 ' HB3' HE22 ' A' ' 81' ' ' GLN . . . -72.37 174.31 7.52 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.641 -179.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.464 ' O ' ' HE2' ' A' ' 84' ' ' MET . 21.1 m-80 -57.14 -58.29 8.84 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.496 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.44 HE22 ' HB3' ' A' ' 79' ' ' ALA . 6.1 pm0 -58.37 -34.12 70.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.045 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.448 ' HB3' ' HB2' ' A' ' 78' ' ' LYS . 2.8 mt-10 -70.77 -39.2 73.35 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.25 0.548 . . . . 0.0 109.867 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.6 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -69.13 -43.52 74.21 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.573 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.481 ' HG3' HG21 ' A' ' 44' ' ' ILE . 1.0 OUTLIER -64.61 -29.29 70.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.067 179.176 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -78.99 -35.76 42.4 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.433 ' HA ' ' HD2' ' A' ' 89' ' ' ARG . 1.6 m -65.36 -36.51 84.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.403 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.775 HD12 ' N ' ' A' ' 88' ' ' ARG . 4.4 pp -78.35 -34.26 48.55 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.775 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -60.7 -49.45 77.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.744 179.349 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.558 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.15 -45.7 59.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.98 179.683 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 45.9 p -60.25 -29.35 68.72 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.763 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.918 ' HE2' HD22 ' A' ' 26' ' ' LEU . 2.5 ptp -88.07 -29.36 20.71 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.493 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.58 35.46 4.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.761 -179.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.558 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.3 OUTLIER -166.42 -24.05 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.474 ' HG3' HG22 ' A' ' 93' ' ' THR . 6.6 mt-10 -123.92 -59.44 1.51 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.989 0.424 . . . . 0.0 111.175 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.428 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -66.59 -25.35 72.78 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.1 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.901 ' HB2' HD11 ' A' ' 18' ' ' LEU . 0.8 OUTLIER -78.28 -35.59 47.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.963 0.411 . . . . 0.0 110.185 179.671 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.46 ' HD3' ' O ' ' A' ' 93' ' ' THR . 27.7 mmmt -45.52 -42.28 10.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.985 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.91 -27.92 23.08 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.629 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 121.94 -6.67 10.25 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.934 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.468 ' SD ' ' HB3' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -158.33 142.38 15.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.013 0.435 . . . . 0.0 111.301 -179.759 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.786 HD11 HD11 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -109.45 144.79 17.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.996 -179.841 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.598 ' OE1' HG23 ' A' ' 13' ' ' THR . 1.5 tm0? -85.83 140.35 30.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.168 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.892 HD23 HG23 ' A' ' 16' ' ' VAL . 2.7 mm? -130.4 139.81 50.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.039 0.447 . . . . 0.0 111.867 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.79 HD12 ' HB3' ' A' ' 69' ' ' ALA . 66.5 mt -128.6 112.91 27.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.596 178.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.967 HG23 HD12 ' A' ' 12' ' ' LEU . 28.6 m -122.71 176.94 4.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.84 -178.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.971 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -147.71 117.53 7.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.475 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 5.6 ttm180 . . . . . 0 C--N 1.326 -0.433 0 CA-C-O 120.928 0.394 . . . . 0.0 110.773 -179.878 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.494 HD13 ' HB3' ' A' ' 31' ' ' LYS . 1.5 mm . . . . . 0 CA--C 1.52 -0.174 0 CA-C-O 121.177 0.513 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 90.5 m -79.0 116.39 19.27 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.744 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt -79.11 129.0 33.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.861 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.75 HG11 HD11 ' A' ' 87' ' ' LEU . 21.3 m . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.126 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 121.028 0.442 . . . . 0.0 111.357 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.429 ' CD2' HG13 ' A' ' 68' ' ' ILE . 3.8 m-85 -101.95 145.03 29.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.405 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.69 HD13 ' CZ ' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -147.6 137.36 22.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.126 0.489 . . . . 0.0 111.428 -179.652 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.469 HG23 ' OE1' ' A' ' 102' ' ' GLN . 86.8 m -88.77 145.9 25.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.242 179.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.69 ' CZ ' HD13 ' A' ' 12' ' ' LEU . 21.3 m-85 -140.37 116.51 10.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.03 0.443 . . . . 0.0 111.979 -179.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.411 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.6 OUTLIER -86.99 109.15 19.19 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.565 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.509 HG11 ' HG ' ' A' ' 26' ' ' LEU . 39.6 t -106.54 103.37 45.98 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -177.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.749 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 3.7 Cg_exo -75.42 128.01 10.83 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.606 2.204 . . . . 0.0 110.661 178.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.78 HD11 ' HB2' ' A' ' 96' ' ' ASN . 0.4 OUTLIER -124.03 28.36 6.83 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.713 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -39.71 -31.2 0.1 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.069 0.461 . . . . 0.0 111.092 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -113.7 -32.69 6.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.234 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.747 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 45.9 t -70.65 -8.6 53.04 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.074 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.678 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -46.36 -27.64 2.91 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.603 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 52.4 m -84.9 -33.17 22.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.874 0.369 . . . . 0.0 110.693 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.78 11.13 20.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.49 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.14 -55.64 5.04 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.897 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.954 HD22 ' HE2' ' A' ' 91' ' ' MET . 9.2 tp -178.49 -31.38 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.658 0.266 . . . . 0.0 110.96 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.443 ' HA3' ' HA3' ' A' ' 53' ' ' GLY . . . 112.73 32.49 2.26 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.421 -0.895 . . . . 0.0 113.286 179.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.75 HG12 HG23 ' A' ' 49' ' ' ILE . 35.2 m -156.34 150.55 10.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.1 0.476 . . . . 0.0 111.915 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.443 ' O ' ' N ' ' A' ' 47' ' ' LYS . 73.0 m -107.48 123.13 47.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.032 178.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.6 m -107.47 153.67 8.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 -178.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.513 ' O ' ' HG3' ' A' ' 31' ' ' LYS . 0.1 OUTLIER -155.62 129.93 8.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.206 179.303 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -103.97 160.46 16.09 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.181 -1.009 . . . . 0.0 113.101 -179.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -116.01 175.32 5.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.004 0.43 . . . . 0.0 111.133 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 29.5 mtt85 -121.41 153.05 38.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.749 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.894 ' HA ' HD21 ' A' ' 42' ' ' LEU . 0.5 OUTLIER -47.7 156.87 0.28 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.484 -179.866 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.87 -51.98 41.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.394 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.21 -51.74 28.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.704 -179.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -117.97 -177.12 3.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.752 0.31 . . . . 0.0 111.078 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 -92.34 40.38 1.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.049 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.18 110.2 17.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.829 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.603 ' OD2' ' HB1' ' A' ' 79' ' ' ALA . 1.2 m-20 -48.37 124.5 8.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.443 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.894 HD21 ' HA ' ' A' ' 35' ' ' SER . 17.0 mt -88.88 -36.25 16.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.72 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.484 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 154.44 -178.71 31.09 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.898 -0.667 . . . . 0.0 111.897 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.741 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -106.58 137.82 35.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.845 0.355 . . . . 0.0 111.274 -179.854 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.461 ' CE2' ' NE2' ' A' ' 66' ' ' GLN . 0.5 OUTLIER -123.68 140.13 53.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.497 179.621 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.609 ' O ' HG13 ' A' ' 63' ' ' VAL . 27.5 t -55.95 107.56 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.068 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 29' ' ' SER . 21.5 tptt -71.61 -46.87 57.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.625 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 27.2 t -166.42 123.83 1.36 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.857 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.75 HG23 HG12 ' A' ' 28' ' ' VAL . 66.9 mt -87.32 122.54 39.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.274 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.51 HD12 ' N ' ' A' ' 28' ' ' VAL . 2.5 mp -64.84 111.77 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.289 179.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -68.06 72.63 0.18 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.212 0.53 . . . . 0.0 110.404 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 165.12 -28.89 0.21 Allowed Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.877 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.443 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -66.84 -170.56 4.2 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.662 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.749 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -69.24 -37.7 78.1 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.744 ' HB1' HD13 ' A' ' 61' ' ' LEU . . . -67.96 -44.26 77.15 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.792 0.33 . . . . 0.0 111.312 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.416 ' HB2' HG22 ' A' ' 49' ' ' ILE . 6.9 t -65.53 -34.79 79.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.224 0.535 . . . . 0.0 109.759 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -69.23 -31.41 69.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.766 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.59 -30.84 61.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.654 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 68.93 16.19 70.18 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.897 -0.668 . . . . 0.0 113.277 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.441 ' HG3' ' CD1' ' A' ' 14' ' ' PHE . 7.0 ptp180 -135.23 10.91 3.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.002 0.401 . . . . 0.0 111.143 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.744 HD13 ' HB1' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -104.07 134.01 48.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.596 179.877 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.39 145.63 50.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.802 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.609 HG13 ' O ' ' A' ' 46' ' ' VAL . 45.2 t -66.07 148.91 11.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.845 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.43 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 15.9 m-80 84.65 -4.02 0.98 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.428 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.3 128.25 35.27 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.694 0.283 . . . . 0.0 110.697 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.461 ' NE2' ' CE2' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -85.55 130.01 34.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.937 -179.729 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.907 HD23 HG12 ' A' ' 105' ' ' VAL . 77.5 mt -81.13 135.95 35.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.575 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.429 HG13 ' CD2' ' A' ' 11' ' ' PHE . 18.7 mm -118.93 -29.14 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.298 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.744 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -160.04 148.73 17.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.983 0.42 . . . . 0.0 111.378 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.64 HG22 HD22 ' A' ' 71' ' ' ASN . 7.1 p -137.89 129.79 39.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.488 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.64 HD22 HG22 ' A' ' 70' ' ' VAL . 13.5 m-80 60.01 26.08 15.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.763 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.8 20.67 59.23 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.193 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -128.19 111.55 13.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.823 0.344 . . . . 0.0 110.723 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.47 149.83 20.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.158 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.586 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . 4.2 mt -114.09 -20.2 11.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.347 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.1 tp -54.83 -24.35 22.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.674 0.273 . . . . 0.0 111.278 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.39 -2.17 83.48 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.031 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.433 ' HG3' ' HB2' ' A' ' 83' ' ' ALA . 4.6 ptpp? -135.83 161.13 36.47 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.293 0.568 . . . . 0.0 111.301 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.603 ' HB1' ' OD2' ' A' ' 41' ' ' ASP . . . -60.52 176.94 0.32 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.525 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.435 ' HB3' ' HA3' ' A' ' 32' ' ' GLY . 19.5 m-80 -67.14 -57.64 6.38 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.118 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.438 ' HA ' ' HE3' ' A' ' 84' ' ' MET . 3.1 pp0? -58.36 -35.21 71.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.036 0.446 . . . . 0.0 110.591 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.53 -42.45 71.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.484 179.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.586 ' HB1' ' HB3' ' A' ' 75' ' ' LEU . . . -69.59 -30.99 68.88 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.934 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.47 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 0.5 OUTLIER -72.36 -33.32 67.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.596 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -77.63 -28.07 51.29 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.2 m -72.66 -36.85 68.03 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.528 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 84' ' ' MET . 4.4 pp -78.65 -34.24 46.57 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -61.4 -52.1 66.0 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.461 179.243 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.5 ' O ' HG22 ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.17 -33.97 68.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.19 179.594 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.491 ' N ' ' HD3' ' A' ' 89' ' ' ARG . 41.7 m -72.57 -29.68 63.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.672 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.954 ' HE2' HD22 ' A' ' 26' ' ' LEU . 3.2 ptp -87.35 -22.4 25.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.31 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.0 t -112.81 22.65 14.26 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.946 0.351 . . . . 0.0 111.946 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.558 HG23 ' HG2' ' A' ' 94' ' ' GLU . 0.5 OUTLIER -154.77 -39.46 0.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.558 ' HG2' HG23 ' A' ' 93' ' ' THR . 5.7 mt-10 -110.77 -22.06 11.76 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.868 0.366 . . . . 0.0 111.206 -179.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.505 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -93.27 -30.3 9.4 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 179.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.78 ' HB2' HD11 ' A' ' 18' ' ' LEU . 1.2 t-20 -86.67 -37.05 18.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.791 0.329 . . . . 0.0 110.29 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.551 ' HG2' ' HA ' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -45.32 -28.53 0.85 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.31 179.627 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.427 ' HD3' ' HD2' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -106.8 -27.04 11.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.534 178.964 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 118.36 -1.64 16.3 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.135 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.49 ' HE2' ' O ' ' A' ' 100' ' ' MET . 0.0 OUTLIER -165.14 141.44 5.59 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.0 0.429 . . . . 0.0 111.649 -179.74 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.545 HG22 HD21 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -115.47 134.56 58.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.043 179.848 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.469 ' OE1' HG23 ' A' ' 13' ' ' THR . 1.7 pp0? -81.55 140.32 34.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.001 178.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.451 HD13 HG21 ' A' ' 16' ' ' VAL . 1.8 mp -134.84 111.59 10.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.736 0.303 . . . . 0.0 111.686 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.744 HD12 ' HB3' ' A' ' 69' ' ' ALA . 62.6 mt -90.19 112.45 24.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.907 HG12 HD23 ' A' ' 67' ' ' LEU . 14.6 m -118.37 -179.2 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.882 0.373 . . . . 0.0 111.384 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -147.01 134.99 21.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.755 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.616 ' HD2' HD21 ' A' ' 12' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.969 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.472 HD13 ' HB3' ' A' ' 31' ' ' LYS . 14.5 mm . . . . . 0 N--CA 1.449 -0.495 0 CA-C-O 120.839 0.352 . . . . 0.0 111.079 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 1.9 m -162.05 122.37 2.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.584 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -80.46 145.1 32.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.15 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.402 ' CG1' ' HG3' ' A' ' 88' ' ' ARG . 27.2 m . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.175 -0.917 . . . . 0.0 111.093 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.848 0.356 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -96.93 148.35 23.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.859 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.86 HD12 HG23 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -132.27 109.9 10.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.109 -179.848 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.689 HG23 ' OE1' ' A' ' 102' ' ' GLN . 87.9 m -96.71 133.02 41.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.496 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.407 ' CE1' ' HG2' ' A' ' 60' ' ' ARG . 47.8 m-85 -140.59 172.67 12.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.164 0.506 . . . . 0.0 112.043 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.427 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.4 OUTLIER -129.67 112.22 13.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.228 179.105 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.901 HG23 HD23 ' A' ' 103' ' ' LEU . 25.8 t -105.31 111.53 64.99 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -177.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.578 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 1.2 Cg_endo -81.7 127.61 5.69 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.817 2.345 . . . . 0.0 111.049 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.775 HD11 ' HB2' ' A' ' 96' ' ' ASN . 0.4 OUTLIER -122.09 28.67 7.4 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -179.002 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -38.72 -31.72 0.07 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.036 0.446 . . . . 0.0 111.195 179.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -112.26 -33.52 6.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.18 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.472 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 30.4 t -70.02 -7.57 42.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.2 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.745 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -45.3 -28.65 2.2 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.759 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.0 t -84.83 -34.23 22.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.783 0.325 . . . . 0.0 110.63 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.01 8.88 27.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.319 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.28 -55.26 4.94 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.969 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.864 HD22 ' HE2' ' A' ' 91' ' ' MET . 8.2 tp -176.02 -34.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.508 0.194 . . . . 0.0 110.657 179.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.42 ' HA2' HD13 ' A' ' 50' ' ' ILE . . . 111.68 44.28 0.91 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.328 -0.939 . . . . 0.0 113.56 179.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.782 HG12 HG23 ' A' ' 49' ' ' ILE . 19.4 m -158.27 167.55 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.155 0.503 . . . . 0.0 111.902 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' B' ' 12' ' ' LYS . 0.0 OUTLIER -126.67 116.67 21.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.276 178.636 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.961 HG11 HD11 ' A' ' 67' ' ' LEU . 1.0 OUTLIER -111.18 144.47 19.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.013 0.435 . . . . 0.0 111.981 -178.836 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.417 ' O ' ' HG3' ' A' ' 31' ' ' LYS . 2.2 ptmt -138.05 134.06 34.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.365 179.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.514 ' HA3' ' HB3' ' A' ' 80' ' ' ASN . . . -100.07 147.6 18.19 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.939 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.404 ' ND2' ' CE1' ' A' ' 45' ' ' PHE . 76.6 m-20 -127.12 130.49 49.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.888 0.375 . . . . 0.0 110.866 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.16 145.74 26.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.468 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.85 ' OG ' HD21 ' A' ' 42' ' ' LEU . 8.3 m -44.1 130.61 6.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.269 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.13 -19.85 65.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.568 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -106.08 -44.09 4.67 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.825 0.345 . . . . 0.0 111.421 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -87.3 -16.91 33.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.522 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 30.2 m-70 61.47 21.3 11.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.746 0.308 . . . . 0.0 110.888 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -99.29 134.47 42.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.011 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -50.18 126.94 15.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.315 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.85 HD21 ' OG ' ' A' ' 35' ' ' SER . 45.8 mt -94.39 -19.4 20.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.919 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.464 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 128.82 169.66 12.63 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.308 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.755 ' CG1' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -102.05 130.95 51.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.835 0.35 . . . . 0.0 111.29 179.85 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.463 ' CE2' ' NE2' ' A' ' 66' ' ' GLN . 0.1 OUTLIER -113.56 146.79 39.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.486 179.868 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.534 ' O ' HG13 ' A' ' 63' ' ' VAL . 49.1 t -60.53 104.66 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.563 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.437 ' HD3' HD12 ' B' ' 10' ' ' ILE . 18.1 tptt -75.48 -40.05 57.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.889 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -168.77 126.41 1.03 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.981 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.782 HG23 HG12 ' A' ' 28' ' ' VAL . 63.7 mt -94.44 121.21 44.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.048 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.52 HD12 ' N ' ' A' ' 28' ' ' VAL . 1.5 mp -58.96 109.74 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.432 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -65.83 72.91 0.06 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.071 0.462 . . . . 0.0 110.691 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 163.76 -26.51 0.21 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.262 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.404 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -70.87 -165.41 6.05 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.777 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.578 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -69.09 -42.18 76.49 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.756 ' HB1' HD22 ' A' ' 61' ' ' LEU . . . -63.13 -43.84 97.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.342 -179.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.4 t -68.73 -33.56 74.13 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.132 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -72.2 -31.9 66.29 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.876 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -65.18 -25.17 67.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.709 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.12 29.7 65.9 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.575 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.407 ' HG2' ' CE1' ' A' ' 14' ' ' PHE . 15.0 mtm180 -124.9 -33.02 2.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.609 0.242 . . . . 0.0 111.254 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.756 HD22 ' HB1' ' A' ' 55' ' ' ALA . 5.5 mp -72.01 150.15 44.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.904 0.383 . . . . 0.0 111.055 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.11 135.71 20.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.082 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.54 ' O ' ' HB3' ' A' ' 64' ' ' ASN . 82.9 t -64.99 94.89 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.817 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.54 ' HB3' ' O ' ' A' ' 63' ' ' VAL . 12.2 p30 149.55 -4.45 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.92 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -84.22 131.78 34.71 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 121.096 0.474 . . . . 0.0 111.594 -179.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.463 ' NE2' ' CE2' ' A' ' 45' ' ' PHE . 0.3 OUTLIER -89.93 117.25 28.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.11 179.343 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.961 HD11 HG11 ' A' ' 30' ' ' VAL . 5.2 mt -71.91 133.52 45.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.929 0.395 . . . . 0.0 111.404 -179.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.725 HD11 ' CB ' ' A' ' 106' ' ' ALA . 23.6 mt -122.12 -22.86 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.488 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.703 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -155.69 167.26 30.96 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.935 0.398 . . . . 0.0 111.466 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.83 HG22 HD22 ' A' ' 71' ' ' ASN . 10.3 p -158.18 126.34 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.694 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.83 HD22 HG22 ' A' ' 70' ' ' VAL . 2.7 m-80 66.19 15.4 10.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.082 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 96.34 7.48 58.17 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.529 -0.843 . . . . 0.0 113.125 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.427 ' CG ' ' O ' ' A' ' 70' ' ' VAL . 2.4 pt-20 -121.13 109.15 14.66 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.889 0.376 . . . . 0.0 111.002 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.4 m -59.65 145.9 43.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.024 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.423 ' HB2' ' CB ' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -121.16 4.41 10.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.247 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.598 HD13 HG23 ' A' ' 68' ' ' ILE . 5.0 tp -61.21 -28.53 69.21 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.741 0.305 . . . . 0.0 111.029 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -74.87 -24.95 70.65 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.558 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -97.34 166.17 11.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.259 0.552 . . . . 0.0 111.212 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.592 ' HB3' HE21 ' A' ' 81' ' ' GLN . . . -67.21 165.2 16.59 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.245 -0.888 . . . . 0.0 111.418 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.514 ' HB3' ' HA3' ' A' ' 32' ' ' GLY . 20.3 m-80 -54.78 -57.77 10.24 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.269 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.592 HE21 ' HB3' ' A' ' 79' ' ' ALA . 3.0 pp0? -56.83 -34.49 67.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.83 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.72 -38.64 73.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.313 0.578 . . . . 0.0 109.625 179.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.534 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -69.08 -40.74 78.26 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.405 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.462 ' HG2' HG23 ' A' ' 30' ' ' VAL . 1.1 mtm -66.3 -29.62 69.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.854 179.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -79.88 -35.88 37.37 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.432 ' HA ' ' HD2' ' A' ' 89' ' ' ARG . 2.9 m -65.21 -36.33 83.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.375 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.809 HD12 ' N ' ' A' ' 88' ' ' ARG . 4.4 pp -79.06 -34.6 43.57 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.809 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -62.32 -50.68 70.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.605 179.322 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.499 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.16 -37.34 69.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.233 179.634 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.413 ' HB3' ' ND2' ' A' ' 71' ' ' ASN . 34.8 m -67.11 -29.51 69.27 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.077 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.864 ' HE2' HD22 ' A' ' 26' ' ' LEU . 4.5 ptp -89.34 -30.28 18.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.624 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.0 23.46 13.97 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.499 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.4 OUTLIER -155.04 -31.05 0.1 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.851 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.418 ' HG3' HG22 ' A' ' 93' ' ' THR . 7.8 mt-10 -113.9 -63.89 1.39 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.894 0.378 . . . . 0.0 111.524 -179.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.459 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -58.11 -31.89 66.19 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.451 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.775 ' HB2' HD11 ' A' ' 18' ' ' LEU . 0.7 OUTLIER -72.95 -33.71 66.07 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.715 0.293 . . . . 0.0 110.612 179.92 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 93' ' ' THR . 54.4 mtpt -43.56 -39.45 3.45 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.035 0.445 . . . . 0.0 111.325 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.31 -26.23 15.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.957 178.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 117.27 2.07 18.17 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.613 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.512 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -158.17 141.91 15.49 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.011 0.434 . . . . 0.0 111.28 -179.689 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.828 HD11 HD11 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -112.86 146.15 17.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.967 179.915 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.689 ' OE1' HG23 ' A' ' 13' ' ' THR . 1.5 tm0? -86.9 138.45 31.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.034 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.901 HD23 HG23 ' A' ' 16' ' ' VAL . 2.8 mm? -128.51 138.98 52.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.0 0.428 . . . . 0.0 111.961 -179.172 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.703 HD12 ' HB3' ' A' ' 69' ' ' ALA . 55.1 mt -127.67 112.79 28.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.745 178.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.86 HG23 HD12 ' A' ' 12' ' ' LEU . 34.7 m -121.76 175.88 4.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.048 -179.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.725 ' CB ' HD11 ' A' ' 68' ' ' ILE . . . -147.52 141.77 26.21 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.842 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.668 ' CG ' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.333 0 CA-C-O 120.886 0.374 . . . . 0.0 111.175 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.437 HD12 ' HD3' ' A' ' 47' ' ' LYS . 1.6 mm . . . . . 0 N--CA 1.454 -0.253 0 CA-C-O 120.981 0.419 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 27.3 m -138.06 97.8 3.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.795 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 29' ' ' SER . 8.1 ttpt -69.19 109.67 4.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.989 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.755 HG11 HD11 ' A' ' 87' ' ' LEU . 18.5 m . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.321 -0.847 . . . . 0.0 111.103 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 . . . . . 0 C--O 1.231 0.132 0 CA-C-O 120.843 0.354 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -90.98 146.28 24.0 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.801 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.609 HD11 ' CG ' ' A' ' 107' ' ' ARG . 0.3 OUTLIER -138.62 109.92 6.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.992 0.425 . . . . 0.0 111.088 -179.829 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.703 HG23 ' OE1' ' A' ' 102' ' ' GLN . 92.7 m -88.54 121.43 30.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.086 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.439 ' CZ ' ' HB3' ' A' ' 12' ' ' LEU . 32.8 m-85 -131.14 150.53 52.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.214 0.53 . . . . 0.0 112.33 -179.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.486 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.6 OUTLIER -112.46 111.14 21.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.285 -0.87 . . . . 0.0 108.93 178.79 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.546 HG11 ' HG ' ' A' ' 26' ' ' LEU . 10.3 t -100.14 115.33 65.6 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -177.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.776 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 93.8 Cg_endo -85.98 128.2 3.19 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.758 2.305 . . . . 0.0 110.842 178.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.808 HD12 ' HA2' ' A' ' 22' ' ' GLY . 0.4 OUTLIER -127.95 28.79 5.52 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -178.664 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -38.84 -33.35 0.11 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.061 0.458 . . . . 0.0 111.28 179.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -107.71 -33.87 7.15 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.231 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.758 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 7.6 t -70.51 -6.39 35.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.25 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.808 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -42.12 -30.49 0.75 Allowed Glycine 0 C--N 1.337 0.613 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.775 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.02 -38.81 20.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.866 0.365 . . . . 0.0 110.672 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -82.51 1.7 36.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.449 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.88 -53.81 4.86 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.978 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.942 HD22 ' HE2' ' A' ' 91' ' ' MET . 7.7 tp -175.62 -36.06 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.735 0.302 . . . . 0.0 110.589 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.443 ' HA3' ' HA3' ' A' ' 53' ' ' GLY . . . 109.03 47.5 0.88 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.524 -0.846 . . . . 0.0 113.531 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.8 HG12 HG23 ' A' ' 49' ' ' ILE . 22.3 m -158.18 156.67 3.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 117.058 0.429 . . . . 0.0 111.75 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.414 ' O ' ' HB3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -114.13 114.17 25.69 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.383 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.606 HG11 HD11 ' A' ' 67' ' ' LEU . 0.4 OUTLIER -106.94 146.97 12.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.269 0.556 . . . . 0.0 111.979 -178.659 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.466 ' HB3' HD13 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -148.18 130.9 15.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.321 179.41 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 44' ' ' ILE . . . -100.08 176.97 28.57 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.941 -179.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.708 ' ND2' HD12 ' A' ' 42' ' ' LEU . 50.8 p30 -125.15 -174.8 3.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.303 0.573 . . . . 0.0 111.637 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.426 ' O ' ' C ' ' A' ' 35' ' ' SER . 4.5 mtm180 -144.27 126.13 15.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.698 179.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.456 ' CA ' HD21 ' A' ' 42' ' ' LEU . 57.7 m -28.68 142.77 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.22 -178.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -37.21 83.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.354 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.78 -63.16 1.42 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.933 0.397 . . . . 0.0 110.925 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -112.78 -179.92 3.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.882 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 53.1 m-70 -87.56 53.62 2.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.968 0.413 . . . . 0.0 110.857 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.497 ' O ' HD23 ' A' ' 42' ' ' LEU . . . -104.24 105.0 14.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.074 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -49.06 139.75 10.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.554 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.708 HD12 ' ND2' ' A' ' 33' ' ' ASN . 5.4 mt -103.66 -16.37 15.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.737 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 137.5 -177.94 19.46 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.036 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.687 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -115.98 136.59 52.42 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-O 120.819 0.342 . . . . 0.0 110.672 179.749 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -126.47 144.08 50.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.87 0.366 . . . . 0.0 110.827 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.606 ' O ' HG13 ' A' ' 63' ' ' VAL . 40.1 t -57.06 113.79 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.825 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.51 ' HG2' HD12 ' B' ' 10' ' ' ILE . 30.1 tptt -83.03 -38.16 22.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.653 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -168.3 120.09 0.82 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.082 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.8 HG23 HG12 ' A' ' 28' ' ' VAL . 70.4 mt -85.75 120.61 36.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.971 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.545 HD12 ' N ' ' A' ' 28' ' ' VAL . 1.4 mp -57.55 103.95 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.623 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -60.24 83.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.484 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 148.97 -28.03 1.27 Allowed Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.664 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.505 ' H ' HG22 ' A' ' 50' ' ' ILE . . . -67.09 -176.15 7.98 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.543 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.776 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -61.77 -39.29 91.16 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.713 ' HB1' HD13 ' A' ' 61' ' ' LEU . . . -64.65 -48.6 74.2 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.98 0.419 . . . . 0.0 111.486 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.69 -28.52 69.95 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.113 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.7 mtpt -77.46 -29.03 52.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.948 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.407 ' OD1' ' NH2' ' A' ' 60' ' ' ARG . 4.5 t0 -56.13 -31.7 63.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.412 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.77 13.51 80.5 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.887 -0.673 . . . . 0.0 113.35 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.428 ' HG3' ' CG ' ' A' ' 14' ' ' PHE . 2.9 ptp180 -135.62 7.09 3.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 117.089 0.445 . . . . 0.0 111.373 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.772 ' HB3' HD13 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -98.99 133.49 43.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.46 179.827 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.9 142.16 38.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.911 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.606 HG13 ' O ' ' A' ' 46' ' ' VAL . 52.3 t -59.3 147.35 8.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.912 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.434 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 16.3 m-20 85.36 12.99 0.21 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.3 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.441 ' CG ' HG21 ' A' ' 105' ' ' VAL . 1.3 m-20 -85.26 109.53 18.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.854 0.359 . . . . 0.0 110.611 179.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -73.59 111.17 8.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.841 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.888 HD23 HG12 ' A' ' 105' ' ' VAL . 14.8 mt -66.08 141.47 58.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.66 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.824 HG23 HD12 ' A' ' 76' ' ' LEU . 34.8 mt -129.51 -39.69 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.437 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.73 ' HB3' ' CD1' ' A' ' 104' ' ' ILE . . . -147.0 124.03 11.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.991 0.424 . . . . 0.0 111.227 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.892 HG22 HD22 ' A' ' 71' ' ' ASN . 8.4 p -120.33 124.93 73.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.437 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.892 HD22 HG22 ' A' ' 70' ' ' VAL . 4.9 m-80 60.93 42.74 12.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.905 0.383 . . . . 0.0 110.477 -179.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 64.8 21.51 67.47 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.225 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -126.94 118.61 24.87 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.771 0.319 . . . . 0.0 110.767 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.3 t -60.5 152.43 25.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.941 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.686 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . 36.2 mt -118.39 -31.89 4.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.233 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.824 HD12 HG23 ' A' ' 68' ' ' ILE . 1.5 mt -53.96 -29.73 43.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.22 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.03 -11.6 63.81 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.837 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.428 ' HG3' ' HB2' ' A' ' 83' ' ' ALA . 7.0 ptpp? -126.01 156.26 40.16 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.252 0.548 . . . . 0.0 111.206 -179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.07 162.45 0.66 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.882 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -54.66 -57.62 10.74 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.079 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -59.55 -35.4 74.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.061 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.407 ' HB3' ' HB2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -70.49 -40.53 73.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.153 0.502 . . . . 0.0 109.655 179.458 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.686 ' HB1' ' HB3' ' A' ' 75' ' ' LEU . . . -69.13 -38.83 79.07 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.45 179.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.435 ' HG3' HG21 ' A' ' 44' ' ' ILE . 0.5 OUTLIER -65.95 -30.67 71.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.865 179.239 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -79.72 -31.95 41.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.341 178.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.437 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 1.7 m -69.48 -35.39 75.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.33 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.833 HD12 ' N ' ' A' ' 88' ' ' ARG . 4.3 pp -78.72 -34.61 45.81 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.833 ' N ' HD12 ' A' ' 87' ' ' LEU . 5.0 mtp180 -61.4 -52.11 65.98 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 114.937 -1.028 . . . . 0.0 110.616 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.517 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.42 -33.48 67.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.993 179.613 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.443 ' N ' ' HD3' ' A' ' 89' ' ' ARG . 28.6 m -70.99 -29.54 65.55 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.46 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.942 ' HE2' HD22 ' A' ' 26' ' ' LEU . 2.3 ptp -88.94 -21.34 23.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.386 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.5 31.81 6.29 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.517 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.4 OUTLIER -160.01 -31.68 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 179.899 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.457 ' HG3' HG22 ' A' ' 93' ' ' THR . 5.1 mt-10 -115.88 -45.94 2.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.885 0.374 . . . . 0.0 111.239 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.478 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -73.34 -35.25 56.73 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.665 -0.778 . . . . 0.0 111.945 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.678 ' HB2' HD11 ' A' ' 18' ' ' LEU . 0.8 OUTLIER -71.25 -33.82 70.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.898 0.38 . . . . 0.0 110.089 179.568 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 93' ' ' THR . 49.3 mtpt -40.85 -32.59 0.23 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.739 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.15 -28.21 10.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.797 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 128.22 -8.88 6.66 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.731 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.486 ' SD ' ' HB3' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -154.38 144.44 21.9 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.962 0.411 . . . . 0.0 110.852 -179.847 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.615 HG22 HD21 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -107.2 144.63 15.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.597 -179.483 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.703 ' OE1' HG23 ' A' ' 13' ' ' THR . 0.8 OUTLIER -77.01 137.17 38.82 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.429 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.465 HD12 HG23 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -135.57 147.12 48.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.335 0.588 . . . . 0.0 112.198 -178.807 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.73 ' CD1' ' HB3' ' A' ' 69' ' ' ALA . 8.5 mt -140.45 112.63 4.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.311 178.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.888 HG12 HD23 ' A' ' 67' ' ' LEU . 28.1 m -122.47 176.61 4.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.056 0.455 . . . . 0.0 111.677 -178.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.686 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -147.48 132.67 18.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.561 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.609 ' CG ' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.343 0 CA-C-O 120.842 0.353 . . . . 0.0 111.212 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.51 HD12 ' HG2' ' A' ' 47' ' ' LYS . 2.7 mm . . . . . 0 CA--C 1.522 -0.097 0 CA-C-O 121.197 0.522 . . . . 0.0 111.774 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 55.0 m -140.36 106.63 5.25 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.484 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 9.2 ttmt -68.89 112.8 5.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.269 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.758 HG11 HD11 ' A' ' 87' ' ' LEU . 30.8 m . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.979 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.917 0.389 . . . . 0.0 111.467 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.57 ' HD1' ' HB2' ' A' ' 106' ' ' ALA . 17.4 m-85 -94.88 144.06 25.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.264 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.59 HD11 ' HD2' ' A' ' 107' ' ' ARG . 0.1 OUTLIER -134.46 127.78 32.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.942 0.401 . . . . 0.0 111.606 -179.476 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 99.2 m -97.47 133.99 41.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.741 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.464 ' O ' ' N ' ' A' ' 103' ' ' LEU . 21.6 m-85 -140.71 148.19 40.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.268 0.556 . . . . 0.0 112.404 -179.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.425 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.2 OUTLIER -112.39 111.5 22.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.401 -0.818 . . . . 0.0 108.928 178.727 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.801 HG21 HD11 ' A' ' 61' ' ' LEU . 21.2 t -103.41 111.22 64.97 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -177.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.735 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 86.4 Cg_endo -81.03 128.18 6.39 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.427 2.085 . . . . 0.0 111.014 178.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.926 HD22 HD13 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -126.22 29.39 5.83 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -178.85 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -37.43 -32.33 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.411 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -112.32 -34.1 6.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.248 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.606 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 10.5 t -67.03 -11.92 58.43 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.147 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.678 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -45.86 -28.58 2.8 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.737 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.1 t -81.68 -36.77 28.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.89 0.376 . . . . 0.0 110.67 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.17 -24.54 37.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.062 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.9 -52.59 0.7 Allowed Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.926 HD13 HD22 ' A' ' 18' ' ' LEU . 9.3 tp 179.15 -32.82 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.654 0.264 . . . . 0.0 110.796 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.13 43.11 1.42 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.969 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.62 ' N ' HD12 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -164.77 151.44 2.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.068 0.461 . . . . 0.0 111.343 179.738 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' B' ' 12' ' ' LYS . 0.0 OUTLIER -111.85 123.32 49.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.931 179.356 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.75 HG11 HD11 ' A' ' 67' ' ' LEU . 0.9 OUTLIER -112.43 141.36 28.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.895 0.379 . . . . 0.0 111.501 -179.534 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.04 130.29 25.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.648 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -96.75 144.18 17.18 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.851 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.415 ' O ' ' HA ' ' A' ' 41' ' ' ASP . 1.5 m-80 -94.4 -176.3 3.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.711 0.291 . . . . 0.0 110.624 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.3 mtt180 -142.67 148.86 38.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.906 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.473 ' HB2' HD21 ' A' ' 42' ' ' LEU . 8.3 t -66.59 137.05 56.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.938 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -67.09 -29.14 68.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.154 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -70.2 -50.36 40.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.976 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.574 ' OD1' ' HB2' ' A' ' 40' ' ' ALA . 10.4 p30 -141.28 165.32 27.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.756 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -70.48 66.05 0.31 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.908 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.574 ' HB2' ' OD1' ' A' ' 38' ' ' ASN . . . -120.33 119.06 32.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.94 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.415 ' HA ' ' O ' ' A' ' 33' ' ' ASN . 9.2 p-10 -53.4 142.57 21.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.175 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.473 HD21 ' HB2' ' A' ' 35' ' ' SER . 43.2 mt -107.27 3.94 26.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.392 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.444 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 113.92 160.33 13.59 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.524 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.677 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -98.73 130.59 47.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.733 0.301 . . . . 0.0 111.063 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.15 142.4 47.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.808 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.611 ' O ' HG13 ' A' ' 63' ' ' VAL . 39.5 t -57.8 105.84 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.903 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.48 ' HG2' HG21 ' B' ' 10' ' ' ILE . 6.3 tptt -73.92 -41.42 62.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.106 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.2 m -171.89 123.35 0.52 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.913 0.387 . . . . 0.0 111.371 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.554 ' CD1' ' HB3' ' A' ' 61' ' ' LEU . 76.1 mt -85.66 110.95 20.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.068 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.62 HD12 ' N ' ' A' ' 28' ' ' VAL . 1.9 mp -48.74 104.01 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.774 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -62.16 75.38 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.778 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 160.33 -28.79 0.34 Allowed Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.655 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.478 ' H ' HG22 ' A' ' 50' ' ' ILE . . . -70.11 -161.71 3.49 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.476 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.735 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -76.41 -38.13 56.08 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.919 0.341 . . . . 0.0 111.919 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.736 ' HA ' HD13 ' A' ' 61' ' ' LEU . . . -62.64 -38.29 89.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.889 0.376 . . . . 0.0 111.022 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.6 t -78.03 -35.49 49.72 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.149 0.5 . . . . 0.0 109.736 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.5 mtpt -69.69 -31.34 69.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.813 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -64.47 -25.43 68.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.668 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.31 28.99 65.27 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.58 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.424 ' HB3' ' CG ' ' A' ' 14' ' ' PHE . 12.7 mtm180 -125.76 -32.33 2.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.729 0.3 . . . . 0.0 111.012 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.801 HD11 HG21 ' A' ' 16' ' ' VAL . 2.7 mp -68.94 147.26 51.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.093 0.473 . . . . 0.0 111.371 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 48.8 mtm-85 -142.96 123.74 14.21 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.508 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.611 HG13 ' O ' ' A' ' 46' ' ' VAL . 41.3 t -52.75 142.76 5.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.339 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.429 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 20.2 m-20 85.22 18.66 0.12 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.237 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.43 ' O ' HG23 ' A' ' 46' ' ' VAL . 3.4 m-20 -99.21 118.39 35.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.35 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 16.7 tm0? -74.39 126.16 30.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.945 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.912 HD23 HG12 ' A' ' 105' ' ' VAL . 73.5 mt -76.06 141.77 41.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.296 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.704 HD11 ' HB2' ' A' ' 106' ' ' ALA . 28.9 mt -123.85 -39.64 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.704 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 1.025 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -150.95 154.98 38.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.886 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.761 HG22 ' ND2' ' A' ' 71' ' ' ASN . 8.0 p -142.34 125.6 14.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.633 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.761 ' ND2' HG22 ' A' ' 70' ' ' VAL . 67.0 m-80 64.83 12.89 8.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.65 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.21 13.22 36.86 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.205 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.417 ' CG ' ' O ' ' A' ' 70' ' ' VAL . 4.9 pt-20 -128.18 112.2 14.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 117.036 0.418 . . . . 0.0 111.018 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.4 p -65.15 170.41 4.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.947 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.644 HD22 ' HB1' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -143.68 16.59 1.81 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.216 -179.799 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.8 tp -66.18 -21.31 66.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.628 0.251 . . . . 0.0 111.052 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -91.18 14.76 62.75 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.962 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.403 ' HD2' ' HB3' ' A' ' 75' ' ' LEU . 1.0 OUTLIER -139.35 163.76 31.65 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.403 0.621 . . . . 0.0 111.235 179.845 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.565 ' HB3' HE21 ' A' ' 81' ' ' GLN . . . -67.15 162.38 22.57 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.486 -179.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -55.9 -52.51 63.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.109 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.565 HE21 ' HB3' ' A' ' 79' ' ' ALA . 2.6 pp0? -59.29 -36.29 75.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.971 0.415 . . . . 0.0 110.524 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.58 -38.65 74.07 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.344 179.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.644 ' HB1' HD22 ' A' ' 75' ' ' LEU . . . -69.18 -34.92 75.68 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.128 179.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.594 ' HA ' HD21 ' A' ' 87' ' ' LEU . 1.0 OUTLIER -69.94 -29.45 66.59 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.9 179.043 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -78.01 -39.54 41.82 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.432 ' O ' ' HB2' ' A' ' 90' ' ' SER . 1.8 m -61.79 -37.47 84.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.082 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.684 ' HA ' HG11 ' A' ' 70' ' ' VAL . 3.5 pp -78.18 -33.54 50.06 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.533 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -59.78 -52.0 67.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.668 179.074 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.508 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.85 -35.37 67.21 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.671 -179.909 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' ' 86' ' ' THR . 5.1 t -72.96 -29.85 63.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.851 0.357 . . . . 0.0 110.953 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.685 ' HE2' HD22 ' A' ' 26' ' ' LEU . 4.1 ptm -89.33 -18.23 27.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.283 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.28 29.71 6.59 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.508 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.4 OUTLIER -162.26 -30.24 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 179.897 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.426 ' HG3' HG22 ' A' ' 93' ' ' THR . 6.6 mt-10 -116.82 -44.84 2.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.905 0.383 . . . . 0.0 111.197 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.4 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -69.98 -30.22 70.21 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.908 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.74 ' HB2' HD11 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -76.59 -35.13 58.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.885 0.374 . . . . 0.0 110.173 179.519 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' A' ' 93' ' ' THR . 26.9 mtpt -42.57 -40.12 2.56 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.421 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.08 -25.59 16.39 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.529 179.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 117.56 -3.1 17.95 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.907 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.425 ' SD ' ' HB3' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -160.85 144.06 13.12 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.895 0.379 . . . . 0.0 111.156 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.562 HG22 HD21 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -111.81 145.1 18.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.423 -179.666 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.0 150.42 33.9 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.476 HD12 HG23 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -146.65 113.51 6.1 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.85 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 1.025 HD12 ' HB3' ' A' ' 69' ' ' ALA . 36.1 mt -107.32 112.91 42.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.784 178.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.912 HG12 HD23 ' A' ' 67' ' ' LEU . 22.1 m -123.27 -179.44 2.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.501 -179.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.704 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -147.76 132.4 17.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.488 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.59 ' HD2' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.323 0 CA-C-O 120.962 0.411 . . . . 0.0 111.412 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.48 HG21 ' HG2' ' A' ' 47' ' ' LYS . 1.6 mm . . . . . 0 N--CA 1.453 -0.285 0 CA-C-O 121.392 0.615 . . . . 0.0 111.264 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 20.5 m -96.47 97.76 9.69 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.665 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 29' ' ' SER . 13.6 ttmt -69.52 139.54 53.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.003 0.43 . . . . 0.0 111.145 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.564 HG23 ' O ' ' B' ' 13' ' ' VAL . 13.8 m . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.908 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.791 ' HA ' HD12 ' A' ' 109' ' ' ILE . 65.7 p -118.28 48.68 1.37 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.803 0.335 . . . . 0.0 110.867 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 13.5 mtm180 -144.34 132.35 21.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.477 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -142.7 134.67 27.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.046 0.451 . . . . 0.0 111.6 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.498 ' CE2' HD13 ' A' ' 68' ' ' ILE . 19.8 m-85 -79.02 149.93 32.06 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.238 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.618 HD12 HG23 ' A' ' 105' ' ' VAL . 0.3 OUTLIER -140.09 109.71 6.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.057 0.456 . . . . 0.0 111.649 -179.449 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.683 HG23 ' OE1' ' A' ' 102' ' ' GLN . 85.1 m -99.52 120.81 40.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.715 178.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.435 ' O ' ' N ' ' A' ' 103' ' ' LEU . 28.8 m-85 -134.61 153.87 51.76 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.466 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.2 OUTLIER -110.91 111.95 23.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.901 178.86 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.489 HG11 ' HG ' ' A' ' 26' ' ' LEU . 17.6 t -101.32 112.4 65.01 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -177.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.56 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 94.9 Cg_endo -83.5 127.5 4.43 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.591 2.194 . . . . 0.0 110.847 178.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.794 HD22 HD13 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -122.41 28.5 7.38 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -178.778 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -39.02 -32.15 0.08 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.089 0.471 . . . . 0.0 111.17 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -109.44 -34.81 6.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.255 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.417 ' HB3' ' CB ' ' A' ' 18' ' ' LEU . 39.9 t -71.97 -5.71 36.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.236 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.775 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -43.99 -30.18 1.68 Allowed Glycine 0 C--N 1.338 0.649 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.531 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.0 t -82.72 -38.52 23.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.915 0.388 . . . . 0.0 110.314 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -82.51 -1.74 51.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.395 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.1 -48.5 3.65 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.705 -0.759 . . . . 0.0 111.794 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.984 HD22 ' HE2' ' A' ' 91' ' ' MET . 8.1 tp -179.72 -32.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.585 0.231 . . . . 0.0 110.55 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.471 ' HA3' ' HA3' ' A' ' 53' ' ' GLY . . . 106.9 46.45 1.1 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.457 -0.877 . . . . 0.0 113.453 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.781 HG12 HG23 ' A' ' 49' ' ' ILE . 30.1 m -157.85 154.12 5.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.037 0.446 . . . . 0.0 111.831 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.07 121.72 45.74 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.2 m -106.04 148.02 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -155.48 129.15 8.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.071 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' A' ' 44' ' ' ILE . . . -107.88 166.53 13.14 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.864 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -113.2 -178.61 3.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.954 0.407 . . . . 0.0 110.93 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.04 135.82 24.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.242 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.489 ' OG ' HD21 ' A' ' 42' ' ' LEU . 1.6 m -48.35 143.58 4.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.823 0.345 . . . . 0.0 110.896 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.37 -49.16 67.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.532 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -95.33 -50.02 5.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.384 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 36.8 m-20 -66.04 -23.87 66.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.35 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 58.04 21.47 7.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.807 0.337 . . . . 0.0 110.964 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -94.18 135.52 35.47 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.871 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -46.57 132.05 10.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.536 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.489 HD21 ' OG ' ' A' ' 35' ' ' SER . 38.7 mt -100.79 17.98 20.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.041 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.83 177.67 46.49 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.616 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.902 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -105.78 152.49 7.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.918 0.389 . . . . 0.0 111.202 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.444 ' CE1' ' NE2' ' A' ' 66' ' ' GLN . 2.2 m-85 -135.39 138.21 43.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.708 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.697 ' O ' HG13 ' A' ' 63' ' ' VAL . 31.1 t -54.94 104.46 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.345 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.426 ' HD3' HD12 ' B' ' 10' ' ' ILE . 37.8 tptt -73.74 -42.71 60.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.757 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.5 t -168.95 119.16 0.72 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.182 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.781 HG23 HG12 ' A' ' 28' ' ' VAL . 80.8 mt -85.3 121.97 37.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.244 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.463 HD13 ' HA2' ' A' ' 27' ' ' GLY . 1.9 mp -59.52 107.17 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.371 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -61.17 78.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.887 0.375 . . . . 0.0 110.776 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 155.97 -28.68 0.59 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.194 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.471 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -67.19 -171.59 5.11 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.853 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.56 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -63.09 -40.72 98.5 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.578 ' HA ' HD13 ' A' ' 61' ' ' LEU . . . -64.91 -44.86 88.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.813 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.09 -28.48 66.53 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.592 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.4 mtpt -79.55 -28.23 41.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.061 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.2 -29.94 67.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.603 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.17 14.04 76.53 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.944 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -130.4 1.41 4.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.915 0.357 . . . . 0.0 111.34 179.866 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.689 ' HB3' HD13 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -103.38 128.43 50.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.882 0.372 . . . . 0.0 111.241 -179.755 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.612 HH21 HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -138.14 141.88 40.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.753 179.362 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.697 HG13 ' O ' ' A' ' 46' ' ' VAL . 39.0 t -55.91 146.15 5.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.213 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 18.0 m-20 87.27 13.56 0.11 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.378 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.454 ' O ' HG23 ' A' ' 46' ' ' VAL . 5.0 m-20 -93.4 120.6 33.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.721 0.296 . . . . 0.0 110.39 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.444 ' NE2' ' CE1' ' A' ' 45' ' ' PHE . 0.8 OUTLIER -78.2 135.05 37.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.763 -179.8 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.965 HD23 HG12 ' A' ' 105' ' ' VAL . 80.0 mt -85.25 140.9 30.5 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.841 0.353 . . . . 0.0 110.799 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.944 HD11 ' HB2' ' A' ' 106' ' ' ALA . 24.0 mt -123.17 -40.27 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.219 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.871 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -155.18 138.43 15.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.355 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.771 HG22 HD22 ' A' ' 71' ' ' ASN . 12.3 p -127.74 125.58 65.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.78 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.771 HD22 HG22 ' A' ' 70' ' ' VAL . 58.7 m-80 61.21 27.0 16.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.724 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.53 25.32 56.96 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.002 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -130.4 104.38 7.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.692 0.282 . . . . 0.0 110.779 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.8 t -58.54 155.56 12.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.013 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.472 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . 1.0 OUTLIER -118.32 -9.55 10.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.697 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 30.0 mt -57.01 -20.66 25.4 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.666 0.27 . . . . 0.0 111.408 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -92.75 27.41 11.01 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.788 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.42 ' HD2' ' HA ' ' A' ' 83' ' ' ALA . 1.1 ptpm? -160.71 162.78 32.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.288 0.566 . . . . 0.0 111.189 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.642 ' HB3' HE21 ' A' ' 81' ' ' GLN . . . -66.12 164.03 16.38 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.391 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.408 ' O ' ' HG2' ' A' ' 84' ' ' MET . 20.3 m-80 -56.0 -57.51 11.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.812 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.642 HE21 ' HB3' ' A' ' 79' ' ' ALA . 2.3 pp0? -54.76 -38.61 67.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.955 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.38 -36.16 73.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.007 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.578 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -69.17 -51.07 41.82 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.783 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.432 ' HA ' ' CD2' ' A' ' 87' ' ' LEU . 6.6 ptp -60.39 -29.04 68.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.801 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.39 -31.9 42.91 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.414 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 2.1 m -70.13 -35.79 74.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.291 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.853 HD12 ' N ' ' A' ' 88' ' ' ARG . 4.2 pp -78.0 -34.26 50.89 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.853 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -57.26 -50.45 72.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.339 178.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.488 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.33 -38.06 68.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.171 179.697 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 63.7 m -67.4 -29.1 68.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.929 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.984 ' HE2' HD22 ' A' ' 26' ' ' LEU . 2.6 ptp -88.25 -28.23 21.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.678 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -110.77 26.58 10.54 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.488 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.4 OUTLIER -156.06 -33.04 0.09 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.441 ' HG3' HG22 ' A' ' 93' ' ' THR . 7.6 mt-10 -115.56 -36.68 4.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.822 0.344 . . . . 0.0 111.138 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.475 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -80.44 -32.09 35.44 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.884 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.717 ' HB2' HD11 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -76.73 -34.33 58.11 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 179.543 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 93' ' ' THR . 48.4 mtpt -42.12 -32.49 0.47 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.473 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.97 -25.03 12.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.875 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 121.58 -7.63 10.34 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.789 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.467 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -157.02 144.66 19.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.89 0.376 . . . . 0.0 110.914 -179.895 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.557 HG22 HD21 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -108.3 143.69 18.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.412 -179.71 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.683 ' OE1' HG23 ' A' ' 13' ' ' THR . 1.1 tm0? -76.94 142.18 40.17 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -137.59 145.88 43.34 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.115 0.483 . . . . 0.0 112.115 -178.757 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.871 HD12 ' HB3' ' A' ' 69' ' ' ALA . 22.8 mt -139.1 112.77 6.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.468 178.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.965 HG12 HD23 ' A' ' 67' ' ' LEU . 27.4 m -132.15 150.14 33.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.855 0.36 . . . . 0.0 111.578 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.944 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -114.77 129.27 56.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.686 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.465 ' HB3' HD11 ' A' ' 12' ' ' LEU . 1.8 tmm_? -129.61 143.58 50.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.888 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 8' ' ' THR . 72.3 mtm-85 -85.59 148.28 26.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.971 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.791 HD12 ' HA ' ' A' ' 8' ' ' THR . 31.5 mt -73.41 108.7 5.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.114 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.829 -179.985 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.911 0.386 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -84.72 170.33 13.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.859 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -94.43 23.98 4.84 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.128 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 59.47 28.97 18.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.853 0.359 . . . . 0.0 110.968 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -139.66 30.85 2.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.83 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.31 -165.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.902 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 178.75 147.14 0.17 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.145 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.426 HD12 ' HD3' ' A' ' 47' ' ' LYS . 1.0 OUTLIER -108.23 155.29 9.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.929 0.395 . . . . 0.0 111.203 -179.386 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 66.1 m -138.3 115.91 11.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.732 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -69.94 115.23 8.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.836 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.721 HG12 ' HG3' ' A' ' 88' ' ' ARG . 15.3 m . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.298 -0.858 . . . . 0.0 111.121 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.378 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.5 p -143.03 24.16 1.84 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.627 0.251 . . . . 0.0 110.981 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.6 ttp180 -78.06 146.99 34.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.923 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -155.11 148.09 24.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.04 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -88.01 146.18 25.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.604 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.918 HD12 HG23 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -140.82 109.86 6.14 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.9 0.381 . . . . 0.0 111.333 -179.504 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.5 m -80.55 145.49 31.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.979 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.438 ' CD1' ' HG3' ' A' ' 60' ' ' ARG . 12.8 m-85 -140.28 171.41 14.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.368 0.604 . . . . 0.0 112.132 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -143.55 103.43 4.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.028 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.6 HG11 ' HG ' ' A' ' 26' ' ' LEU . 17.8 t -104.83 112.05 65.26 Favored Pre-proline 0 C--N 1.329 -0.302 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -177.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.593 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 93.7 Cg_endo -83.46 127.53 4.46 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.413 2.076 . . . . 0.0 110.798 178.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.744 HD22 HD13 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -120.85 27.96 8.2 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.848 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -40.93 -30.2 0.12 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.999 0.428 . . . . 0.0 110.744 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -114.87 -31.47 6.1 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.174 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.582 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 43.0 t -72.65 -7.55 50.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.139 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.637 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -45.27 -28.3 2.05 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.624 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.6 m -85.44 -34.86 21.58 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.942 0.401 . . . . 0.0 110.677 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.14 8.97 24.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.526 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.62 -56.23 5.02 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.932 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.799 HD22 ' HE2' ' A' ' 91' ' ' MET . 9.7 tp -178.8 -27.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.518 0.199 . . . . 0.0 111.155 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.485 ' HA3' ' HA3' ' A' ' 53' ' ' GLY . . . 109.75 35.54 2.2 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.31 -0.948 . . . . 0.0 113.536 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.702 HG12 HG23 ' A' ' 49' ' ' ILE . 13.0 m -158.95 157.75 3.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 117.08 0.44 . . . . 0.0 111.538 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.533 ' O ' ' N ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -114.15 134.94 54.55 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.711 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.614 HG11 HD11 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -120.65 143.56 32.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.119 0.485 . . . . 0.0 111.896 -178.809 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.56 ' HB3' HD13 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -142.12 129.71 21.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.587 179.666 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -102.7 153.3 18.32 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.991 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -125.28 175.25 7.57 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.009 0.433 . . . . 0.0 111.252 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.5 mtt85 -122.57 157.42 32.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.736 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.729 ' CA ' HD21 ' A' ' 42' ' ' LEU . 19.5 m -51.28 155.86 1.3 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.269 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.05 -39.59 86.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.111 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.58 -78.68 0.18 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.958 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -81.64 -175.77 5.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.834 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -98.32 29.91 3.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.942 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.24 115.84 14.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.098 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.41 ' CB ' ' ND2' ' A' ' 80' ' ' ASN . 1.2 p30 -59.08 119.62 7.63 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.951 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.729 HD21 ' CA ' ' A' ' 35' ' ' SER . 17.4 mt -75.58 -26.42 57.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.872 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.466 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 133.21 -176.69 19.45 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.121 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.906 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -107.32 134.53 48.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.876 0.369 . . . . 0.0 111.262 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.464 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -117.55 144.08 45.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.565 -179.79 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.674 ' O ' HG13 ' A' ' 63' ' ' VAL . 21.3 t -54.54 106.36 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.124 0.488 . . . . 0.0 110.941 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.599 ' HG3' HG23 ' B' ' 10' ' ' ILE . 0.5 OUTLIER -65.99 -52.58 48.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.638 179.86 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.6 t -169.41 133.86 1.4 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.388 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.709 HD13 ' HB3' ' A' ' 61' ' ' LEU . 65.8 mt -95.06 116.55 36.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.083 0.468 . . . . 0.0 111.826 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.505 HD12 ' N ' ' A' ' 28' ' ' VAL . 2.3 mp -58.09 115.9 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.199 178.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -68.23 69.86 0.15 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.068 0.461 . . . . 0.0 110.69 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 168.21 -29.62 0.16 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.375 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.485 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -68.02 -172.33 6.6 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.907 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.593 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -62.98 -40.87 99.03 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.646 ' CB ' HD13 ' A' ' 61' ' ' LEU . . . -64.69 -48.06 76.09 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.936 0.398 . . . . 0.0 111.561 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.3 t -63.35 -30.66 71.75 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.216 0.531 . . . . 0.0 110.09 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 39.5 mtpt -76.68 -28.85 56.09 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.055 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.72 -29.26 64.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.882 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 68.05 16.51 68.71 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.202 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.438 ' HG3' ' CD1' ' A' ' 14' ' ' PHE . 0.8 OUTLIER -138.47 11.57 2.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.908 0.354 . . . . 0.0 111.274 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.709 ' HB3' HD13 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -106.68 134.92 49.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.689 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.854 ' NH2' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -139.12 144.57 38.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.85 179.774 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.674 HG13 ' O ' ' A' ' 46' ' ' VAL . 46.2 t -61.89 148.69 9.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.085 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 23.7 m-20 88.11 -10.46 0.51 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.431 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.659 ' O ' HG23 ' A' ' 46' ' ' VAL . 1.2 m-20 -66.5 115.05 5.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.769 0.318 . . . . 0.0 110.626 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.468 ' O ' ' HA ' ' A' ' 105' ' ' VAL . 18.3 tm0? -69.16 135.86 51.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.699 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.908 HD23 HG12 ' A' ' 105' ' ' VAL . 93.2 mt -87.75 139.85 30.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.849 0.357 . . . . 0.0 111.148 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.629 HD11 ' HB2' ' A' ' 106' ' ' ALA . 2.4 mt -122.28 -44.36 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.888 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 1.028 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -147.83 145.57 28.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.702 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.765 HG22 HD22 ' A' ' 71' ' ' ASN . 7.1 p -132.68 130.0 58.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.313 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.765 HD22 HG22 ' A' ' 70' ' ' VAL . 23.7 m-80 61.2 26.95 16.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.819 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.97 23.69 59.05 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.389 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -131.89 108.7 9.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.804 0.335 . . . . 0.0 110.864 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.0 t -59.21 154.67 15.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.711 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.508 HD21 HG12 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -115.8 -15.59 11.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.582 -179.723 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.414 ' CD2' HG23 ' A' ' 68' ' ' ILE . 4.1 mm? -46.66 -44.13 18.25 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.942 0.401 . . . . 0.0 111.173 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -57.51 -35.47 72.86 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.574 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.4 ptpm? -101.31 168.12 9.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.286 0.565 . . . . 0.0 111.297 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.45 ' HB3' HE22 ' A' ' 81' ' ' GLN . . . -71.34 174.73 6.12 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.542 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.432 ' HB2' ' HA3' ' A' ' 32' ' ' GLY . 8.1 p30 -67.0 -52.26 44.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.581 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.45 HE22 ' HB3' ' A' ' 79' ' ' ALA . 5.1 pm0 -58.12 -41.26 83.24 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.931 0.396 . . . . 0.0 110.483 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -70.45 -37.85 74.38 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.505 ' HB3' ' CD1' ' A' ' 44' ' ' ILE . . . -66.77 -33.49 75.73 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.229 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.522 ' HE2' ' HB2' ' A' ' 84' ' ' MET . 0.0 OUTLIER -72.54 -32.32 66.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.981 179.236 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -78.48 -35.38 46.62 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.38 178.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.445 ' HA ' ' HD2' ' A' ' 89' ' ' ARG . 1.5 m -67.28 -35.72 80.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.311 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.74 HD12 ' N ' ' A' ' 88' ' ' ARG . 4.4 pp -78.31 -33.71 49.18 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.74 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -63.24 -50.84 68.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.788 179.312 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.445 ' HD2' ' HA ' ' A' ' 86' ' ' THR . 0.0 OUTLIER -73.03 -34.62 66.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.065 179.771 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.415 ' O ' ' ND2' ' A' ' 71' ' ' ASN . 55.9 m -72.19 -31.64 66.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.77 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.799 ' HE2' HD22 ' A' ' 26' ' ' LEU . 3.8 ptm -88.08 -18.72 28.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.614 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.01 18.14 14.73 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.472 HG22 ' HG3' ' A' ' 94' ' ' GLU . 0.4 OUTLIER -153.28 -37.99 0.1 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.898 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.52 ' HA ' ' CG ' ' A' ' 97' ' ' LYS . 8.6 mt-10 -104.15 -42.01 5.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.003 0.43 . . . . 0.0 111.742 -178.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.424 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -68.44 -37.94 86.25 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.806 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.677 ' HB2' HD11 ' A' ' 18' ' ' LEU . 1.1 t-20 -67.13 -33.76 76.14 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.52 ' CG ' ' HA ' ' A' ' 94' ' ' GLU . 4.2 mmmt -31.42 -51.8 0.2 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.464 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.95 -27.48 16.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.757 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 122.8 1.11 9.84 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.813 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.482 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -161.77 142.55 10.76 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 121.038 0.447 . . . . 0.0 111.371 -179.743 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.565 HD11 HG23 ' A' ' 70' ' ' VAL . 0.1 OUTLIER -114.81 138.64 44.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.853 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.42 ' HA ' ' O ' ' A' ' 14' ' ' PHE . 2.2 pp0? -76.54 149.91 36.63 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.463 HD13 HG21 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -140.99 111.16 6.67 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.778 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 1.028 HD12 ' HB3' ' A' ' 69' ' ' ALA . 45.6 mt -98.35 112.77 31.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.918 HG23 HD12 ' A' ' 12' ' ' LEU . 18.1 m -124.28 152.42 30.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.454 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.629 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -124.95 148.11 48.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.113 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.769 ' HG3' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -160.59 171.85 18.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.98 179.797 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 21.4 mtm180 -94.22 135.08 35.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.009 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 7.1 mt -62.61 115.22 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.02 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 46.6 t . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.896 -179.998 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.848 0.356 . . . . 0.0 110.755 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -78.75 170.07 17.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.964 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.41 39.1 1.73 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.536 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 74.34 114.8 0.06 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.695 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 63.02 80.58 0.23 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.75 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 1.1 m -81.46 -93.58 0.05 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.93 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 167.15 154.79 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.599 HG23 ' HG3' ' A' ' 47' ' ' LYS . 4.2 mm -136.36 109.18 8.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.976 0.417 . . . . 0.0 111.333 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . 0.42 ' CB ' ' HG2' ' A' ' 84' ' ' MET . 3.5 m -94.33 97.93 10.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.664 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -73.93 127.81 33.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.121 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 18.4 m . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.562 -0.732 . . . . 0.0 110.693 179.683 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.422 -0.271 . . . . 0.0 112.422 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.3 p -124.05 20.89 9.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.679 0.276 . . . . 0.0 111.029 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 12.0 mtm180 -104.63 121.37 43.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.872 0.368 . . . . 0.0 110.708 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.27 169.1 18.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.069 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.568 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 2.4 p90 -112.36 148.34 34.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.645 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.889 HD11 ' HD2' ' A' ' 107' ' ' ARG . 0.1 OUTLIER -129.14 120.72 26.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.36 -178.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.0 m -83.15 145.43 29.21 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.336 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.435 ' CD1' ' HB3' ' A' ' 60' ' ' ARG . 63.8 m-85 -140.67 171.35 14.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.383 0.611 . . . . 0.0 112.219 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -140.13 106.99 5.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.214 -0.903 . . . . 0.0 108.902 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.776 ' CG2' HD11 ' A' ' 61' ' ' LEU . 17.3 t -105.61 117.75 57.2 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 -177.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.727 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 90.2 Cg_endo -86.69 128.18 2.84 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.764 2.309 . . . . 0.0 110.936 178.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.746 HD11 ' HB2' ' A' ' 96' ' ' ASN . 0.5 OUTLIER -122.77 28.63 7.19 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -178.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -40.91 -30.57 0.13 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.167 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -113.01 -32.53 6.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.14 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.706 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 41.7 t -70.74 -6.56 38.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.182 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.603 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -42.97 -30.03 0.95 Allowed Glycine 0 C--N 1.337 0.605 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.664 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.8 m -83.16 -40.37 19.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.885 0.374 . . . . 0.0 110.434 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.98 -5.79 56.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.266 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.92 -46.8 3.12 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.953 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.888 HD22 ' HE2' ' A' ' 91' ' ' MET . 6.2 tp 178.79 -33.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.661 0.267 . . . . 0.0 110.677 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.452 ' HA3' ' HA3' ' A' ' 53' ' ' GLY . . . 102.96 49.86 1.12 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.442 -0.885 . . . . 0.0 113.565 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.785 HG12 HG23 ' A' ' 49' ' ' ILE . 34.2 m -158.41 154.81 4.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 117.053 0.426 . . . . 0.0 111.78 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.439 ' O ' ' HB3' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -112.24 111.12 21.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.343 178.606 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.535 HG11 HD11 ' A' ' 67' ' ' LEU . 2.3 m -106.93 141.93 20.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.09 0.471 . . . . 0.0 111.843 -178.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.417 ' HB3' HG23 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -145.94 129.68 17.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.199 179.423 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -91.33 158.09 25.28 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.017 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -114.0 -178.76 3.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.9 0.381 . . . . 0.0 110.929 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 67.9 mtt180 -135.96 152.67 51.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.541 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.469 ' OG ' HD21 ' A' ' 42' ' ' LEU . 50.1 m -54.36 144.38 20.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.041 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.75 -33.39 75.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.981 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.14 -68.47 0.7 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.891 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -94.3 -173.41 3.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.85 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 65.2 m-70 -101.53 31.1 3.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.036 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.74 128.34 34.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.953 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.401 ' CB ' ' ND2' ' A' ' 80' ' ' ASN . 3.7 p-10 -57.18 149.0 20.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.137 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.469 HD21 ' OG ' ' A' ' 35' ' ' SER . 35.7 mt -113.14 -1.0 14.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.323 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.475 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 113.7 169.83 17.07 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.313 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.762 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -102.82 131.23 51.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.709 0.29 . . . . 0.0 110.951 179.757 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.445 ' N ' ' CD1' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -119.54 144.95 46.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.866 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.715 ' O ' HG13 ' A' ' 63' ' ' VAL . 39.0 t -60.78 104.57 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.641 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.439 ' HB3' ' O ' ' A' ' 29' ' ' SER . 2.2 tptt -73.71 -42.26 61.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.569 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.48 119.64 1.05 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.113 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.785 HG23 HG12 ' A' ' 28' ' ' VAL . 68.0 mt -85.18 117.8 30.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.015 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.556 HD12 ' N ' ' A' ' 28' ' ' VAL . 1.6 mp -55.72 106.6 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.462 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -64.64 74.2 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.014 0.435 . . . . 0.0 110.73 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 162.6 -26.4 0.23 Allowed Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.326 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.452 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -71.19 -163.46 5.41 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.85 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.727 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -71.28 -41.61 69.8 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.65 ' HB1' HD22 ' A' ' 61' ' ' LEU . . . -65.34 -43.4 91.02 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.317 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.652 ' OG ' HG22 ' A' ' 49' ' ' ILE . 1.2 m -67.5 -36.13 80.48 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.889 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -68.85 -33.95 74.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.597 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -60.24 -26.78 66.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.756 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 58.54 26.76 60.16 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.368 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.435 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 8.7 mtm180 -121.39 -28.52 4.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.63 0.252 . . . . 0.0 111.109 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.776 HD11 ' CG2' ' A' ' 16' ' ' VAL . 4.2 mp -75.91 151.1 37.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.136 0.493 . . . . 0.0 111.677 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.765 HH22 HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -146.56 131.53 18.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.172 179.701 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.715 HG13 ' O ' ' A' ' 46' ' ' VAL . 47.3 t -57.69 141.69 14.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.121 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.466 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 28.4 m-20 89.91 17.41 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.577 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -103.28 123.44 46.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.327 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.427 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -81.52 136.41 35.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.789 0.328 . . . . 0.0 110.793 -179.583 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.762 HD12 HG13 ' A' ' 44' ' ' ILE . 7.9 mt -87.51 131.21 34.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.569 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 1.021 HD11 ' HB2' ' A' ' 106' ' ' ALA . 34.5 mt -110.98 -33.97 2.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.614 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.934 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -153.34 157.47 40.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.132 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.804 HG22 ' ND2' ' A' ' 71' ' ' ASN . 8.4 p -142.25 126.42 15.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.387 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.804 ' ND2' HG22 ' A' ' 70' ' ' VAL . 66.1 m-80 60.68 18.87 8.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.74 0.305 . . . . 0.0 110.931 -179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.0 27.46 23.58 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.118 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -129.04 101.27 5.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.826 0.346 . . . . 0.0 110.828 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.0 t -65.33 148.5 51.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.05 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.62 HD22 ' HB1' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -130.61 14.43 5.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.234 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.5 tp -60.47 -22.5 63.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.725 0.297 . . . . 0.0 111.04 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -82.06 -27.21 46.01 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.662 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.4 ' HD3' ' HB3' ' A' ' 82' ' ' GLU . 1.6 ptpm? -96.05 171.31 8.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.174 0.512 . . . . 0.0 111.24 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.621 ' HB3' HE21 ' A' ' 81' ' ' GLN . . . -76.81 165.02 25.27 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.467 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.402 ' HB2' ' HA3' ' A' ' 32' ' ' GLY . 8.4 p30 -57.0 -47.95 79.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.252 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.621 HE21 ' HB3' ' A' ' 79' ' ' ALA . 2.1 pp0? -59.77 -43.86 94.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.907 0.384 . . . . 0.0 110.938 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.4 ' HB3' ' HD3' ' A' ' 78' ' ' LYS . 1.7 mm-40 -70.01 -32.57 70.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.853 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.62 ' HB1' HD22 ' A' ' 75' ' ' LEU . . . -69.16 -47.42 65.05 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.619 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.546 ' HB3' HG21 ' A' ' 44' ' ' ILE . 6.8 ptp -61.96 -31.64 71.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.101 0.477 . . . . 0.0 109.863 178.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.11 -34.75 66.34 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.442 ' HB ' ' O ' ' A' ' 83' ' ' ALA . 2.1 m -62.97 -34.21 77.03 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.141 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.703 HD13 HD13 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -76.24 -35.05 59.17 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.868 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.4 ' HG3' ' CG1' ' B' ' 13' ' ' VAL . 0.0 OUTLIER -58.06 -51.84 68.03 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.772 179.416 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.482 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -71.57 -43.42 66.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.612 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.435 ' HB2' ' O ' ' A' ' 86' ' ' THR . 1.6 t -65.6 -29.55 70.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.174 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.888 ' HE2' HD22 ' A' ' 26' ' ' LEU . 2.2 ptp -89.58 -19.88 24.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.629 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.21 27.56 8.75 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 -179.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.3 OUTLIER -162.19 -31.23 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.435 ' HA ' ' HG3' ' A' ' 97' ' ' LYS . 7.4 mt-10 -111.62 -72.49 0.71 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.788 0.328 . . . . 0.0 111.55 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.435 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -49.2 -29.67 9.89 Favored Glycine 0 CA--C 1.517 0.204 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.633 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.746 ' HB2' HD11 ' A' ' 18' ' ' LEU . 0.8 OUTLIER -73.68 -34.59 64.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.856 0.36 . . . . 0.0 110.257 179.711 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.435 ' HG3' ' HA ' ' A' ' 94' ' ' GLU . 8.9 mtpp -40.01 -34.6 0.3 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.47 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.87 -25.05 12.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.705 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 122.64 -8.3 9.44 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.006 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.435 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -154.48 144.2 21.6 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.924 0.392 . . . . 0.0 111.53 -179.636 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.481 HG22 HD21 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -110.52 140.54 29.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.034 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.408 ' HB3' ' HA ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -76.88 150.48 36.03 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.922 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.534 HD12 HG23 ' A' ' 16' ' ' VAL . 0.5 OUTLIER -143.54 111.03 5.86 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -178.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.934 HD12 ' HB3' ' A' ' 69' ' ' ALA . 36.5 mt -102.0 113.33 38.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.732 178.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.752 HG23 HD12 ' A' ' 12' ' ' LEU . 4.4 m -116.83 174.9 3.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.058 0.456 . . . . 0.0 111.664 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 1.021 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -147.38 137.02 22.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.998 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.889 ' HD2' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -156.5 -178.18 7.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.709 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -107.58 133.73 51.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.906 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 47.1 mt -64.81 105.38 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.93 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.7 t . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.868 179.99 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.828 0.347 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -112.45 163.48 14.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.967 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -98.9 31.75 2.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.746 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 60.94 81.53 0.19 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.801 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 26.8 m170 58.89 102.63 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.702 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.72 -87.96 0.39 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.134 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 170.21 151.71 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.417 HG23 ' HB3' ' A' ' 31' ' ' LYS . 1.6 mm -112.09 144.54 19.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.991 0.424 . . . . 0.0 111.237 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 99.0 m -119.27 99.48 6.72 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.687 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 9.3 ttmt -72.66 122.63 21.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.001 0.429 . . . . 0.0 110.946 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.4 ' CG1' ' HG3' ' A' ' 88' ' ' ARG . 35.4 m . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.123 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 N-CA-C 112.544 -0.222 . . . . 0.0 112.544 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.402 ' O ' ' HG2' ' A' ' 108' ' ' ARG . 28.8 p -135.54 69.57 1.44 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.891 0.376 . . . . 0.0 110.895 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.02 123.15 9.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.728 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -136.82 137.53 39.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.373 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -83.85 149.91 26.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.539 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.836 HD22 ' NH2' ' A' ' 62' ' ' ARG . 0.2 OUTLIER -136.72 109.83 7.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.97 0.414 . . . . 0.0 111.273 -179.639 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.78 HG23 ' OE1' ' A' ' 102' ' ' GLN . 39.6 m -101.15 127.85 47.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.584 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.463 ' CZ ' ' HB3' ' A' ' 60' ' ' ARG . 29.5 m-85 -140.86 172.62 12.44 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.424 0.63 . . . . 0.0 112.327 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.495 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.4 OUTLIER -126.38 112.43 15.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.021 179.131 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.917 HG23 HD23 ' A' ' 103' ' ' LEU . 21.9 t -104.77 111.7 65.24 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -177.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.562 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 85.8 Cg_endo -83.3 127.64 4.6 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.431 2.087 . . . . 0.0 110.738 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.888 HD11 ' HB2' ' A' ' 96' ' ' ASN . 0.5 OUTLIER -121.54 27.99 7.95 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -178.893 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -39.86 -31.06 0.1 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.289 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -112.23 -32.04 6.66 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.163 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.516 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 12.6 t -70.51 -6.0 33.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.181 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.617 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -43.83 -29.85 1.48 Allowed Glycine 0 C--N 1.337 0.621 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.732 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.39 -36.09 22.68 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.971 0.415 . . . . 0.0 110.598 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.79 -6.71 59.49 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.377 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.25 -47.47 2.87 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.948 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.959 HD22 ' HE2' ' A' ' 91' ' ' MET . 6.8 tp 178.47 -29.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.589 0.233 . . . . 0.0 110.824 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.494 ' HA3' ' HA3' ' A' ' 53' ' ' GLY . . . 104.58 42.67 1.82 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.501 -0.857 . . . . 0.0 113.3 179.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.779 HG12 HG23 ' A' ' 49' ' ' ILE . 33.1 m -157.15 158.5 3.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.206 0.527 . . . . 0.0 111.988 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -117.1 118.03 31.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.208 178.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.626 HG11 HD11 ' A' ' 67' ' ' LEU . 2.5 m -106.35 149.61 9.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.228 0.537 . . . . 0.0 112.379 -178.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.404 ' HG2' ' CD ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -148.38 130.77 15.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.026 179.415 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' A' ' 44' ' ' ILE . . . -104.76 161.59 15.04 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.266 -0.969 . . . . 0.0 113.115 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 -130.67 170.93 13.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.968 0.413 . . . . 0.0 110.907 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.26 154.24 31.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.621 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.845 ' HA ' HD21 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -47.45 149.21 1.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.302 -179.884 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.42 -47.97 68.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.359 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -73.59 -50.07 23.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.328 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -121.14 168.36 11.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.746 0.308 . . . . 0.0 111.039 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -83.41 57.78 4.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.143 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.548 ' HB3' ' HB2' ' A' ' 35' ' ' SER . . . -103.04 109.49 21.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.765 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.404 ' HB3' ' ND2' ' A' ' 80' ' ' ASN . 37.4 m-20 -45.91 119.29 2.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.722 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.845 HD21 ' HA ' ' A' ' 35' ' ' SER . 8.8 mt -88.24 -1.3 57.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.009 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.426 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 106.91 -174.62 20.12 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.172 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.796 ' CG1' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -111.41 138.34 40.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.907 0.384 . . . . 0.0 111.284 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.71 141.5 49.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.629 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.672 ' O ' HG13 ' A' ' 63' ' ' VAL . 38.6 t -54.7 107.2 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.841 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.475 ' HD3' HD12 ' B' ' 10' ' ' ILE . 21.2 tptt -77.21 -41.47 41.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.627 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.6 m -167.5 123.91 1.13 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.06 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.779 HG23 HG12 ' A' ' 28' ' ' VAL . 69.3 mt -90.92 124.26 43.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.359 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.446 HD12 ' N ' ' A' ' 28' ' ' VAL . 2.1 mp -63.89 110.28 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.379 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.13 70.98 0.06 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.084 0.469 . . . . 0.0 110.892 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 166.98 -27.45 0.16 Allowed Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.111 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.494 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -70.04 -166.85 5.92 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.944 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.562 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -68.64 -41.09 79.89 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.711 ' HB1' HD22 ' A' ' 61' ' ' LEU . . . -66.65 -41.12 88.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.57 -179.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 t -70.07 -33.3 71.74 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.139 0.495 . . . . 0.0 110.116 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.3 mtpt -73.62 -29.05 62.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.076 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.78 -29.96 67.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.565 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 68.52 15.74 68.74 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.824 -0.703 . . . . 0.0 113.005 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.463 ' HB3' ' CZ ' ' A' ' 14' ' ' PHE . 0.5 OUTLIER -129.0 -0.72 5.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.764 0.282 . . . . 0.0 111.222 179.832 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.711 HD22 ' HB1' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -99.23 132.98 44.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.91 0.386 . . . . 0.0 111.18 -179.67 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.836 ' NH2' HD22 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -138.27 142.47 39.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.769 179.546 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.672 HG13 ' O ' ' A' ' 46' ' ' VAL . 55.0 t -56.41 147.04 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.175 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 29.9 m-20 89.76 -10.47 0.37 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.371 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -63.62 107.26 1.11 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.821 0.343 . . . . 0.0 110.729 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 21.4 tm0? -71.5 114.0 9.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.608 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.94 HD23 ' CG1' ' A' ' 105' ' ' VAL . 7.9 mt -68.07 142.7 55.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.958 0.408 . . . . 0.0 111.561 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.711 HD11 ' CB ' ' A' ' 106' ' ' ALA . 36.6 mt -129.18 -34.92 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.374 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.976 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -148.65 166.26 28.86 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.896 0.379 . . . . 0.0 111.288 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.631 HG22 ' ND2' ' A' ' 71' ' ' ASN . 12.3 p -155.19 118.85 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.903 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.631 ' ND2' HG22 ' A' ' 70' ' ' VAL . 68.5 m-80 56.72 43.82 24.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.556 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 70.93 23.54 77.94 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.722 -0.752 . . . . 0.0 111.966 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -122.55 97.37 5.43 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.778 0.323 . . . . 0.0 110.862 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.82 119.37 13.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.929 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.635 HD13 ' HB1' ' A' ' 83' ' ' ALA . 9.8 mt -72.27 -15.65 61.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.175 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 21.6 mt -52.2 93.13 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.892 0.377 . . . . 0.0 111.013 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 151.51 -24.16 0.95 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.415 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.5 ptpm? -111.93 167.75 10.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.165 0.507 . . . . 0.0 111.072 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.4 ' HB3' ' NE2' ' A' ' 81' ' ' GLN . . . -74.02 165.13 25.67 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.279 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.43 ' HB3' ' HA3' ' A' ' 32' ' ' GLY . 22.2 m-80 -52.29 -57.47 9.65 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.258 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.413 ' HA ' ' HG2' ' A' ' 84' ' ' MET . 2.6 pp0? -53.82 -38.75 64.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.399 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.85 -38.88 73.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.277 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.635 ' HB1' HD13 ' A' ' 75' ' ' LEU . . . -66.76 -47.88 70.82 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.746 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.498 ' HB3' HG21 ' A' ' 44' ' ' ILE . 5.0 ptp -63.13 -29.7 71.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.977 179.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.66 -32.36 47.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.385 178.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.444 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 1.4 m -69.03 -36.59 77.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.348 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.479 ' CD2' ' HA ' ' A' ' 84' ' ' MET . 4.4 pp -78.46 -33.82 48.13 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.75 ' HG3' HG12 ' B' ' 13' ' ' VAL . 1.1 ttt180 -58.4 -51.69 68.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.465 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.575 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.27 -33.88 67.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.195 179.814 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.435 ' HB2' ' O ' ' A' ' 86' ' ' THR . 5.3 t -70.45 -29.17 65.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.25 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.959 ' HE2' HD22 ' A' ' 26' ' ' LEU . 4.2 ptp -88.77 -20.27 24.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.533 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.75 39.57 3.93 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.575 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.5 OUTLIER -171.71 -22.22 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 179.696 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.479 ' HG3' HG22 ' A' ' 93' ' ' THR . 12.0 mt-10 -127.9 -59.0 1.21 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.91 0.386 . . . . 0.0 111.091 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.438 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -67.52 -25.28 73.87 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.998 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.888 ' HB2' HD11 ' A' ' 18' ' ' LEU . 0.6 OUTLIER -78.44 -32.93 48.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.966 0.412 . . . . 0.0 110.24 179.517 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.497 ' HD3' ' O ' ' A' ' 93' ' ' THR . 10.5 mmmt -44.22 -40.14 4.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.258 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.63 -28.29 19.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.743 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 122.74 -7.43 9.51 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.951 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.495 ' SD ' ' HB3' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -157.05 143.45 18.14 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.061 0.458 . . . . 0.0 111.29 -179.709 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.91 HD11 HD11 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -113.94 146.99 17.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.188 -179.713 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.78 ' OE1' HG23 ' A' ' 13' ' ' THR . 1.2 tm0? -87.86 139.94 30.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.095 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.917 HD23 HG23 ' A' ' 16' ' ' VAL . 2.5 mm? -131.73 141.87 49.64 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.131 0.491 . . . . 0.0 112.046 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.976 HD12 ' HB3' ' A' ' 69' ' ' ALA . 73.5 mt -127.09 112.31 28.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.94 ' CG1' HD23 ' A' ' 67' ' ' LEU . 29.8 m -132.5 133.08 60.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.825 -178.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.711 ' CB ' HD11 ' A' ' 68' ' ' ILE . . . -108.93 139.48 43.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.254 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.655 ' CG ' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -134.52 175.77 9.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.991 0.424 . . . . 0.0 111.382 -179.699 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' A' ' 8' ' ' THR . 5.1 mtm180 -97.76 143.77 28.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.175 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 19.4 mt -87.15 109.85 19.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.937 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 76.6 p . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.013 -179.89 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.886 0.374 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -102.34 166.17 10.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.844 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.82 34.45 4.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.904 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 60.83 169.33 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.808 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 59.2 m170 60.95 30.21 19.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.934 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.0 -175.0 0.53 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.839 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . 0.408 ' O ' ' NE2' ' B' ' 9' ' ' GLN . 1.2 pp0? -178.67 156.61 0.89 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.044 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.475 HD12 ' HD3' ' A' ' 47' ' ' LYS . 1.0 OUTLIER -116.53 155.15 18.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.893 0.378 . . . . 0.0 111.128 -179.536 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . 0.402 HG22 HG13 ' B' ' 13' ' ' VAL . 53.2 m -126.75 134.56 50.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.974 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.27 109.48 16.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.63 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.75 HG12 ' HG3' ' A' ' 88' ' ' ARG . 16.8 m . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.151 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 N-CA-C 112.523 -0.231 . . . . 0.0 112.523 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.407 ' O ' HG13 ' A' ' 109' ' ' ILE . 82.8 p -88.3 -27.22 21.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.773 0.321 . . . . 0.0 111.071 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.406 ' HA ' ' O ' ' A' ' 107' ' ' ARG . 3.3 ttt180 -76.76 113.37 14.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.821 0.343 . . . . 0.0 110.611 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -130.19 156.8 43.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.013 0.435 . . . . 0.0 111.596 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.4 ' CE2' HG12 ' A' ' 68' ' ' ILE . 13.6 m-85 -95.99 151.21 19.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.695 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.997 HD12 HG23 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -137.3 110.99 8.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.885 -179.757 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.635 HG23 ' OE1' ' A' ' 102' ' ' GLN . 97.2 m -97.6 130.63 44.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.639 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.463 ' CZ ' ' HB3' ' A' ' 12' ' ' LEU . 28.4 m-85 -140.87 172.47 12.64 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.26 0.553 . . . . 0.0 112.416 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.439 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.5 OUTLIER -126.98 111.7 14.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.051 179.086 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.906 HG23 HD23 ' A' ' 103' ' ' LEU . 34.3 t -104.26 116.66 60.97 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -177.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.523 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 89.7 Cg_endo -88.57 126.53 1.86 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.47 2.113 . . . . 0.0 110.846 178.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.815 HD11 ' HB2' ' A' ' 96' ' ' ASN . 0.3 OUTLIER -116.16 29.09 8.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.716 0.293 . . . . 0.0 111.547 -178.823 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -38.6 -31.72 0.06 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.434 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -112.2 -32.07 6.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.312 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 t -74.39 -5.49 42.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.181 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.782 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -43.88 -28.77 1.26 Allowed Glycine 0 C--N 1.336 0.561 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.942 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.1 p -88.26 -33.04 18.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.762 0.315 . . . . 0.0 110.897 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.47 9.02 28.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.531 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.62 -54.39 4.95 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.966 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.933 HD22 ' HE2' ' A' ' 91' ' ' MET . 8.4 tp -175.12 -36.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.628 0.252 . . . . 0.0 110.811 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.494 ' HA3' ' HA3' ' A' ' 53' ' ' GLY . . . 114.83 44.91 0.67 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.4 -0.905 . . . . 0.0 113.295 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.803 HG12 HG23 ' A' ' 49' ' ' ILE . 33.1 m -157.24 160.56 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.189 0.518 . . . . 0.0 111.727 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.42 ' O ' ' HB3' ' A' ' 47' ' ' LYS . 0.7 OUTLIER -117.44 110.3 17.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.31 178.774 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.618 HG11 HD11 ' A' ' 67' ' ' LEU . 4.3 m -106.9 137.97 35.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.949 0.404 . . . . 0.0 111.717 -178.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.505 ' CB ' HD13 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -141.46 129.63 22.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.431 179.452 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -89.23 156.92 26.47 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.539 -0.838 . . . . 0.0 113.055 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -128.29 145.22 51.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.827 0.346 . . . . 0.0 110.93 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 45.3 mtt85 -96.22 147.63 23.56 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.646 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.862 ' HA ' HD21 ' A' ' 42' ' ' LEU . 12.4 t -45.64 141.93 2.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.405 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -25.15 64.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.049 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -85.46 -72.18 0.5 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.8 0.333 . . . . 0.0 111.023 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.41 ' OD1' ' HB2' ' A' ' 40' ' ' ALA . 5.5 p30 -106.23 -162.45 0.86 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.744 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 53.5 m-70 -93.76 33.11 1.33 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.013 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.635 ' HB3' ' HB2' ' A' ' 35' ' ' SER . . . -73.48 105.46 4.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.977 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -54.6 106.46 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.154 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.862 HD21 ' HA ' ' A' ' 35' ' ' SER . 21.6 mt -67.79 -25.52 65.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.794 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.463 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 129.14 -178.63 17.2 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.06 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.691 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -104.23 133.05 49.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.911 0.386 . . . . 0.0 111.301 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.455 ' CE2' ' NE2' ' A' ' 66' ' ' GLN . 0.1 OUTLIER -122.47 145.48 48.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.833 -179.935 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.724 ' O ' HG13 ' A' ' 63' ' ' VAL . 42.8 t -60.9 104.9 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.691 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.42 ' HB3' ' O ' ' A' ' 29' ' ' SER . 5.2 tppt? -76.68 -37.82 55.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.721 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.64 122.76 0.87 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.871 0.367 . . . . 0.0 111.422 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.803 HG23 HG12 ' A' ' 28' ' ' VAL . 63.9 mt -89.46 127.41 42.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.166 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.44 HD12 ' N ' ' A' ' 28' ' ' VAL . 1.6 mp -66.33 109.06 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.52 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.28 76.64 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.086 0.47 . . . . 0.0 110.33 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 159.76 -26.71 0.34 Allowed Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.494 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -76.81 174.47 54.18 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.367 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.662 ' HB1' HG12 ' A' ' 16' ' ' VAL . . . -47.19 -46.52 23.92 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.645 ' HB1' HD22 ' A' ' 61' ' ' LEU . . . -61.81 -38.18 87.15 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.735 0.303 . . . . 0.0 111.763 -178.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.7 t -70.45 -43.11 70.52 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.938 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.467 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -66.49 -25.94 66.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.995 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.815 ' OD1' HG13 ' A' ' 16' ' ' VAL . 0.5 OUTLIER -55.03 -52.88 61.78 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.83 0.347 . . . . 0.0 111.33 -179.711 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.87 4.71 69.18 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.401 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.446 ' HD2' ' CD1' ' A' ' 14' ' ' PHE . 1.3 mtm180 -122.15 0.96 9.69 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.761 0.315 . . . . 0.0 110.662 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.729 ' HB3' HD13 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -100.5 136.34 40.53 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.98 -179.807 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.33 143.99 29.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.844 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.724 HG13 ' O ' ' A' ' 46' ' ' VAL . 58.5 t -59.18 142.85 14.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.046 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 29.1 m-20 90.26 12.45 0.05 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.694 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.74 120.93 34.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.721 0.296 . . . . 0.0 110.274 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.455 ' NE2' ' CE2' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -78.05 137.18 38.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.7 -179.831 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.903 HD23 HG12 ' A' ' 105' ' ' VAL . 6.6 mt -93.52 140.95 29.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.024 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.603 HD12 ' HA ' ' A' ' 105' ' ' VAL . 4.5 mp -124.89 -41.44 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.393 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.943 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -139.17 151.03 46.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.018 0.437 . . . . 0.0 111.371 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.602 HG11 ' HA ' ' A' ' 87' ' ' LEU . 14.7 p -140.38 119.56 11.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.025 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 60.96 27.95 17.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.652 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.0 22.53 54.9 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.153 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -125.51 115.07 19.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.861 0.362 . . . . 0.0 110.78 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.5 p -60.22 149.96 31.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.129 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.612 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . 12.0 mt -115.55 -29.72 6.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.064 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.0 mt -51.6 -35.21 40.67 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.236 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.35 -21.38 47.86 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.335 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -120.64 162.14 20.17 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.367 0.603 . . . . 0.0 110.977 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.6 ' HB3' HE21 ' A' ' 81' ' ' GLN . . . -59.48 161.73 5.56 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.154 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.42 ' HB2' ' HA3' ' A' ' 32' ' ' GLY . 10.3 p30 -56.87 -43.81 81.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.158 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.6 HE21 ' HB3' ' A' ' 79' ' ' ALA . 1.9 pp0? -64.58 -42.62 95.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.092 0.472 . . . . 0.0 110.55 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.68 -32.1 70.52 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.649 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.612 ' HB1' ' HB3' ' A' ' 75' ' ' LEU . . . -69.4 -49.04 58.98 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.685 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.611 ' HB3' HG21 ' A' ' 44' ' ' ILE . 6.9 ptp -59.64 -32.93 70.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.481 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -78.15 -31.28 49.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.22 0.533 . . . . 0.0 109.832 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.4 ' HA ' ' HD2' ' A' ' 89' ' ' ARG . 1.3 m -69.88 -36.44 75.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.521 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.851 HD12 ' N ' ' A' ' 88' ' ' ARG . 4.3 pp -78.77 -34.6 45.5 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.418 0.627 . . . . 0.0 109.478 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.851 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -61.11 -47.37 86.59 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.5 179.46 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.458 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -73.18 -43.27 61.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.424 179.544 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.3 p -61.36 -29.54 69.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.381 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.933 ' HE2' HD22 ' A' ' 26' ' ' LEU . 3.5 ptp -86.37 -34.93 20.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.84 -179.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -102.56 25.64 8.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.833 -179.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.552 HG23 ' HG2' ' A' ' 94' ' ' GLU . 0.5 OUTLIER -152.38 -36.66 0.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.796 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.552 ' HG2' HG23 ' A' ' 93' ' ' THR . 4.0 mt-10 -111.37 -60.04 1.89 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.813 0.34 . . . . 0.0 111.408 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.606 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -56.17 -27.31 51.89 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.378 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.815 ' HB2' HD11 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -77.09 -33.73 56.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.712 0.291 . . . . 0.0 110.565 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 94' ' ' GLU . 60.9 mtpt -39.33 -39.53 0.66 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.674 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.77 -27.28 13.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.191 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 121.75 -3.2 10.95 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.7 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.523 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -155.63 143.38 19.7 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.981 0.419 . . . . 0.0 111.257 -179.639 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.665 HD11 HD11 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -112.71 145.11 19.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.023 179.839 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.635 ' OE1' HG23 ' A' ' 13' ' ' THR . 1.3 tm0? -82.04 143.76 31.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.725 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.906 HD23 HG23 ' A' ' 16' ' ' VAL . 2.5 mm? -133.82 149.56 51.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.293 0.568 . . . . 0.0 112.008 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.943 HD12 ' HB3' ' A' ' 69' ' ' ALA . 74.7 mt -139.34 112.35 6.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.361 178.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.997 HG23 HD12 ' A' ' 12' ' ' LEU . 35.2 m -123.66 172.93 10.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.473 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -147.85 132.52 17.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.41 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.671 ' HG3' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -138.55 -179.99 6.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.919 0.39 . . . . 0.0 111.007 -179.803 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 2.1 tpp85 -116.49 132.29 56.72 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.01 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 8' ' ' THR . 47.9 mt -59.68 -25.75 32.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.962 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.834 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.879 0.371 . . . . 0.0 110.986 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -97.56 170.14 9.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.763 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -124.58 -50.13 1.75 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.127 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.88 93.01 1.41 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.781 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 60.99 -175.39 0.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.792 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 33.2 t -166.67 -156.28 0.23 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.657 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -161.37 129.91 4.43 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.505 HD13 ' CB ' ' A' ' 31' ' ' LYS . 1.1 mm -102.38 120.19 51.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.181 0.515 . . . . 0.0 111.514 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . 0.599 HG22 HG13 ' B' ' 13' ' ' VAL . 43.9 m -98.08 102.97 14.87 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.527 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.75 102.75 1.59 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.641 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.599 HG13 HG22 ' B' ' 11' ' ' THR . 34.8 m . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.175 -0.917 . . . . 0.0 111.247 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.267 -0.333 . . . . 0.0 112.267 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 69.4 p -74.76 -6.69 50.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.642 0.258 . . . . 0.0 111.597 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -76.7 109.74 10.71 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.807 0.337 . . . . 0.0 110.676 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -126.71 163.59 23.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.135 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.448 ' CE2' HD13 ' A' ' 68' ' ' ILE . 4.4 m-85 -100.51 147.07 26.31 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.516 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 1.083 HD12 HG23 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -139.51 121.43 15.57 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.958 0.408 . . . . 0.0 111.303 -179.783 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.3 m -94.74 142.7 27.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.249 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.506 ' O ' ' HA ' ' A' ' 102' ' ' GLN . 26.6 m-85 -142.03 172.64 12.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.975 0.417 . . . . 0.0 111.587 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.423 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.7 OUTLIER -132.27 107.63 8.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.55 179.219 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.971 HG23 HD23 ' A' ' 103' ' ' LEU . 32.2 t -104.3 114.36 64.32 Favored Pre-proline 0 C--N 1.33 -0.248 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -178.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.614 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 93.1 Cg_endo -84.58 128.12 3.92 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.645 2.23 . . . . 0.0 110.958 178.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.789 HD11 ' HB2' ' A' ' 96' ' ' ASN . 0.4 OUTLIER -122.26 28.78 7.29 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -178.856 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -39.37 -31.11 0.08 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.101 0.477 . . . . 0.0 111.15 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -112.94 -32.94 6.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.24 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.588 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 43.9 t -71.31 -6.62 41.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.174 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.71 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -44.23 -29.79 1.74 Allowed Glycine 0 C--N 1.336 0.567 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.692 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.21 -37.93 22.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.982 0.42 . . . . 0.0 110.553 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.29 -1.03 54.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.427 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.07 -48.91 3.91 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.879 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.005 HD22 ' HE2' ' A' ' 91' ' ' MET . 6.1 tp 179.78 -31.34 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.611 0.243 . . . . 0.0 110.553 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.449 ' HA2' HD13 ' A' ' 50' ' ' ILE . . . 105.96 48.31 1.02 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.297 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.785 HG12 HG23 ' A' ' 49' ' ' ILE . 20.0 m -157.08 163.97 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.164 0.506 . . . . 0.0 111.94 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.417 ' O ' ' HB3' ' A' ' 47' ' ' LYS . 49.7 m -124.7 117.37 24.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.238 178.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.785 HG11 HD11 ' A' ' 67' ' ' LEU . 4.4 m -111.58 145.62 17.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.079 0.466 . . . . 0.0 112.163 -178.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.492 ' HB3' HD13 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -143.81 130.25 19.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.37 179.331 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 44' ' ' ILE . . . -103.71 156.99 17.57 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.442 -0.885 . . . . 0.0 113.142 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.907 ' ND2' HD12 ' A' ' 42' ' ' LEU . 6.7 p-10 -105.16 178.21 4.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.909 0.385 . . . . 0.0 111.163 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -136.27 126.47 26.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.76 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.664 ' OG ' HD21 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -50.43 121.45 5.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.149 -179.752 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.46 -10.89 55.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.552 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -77.91 -64.39 1.17 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.734 0.302 . . . . 0.0 111.325 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.574 ' OD1' ' HB2' ' A' ' 40' ' ' ALA . 10.8 p30 -124.12 25.87 7.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.498 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 52.46 54.2 11.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.898 0.38 . . . . 0.0 111.153 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.574 ' HB2' ' OD1' ' A' ' 38' ' ' ASN . . . -110.3 120.86 43.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.989 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -48.06 118.56 2.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.3 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.907 HD12 ' ND2' ' A' ' 33' ' ' ASN . 21.3 mt -81.31 -28.29 34.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.62 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 138.53 173.96 13.21 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.494 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.876 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -101.68 153.5 5.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.869 0.366 . . . . 0.0 111.38 -180.0 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.458 ' CE2' ' NE2' ' A' ' 66' ' ' GLN . 0.4 OUTLIER -140.19 141.75 35.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.662 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.747 ' O ' HG13 ' A' ' 63' ' ' VAL . 42.2 t -57.74 104.64 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.59 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.482 ' HD3' HD12 ' B' ' 10' ' ' ILE . 21.9 tptt -75.26 -41.49 57.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.749 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.97 124.52 1.08 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.857 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.803 HD13 ' HB3' ' A' ' 61' ' ' LEU . 77.2 mt -91.62 119.95 39.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.218 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.472 HD12 ' N ' ' A' ' 28' ' ' VAL . 1.7 mp -56.0 108.14 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.376 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.15 72.94 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.873 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 162.45 -26.95 0.24 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.176 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.422 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -69.86 -170.6 8.14 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.901 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.614 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -64.15 -41.49 97.15 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.953 ' HB1' HD13 ' A' ' 61' ' ' LEU . . . -62.87 -47.58 82.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.703 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.0 t -67.85 -29.04 68.08 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.497 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 37.4 mtpt -74.87 -32.31 61.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.151 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -61.18 -27.94 68.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.808 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 66.59 20.76 70.27 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.779 -0.724 . . . . 0.0 113.132 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.429 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 12.5 mtm180 -125.19 -16.57 5.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.778 0.323 . . . . 0.0 110.979 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.953 HD13 ' HB1' ' A' ' 55' ' ' ALA . 0.5 OUTLIER -88.27 135.53 33.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.195 -179.668 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.664 HH21 HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -143.16 137.87 29.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.692 179.671 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.747 HG13 ' O ' ' A' ' 46' ' ' VAL . 48.1 t -52.52 145.91 2.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.267 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.444 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 28.2 m-80 86.98 11.09 0.15 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.613 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.439 ' OD2' HG21 ' A' ' 105' ' ' VAL . 3.0 m-20 -91.82 115.69 28.27 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.458 ' NE2' ' CE2' ' A' ' 45' ' ' PHE . 0.9 OUTLIER -72.89 128.97 37.06 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.779 -179.632 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.876 HD12 HG13 ' A' ' 44' ' ' ILE . 42.6 mt -83.09 152.2 25.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.772 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.474 HD11 ' CB ' ' A' ' 106' ' ' ALA . 30.6 mt -143.63 -40.98 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.637 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.743 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -138.12 158.5 44.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.83 0.348 . . . . 0.0 111.457 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.492 HG23 HD11 ' A' ' 101' ' ' ILE . 12.8 p -151.51 120.6 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.951 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.484 HD22 HG22 ' A' ' 70' ' ' VAL . 70.4 m-80 57.12 29.65 16.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.87 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.19 23.75 50.52 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.308 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -127.75 118.61 24.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.741 0.305 . . . . 0.0 110.753 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.8 t -70.65 150.19 46.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.115 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.499 HD22 ' HA ' ' A' ' 83' ' ' ALA . 22.5 mt -111.16 -19.34 12.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.102 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.8 tp -54.41 -21.99 11.25 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.32 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -91.2 28.74 7.71 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.863 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.413 ' HD2' ' HA ' ' A' ' 83' ' ' ALA . 8.6 ptpp? -164.81 152.04 11.22 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.27 0.557 . . . . 0.0 110.921 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.716 ' HB3' HE21 ' A' ' 81' ' ' GLN . . . -52.96 156.45 2.05 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.329 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -54.16 -47.85 71.52 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.044 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.716 HE21 ' HB3' ' A' ' 79' ' ' ALA . 2.9 pp0? -60.42 -40.0 89.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.016 0.436 . . . . 0.0 110.635 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.1 -34.22 72.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.678 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.563 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -66.5 -50.6 62.71 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.366 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.429 ' HA ' ' CD2' ' A' ' 87' ' ' LEU . 6.9 ptp -60.67 -30.5 69.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.927 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -79.51 -32.94 42.44 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.412 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 2.1 m -68.08 -35.67 78.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.277 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.871 HD11 HG11 ' B' ' 13' ' ' VAL . 4.4 pp -78.31 -34.35 48.73 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.81 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -60.21 -52.14 66.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.655 179.293 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.481 ' O ' HG22 ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.5 -33.91 67.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.295 179.651 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.414 ' N ' ' HD3' ' A' ' 89' ' ' ARG . 24.0 t -71.6 -29.99 65.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.958 0.409 . . . . 0.0 110.424 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 1.005 ' HE2' HD22 ' A' ' 26' ' ' LEU . 1.5 ptp -89.2 -25.14 21.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.163 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.3 t -109.22 23.18 14.87 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.481 HG22 ' O ' ' A' ' 89' ' ' ARG . 0.5 OUTLIER -153.37 -36.19 0.11 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.902 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.455 ' HA ' ' HG3' ' A' ' 97' ' ' LYS . 4.1 mt-10 -107.61 -64.3 1.22 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.828 0.347 . . . . 0.0 111.346 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.545 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -52.92 -33.63 44.06 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.656 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.789 ' HB2' HD11 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -70.49 -34.78 72.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.702 0.287 . . . . 0.0 110.382 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.455 ' HG3' ' HA ' ' A' ' 94' ' ' GLU . 20.7 mtpt -38.23 -47.29 1.16 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.475 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.31 -25.32 19.49 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.662 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 118.97 -3.05 14.58 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.819 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.423 ' SD ' ' HB3' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -159.48 143.43 14.84 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.076 0.465 . . . . 0.0 111.383 -179.744 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.776 HD11 HD11 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -114.33 141.48 30.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.529 179.932 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.506 ' HA ' ' O ' ' A' ' 14' ' ' PHE . 2.2 pp0? -86.88 131.13 34.19 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.981 -0.287 . . . . 0.0 110.403 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.971 HD23 HG23 ' A' ' 16' ' ' VAL . 2.8 mm? -115.87 134.39 55.04 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.275 0.559 . . . . 0.0 112.114 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.743 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 96.7 mt -118.07 112.59 39.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.611 178.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 1.083 HG23 HD12 ' A' ' 12' ' ' LEU . 28.9 m -121.53 177.21 3.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.265 -179.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.474 ' CB ' HD11 ' A' ' 68' ' ' ILE . . . -147.29 139.18 24.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.826 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.566 ' HD2' HD21 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -155.2 177.04 11.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.149 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 15.7 mtm180 -94.46 127.88 40.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.079 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.2 mt -64.04 -41.03 91.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.798 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.938 179.928 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . 0.566 ' HB3' HD11 ' A' ' 42' ' ' LEU . 2.2 m-20 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.837 0.351 . . . . 0.0 110.902 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.25 155.77 16.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.923 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -98.3 34.25 2.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.814 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 64.08 129.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.92 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 27.2 m170 60.64 85.01 0.12 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.866 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.71 -165.55 0.83 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.902 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -168.94 127.62 1.04 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.492 HD13 ' HB3' ' A' ' 31' ' ' LYS . 1.6 mm -101.97 134.92 41.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.135 0.493 . . . . 0.0 111.123 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 2.5 m -110.5 116.4 31.32 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.661 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 27.2 ttmt -78.13 109.2 12.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.925 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.871 HG11 HD11 ' A' ' 87' ' ' LEU . 17.3 m . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.277 -0.868 . . . . 0.0 111.275 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 N-CA-C 112.566 -0.214 . . . . 0.0 112.566 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.2 p -111.74 48.27 0.97 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.903 0.382 . . . . 0.0 110.931 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -112.98 146.54 38.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.692 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -151.73 155.25 37.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.211 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.689 ' HE2' HG21 ' A' ' 68' ' ' ILE . 11.0 m-85 -100.7 148.93 24.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.802 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.892 HD12 HG23 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -133.68 110.88 10.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.026 -179.838 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.842 HG23 ' OE1' ' A' ' 102' ' ' GLN . 89.3 m -96.1 132.47 41.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.577 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.436 ' CZ ' ' HB3' ' A' ' 12' ' ' LEU . 54.9 m-85 -140.73 172.43 12.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.301 0.572 . . . . 0.0 112.113 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.427 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.3 OUTLIER -129.07 112.09 13.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.152 179.174 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.932 HG23 HD23 ' A' ' 103' ' ' LEU . 34.8 t -103.19 112.2 65.58 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -178.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.768 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 84.2 Cg_endo -82.22 127.82 5.4 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.365 2.043 . . . . 0.0 110.886 178.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.866 HD22 ' CD1' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -122.62 28.52 7.3 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -178.724 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -39.12 -31.49 0.07 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.172 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -113.33 -32.83 6.14 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.282 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.716 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 46.7 t -70.96 -7.7 47.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.163 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.744 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -45.25 -28.46 2.09 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.744 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.8 p -85.27 -34.28 21.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.797 0.332 . . . . 0.0 110.563 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.66 7.21 31.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.526 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.03 -54.99 4.78 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.644 -0.789 . . . . 0.0 111.985 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.934 HD22 ' HE2' ' A' ' 91' ' ' MET . 9.8 tp -178.89 -32.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.592 0.234 . . . . 0.0 110.948 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 50' ' ' ILE . . . 114.47 31.91 2.07 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.381 -0.914 . . . . 0.0 113.413 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.809 HG12 HG23 ' A' ' 49' ' ' ILE . 33.7 m -150.83 161.01 3.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 117.164 0.482 . . . . 0.0 111.75 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.42 ' O ' ' N ' ' A' ' 47' ' ' LYS . 0.9 OUTLIER -122.41 118.16 27.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.556 178.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.828 HG11 HD11 ' A' ' 67' ' ' LEU . 3.3 m -110.77 141.67 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.9 0.381 . . . . 0.0 111.937 -178.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.56 ' CB ' HD13 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -140.66 130.54 24.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.545 179.397 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.56 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -90.94 160.75 27.6 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.397 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.454 ' ND2' ' CE1' ' A' ' 45' ' ' PHE . 89.3 m-20 -119.57 179.91 4.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.837 0.351 . . . . 0.0 110.915 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.59 155.66 40.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.624 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.801 ' CA ' HD21 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -57.14 140.49 49.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.063 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.2 mtmm -64.51 -28.25 69.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.984 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -84.96 -74.88 0.38 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.944 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -94.41 177.26 6.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.903 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -93.07 58.42 2.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.881 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -116.78 131.63 56.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.998 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -59.37 144.31 47.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.915 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.801 HD21 ' CA ' ' A' ' 35' ' ' SER . 17.0 mt -105.38 -30.98 9.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.862 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.56 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 148.51 -173.99 28.31 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.098 -0.572 . . . . 0.0 111.866 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.87 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -110.23 148.11 14.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 120.988 0.423 . . . . 0.0 111.735 -179.739 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.454 ' CE1' ' ND2' ' A' ' 33' ' ' ASN . 0.4 OUTLIER -134.4 138.43 44.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.557 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.604 ' O ' HG13 ' A' ' 63' ' ' VAL . 40.0 t -54.17 104.41 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.564 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.511 ' HG2' HG21 ' B' ' 10' ' ' ILE . 5.9 tptm -73.03 -43.01 62.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.841 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 m -168.18 125.02 1.07 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.107 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.809 HG23 HG12 ' A' ' 28' ' ' VAL . 62.7 mt -88.93 116.66 30.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.297 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.531 HD12 ' N ' ' A' ' 28' ' ' VAL . 1.9 mp -55.42 105.26 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.629 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.11 76.4 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.141 0.496 . . . . 0.0 110.588 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 158.95 -27.17 0.39 Allowed Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.907 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.45 -170.62 6.07 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.691 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.768 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -67.94 -38.58 83.0 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.779 ' HB1' HD13 ' A' ' 61' ' ' LEU . . . -67.66 -43.86 79.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.393 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.43 ' HB3' HG22 ' A' ' 49' ' ' ILE . 53.6 p -66.85 -33.28 75.25 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.204 0.526 . . . . 0.0 110.109 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -70.74 -33.53 70.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.171 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -58.05 -28.0 64.13 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.786 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.87 25.0 67.26 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.783 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.411 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 22.1 mtm180 -125.31 -24.22 4.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.812 0.339 . . . . 0.0 111.017 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.785 HD22 HG11 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -71.62 164.06 26.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.444 -179.729 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.461 ' N ' ' HD2' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -160.46 138.83 10.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.713 179.876 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.604 HG13 ' O ' ' A' ' 46' ' ' VAL . 37.0 t -70.5 144.75 13.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.594 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 25.4 m-20 88.75 -2.53 0.43 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.642 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.95 133.14 35.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.96 0.409 . . . . 0.0 110.599 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.424 ' NE2' ' HA3' ' A' ' 43' ' ' GLY . 1.0 OUTLIER -82.63 139.02 33.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.692 -179.806 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.954 HD23 HG12 ' A' ' 105' ' ' VAL . 28.7 mt -88.99 131.81 35.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.839 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.689 HG21 ' HE2' ' A' ' 11' ' ' PHE . 19.3 mm -113.13 -32.19 2.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.473 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.781 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -157.03 170.91 21.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.884 0.373 . . . . 0.0 111.585 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.433 HG11 ' HA ' ' A' ' 87' ' ' LEU . 7.3 p -158.17 127.39 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.767 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 60.24 22.83 12.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.668 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.07 25.53 31.32 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.993 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -130.55 108.45 9.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.796 0.332 . . . . 0.0 110.831 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.418 ' HA ' ' HB2' ' A' ' 69' ' ' ALA . 33.2 t -71.23 138.27 49.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.087 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.777 HD22 ' HB1' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -98.57 -13.24 20.5 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.163 179.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.415 ' CD1' HG23 ' A' ' 68' ' ' ILE . 0.1 OUTLIER -52.82 94.7 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.913 0.387 . . . . 0.0 111.058 -179.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 145.3 -31.09 1.71 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.185 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -97.56 156.89 16.3 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.239 0.542 . . . . 0.0 110.903 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.12 139.45 28.58 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.33 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.9 p30 -50.63 -28.14 8.25 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.172 0.511 . . . . 0.0 109.927 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.4 ' O ' ' HG2' ' A' ' 84' ' ' MET . 0.0 OUTLIER -74.18 -42.04 60.49 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.013 178.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -70.11 -32.99 71.27 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.868 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.777 ' HB1' HD22 ' A' ' 75' ' ' LEU . . . -68.92 -45.46 70.8 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.487 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.434 ' HB3' HG21 ' A' ' 44' ' ' ILE . 6.5 ptp -63.49 -30.05 71.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.816 178.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -78.59 -33.46 47.51 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.502 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 3.4 m -68.34 -35.65 78.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.343 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.749 HD12 ' N ' ' A' ' 88' ' ' ARG . 4.4 pp -78.32 -33.83 48.99 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 178.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.749 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -60.23 -51.24 70.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.65 179.332 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.502 ' HD3' ' O ' ' A' ' 86' ' ' THR . 0.0 OUTLIER -72.26 -34.93 68.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.618 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.421 ' N ' ' HD3' ' A' ' 89' ' ' ARG . 24.7 p -72.92 -29.8 63.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.852 0.358 . . . . 0.0 110.735 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.934 ' HE2' HD22 ' A' ' 26' ' ' LEU . 1.7 ptm -88.85 -17.43 29.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.288 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.85 25.45 9.68 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.522 ' O ' ' HD3' ' A' ' 97' ' ' LYS . 0.4 OUTLIER -157.14 -31.97 0.08 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.458 ' HG3' HG22 ' A' ' 93' ' ' THR . 5.7 mt-10 -117.59 -35.56 3.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.856 0.36 . . . . 0.0 111.443 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.494 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -78.26 -31.25 47.62 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.614 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.771 ' HB2' HD11 ' A' ' 18' ' ' LEU . 0.7 OUTLIER -75.29 -31.89 60.83 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.584 -0.308 . . . . 0.0 110.176 179.576 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.522 ' HD3' ' O ' ' A' ' 93' ' ' THR . 27.1 mmmt -39.54 -47.19 1.86 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.968 0.414 . . . . 0.0 111.096 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.92 -25.49 19.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.889 178.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 114.19 1.09 23.74 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.908 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.485 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -154.66 141.0 18.66 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 120.975 0.417 . . . . 0.0 111.197 -179.588 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.8 HD11 HD11 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -112.85 145.31 18.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.657 179.538 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.842 ' OE1' HG23 ' A' ' 13' ' ' THR . 1.3 tm0? -84.99 139.64 31.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.978 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.932 HD23 HG23 ' A' ' 16' ' ' VAL . 2.7 mm? -129.99 137.66 50.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.045 0.45 . . . . 0.0 111.801 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.781 HD12 ' HB3' ' A' ' 69' ' ' ALA . 72.6 mt -126.5 113.1 31.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.563 178.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.954 HG12 HD23 ' A' ' 67' ' ' LEU . 31.9 m -123.62 174.69 7.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.472 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -147.73 137.43 22.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.841 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.607 ' CG ' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -147.37 -178.62 6.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.946 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.54 151.6 24.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.02 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 31.1 mt -93.61 -39.84 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.074 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.914 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.755 0.312 . . . . 0.0 110.972 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -90.76 135.53 33.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.726 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -113.36 -41.16 3.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.922 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.85 -175.98 3.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.732 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.22 98.03 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.926 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 31.8 t -59.59 -160.77 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.859 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -159.77 130.66 5.82 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.56 HD13 ' CB ' ' A' ' 31' ' ' LYS . 1.1 mm -104.43 121.8 56.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.413 0.625 . . . . 0.0 111.495 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . 0.781 HG22 HG13 ' B' ' 13' ' ' VAL . 16.5 m -92.15 114.9 27.57 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.325 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -75.09 102.85 5.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.507 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.781 HG13 HG22 ' B' ' 11' ' ' THR . 30.0 m . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.726 -0.655 . . . . 0.0 110.532 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.21 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.1 p -133.77 41.33 3.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.867 0.365 . . . . 0.0 110.911 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 18.5 mtm-85 -108.85 135.28 50.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.699 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -123.95 122.74 38.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.217 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.625 ' CD1' ' HB2' ' A' ' 106' ' ' ALA . 30.3 m-85 -77.75 140.48 39.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.462 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.863 HD12 HG23 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -147.16 134.42 20.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.123 0.487 . . . . 0.0 111.238 -179.66 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.428 ' O ' ' CD1' ' A' ' 14' ' ' PHE . 25.4 m -92.63 150.8 20.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.295 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' ' 102' ' ' GLN . 15.5 m-85 -140.08 170.37 15.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.105 0.479 . . . . 0.0 111.683 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -143.43 104.95 4.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.096 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.768 HG21 HD11 ' A' ' 61' ' ' LEU . 20.7 t -109.49 110.86 59.79 Favored Pre-proline 0 CA--C 1.531 0.226 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -177.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.728 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 91.2 Cg_endo -82.49 128.11 5.3 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.527 2.151 . . . . 0.0 110.736 178.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.862 HD22 ' CD1' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -121.82 29.5 7.09 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -178.582 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -40.92 -31.7 0.19 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.103 0.478 . . . . 0.0 111.031 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -111.32 -33.65 6.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.203 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.736 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 29.9 t -70.52 -8.55 52.12 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.111 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.707 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -44.96 -28.05 1.66 Allowed Glycine 0 C--N 1.337 0.613 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.691 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -85.69 -33.44 21.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.834 0.349 . . . . 0.0 110.737 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.37 8.33 28.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.441 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.96 -55.64 4.99 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.629 -0.795 . . . . 0.0 111.908 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.862 ' CD1' HD22 ' A' ' 18' ' ' LEU . 10.2 tp -179.0 -34.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.601 0.239 . . . . 0.0 111.12 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.4 ' HA3' ' HA3' ' A' ' 53' ' ' GLY . . . 115.79 35.02 1.31 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.537 -0.839 . . . . 0.0 113.295 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.736 HG12 HG23 ' A' ' 49' ' ' ILE . 34.2 m -156.3 162.2 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.282 0.563 . . . . 0.0 112.082 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -122.65 116.4 23.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.179 178.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.67 HG11 HD11 ' A' ' 67' ' ' LEU . 3.4 m -106.56 146.35 13.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.143 0.497 . . . . 0.0 111.938 -178.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.528 ' HB3' HD13 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -143.34 131.08 21.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.58 179.705 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' A' ' 44' ' ' ILE . . . -97.32 145.69 17.95 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.697 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.405 ' OD1' ' CE1' ' A' ' 45' ' ' PHE . 21.9 m120 -107.84 -179.17 3.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.828 0.347 . . . . 0.0 111.028 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.4 mtt180 -134.53 156.12 49.2 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.691 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.462 ' HA ' HD21 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -48.92 150.97 1.34 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.194 -179.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -66.48 -40.33 89.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.116 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -108.24 -35.46 6.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.127 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -91.67 168.94 11.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.925 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 -103.25 31.03 4.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.79 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.66 129.5 44.73 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.089 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.436 ' CB ' ' ND2' ' A' ' 80' ' ' ASN . 1.7 p30 -57.1 142.27 43.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.079 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.462 HD21 ' HA ' ' A' ' 35' ' ' SER . 24.2 mt -104.06 12.6 33.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.11 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.423 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 98.47 170.67 31.8 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.586 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.88 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -102.02 135.78 37.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.851 0.358 . . . . 0.0 110.995 179.831 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.435 ' CE2' ' HG3' ' A' ' 66' ' ' GLN . 0.1 OUTLIER -121.02 141.33 50.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.792 -179.834 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.635 ' O ' HG13 ' A' ' 63' ' ' VAL . 46.7 t -56.35 104.64 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.638 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.44 ' HG2' HD12 ' B' ' 10' ' ' ILE . 0.9 OUTLIER -74.9 -40.94 60.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.758 -179.753 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.0 p -166.9 124.72 1.31 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.162 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.736 HG23 HG12 ' A' ' 28' ' ' VAL . 67.6 mt -91.25 111.86 24.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.059 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.629 HD12 ' N ' ' A' ' 28' ' ' VAL . 2.1 mp -51.8 106.41 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.801 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.34 75.52 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.023 0.44 . . . . 0.0 110.675 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 162.56 -29.99 0.28 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.082 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.4 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -66.61 -170.43 3.93 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.686 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.736 ' HB2' ' HB3' ' A' ' 21' ' ' SER . . . -68.54 -38.18 80.59 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.649 ' HB3' HG13 ' A' ' 28' ' ' VAL . . . -66.84 -45.04 79.46 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.455 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.632 ' OG ' HG22 ' A' ' 49' ' ' ILE . 0.4 OUTLIER -66.21 -34.8 78.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.27 0.557 . . . . 0.0 109.861 179.341 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.7 mtpt -68.47 -30.33 69.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.947 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.41 ' OD1' ' CD ' ' A' ' 17' ' ' PRO . 0.8 OUTLIER -64.09 -25.87 68.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.944 179.753 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.01 26.18 65.27 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.643 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.7 mtm180 -122.26 -34.79 3.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.968 0.413 . . . . 0.0 110.769 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.768 HD11 HG21 ' A' ' 16' ' ' VAL . 2.1 mp -66.74 141.86 57.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.473 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -138.45 134.22 33.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.269 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.635 HG13 ' O ' ' A' ' 46' ' ' VAL . 46.3 t -59.51 145.36 11.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.014 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.444 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 22.3 m-20 87.85 -7.3 0.58 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.392 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -76.07 125.66 29.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.787 0.327 . . . . 0.0 110.766 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.435 ' HG3' ' CE2' ' A' ' 45' ' ' PHE . 1.8 tm0? -81.51 140.48 34.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.916 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.911 HD23 HG12 ' A' ' 105' ' ' VAL . 30.8 mt -87.17 139.57 30.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.924 0.392 . . . . 0.0 111.183 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 19.6 mm -120.65 -31.52 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.241 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 1.012 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -161.72 134.73 6.18 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.973 0.416 . . . . 0.0 111.573 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.476 HG23 HD11 ' A' ' 101' ' ' ILE . 7.5 p -121.57 129.36 75.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.366 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.43 ' ND2' ' O ' ' A' ' 90' ' ' SER . 9.3 m-80 64.95 13.96 8.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.538 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.77 -14.72 53.03 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.005 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.639 ' OE1' HG23 ' A' ' 86' ' ' THR . 5.7 pt-20 -99.27 125.64 44.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.879 0.371 . . . . 0.0 111.07 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 21.3 p -75.04 165.1 25.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.901 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.515 HD22 ' HB1' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -128.9 4.38 5.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.267 -179.828 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.88 -41.43 78.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.909 0.385 . . . . 0.0 110.934 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.23 -25.84 73.49 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.691 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.431 ' HD2' ' HA ' ' A' ' 83' ' ' ALA . 1.3 ptpm? -101.7 166.78 10.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.287 0.565 . . . . 0.0 111.179 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.584 ' HB3' HE21 ' A' ' 81' ' ' GLN . . . -74.24 168.04 20.41 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.189 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.489 ' HB2' ' HA3' ' A' ' 32' ' ' GLY . 7.2 p30 -58.66 -50.48 73.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.055 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.584 HE21 ' HB3' ' A' ' 79' ' ' ALA . 2.2 pp0? -58.84 -39.69 82.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.116 0.484 . . . . 0.0 110.516 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.13 -34.48 73.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.9 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.55 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -69.03 -47.66 64.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.785 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.498 ' HB3' HG21 ' A' ' 44' ' ' ILE . 5.6 ptp -61.93 -31.52 71.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.205 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.07 -33.8 65.86 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.639 HG23 ' OE1' ' A' ' 73' ' ' GLU . 1.8 m -64.66 -33.91 77.04 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.26 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.62 HD13 HD13 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -76.02 -36.02 59.3 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.099 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.58 ' HG3' HG11 ' B' ' 13' ' ' VAL . 0.0 OUTLIER -59.14 -51.99 67.62 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.843 179.51 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.5 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.42 -44.86 61.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.429 179.665 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.43 ' O ' ' ND2' ' A' ' 71' ' ' ASN . 40.4 p -64.23 -30.38 71.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.489 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.808 ' HE2' HD22 ' A' ' 26' ' ' LEU . 2.1 ptm -89.01 -22.29 23.06 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.683 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.26 28.87 8.31 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.5 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.3 OUTLIER -164.96 -23.15 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -179.664 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.453 ' HG3' HG22 ' A' ' 93' ' ' THR . 8.7 mt-10 -122.06 -54.96 1.9 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.893 0.378 . . . . 0.0 111.317 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.446 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -66.59 -26.6 72.91 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.016 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.733 ' HB2' HD11 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -77.86 -36.04 50.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.834 0.349 . . . . 0.0 110.207 179.673 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.48 ' HD3' ' O ' ' A' ' 93' ' ' THR . 25.8 mmmt -45.46 -43.04 11.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.969 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.08 -24.53 22.26 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.51 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 111.61 1.9 27.46 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.856 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.546 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -165.17 140.23 5.16 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 121.172 0.51 . . . . 0.0 111.744 -179.818 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.554 HG22 HD21 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -114.38 133.54 60.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.902 179.932 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.462 ' HA ' ' O ' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -76.72 150.2 36.29 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.421 HD12 HG23 ' A' ' 16' ' ' VAL . 0.5 OUTLIER -138.79 112.82 8.57 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.919 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 1.012 HD12 ' HB3' ' A' ' 69' ' ' ALA . 32.6 mt -98.86 112.84 31.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.911 HG12 HD23 ' A' ' 67' ' ' LEU . 34.5 m -128.25 161.92 35.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.942 0.401 . . . . 0.0 111.48 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.625 ' HB2' ' CD1' ' A' ' 11' ' ' PHE . . . -123.55 120.38 32.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.558 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.401 ' HG2' ' N ' ' A' ' 108' ' ' ARG . 0.0 OUTLIER -110.6 146.34 36.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.86 -179.664 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.401 ' N ' ' HG2' ' A' ' 107' ' ' ARG . 0.4 OUTLIER -76.55 126.02 30.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.98 -179.856 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 9.6 mt -62.86 -51.7 68.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.093 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 27.2 t . . . . . 0 C--N 1.326 -0.425 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.928 179.95 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.892 0.377 . . . . 0.0 110.916 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -149.03 170.03 19.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.882 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -106.67 -70.15 0.8 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.879 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -152.53 -56.9 0.13 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.663 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -132.29 145.17 51.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.686 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 32.8 t -120.38 -164.13 1.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.965 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -167.84 127.81 1.34 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.528 HD13 ' HB3' ' A' ' 31' ' ' LYS . 1.4 mm -99.87 100.58 10.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.254 0.549 . . . . 0.0 111.161 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 55.9 m -70.51 102.82 2.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.578 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.6 120.07 20.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.92 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.58 HG11 ' HG3' ' A' ' 88' ' ' ARG . 11.1 m . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.151 -0.928 . . . . 0.0 110.818 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.461 ' C ' ' HG1' ' A' ' 8' ' ' THR . . . . . . . . 0 N--CA 1.452 -0.292 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.482 ' HG1' ' HG3' ' A' ' 108' ' ' ARG . 13.3 p 49.44 34.71 6.99 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.718 0.294 . . . . 0.0 111.277 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.3 mtt85 -92.42 116.59 29.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.65 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.445 ' OE2' HD21 ' A' ' 12' ' ' LEU . 7.3 pt-20 -124.12 152.39 42.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.063 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -94.61 147.46 23.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.604 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.786 HD12 HG23 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -134.23 110.17 9.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.363 -179.711 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 76.5 m -96.59 130.25 43.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.282 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.438 ' CZ ' ' HB3' ' A' ' 12' ' ' LEU . 32.0 m-85 -140.21 172.37 12.84 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.467 0.651 . . . . 0.0 112.249 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.47 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.2 OUTLIER -128.93 111.71 13.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.328 179.354 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.9 HG23 HD23 ' A' ' 103' ' ' LEU . 8.8 t -103.39 117.17 60.77 Favored Pre-proline 0 C--N 1.33 -0.274 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -178.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.53 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 80.7 Cg_endo -86.36 127.22 2.83 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.461 2.108 . . . . 0.0 111.184 178.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.849 HD11 ' HB2' ' A' ' 96' ' ' ASN . 0.4 OUTLIER -119.04 28.12 8.45 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -178.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -39.23 -30.76 0.06 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.209 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -114.63 -31.27 6.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.138 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.439 ' CB ' ' HB2' ' A' ' 54' ' ' ALA . 1.9 t -72.15 -7.6 50.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.095 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.629 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -44.74 -28.49 1.67 Allowed Glycine 0 C--N 1.337 0.602 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.741 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.73 -35.43 20.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.8 0.333 . . . . 0.0 110.824 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.21 8.74 25.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.455 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.87 -54.39 4.95 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.92 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.996 HD22 ' HE2' ' A' ' 91' ' ' MET . 8.8 tp -178.03 -36.1 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.636 0.255 . . . . 0.0 110.657 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.472 ' HA3' ' HA3' ' A' ' 53' ' ' GLY . . . 115.66 41.13 0.81 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.378 -0.915 . . . . 0.0 113.373 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.808 HG12 HG23 ' A' ' 49' ' ' ILE . 14.2 m -156.93 157.69 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 117.147 0.474 . . . . 0.0 111.917 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.422 ' O ' ' HB3' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -116.38 117.2 29.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.279 178.596 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.477 HG11 HD11 ' A' ' 67' ' ' LEU . 2.5 m -110.33 148.24 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.148 0.499 . . . . 0.0 112.159 -178.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.541 ' HB3' HD13 ' B' ' 10' ' ' ILE . 0.2 OUTLIER -147.82 129.67 15.24 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.292 179.28 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.488 ' HA2' ' HA ' ' A' ' 44' ' ' ILE . . . -90.57 163.65 29.96 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.43 -179.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.408 ' HB2' ' CZ ' ' A' ' 45' ' ' PHE . 1.7 m-80 -124.2 179.15 5.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.819 0.343 . . . . 0.0 110.637 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 11.0 ttm180 -135.15 148.75 49.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.574 ' CA ' HD21 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -55.84 128.84 36.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.917 -179.88 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.23 -28.77 69.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.139 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -80.02 -62.83 1.56 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.875 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -117.05 164.64 14.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.831 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -75.05 63.05 1.21 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.939 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -119.56 117.82 29.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.061 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -51.08 142.71 11.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.174 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.574 HD21 ' CA ' ' A' ' 35' ' ' SER . 23.0 mt -107.86 -2.16 20.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.341 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.414 ' HA3' ' NE2' ' A' ' 66' ' ' GLN . . . 111.0 179.93 20.16 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.326 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.768 ' CG1' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -109.27 139.4 32.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.978 0.418 . . . . 0.0 111.491 -179.824 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.42 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -120.47 144.84 47.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.589 179.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.57 ' O ' HG13 ' A' ' 63' ' ' VAL . 35.7 t -62.93 104.44 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.677 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.437 ' HD3' HD12 ' B' ' 10' ' ' ILE . 10.8 tptt -69.8 -45.4 68.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.813 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -167.88 127.91 1.34 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.009 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.808 HG23 HG12 ' A' ' 28' ' ' VAL . 61.8 mt -90.17 122.44 41.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.056 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.541 HD12 ' N ' ' A' ' 28' ' ' VAL . 1.8 mp -61.36 110.08 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.247 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -65.19 75.73 0.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.02 0.438 . . . . 0.0 110.597 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 160.67 -28.33 0.32 Allowed Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.807 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.472 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -74.65 167.53 54.77 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.798 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.53 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -40.76 -45.33 2.41 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.746 ' HB1' HD22 ' A' ' 61' ' ' LEU . . . -61.6 -42.36 98.76 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.178 -0.465 . . . . 0.0 112.164 -178.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.432 ' OG ' HG22 ' A' ' 49' ' ' ILE . 0.4 OUTLIER -74.23 -24.69 59.35 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.021 0.439 . . . . 0.0 110.588 -179.718 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.423 ' HG3' ' HA ' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -77.53 -34.39 53.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.795 -179.894 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -60.33 -33.81 72.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.727 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.78 22.09 79.28 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.811 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.437 ' HB3' ' CG ' ' A' ' 14' ' ' PHE . 17.4 mtm180 -125.19 -20.1 4.95 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.777 0.322 . . . . 0.0 111.08 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.78 HD11 HG21 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -77.39 138.81 39.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.979 0.418 . . . . 0.0 111.295 -179.771 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.411 ' NH2' HD13 ' A' ' 12' ' ' LEU . 0.1 OUTLIER -136.82 139.92 42.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.417 179.9 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.57 HG13 ' O ' ' A' ' 46' ' ' VAL . 41.7 t -67.74 144.03 14.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.066 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.503 ' HB2' ' O ' ' A' ' 63' ' ' VAL . 43.9 m-80 83.4 8.12 0.65 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.119 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.489 ' OD2' HG21 ' A' ' 105' ' ' VAL . 6.9 t0 -84.83 126.05 33.12 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.414 ' NE2' ' HA3' ' A' ' 43' ' ' GLY . 1.2 tt0 -78.15 131.93 37.42 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.734 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.914 HD23 HG12 ' A' ' 105' ' ' VAL . 14.4 mt -87.28 141.41 28.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.749 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.75 HD11 ' HB2' ' A' ' 106' ' ' ALA . 22.6 mt -124.91 -36.87 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.494 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.72 ' HB3' ' CD1' ' A' ' 104' ' ' ILE . . . -153.29 145.47 23.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.047 0.451 . . . . 0.0 111.666 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.71 HG11 ' HA ' ' A' ' 87' ' ' LEU . 14.9 p -133.54 130.25 56.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.588 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.447 HD22 HG22 ' A' ' 70' ' ' VAL . 9.8 m-80 63.2 18.48 11.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.692 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.48 25.27 36.54 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.663 -0.779 . . . . 0.0 111.728 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -133.03 104.11 6.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.873 0.368 . . . . 0.0 110.633 -179.538 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 0.4 OUTLIER -62.95 157.23 22.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.231 -179.712 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.623 HD22 ' HB1' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -123.95 9.49 8.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.104 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.43 -25.61 67.33 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.848 0.356 . . . . 0.0 110.984 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -94.52 25.65 21.82 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.613 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.461 ' HD2' ' HA ' ' A' ' 83' ' ' ALA . 0.5 OUTLIER -151.34 160.71 43.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.25 0.548 . . . . 0.0 111.213 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.47 ' HB1' ' OE1' ' A' ' 81' ' ' GLN . . . -65.08 158.63 25.27 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.104 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.459 ' HB2' ' HA3' ' A' ' 32' ' ' GLY . 7.8 p30 -57.35 -47.73 80.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.311 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.47 ' OE1' ' HB1' ' A' ' 79' ' ' ALA . 5.8 pm0 -58.51 -37.98 76.74 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.996 0.427 . . . . 0.0 110.776 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.406 ' HB3' ' HD3' ' A' ' 78' ' ' LYS . 3.7 mm-40 -70.67 -38.08 73.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.998 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.623 ' HB1' HD22 ' A' ' 75' ' ' LEU . . . -67.24 -46.16 74.59 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.823 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.502 ' HB3' HG21 ' A' ' 44' ' ' ILE . 5.5 ptp -64.26 -29.66 70.75 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -81.09 -30.28 34.69 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.425 178.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.494 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 7.3 m -71.58 -35.08 70.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.209 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.859 HD12 ' N ' ' A' ' 88' ' ' ARG . 4.2 pp -78.44 -34.29 47.93 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.859 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -59.5 -52.0 67.43 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.628 179.203 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.548 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.82 -33.62 66.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.017 179.474 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.448 ' N ' ' HD3' ' A' ' 89' ' ' ARG . 49.5 m -70.5 -29.79 66.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.486 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.996 ' HE2' HD22 ' A' ' 26' ' ' LEU . 2.9 ptp -86.41 -23.38 26.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.248 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.5 33.12 5.76 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.548 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.4 OUTLIER -162.91 -28.35 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.498 ' HG3' HG22 ' A' ' 93' ' ' THR . 5.3 mt-10 -122.62 -37.27 2.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.912 0.387 . . . . 0.0 111.196 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.445 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -82.27 -33.06 26.88 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.458 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.849 ' HB2' HD11 ' A' ' 18' ' ' LEU . 0.7 OUTLIER -72.83 -33.25 66.04 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.313 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.469 ' HD3' ' O ' ' A' ' 93' ' ' THR . 10.5 mmmt -40.56 -46.12 2.44 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.098 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.8 -24.31 20.36 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.816 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 118.32 -4.91 15.42 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.784 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.47 ' SD ' ' HB3' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -156.03 143.99 19.7 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.935 0.398 . . . . 0.0 111.097 -179.748 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.858 HD11 HD11 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -111.76 145.28 18.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.225 -179.643 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.643 ' O ' HD13 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -86.24 142.55 28.49 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.128 179.416 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.9 HD23 HG23 ' A' ' 16' ' ' VAL . 2.8 mm? -133.77 139.23 46.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.1 0.476 . . . . 0.0 111.749 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.72 ' CD1' ' HB3' ' A' ' 69' ' ' ALA . 7.4 mt -126.99 112.62 29.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.506 178.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.914 HG12 HD23 ' A' ' 67' ' ' LEU . 32.6 m -125.41 176.02 6.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.513 -179.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.75 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -147.65 136.55 22.07 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.865 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.564 ' HD2' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -150.32 -178.88 6.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.912 0.387 . . . . 0.0 111.212 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.482 ' HG3' ' HG1' ' A' ' 8' ' ' THR . 0.0 OUTLIER -94.02 146.32 24.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.934 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 34.4 mt -75.47 -62.59 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.11 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.876 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.941 0.4 . . . . 0.0 111.129 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -134.46 169.02 17.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.966 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -109.63 39.18 2.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.802 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 65.73 -72.91 0.07 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.054 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 4.6 m80 -78.86 119.53 22.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.068 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.12 -169.47 1.47 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.646 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -174.32 125.1 0.32 Allowed 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.541 HD13 ' HB3' ' A' ' 31' ' ' LYS . 3.3 mm -101.2 137.02 30.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.994 0.426 . . . . 0.0 110.903 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 7.9 m -120.72 113.97 20.98 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.958 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.12 131.61 42.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.591 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.436 ' CG1' ' HG3' ' A' ' 88' ' ' ARG . 10.4 m . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.316 -0.85 . . . . 0.0 111.304 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 67.5 p -149.09 87.6 1.55 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.824 0.345 . . . . 0.0 110.99 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 48.0 mtt-85 -150.55 114.6 5.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.651 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -110.89 122.27 47.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.912 0.387 . . . . 0.0 111.138 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.506 ' CE2' HD13 ' A' ' 68' ' ' ILE . 37.3 m-85 -74.92 144.42 43.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.214 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.839 HD12 HG23 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -145.49 109.86 4.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.034 0.445 . . . . 0.0 111.644 -179.415 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.437 ' O ' ' CD1' ' A' ' 14' ' ' PHE . 11.8 m -81.09 141.4 34.35 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.706 178.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.448 ' CD2' ' CD2' ' A' ' 61' ' ' LEU . 19.5 m-85 -136.38 171.84 13.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.414 0.626 . . . . 0.0 112.595 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -143.05 102.29 3.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.242 178.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.603 HG21 HD13 ' A' ' 103' ' ' LEU . 40.4 t -104.39 106.77 55.49 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -177.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.791 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 5.3 Cg_exo -77.89 127.69 8.77 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.492 2.128 . . . . 0.0 110.623 178.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.871 HD22 ' CD1' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -125.78 28.93 6.05 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.748 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -38.96 -33.11 0.1 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.15 0.5 . . . . 0.0 111.139 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -108.82 -34.07 6.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.071 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.739 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 4.7 t -69.3 -8.3 44.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.056 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.796 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -42.44 -30.52 0.86 Allowed Glycine 0 C--N 1.337 0.619 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.837 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.2 p -82.88 -39.98 20.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.859 0.361 . . . . 0.0 110.438 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -78.63 -3.31 43.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.407 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.87 -50.75 2.87 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.005 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.924 HD22 ' HE2' ' A' ' 91' ' ' MET . 10.2 tp -179.13 -35.28 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.708 0.29 . . . . 0.0 110.785 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.423 ' C ' HD12 ' A' ' 50' ' ' ILE . . . 113.83 31.03 2.4 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.535 -0.84 . . . . 0.0 113.271 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.798 HG12 HG23 ' A' ' 49' ' ' ILE . 27.8 m -150.07 154.0 9.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.045 0.45 . . . . 0.0 112.0 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.41 ' O ' ' HB3' ' A' ' 47' ' ' LYS . 0.9 OUTLIER -111.02 115.61 29.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.315 178.627 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.867 HG11 HD11 ' A' ' 67' ' ' LEU . 3.1 m -108.23 142.4 20.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.046 0.45 . . . . 0.0 111.9 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.567 ' HB3' HD13 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -144.67 131.17 19.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.15 179.556 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -92.01 157.82 24.48 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.478 -0.867 . . . . 0.0 113.351 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -117.33 -176.76 3.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.723 0.297 . . . . 0.0 110.693 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.21 152.15 47.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.684 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.16 139.51 52.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.102 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.22 -29.22 70.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.999 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -83.85 -70.41 0.57 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.998 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 34.2 p30 -100.78 -174.83 2.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.978 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -93.59 45.68 1.17 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.948 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.23 114.3 26.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.082 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -56.07 133.14 51.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.002 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 47.7 mt -94.34 16.94 13.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.274 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.465 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 86.99 179.14 48.87 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.367 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.918 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -103.89 136.26 37.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 120.933 0.397 . . . . 0.0 111.251 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -123.98 147.77 47.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.713 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.728 ' O ' HG13 ' A' ' 63' ' ' VAL . 43.0 t -58.33 105.04 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.796 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.462 ' HG2' HG21 ' B' ' 10' ' ' ILE . 4.0 tptt -75.88 -40.59 54.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.689 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -168.8 115.16 0.62 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.207 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.798 HG23 HG12 ' A' ' 28' ' ' VAL . 52.9 mt -81.31 118.75 29.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.206 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.52 HD12 ' N ' ' A' ' 28' ' ' VAL . 2.0 mp -59.07 104.9 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.565 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.47 76.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.037 0.446 . . . . 0.0 110.615 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 159.82 -27.35 0.35 Allowed Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.022 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.402 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -69.06 -170.03 6.46 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.473 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.791 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -68.67 -39.14 80.76 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.783 ' HB3' HG13 ' A' ' 28' ' ' VAL . . . -65.96 -46.34 78.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.158 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 40.1 p -63.38 -35.38 80.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.215 0.531 . . . . 0.0 109.878 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.0 mtpt -66.68 -32.14 73.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.816 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.24 -30.3 64.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.461 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.66 27.49 66.38 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.836 -0.62 . . . . 0.0 113.406 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.431 ' HG3' ' CD1' ' A' ' 14' ' ' PHE . 15.8 ptp180 -134.85 1.74 3.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 117.162 0.481 . . . . 0.0 111.592 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.448 ' CD2' ' CD2' ' A' ' 14' ' ' PHE . 3.4 mm? -108.85 152.19 25.24 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.9 0.381 . . . . 0.0 111.06 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.44 145.48 26.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.785 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.728 HG13 ' O ' ' A' ' 46' ' ' VAL . 60.1 t -52.96 144.32 3.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.07 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.486 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 37.9 m-20 93.37 -14.11 0.14 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.331 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -60.99 110.0 1.23 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.767 0.317 . . . . 0.0 110.726 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.435 ' HG3' ' CE2' ' A' ' 45' ' ' PHE . 11.8 tm0? -75.34 111.24 10.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.999 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.945 HD23 HG12 ' A' ' 105' ' ' VAL . 42.6 mt -61.02 136.97 58.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.003 0.43 . . . . 0.0 111.085 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 1.045 HD11 ' HB2' ' A' ' 106' ' ' ALA . 29.9 mt -119.84 -34.78 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.139 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.955 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -155.4 143.84 20.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.457 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.64 HG11 ' HA ' ' A' ' 87' ' ' LEU . 7.4 p -133.04 132.04 58.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.431 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 61.88 26.21 15.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.927 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.44 24.43 63.15 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.312 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -129.98 103.86 7.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.853 0.358 . . . . 0.0 110.82 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.6 t -57.23 141.07 47.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.888 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.474 ' HB3' ' CB ' ' A' ' 83' ' ' ALA . 0.7 OUTLIER -101.23 3.19 40.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.572 -179.753 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.2 tp -63.76 -15.79 59.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.574 0.226 . . . . 0.0 111.304 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -88.92 14.34 60.66 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.127 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.41 ' CE ' HD23 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -156.52 177.34 11.58 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.251 0.548 . . . . 0.0 111.333 179.851 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.801 ' HB3' ' OE1' ' A' ' 81' ' ' GLN . . . -81.62 174.05 11.76 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.748 -179.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.402 ' OD1' ' N ' ' A' ' 81' ' ' GLN . 7.3 p30 -60.13 -51.52 69.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.347 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.801 ' OE1' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -60.64 -38.48 84.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.873 0.368 . . . . 0.0 110.619 -179.754 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.3 -40.04 74.47 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.52 ' HB3' ' CD1' ' A' ' 44' ' ' ILE . . . -69.56 -30.91 68.81 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.873 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.638 ' SD ' HG23 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -72.58 -33.26 66.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.73 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.403 ' HG2' ' N ' ' A' ' 86' ' ' THR . 1.9 pt-20 -78.07 -30.38 49.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.114 0.483 . . . . 0.0 109.775 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.403 ' N ' ' HG2' ' A' ' 85' ' ' GLU . 1.5 m -70.65 -35.96 73.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.361 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.865 HD12 ' N ' ' A' ' 88' ' ' ARG . 4.3 pp -78.58 -34.85 46.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.401 0.62 . . . . 0.0 109.472 178.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.865 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -62.49 -51.46 67.36 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.272 179.368 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.508 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -71.82 -35.42 69.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.119 179.602 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.7 m -67.23 -35.61 79.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.926 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.924 ' HE2' HD22 ' A' ' 26' ' ' LEU . 3.5 ptp -83.92 -27.98 28.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.868 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.13 23.58 14.28 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.508 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.4 OUTLIER -155.38 -32.18 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.42 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 5.0 mt-10 -112.94 -65.49 1.18 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.916 0.389 . . . . 0.0 111.513 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.498 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -54.2 -27.57 39.56 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.575 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.54 ' HB2' HD11 ' A' ' 18' ' ' LEU . 0.7 OUTLIER -77.49 -32.79 54.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.692 0.282 . . . . 0.0 110.59 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' A' ' 93' ' ' THR . 40.6 mtpt -41.49 -40.06 1.7 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.005 0.431 . . . . 0.0 111.521 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.77 -25.24 15.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.182 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 117.33 1.55 18.3 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.788 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.499 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -158.36 142.04 15.35 Favored 'General case' 0 N--CA 1.457 -0.089 0 CA-C-O 121.07 0.462 . . . . 0.0 111.845 -179.568 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.591 HG22 HD21 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -115.62 136.25 53.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.6 179.496 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.448 ' HA ' ' O ' ' A' ' 14' ' ' PHE . 2.0 pp0? -76.55 140.85 41.26 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.718 HD11 HD21 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -134.8 112.59 10.84 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -178.715 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.955 HD12 ' HB3' ' A' ' 69' ' ' ALA . 43.1 mt -98.3 112.67 30.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.945 HG12 HD23 ' A' ' 67' ' ' LEU . 35.7 m -124.81 143.14 39.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.978 0.418 . . . . 0.0 111.462 -178.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 1.045 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -110.83 124.78 52.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.731 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.56 146.58 39.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.04 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.08 124.81 26.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.718 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 44.8 mt -69.15 -32.7 55.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.226 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 25.9 t . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.824 -179.857 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.914 0.388 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -74.01 132.7 42.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.987 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -105.05 -31.84 9.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.774 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -113.0 -172.86 2.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.914 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.31 -22.8 65.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.072 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 11.7 t 64.22 -162.38 0.27 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.765 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -176.03 126.9 0.22 Allowed 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.567 HD13 ' HB3' ' A' ' 31' ' ' LYS . 1.8 mm -95.74 100.51 11.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.204 0.526 . . . . 0.0 111.085 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . 0.582 HG22 HG13 ' B' ' 13' ' ' VAL . 88.9 m -71.47 99.41 2.01 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.732 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -69.51 108.02 3.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.093 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.736 HG11 ' HG3' ' A' ' 88' ' ' ARG . 30.1 m . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.65 -0.691 . . . . 0.0 110.651 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.383 0 N-CA-C 112.573 -0.211 . . . . 0.0 112.573 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 35.8 p -121.94 29.83 6.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.778 0.323 . . . . 0.0 110.878 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.81 125.88 30.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.951 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.599 ' HG3' HD21 ' A' ' 12' ' ' LEU . 24.4 pt-20 -133.55 133.94 42.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.937 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.519 ' HD2' HD13 ' A' ' 68' ' ' ILE . 51.7 m-85 -81.43 151.47 27.87 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.785 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.751 HD12 HG23 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -155.02 122.39 5.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.022 0.439 . . . . 0.0 111.236 -179.836 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.419 HG23 HG12 ' A' ' 104' ' ' ILE . 6.8 m -81.46 146.24 30.34 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.209 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.456 ' N ' ' O ' ' A' ' 103' ' ' LEU . 17.6 m-85 -140.63 171.55 13.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.414 0.626 . . . . 0.0 112.243 -179.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -143.65 104.88 4.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.843 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.562 HG12 ' HB1' ' A' ' 54' ' ' ALA . 18.7 t -105.16 114.08 63.92 Favored Pre-proline 0 C--N 1.33 -0.268 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.529 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 97.8 Cg_endo -84.79 126.98 3.52 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.454 2.103 . . . . 0.0 110.849 178.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.802 HD22 ' CD1' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -121.98 28.24 7.66 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -178.672 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -39.2 -32.46 0.1 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.054 0.454 . . . . 0.0 111.205 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -108.74 -34.44 6.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.122 179.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.2 t -70.68 -6.58 38.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.288 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.755 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -42.56 -30.51 0.89 Allowed Glycine 0 C--N 1.337 0.593 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.727 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.3 p -83.01 -39.27 21.5 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.851 0.358 . . . . 0.0 110.528 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -78.61 -15.09 58.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.3 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.04 -46.37 1.39 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.645 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.802 ' CD1' HD22 ' A' ' 18' ' ' LEU . 8.2 tp 178.06 -31.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.7 0.286 . . . . 0.0 110.704 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.455 ' HA3' ' HA3' ' A' ' 53' ' ' GLY . . . 106.12 43.65 1.48 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.405 -0.903 . . . . 0.0 113.384 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.814 HG12 HG23 ' A' ' 49' ' ' ILE . 29.0 m -157.33 155.71 4.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.304 0.573 . . . . 0.0 112.073 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.74 116.91 30.85 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 19.6 m -105.93 143.34 17.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.237 0.541 . . . . 0.0 112.222 -178.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.662 ' HB2' HD13 ' B' ' 10' ' ' ILE . 0.4 OUTLIER -146.54 129.01 15.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.056 179.443 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' A' ' 44' ' ' ILE . . . -104.85 159.66 15.72 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.47 -0.871 . . . . 0.0 112.782 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -134.71 154.03 51.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.8 0.333 . . . . 0.0 110.971 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.41 ' HB3' ' HA ' ' A' ' 41' ' ' ASP . 1.1 ptp180 -109.12 154.62 22.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.097 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.534 ' N ' HD21 ' A' ' 42' ' ' LEU . 0.6 OUTLIER -40.87 151.43 0.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.439 -179.692 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.94 -56.1 11.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.101 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -59.52 -71.51 0.12 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.005 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -85.41 172.89 10.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.881 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -98.54 34.6 1.99 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.85 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.04 124.91 34.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.076 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.588 ' OD2' ' HB1' ' A' ' 79' ' ' ALA . 75.1 m-20 -59.55 139.33 57.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.964 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.534 HD21 ' N ' ' A' ' 35' ' ' SER . 16.7 mt -100.79 -29.76 12.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.887 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 146.25 -176.8 24.99 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.296 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.825 HG21 ' HB3' ' A' ' 84' ' ' MET . 0.0 OUTLIER -105.98 140.12 25.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.675 0.274 . . . . 0.0 110.67 179.837 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -127.09 139.37 53.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.445 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.732 ' O ' HG13 ' A' ' 63' ' ' VAL . 53.2 t -58.03 106.5 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.166 179.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.535 ' HG2' HD12 ' B' ' 10' ' ' ILE . 9.7 tptp -76.08 -40.87 52.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.879 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.3 t -168.06 122.23 0.94 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.028 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.814 HG23 HG12 ' A' ' 28' ' ' VAL . 69.6 mt -88.59 123.02 40.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.19 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.443 HD13 ' HA2' ' A' ' 27' ' ' GLY . 1.8 mp -60.61 109.63 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.221 179.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.82 72.49 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.074 0.464 . . . . 0.0 110.963 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 163.36 -25.85 0.21 Allowed Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.383 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.455 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -71.19 -167.4 7.77 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.574 -0.822 . . . . 0.0 113.018 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.562 ' HB1' HG12 ' A' ' 16' ' ' VAL . . . -65.41 -42.98 91.98 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.305 0.484 . . . . 0.0 112.305 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.577 ' CB ' HD13 ' A' ' 61' ' ' LEU . . . -64.52 -44.65 90.18 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.582 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.561 ' OG ' HG22 ' A' ' 49' ' ' ILE . 1.4 m -67.44 -29.95 69.56 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.289 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.3 mtpt -78.53 -30.84 47.22 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.293 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.86 -30.72 58.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.711 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.71 19.3 77.91 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.757 -0.735 . . . . 0.0 113.147 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.413 ' HG3' ' CD1' ' A' ' 14' ' ' PHE . 2.6 ptp180 -142.68 17.66 2.0 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.892 0.346 . . . . 0.0 110.997 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.699 ' HB3' HD13 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -114.34 130.75 56.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.638 179.713 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.51 142.56 37.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.116 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.732 HG13 ' O ' ' A' ' 46' ' ' VAL . 59.3 t -53.65 152.35 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.064 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.6 ' HB2' ' O ' ' A' ' 63' ' ' VAL . 9.1 m-80 78.27 13.78 1.52 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.498 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.447 ' O ' HG23 ' A' ' 46' ' ' VAL . 0.8 OUTLIER -91.71 114.31 26.81 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.024 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.421 ' O ' ' HA ' ' A' ' 105' ' ' VAL . 12.7 tm0? -71.31 140.41 50.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.008 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.992 HD23 HG12 ' A' ' 105' ' ' VAL . 18.7 mt -98.13 131.76 44.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.122 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.635 ' O ' HD12 ' A' ' 75' ' ' LEU . 2.1 mp -116.15 -45.15 3.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.898 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 1.004 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -137.44 149.85 47.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.25 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.704 HG11 ' HA ' ' A' ' 87' ' ' LEU . 7.1 p -140.91 123.22 15.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.605 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.617 HD22 HG22 ' A' ' 70' ' ' VAL . 66.2 m-80 66.22 11.23 7.74 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.521 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 109.23 -18.28 30.84 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.831 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -94.05 117.29 29.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.919 0.39 . . . . 0.0 111.151 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.71 139.65 39.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.651 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.635 HD12 ' O ' ' A' ' 68' ' ' ILE . 0.1 OUTLIER -118.29 13.13 13.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.419 -179.835 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.438 HD13 HG23 ' A' ' 68' ' ' ILE . 3.1 tp -60.95 -20.88 62.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.654 0.264 . . . . 0.0 111.246 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -85.36 -24.87 41.72 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.91 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.427 ' HE2' ' HB3' ' A' ' 78' ' ' LYS . 5.6 ptpt -98.16 157.29 16.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.307 0.575 . . . . 0.0 111.305 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.588 ' HB1' ' OD2' ' A' ' 41' ' ' ASP . . . -57.33 166.47 1.18 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.253 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.42 ' OD1' ' N ' ' A' ' 81' ' ' GLN . 22.7 p30 -63.12 -38.97 93.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.095 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.564 HE21 ' HB3' ' A' ' 79' ' ' ALA . 2.4 pp0? -67.18 -41.93 85.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.184 0.516 . . . . 0.0 110.469 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.4 ' HB3' ' HD3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -70.94 -35.14 72.08 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.689 179.093 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.598 ' HB3' ' CD1' ' A' ' 44' ' ' ILE . . . -69.12 -46.51 67.48 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.581 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.825 ' HB3' HG21 ' A' ' 44' ' ' ILE . 4.4 ptp -62.47 -30.99 71.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.98 179.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.11 -33.91 56.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.727 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.403 ' HA ' ' HD2' ' A' ' 89' ' ' ARG . 1.3 m -69.81 -36.06 75.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.367 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.808 HD22 HD13 ' A' ' 67' ' ' LEU . 3.7 pp -78.4 -33.91 48.47 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.555 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -59.19 -49.98 75.79 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.342 179.108 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.442 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.85 -37.21 67.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.456 179.648 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.6 t -70.93 -29.36 65.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.399 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.774 ' HE2' HD22 ' A' ' 26' ' ' LEU . 4.5 ptm -89.07 -22.75 22.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.64 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.0 21.92 14.39 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.493 ' O ' ' HG3' ' A' ' 97' ' ' LYS . 0.4 OUTLIER -154.23 -35.21 0.1 Allowed 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.757 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.411 ' HG3' HG22 ' A' ' 93' ' ' THR . 3.7 mt-10 -111.86 -39.33 4.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.84 0.352 . . . . 0.0 111.362 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.476 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -70.94 -30.8 67.53 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.9 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.723 ' HB2' HD11 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -76.97 -34.09 57.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.787 0.327 . . . . 0.0 110.262 179.609 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.493 ' HG3' ' O ' ' A' ' 93' ' ' THR . 46.2 mtpt -39.94 -45.77 1.92 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.79 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.37 -22.98 18.61 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.838 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 115.35 0.11 22.15 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.824 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.473 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -163.82 142.61 7.76 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.992 0.425 . . . . 0.0 111.193 -179.83 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.54 HG22 HD21 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -112.12 142.69 23.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.326 -179.753 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.62 147.63 37.45 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.456 ' O ' ' N ' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -143.39 110.46 5.68 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -178.729 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 1.004 HD12 ' HB3' ' A' ' 69' ' ' ALA . 57.4 mt -101.36 112.54 34.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 177.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.992 HG12 HD23 ' A' ' 67' ' ' LEU . 35.3 m -123.64 157.54 29.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.092 0.472 . . . . 0.0 112.091 -178.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.606 ' CB ' HD11 ' A' ' 68' ' ' ILE . . . -129.4 122.81 30.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.373 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.07 -179.35 5.5 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.953 0.406 . . . . 0.0 111.21 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -91.11 141.15 29.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.054 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 18.4 mt -73.44 110.27 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.933 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.0 t . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.94 -179.941 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 121.007 0.432 . . . . 0.0 110.935 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -105.3 166.16 10.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.95 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . 0.405 ' HB2' ' CG ' ' A' ' 34' ' ' ARG . 0.5 OUTLIER -100.79 36.28 1.98 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.755 179.893 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 67.33 -67.03 0.18 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.96 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -88.02 138.14 31.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.955 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.87 -160.78 1.09 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.81 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -163.37 126.46 2.69 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.662 HD13 ' HB2' ' A' ' 31' ' ' LYS . 1.6 mm -104.73 100.7 11.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.165 0.507 . . . . 0.0 111.228 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 99.0 m -77.61 102.47 7.03 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.356 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 1.3 tptp -68.78 122.33 18.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.293 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 18.3 m . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.559 -0.734 . . . . 0.0 110.758 179.748 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.245 0 N-CA-C 112.429 -0.268 . . . . 0.0 112.429 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.44 ' HG1' ' HG2' ' A' ' 108' ' ' ARG . 44.7 p 50.08 26.92 2.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.711 0.291 . . . . 0.0 111.241 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -91.5 119.81 31.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.74 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.408 ' OE1' HD11 ' A' ' 109' ' ' ILE . 23.7 pt-20 -128.91 151.06 50.06 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.094 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -92.05 148.37 22.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.572 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.637 HD12 HG23 ' A' ' 105' ' ' VAL . 0.3 OUTLIER -134.7 109.88 8.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.069 0.461 . . . . 0.0 111.229 -179.645 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.534 HG23 ' OE1' ' A' ' 102' ' ' GLN . 94.4 m -92.24 124.63 36.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.127 179.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.451 ' CG ' ' HB3' ' A' ' 60' ' ' ARG . 25.1 m-85 -134.83 151.36 50.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.358 0.599 . . . . 0.0 112.103 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.486 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.4 OUTLIER -111.98 110.67 21.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.097 178.948 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.749 ' CG2' HD11 ' A' ' 61' ' ' LEU . 11.7 t -100.33 116.52 64.33 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -177.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.735 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 84.6 Cg_endo -87.22 127.88 2.56 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.784 2.323 . . . . 0.0 111.086 178.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.861 HD22 HD13 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -127.49 28.49 5.66 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -178.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -39.08 -33.27 0.12 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.151 0.5 . . . . 0.0 111.179 179.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -108.04 -33.76 7.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.072 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.697 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 7.2 t -70.67 -6.82 39.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.141 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.806 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -41.61 -31.35 0.69 Allowed Glycine 0 C--N 1.338 0.653 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.789 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.3 p -82.52 -41.75 19.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.888 0.375 . . . . 0.0 110.386 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -77.5 -4.66 46.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.458 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.18 -50.16 3.32 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.867 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.943 HD22 ' HE2' ' A' ' 91' ' ' MET . 9.9 tp 179.87 -33.0 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.722 0.296 . . . . 0.0 110.635 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.448 ' HA3' ' HA3' ' A' ' 53' ' ' GLY . . . 109.1 44.04 1.13 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.5 -0.857 . . . . 0.0 113.426 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.73 HG12 HG23 ' A' ' 49' ' ' ILE . 20.8 m -157.56 173.79 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.146 0.498 . . . . 0.0 112.077 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.422 ' O ' ' N ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -134.25 117.09 16.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.312 178.907 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.7 HG11 HD11 ' A' ' 67' ' ' LEU . 3.4 m -109.55 149.48 12.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.009 0.433 . . . . 0.0 111.937 -178.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.427 ' O ' ' HG3' ' A' ' 31' ' ' LYS . 13.5 ptmt -143.63 133.47 23.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.595 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.44 ' HA2' ' HA ' ' A' ' 44' ' ' ILE . . . -95.15 150.94 19.86 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.919 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -112.16 165.69 11.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.813 0.339 . . . . 0.0 110.894 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.434 ' HB3' ' HB2' ' B' ' 5' ' ' ASP . 6.8 ttm180 -128.84 140.52 51.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.629 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.2 123.41 13.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.921 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.05 -32.56 74.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.955 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -75.31 -31.52 60.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.962 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -149.03 136.55 20.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.708 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -61.45 83.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.948 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.95 126.96 12.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.844 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -50.89 145.69 6.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.222 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.62 HD11 ' OD1' ' B' ' 3' ' ' ASP . 43.9 mt -111.34 -23.2 10.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.801 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.421 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 132.03 162.98 10.6 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.354 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.935 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -98.69 136.22 30.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.059 0.457 . . . . 0.0 111.163 -179.866 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -123.69 147.16 47.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.663 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.668 ' O ' HG13 ' A' ' 63' ' ' VAL . 35.0 t -60.3 104.59 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 29' ' ' SER . 24.5 tptt -72.25 -44.12 63.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.516 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 m -166.22 128.45 1.9 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.813 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.73 HG23 HG12 ' A' ' 28' ' ' VAL . 73.4 mt -94.03 121.61 44.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.145 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.585 HD12 ' N ' ' A' ' 28' ' ' VAL . 1.6 mp -58.71 113.59 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.406 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -68.12 74.25 0.21 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.682 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 159.89 -27.22 0.34 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.112 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.448 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -69.12 -171.91 7.84 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.601 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.735 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -64.12 -40.54 96.41 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.187 0.439 . . . . 0.0 112.187 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.645 ' HA ' HD13 ' A' ' 61' ' ' LEU . . . -61.57 -51.13 69.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.321 -179.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.8 t -63.43 -30.09 71.27 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.104 0.478 . . . . 0.0 109.807 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.0 mtpt -74.86 -35.01 62.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.738 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -58.9 -27.12 64.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.774 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 63.3 25.25 68.23 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.57 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.451 ' HB3' ' CG ' ' A' ' 14' ' ' PHE . 19.4 mtm180 -127.44 -29.3 2.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.693 0.283 . . . . 0.0 111.224 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.749 HD11 ' CG2' ' A' ' 16' ' ' VAL . 2.3 mp -74.13 143.19 45.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.117 0.484 . . . . 0.0 111.291 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.41 ' NH2' HD13 ' A' ' 12' ' ' LEU . 0.1 OUTLIER -144.83 134.83 23.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.313 179.84 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.668 HG13 ' O ' ' A' ' 46' ' ' VAL . 58.1 t -53.68 143.05 6.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.587 -0.278 . . . . 0.0 110.908 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 30.5 m-20 89.7 -8.88 0.39 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.073 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -63.11 110.21 1.76 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.854 0.359 . . . . 0.0 110.725 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.402 ' NE2' ' O ' ' A' ' 67' ' ' LEU . 20.7 tm0? -74.28 112.93 10.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.915 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.935 HD12 HG13 ' A' ' 44' ' ' ILE . 45.7 mt -66.84 146.44 54.42 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.044 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.735 HD11 ' CB ' ' A' ' 106' ' ' ALA . 52.9 mt -135.77 -42.67 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.277 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.878 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -146.0 126.04 13.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.067 0.461 . . . . 0.0 111.621 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.706 HG22 HD22 ' A' ' 71' ' ' ASN . 11.4 p -118.56 127.55 75.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.152 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.706 HD22 HG22 ' A' ' 70' ' ' VAL . 2.3 m-80 62.0 35.1 16.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.959 0.409 . . . . 0.0 110.293 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 68.64 24.1 75.38 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.166 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -126.34 98.11 5.32 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.73 0.3 . . . . 0.0 110.822 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.0 t -60.81 136.95 58.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.815 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.62 HD22 ' HB1' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -98.38 12.53 34.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.309 -179.851 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 12.8 mt -63.89 -23.52 67.38 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.72 0.295 . . . . 0.0 111.011 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -93.05 21.16 41.41 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.736 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -150.73 167.02 28.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.176 0.512 . . . . 0.0 111.052 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.566 ' HB3' HE22 ' A' ' 81' ' ' GLN . . . -78.25 175.71 9.95 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.174 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -61.73 -55.83 26.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.239 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.566 HE22 ' HB3' ' A' ' 79' ' ' ALA . 4.8 pm0 -53.9 -38.94 65.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.009 0.433 . . . . 0.0 111.222 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.62 -37.4 73.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.22 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.62 ' HB1' HD22 ' A' ' 75' ' ' LEU . . . -68.96 -47.6 65.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.821 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.475 ' HA ' ' CD2' ' A' ' 87' ' ' LEU . 9.1 ptp -62.88 -30.08 71.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.295 -0.412 . . . . 0.0 109.945 179.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -79.12 -35.66 41.83 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 178.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.8 m -67.68 -35.84 79.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.194 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.745 HD12 ' N ' ' A' ' 88' ' ' ARG . 4.4 pp -78.22 -33.88 49.64 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 178.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.745 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -56.17 -50.05 72.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.007 178.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.705 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.35 -49.74 31.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.313 178.734 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.431 ' HB3' ' ND2' ' A' ' 71' ' ' ASN . 1.4 m -54.75 -29.38 53.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.602 179.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.943 ' HE2' HD22 ' A' ' 26' ' ' LEU . 1.5 ptp -89.98 -37.85 14.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.306 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.21 37.91 2.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.988 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.705 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 72.3 m -162.56 -41.48 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.566 -0.454 . . . . 0.0 112.214 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -111.62 -48.58 3.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.058 0.456 . . . . 0.0 110.777 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.454 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -69.74 -20.45 75.86 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.146 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.526 ' HB2' HD11 ' A' ' 18' ' ' LEU . 0.7 OUTLIER -83.09 -32.26 26.85 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.653 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -40.8 -35.88 0.55 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.383 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.25 -30.72 11.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.69 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 125.93 -6.14 7.83 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.689 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.491 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -153.97 143.64 21.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.983 0.42 . . . . 0.0 111.147 -179.924 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.617 HG22 HD21 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -109.42 147.14 14.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.452 -179.707 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.534 ' OE1' HG23 ' A' ' 13' ' ' THR . 0.0 OUTLIER -79.47 143.47 34.92 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.714 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.473 HD12 HG23 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -138.65 148.22 43.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.125 0.488 . . . . 0.0 111.902 -179.072 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.878 HD12 ' HB3' ' A' ' 69' ' ' ALA . 68.9 mt -144.63 113.33 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.047 179.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.931 HG12 HD23 ' A' ' 67' ' ' LEU . 30.0 m -124.3 179.32 2.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.468 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.735 ' CB ' HD11 ' A' ' 68' ' ' ILE . . . -147.75 139.89 24.28 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.93 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.625 ' CG ' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -152.42 179.48 8.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.997 179.872 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.44 ' HG2' ' HG1' ' A' ' 8' ' ' THR . 3.2 mtm180 -100.82 154.44 18.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.026 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.408 HD11 ' OE1' ' A' ' 10' ' ' GLU . 17.6 mt -100.77 -34.08 3.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.131 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.798 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . 0.62 ' OD1' HD11 ' A' ' 42' ' ' LEU . 4.8 t70 . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.932 0.396 . . . . 0.0 110.88 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -79.87 158.58 26.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.969 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . 0.434 ' HB2' ' HB3' ' A' ' 34' ' ' ARG . 19.7 t70 -108.24 -76.03 0.62 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.892 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.8 -54.76 2.41 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.078 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 26.5 t-80 -146.3 145.82 30.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.047 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 54.4 p -105.62 -163.45 0.94 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.743 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 177.7 149.31 0.17 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.267 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.411 HD12 ' HD3' ' A' ' 47' ' ' LYS . 2.1 mm -118.27 148.71 20.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.038 0.446 . . . . 0.0 111.156 -179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . 0.8 HG22 HG13 ' B' ' 13' ' ' VAL . 55.2 m -123.41 104.36 9.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.568 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.67 102.84 5.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.026 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.8 HG13 HG22 ' B' ' 11' ' ' THR . 35.2 m . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.936 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.539 -0.224 . . . . 0.0 112.539 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.4 p -109.44 -15.99 14.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.622 0.248 . . . . 0.0 111.296 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.64 143.13 40.35 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.714 0.293 . . . . 0.0 110.665 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -163.97 161.99 23.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.005 0.431 . . . . 0.0 111.291 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -104.07 145.32 30.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.413 179.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 1.093 HD12 HG23 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -134.32 119.58 18.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.025 0.44 . . . . 0.0 111.301 -179.676 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.409 ' O ' ' CD1' ' A' ' 14' ' ' PHE . 90.0 m -86.68 143.02 27.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.975 179.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.417 ' CE1' ' HG2' ' A' ' 60' ' ' ARG . 24.9 m-85 -139.59 169.41 17.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.286 0.565 . . . . 0.0 112.158 -179.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -139.52 107.54 5.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.173 -0.921 . . . . 0.0 108.923 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.7 HG21 HD11 ' A' ' 61' ' ' LEU . 17.6 t -104.28 111.43 65.17 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -177.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.785 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 84.6 Cg_endo -81.72 127.71 5.71 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.441 2.094 . . . . 0.0 110.794 178.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.828 HD22 HD13 ' A' ' 26' ' ' LEU . 0.5 OUTLIER -125.44 29.15 6.1 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.595 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -39.56 -32.75 0.14 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.112 0.482 . . . . 0.0 111.245 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -109.18 -35.26 6.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.105 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.704 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 9.9 t -67.83 -9.65 46.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.099 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.731 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -43.01 -29.76 0.92 Allowed Glycine 0 C--N 1.339 0.713 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.808 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.3 m -82.58 -39.09 22.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.884 0.373 . . . . 0.0 110.572 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -78.28 -20.85 50.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.197 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.29 -50.31 0.78 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.833 -0.698 . . . . 0.0 111.507 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.828 HD13 HD22 ' A' ' 18' ' ' LEU . 10.9 tp 179.0 -32.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.56 0.219 . . . . 0.0 110.836 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.453 ' HA3' ' HA3' ' A' ' 53' ' ' GLY . . . 110.79 37.74 1.67 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.342 -0.932 . . . . 0.0 113.171 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.744 HG12 HG23 ' A' ' 49' ' ' ILE . 14.4 m -156.51 164.37 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.229 0.538 . . . . 0.0 111.957 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.405 ' O ' ' HB3' ' A' ' 47' ' ' LYS . 2.0 m -123.73 115.18 20.97 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.17 178.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.561 HG11 HD11 ' A' ' 67' ' ' LEU . 4.5 m -106.75 141.12 22.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.089 0.471 . . . . 0.0 111.93 -178.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.522 ' CB ' HD13 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -145.53 131.28 19.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.101 179.452 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 44' ' ' ILE . . . -102.25 162.36 17.0 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.442 -0.885 . . . . 0.0 113.052 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.4 ' HB3' ' O ' ' B' ' 3' ' ' ASP . 11.5 m120 -135.94 156.58 48.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.949 0.404 . . . . 0.0 111.019 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.467 ' HD2' ' HA ' ' A' ' 39' ' ' HIS . 0.0 OUTLIER -108.87 152.28 25.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.736 179.972 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.593 ' CB ' HD21 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -50.11 137.58 17.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.983 179.954 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.19 -23.81 65.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.494 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -71.14 -51.02 27.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.079 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -135.34 160.29 38.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.838 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.467 ' HA ' ' HD2' ' A' ' 34' ' ' ARG . 74.5 m-70 -70.39 66.0 0.3 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.87 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -126.17 121.34 32.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.172 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.411 ' CB ' ' ND2' ' A' ' 80' ' ' ASN . 3.4 p-10 -53.39 145.21 14.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.383 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.593 HD21 ' CB ' ' A' ' 35' ' ' SER . 32.4 mt -109.71 -29.83 8.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.47 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.416 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 142.12 -178.58 20.67 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.995 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.827 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -108.05 140.56 26.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.965 0.412 . . . . 0.0 111.219 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -128.6 142.3 51.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.708 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.58 ' O ' HG13 ' A' ' 63' ' ' VAL . 40.0 t -57.58 104.33 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.784 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' A' ' 29' ' ' SER . 36.4 tptt -72.66 -42.91 63.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.801 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.47 129.62 1.61 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.084 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.744 HG23 HG12 ' A' ' 28' ' ' VAL . 78.0 mt -95.16 118.31 41.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.212 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.564 HD12 ' N ' ' A' ' 28' ' ' VAL . 1.8 mp -55.03 107.09 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.619 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.52 77.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.112 0.482 . . . . 0.0 110.593 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 155.27 -26.21 0.61 Allowed Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.872 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.453 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -67.73 -172.41 6.27 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.621 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.785 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -64.76 -39.35 93.47 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.684 ' HB1' HD13 ' A' ' 61' ' ' LEU . . . -64.79 -48.66 73.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.269 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 60.1 p -63.03 -31.51 72.67 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.864 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 34.6 mtpt -75.23 -34.43 61.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.911 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -59.53 -27.65 66.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.741 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.47 40.0 95.62 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.662 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.417 ' HG2' ' CE1' ' A' ' 14' ' ' PHE . 4.5 mtm180 -134.88 -40.96 0.76 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.857 0.361 . . . . 0.0 110.913 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.7 HD11 HG21 ' A' ' 16' ' ' VAL . 3.7 mp -58.22 166.89 1.47 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.294 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.6 mtm105 -162.15 118.78 2.04 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.301 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.58 HG13 ' O ' ' A' ' 46' ' ' VAL . 34.1 t -47.98 143.12 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.385 -179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.427 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 22.3 m-80 85.76 -5.36 0.83 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.326 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.15 127.41 32.53 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.754 0.311 . . . . 0.0 110.388 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.412 ' NE2' ' HA3' ' A' ' 43' ' ' GLY . 0.8 OUTLIER -79.66 136.37 36.79 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.678 -179.631 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.852 HD23 HG12 ' A' ' 105' ' ' VAL . 49.7 mt -89.0 133.04 34.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.274 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.8 mm -116.8 -30.09 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.994 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.831 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -159.86 159.02 32.0 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.06 0.457 . . . . 0.0 111.203 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.803 HG22 ' ND2' ' A' ' 71' ' ' ASN . 8.0 p -145.74 125.07 5.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.416 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.803 ' ND2' HG22 ' A' ' 70' ' ' VAL . 66.7 m-80 61.17 18.22 8.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.922 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.75 25.36 23.02 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.114 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -124.65 101.06 6.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.736 0.303 . . . . 0.0 110.692 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.5 p -62.67 138.26 58.46 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.018 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -104.39 -16.27 15.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.239 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.5 tp -55.27 89.72 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.913 0.387 . . . . 0.0 111.13 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 156.7 -27.92 0.53 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.294 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.47 ' HD3' ' HB3' ' A' ' 82' ' ' GLU . 0.5 OUTLIER -106.63 159.54 16.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.253 0.549 . . . . 0.0 111.048 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.13 158.0 12.08 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.135 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.411 ' ND2' ' CB ' ' A' ' 41' ' ' ASP . 26.7 m-80 -51.18 -57.38 8.91 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.164 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.429 ' NE2' ' CG ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -51.65 -37.72 51.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.562 -179.47 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.47 ' HB3' ' HD3' ' A' ' 78' ' ' LYS . 1.9 mt-10 -70.92 -40.9 71.83 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.055 0.455 . . . . 0.0 110.331 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.521 ' HB3' ' CD1' ' A' ' 44' ' ' ILE . . . -66.53 -50.07 64.41 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.835 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.575 ' HB3' HG21 ' A' ' 44' ' ' ILE . 5.6 ptp -60.92 -29.65 69.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.062 179.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -76.98 -33.73 57.61 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.4 m -67.95 -36.88 80.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.224 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.692 HD12 ' N ' ' A' ' 88' ' ' ARG . 4.4 pp -78.43 -33.36 48.59 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.692 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -58.1 -49.03 78.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.262 178.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.529 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -73.15 -44.29 60.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.065 179.293 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.7 t -62.9 -29.8 71.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.178 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.768 ' HE2' HD22 ' A' ' 26' ' ' LEU . 3.3 ptm -89.81 -25.25 21.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.701 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.21 31.72 6.55 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.529 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.3 OUTLIER -164.25 -33.31 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 179.849 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.409 ' HG3' HG22 ' A' ' 93' ' ' THR . 7.7 mt-10 -111.09 -69.04 0.89 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.803 0.335 . . . . 0.0 111.37 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.427 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -48.8 -27.44 6.36 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.604 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.714 ' HB2' HD11 ' A' ' 18' ' ' LEU . 0.7 OUTLIER -76.41 -33.13 58.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.626 0.25 . . . . 0.0 110.434 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 94' ' ' GLU . 38.0 mtpt -39.62 -41.51 1.06 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.066 0.46 . . . . 0.0 111.373 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.63 -26.99 15.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.061 179.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 120.5 -3.51 12.26 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.883 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.457 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.3 OUTLIER -154.0 141.32 19.61 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.89 0.376 . . . . 0.0 111.412 -179.628 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.571 HG22 HD21 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -110.27 141.69 24.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.036 179.82 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.61 150.47 36.45 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.514 HD12 HG23 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -144.24 112.01 6.18 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.831 HD12 ' HB3' ' A' ' 69' ' ' ALA . 76.4 mt -103.39 113.27 39.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 1.093 HG23 HD12 ' A' ' 12' ' ' LEU . 16.9 m -120.99 174.99 5.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.857 0.36 . . . . 0.0 111.542 -179.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -147.36 142.82 27.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.206 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.475 ' HD2' HD21 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -159.38 -178.99 7.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.783 179.836 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 5.9 ttp85 -116.36 139.03 50.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.902 0.382 . . . . 0.0 111.124 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.495 HG22 ' N ' ' A' ' 110' ' ' SER . 28.9 mt -76.94 158.72 5.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.031 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.495 ' N ' HG22 ' A' ' 109' ' ' ILE . 32.5 t . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.892 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . 0.479 ' OD1' HD11 ' A' ' 42' ' ' LEU . 0.7 OUTLIER . . . . . 0 CA--C 1.527 0.081 0 CA-C-O 120.849 0.356 . . . . 0.0 110.996 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -158.59 169.23 24.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.988 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -103.89 38.26 1.87 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.537 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 68.9 -65.17 0.3 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.045 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 14.1 p80 -107.51 98.26 7.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.119 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.85 -158.84 0.21 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.585 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -158.19 124.04 4.59 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.522 HD13 ' CB ' ' A' ' 31' ' ' LYS . 1.4 mm -102.26 120.29 51.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.185 0.516 . . . . 0.0 111.226 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 28.0 m -94.84 109.61 21.58 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.644 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 7.0 tppt? -70.99 126.72 30.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.095 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.551 HG11 ' HG3' ' A' ' 88' ' ' ARG . 4.1 m . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.554 -0.736 . . . . 0.0 110.862 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.255 0 N-CA-C 112.489 -0.245 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 108' ' ' ARG . 41.8 p -134.54 80.02 1.83 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.694 0.283 . . . . 0.0 110.832 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.91 127.07 33.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.838 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -128.27 136.97 51.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.178 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -86.96 147.5 25.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.891 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.994 HD12 HG23 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -137.77 110.46 7.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.204 -179.656 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 71.2 m -103.89 128.03 51.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.489 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -140.95 172.65 12.38 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 121.354 0.597 . . . . 0.0 112.341 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.404 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.5 OUTLIER -127.8 111.19 13.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.853 179.26 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.845 HG13 ' OD1' ' A' ' 58' ' ' ASP . 66.5 t -103.99 113.66 65.16 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -177.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.624 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 83.3 Cg_endo -84.13 127.58 4.06 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.373 2.049 . . . . 0.0 110.748 177.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.882 HD22 ' CD1' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -122.54 30.05 6.66 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -178.628 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -36.94 -33.87 0.06 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.172 0.511 . . . . 0.0 111.291 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -111.57 -34.47 6.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.16 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.503 ' HB2' ' HB2' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -66.26 -13.83 61.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.943 179.761 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.743 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -45.97 -28.01 2.69 Favored Glycine 0 C--N 1.337 0.608 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.78 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.33 -36.02 27.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.847 0.356 . . . . 0.0 110.78 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -82.64 -24.43 33.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.253 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.78 -54.59 0.64 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.932 -0.652 . . . . 0.0 111.481 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.986 HD22 ' HE2' ' A' ' 91' ' ' MET . 10.0 tp 179.41 -35.3 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.616 0.246 . . . . 0.0 110.893 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 50' ' ' ILE . . . 117.28 32.69 1.45 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.296 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.775 HG11 HD22 ' A' ' 61' ' ' LEU . 33.4 m -157.88 157.04 3.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.121 0.486 . . . . 0.0 111.897 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.92 116.05 26.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.431 178.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.958 HG11 HD11 ' A' ' 67' ' ' LEU . 3.9 m -106.76 142.64 19.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.014 0.435 . . . . 0.0 111.691 -179.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.584 ' HB3' HD13 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -139.5 135.18 33.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.617 179.821 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.501 ' HA3' ' HB2' ' A' ' 80' ' ' ASN . . . -89.73 152.42 22.43 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.013 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.44 ' ND2' ' CE1' ' A' ' 45' ' ' PHE . 91.2 m-20 -120.77 163.74 17.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.757 0.313 . . . . 0.0 110.873 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -116.44 151.76 35.38 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.752 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.606 ' HA ' HD21 ' A' ' 42' ' ' LEU . 0.9 OUTLIER -51.97 167.71 0.11 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.207 -179.909 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.11 -56.13 11.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.105 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -116.93 -38.22 3.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.031 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -55.06 -24.35 24.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.202 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 60.68 32.8 20.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.002 0.43 . . . . 0.0 110.737 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -107.87 135.43 49.28 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.009 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -58.17 122.3 12.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.809 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.606 HD21 ' HA ' ' A' ' 35' ' ' SER . 16.0 mt -82.66 -30.23 29.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.2 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.481 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 140.99 177.85 16.68 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.017 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.849 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -99.79 134.13 40.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.951 0.405 . . . . 0.0 111.297 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.468 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -123.15 143.29 50.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.54 -179.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.623 ' O ' HG13 ' A' ' 63' ' ' VAL . 42.6 t -55.78 104.52 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.856 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.548 ' HD3' HD12 ' B' ' 10' ' ' ILE . 6.3 tptp -74.05 -42.17 60.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.644 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.42 125.57 1.53 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.949 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.723 HG23 HG12 ' A' ' 28' ' ' VAL . 69.8 mt -89.94 120.77 39.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.275 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.64 HD12 ' N ' ' A' ' 28' ' ' VAL . 2.1 mp -61.88 108.87 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.794 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -66.68 74.24 0.1 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.926 0.393 . . . . 0.0 110.399 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 164.47 -28.04 0.21 Allowed Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.119 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.15 -176.33 23.28 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.601 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.624 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -61.27 -41.15 96.43 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.809 ' HB1' HD13 ' A' ' 61' ' ' LEU . . . -64.76 -48.0 76.16 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.9 0.381 . . . . 0.0 111.58 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.464 ' HB2' HG22 ' A' ' 49' ' ' ILE . 5.6 t -63.36 -29.06 70.43 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.219 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 32.4 mtpt -75.1 -28.99 60.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.933 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.845 ' OD1' HG13 ' A' ' 16' ' ' VAL . 1.2 m-20 -63.31 -26.99 69.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.016 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.11 20.24 57.89 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.282 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.9 mtm180 -118.52 -28.28 5.73 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.909 0.385 . . . . 0.0 110.791 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.809 HD13 ' HB1' ' A' ' 55' ' ' ALA . 0.6 OUTLIER -68.94 149.81 48.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.1 0.476 . . . . 0.0 111.271 -179.735 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.645 HH21 HD22 ' A' ' 12' ' ' LEU . 76.1 mtm-85 -146.98 128.64 15.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.722 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.623 HG13 ' O ' ' A' ' 46' ' ' VAL . 46.6 t -55.39 143.91 7.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.042 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.438 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 19.2 m-20 85.21 10.37 0.31 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.136 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -88.67 115.79 26.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.822 0.344 . . . . 0.0 110.402 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 10.9 tm0? -75.31 123.28 25.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.9 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.958 HD11 HG11 ' A' ' 30' ' ' VAL . 9.4 mt -75.28 133.86 41.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.24 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.905 HD11 ' HB2' ' A' ' 106' ' ' ALA . 18.3 mt -114.47 -28.02 2.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.281 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.855 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -158.4 166.47 32.16 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.104 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.685 HG11 ' HA ' ' A' ' 87' ' ' LEU . 12.0 p -154.05 126.07 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.009 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.597 ' ND2' HG22 ' A' ' 70' ' ' VAL . 68.6 m-80 58.69 20.17 7.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.051 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.35 28.05 18.46 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.957 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 70' ' ' VAL . 0.4 OUTLIER -128.5 101.48 6.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.841 0.353 . . . . 0.0 110.747 -179.638 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.1 t -66.81 133.26 49.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.816 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.595 HD22 ' HA ' ' A' ' 83' ' ' ALA . 0.9 OUTLIER -93.8 -11.32 31.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.297 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.1 mt -54.01 91.52 0.01 OUTLIER 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.82 0.343 . . . . 0.0 111.118 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 151.21 -29.21 0.98 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.884 -0.675 . . . . 0.0 112.259 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.474 ' HD3' ' HB3' ' A' ' 82' ' ' GLU . 5.5 ptpp? -104.29 152.2 22.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.193 0.521 . . . . 0.0 110.943 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.85 149.73 6.05 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.108 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.501 ' HB2' ' HA3' ' A' ' 32' ' ' GLY . 25.1 p30 -52.8 -30.4 33.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.222 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.466 ' HA ' ' HG2' ' A' ' 84' ' ' MET . 1.1 pp0? -73.9 -38.28 64.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.274 0.559 . . . . 0.0 110.328 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.474 ' HB3' ' HD3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -70.23 -33.82 72.13 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.739 179.13 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.595 ' HA ' HD22 ' A' ' 75' ' ' LEU . . . -69.2 -44.96 71.07 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.77 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.677 ' HB3' HG21 ' A' ' 44' ' ' ILE . 6.1 ptp -63.53 -30.83 71.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.304 -0.407 . . . . 0.0 109.992 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -78.17 -32.98 50.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.518 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.55 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 1.9 m -69.81 -35.09 74.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.541 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.854 HD12 ' N ' ' A' ' 88' ' ' ARG . 4.2 pp -78.01 -34.22 50.82 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.854 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -61.01 -51.11 70.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.926 -1.033 . . . . 0.0 110.964 179.464 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.55 ' HD3' ' O ' ' A' ' 86' ' ' THR . 0.0 OUTLIER -72.25 -33.39 67.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.373 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.445 ' OG ' ' HA ' ' A' ' 87' ' ' LEU . 66.6 p -71.95 -29.84 64.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.991 0.424 . . . . 0.0 110.49 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.986 ' HE2' HD22 ' A' ' 26' ' ' LEU . 2.9 ptp -85.42 -23.07 28.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.358 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.3 m -117.42 27.01 9.34 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.511 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.4 OUTLIER -156.81 -31.64 0.09 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.905 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.412 ' HG3' HG22 ' A' ' 93' ' ' THR . 7.0 mt-10 -115.98 -45.93 2.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.887 0.375 . . . . 0.0 111.518 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.496 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -72.23 -32.6 62.6 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.844 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.592 ' HB2' HD11 ' A' ' 18' ' ' LEU . 0.8 OUTLIER -73.32 -32.83 64.82 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.577 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' A' ' 93' ' ' THR . 47.5 mtpt -41.12 -41.44 1.76 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.263 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.2 -27.58 16.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.688 178.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.542 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 115.77 0.82 21.39 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.696 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.531 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.2 OUTLIER -153.89 140.59 19.0 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 120.986 0.422 . . . . 0.0 111.429 -179.627 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.731 HD11 HD11 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -113.29 144.15 21.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.733 179.615 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.559 ' O ' HD13 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -83.51 142.3 31.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.04 179.266 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.731 HD11 HD11 ' A' ' 101' ' ' ILE . 2.9 mm? -131.25 136.09 47.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.98 0.419 . . . . 0.0 111.848 -179.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.855 HD12 ' HB3' ' A' ' 69' ' ' ALA . 73.4 mt -128.56 112.89 27.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.325 178.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.994 HG23 HD12 ' A' ' 12' ' ' LEU . 27.0 m -127.16 173.58 12.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.133 0.492 . . . . 0.0 111.441 -178.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.905 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -147.45 128.09 14.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.263 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.718 ' HG3' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -131.16 -178.81 5.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.977 0.418 . . . . 0.0 111.25 -179.564 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.423 ' HA ' ' O ' ' A' ' 8' ' ' THR . 4.5 mtm180 -99.7 150.55 22.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.18 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 45.2 mt -78.09 -29.59 15.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.035 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.98 179.934 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.747 0.308 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -133.24 170.16 15.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.846 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -109.5 -80.57 0.58 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.864 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.67 -69.5 0.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.936 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 31.7 m80 -79.86 136.8 36.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.052 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 77.6 p -134.17 -171.09 2.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.665 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -177.84 130.17 0.15 Allowed 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.584 HD13 ' HB3' ' A' ' 31' ' ' LYS . 3.2 mm -107.34 100.7 11.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.206 0.527 . . . . 0.0 111.006 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 92.1 m -73.16 99.51 2.84 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.852 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.1 110.75 14.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.922 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.738 HG11 ' CG ' ' A' ' 88' ' ' ARG . 15.7 m . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.343 -0.837 . . . . 0.0 111.039 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 N-CA-C 112.565 -0.214 . . . . 0.0 112.565 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -154.6 27.8 0.44 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.788 0.328 . . . . 0.0 111.145 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.1 137.47 33.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.548 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -152.83 154.5 35.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.905 0.383 . . . . 0.0 111.281 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -91.75 150.31 21.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.521 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.763 HD12 HG23 ' A' ' 105' ' ' VAL . 0.5 OUTLIER -139.16 113.08 8.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.908 0.385 . . . . 0.0 111.62 -179.42 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.485 HG23 ' OE1' ' A' ' 102' ' ' GLN . 98.4 m -98.86 133.57 42.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.778 178.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 102' ' ' GLN . 52.0 m-85 -141.55 172.69 12.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.118 0.485 . . . . 0.0 111.939 -179.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.448 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.6 OUTLIER -128.53 109.51 11.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.547 179.272 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.907 HG23 HD23 ' A' ' 103' ' ' LEU . 34.2 t -104.55 109.21 62.5 Favored Pre-proline 0 C--N 1.33 -0.246 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.75 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 83.5 Cg_endo -81.48 127.64 5.85 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.418 2.079 . . . . 0.0 110.762 178.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.823 HD22 ' CD1' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -121.22 29.07 7.48 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -178.849 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -37.84 -31.4 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.366 179.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -112.95 -33.77 5.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.26 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.655 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 25.9 t -69.77 -9.87 56.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.209 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.755 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -45.57 -28.51 2.46 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.795 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.53 -35.12 25.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.85 0.357 . . . . 0.0 110.698 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -82.51 -24.45 34.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.129 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.44 -51.98 0.71 Allowed Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.931 HD22 ' HE2' ' A' ' 91' ' ' MET . 10.5 tp 179.45 -35.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.658 0.266 . . . . 0.0 110.633 179.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.409 ' O ' ' N ' ' A' ' 50' ' ' ILE . . . 116.26 34.46 1.33 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.473 -0.87 . . . . 0.0 113.232 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.778 HG11 HD22 ' A' ' 61' ' ' LEU . 33.1 m -157.22 157.02 3.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 117.153 0.477 . . . . 0.0 112.0 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.4 ' O ' ' N ' ' A' ' 47' ' ' LYS . 0.9 OUTLIER -117.65 123.9 47.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.342 178.81 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.928 HG11 HD11 ' A' ' 67' ' ' LEU . 5.4 m -106.69 153.97 7.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.171 0.51 . . . . 0.0 112.32 -178.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.506 ' HB3' HD13 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -152.4 132.27 13.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.35 179.513 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.504 ' HA2' ' HA ' ' A' ' 44' ' ' ILE . . . -107.64 153.97 16.69 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.473 -0.87 . . . . 0.0 113.153 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.925 ' ND2' HD12 ' A' ' 42' ' ' LEU . 18.2 p-10 -106.73 -179.16 3.86 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.177 0.513 . . . . 0.0 111.318 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -135.86 127.54 29.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.53 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.732 ' CA ' HD21 ' A' ' 42' ' ' LEU . 10.6 t -38.61 134.67 0.9 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.739 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.13 -35.13 79.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.267 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -73.74 -57.34 4.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.012 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -119.26 161.07 21.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.932 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 40.6 m-70 -77.84 61.94 2.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.867 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.23 126.76 48.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.993 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -61.49 131.46 50.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.01 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.925 HD12 ' ND2' ' A' ' 33' ' ' ASN . 11.6 mt -89.54 -24.62 21.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.896 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.448 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 140.31 169.92 11.86 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.346 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.915 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -101.37 140.45 20.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.8 0.333 . . . . 0.0 111.309 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.46 ' CE2' ' HG3' ' A' ' 66' ' ' GLN . 0.1 OUTLIER -126.31 143.14 51.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.611 179.858 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.645 ' O ' HG13 ' A' ' 63' ' ' VAL . 44.8 t -55.35 105.42 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.412 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.473 ' HD3' HD12 ' B' ' 10' ' ' ILE . 18.3 tptt -72.6 -43.61 63.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.679 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.2 m -165.01 126.53 2.07 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.999 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.742 HG23 HG12 ' A' ' 28' ' ' VAL . 66.9 mt -91.82 119.04 38.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.324 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.558 HD12 ' N ' ' A' ' 28' ' ' VAL . 1.9 mp -58.83 101.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.571 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -59.96 80.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.08 0.467 . . . . 0.0 110.584 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 153.63 -30.34 0.76 Allowed Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.624 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.402 ' H ' HG22 ' A' ' 50' ' ' ILE . . . -63.37 -174.98 3.02 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.585 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.75 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -65.13 -36.22 83.58 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.741 ' HB1' HD13 ' A' ' 61' ' ' LEU . . . -68.74 -45.87 70.35 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.748 0.309 . . . . 0.0 111.551 -179.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.56 -29.9 70.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.104 0.478 . . . . 0.0 110.053 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.1 mtpt -72.77 -32.67 65.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.971 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.409 ' OD1' ' NH2' ' A' ' 60' ' ' ARG . 1.3 t0 -57.49 -29.78 64.56 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.787 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.16 16.84 75.37 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.045 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.409 ' NH2' ' OD1' ' A' ' 58' ' ' ASP . 0.6 OUTLIER -128.82 -2.03 5.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.933 0.366 . . . . 0.0 111.202 179.837 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.778 HD22 HG11 ' A' ' 28' ' ' VAL . 0.1 OUTLIER -96.03 125.04 40.3 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.007 0.432 . . . . 0.0 111.472 -179.642 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.412 ' N ' ' HD2' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -128.66 140.28 51.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.556 179.707 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.678 ' O ' ' HB2' ' A' ' 64' ' ' ASN . 39.7 t -61.41 150.86 7.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.461 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.678 ' HB2' ' O ' ' A' ' 63' ' ' VAL . 22.4 m-80 83.44 3.37 0.93 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.05 0.54 . . . . 0.0 111.95 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.511 ' OD2' HG21 ' A' ' 105' ' ' VAL . 1.2 m-20 -81.1 117.76 21.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.852 0.358 . . . . 0.0 110.298 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.46 ' HG3' ' CE2' ' A' ' 45' ' ' PHE . 9.9 tm0? -75.73 115.03 14.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.248 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.928 HD11 HG11 ' A' ' 30' ' ' VAL . 32.8 mt -63.34 152.01 39.19 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.153 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.943 HD11 ' HB2' ' A' ' 106' ' ' ALA . 21.1 mt -136.77 -43.65 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.169 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.9 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -143.18 150.97 40.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.966 0.412 . . . . 0.0 111.399 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.582 HG11 ' HA ' ' A' ' 87' ' ' LEU . 10.3 p -140.62 116.28 7.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.819 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.539 ' ND2' HG22 ' A' ' 70' ' ' VAL . 69.3 m-80 55.79 55.36 7.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.789 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 60.89 18.69 54.53 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.435 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -118.11 88.72 2.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.881 0.372 . . . . 0.0 110.82 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.3 m -62.0 118.46 7.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.026 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.482 HD22 ' HA ' ' A' ' 83' ' ' ALA . 2.1 mt -73.59 -16.52 61.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.214 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.599 HD13 HG23 ' A' ' 68' ' ' ILE . 1.0 OUTLIER -53.33 91.5 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.927 0.394 . . . . 0.0 111.133 -179.906 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 152.77 -28.62 0.83 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.256 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.3 ptpp? -106.38 154.69 20.44 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.215 0.531 . . . . 0.0 110.963 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.677 ' HB3' HE21 ' A' ' 81' ' ' GLN . . . -54.36 156.42 3.29 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.303 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -53.85 -42.47 68.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.316 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.677 HE21 ' HB3' ' A' ' 79' ' ' ALA . 4.7 pp0? -66.42 -38.01 86.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.966 0.412 . . . . 0.0 110.872 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.69 -33.18 72.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.185 0.517 . . . . 0.0 110.109 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.602 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -69.13 -46.69 67.01 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.782 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.42 ' HA ' ' CD2' ' A' ' 87' ' ' LEU . 6.1 ptp -63.26 -31.97 73.26 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.333 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -80.42 -32.05 37.46 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.6 m -68.73 -36.44 78.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.29 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.852 HD12 ' N ' ' A' ' 88' ' ' ARG . 4.3 pp -78.54 -35.05 46.7 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.369 0.604 . . . . 0.0 109.388 178.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.852 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -60.04 -48.54 81.31 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.171 179.422 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.516 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.82 -42.33 63.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.964 179.329 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.0 t -62.75 -29.42 70.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.179 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.931 ' HE2' HD22 ' A' ' 26' ' ' LEU . 3.2 ptp -85.47 -30.86 23.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.658 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.2 30.31 6.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.701 -179.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.516 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.4 OUTLIER -158.86 -28.98 0.07 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -179.79 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.5 ' HG3' HG22 ' A' ' 93' ' ' THR . 4.9 mt-10 -122.1 -38.98 2.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.959 0.409 . . . . 0.0 111.103 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.513 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -78.63 -31.45 45.05 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.724 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.741 ' HB2' HD11 ' A' ' 18' ' ' LEU . 0.7 OUTLIER -75.02 -33.43 61.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.786 0.326 . . . . 0.0 110.14 179.493 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.45 ' HD3' ' O ' ' A' ' 93' ' ' THR . 26.2 mmmt -43.52 -44.8 6.23 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.157 0.504 . . . . 0.0 111.108 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.58 -23.57 21.94 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.715 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 113.69 -1.3 24.67 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.789 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.448 ' SD ' ' HB3' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -163.06 143.24 9.14 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.055 0.455 . . . . 0.0 111.341 -179.639 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.884 HD11 HD11 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -116.47 139.77 41.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.277 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.533 ' C ' HD22 ' A' ' 103' ' ' LEU . 3.0 pp0? -87.25 135.32 33.36 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.907 HD23 HG23 ' A' ' 16' ' ' VAL . 2.2 mm? -121.33 138.31 54.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.285 0.564 . . . . 0.0 112.286 -179.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.9 HD12 ' HB3' ' A' ' 69' ' ' ALA . 96.2 mt -120.02 112.67 37.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.278 178.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.829 HG12 HD23 ' A' ' 67' ' ' LEU . 28.5 m -125.98 154.06 34.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.448 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.943 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -125.63 135.31 52.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.417 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.563 ' HG3' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -148.04 -179.04 6.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.099 0.476 . . . . 0.0 111.52 -179.41 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 2.6 tpp85 -100.05 124.21 45.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.826 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.7 mt -67.73 150.41 10.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.057 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.0 t . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.852 179.949 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 59.1 t0 . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.906 0.384 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -85.08 160.17 20.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.899 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -91.56 -67.89 0.83 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.959 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -136.66 -47.73 0.62 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.929 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -156.55 112.33 2.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.86 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 4.2 t -71.87 -165.49 0.17 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.766 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -170.55 129.11 0.83 Allowed 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.506 HD13 ' HB3' ' A' ' 31' ' ' LYS . 1.6 mm -100.75 125.78 54.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.223 0.535 . . . . 0.0 111.388 -179.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 22.7 m -101.21 100.5 11.04 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.442 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.16 124.09 23.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.219 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.53 HG23 ' O ' ' B' ' 13' ' ' VAL . 12.0 m . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.386 -0.816 . . . . 0.0 110.797 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.396 -0.281 . . . . 0.0 112.396 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 67.4 p -153.73 74.31 0.99 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.805 0.336 . . . . 0.0 110.87 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.7 mtm180 -148.25 121.15 8.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.691 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -114.51 121.89 44.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.091 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -78.43 136.06 37.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.638 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.967 HD12 HG23 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -130.58 111.08 11.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.902 0.382 . . . . 0.0 111.29 -179.746 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.598 HG23 ' OE1' ' A' ' 102' ' ' GLN . 99.2 m -99.93 132.12 45.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.346 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.427 ' CG ' ' HB3' ' A' ' 60' ' ' ARG . 28.4 m-85 -140.69 172.52 12.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.321 0.582 . . . . 0.0 112.202 -179.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.468 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.4 OUTLIER -130.74 111.24 11.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.276 179.295 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.892 HG23 HD23 ' A' ' 103' ' ' LEU . 24.2 t -103.65 117.01 60.91 Favored Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -178.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.775 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 82.9 Cg_endo -86.97 128.07 2.69 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.738 2.292 . . . . 0.0 110.898 178.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.901 HD11 ' HB2' ' A' ' 96' ' ' ASN . 0.4 OUTLIER -122.71 28.75 7.16 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -178.899 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -38.38 -31.96 0.06 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.319 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -111.92 -32.5 6.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.123 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.762 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 25.0 t -71.74 -5.21 32.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.308 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.771 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -44.43 -29.37 1.75 Allowed Glycine 0 C--N 1.337 0.605 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.726 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.1 m -85.03 -35.1 22.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.001 0.429 . . . . 0.0 110.657 179.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.92 5.14 34.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.424 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.81 -56.35 5.04 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.958 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.918 HD22 ' HE2' ' A' ' 91' ' ' MET . 8.4 tp -175.06 -36.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.635 0.255 . . . . 0.0 110.839 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.83 45.54 0.7 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.554 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.775 HG12 HG23 ' A' ' 49' ' ' ILE . 23.4 m -157.16 156.71 4.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.185 0.517 . . . . 0.0 112.122 179.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.43 ' O ' ' HB3' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -116.07 114.63 24.8 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.091 178.582 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.88 HG11 HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -108.88 146.4 14.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.14 0.495 . . . . 0.0 111.993 -178.683 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.494 ' HB3' HD13 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -144.43 131.03 19.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.306 179.621 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.507 ' HA2' ' HA ' ' A' ' 44' ' ' ILE . . . -96.85 155.18 20.74 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.967 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -104.2 -171.19 1.89 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.864 0.364 . . . . 0.0 110.821 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.469 ' CD ' ' O ' ' A' ' 35' ' ' SER . 0.0 OUTLIER -145.17 141.27 28.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.505 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.764 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 0.2 OUTLIER -43.7 146.68 0.52 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.119 0.485 . . . . 0.0 111.905 -179.246 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.03 -19.36 65.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.36 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -103.13 -82.27 0.49 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.692 0.282 . . . . 0.0 111.393 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -98.19 166.5 11.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.116 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.442 ' HA ' ' CG ' ' A' ' 34' ' ' ARG . 88.3 m-70 -66.74 73.52 0.1 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.917 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.764 ' HB3' ' HB2' ' A' ' 35' ' ' SER . . . -115.65 88.34 2.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.866 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.404 ' HB3' ' ND2' ' A' ' 80' ' ' ASN . 2.0 p-10 -37.97 121.93 0.97 Allowed 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.918 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.645 HD21 ' HA ' ' A' ' 35' ' ' SER . 19.2 mt -88.92 6.67 38.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.04 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.457 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 103.16 -174.31 23.02 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.384 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.827 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -114.45 144.7 21.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.842 0.353 . . . . 0.0 111.478 -179.719 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -127.44 143.16 51.24 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.714 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.589 ' O ' HG13 ' A' ' 63' ' ' VAL . 41.9 t -60.04 104.37 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.486 179.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.43 ' HB3' ' O ' ' A' ' 29' ' ' SER . 2.8 tptt -73.37 -42.35 62.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.881 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.0 m -168.66 122.6 0.86 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.028 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.775 HG23 HG12 ' A' ' 28' ' ' VAL . 75.1 mt -84.82 116.55 28.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.908 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.619 HD12 ' N ' ' A' ' 28' ' ' VAL . 1.8 mp -52.65 101.91 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.742 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -60.1 80.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.129 0.49 . . . . 0.0 110.628 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 153.58 -30.0 0.76 Allowed Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.718 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.477 ' H ' HG22 ' A' ' 50' ' ' ILE . . . -65.07 -171.19 2.82 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.366 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.775 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -68.43 -37.12 79.97 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.734 ' HB1' HD13 ' A' ' 61' ' ' LEU . . . -66.48 -43.54 85.15 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.468 -179.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.419 ' OG ' HG22 ' A' ' 49' ' ' ILE . 0.5 OUTLIER -69.92 -32.11 70.24 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.049 179.702 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 26.7 mtpt -72.29 -33.21 67.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.852 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -62.16 -26.79 68.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.795 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.64 37.31 92.1 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.641 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.427 ' HB3' ' CG ' ' A' ' 14' ' ' PHE . 7.3 mtm180 -131.4 -33.48 1.46 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.674 0.273 . . . . 0.0 110.949 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.795 HD11 HG21 ' A' ' 16' ' ' VAL . 2.1 mp -64.45 157.89 25.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.048 0.451 . . . . 0.0 111.185 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -149.49 124.05 9.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.521 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.589 HG13 ' O ' ' A' ' 46' ' ' VAL . 41.2 t -56.9 143.05 11.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.198 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.435 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 21.5 m-20 86.26 -2.78 0.73 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.238 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -78.43 124.03 27.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.718 0.295 . . . . 0.0 110.52 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.438 ' O ' ' HA ' ' A' ' 105' ' ' VAL . 0.7 OUTLIER -74.9 134.46 41.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.665 -179.86 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.904 HD23 HG12 ' A' ' 105' ' ' VAL . 19.3 mt -86.17 137.8 32.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.754 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.971 HD11 ' HB2' ' A' ' 106' ' ' ALA . 24.5 mt -120.99 -37.27 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.458 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.79 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -149.92 170.8 17.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.904 0.383 . . . . 0.0 111.275 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.711 HG23 ' CD1' ' A' ' 103' ' ' LEU . 7.2 p -157.78 121.87 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.934 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.512 ' ND2' HG22 ' A' ' 70' ' ' VAL . 70.0 m-80 61.07 25.62 15.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.628 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.47 23.02 45.07 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.143 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -127.04 119.02 25.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.779 0.323 . . . . 0.0 110.71 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 60.9 p -69.8 153.31 43.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.097 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.439 HD22 ' HB1' ' A' ' 83' ' ' ALA . 6.8 mt -113.38 -15.4 12.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.314 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.7 mt -57.45 -18.3 17.61 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.521 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -87.87 21.28 24.05 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.079 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.448 ' HB2' ' HB3' ' A' ' 82' ' ' GLU . 1.9 ptpt -160.38 168.69 24.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.262 0.553 . . . . 0.0 111.221 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.44 ' HB3' HE22 ' A' ' 81' ' ' GLN . . . -72.37 174.31 7.52 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.641 -179.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.464 ' O ' ' HE2' ' A' ' 84' ' ' MET . 21.1 m-80 -57.14 -58.29 8.84 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.496 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.44 HE22 ' HB3' ' A' ' 79' ' ' ALA . 6.1 pm0 -58.37 -34.12 70.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.045 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.448 ' HB3' ' HB2' ' A' ' 78' ' ' LYS . 2.8 mt-10 -70.77 -39.2 73.35 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.25 0.548 . . . . 0.0 109.867 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.6 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -69.13 -43.52 74.21 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.573 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.481 ' HG3' HG21 ' A' ' 44' ' ' ILE . 1.0 OUTLIER -64.61 -29.29 70.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.067 179.176 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -78.99 -35.76 42.4 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.433 ' HA ' ' HD2' ' A' ' 89' ' ' ARG . 1.6 m -65.36 -36.51 84.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.403 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.775 HD12 ' N ' ' A' ' 88' ' ' ARG . 4.4 pp -78.35 -34.26 48.55 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.775 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -60.7 -49.45 77.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.744 179.349 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.558 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.15 -45.7 59.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.98 179.683 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 45.9 p -60.25 -29.35 68.72 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.763 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.918 ' HE2' HD22 ' A' ' 26' ' ' LEU . 2.5 ptp -88.07 -29.36 20.71 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.493 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.58 35.46 4.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.761 -179.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.558 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.3 OUTLIER -166.42 -24.05 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.474 ' HG3' HG22 ' A' ' 93' ' ' THR . 6.6 mt-10 -123.92 -59.44 1.51 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.989 0.424 . . . . 0.0 111.175 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.428 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -66.59 -25.35 72.78 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.1 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.901 ' HB2' HD11 ' A' ' 18' ' ' LEU . 0.8 OUTLIER -78.28 -35.59 47.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.963 0.411 . . . . 0.0 110.185 179.671 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.46 ' HD3' ' O ' ' A' ' 93' ' ' THR . 27.7 mmmt -45.52 -42.28 10.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.985 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.91 -27.92 23.08 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.629 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 121.94 -6.67 10.25 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.934 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.468 ' SD ' ' HB3' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -158.33 142.38 15.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.013 0.435 . . . . 0.0 111.301 -179.759 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.786 HD11 HD11 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -109.45 144.79 17.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.996 -179.841 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.598 ' OE1' HG23 ' A' ' 13' ' ' THR . 1.5 tm0? -85.83 140.35 30.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.168 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.892 HD23 HG23 ' A' ' 16' ' ' VAL . 2.7 mm? -130.4 139.81 50.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.039 0.447 . . . . 0.0 111.867 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.79 HD12 ' HB3' ' A' ' 69' ' ' ALA . 66.5 mt -128.6 112.91 27.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.596 178.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.967 HG23 HD12 ' A' ' 12' ' ' LEU . 28.6 m -122.71 176.94 4.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.84 -178.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.971 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -147.71 117.53 7.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.475 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 5.6 ttm180 -105.73 142.05 36.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.928 0.394 . . . . 0.0 110.773 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 5.8 tpp180 -84.72 148.25 26.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.097 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 20.8 mt -99.24 -31.16 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.079 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.8 t . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.913 -179.959 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.935 0.398 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -91.56 170.17 10.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.953 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . 0.46 ' OD1' ' NH1' ' A' ' 34' ' ' ARG . 49.0 m-20 -98.26 35.78 1.71 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.533 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 77.09 -61.37 0.43 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.919 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -98.71 108.77 21.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.831 0.348 . . . . 0.0 110.986 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 60.4 p -104.13 -164.29 1.05 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.892 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -168.81 125.47 0.97 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.494 HD13 ' HB3' ' A' ' 31' ' ' LYS . 1.5 mm -99.97 100.77 11.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.177 0.513 . . . . 0.0 111.192 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 90.5 m -79.0 116.39 19.27 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.744 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt -79.11 129.0 33.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.861 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.75 HG11 HD11 ' A' ' 87' ' ' LEU . 21.3 m . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.126 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.38 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.494 ' HA ' HD12 ' A' ' 109' ' ' ILE . 52.0 p -116.53 -20.33 9.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.567 0.223 . . . . 0.0 111.341 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.4 mtt85 -76.34 133.1 40.07 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.713 0.292 . . . . 0.0 110.643 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -162.38 161.3 27.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.028 0.442 . . . . 0.0 111.357 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.429 ' CD2' HG13 ' A' ' 68' ' ' ILE . 3.8 m-85 -101.95 145.03 29.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.405 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.69 HD13 ' CZ ' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -147.6 137.36 22.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.126 0.489 . . . . 0.0 111.428 -179.652 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.469 HG23 ' OE1' ' A' ' 102' ' ' GLN . 86.8 m -88.77 145.9 25.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.242 179.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.69 ' CZ ' HD13 ' A' ' 12' ' ' LEU . 21.3 m-85 -140.37 116.51 10.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.03 0.443 . . . . 0.0 111.979 -179.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.411 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.6 OUTLIER -86.99 109.15 19.19 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.565 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.509 HG11 ' HG ' ' A' ' 26' ' ' LEU . 39.6 t -106.54 103.37 45.98 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -177.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.749 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 3.7 Cg_exo -75.42 128.01 10.83 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.606 2.204 . . . . 0.0 110.661 178.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.78 HD11 ' HB2' ' A' ' 96' ' ' ASN . 0.4 OUTLIER -124.03 28.36 6.83 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.713 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -39.71 -31.2 0.1 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.069 0.461 . . . . 0.0 111.092 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -113.7 -32.69 6.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.234 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.747 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 45.9 t -70.65 -8.6 53.04 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.074 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.678 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -46.36 -27.64 2.91 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.603 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 52.4 m -84.9 -33.17 22.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.874 0.369 . . . . 0.0 110.693 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.78 11.13 20.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.49 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.14 -55.64 5.04 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.897 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.954 HD22 ' HE2' ' A' ' 91' ' ' MET . 9.2 tp -178.49 -31.38 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.658 0.266 . . . . 0.0 110.96 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.443 ' HA3' ' HA3' ' A' ' 53' ' ' GLY . . . 112.73 32.49 2.26 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.421 -0.895 . . . . 0.0 113.286 179.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.75 HG12 HG23 ' A' ' 49' ' ' ILE . 35.2 m -156.34 150.55 10.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.1 0.476 . . . . 0.0 111.915 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.443 ' O ' ' N ' ' A' ' 47' ' ' LYS . 73.0 m -107.48 123.13 47.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.032 178.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.6 m -107.47 153.67 8.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 -178.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.513 ' O ' ' HG3' ' A' ' 31' ' ' LYS . 0.1 OUTLIER -155.62 129.93 8.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.206 179.303 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -103.97 160.46 16.09 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.181 -1.009 . . . . 0.0 113.101 -179.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -116.01 175.32 5.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.004 0.43 . . . . 0.0 111.133 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 29.5 mtt85 -121.41 153.05 38.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.749 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.894 ' HA ' HD21 ' A' ' 42' ' ' LEU . 0.5 OUTLIER -47.7 156.87 0.28 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.484 -179.866 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.87 -51.98 41.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.394 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.21 -51.74 28.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.704 -179.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -117.97 -177.12 3.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.752 0.31 . . . . 0.0 111.078 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 -92.34 40.38 1.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.049 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.18 110.2 17.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.829 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.603 ' OD2' ' HB1' ' A' ' 79' ' ' ALA . 1.2 m-20 -48.37 124.5 8.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.443 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.894 HD21 ' HA ' ' A' ' 35' ' ' SER . 17.0 mt -88.88 -36.25 16.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.72 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.484 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 154.44 -178.71 31.09 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.898 -0.667 . . . . 0.0 111.897 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.741 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -106.58 137.82 35.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.845 0.355 . . . . 0.0 111.274 -179.854 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.461 ' CE2' ' NE2' ' A' ' 66' ' ' GLN . 0.5 OUTLIER -123.68 140.13 53.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.497 179.621 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.609 ' O ' HG13 ' A' ' 63' ' ' VAL . 27.5 t -55.95 107.56 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.068 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 29' ' ' SER . 21.5 tptt -71.61 -46.87 57.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.625 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 27.2 t -166.42 123.83 1.36 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.857 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.75 HG23 HG12 ' A' ' 28' ' ' VAL . 66.9 mt -87.32 122.54 39.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.274 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.51 HD12 ' N ' ' A' ' 28' ' ' VAL . 2.5 mp -64.84 111.77 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.289 179.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -68.06 72.63 0.18 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.212 0.53 . . . . 0.0 110.404 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 165.12 -28.89 0.21 Allowed Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.877 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.443 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -66.84 -170.56 4.2 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.662 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.749 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -69.24 -37.7 78.1 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.744 ' HB1' HD13 ' A' ' 61' ' ' LEU . . . -67.96 -44.26 77.15 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.792 0.33 . . . . 0.0 111.312 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.416 ' HB2' HG22 ' A' ' 49' ' ' ILE . 6.9 t -65.53 -34.79 79.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.224 0.535 . . . . 0.0 109.759 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -69.23 -31.41 69.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.766 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.59 -30.84 61.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.654 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 68.93 16.19 70.18 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.897 -0.668 . . . . 0.0 113.277 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.441 ' HG3' ' CD1' ' A' ' 14' ' ' PHE . 7.0 ptp180 -135.23 10.91 3.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.002 0.401 . . . . 0.0 111.143 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.744 HD13 ' HB1' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -104.07 134.01 48.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.596 179.877 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.39 145.63 50.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.802 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.609 HG13 ' O ' ' A' ' 46' ' ' VAL . 45.2 t -66.07 148.91 11.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.845 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.43 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 15.9 m-80 84.65 -4.02 0.98 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.428 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.3 128.25 35.27 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.694 0.283 . . . . 0.0 110.697 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.461 ' NE2' ' CE2' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -85.55 130.01 34.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.937 -179.729 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.907 HD23 HG12 ' A' ' 105' ' ' VAL . 77.5 mt -81.13 135.95 35.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.575 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.429 HG13 ' CD2' ' A' ' 11' ' ' PHE . 18.7 mm -118.93 -29.14 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.298 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.744 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -160.04 148.73 17.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.983 0.42 . . . . 0.0 111.378 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.64 HG22 HD22 ' A' ' 71' ' ' ASN . 7.1 p -137.89 129.79 39.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.488 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.64 HD22 HG22 ' A' ' 70' ' ' VAL . 13.5 m-80 60.01 26.08 15.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.763 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.8 20.67 59.23 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.193 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -128.19 111.55 13.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.823 0.344 . . . . 0.0 110.723 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.47 149.83 20.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.158 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.586 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . 4.2 mt -114.09 -20.2 11.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.347 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.1 tp -54.83 -24.35 22.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.674 0.273 . . . . 0.0 111.278 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.39 -2.17 83.48 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.031 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.433 ' HG3' ' HB2' ' A' ' 83' ' ' ALA . 4.6 ptpp? -135.83 161.13 36.47 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.293 0.568 . . . . 0.0 111.301 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.603 ' HB1' ' OD2' ' A' ' 41' ' ' ASP . . . -60.52 176.94 0.32 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.525 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.435 ' HB3' ' HA3' ' A' ' 32' ' ' GLY . 19.5 m-80 -67.14 -57.64 6.38 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.118 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.438 ' HA ' ' HE3' ' A' ' 84' ' ' MET . 3.1 pp0? -58.36 -35.21 71.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.036 0.446 . . . . 0.0 110.591 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.53 -42.45 71.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.484 179.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.586 ' HB1' ' HB3' ' A' ' 75' ' ' LEU . . . -69.59 -30.99 68.88 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.934 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.47 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 0.5 OUTLIER -72.36 -33.32 67.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.596 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -77.63 -28.07 51.29 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.2 m -72.66 -36.85 68.03 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.528 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 84' ' ' MET . 4.4 pp -78.65 -34.24 46.57 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -61.4 -52.1 66.0 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.461 179.243 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.5 ' O ' HG22 ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.17 -33.97 68.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.19 179.594 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.491 ' N ' ' HD3' ' A' ' 89' ' ' ARG . 41.7 m -72.57 -29.68 63.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.672 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.954 ' HE2' HD22 ' A' ' 26' ' ' LEU . 3.2 ptp -87.35 -22.4 25.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.31 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.0 t -112.81 22.65 14.26 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.946 0.351 . . . . 0.0 111.946 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.558 HG23 ' HG2' ' A' ' 94' ' ' GLU . 0.5 OUTLIER -154.77 -39.46 0.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.558 ' HG2' HG23 ' A' ' 93' ' ' THR . 5.7 mt-10 -110.77 -22.06 11.76 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.868 0.366 . . . . 0.0 111.206 -179.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.505 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -93.27 -30.3 9.4 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 179.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.78 ' HB2' HD11 ' A' ' 18' ' ' LEU . 1.2 t-20 -86.67 -37.05 18.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.791 0.329 . . . . 0.0 110.29 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.551 ' HG2' ' HA ' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -45.32 -28.53 0.85 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.31 179.627 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.427 ' HD3' ' HD2' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -106.8 -27.04 11.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.534 178.964 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 118.36 -1.64 16.3 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.135 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.49 ' HE2' ' O ' ' A' ' 100' ' ' MET . 0.0 OUTLIER -165.14 141.44 5.59 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.0 0.429 . . . . 0.0 111.649 -179.74 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.545 HG22 HD21 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -115.47 134.56 58.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.043 179.848 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.469 ' OE1' HG23 ' A' ' 13' ' ' THR . 1.7 pp0? -81.55 140.32 34.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.001 178.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.451 HD13 HG21 ' A' ' 16' ' ' VAL . 1.8 mp -134.84 111.59 10.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.736 0.303 . . . . 0.0 111.686 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.744 HD12 ' HB3' ' A' ' 69' ' ' ALA . 62.6 mt -90.19 112.45 24.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.907 HG12 HD23 ' A' ' 67' ' ' LEU . 14.6 m -118.37 -179.2 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.882 0.373 . . . . 0.0 111.384 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -147.01 134.99 21.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.755 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.616 ' HD2' HD21 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -151.93 -178.9 7.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.969 -179.864 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 3.7 mtm180 -107.73 129.57 55.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.027 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.494 HD12 ' HA ' ' A' ' 8' ' ' THR . 17.9 mt -63.08 115.75 2.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.923 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 35.9 t . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.822 179.878 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.049 0 CA-C-O 120.874 0.368 . . . . 0.0 110.807 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -75.26 144.79 42.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.945 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.41 -73.79 0.63 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.929 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 71.7 mm-40 -118.39 -66.48 1.07 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.816 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 68.1 m-70 -111.98 118.09 34.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.878 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . 0.516 ' O ' ' HB2' ' B' ' 9' ' ' GLN . 77.1 p -62.76 -35.15 78.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.859 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . 0.516 ' HB2' ' O ' ' B' ' 8' ' ' SER . 0.0 OUTLIER 82.09 66.11 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.511 0.672 . . . . 0.0 109.689 -179.432 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.472 HD13 ' HB3' ' A' ' 31' ' ' LYS . 14.5 mm -77.67 142.18 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.079 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 1.9 m -162.05 122.37 2.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.584 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -80.46 145.1 32.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.15 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.402 ' CG1' ' HG3' ' A' ' 88' ' ' ARG . 27.2 m . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.175 -0.917 . . . . 0.0 111.093 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.404 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 31.2 p -94.63 42.05 1.09 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.855 0.359 . . . . 0.0 111.071 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.7 mtm180 -98.41 136.11 39.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.827 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -143.14 150.66 39.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.024 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -96.93 148.35 23.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.859 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.86 HD12 HG23 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -132.27 109.9 10.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.109 -179.848 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.689 HG23 ' OE1' ' A' ' 102' ' ' GLN . 87.9 m -96.71 133.02 41.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.496 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.407 ' CE1' ' HG2' ' A' ' 60' ' ' ARG . 47.8 m-85 -140.59 172.67 12.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.164 0.506 . . . . 0.0 112.043 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.427 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.4 OUTLIER -129.67 112.22 13.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.228 179.105 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.901 HG23 HD23 ' A' ' 103' ' ' LEU . 25.8 t -105.31 111.53 64.99 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -177.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.578 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 1.2 Cg_endo -81.7 127.61 5.69 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.817 2.345 . . . . 0.0 111.049 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.775 HD11 ' HB2' ' A' ' 96' ' ' ASN . 0.4 OUTLIER -122.09 28.67 7.4 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -179.002 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -38.72 -31.72 0.07 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.036 0.446 . . . . 0.0 111.195 179.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -112.26 -33.52 6.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.18 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.472 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 30.4 t -70.02 -7.57 42.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.2 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.745 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -45.3 -28.65 2.2 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.759 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.0 t -84.83 -34.23 22.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.783 0.325 . . . . 0.0 110.63 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.01 8.88 27.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.319 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.28 -55.26 4.94 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.969 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.864 HD22 ' HE2' ' A' ' 91' ' ' MET . 8.2 tp -176.02 -34.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.508 0.194 . . . . 0.0 110.657 179.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.42 ' HA2' HD13 ' A' ' 50' ' ' ILE . . . 111.68 44.28 0.91 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.328 -0.939 . . . . 0.0 113.56 179.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.782 HG12 HG23 ' A' ' 49' ' ' ILE . 19.4 m -158.27 167.55 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.155 0.503 . . . . 0.0 111.902 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' B' ' 12' ' ' LYS . 0.0 OUTLIER -126.67 116.67 21.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.276 178.636 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.961 HG11 HD11 ' A' ' 67' ' ' LEU . 1.0 OUTLIER -111.18 144.47 19.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.013 0.435 . . . . 0.0 111.981 -178.836 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.417 ' O ' ' HG3' ' A' ' 31' ' ' LYS . 2.2 ptmt -138.05 134.06 34.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.365 179.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.514 ' HA3' ' HB3' ' A' ' 80' ' ' ASN . . . -100.07 147.6 18.19 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.939 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.404 ' ND2' ' CE1' ' A' ' 45' ' ' PHE . 76.6 m-20 -127.12 130.49 49.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.888 0.375 . . . . 0.0 110.866 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.16 145.74 26.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.468 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.85 ' OG ' HD21 ' A' ' 42' ' ' LEU . 8.3 m -44.1 130.61 6.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.269 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.13 -19.85 65.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.568 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -106.08 -44.09 4.67 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.825 0.345 . . . . 0.0 111.421 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -87.3 -16.91 33.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.522 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 30.2 m-70 61.47 21.3 11.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.746 0.308 . . . . 0.0 110.888 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -99.29 134.47 42.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.011 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -50.18 126.94 15.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.315 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.85 HD21 ' OG ' ' A' ' 35' ' ' SER . 45.8 mt -94.39 -19.4 20.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.919 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.464 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 128.82 169.66 12.63 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.308 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.755 ' CG1' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -102.05 130.95 51.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.835 0.35 . . . . 0.0 111.29 179.85 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.463 ' CE2' ' NE2' ' A' ' 66' ' ' GLN . 0.1 OUTLIER -113.56 146.79 39.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.486 179.868 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.534 ' O ' HG13 ' A' ' 63' ' ' VAL . 49.1 t -60.53 104.66 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.563 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.437 ' HD3' HD12 ' B' ' 10' ' ' ILE . 18.1 tptt -75.48 -40.05 57.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.889 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -168.77 126.41 1.03 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.981 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.782 HG23 HG12 ' A' ' 28' ' ' VAL . 63.7 mt -94.44 121.21 44.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.048 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.52 HD12 ' N ' ' A' ' 28' ' ' VAL . 1.5 mp -58.96 109.74 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.432 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -65.83 72.91 0.06 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.071 0.462 . . . . 0.0 110.691 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 163.76 -26.51 0.21 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.262 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.404 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . -70.87 -165.41 6.05 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.777 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.578 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -69.09 -42.18 76.49 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.756 ' HB1' HD22 ' A' ' 61' ' ' LEU . . . -63.13 -43.84 97.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.342 -179.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.4 t -68.73 -33.56 74.13 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.132 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -72.2 -31.9 66.29 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.876 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -65.18 -25.17 67.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.709 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.12 29.7 65.9 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.575 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.407 ' HG2' ' CE1' ' A' ' 14' ' ' PHE . 15.0 mtm180 -124.9 -33.02 2.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.609 0.242 . . . . 0.0 111.254 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.756 HD22 ' HB1' ' A' ' 55' ' ' ALA . 5.5 mp -72.01 150.15 44.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.904 0.383 . . . . 0.0 111.055 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.11 135.71 20.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.082 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.54 ' O ' ' HB3' ' A' ' 64' ' ' ASN . 82.9 t -64.99 94.89 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.817 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.54 ' HB3' ' O ' ' A' ' 63' ' ' VAL . 12.2 p30 149.55 -4.45 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.92 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -84.22 131.78 34.71 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 121.096 0.474 . . . . 0.0 111.594 -179.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.463 ' NE2' ' CE2' ' A' ' 45' ' ' PHE . 0.3 OUTLIER -89.93 117.25 28.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.11 179.343 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.961 HD11 HG11 ' A' ' 30' ' ' VAL . 5.2 mt -71.91 133.52 45.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.929 0.395 . . . . 0.0 111.404 -179.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.725 HD11 ' CB ' ' A' ' 106' ' ' ALA . 23.6 mt -122.12 -22.86 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.488 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.703 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -155.69 167.26 30.96 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.935 0.398 . . . . 0.0 111.466 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.83 HG22 HD22 ' A' ' 71' ' ' ASN . 10.3 p -158.18 126.34 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.694 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.83 HD22 HG22 ' A' ' 70' ' ' VAL . 2.7 m-80 66.19 15.4 10.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.082 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 96.34 7.48 58.17 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.529 -0.843 . . . . 0.0 113.125 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.427 ' CG ' ' O ' ' A' ' 70' ' ' VAL . 2.4 pt-20 -121.13 109.15 14.66 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.889 0.376 . . . . 0.0 111.002 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.4 m -59.65 145.9 43.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.024 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.423 ' HB2' ' CB ' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -121.16 4.41 10.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.247 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.598 HD13 HG23 ' A' ' 68' ' ' ILE . 5.0 tp -61.21 -28.53 69.21 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.741 0.305 . . . . 0.0 111.029 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -74.87 -24.95 70.65 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.558 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -97.34 166.17 11.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.259 0.552 . . . . 0.0 111.212 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.592 ' HB3' HE21 ' A' ' 81' ' ' GLN . . . -67.21 165.2 16.59 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.245 -0.888 . . . . 0.0 111.418 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.514 ' HB3' ' HA3' ' A' ' 32' ' ' GLY . 20.3 m-80 -54.78 -57.77 10.24 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.269 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.592 HE21 ' HB3' ' A' ' 79' ' ' ALA . 3.0 pp0? -56.83 -34.49 67.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.83 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.72 -38.64 73.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.313 0.578 . . . . 0.0 109.625 179.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.534 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -69.08 -40.74 78.26 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.405 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.462 ' HG2' HG23 ' A' ' 30' ' ' VAL . 1.1 mtm -66.3 -29.62 69.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.854 179.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -79.88 -35.88 37.37 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.432 ' HA ' ' HD2' ' A' ' 89' ' ' ARG . 2.9 m -65.21 -36.33 83.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.375 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.809 HD12 ' N ' ' A' ' 88' ' ' ARG . 4.4 pp -79.06 -34.6 43.57 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.809 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -62.32 -50.68 70.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.605 179.322 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.499 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.16 -37.34 69.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.233 179.634 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.413 ' HB3' ' ND2' ' A' ' 71' ' ' ASN . 34.8 m -67.11 -29.51 69.27 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.077 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.864 ' HE2' HD22 ' A' ' 26' ' ' LEU . 4.5 ptp -89.34 -30.28 18.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.624 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.0 23.46 13.97 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.499 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.4 OUTLIER -155.04 -31.05 0.1 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.851 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.418 ' HG3' HG22 ' A' ' 93' ' ' THR . 7.8 mt-10 -113.9 -63.89 1.39 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.894 0.378 . . . . 0.0 111.524 -179.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.459 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -58.11 -31.89 66.19 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.451 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.775 ' HB2' HD11 ' A' ' 18' ' ' LEU . 0.7 OUTLIER -72.95 -33.71 66.07 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.715 0.293 . . . . 0.0 110.612 179.92 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 93' ' ' THR . 54.4 mtpt -43.56 -39.45 3.45 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.035 0.445 . . . . 0.0 111.325 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.31 -26.23 15.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.957 178.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 117.27 2.07 18.17 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.613 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.512 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -158.17 141.91 15.49 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.011 0.434 . . . . 0.0 111.28 -179.689 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.828 HD11 HD11 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -112.86 146.15 17.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.967 179.915 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.689 ' OE1' HG23 ' A' ' 13' ' ' THR . 1.5 tm0? -86.9 138.45 31.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.034 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.901 HD23 HG23 ' A' ' 16' ' ' VAL . 2.8 mm? -128.51 138.98 52.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.0 0.428 . . . . 0.0 111.961 -179.172 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.703 HD12 ' HB3' ' A' ' 69' ' ' ALA . 55.1 mt -127.67 112.79 28.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.745 178.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.86 HG23 HD12 ' A' ' 12' ' ' LEU . 34.7 m -121.76 175.88 4.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.048 -179.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.725 ' CB ' HD11 ' A' ' 68' ' ' ILE . . . -147.52 141.77 26.21 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.842 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.668 ' CG ' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -150.38 -178.86 6.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.886 0.374 . . . . 0.0 111.175 -179.836 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.39 144.29 31.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.858 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.6 mt -71.01 -52.96 23.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.992 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 47.4 t . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.999 179.992 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.776 0.322 . . . . 0.0 110.948 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -69.97 148.82 48.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.818 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -91.22 -39.82 11.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.021 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -150.11 -69.55 0.19 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.001 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -119.1 131.75 55.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.03 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 57.8 p -104.9 -162.34 0.88 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.776 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -180.0 145.64 0.22 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.259 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.437 HD12 ' HD3' ' A' ' 47' ' ' LYS . 1.6 mm -109.81 153.99 11.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.981 0.419 . . . . 0.0 111.146 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 27.3 m -138.06 97.8 3.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.795 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 29' ' ' SER . 8.1 ttpt -69.19 109.67 4.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.989 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.755 HG11 HD11 ' A' ' 87' ' ' LEU . 18.5 m . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.321 -0.847 . . . . 0.0 111.103 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.443 ' O ' HG23 ' A' ' 8' ' ' THR . . . . . . . . 0 N--CA 1.45 -0.407 0 N-CA-C 112.448 -0.261 . . . . 0.0 112.448 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.443 HG23 ' O ' ' A' ' 7' ' ' GLY . 35.6 p -158.28 62.86 0.44 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.865 0.364 . . . . 0.0 110.941 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 15.4 ttp85 -95.55 147.41 23.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.791 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -151.63 146.12 25.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.146 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -90.98 146.28 24.0 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.801 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.609 HD11 ' CG ' ' A' ' 107' ' ' ARG . 0.3 OUTLIER -138.62 109.92 6.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.992 0.425 . . . . 0.0 111.088 -179.829 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.703 HG23 ' OE1' ' A' ' 102' ' ' GLN . 92.7 m -88.54 121.43 30.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.086 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.439 ' CZ ' ' HB3' ' A' ' 12' ' ' LEU . 32.8 m-85 -131.14 150.53 52.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.214 0.53 . . . . 0.0 112.33 -179.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.486 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.6 OUTLIER -112.46 111.14 21.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.285 -0.87 . . . . 0.0 108.93 178.79 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.546 HG11 ' HG ' ' A' ' 26' ' ' LEU . 10.3 t -100.14 115.33 65.6 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -177.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.776 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 93.8 Cg_endo -85.98 128.2 3.19 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.758 2.305 . . . . 0.0 110.842 178.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.808 HD12 ' HA2' ' A' ' 22' ' ' GLY . 0.4 OUTLIER -127.95 28.79 5.52 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -178.664 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -38.84 -33.35 0.11 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.061 0.458 . . . . 0.0 111.28 179.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -107.71 -33.87 7.15 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.231 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.758 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 7.6 t -70.51 -6.39 35.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.25 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.808 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -42.12 -30.49 0.75 Allowed Glycine 0 C--N 1.337 0.613 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.775 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.02 -38.81 20.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.866 0.365 . . . . 0.0 110.672 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -82.51 1.7 36.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.449 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.88 -53.81 4.86 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.978 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.942 HD22 ' HE2' ' A' ' 91' ' ' MET . 7.7 tp -175.62 -36.06 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.735 0.302 . . . . 0.0 110.589 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.443 ' HA3' ' HA3' ' A' ' 53' ' ' GLY . . . 109.03 47.5 0.88 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.524 -0.846 . . . . 0.0 113.531 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.8 HG12 HG23 ' A' ' 49' ' ' ILE . 22.3 m -158.18 156.67 3.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 117.058 0.429 . . . . 0.0 111.75 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.414 ' O ' ' HB3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -114.13 114.17 25.69 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.383 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.606 HG11 HD11 ' A' ' 67' ' ' LEU . 0.4 OUTLIER -106.94 146.97 12.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.269 0.556 . . . . 0.0 111.979 -178.659 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.466 ' HB3' HD13 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -148.18 130.9 15.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.321 179.41 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 44' ' ' ILE . . . -100.08 176.97 28.57 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.941 -179.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.708 ' ND2' HD12 ' A' ' 42' ' ' LEU . 50.8 p30 -125.15 -174.8 3.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.303 0.573 . . . . 0.0 111.637 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.426 ' O ' ' C ' ' A' ' 35' ' ' SER . 4.5 mtm180 -144.27 126.13 15.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.698 179.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.456 ' CA ' HD21 ' A' ' 42' ' ' LEU . 57.7 m -28.68 142.77 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.22 -178.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.407 ' HD2' ' CB ' ' B' ' 3' ' ' ASP . 0.0 OUTLIER -67.09 -37.21 83.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.354 -179.838 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.78 -63.16 1.42 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.933 0.397 . . . . 0.0 110.925 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -112.78 -179.92 3.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.882 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 53.1 m-70 -87.56 53.62 2.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.968 0.413 . . . . 0.0 110.857 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.497 ' O ' HD23 ' A' ' 42' ' ' LEU . . . -104.24 105.0 14.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.074 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -49.06 139.75 10.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.554 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.708 HD12 ' ND2' ' A' ' 33' ' ' ASN . 5.4 mt -103.66 -16.37 15.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.737 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 137.5 -177.94 19.46 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.036 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.687 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -115.98 136.59 52.42 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-O 120.819 0.342 . . . . 0.0 110.672 179.749 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -126.47 144.08 50.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.87 0.366 . . . . 0.0 110.827 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.606 ' O ' HG13 ' A' ' 63' ' ' VAL . 40.1 t -57.06 113.79 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.825 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.51 ' HG2' HD12 ' B' ' 10' ' ' ILE . 30.1 tptt -83.03 -38.16 22.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.653 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -168.3 120.09 0.82 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.082 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.8 HG23 HG12 ' A' ' 28' ' ' VAL . 70.4 mt -85.75 120.61 36.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.971 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.545 HD12 ' N ' ' A' ' 28' ' ' VAL . 1.4 mp -57.55 103.95 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.623 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -60.24 83.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.484 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 148.97 -28.03 1.27 Allowed Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.664 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.505 ' H ' HG22 ' A' ' 50' ' ' ILE . . . -67.09 -176.15 7.98 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.543 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.776 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -61.77 -39.29 91.16 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.713 ' HB1' HD13 ' A' ' 61' ' ' LEU . . . -64.65 -48.6 74.2 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.98 0.419 . . . . 0.0 111.486 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.69 -28.52 69.95 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.113 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.7 mtpt -77.46 -29.03 52.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.948 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.407 ' OD1' ' NH2' ' A' ' 60' ' ' ARG . 4.5 t0 -56.13 -31.7 63.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.412 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.77 13.51 80.5 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.887 -0.673 . . . . 0.0 113.35 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.428 ' HG3' ' CG ' ' A' ' 14' ' ' PHE . 2.9 ptp180 -135.62 7.09 3.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 117.089 0.445 . . . . 0.0 111.373 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.772 ' HB3' HD13 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -98.99 133.49 43.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.46 179.827 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.9 142.16 38.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.911 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.606 HG13 ' O ' ' A' ' 46' ' ' VAL . 52.3 t -59.3 147.35 8.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.912 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.434 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 16.3 m-20 85.36 12.99 0.21 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.3 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.441 ' CG ' HG21 ' A' ' 105' ' ' VAL . 1.3 m-20 -85.26 109.53 18.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.854 0.359 . . . . 0.0 110.611 179.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -73.59 111.17 8.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.841 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.888 HD23 HG12 ' A' ' 105' ' ' VAL . 14.8 mt -66.08 141.47 58.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.66 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.824 HG23 HD12 ' A' ' 76' ' ' LEU . 34.8 mt -129.51 -39.69 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.437 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.73 ' HB3' ' CD1' ' A' ' 104' ' ' ILE . . . -147.0 124.03 11.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.991 0.424 . . . . 0.0 111.227 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.892 HG22 HD22 ' A' ' 71' ' ' ASN . 8.4 p -120.33 124.93 73.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.437 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.892 HD22 HG22 ' A' ' 70' ' ' VAL . 4.9 m-80 60.93 42.74 12.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.905 0.383 . . . . 0.0 110.477 -179.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 64.8 21.51 67.47 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.225 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -126.94 118.61 24.87 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.771 0.319 . . . . 0.0 110.767 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.3 t -60.5 152.43 25.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.941 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.686 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . 36.2 mt -118.39 -31.89 4.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.233 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.824 HD12 HG23 ' A' ' 68' ' ' ILE . 1.5 mt -53.96 -29.73 43.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.22 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.03 -11.6 63.81 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.837 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.428 ' HG3' ' HB2' ' A' ' 83' ' ' ALA . 7.0 ptpp? -126.01 156.26 40.16 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.252 0.548 . . . . 0.0 111.206 -179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.07 162.45 0.66 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.882 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -54.66 -57.62 10.74 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.079 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -59.55 -35.4 74.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.061 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.407 ' HB3' ' HB2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -70.49 -40.53 73.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.153 0.502 . . . . 0.0 109.655 179.458 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.686 ' HB1' ' HB3' ' A' ' 75' ' ' LEU . . . -69.13 -38.83 79.07 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.45 179.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.435 ' HG3' HG21 ' A' ' 44' ' ' ILE . 0.5 OUTLIER -65.95 -30.67 71.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.865 179.239 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -79.72 -31.95 41.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.341 178.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.437 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 1.7 m -69.48 -35.39 75.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.33 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.833 HD12 ' N ' ' A' ' 88' ' ' ARG . 4.3 pp -78.72 -34.61 45.81 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.833 ' N ' HD12 ' A' ' 87' ' ' LEU . 5.0 mtp180 -61.4 -52.11 65.98 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 114.937 -1.028 . . . . 0.0 110.616 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.517 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.42 -33.48 67.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.993 179.613 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.443 ' N ' ' HD3' ' A' ' 89' ' ' ARG . 28.6 m -70.99 -29.54 65.55 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.46 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.942 ' HE2' HD22 ' A' ' 26' ' ' LEU . 2.3 ptp -88.94 -21.34 23.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.386 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.5 31.81 6.29 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.517 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.4 OUTLIER -160.01 -31.68 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 179.899 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.457 ' HG3' HG22 ' A' ' 93' ' ' THR . 5.1 mt-10 -115.88 -45.94 2.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.885 0.374 . . . . 0.0 111.239 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.478 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -73.34 -35.25 56.73 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.665 -0.778 . . . . 0.0 111.945 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.678 ' HB2' HD11 ' A' ' 18' ' ' LEU . 0.8 OUTLIER -71.25 -33.82 70.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.898 0.38 . . . . 0.0 110.089 179.568 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 93' ' ' THR . 49.3 mtpt -40.85 -32.59 0.23 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.739 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.15 -28.21 10.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.797 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 128.22 -8.88 6.66 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.731 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.486 ' SD ' ' HB3' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -154.38 144.44 21.9 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.962 0.411 . . . . 0.0 110.852 -179.847 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.615 HG22 HD21 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -107.2 144.63 15.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.597 -179.483 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.703 ' OE1' HG23 ' A' ' 13' ' ' THR . 0.8 OUTLIER -77.01 137.17 38.82 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.429 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.465 HD12 HG23 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -135.57 147.12 48.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.335 0.588 . . . . 0.0 112.198 -178.807 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.73 ' CD1' ' HB3' ' A' ' 69' ' ' ALA . 8.5 mt -140.45 112.63 4.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.311 178.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.888 HG12 HD23 ' A' ' 67' ' ' LEU . 28.1 m -122.47 176.61 4.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.056 0.455 . . . . 0.0 111.677 -178.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.686 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -147.48 132.67 18.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.561 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.609 ' CG ' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -142.33 -179.7 6.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.842 0.353 . . . . 0.0 111.212 -179.919 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.408 ' HA ' ' O ' ' A' ' 8' ' ' THR . 15.5 mtm-85 -95.8 142.88 27.54 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.125 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 44.0 mt -68.26 -22.48 27.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.074 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.332 -0.195 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.901 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . 0.407 ' CB ' ' HD2' ' A' ' 36' ' ' LYS . 39.7 m-20 . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.813 0.339 . . . . 0.0 110.915 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . 0.416 ' HA ' ' HB2' ' A' ' 33' ' ' ASN . 5.6 pt-20 -99.12 167.57 10.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.083 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.22 -65.7 0.64 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.914 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -130.57 -75.53 0.53 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.927 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -126.42 22.17 7.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.196 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 55.68 -159.7 0.2 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.095 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -164.44 121.0 1.58 Allowed 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.51 HD12 ' HG2' ' A' ' 47' ' ' LYS . 2.7 mm -94.45 145.94 7.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.197 0.522 . . . . 0.0 111.774 -178.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 55.0 m -140.36 106.63 5.25 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.484 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 9.2 ttmt -68.89 112.8 5.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.269 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.758 HG11 HD11 ' A' ' 87' ' ' LEU . 30.8 m . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.979 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 N-CA-C 112.484 -0.247 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.467 ' HG1' ' HG3' ' A' ' 108' ' ' ARG . 69.1 p 51.68 94.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.025 0.441 . . . . 0.0 111.191 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.3 mtp85 -153.38 136.33 15.46 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.596 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -156.86 152.58 26.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.917 0.389 . . . . 0.0 111.467 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.57 ' HD1' ' HB2' ' A' ' 106' ' ' ALA . 17.4 m-85 -94.88 144.06 25.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.264 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.59 HD11 ' HD2' ' A' ' 107' ' ' ARG . 0.1 OUTLIER -134.46 127.78 32.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.942 0.401 . . . . 0.0 111.606 -179.476 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 99.2 m -97.47 133.99 41.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.741 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.464 ' O ' ' N ' ' A' ' 103' ' ' LEU . 21.6 m-85 -140.71 148.19 40.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.268 0.556 . . . . 0.0 112.404 -179.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.425 ' HB3' ' SD ' ' A' ' 100' ' ' MET . 0.2 OUTLIER -112.39 111.5 22.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.401 -0.818 . . . . 0.0 108.928 178.727 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.801 HG21 HD11 ' A' ' 61' ' ' LEU . 21.2 t -103.41 111.22 64.97 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -177.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.735 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 86.4 Cg_endo -81.03 128.18 6.39 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.427 2.085 . . . . 0.0 111.014 178.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.926 HD22 HD13 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -126.22 29.39 5.83 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -178.85 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -37.43 -32.33 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.411 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -112.32 -34.1 6.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.248 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.606 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 10.5 t -67.03 -11.92 58.43 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.147 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.678 ' HA2' HD12 ' A' ' 18' ' ' LEU . . . -45.86 -28.58 2.8 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.737 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.1 t -81.68 -36.77 28.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.89 0.376 . . . . 0.0 110.67 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.17 -24.54 37.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.062 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.9 -52.59 0.7 Allowed Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.926 HD13 HD22 ' A' ' 18' ' ' LEU . 9.3 tp 179.15 -32.82 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.654 0.264 . . . . 0.0 110.796 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.13 43.11 1.42 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.969 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.62 ' N ' HD12 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -164.77 151.44 2.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.068 0.461 . . . . 0.0 111.343 179.738 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' B' ' 12' ' ' LYS . 0.0 OUTLIER -111.85 123.32 49.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.931 179.356 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.75 HG11 HD11 ' A' ' 67' ' ' LEU . 0.9 OUTLIER -112.43 141.36 28.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.895 0.379 . . . . 0.0 111.501 -179.534 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.04 130.29 25.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.648 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -96.75 144.18 17.18 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.851 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.415 ' O ' ' HA ' ' A' ' 41' ' ' ASP . 1.5 m-80 -94.4 -176.3 3.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.711 0.291 . . . . 0.0 110.624 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.3 mtt180 -142.67 148.86 38.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.906 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.473 ' HB2' HD21 ' A' ' 42' ' ' LEU . 8.3 t -66.59 137.05 56.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.938 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -67.09 -29.14 68.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.154 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -70.2 -50.36 40.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.976 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.574 ' OD1' ' HB2' ' A' ' 40' ' ' ALA . 10.4 p30 -141.28 165.32 27.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.756 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -70.48 66.05 0.31 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.908 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.574 ' HB2' ' OD1' ' A' ' 38' ' ' ASN . . . -120.33 119.06 32.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.94 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.415 ' HA ' ' O ' ' A' ' 33' ' ' ASN . 9.2 p-10 -53.4 142.57 21.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.175 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.473 HD21 ' HB2' ' A' ' 35' ' ' SER . 43.2 mt -107.27 3.94 26.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.392 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.444 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 113.92 160.33 13.59 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.524 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.677 HG13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -98.73 130.59 47.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.733 0.301 . . . . 0.0 111.063 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.15 142.4 47.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.808 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.611 ' O ' HG13 ' A' ' 63' ' ' VAL . 39.5 t -57.8 105.84 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.903 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.48 ' HG2' HG21 ' B' ' 10' ' ' ILE . 6.3 tptt -73.92 -41.42 62.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.106 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.2 m -171.89 123.35 0.52 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.913 0.387 . . . . 0.0 111.371 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.554 ' CD1' ' HB3' ' A' ' 61' ' ' LEU . 76.1 mt -85.66 110.95 20.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.068 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.62 HD12 ' N ' ' A' ' 28' ' ' VAL . 1.9 mp -48.74 104.01 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.774 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -62.16 75.38 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.778 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . 160.33 -28.79 0.34 Allowed Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.655 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.478 ' H ' HG22 ' A' ' 50' ' ' ILE . . . -70.11 -161.71 3.49 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.476 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.735 ' HB1' ' O ' ' A' ' 17' ' ' PRO . . . -76.41 -38.13 56.08 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.919 0.341 . . . . 0.0 111.919 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.736 ' HA ' HD13 ' A' ' 61' ' ' LEU . . . -62.64 -38.29 89.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.889 0.376 . . . . 0.0 111.022 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.6 t -78.03 -35.49 49.72 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.149 0.5 . . . . 0.0 109.736 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.5 mtpt -69.69 -31.34 69.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.813 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -64.47 -25.43 68.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.668 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.31 28.99 65.27 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.58 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.424 ' HB3' ' CG ' ' A' ' 14' ' ' PHE . 12.7 mtm180 -125.76 -32.33 2.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.729 0.3 . . . . 0.0 111.012 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.801 HD11 HG21 ' A' ' 16' ' ' VAL . 2.7 mp -68.94 147.26 51.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.093 0.473 . . . . 0.0 111.371 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 48.8 mtm-85 -142.96 123.74 14.21 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.508 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.611 HG13 ' O ' ' A' ' 46' ' ' VAL . 41.3 t -52.75 142.76 5.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.339 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.429 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 20.2 m-20 85.22 18.66 0.12 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.237 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.43 ' O ' HG23 ' A' ' 46' ' ' VAL . 3.4 m-20 -99.21 118.39 35.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.35 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 16.7 tm0? -74.39 126.16 30.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.945 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.912 HD23 HG12 ' A' ' 105' ' ' VAL . 73.5 mt -76.06 141.77 41.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.296 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.704 HD11 ' HB2' ' A' ' 106' ' ' ALA . 28.9 mt -123.85 -39.64 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.704 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 1.025 ' HB3' HD12 ' A' ' 104' ' ' ILE . . . -150.95 154.98 38.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.886 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.761 HG22 ' ND2' ' A' ' 71' ' ' ASN . 8.0 p -142.34 125.6 14.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.633 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.761 ' ND2' HG22 ' A' ' 70' ' ' VAL . 67.0 m-80 64.83 12.89 8.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.65 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.21 13.22 36.86 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.205 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.417 ' CG ' ' O ' ' A' ' 70' ' ' VAL . 4.9 pt-20 -128.18 112.2 14.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 117.036 0.418 . . . . 0.0 111.018 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.4 p -65.15 170.41 4.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.947 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.644 HD22 ' HB1' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -143.68 16.59 1.81 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.216 -179.799 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.8 tp -66.18 -21.31 66.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.628 0.251 . . . . 0.0 111.052 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -91.18 14.76 62.75 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.962 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.403 ' HD2' ' HB3' ' A' ' 75' ' ' LEU . 1.0 OUTLIER -139.35 163.76 31.65 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.403 0.621 . . . . 0.0 111.235 179.845 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.565 ' HB3' HE21 ' A' ' 81' ' ' GLN . . . -67.15 162.38 22.57 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.486 -179.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -55.9 -52.51 63.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.109 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.565 HE21 ' HB3' ' A' ' 79' ' ' ALA . 2.6 pp0? -59.29 -36.29 75.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.971 0.415 . . . . 0.0 110.524 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.58 -38.65 74.07 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.344 179.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.644 ' HB1' HD22 ' A' ' 75' ' ' LEU . . . -69.18 -34.92 75.68 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.128 179.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.594 ' HA ' HD21 ' A' ' 87' ' ' LEU . 1.0 OUTLIER -69.94 -29.45 66.59 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.9 179.043 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -78.01 -39.54 41.82 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.432 ' O ' ' HB2' ' A' ' 90' ' ' SER . 1.8 m -61.79 -37.47 84.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.082 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.684 ' HA ' HG11 ' A' ' 70' ' ' VAL . 3.5 pp -78.18 -33.54 50.06 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.533 ' N ' HD12 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -59.78 -52.0 67.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.668 179.074 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.508 ' O ' ' HB ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -72.85 -35.37 67.21 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.671 -179.909 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' ' 86' ' ' THR . 5.1 t -72.96 -29.85 63.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.851 0.357 . . . . 0.0 110.953 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.685 ' HE2' HD22 ' A' ' 26' ' ' LEU . 4.1 ptm -89.33 -18.23 27.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.283 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.28 29.71 6.59 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.508 ' HB ' ' O ' ' A' ' 89' ' ' ARG . 0.4 OUTLIER -162.26 -30.24 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 179.897 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.426 ' HG3' HG22 ' A' ' 93' ' ' THR . 6.6 mt-10 -116.82 -44.84 2.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.905 0.383 . . . . 0.0 111.197 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.4 ' HA3' ' HB ' ' A' ' 101' ' ' ILE . . . -69.98 -30.22 70.21 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.908 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.74 ' HB2' HD11 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -76.59 -35.13 58.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.885 0.374 . . . . 0.0 110.173 179.519 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' A' ' 93' ' ' THR . 26.9 mtpt -42.57 -40.12 2.56 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.421 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.08 -25.59 16.39 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.529 179.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' A' ' 17' ' ' PRO . . . 117.56 -3.1 17.95 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.907 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.425 ' SD ' ' HB3' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -160.85 144.06 13.12 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.895 0.379 . . . . 0.0 111.156 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.562 HG22 HD21 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -111.81 145.1 18.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.423 -179.666 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.0 150.42 33.9 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.476 HD12 HG23 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -146.65 113.51 6.1 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.85 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 1.025 HD12 ' HB3' ' A' ' 69' ' ' ALA . 36.1 mt -107.32 112.91 42.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.784 178.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.912 HG12 HD23 ' A' ' 67' ' ' LEU . 22.1 m -123.27 -179.44 2.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.501 -179.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.704 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -147.76 132.4 17.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.488 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.59 ' HD2' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -150.23 -178.75 6.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.962 0.411 . . . . 0.0 111.412 -179.614 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.467 ' HG3' ' HG1' ' A' ' 8' ' ' THR . 0.3 OUTLIER -80.22 141.16 35.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.889 -179.904 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 24.2 mt -73.19 -40.13 57.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.015 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.3 t . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.991 179.84 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.938 0.399 . . . . 0.0 110.843 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.11 168.96 8.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.819 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -102.73 36.63 2.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.7 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . 0.416 ' O ' ' HB2' ' B' ' 7' ' ' HIS . 20.6 mp0 63.83 129.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.746 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . 0.416 ' HB2' ' O ' ' B' ' 6' ' ' GLN . 51.6 m-70 68.06 -63.68 0.32 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.192 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 71.32 -156.86 0.11 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.75 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.13 147.15 2.02 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.48 HG21 ' HG2' ' A' ' 47' ' ' LYS . 1.6 mm -115.01 124.39 71.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.392 0.615 . . . . 0.0 111.264 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 20.5 m -96.47 97.76 9.69 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.665 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 29' ' ' SER . 13.6 ttmt -69.52 139.54 53.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.003 0.43 . . . . 0.0 111.145 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.564 HG23 ' O ' ' B' ' 13' ' ' VAL . 13.8 m . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.908 179.885 . . . . . . . . 1 1 . 1 stop_ save_